Citrus Sinensis ID: 012599
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 460 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VYY5 | 565 | Receptor-like serine/thre | yes | no | 0.934 | 0.761 | 0.540 | 1e-132 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.489 | 0.295 | 0.529 | 4e-60 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.489 | 0.317 | 0.527 | 7e-58 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.493 | 0.319 | 0.491 | 6e-57 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.493 | 0.316 | 0.495 | 7e-57 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.497 | 0.336 | 0.5 | 9e-57 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.493 | 0.348 | 0.491 | 2e-56 | |
| Q9XI96 | 699 | Proline-rich receptor-lik | no | no | 0.493 | 0.324 | 0.508 | 4e-56 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.493 | 0.315 | 0.491 | 5e-56 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.558 | 0.383 | 0.471 | 8e-56 |
| >sp|Q8VYY5|NCRK_ARATH Receptor-like serine/threonine-protein kinase NCRK OS=Arabidopsis thaliana GN=NCRK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 246/455 (54%), Positives = 321/455 (70%), Gaps = 25/455 (5%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK++V+ A L+ LI IQ+ G N+ CTC SS G++S+IL+ NCS SC+
Sbjct: 1 MKMRVETALAILLVLISIQQCY-------GGVSNYTCTCFSS--GNRSDILESNCSTSCN 51
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C P +W C+C A+G P +A +++CF SC C++G+ K +++S K+V
Sbjct: 52 CRP-----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKK--QYLSRKLV 104
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPE 179
+++LL C +L ++AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +
Sbjct: 105 IVILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRKSSVSQS 164
Query: 180 TRVEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 237
S GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GG
Sbjct: 165 KISISSS----VAGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGG 220
Query: 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297
SS VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK
Sbjct: 221 SSCVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGK 280
Query: 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
A RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+
Sbjct: 281 HAERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDV 340
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLM 416
KS+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS M
Sbjct: 341 KSTNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQM 400
Query: 417 SDVFSFGVVLLELITGRQPIHR-SITKGEESLVLW 450
SDVFSFGVVLLELITGR+PI + S KGEESLV+W
Sbjct: 401 SDVFSFGVVLLELITGRKPIQKPSNNKGEESLVIW 435
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (592), Expect = 4e-60, Method: Compositional matrix adjust.
Identities = 126/238 (52%), Positives = 160/238 (67%), Gaps = 13/238 (5%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 275 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 392
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 644
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (573), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 125/237 (52%), Positives = 161/237 (67%), Gaps = 12/237 (5%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIA 478
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 393
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 590
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 222 bits (565), Expect = 6e-57, Method: Compositional matrix adjust.
Identities = 116/236 (49%), Positives = 154/236 (65%), Gaps = 9/236 (3%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L T+ FS NI+G+GG VY+G+L DG++VAVK+ K G D F EV+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSG-QGDREFKAEVE 399
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC + RLL++E++PN L L G + W RV IA
Sbjct: 400 IISRVHHRHLVSLVGYCI----ADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIA 455
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
IG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+AK + + +
Sbjct: 456 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDS----TQTHVST 511
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + GEESLV W
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEW 567
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 221 bits (564), Expect = 7e-57, Method: Compositional matrix adjust.
Identities = 117/236 (49%), Positives = 155/236 (65%), Gaps = 9/236 (3%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L +G+ VAVK+ K +G + F EV
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLK-EGSSQGEREFQAEVG 400
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC A RLLV+EF+PN L L G M W +R+ IA
Sbjct: 401 IISRVHHRHLVALVGYCI----ADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIA 456
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 457 VGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 512
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+PI + + SLV W
Sbjct: 513 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDW 568
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 9e-57, Method: Compositional matrix adjust.
Identities = 118/236 (50%), Positives = 153/236 (64%), Gaps = 7/236 (2%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCI----SEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV W
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEW 555
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 116/236 (49%), Positives = 155/236 (65%), Gaps = 9/236 (3%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V L+GYC RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYCM----AGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV W
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDW 494
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 4e-56, Method: Compositional matrix adjust.
Identities = 120/236 (50%), Positives = 154/236 (65%), Gaps = 9/236 (3%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT FS ++GQGG YV++G L +G+ +AVK K G + F EV+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSG-QGEREFQAEVE 382
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYCS G+R LLV+EF+PN L L G M+W TR+ IA
Sbjct: 383 IISRVHHRHLVSLVGYCSNAGGQR---LLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIA 439
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNILLD N AK+ D G+AK L D S+
Sbjct: 440 LGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAK-LSQDNNTHVST--- 495
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGV+LLELITGR P+ S E+SLV W
Sbjct: 496 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDW 550
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 218 bits (556), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 116/236 (49%), Positives = 153/236 (64%), Gaps = 9/236 (3%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L T F+ NI+G+GG VY+G L DG++VAVK+ K G D F EV+
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSG-QGDREFKAEVE 417
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC + RLL++E++ N L L G + + W RV IA
Sbjct: 418 IISRVHHRHLVSLVGYCISDQ----HRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIA 473
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
IG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+A RL S+
Sbjct: 474 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA-RLNDTTQTHVST--- 529
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLEL+TGR+P+ ++ GEESLV W
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEW 585
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 126/267 (47%), Positives = 163/267 (61%), Gaps = 10/267 (3%)
Query: 184 VVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYR 243
V P A+ +T + T+ F+Y L AT+ F+ SN++GQGG YV++
Sbjct: 269 VSGPHSDASNLTGRTAIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHK 328
Query: 244 GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303
G L G+ VAVK K G + F EVD++SR+HH H+V LVGYC G RLL
Sbjct: 329 GVLPSGKEVAVKSLKLGSG-QGEREFQAEVDIISRVHHRHLVSLVGYC--ISG--GQRLL 383
Query: 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363
V+EF+PN L L G ++W TRV IA+G+ARGL YLHE PRI+HRDIK++NIL
Sbjct: 384 VYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANIL 443
Query: 364 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFG 423
LD + K+ D G+AK L D S+ R+ GTFGY APEYA G+ S SDVFSFG
Sbjct: 444 LDFSFETKVADFGLAK-LSQDNYTHVST---RVMGTFGYLAPEYASSGKLSDKSDVFSFG 499
Query: 424 VVLLELITGRQPIHRSITKGEESLVLW 450
V+LLELITGR P+ + + E+SLV W
Sbjct: 500 VMLLELITGRPPLDLT-GEMEDSLVDW 525
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 460 | ||||||
| 297746278 | 635 | unnamed protein product [Vitis vinifera] | 0.978 | 0.708 | 0.715 | 0.0 | |
| 359478364 | 628 | PREDICTED: receptor-like serine/threonin | 0.963 | 0.705 | 0.708 | 0.0 | |
| 255578119 | 625 | kinase, putative [Ricinus communis] gi|2 | 0.958 | 0.705 | 0.678 | 1e-179 | |
| 224106790 | 563 | predicted protein [Populus trichocarpa] | 0.969 | 0.792 | 0.684 | 1e-173 | |
| 224132516 | 532 | predicted protein [Populus trichocarpa] | 0.917 | 0.793 | 0.702 | 1e-170 | |
| 449456024 | 614 | PREDICTED: receptor-like serine/threonin | 0.978 | 0.732 | 0.610 | 1e-159 | |
| 356542635 | 612 | PREDICTED: receptor-like serine/threonin | 0.982 | 0.738 | 0.614 | 1e-158 | |
| 351725463 | 610 | protein kinase family protein precursor | 0.973 | 0.734 | 0.630 | 1e-158 | |
| 449519593 | 610 | PREDICTED: receptor-like serine/threonin | 0.971 | 0.732 | 0.602 | 1e-155 | |
| 351727637 | 612 | protein kinase family protein precursor | 0.967 | 0.727 | 0.607 | 1e-155 |
| >gi|297746278|emb|CBI16334.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 654 bits (1688), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 324/453 (71%), Positives = 376/453 (83%), Gaps = 3/453 (0%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+CD LS+ S W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLCDVLSDTSNINKWTCTCSSANQGSQNYILAGNCSTSCD 60
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 119
CSPA GGS+ +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 61 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 120
Query: 120 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 178
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 121 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 180
Query: 179 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 237
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 181 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 240
Query: 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 241 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 300
Query: 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 301 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 360
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 417
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 361 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 420
Query: 418 DVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
DVFSFGVVLLELI+GR+PIH+S KGEESLV+W
Sbjct: 421 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIW 453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478364|ref|XP_002282467.2| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/453 (70%), Positives = 372/453 (82%), Gaps = 10/453 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+C G W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLC-------GLNKWTCTCSSANQGSQNYILAGNCSTSCD 53
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 119
CSPA GGS+ +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 54 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 113
Query: 120 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 178
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 114 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 173
Query: 179 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 237
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 174 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 233
Query: 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 234 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 293
Query: 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 294 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 353
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 417
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 354 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 413
Query: 418 DVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
DVFSFGVVLLELI+GR+PIH+S KGEESLV+W
Sbjct: 414 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIW 446
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578119|ref|XP_002529929.1| kinase, putative [Ricinus communis] gi|223530559|gb|EEF32437.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 306/451 (67%), Positives = 360/451 (79%), Gaps = 10/451 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQV+V ACL+GLIWIQ+ +C G NW CTCS S QG+Q+ + K NCS SCD
Sbjct: 1 MKLQVEVALACLVGLIWIQQGLC-------GLNNWTCTCSLSSQGNQTYV-KSNCSTSCD 52
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C+P GGS + W C CAADGLP++A+ S+D+TCF +C CTSGSV+ + KH S KVV
Sbjct: 53 CNPVAGGSKDSTWGCTCAADGLPRIASGSHDSTCFTACNCTSGSVAQAQEKRKHFSGKVV 112
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI+LLLCVILTT+AFL + CYVYRK +S + SD+E S SATNLISH+ +S+ E
Sbjct: 113 VIILLLCVILTTLAFLASITCYVYRKDNCPFQSPIFISDRETSYTSATNLISHKASSLLE 172
Query: 180 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 239
T V + + ++ GCF + F R + I+GTI+RFSYS LEHAT FS SN++G GGSS
Sbjct: 173 TGVSIDTHLNPMPGCF-RRAFYRGSSDIINGTIVRFSYSELEHATKNFSNSNLIGLGGSS 231
Query: 240 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
YVYRGQL +G+ VA+KR QGGP+ADS+F EV++LSRLHHCHVVPL+G CSEF+GK +
Sbjct: 232 YVYRGQLRNGKTVAIKRLNAQGGPDADSLFSKEVEVLSRLHHCHVVPLLGCCSEFQGKHS 291
Query: 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359
RLLVFE+MPNGNLRDCLDG+ E M W+TRVAIAIGAARGLEYLHEAAAPRILHRD+KS
Sbjct: 292 KRLLVFEYMPNGNLRDCLDGISGESMKWETRVAIAIGAARGLEYLHEAAAPRILHRDVKS 351
Query: 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
+NILLDEN AKITDLGMAKRLKADG+PS SSSPARMQGTFGYFAPEYAMVGRASLMSDV
Sbjct: 352 TNILLDENWGAKITDLGMAKRLKADGVPSSSSSPARMQGTFGYFAPEYAMVGRASLMSDV 411
Query: 420 FSFGVVLLELITGRQPIHRSITKGEESLVLW 450
FSFGVVLLELI+GRQPIH+S KGEESLVLW
Sbjct: 412 FSFGVVLLELISGRQPIHKSTNKGEESLVLW 442
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106790|ref|XP_002314286.1| predicted protein [Populus trichocarpa] gi|222850694|gb|EEE88241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 612 bits (1579), Expect = e-173, Method: Compositional matrix adjust.
Identities = 315/460 (68%), Positives = 369/460 (80%), Gaps = 14/460 (3%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQ+KV A LIGLIWIQ++ +SG W CTCS+S QG+QS I K NCS SCD
Sbjct: 1 MKLQLKVALAFLIGLIWIQQA-------KSGINKWTCTCSASYQGNQSYI-KSNCSTSCD 52
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
CSP + G G WTC C++DGLPKVA DTTCF +C CTSG+ + + KH SSK+V
Sbjct: 53 CSPGMPG---GMWTCTCSSDGLPKVATGIQDTTCFTACNCTSGTWFLWQYTRKHFSSKIV 109
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
+++LLLCVILTT+AFL + CY+YRK K ++S V SD+E SCNSATNLISHR +SV E
Sbjct: 110 LVILLLCVILTTLAFLASITCYLYRKDKCLVQSPVFLSDRERSCNSATNLISHRASSVSE 169
Query: 180 TRVEVVSPIDLATGCFLKTTF-CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 238
T++ V SPI+ +GCF K +F CRSKT I G +I F+YS LEHAT+KFS SN++G GGS
Sbjct: 170 TKIRVDSPINPISGCFRKASFLCRSKTEIIQGNLILFTYSELEHATNKFSHSNLIGLGGS 229
Query: 239 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298
SYVY GQL DGR VAVKR K QGGP+AD +F TEV++L++LHHCHVVPL+GYCS+F+GK
Sbjct: 230 SYVYHGQLKDGRTVAVKRLKAQGGPDADFLFSTEVELLAKLHHCHVVPLLGYCSKFQGKF 289
Query: 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
+ RLLVFE+MPNGNLRDCLDGVL E MNW TRV IAIGAARGLEYLHE+AAPRILHRD+K
Sbjct: 290 SERLLVFEYMPNGNLRDCLDGVLGEKMNWQTRVTIAIGAARGLEYLHESAAPRILHRDVK 349
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
S+NIL+DEN AKITDLGMAKRL+ DG+PS SSPARMQGTFGYFAPEYAM+GRAS MSD
Sbjct: 350 STNILMDENWRAKITDLGMAKRLRGDGVPSSPSSPARMQGTFGYFAPEYAMIGRASPMSD 409
Query: 419 VFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIYLD 458
VFSFGVVLLELITGRQPIH+S KGEESLVLW AT + D
Sbjct: 410 VFSFGVVLLELITGRQPIHKSTNKGEESLVLW-ATPLLQD 448
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132516|ref|XP_002328308.1| predicted protein [Populus trichocarpa] gi|222837823|gb|EEE76188.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 605 bits (1561), Expect = e-170, Method: Compositional matrix adjust.
Identities = 302/430 (70%), Positives = 349/430 (81%), Gaps = 8/430 (1%)
Query: 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPAVGGSSEGKWTCICAADGLPKVAANSY 90
G NW CTCS+S QG+QS K NCS SCDC+ G S G WTC C+ DGLPKVAA S
Sbjct: 1 GINNWTCTCSASYQGNQS-YTKSNCSTSCDCT---GRQSRGTWTCTCSTDGLPKVAAGSQ 56
Query: 91 DTTCFASCTCTSGSVSGVKASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFH 150
DTTCF +C CTSGS++ +A+ KHISSK+VV V+LLCVILTT+AFL Y+ RK K
Sbjct: 57 DTTCFTACNCTSGSLTDAQATRKHISSKIVV-VILLCVILTTLAFLASTTWYLCRKDKCP 115
Query: 151 LRSSVISSDKE-SCNSATNLISHRITSVPETRVEVVSPIDLATGCFLKTTF-CRSKTWTI 208
++S SD+E SCNSATNLISHR +SV ET++ V SPI+ +GCF K +F CRSKT I
Sbjct: 116 IQSPTFLSDRETSCNSATNLISHRASSVSETKIRVDSPINPISGCFRKASFLCRSKTEII 175
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV 268
HGT+I F+YS LEHATDKFS SN++G GGSSYVYRGQL DG VAVKR K QGG +AD +
Sbjct: 176 HGTLICFAYSELEHATDKFSHSNLIGLGGSSYVYRGQLKDGTTVAVKRLKAQGGTDADLL 235
Query: 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD 328
F EV++L++LHHCHVVPL+GYCSEFRGK + RLLVFE+MPNGNLRDCLDG++ E MNW
Sbjct: 236 FSREVELLAKLHHCHVVPLLGYCSEFRGKLSERLLVFEYMPNGNLRDCLDGIMGENMNWQ 295
Query: 329 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
TRV IAIGAARGLEYLHEAAAPRILHRD+KS+NIL+DE AKITDLGMAKRL+ADG+PS
Sbjct: 296 TRVTIAIGAARGLEYLHEAAAPRILHRDVKSTNILMDELWRAKITDLGMAKRLRADGVPS 355
Query: 389 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
SSSPARMQGTFGYFAPEYAM+GRASLMSDVFSFGVVLLE+ITGRQPIH++ K EESLV
Sbjct: 356 SSSSPARMQGTFGYFAPEYAMIGRASLMSDVFSFGVVLLEVITGRQPIHKTTNKVEESLV 415
Query: 449 LWTATGIYLD 458
LW AT + D
Sbjct: 416 LW-ATPLLQD 424
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456024|ref|XP_004145750.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 567 bits (1460), Expect = e-159, Method: Compositional matrix adjust.
Identities = 277/454 (61%), Positives = 344/454 (75%), Gaps = 4/454 (0%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISHR +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHRSSSTPD 178
Query: 180 TRVEVVSPIDLATGCF-LKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 238
++V + SP++ GCF + R+K+ ++ G II+FSYS LE+AT+KFS S++VG+GGS
Sbjct: 179 SKVMMDSPVNNIKGCFFMNQCLLRTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGS 238
Query: 239 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298
S+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 239 SFVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKH 298
Query: 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 299 TERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVK 358
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
S+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SD
Sbjct: 359 STNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSD 418
Query: 419 VFSFGVVLLELITGRQPIHRSITKGEESLVLWTA 452
VFSFGVVLLELITG+ PIH+S KGEESL +W A
Sbjct: 419 VFSFGVVLLELITGQHPIHKSAGKGEESLAIWAA 452
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542635|ref|XP_003539772.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1457), Expect = e-158, Method: Compositional matrix adjust.
Identities = 284/462 (61%), Positives = 349/462 (75%), Gaps = 10/462 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A +I L+WIQ S CD+ SE S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVISLLWIQHSFCDENSETSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C + S WTC+C ++G P+VAA+ + CF++C CT G+VS S KH+SSK+V
Sbjct: 58 CH-SDSEESASVWTCVCDSNGFPQVAADGRSSNCFSTCNCTWGTVSRPGGSKKHVSSKIV 116
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSV 177
V++LL+CVI TT+AFL+ ++C+VYRK + ++S + S+DKE S S TNLISHR +SV
Sbjct: 117 VVILLICVICTTMAFLVSLICHVYRKDRCTIQSPIFSTDKETSSGSTTNLISHRSGASSV 176
Query: 178 PETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQG 236
PET+ + SPI TGCF K +F S T HG I FS + LE+AT+ FS SN++G G
Sbjct: 177 PETKYAINSPIYHITGCFQKASFLFGSPKETYHGNIFPFSLAELENATENFSSSNLIGVG 236
Query: 237 GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296
GSSYVY G+L DG VAVKR K QGGP ADS F E+++L+RLHHCH+VPL+GYCSE +G
Sbjct: 237 GSSYVYLGRLKDGSNVAVKRLKDQGGPEADSAFFKEIELLARLHHCHLVPLLGYCSELKG 296
Query: 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
K RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD
Sbjct: 297 KHVQRLLVFDYMANGNLRDCLDGVSGKHIDWATRVMIAIGAARGLEYLHEAAAPRILHRD 356
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM 416
+KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL
Sbjct: 357 VKSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLE 416
Query: 417 SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIYLD 458
SDVFSFGVVLLELI+GR PIH+S K EESLV+W AT + D
Sbjct: 417 SDVFSFGVVLLELISGRHPIHKSTGK-EESLVIW-ATPRFQD 456
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351725463|ref|NP_001237605.1| protein kinase family protein precursor [Glycine max] gi|223452292|gb|ACM89474.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 287/455 (63%), Positives = 345/455 (75%), Gaps = 7/455 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+ V A +I L+ IQ S CD+ S+ +G WKC CSS LQG++ L NCS+SCD
Sbjct: 1 MKPQLNVAVALVISLLCIQHSFCDEPSD-TGLNKWKCRCSS-LQGNKIYSLA-NCSKSCD 57
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C P ++ WTC C +G PKV A+ ++ +CF +C CT G+V S K ISSK+V
Sbjct: 58 CHPDAEENA-SIWTCECDPNGFPKVTADVHNLSCFNACNCTWGTVRKPLGSKKQISSKIV 116
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI L +CVI TTIAFL V+C+VYR+ K ++S +ISSDKE S +S TNLISHR +SVPE
Sbjct: 117 VIFLSICVICTTIAFLTSVVCHVYRRDKGPIQSPMISSDKETSYSSTTNLISHRTSSVPE 176
Query: 180 TRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 238
T+V + SPI TGCF K S+ T HG II+FS++ LE+AT+ FS SN++G GGS
Sbjct: 177 TKVAITSPISHITGCFQKAALLFGSQRETFHGNIIQFSFAELENATENFSTSNLIGLGGS 236
Query: 239 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298
SYVYRG+L DG VAVKR K Q GP ADS F TE+++LSRLHHCH+VPLVGYCSE +GK
Sbjct: 237 SYVYRGRLKDGSNVAVKRIKDQRGPEADSEFFTEIELLSRLHHCHLVPLVGYCSELKGKN 296
Query: 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
RLLVFE+M NGNLRD LDG+L + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 297 VQRLLVFEYMTNGNLRDRLDGILGQKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVK 356
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
S+NILLD+N AKITDLGMAK L+AD PSCS SPARMQGTFGYFAPEYA+VGRASL SD
Sbjct: 357 STNILLDKNWQAKITDLGMAKNLRADDHPSCSDSPARMQGTFGYFAPEYAIVGRASLESD 416
Query: 419 VFSFGVVLLELITGRQPIHRSITKGEESLVLWTAT 453
VFSFGVVLLELI+GRQPIH+S K EESLV+W +
Sbjct: 417 VFSFGVVLLELISGRQPIHKSAGK-EESLVIWATS 450
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519593|ref|XP_004166819.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1432), Expect = e-155, Method: Compositional matrix adjust.
Identities = 273/453 (60%), Positives = 341/453 (75%), Gaps = 6/453 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISH+ +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHKSSSTPD 178
Query: 180 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 239
++V + SP++ G + +K+ ++ G II+FSYS LE+AT+KFS S++VG+GGSS
Sbjct: 179 SKVMMDSPVNNIKGVLV---LLGTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGSS 235
Query: 240 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 236 FVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKHT 295
Query: 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 296 ERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVKS 355
Query: 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SDV
Sbjct: 356 TNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSDV 415
Query: 420 FSFGVVLLELITGRQPIHRSITKGEESLVLWTA 452
FSFGVVLLELITG+ PIH+S KGEESL +W A
Sbjct: 416 FSFGVVLLELITGQHPIHKSAGKGEESLAIWAA 448
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727637|ref|NP_001235120.1| protein kinase family protein precursor [Glycine max] gi|223452424|gb|ACM89539.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1430), Expect = e-155, Method: Compositional matrix adjust.
Identities = 276/454 (60%), Positives = 342/454 (75%), Gaps = 9/454 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A ++ L+WIQ+S CD+ S+ S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVVSLLWIQQSFCDETSDTSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C + S WTC+C ++G P+VAA+ + + CF +C CT G+ S S KH+SSK+V
Sbjct: 58 CF-SDSEESASVWTCVCDSNGFPQVAADGHSSNCFNACNCTWGTFSRPGGSKKHVSSKIV 116
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSV 177
V++LL+CVI TT+AFL+ ++C+VYRK + + S + S DKE S S TNLISHR +SV
Sbjct: 117 VVILLICVICTTMAFLVSLICHVYRKDRCTIHSPIFSMDKETSSGSTTNLISHRSGTSSV 176
Query: 178 PETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQG 236
PET+ + SPI TGCF K +F + T HG I FS + LE+AT+ FS SN++G G
Sbjct: 177 PETKYAMNSPIYHITGCFQKASFFFGNPKETYHGNIFPFSLAELENATENFSSSNLIGVG 236
Query: 237 GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296
GSSYVY G+L DG VAVKR K QGG ADS F E+++L+RLHHCH+VPL+GYCSE +G
Sbjct: 237 GSSYVYLGRLKDGSNVAVKRLKDQGGSEADSAFFKEIELLARLHHCHLVPLLGYCSELKG 296
Query: 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
K RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD
Sbjct: 297 KHVQRLLVFDYMANGNLRDCLDGVSGKHVDWATRVMIAIGAARGLEYLHEAAAPRILHRD 356
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM 416
+KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL
Sbjct: 357 VKSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLE 416
Query: 417 SDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
SDVFSFGVVLLELI+GR PIH+S K EESLV+W
Sbjct: 417 SDVFSFGVVLLELISGRHPIHKSTGK-EESLVIW 449
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 460 | ||||||
| TAIR|locus:2062824 | 565 | NCRK [Arabidopsis thaliana (ta | 0.934 | 0.761 | 0.525 | 4.9e-117 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.571 | 0.362 | 0.475 | 1.1e-57 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.489 | 0.295 | 0.529 | 6.8e-56 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.489 | 0.317 | 0.527 | 3.7e-55 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.497 | 0.336 | 0.5 | 8.9e-54 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.493 | 0.350 | 0.504 | 1.1e-53 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.493 | 0.324 | 0.508 | 2.4e-53 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.493 | 0.319 | 0.504 | 2.4e-53 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.493 | 0.348 | 0.495 | 2.4e-53 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.484 | 0.299 | 0.481 | 4.9e-53 |
| TAIR|locus:2062824 NCRK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1153 (410.9 bits), Expect = 4.9e-117, P = 4.9e-117
Identities = 238/453 (52%), Positives = 309/453 (68%)
Query: 3 LQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS 62
++++V A I L+ I C G N+ CTC SS G++S+IL+ NCS SC+C
Sbjct: 1 MKMRVETALAILLVLISIQQC-----YGGVSNYTCTCFSS--GNRSDILESNCSTSCNCR 53
Query: 63 PAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTXXXXXXXXXXXXHISSKXXXX 122
P +W C+C A+G P +A +++CF SC C+ ++S K
Sbjct: 54 P-----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKKQ--YLSRKLVIV 106
Query: 123 XXXXXXXXXXXAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPETR 181
AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +SV +++
Sbjct: 107 ILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRK-SSVSQSK 165
Query: 182 VEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 239
+ + S + GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GGSS
Sbjct: 166 ISISSSV---AGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGGSS 222
Query: 240 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK A
Sbjct: 223 CVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKHA 282
Query: 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359
RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 283 ERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVKS 342
Query: 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSD 418
+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS MSD
Sbjct: 343 TNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMSD 402
Query: 419 VFSFGVVLLELITGRQPIHR-SITKGEESLVLW 450
VFSFGVVLLELITGR+PI + S KGEESLV+W
Sbjct: 403 VFSFGVVLLELITGRKPIQKPSNNKGEESLVIW 435
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 1.1e-57, P = 1.1e-57
Identities = 135/284 (47%), Positives = 175/284 (61%)
Query: 173 RITSVPETRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRF-SYSALEHATDKFSGSN 231
R P+ E V P +L G F + H RF SY L+ AT F ++
Sbjct: 333 REEKAPDPHKEAVKPRNLDAGSFGGSL--------PHPASTRFLSYEELKEATSNFESAS 384
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
I+G+GG VYRG L DG VA+K+ T GGP D F E+DMLSRLHH ++V LVGY
Sbjct: 385 ILGEGGFGKVYRGILADGTAVAIKKL-TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYY 443
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN----WDTRVAIAIGAARGLEYLHEA 347
S R + LL +E +PNG+L L G L G+N WDTR+ IA+ AARGL YLHE
Sbjct: 444 SS-RDS-SQHLLCYELVPNGSLEAWLHGPL--GLNCPLDWDTRMKIALDAARGLAYLHED 499
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ P ++HRD K+SNILL+ N NAK+ D G+AK+ +G + S+ R+ GTFGY APEY
Sbjct: 500 SQPSVIHRDFKASNILLENNFNAKVADFGLAKQAP-EGRGNHLST--RVMGTFGYVAPEY 556
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWT 451
AM G + SDV+S+GVVLLEL+TGR+P+ S G+E+LV WT
Sbjct: 557 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWT 600
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 6.8e-56, P = 6.8e-56
Identities = 126/238 (52%), Positives = 160/238 (67%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 275 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 392
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEW 644
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 569 (205.4 bits), Expect = 3.7e-55, P = 3.7e-55
Identities = 125/237 (52%), Positives = 161/237 (67%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGEK-SVLDWATRVKIA 478
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 393
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV W
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 590
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.9e-54, P = 8.9e-54
Identities = 118/236 (50%), Positives = 153/236 (64%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCIS----EQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV W
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEW 555
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
Identities = 119/236 (50%), Positives = 157/236 (66%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSG-QGEREFQAEVE 321
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC G A RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 322 IISRVHHRHLVSLVGYC--IAG--AKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIA 377
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 378 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 433
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV W
Sbjct: 434 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDW 489
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 2.4e-53, P = 2.4e-53
Identities = 120/236 (50%), Positives = 154/236 (65%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT FS ++GQGG YV++G L +G+ +AVK K G + F EV+
Sbjct: 324 FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSG-QGEREFQAEVE 382
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYCS G+R LLV+EF+PN L L G M+W TR+ IA
Sbjct: 383 IISRVHHRHLVSLVGYCSNAGGQR---LLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKIA 439
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNILLD N AK+ D G+AK L D S+
Sbjct: 440 LGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAK-LSQDNNTHVST--- 495
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGV+LLELITGR P+ S E+SLV W
Sbjct: 496 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDM-EDSLVDW 550
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 2.4e-53, P = 2.4e-53
Identities = 119/236 (50%), Positives = 156/236 (66%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L T+ FS NI+G+GG VY+G+L DG++VAVK+ K G D F EV+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSG-QGDREFKAEVE 399
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC + RLL++E++PN L L G + W RV IA
Sbjct: 400 IISRVHHRHLVSLVGYCIA----DSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIA 455
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
IG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+AK L D + S+
Sbjct: 456 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LN-DSTQTHVST-- 511
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + GEESLV W
Sbjct: 512 RVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEW 567
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 552 (199.4 bits), Expect = 2.4e-53, P = 2.4e-53
Identities = 117/236 (49%), Positives = 156/236 (66%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V L+GYC G RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYC--MAG--VQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV W
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDW 494
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
Identities = 114/237 (48%), Positives = 158/237 (66%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 333
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A+ +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHIST-- 504
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV W
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTW 560
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8VYY5 | NCRK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5406 | 0.9347 | 0.7610 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024559001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (580 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 460 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-20 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+GG VY + G+ VA+K K + + L E+++L +L+H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ LV E+ G+L+D L ++ D + I + GLEYLH
Sbjct: 61 EDENH----LYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 352 ILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-YAM 409
I+HRD+K NILLD N K+ D G++K L +D + + GT Y APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-----IVGTPAYMAPEVLLG 167
Query: 410 VGRASLMSDVFSFGVVLLEL 429
G S SD++S GV+L EL
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 78/210 (37%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G VY+ + G+IVAVK K + D E+ +L RL H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 347
F K + LV E+ G+L D L G ++ D IA+ RGLEYLH
Sbjct: 66 A---FEDKDHL-YLVMEYCEGGDLFD----YLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 406
I+HRD+K NILLDEN KI D G+AK SSS GT Y APE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAK------KLLKSSSSLTTFVGTPWYMAPE 168
Query: 407 YAMVGR-ASLMSDVFSFGVVLLELITGRQP 435
+ G DV+S GV+L EL+TG+ P
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 6e-40
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G+G VY + G++VA+K K + L E+ +L +L H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
E K + V E+ G+L D L G L E A LEYLH
Sbjct: 65 VF-EDEDKLYL---VMEYCEGGDLFDLLKKRGRLSE------DEARFYLRQILSALEYLH 114
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
I+HRD+K NILLDE+ + K+ D G+A++L + GT Y AP
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT------TFVGTPEYMAP 165
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQP 435
E + D++S GV+L EL+TG+ P
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-39
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 241 VYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295
VY+G L VAVK K FL E ++ +L H ++V L+G C+E
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-- 72
Query: 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355
+ M +V E+MP G+L D L + ++ ++ A+ ARG+EYL +HR
Sbjct: 73 EEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHR 127
Query: 356 DIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRA 413
D+ + N L+ ENL KI+D G+++ L D P R + APE G+
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR------WMAPESLKEGKF 181
Query: 414 SLMSDVFSFGVVLLELIT-GRQP 435
+ SDV+SFGV+L E+ T G +P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 241 VYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295
VY+G+L VAVK K FL E ++ +L H +VV L+G C+E
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE-- 72
Query: 296 GKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+V E+M G+L L L + ++ A+ ARG+EYL
Sbjct: 73 --EEPLYIVMEYMEGGDLLSYLRKNRPKL----SLSDLLSFALQIARGMEYLESK---NF 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMV 410
+HRD+ + N L+ ENL KI+D G+++ L D P R + APE
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------WMAPESLKE 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
G+ + SDV+SFGV+L E+ T G QP
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 1e-36
Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 40/238 (16%)
Query: 231 NIVGQG--GSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G+G G VY+G+L VAVK K FL E ++ +L H +V
Sbjct: 1 KKLGEGAFGE--VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGA 337
V L+G C+E LV E+M G+L R ++ ++ AI
Sbjct: 59 VRLLGVCTE----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PA 394
A+G+EYL + +HRD+ + N L+ E+L KI+D G+++ + D + P
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 443
R + APE G + SDV+SFGV+L E+ T G P + + KG
Sbjct: 172 R------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG 223
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLV 288
++G+G VY D G ++AVK + G + L E+ +LS L H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 289 GYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRV-AIAIGAARGLEYL 344
G R + L +F E++ G+L L G L E + R I GL YL
Sbjct: 66 GSE---RDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQI--LEGLAYL 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H I+HRDIK +NIL+D + K+ D G AKRL + S ++GT + A
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS---VRGTPYWMA 171
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
PE +D++S G ++E+ TG+ P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 234 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
G+G G VY+G L VAVK K FL E ++ +L H ++V
Sbjct: 8 GEGAFGE--VYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L+G C++ G+ +V E+MP G+L D L L + +A+ A+G+EY
Sbjct: 66 LLGVCTQ--GEPLY--IVTEYMPGGDLLDFLRKHGEKL----TLKDLLQMALQIAKGMEY 117
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L +HRD+ + N L+ ENL KI+D G+++ + D R +G G
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-------YRKRGG-GKL 166
Query: 404 -----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE G+ + SDV+SFGV+L E+ T G QP
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+GG VY+ G+ VA+K K + + + + E+ +L + H ++V Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI-INEIQILKKCKHPNIVKY--YG 64
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S + +V EF G+L+D L + + + +GLEYLH
Sbjct: 65 SYLKKDELW--IVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN---G 118
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 409
I+HRDIK++NILL + K+ D G++ +L S + AR M GT + APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQL--------SDTKARNTMVGTPYWMAPEVIN 170
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRS 439
+D++S G+ +EL G+ P
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCH 283
+ +++G+G VY+G L G VA+K+ + + E+D+L L H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA-RG 340
+V +G ++ ++ E+ NG+LR + G E + VA+ + +G
Sbjct: 61 IVKYIGS---IETSDSL-YIILEYAENGSLRQIIKKFGPFPE-----SLVAVYVYQVLQG 111
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLHE ++HRDIK++NIL ++ K+ D G+A +L S GT
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-----VGTP 163
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ APE + AS SD++S G ++EL+TG P +
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY 200
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 230 SNIVGQG--GSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G+G G + R G VAVK G S F E+++L L H ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V G E G R++RL + E++P+G+LRD L + +N + + +G++YL
Sbjct: 69 VKYKG-VCEKPGGRSLRL-IMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYL 125
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----LPSCSSSPARMQGTF 400
R +HRD+ + NIL++ KI+D G+AK L D + SP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----- 177
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
++APE + S SDV+SFGV L EL T
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (279), Expect = 3e-27
Identities = 71/226 (31%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRL-HHCHVVPLVG 289
+G+G VY + D ++VA+K + + V FL E+ +L+ L H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 348
+ + LV E++ G+L D L + +G ++ + I LEYLH
Sbjct: 66 FFQDEGSL----YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 349 APRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 406
I+HRDIK NILLD + K+ D G+AK L G S + GT GY APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 407 YAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
+ + AS SD++S G+ L EL+TG P S L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 37/226 (16%)
Query: 233 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G V+ G+ D +VAVK K +A F E ++L+ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR-------VAIA 334
G C+E G + +VFE+M +G+L L D ++ + + IA
Sbjct: 73 FYGVCTE--GDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+ A G+ YL A+ +HRD+ + N L+ +L KI D GM++ + ++
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYY 178
Query: 395 RMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
R+ G + PE M + + SDV+SFGVVL E+ T G+QP
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 68/208 (32%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 234 GQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-YC 291
GQG S VY+ + G+I A+K+ G L E+ L +VV G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVA-IAIGAARGLEYLHEAA 348
E G+ + +V E+M G+L D L G + E + +A IA +GL+YLH
Sbjct: 70 KE--GEIS---IVLEYMDGGSLADLLKKVGKIPEPV-----LAYIARQILKGLDYLHTKR 119
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
I+HRDIK SN+L++ KI D G++K L + L C++ GT Y +PE
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTF----VGTVTYMSPE-R 171
Query: 409 MVGRA-SLMSDVFSFGVVLLELITGRQP 435
+ G + S +D++S G+ LLE G+ P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 37/227 (16%)
Query: 233 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G VY+G+LT VA+K K P F E +++S L H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVA 332
L+G C+ K ++FE++ +G+L + L D + ++ +
Sbjct: 73 LLGVCT----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-KAD--GLPSC 389
IAI A G+EYL ++ +HRD+ + N L+ E L KI+D G+++ + AD + S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
S P R + PE + G+ + SD++SFGVVL E+ + G QP
Sbjct: 186 SLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 72/208 (34%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G G V+ G VAVK K G P A FL E ++ +L H +V L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEA---FLQEAQIMKKLRHDKLVQLYAVC 70
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEG--MNWDTRVAIAIGAARGLEYLHEAA 348
SE +V E+M G+L D L G EG + V +A A G+ YL
Sbjct: 71 SE----EEPIYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
+HRD+ + NIL+ ENL KI D G+A+ ++ D + + ++ T APE A
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 409 MVGRASLMSDVFSFGVVLLELIT-GRQP 435
GR ++ SDV+SFG++L E++T GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 280
E ++F+ +G G V+ G + VA+K K+ F EV L RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLR 60
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 338
H H++ L CS ++ E M G+L L EG I + A
Sbjct: 61 HKHLISLFAVCSVGEPV----YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVA 114
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQ 397
G+ YL E +HRD+ + NIL+ E+L K+ D G+A+ +K D L S P +
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-- 169
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
+ APE A G S SDV+SFG++L E+ T
Sbjct: 170 ----WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 67/222 (30%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 230 SNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPL 287
N +G G VY L G ++AVK + Q P E+ +L L H ++V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV-- 62
Query: 288 VGYCSEFRGKRAMR--LLVF-EFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLE 342
++ G R + +F E+ G L + +L G D V + GL
Sbjct: 63 -----KYYGVEVHREKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQLLEGLA 113
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH I+HRDIK +NI LD N K+ D G A +LK + + GT Y
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-MGEEVQSLAGTPAY 169
Query: 403 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
APE GRA +D++S G V+LE+ TG++P
Sbjct: 170 MAPEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 45/224 (20%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLV 288
+G+G VY+ + G +VA+K+ + + + + E+ +L +L H ++V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 289 G-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 339
S+ +G M VFE+M + D L G+L V +
Sbjct: 65 EIVTSKGKGSIYM---VFEYMDH----D-LTGLLDS-----PEVKFTESQIKCYMKQLLE 111
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL+YLH ILHRDIK SNIL++ + K+ D G+A+ ++ R+ T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN---RVI-T 164
Query: 400 FGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPI 436
Y PE Y G D++S G +L EL G+ PI
Sbjct: 165 LWYRPPELLLGATRY---GPE---VDMWSVGCILAELFLGK-PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G+G V G G+ VAVK K A + FL E +++ L H ++V L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTA-AQA-FLAEASVMTTLRHPNLVQLLGVV- 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+G +V E+M G+L D L + ++ A+ G+EYL E
Sbjct: 70 -LQGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAK--RLKADG--LPSCSSSPARMQGTFGYFAPEYA 408
+HRD+ + N+L+ E+L AK++D G+AK D LP + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------------VKWTAPEAL 171
Query: 409 MVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438
+ S SDV+SFG++L E+ + GR P R
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 19/233 (8%)
Query: 227 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHV 284
F N +G+G V++ + D R+ A+K+ + + E +L++L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
+ Y F K + + V E+ NG+L L + D I GL +L
Sbjct: 62 IR---YYESFLDKGKLNI-VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYF 403
H + +ILHRDIKS N+ LD N KI DLG+AK L S +++ A + GT Y
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIVGTPYYL 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIY 456
+PE + SDV++ GVVL E TG+ P + +L+L G++
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILKIIRGVF 218
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 68/208 (32%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G +VAVK K + G S + E+++L L+H ++V G CSE GK L+ E++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL--QLIMEYV 90
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
P G+LRD L +N + A G+ YLH + +HRD+ + N+LLD +
Sbjct: 91 PLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDR 144
Query: 369 NAKITDLGMAK---------RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
KI D G+AK R++ DG SP ++A E + S SDV
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDG-----DSPVF------WYAVECLKENKFSYASDV 193
Query: 420 FSFGVVLLELITGRQPIHRSITKGEESL 447
+SFGV L EL+T K EE +
Sbjct: 194 WSFGVTLYELLTHCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G+G VY+G L VAVK ++ P+ FL E ++L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ + +V E +P G+L L + + +++ AA G+EYL +
Sbjct: 63 Q----KQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 412
+HRD+ + N L+ EN KI+D GM+ R + G+ + S Q + APE GR
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-REEEGGIYTVSD--GLKQIPIKWTAPEALNYGR 171
Query: 413 ASLMSDVFSFGVVLLELITG 432
+ SDV+S+G++L E +
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 62/183 (33%), Positives = 93/183 (50%), Gaps = 9/183 (4%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G +VAVK+ + F E+++L L H ++V G C G+R +RL V E++
Sbjct: 33 GEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLRL-VMEYL 89
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
P G+LRD L E ++ + A +G+EYL + R +HRD+ + NIL++
Sbjct: 90 PYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESEN 145
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
KI D G+ K L D P + ++APE + S+ SDV+SFGVVL E
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPG--ESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 429 LIT 431
L T
Sbjct: 204 LFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G + VAVK K G FL E ++ +L H ++ L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+V E M G+L + L G + + +A A G+ YL A
Sbjct: 72 ----LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNY 124
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD+ + N+L+ EN K+ D G+A+ +K D AR F + APE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGAKFPIKWTAPEAALY 178
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
R S+ SDV+SFG++L E++T GR P
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+GQG V+ G VA+K K G + FL E ++ +L H +V L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
E +V E+M G+L D L G + + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ ENL K+ D G+A RL D + AR F + APE A+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
GR ++ SDV+SFG++L EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 71/206 (34%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+GQG V+ G VA+K K G FL E ++ +L H +VPL S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
E +V EFM G+L D L + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ +NL KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
GR ++ SDV+SFG++L EL+T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-21
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G VAVK K G + FL E ++ +L H +V L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
E +V E+M G+L D L + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++S+NIL+ + L KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
GR ++ SDV+SFG++L EL+T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 6e-21
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 40/219 (18%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHCHVVPLVGY 290
+G+G VY + +DG++ +K + L EV +L +L+H +++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII---KY 64
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--------MNWDTRVAIAIGAARGLE 342
F K + +V E+ G+L + EG ++W ++ +A L+
Sbjct: 65 YESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LK 117
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH +ILHRDIK NI L N K+ D G++K L + + + + GT Y
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKT----VVGTPYY 169
Query: 403 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE Y + SD++S G VL EL T + P
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ + +G+G S VY+ G+ VA+K+ + + + + E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHP 75
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGL 341
++V +V E+M G+L D + V MN + ++A +GL
Sbjct: 76 NIVDYYD-SYLVGD---ELWVVMEYMDGGSLTDIITQNFVR-MN-EPQIAYVCREVLQGL 129
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH + ++HRDIKS NILL ++ + K+ D G A +L + S + GT
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSVVGTPY 181
Query: 402 YFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQP 435
+ APE V + D++S G++ +E+ G P
Sbjct: 182 WMAPE---VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 59/172 (34%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 270 LTEVDMLSRLHHCHVVP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN 326
L E +L L+H P LV F+ + M LV + + G+LR L E
Sbjct: 48 LNERRILQELNH----PFLVNLWYSFQDEENM-YLVVDLLLGGDLRYHLSQKVKFSEEQ- 101
Query: 327 WDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
+ I I A LEYLH I+HRDIK NILLDE + ITD +A ++ D
Sbjct: 102 --VKFWICEIVLA--LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
L + +S GT GY APE S+ D +S GV E + G++P
Sbjct: 155 LTTSTS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHHC 282
+K+ +VG+G V + + G IVA+K+FK + + L EV +L +L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 283 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
++V L +R RL LVFE++ L + L+ G+ D + + +
Sbjct: 61 NIVNLKEAF-----RRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAI 113
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H + I+HRDIK NIL+ E+ K+ D G A+ L+A + A T
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA----TRW 166
Query: 402 YFAPE----YAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE G+ DV++ G ++ EL+ G
Sbjct: 167 YRAPELLVGDTNYGKP---VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 231 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G V RG+L VA+K K FLTE ++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG---MNWDTRVAIAIGAARGLEY 343
L G + + + M ++ E+M NG LD L E V + G A G++Y
Sbjct: 70 LEGVVT--KSRPVM--IITEYMENG----SLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-ADGLPSCSS--SPARMQGTF 400
L E +HRD+ + NIL++ NL K++D G+++RL+ ++ + P R
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----- 173
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ APE + + SDV+SFG+V+ E+++ G +P
Sbjct: 174 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 15/215 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+K + +G+G V + +L G I A+K T P+ L E+++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGL 341
+V G + + + E+ G+L V G +V IA +GL
Sbjct: 61 IVKYYGAFLD--ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
YLH +I+HRDIK SNILL K+ D G++ L +S GT
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSF 168
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
Y APE S+ SDV+S G+ LLE+ R P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-20
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+GG V Q+ G++ A K R K + G + + L E +L ++ +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVS 57
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
L Y E + LV M G+L+ + V G + A GLE+LH+
Sbjct: 58 L-AYAFETKDDLC---LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
RI++RD+K N+LLD++ N +I+DLG+A LK GT GY APE
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPE 164
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
D F+ G L E+I GR P + K E
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 5e-20
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 237 GSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
G ++ + + T G I A+K K N LTE D+LS+ +VV L Y S F
Sbjct: 7 GRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYS-F 62
Query: 295 RGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARGLEYLHEAAAPR 351
+GK+ + LV E++P G+L L+ G L E + R+ IA I A LEYLH
Sbjct: 63 QGKKNL-YLVMEYLPGGDLASLLENVGSLDEDV---ARIYIAEIVLA--LEYLHSNG--- 113
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAK---RLKADGLPSCSSSPARMQGTFGYFAPEYA 408
I+HRD+K NIL+D N + K+TD G++K + L R+ GT Y APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-V 172
Query: 409 MVGRA-SLMSDVFSFGVVLLELITGRQPIH 437
++G+ S D +S G +L E + G P H
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 46/237 (19%)
Query: 232 IVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G +G VA+K + + P A+ L E +++ + H HVV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 339
L+G C + L+ + MP G L +D + + +NW ++A +
Sbjct: 74 LLGICL---SSQVQ--LITQLMPLGCLLDYVRNHKDNIGSQYL--LNWCVQIA------K 120
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARM 396
G+ YL E R++HRD+ + N+L+ + KITD G+AK L D P +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK- 176
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGE 444
+ A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 177 -----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 39/230 (16%)
Query: 233 VGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+ +Y+G L ++VA+K K P F E +++ LHH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---------------DGVLVEGMNWDTRVA 332
+G ++ ++FE++ G+L + L DG + ++ +
Sbjct: 73 LGVVTQ----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
IAI A G+EYL ++ +H+D+ + NIL+ E L+ KI+DLG+++ + S+
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-------SAD 178
Query: 393 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437
R+Q + PE M G+ S SD++SFGVVL E+ + G QP +
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 63/189 (33%), Positives = 92/189 (48%), Gaps = 28/189 (14%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNW 327
LTE ++LSR++H +V L + + F+ + + LV E+ P G L L G E
Sbjct: 41 LTERNILSRINHPFIVKL--HYA-FQTEEKL-YLVLEYAPGGELFSHLSKEGRFSEE--- 93
Query: 328 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
R A I A LEYLH I++RD+K NILLD + + K+TD G+AK L ++G
Sbjct: 94 RARFYAAEIVLA--LEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 438
++ GT Y APE + D +S GV+L E++TG+ P I+
Sbjct: 148 SRTNT----FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
Query: 439 SITKGEESL 447
I K
Sbjct: 204 KILKDPLRF 212
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
I+G+G V +G+ T G+ VAVK K A FL E ++++LHH ++V L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
G +V E M GNL + L ++ + ++ A G+EYL + +
Sbjct: 69 LH-NGLY----IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 411
++HRD+ + NIL+ E+ AK++D G+A R+ + G+ + S P + + APE
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDN-SKLPVK------WTAPEALKHK 172
Query: 412 RASLMSDVFSFGVVLLELIT-GRQP 435
+ S SDV+S+GV+L E+ + GR P
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 25/209 (11%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G + R VA+K + G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
E R+ LVFEFM +G L D L G + +T + + + G+ YL +
Sbjct: 70 E----RSPICLVFEFMEHGCLSDYLRAQRGKFSQ----ETLLGMCLDVCEGMAYLESSN- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEY 407
++HRD+ + N L+ EN K++D GM + + D S + + P + + +PE
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEV 172
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S SDV+SFGV++ E+ + G+ P
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G G S V + G+I+AVK + + L E+D+L H C+ +VG+
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDIL---HKCNSPYIVGFYG 66
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW-DTRV--AIAIGAARGLEYLHEAAA 349
F + + + E+M G LD +L E R+ IA+ +GL YLHE
Sbjct: 67 AFYNNGDISICM-EYMDGG----SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCSS--SPARMQGTFGYFA 404
+I+HRD+K SNIL++ K+ D G++ +L A SS +P R+QG Y
Sbjct: 121 -KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN-DY-- 176
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
S+ SD++S G+ L+EL TGR P
Sbjct: 177 ---------SVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 34/214 (15%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G+G VY+ + L+D + A+K D+V E+ +L+ ++H +++
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--NEIRILASVNHPNII---S 63
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNL------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
Y F + +V E+ P G+L R ++ E W I I RGL+
Sbjct: 64 YKEAFLDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQA 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGY 402
LHE +ILHRD+KS+NILL N KI DLG++K LK + A+ Q GT Y
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--------KNMAKTQIGTPHY 167
Query: 403 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
APE GR S SD++S G +L E+ T P
Sbjct: 168 MAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 9e-19
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
++G+G V++G L D VAVK K FL+E +L + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 292 SEFRGKRAMRLLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
++ R +V E +P G+ LR D + + + V A+ AA G+ YL
Sbjct: 62 TQ----RQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE-- 110
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ +HRD+ + N L+ EN KI+D GM+ R + DG+ SS Q + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMS-RQEDDGI---YSSSGLKQIPIKWTAPEA 165
Query: 408 AMVGRASLMSDVFSFGVVLLE 428
GR S SDV+S+G++L E
Sbjct: 166 LNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 236 GGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
GG Y VY G VAVK K + FL E ++ + H ++V L+G C+
Sbjct: 15 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ ++ EFM GNL D L + +N + +A + +EYL
Sbjct: 73 ----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 412
+HRD+ + N L+ EN K+ D G+++ + D ++ A + + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 181
Query: 413 ASLMSDVFSFGVVLLELIT 431
S+ SDV++FGV+L E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G VA+K K G + FL E +++ +L H +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 72 -----QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ E L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFPIKWTAPEAINY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
G ++ SDV+SFG++L E++T GR P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 58/191 (30%), Positives = 85/191 (44%), Gaps = 25/191 (13%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VAVK K + FL E ++++L H +V L+G C K +LV E P G
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KGEPLMLVMELAPLG 80
Query: 312 NLRDCLDG----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
L L + + +VA G+ YL +HRD+ + N+LL
Sbjct: 81 PLLKYLKKRREIPVSDLKELAHQVA------MGMAYLESK---HFVHRDLAARNVLLVNR 131
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 425
AKI+D GM++ L A A G + ++APE G+ S SDV+S+GV
Sbjct: 132 HQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT 187
Query: 426 LLELIT-GRQP 435
L E + G +P
Sbjct: 188 LWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 232 IVGQGGSSYVYRGQL-TDGRIVAVK----RFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 285
I+G+G S V + + A+K R + V E ++L+RL H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KVKYVK-IEKEVLTRLNGHPGII 65
Query: 286 PLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLE 342
L Y + F+ + L V E+ PNG L L + G + D + A LE
Sbjct: 66 KL--YYT-FQDEE--NLYFVLEYAPNGEL---LQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--------CSSSPA 394
YLH I+HRD+K NILLD++++ KITD G AK L + P S
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 395 RMQGTFGYF-------APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ + F F +PE A SD+++ G ++ +++TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 23/212 (10%)
Query: 233 VGQGGSSYVYRGQLTD--GRI--VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
+G G V RG+ + G++ VAVK K+ + FL E ++ L H +++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYL 344
G M +V E P G+L D L G + D V IA G+ YL
Sbjct: 63 GVV---LTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYL 113
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
R +HRD+ + NILL + KI D G+ + L + ++ F + A
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
PE S SDV+ FGV L E+ T G +P
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 4e-18
Identities = 54/183 (29%), Positives = 98/183 (53%), Gaps = 8/183 (4%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G VAVK K + G N + E+++L L+H ++V G C+E G ++L + EF+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE-DGGNGIKL-IMEFL 90
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
P+G+L++ L +N ++ A+ +G++YL + + +HRD+ + N+L++
Sbjct: 91 PSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
KI D G+ K ++ D + + ++APE + + + SDV+SFGV L E
Sbjct: 147 QVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 429 LIT 431
L+T
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
++G G ++ VY L + VA+KR + + D + EV +S+ +H +VV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL-RKEVQAMSQCNHPNVVKY- 64
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAARGLEY 343
Y S F + LV ++ G+L D + G L E + +GLEY
Sbjct: 65 -YTS-FVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEY 117
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFG 401
LH +HRDIK+ NILL E+ + KI D G++ L G + R GT
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG---DRTRKVRKTFVGTPC 171
Query: 402 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 438
+ APE +D++SFG+ +EL TG P +
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 66/235 (28%), Positives = 95/235 (40%), Gaps = 59/235 (25%)
Query: 233 VGQGGSSYVYRGQL-------TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 283
+GQG VY G + R VA+K + FL E ++ + H
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETR-VAIK--TVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------DGV----LVEGMNWDT 329
VV L+G S G+ + +V E M G+L+ L G+ L + +
Sbjct: 71 VVRLLGVVS--TGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-- 124
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RL 381
A A G+ YL + +HRD+ + N ++ E+L KI D GM + R
Sbjct: 125 ----AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
GL P R + APE G + SDV+SFGVVL E+ T QP
Sbjct: 178 GGKGL-----LPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G V+ G+L D VAVK + P+ + FL E +L + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI--GAARGLEYLHEAAA 349
++ K+ + +V E + G D L + EG + I + AA G+EYL +
Sbjct: 63 TQ---KQPI-YIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---S 112
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + N L+ E KI+D GM+ R + DG+ +S+ Q + APE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS-REEEDGV--YASTGGMKQIPVKWTAPEALN 169
Query: 410 VGRASLMSDVFSFGVVLLE 428
GR S SDV+SFG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 72/245 (29%), Positives = 115/245 (46%), Gaps = 47/245 (19%)
Query: 233 VGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G V+ + D +VAVK K + +A F E ++L+ L H H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEG--------MNWDTRVAI 333
G C+E R L+VFE+M +G+L L D ++ G + +AI
Sbjct: 72 FYGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
A A G+ YL A+ +HRD+ + N L+ + L KI D GM++ + S+
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-------STDY 177
Query: 394 ARMQG----TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR--------SI 440
R+ G + PE + + + SD++SFGVVL E+ T G+QP ++ I
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 441 TKGEE 445
T+G E
Sbjct: 238 TQGRE 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 248 DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307
D +VAVK K NA F E ++L+ L H H+V G C E G ++VFE+
Sbjct: 34 DKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPL--IMVFEY 88
Query: 308 MPNGNLRDCL-----DGVLVEGMNWDTRVA------IAIGAARGLEYLHEAAAPRILHRD 356
M +G+L L D VL+ N + IA A G+ YL A+ +HRD
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRD 145
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGR 412
+ + N L+ ENL KI D GM++ + S+ R+ G + PE M +
Sbjct: 146 LATRNCLVGENLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPESIMYRK 198
Query: 413 ASLMSDVFSFGVVLLELIT-GRQPIHR 438
+ SDV+S GVVL E+ T G+QP ++
Sbjct: 199 FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 231 NIVGQGGSSYVYRGQLTD------GRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
N +G G VY G TD G I VAVK + FL E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-----GMNWDTRVAIAIGAA 338
+V L+G C + ++ E M G+L L VE + + I + A
Sbjct: 61 IVKLLGVCLL----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAK--------RLKADG 385
+G YL + +HRD+ + N L+ E KI D G+A+ R + +G
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
L P R + APE + G+ + SDV+SFGV++ E++T G+QP
Sbjct: 174 L-----LPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLHHCHVVPL 287
+G+G VY+ + G IVA+K+ + + + T E+ +L L H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ +R + LVFE+ +L+ LD ++ + +I RGL Y H
Sbjct: 64 LDVI---HTERKL-YLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE- 406
RILHRD+K NIL++ + K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLA---RAFGIPLRTYTHEVV--TLWYRAPEI 169
Query: 407 ------YAMVGRASLMSDVFSFGVVLLELITGR 433
Y S D++S G + E+ITG+
Sbjct: 170 LLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 72/217 (33%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G G VY G L DG AVK Q G A E+ +LS+L H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 288 VGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLE 342
+G E L +F E +P G+L L G E + + TR + GLE
Sbjct: 68 LGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY-TRQILL-----GLE 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFG 401
YLH +HRDIK +NIL+D N K+ D GMAK++ S SP M
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM----- 168
Query: 402 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIH 437
APE G L +D++S G +LE+ TG+ P
Sbjct: 169 --APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 33/221 (14%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS---------VFLTEVDMLSRLHH 281
++G G VY G + G ++AVK+ + +A S E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPS-VSASSKDRKRSMLDALAREIALLKELQH 65
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIG 336
++V +G + A L +F E++P G++ L+ G E + N+ ++
Sbjct: 66 ENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---- 116
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR- 395
+GL YLH I+HRDIK +NIL+D KI+D G++K+L+A+ L S ++ AR
Sbjct: 117 --KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL-STKTNGARP 170
Query: 396 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+QG+ + APE + +D++S G +++E++TG+ P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G+ VA+K + +G + D F+ E ++ +L H ++V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDD-FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ R +V E+M NG L + L G L G W + + +EYL
Sbjct: 70 KQRPIF----IVTEYMANGCLLNYLRERKGKL--GTEWLLDMCSDV--CEAMEYLESNG- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FGYFAPE 406
+HRD+ + N L+ E+ K++D G+A R D + S QGT + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSS------QGTKFPVKWAPPE 171
Query: 407 YAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438
R S SDV+SFGV++ E+ + G+ P R
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 284
++GQG VY D GR +AVK+ P++ E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPF--DPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 285 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
V G C L +F E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH I+HRDIK +NIL D N K+ D G +KRL+ + GT
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPY 172
Query: 402 YFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQP 435
+ +PE GR +DV+S G ++E++T + P
Sbjct: 173 WMSPEVISGEGYGRK---ADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
D+ + S+++ +G ++ G L D V VK K ++ L E +L L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGMNWDTR--VAI 333
H +++P++ C E +++ +M GNL + C G T+ V +
Sbjct: 66 SHQNILPILHVCIEDGEPP---FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCS 390
AI A G+ YLH+ ++H+DI + N ++DE L KITD +++ L L
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ P + + A E + S SDV+SFGV+L EL+T G+ P
Sbjct: 180 NRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 284
++G+G VY G G+++AVK+ + N + EVD+L L H ++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS-NVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 342
V +G C + + EF+P G++ L+ G L E + I G A
Sbjct: 65 VQYLGTCLD----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA---- 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFG 401
YLH ++HRDIK +N++L N K+ D G A+RL GL S+ + M GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+ APE SD++S G + E+ TG+ P+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 38/209 (18%)
Query: 248 DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305
D +VAVK K P A F E ++L+ L H H+V G C G ++VF
Sbjct: 34 DKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVC----GDGDPLIMVF 86
Query: 306 EFMPNGNLRDCLDG------VLVEG--------MNWDTRVAIAIGAARGLEYLHEAAAPR 351
E+M +G+L L +LV+G + + IA A G+ YL A+
Sbjct: 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQH 143
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEY 407
+HRD+ + N L+ NL KI D GM++ + S+ R+ G + PE
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPES 196
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
M + + SDV+SFGV+L E+ T G+QP
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G L D AVK FL E ++ H +V+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG--AARGLEYL 344
L+G C G L+V +M +G+LR+ + E N + I G A+G+EYL
Sbjct: 61 LLGICLPSEG---SPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FG 401
A+ + +HRD+ + N +LDE+ K+ D G+A+ D S G
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVK 167
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440
+ A E + + SDV+SFGV+L EL+T P + +
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 28/195 (14%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK + A + FL E+ ++SRL + +++ L+G C ++ E+M N
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV----SDDPLCMITEYMEN 101
Query: 311 GNLRDCLDGVLVEG----------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
G+L L +E ++ + +A+ A G++YL A+ +HRD+ +
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158
Query: 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLM 416
N L+ + KI D GM++ L S R+QG + A E ++G+ +
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211
Query: 417 SDVFSFGVVLLELIT 431
SDV++FGV L E+ T
Sbjct: 212 SDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 35/201 (17%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK + NA + FL EV +LSRL +++ L+G C + ++ E+M N
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD----EDPLCMITEYMEN 103
Query: 311 GNLRDCLDG-VLVEG----------------MNWDTRVAIAIGAARGLEYLHEAAAPRIL 353
G+L L L + +++ + + +A+ A G++YL ++ +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 354 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAM 409
HRD+ + N L+ ENL KI D GM++ L A R+QG + A E +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA-------GDYYRIQGRAVLPIRWMAWECIL 213
Query: 410 VGRASLMSDVFSFGVVLLELI 430
+G+ + SDV++FGV L E++
Sbjct: 214 MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNA----DSVFLTEVDMLSRLHHCHVVPL 287
+G+G + VY+ GRIVA+K+ K A + L E+ +L L H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ F K + L VFEFM +L + + D + + + RGLEYLH
Sbjct: 68 L---DVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLHSN 121
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG---TFGYFA 404
ILHRD+K +N+L+ + K+ D G+A+ S S +M T Y A
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLAR--------SFGSPNRKMTHQVVTRWYRA 170
Query: 405 PEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
PE R + D++S G + EL+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADS-----VFLTEVDMLSRLHHCHVV 285
+G G S Y+ + + G ++AVK+ +++ E+ +++RL+H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 343
++G E + L E+M G++ L G E + + RGL Y
Sbjct: 67 RMLGATCE----DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSY 118
Query: 344 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
LHE +I+HRD+K +N+L+D +I D G A RL A ++ GT +
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK-GTGAGEFQGQLLGTIAF 174
Query: 403 FAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP 435
APE GR+ DV+S G V++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRS---CDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 54/234 (23%)
Query: 232 IVGQGGSSYVYRGQLT--DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVP 286
I+G+G V GQL+ DG VAVK K ++ FL+E + H +V+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 287 LVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARG 340
L+G C + K +++ FM +G+L L G L E + T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
+EYL + +HRD+ + N +L E++ + D G++K++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI------------------- 163
Query: 401 GYFAPEYAMVGRASLM------------------SDVFSFGVVLLELIT-GRQP 435
++ +Y GR + M SDV++FGV + E+ T G+ P
Sbjct: 164 --YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 23/225 (10%)
Query: 230 SNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL---HHCHV 284
+G+G VY+ + L GR VA+K+ + + L E+ +L +L H ++
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 285 VPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
V L+ C R R ++L LVFE + + +L L G+ +T + RG+++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQGTFGY 402
LH + RI+HRD+K NIL+ + KI D G+A+ + L S T Y
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-------TLWY 172
Query: 403 FAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEE 445
APE + ++S + D++S G + EL R+P+ R ++ ++
Sbjct: 173 RAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 32/217 (14%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIV----AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G + +G V A+K GP A+ F+ E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 339
L+G C LV + MP+G L +D + L+ +NW ++A +
Sbjct: 74 LLGVCLS-----PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQIA------K 120
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+ YL E R++HRD+ + N+L+ + KITD G+A+ L+ D ++ +M
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKM--P 174
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ A E + + SDV+S+GV + EL+T G +P
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 21/212 (9%)
Query: 232 IVGQGGSSYVYRGQL-TDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
++G G V+RG L GR VA+K K FL+E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
G ++F K AM ++ E+M NG L L DG V + G A G++YL
Sbjct: 72 EGVVTKF--KPAM--IITEYMENGALDKYLRDHDGEFSSYQ----LVGMLRGIAAGMKYL 123
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
+ +HRD+ + NIL++ NL K++D G+++ L+ D + ++S ++ + A
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
PE + + SDV+SFG+V+ E+++ G +P
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 234 GQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G GGS S V + G ++A K + L E+ ++ H C +V +
Sbjct: 16 GNGGSVSKVKH--IPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFYG 70
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAP 350
F + + + EFM G+L D + +G + + IA+ GL YL+
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
RI+HRDIK SNIL++ K+ D G++ L +S GT Y +PE
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-------INSIADTFVGTSTYMSPERIQG 176
Query: 411 GRASLMSDVFSFGVVLLELITGRQP 435
G+ ++ SDV+S G+ ++EL G+ P
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLH---HCHVVPL 287
+G G VY+ + G VA+K + Q + + + EV +L RL H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
+ C+ R R ++ LVFE + + +LR LD V G+ +T + RGL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
A I+HRD+K NIL+ K+ D G+A+ + SC + + T Y APE
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+ + D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDG-RI-VAVKRFKTQGGPNADSVFLTEV 273
Y LE KF +++G+G V + ++ DG R+ A+KR K + F E+
Sbjct: 1 YPVLEWNDIKFQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 274 DMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------- 322
++L +L HH +++ L+G C R L E+ P+GNL D L V
Sbjct: 59 EVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 323 ----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
++ + A ARG++YL + + +HRD+ + NIL+ EN AKI D G++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
+ + + P R + A E + SDV+S+GV+L E+++
Sbjct: 172 RGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 71/221 (32%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+GG V Q+ G++ A K R K + G V E +L+++H +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKVHSRFIVS 57
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA--RGLEYL 344
L F+ K + LV M G+LR + V E + A A GLE+L
Sbjct: 58 LA---YAFQTKTDL-CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H+ RI++RD+K N+LLD + N +I+DLG+A LK DG S GT G+ A
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DG----QSKTKGYAGTPGFMA 165
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
PE D F+ GV L E+I R P +GE+
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA---RGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + VY+G+ T G IVA+K S + E+ ++ L H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 292 SEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+ +LVFE+M G R LD V+ + +G+
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQL--------LKGIA 114
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+ HE R+LHRD+K N+L+++ K+ D G+A +A G+P + S + T Y
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA---RAFGIPVNTFSNEVV--TLWY 166
Query: 403 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
AP+ + R S D++S G ++ E+ITGR P+ T E+ L+
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPG-TNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 231 NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
I+G G VY+ L RI+AVK ++E+++L + C ++G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL---YKCDSPYIIG 63
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNL---RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
+ F + + + EFM G+L R + VL R+A+A+ +GL YL
Sbjct: 64 FYGAFFVENRISICT-EFMDGGSLDVYRKIPEHVL-------GRIAVAV--VKGLTYLW- 112
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
+ +ILHRD+K SN+L++ K+ D G++ +L +S GT Y APE
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAKTYVGTNAYMAPE 163
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
+ + SDV+S G+ +EL GR P + I K + SL+
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP-YPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 30/228 (13%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT----EVDM 275
E+ D+ ++G+G VY + L+ +A+K P DS ++ E+ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIAL 58
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVA 332
S L H ++V +G SE + E +P G+L L G L + N T +
Sbjct: 59 HSYLKHRNIVQYLGSDSE----NGFFKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIIF 112
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSS 391
GL+YLH+ +I+HRDIK N+L++ KI+D G +KRL G+ C+
Sbjct: 113 YTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTE 167
Query: 392 SPARMQGTFGYFAPEYAMVGRASL--MSDVFSFGVVLLELITGRQPIH 437
+ GT Y APE G +D++S G ++E+ TG+ P
Sbjct: 168 T---FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRF---KTQGGPNAD------SVFLTEVDMLSRLHH 281
++G+G VY +T G ++AVK+ T G + +E++ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 335
++V +G F + E++P G++ CL + LV
Sbjct: 68 LNIVQYLG----FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------ 117
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
GL YLH ILHRD+K+ N+L+D + KI+D G++K K+D + +
Sbjct: 118 --LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYD-NDQNMS 169
Query: 396 MQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
MQG+ + APE S D++S G V+LE+ GR+P
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G+G S VY+ L DGR+VA+K+ + A L E+D+L +L H +V+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK--- 66
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 343
Y + F + +V E G+L + ++ E W V + LE+
Sbjct: 67 YLASFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H RI+HRDIK +N+ + K+ DLG+ + + + S + GT Y
Sbjct: 122 MHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGTPYYM 173
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE + SD++S G +L E+ + P
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 284
++GQG VY D GR +A K + Q P + S E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 342
V G C R ++ + + + E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDRAEKTLTIFM-EYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMS 120
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQ 397
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM- 176
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE +DV+S G ++E++T + P
Sbjct: 177 ------SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 37/221 (16%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
+K+ +VG+G V + + + G+IVA+K+F +++ + + E+ ML +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 283 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAI 335
++V L+ +R RL LVFEF+ + L D LD V +
Sbjct: 61 NLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI------ 109
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
RG+E+ H + I+HRDIK NIL+ ++ K+ D G A+ L A G + A
Sbjct: 110 --LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA- 162
Query: 396 MQGTFGYFAPEYAM----VGRASLMSDVFSFGVVLLELITG 432
T Y APE + GRA D+++ G ++ E++TG
Sbjct: 163 ---TRWYRAPELLVGDTKYGRA---VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G VAVK K A FL E ++++L H ++V L+G E +G +V E+M
Sbjct: 29 GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL---YIVTEYM 82
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
G+L D L + D + ++ +EYL A +HRD+ + N+L+ E+
Sbjct: 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDN 139
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
AK++D G+ K +A P + + APE + S SDV+SFG++L E
Sbjct: 140 VAKVSDFGLTK--EASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 429 LIT-GRQPIHR 438
+ + GR P R
Sbjct: 192 IYSFGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIV-AVKRFKTQGGPNADSVFLTEVDMLSRL 279
E D F + +G G V + Q ++ A K + P + + E L L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGA 337
H C+ +VG+ F + + + E M G+L D VL E + ++I
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKEAKRIPEEILGKVSIAV 112
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
RGL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 LRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
GT Y +PE S+ SD++S G+ L+EL GR PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVGY 290
+G G V+ G + VAVK K P SV FL E +++ L H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
+ K ++ E+M G+L D L + + + A G+ Y+
Sbjct: 70 VT----KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYA 408
+HRD++++N+L+ E+L KI D G+A+ ++ + AR F + APE
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAI 176
Query: 409 MVGRASLMSDVFSFGVVLLELIT-GRQP 435
G ++ SDV+SFG++L E++T G+ P
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 37/209 (17%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK K + + + F E +++ H ++V L+G C+ + M LL FE+M
Sbjct: 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---GKPMCLL-FEYMAY 92
Query: 311 GNL----RDCLDGVLVEGMNWDTR----------------VAIAIGAARGLEYLHEAAAP 350
G+L R + + + IA A G+ YL E
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--- 149
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQGTFGYFAPEY 407
+ +HRD+ + N L+ EN+ KI D G+++ + + S + P R + PE
Sbjct: 150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPES 203
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
R + SDV+++GVVL E+ + G QP
Sbjct: 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 64/237 (27%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 232 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRLHHCHVVP 286
++G+GG VY D R VA+K+ + N FL E + + L H +VP
Sbjct: 9 LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 287 LVGYCSEFRGKRAMRLLVFEFMP--NG--------NLRDC--LDGVLVEGMNWDTRVAIA 334
+ CS+ V+ MP G ++ L L E + ++I
Sbjct: 67 VYSICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR----------LKAD 384
+EY+H +LHRD+K NILL I D G A + D
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 385 GLPSCSSS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
C SS P ++ GT Y APE + AS +D+++ GV+L +++T P R
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 242 YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301
+RGQ VA+K K G ++ F+ E ++ +L H +V L G C+ K+
Sbjct: 25 WRGQYD----VAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT----KQRPI 74
Query: 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI---AIGAARGLEYLHEAAAPRILHRDIK 358
+V E+M NG CL L E + G+ YL + + +HRD+
Sbjct: 75 YIVTEYMSNG----CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLM 416
+ N L+D+ K++D G+++ + D S S P R + PE + + S
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSKFSSK 181
Query: 417 SDVFSFGVVLLELIT-GRQPIHR 438
SDV++FGV++ E+ + G+ P R
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+ + G IVA+K+ K ++G P L E+ +L L+H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA---LREIKLLKELNHPNIIKL 63
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ FR K + LVFEFM + +L + G+ + +GL + H
Sbjct: 64 L---DVFRHKGDL-YLVFEFM-DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----GTFGYF 403
ILHRD+K N+L++ K+ D G+A+ SP R T Y
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSF---------GSPVRPYTHYVVTRWYR 165
Query: 404 APE--YAMVGRASLMSDVFSFGVVLLELITGR 433
APE G ++ + D++S G + EL++ R
Sbjct: 166 APELLLGDKGYSTPV-DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 42/227 (18%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
+K+ + +G+G V++ + + G+IVA+K+F +++ P + L E+ ML +L H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFM-----------PNGNLRDCLDGVLVEGMNWDTRV 331
++V L+ FR KR + L VFE+ P G + L++ + W T
Sbjct: 61 NLVNLI---EVFRRKRKLHL-VFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQT-- 109
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+ + + H +HRD+K NIL+ + K+ D G A+ L G
Sbjct: 110 ------LQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
Query: 392 SPARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI 436
R Y APE +VG DV++ G V EL+TG QP+
Sbjct: 161 VATRW-----YRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
+++G+G V + ++ DG + A+KR K + F E+++L +L HH +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 332
L+G C R L E+ P+GNL D L V ++ +
Sbjct: 61 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ + +
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
P R + A E + SDV+S+GV+L E+++
Sbjct: 174 PVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 41/219 (18%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+ + G IVA+K+ + +G P S + E+ +L L+H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKELNHPNIVRL 63
Query: 288 --VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V + +L LVFEF+ + +L+ +D + G++ + +G+ Y
Sbjct: 64 LDVVHSEN-------KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG------ 398
H + R+LHRD+K N+L+D K+ D G+A +A G+P ++
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLA---RAFGVP--------VRTYTHEVV 161
Query: 399 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 436
T Y APE + R S D++S G + E++ R+P+
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 280
F ++G+GG V Q+ G++ A K R K + G +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---ESMALNEKQILEKVN 58
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
VV L Y E K A+ LV M G+L+ + + G V A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE LH+ RI++RD+K NILLD++ + +I+DLG+A +P + R+ GT
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVH-----VPEGQTIKGRV-GTV 165
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442
GY APE R + D ++ G +L E+I G+ P + K
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 27/220 (12%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT-EVDMLSRLHHCHVVPLV 288
+G+G V + + +DG+I+ K + L EV++L L H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNL----RDC--LDGVLVEGMNWD--TRVAIAIGAAR 339
Y + L +V E+ G+L + C + E W T++ +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----- 117
Query: 340 GLEYLH--EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
L H +LHRD+K +NI LD N N K+ D G+AK L D SS
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-----SSFAKTYV 171
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y +PE SD++S G ++ EL P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
E D F + +G G V++ G I+A K + P + + E L L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA 337
H C+ +VG+ F + + + E M G+L L G + E + +V+IA+
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQIL--GKVSIAV-- 112
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
GT Y +PE S+ SD++S G+ L+E+ GR PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
+++G+G V R + DG + A+K K N F E+++L +L HH +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 332
L+G C R + E+ P GNL D L V + +
Sbjct: 68 LLGACE----NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
A A G++YL E + +HRD+ + N+L+ ENL +KI D G+++ + +
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
P R + A E + SDV+SFGV+L E+++
Sbjct: 181 PVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ F+ +G+G VY+ ++VA+K + + E+ LS+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 338
+ G S +G +L ++ E+ G+ D L G L E IA
Sbjct: 61 ITKYYG--SFLKG---SKLWIIMEYCGGGSCLDLLKPGKLDET-------YIAFILREVL 108
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 397
GLEYLHE +HRDIK++NILL E + K+ D G++ +L +S+ ++
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--------TSTMSKRNT 157
Query: 398 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT + APE +D++S G+ +EL G P
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDM 275
+ DKF +G+G VY+ + D G +VA+K+ + N F + E+ +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIREIKI 59
Query: 276 LSRLHHCHVVPLVGYCS------EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM---N 326
L +L+H ++V L + +F+ + LVFE+M + L G+L G+ +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFS 114
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
D + GL Y H+ LHRDIK SNILL+ K+ D G+A+ ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-- 169
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPI 436
S P + ++ P ++G R DV+S G +L EL T ++PI
Sbjct: 170 ---ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 51/238 (21%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSR 278
D+ + +G+G V + + + VAVK K S ++E++M+
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 279 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVE 323
+ H +++ L+G C++ G +V E+ +GNLRD L E
Sbjct: 72 IGKHKNIINLLGVCTQ-EGPL---YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK---- 379
+ V+ A ARG+E+L A+ + +HRD+ + N+L+ E+ KI D G+A+
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 380 ----RLKADG-LPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELIT 431
R +G LP + APE A+ R + SDV+SFGV+L E+ T
Sbjct: 185 IDYYRKTTNGRLP------------VKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 31/212 (14%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G VY+ G++VA+K + + E+ +L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYG- 65
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD-TRVAIAI---GAARGLEYLHE 346
S F K +V E+ G++ D +++ N T IA +GLEYLH
Sbjct: 66 -SYF--KNTDLWIVMEYCGAGSVSD-----IMKITNKTLTEEEIAAILYQTLKGLEYLH- 116
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYF 403
+ + +HRDIK+ NILL+E AK+ D G++ +L + + A+ GT +
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--------TDTMAKRNTVIGTPFWM 166
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE + +D++S G+ +E+ G+ P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+GG V Q+ G++ A K R K + G + + L E ++L +++ +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG---EKMALLEKEILEKVNSPFIVN 57
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
L Y E + LV M G+L+ + V G+ + + + G+ +LH
Sbjct: 58 L-AYAFE---SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
I++RD+K N+LLD+ N +++DLG+A LK DG + GT GY APE
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRA-----GTNGYMAPE 164
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQP 435
S D F+ G + E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 7e-14
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 226 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
K++ +GQG S V+ D G+ VA+K+ Q P + + + E+ ++ L +
Sbjct: 20 KYTRYEKIGQGASGTVFTA--IDVATGQEVAIKQINLQKQPKKE-LIINEILVMKELKNP 76
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGA 337
++V + S G +V E++ G+L D C+D + A+
Sbjct: 77 NIVNFLD--SFLVGDEL--FVVMEYLAGGSLTDVVTETCMDEAQI--------AAVCREC 124
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ LE+LH A +++HRDIKS N+LL + + K+TD G ++ + S + M
Sbjct: 125 LQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-----QSKRSTMV 176
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT + APE D++S G++ +E++ G P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ H ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKHPNI 78
Query: 285 VPLVG---YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARG 340
V + E +V E++ G+L D V+ E M+ A+ +
Sbjct: 79 VNYLDSYLVGDEL-------WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQA 127
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE+LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT
Sbjct: 128 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTP 179
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ APE D++S G++ +E++ G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+ + G +VA+K+ + T+G P S + E+ +L L+H ++V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHPNIVKL 64
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ + LVFEF+ + +L+ +D + G+ + +GL + H
Sbjct: 65 L----DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ R+LHRD+K N+L++ K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLA---RAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 408 AMVGR-ASLMSDVFSFGVVLLELITGR 433
+ + S D++S G + E++T R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 207 TIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNA 265
TI G + LE+ + +G G VY+ + G ++AVK+ + G
Sbjct: 4 TIDGQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE 56
Query: 266 DSVFLTEVDMLSRLHHC-HVVPLVGY-CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV- 322
+ L ++D++ + H C ++V GY ++ M L+ CLD +L
Sbjct: 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM----------STCLDKLLKR 106
Query: 323 --EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ D + + + L YL E ++HRD+K SNILLD + N K+ D G++ R
Sbjct: 107 IQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 381 LKADGLPSCSSSPARMQGTFGYFAPEY----AMVGRASLMSDVFSFGVVLLELITGRQPI 436
L D S + R G Y APE + + +DV+S G+ L+EL TG+ P
Sbjct: 165 L-VD-----SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218
Query: 437 H 437
Sbjct: 219 K 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 36/204 (17%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VAVK K + L+E ++L +++H HV+ L G CS+ LL+ E+ G
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYG 88
Query: 312 NLR----------------------DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+LR LD + ++ A +RG++YL E
Sbjct: 89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-- 146
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEY 407
+++HRD+ + N+L+ E KI+D G+++ + + S R +G + A E
Sbjct: 147 -KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE-----DSYVKRSKGRIPVKWMAIES 200
Query: 408 AMVGRASLMSDVFSFGVVLLELIT 431
+ SDV+SFGV+L E++T
Sbjct: 201 LFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 233 VGQGGSSYVYRGQ--LTDGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLH---HCH 283
+G+G V++ + GR VA+KR + Q G P + + EV +L L H +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHPN 65
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
VV L C+ R R +L LVFE + + +L LD V G+ +T + RGL+
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH + R++HRD+K NIL+ + K+ D G+A+ + S + + T Y
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSVVVTLWY 175
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
APE + + D++S G + E+ R+P+ R
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
N++ +G Y+G+ + +G VK + +S+ +E+ + +L H ++V L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C +G L+ E++ NL + L ++W+ R IAIG A+ L +LH +
Sbjct: 751 LCRSEKGA----YLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
P ++ ++ I++D + L + L D SS+ Y APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---------YVAPETRE 851
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
+ SD++ FG++L+EL+TG+ P S+V W
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 27/194 (13%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK + NA + FL E+ ++SRL +++ L+ C ++ E+M N
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT----SDPLCMITEYMEN 103
Query: 311 GNLRDCLDGVLVEG---------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361
G+L L + +++ T + +A A G++YL ++ +HRD+ + N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN 160
Query: 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLMS 417
L+ +N KI D GM++ L S R+QG + + E ++G+ + S
Sbjct: 161 CLVGKNYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213
Query: 418 DVFSFGVVLLELIT 431
DV++FGV L E++T
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 241 VYRGQL---TDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
VY+G L G + VA+K K + F E M SRL H ++V L+G +
Sbjct: 21 VYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-- 78
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARG 340
K ++F + + +L + L D + + V I A G
Sbjct: 79 --KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARMQ 397
+E+L ++ ++H+D+ + N+L+ + LN KI+DLG+ + + A L S P R
Sbjct: 137 MEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-- 191
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ +PE M G+ S+ SD++S+GVVL E+ + G QP
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCH 283
F ++G+GG V Q+ G++ A KR + + +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
VV L Y E K A+ LV M G+L+ + + G + + A GLE
Sbjct: 62 VVNL-AYAYE--TKDAL-CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH ++RD+K NILLD+ + +I+DLG+A + +P S R+ GT GY
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK-----IPEGESIRGRV-GTVGYM 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE R +L D + G ++ E+I G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 20/165 (12%)
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG----MNWDTRV 331
L LH C+ +VG+ F + + + E M G+L D VL + N ++
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKKAGRIPENILGKI 104
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+IA+ RGL YL E I+HRD+K SNIL++ K+ D G++ +L + S ++
Sbjct: 105 SIAV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMAN 156
Query: 392 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
S GT Y +PE ++ SD++S G+ L+E+ GR PI
Sbjct: 157 S---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 71/225 (31%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 283
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
+ + Y K + + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMSYAFHTPDKLS---FILDLMNGGDLHYHLSQHGVFSEA---EMRF-YAAEIILGL 110
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQG 398
E++H +++RD+K +NILLDE+ + +I+DLG+A C S P G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----------CDFSKKKPHASVG 157
Query: 399 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITK 442
T GY APE G A S D FS G +L +L+ G P + TK
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 65/220 (29%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G V G+ G A VK + P+ +FL EV L+H +V+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGM-NWDTRVAIAIGAARGLEYLHE 346
C E LLV EF P G+L++ L + +V M D +A A GL +LH+
Sbjct: 63 QCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPS--CSSSPARMQGTFGYF 403
A +H D+ N L +L+ KI D G+A ++ D + C + P R +
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WL 169
Query: 404 APEYAMVGRASLM-------SDVFSFGVVLLELIT-GRQP 435
APE + L+ S+++S GV + EL T QP
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 24/140 (17%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEGM-----NWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
LV E++ G DC L++ + +W + + G+E LH+ I+HRDI
Sbjct: 74 LVMEYLNGG---DC--ASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQRG---IIHRDI 123
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 417
K N+L+D+ + K+TD G+++ +GL + GT Y APE + MS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR----NGL-----ENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 418 DVFSFGVVLLELITGRQPIH 437
D +S G V+ E + G P H
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 63/216 (29%), Positives = 110/216 (50%), Gaps = 27/216 (12%)
Query: 232 IVGQGGSSYVYRGQLT-DGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
++G G V RG+L G+ VA+K K+ FL+E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAARGLEYLHE 346
G ++ R +++ EFM NG L L +G + V + G A G++YL E
Sbjct: 71 EGVVTKSRPV----MIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSS-----PARMQGTF 400
+HRD+ + NIL++ NL K++D G+++ L+ D P+ +SS P R
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR----- 176
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ APE + + SDV+S+G+V+ E+++ G +P
Sbjct: 177 -WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 50/220 (22%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPLVGY 290
G GG+ Y + T GR+ A+K G + D+V E+++L ++H +VV
Sbjct: 85 GAGGTVYKVIHRPT-GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK---- 136
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-------IAIGAARGLEY 343
C + ++ EFM G+L EG T +A +A G+ Y
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL---------EG----THIADEQFLADVARQILSGIAY 183
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH I+HRDIK SN+L++ N KI D G++ R+ A + C+SS GT Y
Sbjct: 184 LHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS-RILAQTMDPCNSS----VGTIAYM 235
Query: 404 APEY--------AMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE A G A D++S GV +LE GR P
Sbjct: 236 SPERINTDLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 34/224 (15%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLH 280
+F ++G G VY+G + +G +I VA+K + P A+ L E +++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM-NWDTRVAIAI 335
+ HV L+G C + L+ + MP G L D + D + + + NW ++A
Sbjct: 68 NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA--- 119
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+G+ YL E R++HRD+ + N+L+ + KITD G+AK L AD
Sbjct: 120 ---KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EKEYH 167
Query: 396 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+G + A E + + SDV+S+GV + EL+T G +P
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 236 GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G +Y VY+ + + G +VA+K K + G + + + E+ ML H ++V G S
Sbjct: 12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII-QQEISMLKECRHPNIVAYFG--S 68
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
R + +V E+ G+L+D V ++ + +GL YLHE
Sbjct: 69 YLRRDKLW--IVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHET---GK 122
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYFAPEYAM 409
+HRDIK +NILL E+ + K+ D G++ +L A + A+ + GT + APE A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTA--------TIAKRKSFIGTPYWMAPEVAA 174
Query: 410 V---GRASLMSDVFSFGVVLLELITGRQP 435
V G D+++ G+ +EL + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 45/222 (20%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G+G V + + + G I+AVKR + L ++D+ R C Y
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP------YTV 63
Query: 293 EFRGKRAMRLLVFEFMPNGNLRD-CLD----GVLVEGMNWDTRV--AIAIGAARGLEYLH 345
F G V+ M + D LD V +G+ + IA+ + LEYLH
Sbjct: 64 TFYGALFREGDVWICM---EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLG--------MAKRLKADGLPSCSSSPARMQ 397
++HRD+K SN+L++ N K+ D G +AK + A P
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------- 168
Query: 398 GTFGYFAPEY---AMVGRA-SLMSDVFSFGVVLLELITGRQP 435
Y APE + + + SDV+S G+ ++EL TGR P
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+V VK + N S F E+DM +L H +VV L+G C E ++ E+
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----AEPHYMILEYTDL 92
Query: 311 GNLRDCL-------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363
G+L+ L + + ++ +VA+ A G+++L A R +HRD+ + N L
Sbjct: 93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCL 149
Query: 364 LDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLMSDVFS 421
+ K++ L ++K + ++ P R + APE S SDV+S
Sbjct: 150 VSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWS 203
Query: 422 FGVVLLELIT-GRQP 435
FGV++ E+ T G P
Sbjct: 204 FGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K+ S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 108
Query: 311 GNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L V E +++ V+ A ARG+EYL A+ + +HRD
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRD 165
Query: 357 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 414
+ + N+L+ E+ KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPE-ALFDRIYT 220
Query: 415 LMSDVFSFGVVLLELIT 431
SDV+SFGV+L E+ T
Sbjct: 221 HQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 30/207 (14%)
Query: 244 GQLTDGRI---------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
G++ GR+ VA+K K FL+E ++ + H +++ L G +
Sbjct: 18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-- 75
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL---DG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ K M +V E+M NG+L L DG +++ V + G A G++YL +
Sbjct: 76 KSKPVM--IVTEYMENGSLDAFLRKHDGQFTVIQ------LVGMLRGIASGMKYLSDMGY 127
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + NIL++ NL K++D G+++ L+ D P + + + + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIA 182
Query: 410 VGRASLMSDVFSFGVVLLELIT-GRQP 435
+ + SDV+S+G+V+ E+++ G +P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 232 IVGQGGSSYVYRGQL-TDGRIVAVKRF--KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
++G+GG V Q+ G++ A K+ K +++ L E +L +++ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
Y E K A+ LV M G+L+ + + G + + V A GLE LH
Sbjct: 66 AYAYE--TKDAL-CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE- 121
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEY 407
RI++RD+K NILLD+ + +I+DLG+A + R + GT GY APE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-------EGETIRGRVGTVGYMAPEV 172
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
R + D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 22/206 (10%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
++G+G G + +YR + D +V K T+ L E+ +LS L H +++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII--- 62
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 345
Y + F + L+ E+ G L D + G L E + + + Y+H
Sbjct: 63 AYYNHFMDDNTL-LIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIH 118
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+A ILHRDIK+ NI L + K+ D G++K L ++ S + GT Y +P
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-----YSMAETVVGTPYYMSP 170
Query: 406 EYAMVGRASLMSDVFSFGVVLLELIT 431
E + + SD+++ G VL EL+T
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + V + GR VAVK+ + + +F EV ++ H ++V + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIVEM--YS 83
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S G +V EF+ G L D V MN + + + + L +LH A
Sbjct: 84 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 409
++HRDIKS +ILL + K++D G ++ + P R + GT + APE +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAPE--V 186
Query: 410 VGRASLMS--DVFSFGVVLLELITGRQP 435
+ R + D++S G++++E++ G P
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 30/211 (14%)
Query: 233 VGQGGSSYVYR-GQLTDGRIVAVKRF----KTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++ G VA+K+ G PN L E+ L H +VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEY 343
+ F +LV E+MP+ L VL + A R G+ Y
Sbjct: 65 L---DVFPHGSGF-VLVMEYMPSD-----LSEVLRDEERPLPE-AQVKSYMRMLLKGVAY 114
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H I+HRD+K +N+L+ + KI D G+A+ + S A T Y
Sbjct: 115 MHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA----TRWYR 167
Query: 404 APEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
APE R D+++ G + EL+ G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 227 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 282
F+ +G G G+ Y R T +VA+K+ G + + + EV L +L H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 283 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 76 NTI-------EYKGCYLREHTAWLVMEYCL-GSASDILE-VHKKPLQEVEIAAICHGALQ 126
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQG 398
GL YLH + +HRDIK+ NILL E K+ D G A + SPA G
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV----------SPANSFVG 173
Query: 399 TFGYFAPE--YAM-VGRASLMSDVFSFGVVLLELITGRQPI 436
T + APE AM G+ DV+S G+ +EL + P+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ VAVK K G + FL E +++ L H +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ ++ EFM G+L D L + + A G+ ++ +
Sbjct: 72 -----KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ +L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAINF 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
G ++ SDV+SFG++L+E++T GR P
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT---QGGPNADSVFLTEVDMLSRLHHCHVVP 286
N +G+G VYR + T G IVA+K+ + + G S L E+ +L L H ++V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVE 70
Query: 287 LVGYCSEFRGKRAMRL-LVFEFMPN--GNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLE 342
L GK + LV E+ +L D + E ++V + + RGL+
Sbjct: 71 LKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-----SQVKCLMLQLLRGLQ 122
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLHE I+HRD+K SN+LL + KI D G+A+ GLP+ +P + T Y
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVV--TLWY 174
Query: 403 FAPEYAMVGRASLMS-DVFSFGVVLLELITGR 433
APE + + D+++ G +L EL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 42/261 (16%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD---GRI---VAVKRFKTQGGPNADSVFLTEVD 274
E + +K + +GQG VY G D G VAVK FL E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---- 330
++ HVV L+G S K L+V E M +G+L+ L + E N R
Sbjct: 62 VMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 331 ----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------- 379
+ +A A G+ YL+ A + +HRD+ + N ++ + KI D GM +
Sbjct: 118 LQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 380 -RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
R GL P R + APE G + SD++SFGVVL E+ + + ++
Sbjct: 175 YRKGGKGL-----LPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223
Query: 439 SITKGEESLVLWTATGIYLDH 459
++ E ++ + G YLD
Sbjct: 224 GLSN--EQVLKFVMDGGYLDQ 242
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 5e-13
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S VY + G+ VA+++ Q P + + + E+ ++ + ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNI 79
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEY 343
V Y + + +V E++ G+L D V+ E M+ A+ + LE+
Sbjct: 80 V---NYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEF 131
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWM 183
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE D++S G++ +E+I G P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 23/232 (9%)
Query: 227 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 281
F+ ++G+G V QL + VAVK K ++D FL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 282 CHVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAI 335
+V+ L+G S +G+ + +++ FM +G+L L G + T V I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS- 392
A G+EYL ++ +HRD+ + N +L+EN+ + D G++K++ + C+S
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
P + + A E + SDV++FGV + E++T Q + + E
Sbjct: 178 PVK------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 284
++GQG VY D GR +AVK + Q P + + E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 285 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
V G R L +F E MP G+++D L G L E + I G+
Sbjct: 67 VQYYGC---LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARM 396
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE +D++S G ++E++T + P
Sbjct: 177 -------SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 71/233 (30%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 283
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
+ + Y K + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGVFSEK---EMRF-YATEIILGL 110
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
E++H +++RD+K +NILLDE+ + +I+DLG+A P GT G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVGTHG 160
Query: 402 YFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLVLWTAT 453
Y APE G A S D FS G +L +L+ G P + TK + + T T
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 68/234 (29%), Positives = 97/234 (41%), Gaps = 55/234 (23%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL- 287
G+G VY+ Q+ GR+VA+K+ N F L E+ +L +L H +VVPL
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 288 ---VGYCSEFRGKRAMRLLVFEFM----------PNGNLRD----CLDGVLVEGMNWDTR 330
V + + KR +V +M P+ L + C L+EG+N
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN---- 129
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
YLHE ILHRDIK++NIL+D KI D G+A R P+
Sbjct: 130 ------------YLHEN---HILHRDIKAANILIDNQGILKIADFGLA-RPYDGPPPNPK 173
Query: 391 SSPAR-------MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI 436
+ T Y PE + R + D++ G V E+ T R PI
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 52/159 (32%), Positives = 70/159 (44%), Gaps = 29/159 (18%)
Query: 303 LVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361
++ E+ G L L D L + + R IA EYLH I++RD+K N
Sbjct: 70 MLMEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLHNRG---IIYRDLKPEN 123
Query: 362 ILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
+LLD N K+ D G AK+LK G + C GT Y APE + D
Sbjct: 124 LLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC--------GTPEYVAPEIILNKGYDFSVD 174
Query: 419 VFSFGVVLLELITGRQP----------IHRSITKGEESL 447
+S G++L EL+TGR P I+ I KG L
Sbjct: 175 YWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VA+K K + + + E +++ +L + ++V ++G C + +LV E G
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EAEALMLVMEMASGG 79
Query: 312 NLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
L L D + V + V + + G++YL +HRD+ + N+LL
Sbjct: 80 PLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 425
AKI+D G++K L AD S AR G + ++APE + S SDV+S+G+
Sbjct: 132 HYAKISDFGLSKALGADD----SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187
Query: 426 LLELIT-GRQPIHRSITKGEE 445
+ E + G++P + KG E
Sbjct: 188 MWEAFSYGQKPYKK--MKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 63/240 (26%), Positives = 98/240 (40%), Gaps = 47/240 (19%)
Query: 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDML 276
L T F ++G+G VY+ + G++VA+K D E ++L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNIL 56
Query: 277 SRL-HHCHVVPLVG--YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM----NWDT 329
+ +H ++ G G LV E G++ D + G+ +G W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-- 114
Query: 330 RVA-IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 387
+A I RGL YLHE +++HRDIK NILL +N K+ D G++ +L +
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 388 -SCSSSPARMQGTFGYFAPE-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ +P M APE Y SDV+S G+ +EL G+ P
Sbjct: 171 NTFIGTPYWM-------APEVIACDEQPDASYDA------RSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-Y 290
VG G VY+ + L G + AVK K + G + S+ E+ M+ HC++V G Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAA 349
S R + E+ G+L+D V G + ++A + +GL YLH
Sbjct: 76 LS-----REKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRDIK +NILL +N + K+ D G+A ++ A + GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPEVAA 179
Query: 410 V---GRASLMSDVFSFGVVLLELITGRQPI 436
V G + + D+++ G+ +EL + P+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 280
F ++G+GG V Q+ G++ A K R K + G +++ L E +L +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---EAMALNEKRILEKVN 58
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
VV L Y E K A+ LV M G+L+ + + G + + A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE L RI++RD+K NILLD+ + +I+DLG+A + +P + R+ GT
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ-----IPEGETVRGRV-GTV 165
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
GY APE + + D + G ++ E+I G+ P +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
++G+G VYRG + GR+VA+K + S EV +LS+L + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 291 C-SEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
S +G R ++ E+ G++R + + + + VA L+Y+
Sbjct: 68 YGSYLKGPRLW--IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA--------LKYI 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H+ ++HRDIK++NIL+ N K+ D G+A L SS + GT + A
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTPYWMA 169
Query: 405 PEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
PE G+ +D++S G+ + E+ TG P
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ + ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKNPNI 78
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEY 343
V Y + + +V E++ G+L D V+ E M+ A+ + L++
Sbjct: 79 V---NYLDSYLVGDEL-WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDF 130
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 131 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWM 182
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE D++S G++ +E++ G P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 226 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
K+ +VG+G G ++ R D ++V +K+ + + E +L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+++ Y F +A+ ++V E+ P G L + + ++ DT + + L
Sbjct: 60 NII---EYYENFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
++H ILHRD+K+ NILLD++ KI D G++K L S S + GT
Sbjct: 116 HVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVVGTPC 166
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
Y +PE + SD+++ G VL EL +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS----VFLTEVDMLSRLHHCHVVP 286
++G+G VY D GR +AVK+ S E+ +L L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 287 LVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 343
G C R +L +F E+MP G+++D L G L E N R I +G+ Y
Sbjct: 69 YYG-C--LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE--NVTRRYTRQI--LQGVSY 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQG 398
LH + I+HRDIK +NIL D N K+ D G +KR++ G+ S + +P M
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM-- 176
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE +DV+S ++E++T + P
Sbjct: 177 -----SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 20/106 (18%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A ++HRD+K SN+L++E+ +I D GMA+ L SSSP +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL--------SSSPTEHKY 166
Query: 399 -------TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPI 436
T Y APE + + D++S G + E++ GR+ +
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 231 NIVGQ-GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
I+G+ G ++ VY+ Q G A K + + + F+ E+D+LS H ++V
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVG 66
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE---GMNWDTRVAIAIGAARGLEY 343
L + K + + EF G LD +++E G+ + L +
Sbjct: 67 LYEAYF-YENKLWILI---EFCDGG----ALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------ 397
LH +++HRD+K+ NILL + + K+ D G++ + K+ +Q
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-----------LQKRDTFI 164
Query: 398 GTFGYFAPEYAMVGRAS-----LMSDVFSFGVVLLELITGRQPIH 437
GT + APE +D++S G+ L+EL P H
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 232 IVGQGGSSYVYRG---QLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+G + +I VAVK K P+ FL E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+G +E +V E P G LR L V ++ + + + + L YL
Sbjct: 73 IGVITE-----NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLE-- 124
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ R +HRDI + N+L+ K+ D G+++ L+ + S ++ + APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPES 179
Query: 408 AMVGRASLMSDVFSFGVVLLE-LITGRQPIH 437
R + SDV+ FGV + E L+ G +P
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 105
Query: 311 GNLRDCLDG--------------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L V E M + V+ ARG+EYL A+ + +HRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 357 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 414
+ + N+L+ EN KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 217
Query: 415 LMSDVFSFGVVLLELIT 431
SDV+SFGV++ E+ T
Sbjct: 218 HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 29/197 (14%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K S ++E++M+ + H +++ L+G C++ + +LV E+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLYVLV-EYASK 102
Query: 311 GNLRDCLDGVLVEGMNW--DT------------RVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L GM++ DT V+ A ARG+EYL A+ + +HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 357 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 414
+ + N+L+ E+ KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 214
Query: 415 LMSDVFSFGVVLLELIT 431
SDV+SFGV+L E+ T
Sbjct: 215 HQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 33/203 (16%)
Query: 250 RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309
+VAVK + NA FL EV +LSRL ++ L+G C+ ++ E+M
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP----PLCMIMEYME 102
Query: 310 NGNL------RDCLDGVLVEGMN---WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
NG+L L + T + +A A G+ YL +HRD+ +
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 361 NILLDENLNAKITDLGMAKRL------KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS 414
N L+ +N KI D GM++ L + G P R + A E ++G+ +
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL---PIR------WMAWESVLLGKFT 210
Query: 415 LMSDVFSFGVVLLELIT--GRQP 435
SDV++FGV L E++T QP
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 68/239 (28%), Positives = 103/239 (43%), Gaps = 43/239 (17%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRI-------VAVKRFKTQGGPNADSVFLTEV 273
E A +K + S +GQG VY G + G + VA+K FL E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--- 330
++ + HVV L+G S+ + L++ E M G+L+ L + E N +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 331 -----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------ 379
+ +A A G+ YL+ A + +HRD+ + N ++ E+ KI D GM +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 380 --RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
R GL P R + +PE G + SDV+SFGVVL E+ T QP
Sbjct: 174 YYRKGGKGL-----LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G+ VA+K G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ + +V EFM NG L + L G L + D +++ G+EYL +
Sbjct: 70 Q----QKPLYIVTEFMENGCLLNYLRQRQGKLSK----DMLLSMCQDVCEGMEYLERNS- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + N L+ K++D GM + + D SSS A+ + PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKF--PVKWSPPEVFN 174
Query: 410 VGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439
+ S SDV+SFGV++ E+ T G+ P +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 48/237 (20%)
Query: 232 IVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVV 285
++G+G V L G++ A+K + + + E D+L+ +V
Sbjct: 8 VIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLE 342
L Y S F+ + + LV E+MP G+L + L V E R IA + A L+
Sbjct: 65 KL--YYS-FQDEEHL-YLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVLA--LD 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----------------- 385
+H+ +HRDIK NIL+D + + K+ D G+ K++
Sbjct: 116 SVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 386 -LPSCSSSPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
L R GT Y APE L D +S GV+L E++ G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 70/228 (30%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 225 DKFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLH 280
F ++VG+G G V R + T G I A+K K S F E D+LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSI-S 58
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMN--WDTRVAIAI 335
+ +P + Y F+ K + LV E+ P G+L L + E M + + +AI
Sbjct: 59 NSPWIPQLQYA--FQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ + Y+H RDIK N+L+D + K+ D G A RL A+ + + S P
Sbjct: 116 HSVHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPV- 164
Query: 396 MQGTFGYFAPEY--AMVGRASLMSDV----FSFGVVLLELITGRQPIH 437
GT Y APE M G V +S GV+ E+I GR P H
Sbjct: 165 --GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 41/228 (17%)
Query: 231 NIVGQGGSSYVYRGQLTDGRI------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G G VY G VAVK +S FL E ++S+ +H ++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---------VAIAI 335
V L+G E R R ++ E M G+L+ L E R + A
Sbjct: 72 VRLIGVSFE----RLPRFILLELMAGGDLKS----FLRENRPRPERPSSLTMKDLLFCAR 123
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSS 392
A+G +YL E +HRDI + N LL AKI D GMA+ + +S
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-------RAS 173
Query: 393 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
R G + PE + G + +DV+SFGV+L E+ + G P
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + V + + G++VAVK+ + + +F EV ++ H +VV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 84
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S G +V EF+ G L D V MN + A+ + + L LH A
Sbjct: 85 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 411
++HRDIKS +ILL + K++D G ++ + +P S + GT + APE ++
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKS----LVGTPYWMAPE--LIS 189
Query: 412 RASLMS--DVFSFGVVLLELITGRQP 435
R D++S G++++E++ G P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
IA+ + L YL E +I+HRD+K SNILLD N N K+ D G++ +L
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--------D 160
Query: 392 SPARMQ--GTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQP 435
S A+ + G Y APE + SDV+S G+ L E+ TG+ P
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 52/232 (22%), Positives = 105/232 (45%), Gaps = 19/232 (8%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
++ + + +Y+G + + V ++ FK +G + E+ L R+ +++ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AA 348
+ + L+ E+ G LR+ LD + +++ T++ +AI +GL L++
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
P ++++ S + L+ EN KI G+ K L SS P + YF+ +
Sbjct: 144 KP---YKNLTSVSFLVTENYKLKIICHGLEKIL--------SSPPFKNVNFMVYFSYKML 192
Query: 409 --MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIYLD 458
+ ++ D++S GVVL E+ TG+ P TK L++ + L
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 233 VGQGGSSYV-YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + V + G+ VAVK+ + + +F EV ++ HH +VV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDM--YN 86
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S G +V EF+ G L D V MN + + + R L YLH
Sbjct: 87 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQG--- 138
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 409
++HRDIKS +ILL + K++D G ++ + P R + GT + APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-------VPKRKSLVGTPYWMAPEVIS 191
Query: 410 VGRASLMSDVFSFGVVLLELITGRQP 435
D++S G++++E+I G P
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 43/217 (19%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290
+G G VY + G +VA+K+ K + + + L EV L +L H ++V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64
Query: 291 CSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------G 340
E FR L VFE+M GNL M + R G
Sbjct: 65 --EVFREND--ELYFVFEYM-EGNLYQL--------MKDRKGKPFSESVIRSIIYQILQG 111
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 399
L ++H+ HRD+K N+L+ KI D G+A+ ++ S P T
Sbjct: 112 LAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-------SRPPYTDYVST 161
Query: 400 FGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGR 433
Y APE ++ R++ S D+++ G ++ EL T R
Sbjct: 162 RWYRAPE--ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 67/238 (28%), Positives = 98/238 (41%), Gaps = 58/238 (24%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVD-------MLSRLHHCHV 284
+G G V + G+ A+K V L +V+ +L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRILQSIRH--- 60
Query: 285 VP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARG 340
P LV F+ + LV E++P G L L G E + R A + A
Sbjct: 61 -PFLVNLYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPV---ARFYAAQVVLA-- 113
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LEYLH I++RD+K N+LLD + KITD G AKR+K C GT
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--------GTP 162
Query: 401 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
Y APE Y G+A D ++ G+++ E++ G P I+ I +G+
Sbjct: 163 EYLAPEIILSKGY---GKA---VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 42/222 (18%)
Query: 232 IVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G + DG +I VA+K + P A+ L E +++ + +V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-NWDTRVAIAIGAARGL 341
L+G C + LV + MP G L R+ D + + + NW ++A +G+
Sbjct: 74 LLGICLT-----STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA------KGM 122
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-------ADGLPSCSSSPA 394
YL E R++HRD+ + N+L+ + KITD G+A+ L ADG P
Sbjct: 123 SYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG----GKVPI 175
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ + A E + R + SDV+S+GV + EL+T G +P
Sbjct: 176 K------WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 33/195 (16%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VA+K + + G + + L H ++V L+G C A LV + P G
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----ASLQLVTQLSPLG 93
Query: 312 NL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364
+L RD LD + +NW ++A +G+ YL E R++HR++ + NILL
Sbjct: 94 SLLDHVRQHRDSLDPQRL--LNWCVQIA------KGMYYLEEH---RMVHRNLAARNILL 142
Query: 365 DENLNAKITDLGMAKRLKADG---LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFS 421
+ +I D G+A L D S +P + + A E + GR + SDV+S
Sbjct: 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK------WMALESILFGRYTHQSDVWS 196
Query: 422 FGVVLLELIT-GRQP 435
+GV + E+++ G +P
Sbjct: 197 YGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 26/224 (11%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G + V++G +LT +VA+K + + A + EV +L L H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 347
+R + L VFE++ + +L+ LD G L+ N V I + RGL Y H+
Sbjct: 72 ---IHTERCLTL-VFEYLDS-DLKQYLDNCGNLMSMHN----VKIFMFQLLRGLSYCHKR 122
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ILHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 173
Query: 408 AMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
++G + D++ G +L E+ TGR S K E L+
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 55/169 (32%), Positives = 84/169 (49%), Gaps = 20/169 (11%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV 331
E D+L+ ++H +V L Y + GK L+ +F+ G+L L E M + V
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKL---YLILDFLRGGDLFTRLSK---EVMFTEEDV 100
Query: 332 AIAIGA-ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ A L++LH I++RD+K NILLDE + K+TD G++K D
Sbjct: 101 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAY 156
Query: 391 SSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIH 437
S GT Y APE +V R + +D +SFGV++ E++TG P
Sbjct: 157 S----FCGTVEYMAPE--VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G VY+ + + G + A+K K + G + V E+ M+ H ++V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNIVAYFG-- 73
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAAP 350
S R R + EF G+L+D V G ++++A ++ +GL YLH
Sbjct: 74 SYLR--RDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
+HRDIK +NILL +N + K+ D G++ ++ A + GT + APE A V
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEVAAV 180
Query: 411 GRA---SLMSDVFSFGVVLLELITGRQPI 436
R + + D+++ G+ +EL + P+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 224 TDKFSGSNIVGQGGSSYV--YRGQLTDGRIVAVKR----FKTQGGPNADSVFLTEVDMLS 277
T+++ VG G V R QLT G+ VA+K+ F T A + E+ +L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPV--LAKRTY-RELKLLK 64
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAI 335
L H +++ L F V E + R L+ + +
Sbjct: 65 HLRHENIISL---SDIFISPLEDIYFVTELLGTDLHR------LLTSRPLEKQFIQYFLY 115
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
RGL+Y+H A ++HRD+K SNIL++EN + KI D G+A+ +
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-----------IQDPQ 161
Query: 396 MQG---TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGR 433
M G T Y APE + + + D++S G + E++ G+
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 27/196 (13%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K + ++E++++ + H +++ L+G C++ ++ E+
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ----EGPLYVIVEYAAK 102
Query: 311 GNLRDCL------------DGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L D V E +++ V+ A ARG+EYL + R +HRD
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRD 159
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SL 415
+ + N+L+ E+ KI D G+A+ + +S R+ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRL--PVKWMAPE-ALFDRVYTH 215
Query: 416 MSDVFSFGVVLLELIT 431
SDV+SFG+++ E+ T
Sbjct: 216 QSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G VY+ + + G + A K +T+ + ++ E+++L+ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLLG-A 77
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ GK ++ EF P G +D +++E T I + + LE L + +
Sbjct: 78 FYWDGKLW---IMIEFCPGG----AVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 352 ILHRDIKSSNILLDENLNAKITDLGM-AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
I+HRD+K+ N+LL + + K+ D G+ AK +K L S GT + APE M
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDS----FIGTPYWMAPEVVMC 184
Query: 411 GRAS-----LMSDVFSFGVVLLELITGRQPIH 437
+D++S G+ L+E+ P H
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 3e-11
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 227 FSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 284
F +VG G VY+G+ + G++ A+K G + + E++ML + HH ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65
Query: 285 VPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
G + G LV EF G++ D + + + I RGL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH+ +++HRDIK N+LL EN K+ D G++ +L GT +
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-----RTVGRRNTFIGTPYW 177
Query: 403 FAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPI 436
APE SD++S G+ +E+ G P+
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 27/214 (12%)
Query: 232 IVGQGGSSYVYRG--QLTDGR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
I+G G + RG +L R VA+ + FL E L + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
G + RG M +V E+M NG L L +G LV G + G A G++YL
Sbjct: 72 EGVIT--RGNTMM--IVTEYMSNGALDSFLRKHEGQLVAGQLMG----MLPGLASGMKYL 123
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS--SPARMQGTFGY 402
E +H+ + + +L++ +L KI+ + K++ + + S SP +
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL------W 174
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE S SDV+SFG+V+ E+++ G +P
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G + VY+G +LTD +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
+ LVFE++ + +L+ LD G + N + + RGL Y H
Sbjct: 70 -HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYCHRR- 123
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYSNEVV--TLWYRPPD-I 175
Query: 409 MVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
++G S D++ G + E+ TGR P+ T E+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 33/217 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+G+ G+IVA+K+ + +G P S + E+ +L L H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKELQHPNIVCL 64
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLEYLH 345
+ RL L+FEF+ + +L+ LD + V + +G+ + H
Sbjct: 65 QDVLMQ-----ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFG 401
+ R+LHRD+K N+L+D K+ D G+A +A G+ P R+ T
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA---RAFGI------PVRVYTHEVVTLW 166
Query: 402 YFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + R S D++S G + E+ T + H
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 227 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 283
F G + +G G VY +VAVK+ G + + EV L +L H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 284 VVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
+ E++G K LV E+ G+ D L+ V + + AI GA +G
Sbjct: 83 TI-------EYKGCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQG 133
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGT 399
L YLH ++HRDIK+ NILL E K+ D G A + SSPA GT
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----------SSPANSFVGT 180
Query: 400 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPI 436
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDML 276
K+ +GQG V++ + +IVA+K+ + N F L E+ +L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKIL 65
Query: 277 SRLHHCHVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
L H +VV L+ C + + + LVFEF + +L L V+
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSEIKK 123
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+ GL Y+H +ILHRD+K++NIL+ ++ K+ D G+A+ S +S
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL----SKNSK 176
Query: 393 PARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 436
P R T Y PE + R D++ G ++ E+ T R PI
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
F+ +G+G VY+G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKG--IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLE 342
+ G S +G + ++ E++ G+ D L +E +T +A + +GL+
Sbjct: 64 ITRYYG--SYLKGTKLW--IIMEYLGGGSALDLLKPGPLE----ETYIATILREILKGLD 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH + R +HRDIK++N+LL E + K+ D G+A +L + + GT +
Sbjct: 116 YLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFW 167
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE +D++S G+ +EL G P
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 12/99 (12%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+YLH A ++HRD+K SNIL++ N + KI D G+A+ + D +
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-----DEKGFLTE 165
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 433
T Y APE + R + D++S G + EL+T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293
G GS Y + T G +A+K + + + + + E+D+L H V P Y +
Sbjct: 12 GNYGSVYKVLHRPT-GVTMAMKEIRLELDESKFNQIIMELDIL---HKA-VSP---YIVD 63
Query: 294 FRGKRAMRLLVF---EFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
F G + V+ E+M G+L G V EG+ D I +GL++L E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEYA 408
I+HRD+K +N+L++ N K+ D G++ L A S A+ G Y APE
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--------SLAKTNIGCQSYMAPERI 173
Query: 409 MVGRA------SLMSDVFSFGVVLLELITGRQP 435
G ++ SDV+S G+ +LE+ GR P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT----QGGPNADSVFLTEVDMLSRL 279
D + +G+G VY+ + G++VA+K+ + +G P L E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP---PTALREISLLQML 57
Query: 280 HHC-HVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAI 333
++V L V + E GK LVFE++ + +L+ +D + T +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGK-PSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSS 392
+G+ + H+ ++HRD+K N+L+D+ KI DLG+ +A +P S +
Sbjct: 116 MYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG---RAFSIPVKSYT 169
Query: 393 PARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 436
+ T Y APE + S D++S G + E+ +QP+
Sbjct: 170 HEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G S VYR L DG VA+K+ + AD + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIK- 66
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGL 341
Y + F + + V E G+L + ++ E W V + L
Sbjct: 67 --YYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SAL 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
E++H + R++HRDIK +N+ + K+ DLG+ + S +++ + GT
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-----SKTTAAHSLVGTPY 171
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y +PE + SD++S G +L E+ + P +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 218 SALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDML 276
SAL F +VG G VY+G+ + G++ A+K + + E++ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINML 66
Query: 277 SRL-HHCHVVPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+ HH ++ G + G LV EF G++ D + + D I
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
RGL +LH A +++HRDIK N+LL EN K+ D G++ +L +
Sbjct: 127 CREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--------DRTV 175
Query: 394 ARMQ---GTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPI 436
R GT + APE SD++S G+ +E+ G P+
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 46/181 (25%), Positives = 87/181 (48%), Gaps = 11/181 (6%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K + ++E+ ++S L +H ++V L+G C+ L++ E+
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----IGGPILVITEYCCY 123
Query: 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370
G+L + L + + ++ + A+G+ +L A+ +HRD+ + N+LL
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIV 180
Query: 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430
KI D G+A+ + D AR+ + APE + SDV+S+G++L E+
Sbjct: 181 KICDFGLARDIMNDS-NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 431 T 431
+
Sbjct: 238 S 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 28/232 (12%)
Query: 219 ALEHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLS 277
+L TD + +G+G VY+ DG + AVK + D E ++L
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQ 73
Query: 278 RL-HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--I 333
L +H +VV G + +L LV E G++ + + G+L+ G D + I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
GA GL++LH RI+HRD+K +NILL K+ D G++ +L + L +S
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189
Query: 394 ARMQGTFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITGRQPI 436
GT + APE Y+ R DV+S G+ +EL G P+
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 27/191 (14%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-- 325
E +L+++ H ++V + F + +V E+ G+L + + E
Sbjct: 48 EAVLLAKMKHPNIV---AFKESFEADGHL-YIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
W ++ + G++++HE R+LHRDIKS NI L +N K+ D G A+ L + G
Sbjct: 104 QWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
+C+ GT Y PE + SD++S G +L EL T + P + K
Sbjct: 155 AYACT-----YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--- 206
Query: 446 SLVLWTATGIY 456
+L+L G Y
Sbjct: 207 NLILKVCQGSY 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL++LH I++RD+K NILLD + + KI D GM K +C+ GT
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-----FCGT 159
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + + + D +SFGV+L E++ G+ P H
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
VGQGG V+ + D G IVA+KR K + V LTE D+L+ +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAI-----AIGAARGLE 342
Y F+ + L E++P G+ R L+ GVL E R + A+ A
Sbjct: 68 Y--AFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFEAVDA----- 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
LHE +HRD+K N L+D + + K+TD G++K G+ + ++S + G+ Y
Sbjct: 117 -LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANS---VVGSPDY 164
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE D +S G +L E + G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL--VFEFMPNGNLRDCL--DGVLVEG 324
F E + +RL+H ++V L+ G+ LL VFE++P LR+ L DG L G
Sbjct: 25 FRRETALCARLYHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 325 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 381
+ + L H I+HRD+K NI++ +AK+ D G+ L
Sbjct: 80 ----ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 382 KA--DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
D + + + GT Y APE + SD++++G++ LE +TG+
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 26/183 (14%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 325
E +LS+L H ++V Y + G+ + +V F G+L L G L+ + +
Sbjct: 49 EAQLLSQLKHPNIV---AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
W ++A+A L+YLHE ILHRD+K+ N+ L K+ DLG+A+ L+
Sbjct: 106 EWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--- 153
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
+ + + GT Y +PE + SDV++ G + E+ T + H K
Sbjct: 154 --NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMN 208
Query: 446 SLV 448
SLV
Sbjct: 209 SLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 226 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHC 282
++ +G+G G Y+ + + +D +K P + EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEG---MNWDTRVAIAIG 336
++V + + F+ + +V E+ G+L ++ GVL ++W ++++
Sbjct: 60 NIV---TFFASFQENGRL-FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL--- 112
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLK--ADGLPSCSSSP 393
GL+++H+ +ILHRDIKS NI L +N + AK+ D G+A++L + +C +P
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y +PE + +D++S G VL EL T + P
Sbjct: 167 Y-------YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 38/103 (36%), Positives = 53/103 (51%), Gaps = 26/103 (25%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SNI ++E+ KI D G+A R D M G
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA-RHTDD----------EMTG 174
Query: 399 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGR 433
T Y APE M+ M D++S G ++ EL+TG+
Sbjct: 175 YVATRWYRAPE-IMLNW---MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 2e-10
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 227 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 282
F+ +G G G+ Y R T+ +VA+K+ G + + + EV L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 283 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 86 NSI-------EYKGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQ 136
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL YLH + ++HRDIK+ NILL E K+ D G A S +S GT
Sbjct: 137 GLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA---------SIASPANSFVGT 184
Query: 400 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPI 436
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
V G S +G + ++ E++ G+ D L + T + + +GL+Y
Sbjct: 64 VTKYYG--SYLKGTKLW--IIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 116
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH + + +HRDIK++N+LL E + K+ D G+A +L + + GT +
Sbjct: 117 LH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFWM 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE +D++S G+ +EL G P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAIGAA-RGL 341
V G S + + ++ E++ G+ D L+ G L E T++A + +GL
Sbjct: 64 VTKYYG--SYLKDTKLW--IIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGL 114
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
+YLH + + +HRDIK++N+LL E+ K+ D G+A +L + GT
Sbjct: 115 DYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----NTFVGTPF 166
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ APE +D++S G+ +EL G P
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+YLH A ILHRDIK N+L++ N KI D G+A+ + D S + +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVV-- 166
Query: 399 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGR 433
T Y APE M R + D++S G + EL+ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 14/101 (13%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARM 396
GL++LH+ I++RD+K N+LLD++ + KI D GM K + +G S C
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------- 157
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G VY+ Q + ++A + ++ E+D+L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL---D 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE---YLHEAAA 349
F + + +L+ EF G +D V++E T I + + LE YLHE
Sbjct: 70 AFYYENNLWILI-EFCAGG----AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-- 122
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+I+HRD+K+ NIL + + K+ D G++ + + S GT + APE M
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS----FIGTPYWMAPEVVM 176
Query: 410 VGRAS-----LMSDVFSFGVVLLELITGRQPIH 437
+ +DV+S G+ L+E+ P H
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
D + +G+G + VY+G+ +G++VA+K + Q + E +L L H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+V L + + LVFE++ + +L +D G++ + RGL Y
Sbjct: 65 IVLL----HDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSY 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H+ ILHRD+K N+L+ + K+ D G+A +A +PS + S + T Y
Sbjct: 119 IHQR---YILHRDLKPQNLLISDTGELKLADFGLA---RAKSVPSHTYSNEVV--TLWYR 170
Query: 404 APEYAMVGRA--SLMSDVFSFGVVLLELITG 432
P+ ++G S D++ G + +E+I G
Sbjct: 171 PPD-VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 233 VGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLV 288
+G+G V GQL D I VAVK K ++ FL+E + H +V+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 289 GYC---SEFRGKRAMRLLVFEFMPNGNLRDCLD----GVLVEGMNWDTRVAIAIGAARGL 341
G C E G + +++ FM +G+L L G + + V A G+
Sbjct: 67 GVCLQTVESEGYPS-PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYL ++ +HRD+ + N +L+EN+N + D G++K++ +G A+M
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM--PVK 179
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ A E + SDV+SFGV + E+ T G+ P
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
+G G VY + + + +VA+K+ G + + + EV L +L H + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---- 78
Query: 290 YCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
++RG + LV E+ G+ D L+ V + + A+ GA +GL YLH
Sbjct: 79 ---QYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 405
++HRD+K+ NILL E K+ D G A + +PA GT + AP
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APANXFVGTPYWMAP 180
Query: 406 EYAMV---GRASLMSDVFSFGVVLLELITGRQPI 436
E + G+ DV+S G+ +EL + P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G + V++G +LT+ +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 347
+ LVFE++ + +L+ +D G ++ N V I + RGL Y H
Sbjct: 70 -HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCHRR 123
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 174
Query: 408 AMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
++G + S D++ G + E+ +GR S + E L+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHH 281
D++ +G+G VY+ + +T+ +A+K+ + Q S + E+ +L + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 282 CHVVPL--VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIG 336
++V L V + + RL LVFE++ + +L+ +D + R+
Sbjct: 61 GNIVRLQDVVHSEK-------RLYLVFEYL-DLDLKKHMDSS--PDFAKNPRLIKTYLYQ 110
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPAR 395
RG+ Y H + R+LHRD+K N+L+D NA K+ D G+A +A G+P + +
Sbjct: 111 ILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA---RAFGIPVRTFTHEV 164
Query: 396 MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
+ T Y APE + R S D++S G + E++ +
Sbjct: 165 V--TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 33/94 (35%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH I++RD+K N+LLD + K+TD G AK++ C GT
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--------GTPE 180
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV+L E I G P
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L++LH+ I++RDIK NILLD + +TD G++K A+ S GT
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS----FCGTI 170
Query: 401 GYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
Y APE G D +S GV+ EL+TG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 26/218 (11%)
Query: 233 VGQGGSSYVYRGQLTDGRI---VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G V G++ G V VK + FL E L H +++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRV--AIAIGAARGLEYLHE 346
C+E LLV EF P G+L+ L E M D +A A GL +LH+
Sbjct: 63 QCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPSCSSSPARMQGTFGYFAP 405
+H D+ N LL +L KI D G++ + K D +P ++ + AP
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY----VTPDQLWVPLRWIAP 171
Query: 406 EYA-------MVGRASLMSDVFSFGVVLLELIT-GRQP 435
E +V + S+V+S GV + EL G QP
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL++LH I++RD+K N++LD + + KI D GM K G + + GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFG----DNRASTFCGT 159
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 37/104 (35%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
GL++LHE I++RD+K N+LLD + KI D GM K G+ + C
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC------- 157
Query: 397 QGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE Y G A D ++ GV+L E++ G+ P
Sbjct: 158 -GTPDYIAPEILSYQPYGPA---VDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 37/233 (15%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRF-KTQGGPNADSVFL-TEVDMLSRLHHCHVVPL 287
++G+G G + R + T ++ A+K K + +DS F E D+++ + VV L
Sbjct: 50 VIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW----DTRVAIAIGAARGLEY 343
F+ R + +V E+MP G+L + + V W V +A+ A + +
Sbjct: 109 F---YAFQDDRYL-YMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF 163
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H RD+K N+LLD++ + K+ D G ++ +G+ C ++ GT Y
Sbjct: 164 IH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYI 210
Query: 404 APEY-------AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
+PE GR D +S GV L E++ G P + G S ++
Sbjct: 211 SPEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHC 282
+KF +VG+G V + + + + IVA+K+FK ++ L E+ ML L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEF-----------MPNGNLRDCLDGV---LVEGMNWD 328
++V L FR +R LVFE+ MPNG + + L++ ++W
Sbjct: 61 NIVELK---EAFR-RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW- 115
Query: 329 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
H+ I+HRDIK N+L+ N K+ D G A+ L
Sbjct: 116 ---------------CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE----G 153
Query: 389 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+++ T Y +PE + D++S G +L EL G QP+
Sbjct: 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 30/109 (27%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + S M
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTE 167
Query: 399 ---TFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQPI 436
T Y APE L++ DV+S G + EL+ GR+P+
Sbjct: 168 YVVTRWYRAPEL-------LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 29/215 (13%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCS 292
++ + + T +VAVK+ D L E+ +L H +++P Y +
Sbjct: 11 EDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVT 66
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI---GAARGLEYLHEAAA 349
F + +V M G+ D L EG+ +AIA L+Y+H
Sbjct: 67 SFIVDSEL-YVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKG- 121
Query: 350 PRILHRDIKSSNILLDENLNAKITDL----GMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+HR +K+S+ILL + ++ L M K K + P + +P
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSP 177
Query: 406 EYAMVGRASLM-----SDVFSFGVVLLELITGRQP 435
E V + +L SD++S G+ EL G P
Sbjct: 178 E---VLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 233 VGQGGSSYVYRG---QLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLV 288
+G G V +G + VAVK K P L E +++ +L + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLH 345
G C + M LV E G L L V + + + + G++YL
Sbjct: 63 GIC---EAESWM--LVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE 112
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYF 403
E +HRD+ + N+LL AKI+D G++K L AD + A+ G + ++
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE----NYYKAKTHGKWPVKWY 165
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 449
APE + S SDV+SFGV++ E + G++P KG E +
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 14/101 (13%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A GL +LH I++RD+K N++LD + KI D GM K G + +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-----FC 162
Query: 398 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G++ D ++FGV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 23/107 (21%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + P
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR----------IADPEHDHT 163
Query: 399 TF--------GYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI 436
F Y APE + + + D++S G +L E+++ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
LE+LH+ I++RDIK NILLD N + +TD G++K D + S GT
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS----FCGT 169
Query: 400 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
Y AP+ G D +S GV++ EL+TG P
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 64/237 (27%), Positives = 102/237 (43%), Gaps = 48/237 (20%)
Query: 233 VGQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLT-----EVDMLSRLHHCHV 284
+G+G VY+ + DG+ A+K+FK G ++ E+ +L L H +V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK---GDKEQYTGISQSACREIALLRELKHENV 64
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAA----- 338
V LV E K L+F++ + D L + + + + ++I +
Sbjct: 65 VSLVEVFLEHADKSVY--LLFDYAEH-------D--LWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 339 -----RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSC 389
G+ YLH +LHRD+K +NIL+ E KI DLG+A+ A P
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEE 445
P + T Y APE + R + D+++ G + EL+T PI KG E
Sbjct: 171 DLDPVVV--TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PIF----KGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 54/177 (30%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEGMNWD----------TRVAIAIGAARGLEYLHEAAAPRI 352
+V E+MP G+L + + N+D V +A+ A + ++H
Sbjct: 120 MVMEYMPGGDLVNLMS-------NYDIPEKWARFYTAEVVLALDAIHSMGFIH------- 165
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--- 409
RD+K N+LLD++ + K+ D G ++ A+G+ C ++ GT Y +PE
Sbjct: 166 --RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDYISPEVLKSQG 219
Query: 410 ----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIY---LDH 459
GR D +S GV L E++ G P + +SLV G Y +DH
Sbjct: 220 GDGYYGRE---CDWWSVGVFLYEMLVGDTPFY------ADSLV-----GTYSKIMDH 262
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 16/187 (8%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
GR VAVK + + +F EV ++ H +VV + Y S G+ L+ EF+
Sbjct: 46 GRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEM--YKSYLVGEELWVLM--EFL 100
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
G L D + +N + + + L YLH + ++HRDIKS +ILL +
Sbjct: 101 QGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDG 154
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
K++D G ++ D +P S + GT + APE D++S G++++E
Sbjct: 155 RVKLSDFGFCAQISKD-VPKRKS----LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
Query: 429 LITGRQP 435
++ G P
Sbjct: 210 MVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 67/303 (22%), Positives = 130/303 (42%), Gaps = 63/303 (20%)
Query: 151 LRSSVISSDKESCNSATNLISHRITSVPETRVEVVSPIDLATGC------FLKTTFCRSK 204
L+S+ SS+K++ S ++SH P + ++L C ++ T +CR
Sbjct: 75 LKSTARSSEKQALMSELKIMSHL---GPHLNI-----VNLLGACTKGGPIYIITEYCR-- 124
Query: 205 TWTIHGTII----RFSYSALEHATDK-------FSGSNIVGQGGSSYVYRGQLTDGRIVA 253
+G ++ R ++ L++ DK SG + S+V G +DG +
Sbjct: 125 ----YGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180
Query: 254 VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL 313
+ + + + ++ DM + + + Y S + +++P+
Sbjct: 181 MSK-------DESADYVPMQDMKGTVKYADIES-SNYESPYD----------QYLPSAPE 222
Query: 314 RDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371
R D ++ E +++ V + A G+E+L A+ +HRD+ + N+L+ E K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVK 279
Query: 372 ITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGVVLLE 428
I D G+A+ + D S+ TF + APE + +SDV+SFG++L E
Sbjct: 280 ICDFGLARDIMRD------SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 429 LIT 431
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 50/242 (20%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + VY+G +G++VA+K + + E +L L H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 292 SEFRGKRAMRLLVFEFM-----------PNG----NLRDCLDGVLVEGMNWDTRVAIAIG 336
+ + VFE+M P G N+R + +L
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL--------------- 113
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
RGL Y+H ILHRD+K N+L+ K+ D G+A +A +PS + S +
Sbjct: 114 --RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA---RAKSIPSQTYSSEVV 165
Query: 397 QGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLV-LWTAT 453
T Y P+ ++G S D++ G + +E++ G QP ++ E L +WT
Sbjct: 166 --TLWYRPPD-VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIWTVL 221
Query: 454 GI 455
G+
Sbjct: 222 GV 223
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G+G S VYR L D + VA+K+ + A + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK--- 66
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 343
Y F + + V E G+L + ++ E W V + +E+
Sbjct: 67 YLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H + R++HRDIK +N+ + K+ DLG+ + + +++ + GT Y
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYM 173
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+PE + SD++S G +L E+ + P +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGY 402
+H + ++HRDIKS+NILL N K+ D G +K A + S R GT Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----TVSDDVGRTFCGTPYY 211
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE S +D+FS GV+L EL+T ++P
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 398
L YLHE I++RD+K N+LLD + K+TD GM K +GL P ++S G
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTS--TFCG 158
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 398
L +LHE I++RD+K N+LLD + + K+TD GM K +GL P ++S G
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTST--FCG 158
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++ + + IVA+KR + +G P S L E+ +L L H ++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRL 64
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
Y K+ LVFE+ + +L+ D + ++ + + +GL + H
Sbjct: 65 --YDVLHSDKKLT--LVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+LHRD+K N+L+++N K+ D G+A +A G+P S + T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVRCYSAEVV--TLWYRPPD- 169
Query: 408 AMVGRASLMS---DVFSFGVVLLELITGRQPI 436
+ G A L S D++S G + EL +P+
Sbjct: 170 VLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 36/95 (37%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 396
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 237
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
+ APE + SDV+SFGV+L E+ +
Sbjct: 238 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 189 DLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVY----RG 244
L+ + C + + + +++R Y+ L T G V+ G
Sbjct: 66 SLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLT----------PGSEGEVFVCTKHG 115
Query: 245 QLTDGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302
+++ AV KT G E+D+L + H ++ L+ +R K
Sbjct: 116 DEQRKKVIVKAVTGGKTPG---------REIDILKTISHRAIINLI---HAYRWKS---- 159
Query: 303 LVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
V MP +L +D + + + I L YLH I+HRD+K+
Sbjct: 160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTE 214
Query: 361 NILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
NI LDE NA + D G A +L A P C GT +PE + +D+
Sbjct: 215 NIFLDEPENAVLGDFGAACKLDAHPDTPQCYG----WSGTLETNSPELLALDPYCAKTDI 270
Query: 420 FSFGVVLLELITGRQPI 436
+S G+VL E+ +
Sbjct: 271 WSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 20/103 (19%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--- 397
LEYLH + +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTFC 156
Query: 398 GTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE GRA D + GVV+ E++ GR P +
Sbjct: 157 GTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 57/218 (26%)
Query: 241 VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL----VG-- 289
VYR + G IVA+K+ K + F L E+++L +L H ++V + VG
Sbjct: 21 VYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77
Query: 290 ----YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA----IAIGAARGL 341
Y +V E++ + +L+ L+E M + + + G+
Sbjct: 78 LDKIY------------MVMEYVEH-DLKS-----LMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----MQ 397
+LH+ ILHRD+K+SN+LL+ KI D G+A+ SP + +
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY---------GSPLKPYTQLV 167
Query: 398 GTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQ 434
T Y APE + S D++S G + EL+T +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 265 ADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE 323
+DS F E D+++ + VV L +C+ F+ + + +V E+MP G+L + + V
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQL--FCA-FQDDKYL-YMVMEYMPGGDLVNLMSNYDVP 140
Query: 324 ---GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ V +A+ A +H ++HRD+K N+LLD++ + K+ D G +
Sbjct: 141 EKWAKFYTAEVVLALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 381 LKADGLPSCSSSPARMQGTFGYFAPEY-------AMVGRASLMSDVFSFGVVLLELITGR 433
+ G+ C ++ GT Y +PE GR D +S GV L E++ G
Sbjct: 192 MDETGMVRCDTA----VGTPDYISPEVLKSQGGDGYYGRE---CDWWSVGVFLFEMLVGD 244
Query: 434 QPIHRSITKGEESLVL 449
P + G S ++
Sbjct: 245 TPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L +LHE I++RD+K N+LLD + K+TD GM K G + + GT
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-----DTTSTFCGTP 160
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV++ E++ GR P
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 20/103 (19%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLH +++RD+K N++LD++ + KITD G+ K +DG ++ GT
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTP 159
Query: 401 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE Y GRA D + GVV+ E++ GR P +
Sbjct: 160 EYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 9/100 (9%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 396
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGSARL 238
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ APE + SDV+SFGV+L E+ + G P
Sbjct: 239 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ GL +LH I++RD+K N++LD + KI D GM K DG+ + +
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-----FC 162
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE D +++GV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L+YLH + +++RD+K N++LD++ + KITD G+ K DG ++ GT
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-----ATMKTFCGT 159
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE D + GVV+ E++ GR P +
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GL YLH A RI+HRD+K+ NI +++ I DLG A+ P + + + G
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ------FPVVAPAFLGLAG 218
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430
T APE + + +D++S G+VL E++
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMN--W 327
E +L + H ++ L + +E +R + +L E++P G L L G +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTE-HDQRFLYML-MEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 328 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387
+ + A+ EYLH + I++RD+K NILLD+ + K+TD G AK+L+
Sbjct: 107 ASEIVCAL------EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157
Query: 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
C GT Y APE + D ++ G+++ E++ G P
Sbjct: 158 LC--------GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L+YLH +I++RD+K N++LD++ + KITD G+ K D +++ GT
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-----AATMKTFCGT 158
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE D + GVV+ E++ GR P +
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 9/100 (9%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 396
A+G+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 243
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ APE ++ SDV+SFGV+L E+ + G P
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 234 GQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G+G + VY+G+ LT ++VA+K + + A + E +L L H ++V L
Sbjct: 14 GEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---- 68
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ + LVFE++ + +L+ +D G++ RGL Y H+ R
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 411
+LHRD+K N+L+ E K+ D G+A +A +PS + S + T Y P+ +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 412 RA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
S D++ G + E+ TGR P+ T E+ L
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR-PLFPGSTDVEDQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 232 IVGQGGSSYVYRGQLTDG----RIVAVKRFKTQG-GPNADSVFLT--EVDMLSRLHHCHV 284
++G+GG V++ + G +I A+K K N T E ++L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 342
V L+ Y + GK L+ E++ G L L+ G+ +E DT + LE
Sbjct: 63 VDLI-YAFQTGGKL---YLILEYLSGGELFMHLEREGIFME----DTACFYLSEISLALE 114
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH+ I++RD+K NILLD + K+TD G+ K +G + GT Y
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----TVTHTFCGTIEY 166
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE M D +S G ++ +++TG P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-----------TDDEMTG 176
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 433
T Y APE + + D++S G ++ EL+TGR
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 14/101 (13%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A GL +LH I++RD+K N++LD + KI D GM K DG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-----TTKTFC 162
Query: 398 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G++ D ++FGV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 10/99 (10%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 397
+ L+Y+H ++HRD+K SNILL+ + K+ D G+A+ L L +P
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDY 172
Query: 398 -GTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 433
T Y APE ++G R + D++S G +L E++ G+
Sbjct: 173 VATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 58/270 (21%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
D F ++G+G V Q D G I A+K + + V E D+L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMN-WDTRVAIAIGA 337
VV + F+ KR + L+ EF+P G++ L D + E + +AI A
Sbjct: 61 AWVVKMF---YSFQDKRNL-YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----------ADGL 386
L ++H RDIK N+LLD + K++D G+ LK
Sbjct: 117 IHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 387 PSCSS-------------SPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLL 427
PS S R Q GT Y APE M + + D +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 428 ELITGRQPI--------HRSITKGEESLVL 449
E++ G P +R + +E+LV
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKETLVF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 48/234 (20%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADS-------------VFLTEVDML 276
+G+G V + T G+IVA+K+ K N + L E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 277 SRLHHCHVVPLVG-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--- 332
+ + H +++ LV Y LV + M +L+ +D R+
Sbjct: 75 NEIKHENIMGLVDVYVEG-----DFINLVMDIM-ASDLKKVVDR--------KIRLTESQ 120
Query: 333 ---IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389
I + GL LH+ +HRD+ +NI ++ KI D G+A+R
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 390 SSSPARMQG---------TFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGR 433
S MQ T Y APE M + D++S G + EL+TG+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 34/127 (26%), Positives = 62/127 (48%), Gaps = 12/127 (9%)
Query: 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
+ +++ L EG+ ++ ARG+E+L A+ +HRD+ + N+LL +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG 273
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGV 424
KI D G+A+ + D S+ TF + APE + +SDV+S+G+
Sbjct: 274 KIVKICDFGLARDIMHD------SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 425 VLLELIT 431
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 18/99 (18%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+GL+Y+H A I+HRD+K N+ ++E+ KI D G+A++ + + M G
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-----------TDSEMTG 174
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 433
T Y APE + + D++S G ++ E++TG+
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY--A 408
+HRDIK N+LLD+N + ++ D G RL ADG + S+ A GT Y +PE A
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--VGTPDYISPEILQA 177
Query: 409 M---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
M GR D +S GV + E++ G P + ESLV
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 26/167 (15%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 325
EV +LS + H ++V Y F + +V ++ G+L ++ GVL + +
Sbjct: 49 EVAVLSNMKHPNIVQ---YQESFE-ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
+W ++ +A L+++H+ +ILHRDIKS NI L ++ K+ D G+A+ L +
Sbjct: 105 DWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-- 153
Query: 386 LPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
+ AR GT Y +PE + SD+++ G VL E+ T
Sbjct: 154 ----TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 22/107 (20%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GL+Y+H A +LHRD+K N+L++ + KI D G+A+ S +P G
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGENAG 164
Query: 399 -------TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI 436
T Y APE M+ S DV+S G +L EL+ GR+P+
Sbjct: 165 FMTEYVATRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L E + +++HRD+KS+NI L K+ D G +K+ +SS GT Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS---FCGTPYYL 238
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE R S +D++S GV+L EL+T +P
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 64/208 (30%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-- 329
E D+L+ + VV L Y S F+ + + L+ E++P G++ L M DT
Sbjct: 51 ERDILAEADNPWVVKL--YYS-FQDENYL-YLIMEYLPGGDMMTLL-------MKKDTFT 99
Query: 330 ---------RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+AI + L Y+H RDIK N+LLD + K++D G+
Sbjct: 100 EEETRFYIAETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTG 150
Query: 381 LKADG---------------LPSCSSSP------------ARMQ------GTFGYFAPEY 407
LK S P R GT Y APE
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
+ + D +S GV++ E++ G P
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLH 280
+D + +G+G V++ +G AVK P + D E ++L L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD----PIHDIDEEIEAEYNILKALS 72
Query: 281 -HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIG 336
H +VV G + K +L LV E G++ D + G L G M I
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
A GL++LH + +HRD+K +NILL K+ D G++ +L + L +S
Sbjct: 133 ALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV---- 185
Query: 397 QGTFGYFAPEYAMVGRASLMS------DVFSFGVVLLELITGRQPI 436
GT + APE + L S DV+S G+ +EL G P+
Sbjct: 186 -GTPFWMAPE-VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 41/202 (20%)
Query: 267 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVL 321
S + EV+++ L H ++V Y F K +L ++ EF G N++ C +
Sbjct: 57 SQLVIEVNVMRELKHKNIVR---YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--M 111
Query: 322 VEGMNWDTRVAIAIGAARGLEYLHEAA----APRILHRDIKSSNILLD------------ 365
+ V I L Y H R+LHRD+K NI L
Sbjct: 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 366 -ENLN----AKITDLGMAKRLKADGLP-SCSSSPARMQGTFGYFAPEYAMVGRASL--MS 417
NLN AKI D G++K + + + SC +P Y++PE + S S
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPY-------YWSPELLLHETKSYDDKS 224
Query: 418 DVFSFGVVLLELITGRQPIHRS 439
D+++ G ++ EL +G+ P H++
Sbjct: 225 DMWALGCIIYELCSGKTPFHKA 246
|
Length = 1021 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+ Y+H+ RILHRD+K+ NI L NL KI D G+++ L + SC + GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL----MGSCDLATT-FTGT 168
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLEL 429
Y +PE SD++S G +L E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
R L+Y+H A + HRD+K NIL + + KI D G+A+ D + +
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVA 168
Query: 399 TFGYFAPEY--AMVGRASLMSDVFSFGVVLLELITGR 433
T Y APE + + + D++S G + E++TG+
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L +LH+ I++RD+K N+LLD + K+ D GM K +G + + GT
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT-----STFCGTP 160
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV+L E++ G P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H +HRDIK N+LLD N + ++ D G ++ DG + SS A GT Y
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVA--VGTPDYI 170
Query: 404 APEY--AM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
+PE AM +G+ D +S GV + E++ G P + ESLV
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE+LH+ I++RDIK NILLD + +TD G++K L GT
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEKERTYSFCGTI 170
Query: 401 GYFAPEY--AMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE G + D +S G+++ EL+TG P
Sbjct: 171 EYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
VG+G +VY+ + DG+ K G E+ +L L H +V+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 293 EFRGKRAMRLLVFEF-----------------------MPNGNLRDCLDGVLVEGMNWDT 329
++ L+F++ +P G ++ L +L
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-------- 118
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADG 385
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ +
Sbjct: 119 ---------DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 437
P P + TF Y APE + R + D+++ G + EL+T H
Sbjct: 167 KPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 26/103 (25%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GL+Y+H A I+HRD+K N+ ++E+ KI D G+A+ + A M G
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAEMTG 173
Query: 399 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGR 433
T Y APE + + M D++S G ++ E++TG+
Sbjct: 174 YVVTRWYRAPEVIL----NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 40/123 (32%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ IAI + L Y+H RDIK NIL+D N + ++ D G +L DG +
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQ 159
Query: 391 SSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
SS A GT Y +PE G+ D +S GV + E++ G P + E
Sbjct: 160 SSVA--VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY------AE 211
Query: 446 SLV 448
SLV
Sbjct: 212 SLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 29/221 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G V ++ VA VK K + FL + D L H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT----RVAIAIGAARGLEYLH 345
C E LLVFE+ G+L+ L N R+A I A G+ ++H
Sbjct: 63 QCVE----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMH 116
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPSCSSSPARMQGTFGYFA 404
+ LH D+ N L +L K+ D G+ R K D + + ++ + A
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLA 169
Query: 405 PEYAMVGRASLM-------SDVFSFGVVLLELI-TGRQPIH 437
PE L+ S+V++ GV L EL QP
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 19/139 (13%)
Query: 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366
FM G+ L EGM+ I GA RGL YLH+ +HR+IK+S+IL+
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISG 136
Query: 367 NLNAKITDLGMAKRLKADG--------LPSCSSSPARMQGTFGYFAPEYAM--VGRASLM 416
+ ++ L L +G P S+S + +PE + ++
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS------VLPWLSPELLRQDLYGYNVK 190
Query: 417 SDVFSFGVVLLELITGRQP 435
SD++S G+ EL TGR P
Sbjct: 191 SDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLH+ RI+HRD+ +NI+L E+ ITD G+AK+ + + S + GT
Sbjct: 126 LRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE------SKLTSVVGTI 177
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439
Y PE +DV++FG +L ++ T + P + +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ + P P
Sbjct: 120 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 396 MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 437
+ TF Y APE + R + D+++ G + EL+T H
Sbjct: 177 V--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 27/192 (14%)
Query: 252 VAVKRF---KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
VA+KRF K D VF +E +L+ ++H V L G F+ + + LV EF+
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYG---SFKDESYL-YLVLEFV 113
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL--EYLHEAAAPRILHRDIKSSNILLDE 366
G L + V A L EYL I++RD+K N+LLD+
Sbjct: 114 IGGEFFT----FLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDK 166
Query: 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVV 425
+ K+TD G AK + C GT Y APE + VG +D ++ G+
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLC--------GTPEYIAPEILLNVGHGK-AADWWTLGIF 217
Query: 426 LLELITGRQPIH 437
+ E++ G P +
Sbjct: 218 IYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARMQ 397
LE+LH+ I++RD+K NILLD + + D G++K L + + C
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-------- 157
Query: 398 GTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE + + + D +S GV++ E+ G P +
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SN+ ++E+ +I D G+A++ + M G
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-----------ADDEMTG 174
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 433
T Y APE + + D++S G ++ EL+ G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 51/218 (23%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
G+G S V + Q G+ A+K K L E+ L RL H +++ L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 292 SEFRGKRAMRL-LVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+ ++ RL LVFE M + NL + L V+ + + L++
Sbjct: 68 FD---RKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL--------LKSLDH 115
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGTFGY 402
+H I HRDIK NIL+ +++ K+ D G + + S P T Y
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGI-------YSKPPYTEYISTRWY 164
Query: 403 FAPE---------YAMVGRASLMSDVFSFGVVLLELIT 431
APE M D+++ G V E+++
Sbjct: 165 RAPECLLTDGYYGPKM--------DIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
NI+G G VY D VA+K K P + E+ ++ L+H +++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN---RELLIMKNLNHINIIFLKD 126
Query: 290 Y----CSEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIG 336
Y C + K +V EF+P L LV+ ++
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL------- 179
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPAR 395
R L Y+H + I HRD+K N+L+D N + K+ D G AK L A G S S +R
Sbjct: 180 -CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-GQRSVSYICSR 234
Query: 396 MQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITG 432
Y APE M+G + + D++S G ++ E+I G
Sbjct: 235 F-----YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L +LH +++RD+K NILLD + K+ D GM K +G+ + + GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-----FCGTP 160
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV++ E++ G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 54/268 (20%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F ++G+G V Q D G + A+K + + V E D+L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR 339
VV + F+ K + L+ EF+P G++ L L E +T+ IA
Sbjct: 61 LWVVKMF---YSFQDKLNL-YLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIA-ETVL 112
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-----------DGLPS 388
++ +H+ +HRDIK N+LLD + K++D G+ LK LPS
Sbjct: 113 AIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 389 -------CSSSPA------RMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 429
S A R Q GT Y APE M + + D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 430 ITGRQPI--------HRSITKGEESLVL 449
+ G P ++ + +E+L+
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + P S +
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVD----PHYSHKGYLSE 177
Query: 398 G--TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
G T Y +P + + D+++ G + E++TG+
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE LH+ +++RD+K NILLD + + D G+ K D GT
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-----DDKTNTFCGTP 157
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + + D ++ GV+L E++TG P +
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 14/99 (14%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL+YLHE +I++RD+K N+LLD KI D G+ K G + GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-----DRTSTFCGT 164
Query: 400 FGYFAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP 435
+ APE RA D + GV++ E++ G P
Sbjct: 165 PEFLAPEVLTETSYTRA---VDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A L YLH I++RD+K NILLD + +TD G+ K +G+ + S +
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGI-AQSDTTTTFC 157
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE D + G VL E++ G P +
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G G+ Y+ R + T R A+K+ Q VF+ E D+L+ + VV + +
Sbjct: 12 GAYGAVYLVRHKETRQRF-AMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM--F 67
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------GLE 342
CS F KR + +V E++ G DC L++ + A+ + AR LE
Sbjct: 68 CS-FETKRHL-CMVMEYVEGG---DC--ATLLKNIG-----ALPVDMARMYFAETVLALE 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS----------- 391
YLH I+HRD+K N+L+ + K+TD G++K GL S ++
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDT 168
Query: 392 ---SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
++ GT Y APE + D ++ G++L E + G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 34/108 (31%), Positives = 45/108 (41%), Gaps = 35/108 (32%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQG 398
L LH+ I+H DIK N+L D + + D G+ K + G PSC G
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSC------YDG 168
Query: 399 TFGYFAPE------YAMVGRASLMSDVFSF-----GVVLLELITGRQP 435
T YF+PE Y SF GV+ EL+TG+ P
Sbjct: 169 TLDYFSPEKIKGHNYD-----------VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+A A+G YLH I++RD+K NILLD + +TD G+ K +G+ S
Sbjct: 105 IASALG------YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEH-S 150
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ + GT Y APE D + G VL E++ G P +
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A+G+ +L A+ +HRD+ + NILL KI D G+A+ ++ D AR+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNARL- 278
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ APE + SDV+S+G++L E+ + G P
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A+G+++L A+ +HRD+ + N+LL + AKI D G+A+ + D AR+
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNARL- 276
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ APE ++ SDV+S+G++L E+ + G+ P
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 34/203 (16%)
Query: 249 GRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307
G V V+R + N FL E+ + +H ++VP Y + F + +V F
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP---YRATFIADNEL-WVVTSF 80
Query: 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-- 365
M G+ +D + ++GM+ I G + L+Y+H +HR +K+S+IL+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVD 137
Query: 366 -----ENLNAKITDLGMAKRLKA-DGLPSCSS------SPARMQGTF-GYFAPEYAMVGR 412
L + ++ + +RL+ P S SP +Q GY A
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK------- 190
Query: 413 ASLMSDVFSFGVVLLELITGRQP 435
SD++S G+ EL G P
Sbjct: 191 ----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 41/174 (23%), Positives = 67/174 (38%), Gaps = 47/174 (27%)
Query: 304 VFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361
V +++P G++ L G+ E + R IA +E +H+ +HRDIK N
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVHKMG---FIHRDIKPDN 131
Query: 362 ILLDENLNAKITDLGMAKRLK------------------------ADGLPSCSSSP---- 393
IL+D + + K+TD G+ + + C P
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 394 -ARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
R GT Y APE + + + D +S GV+L E++ G+ P
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 10/101 (9%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPSCSSSPARM 396
A L YLH I++RD+K NILLD + +TD G+ K ++ +G S
Sbjct: 106 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST------F 156
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE D + G VL E++ G P +
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A R +P + T
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSF---MMTPYVV--T 180
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE + D++S G ++ E+I G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSC 389
VA AIG YLH + I++RD+K NILLD + +TD G+ K +G+ P
Sbjct: 105 VASAIG------YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEE 151
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
++S GT Y APE D + G VL E++ G P +
Sbjct: 152 TTST--FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 51/200 (25%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM 325
LTE ++L+ L H + L Y S F+ + + LV ++ P G L L L E
Sbjct: 49 LTEQEILATLDHPFLPTL--YAS-FQTETYL-CLVMDYCPGGELFRLLQRQPGKCLSE-- 102
Query: 326 NWDTRVAIAIGAAR---GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD------LG 376
AA LEYLH I++RD+K NILL E+ + ++D
Sbjct: 103 -----EVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
Query: 377 MAKRLKADGLPSCSSSPARMQ------------------GTFGYFAPEYAMVGRASLMS- 417
+ + L S + GT Y APE V
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE---VISGDGHGS 211
Query: 418 --DVFSFGVVLLELITGRQP 435
D ++ G++L E++ G P
Sbjct: 212 AVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A+ + + +P + T
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM----MTPYVV--T 185
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 432
Y APE + D++S G ++ EL+ G
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 17/137 (12%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGY 290
++ G ++ VY D V +K ++ + EV +L L + VP V
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSR---EKGADREREVAILQLLARKGLPVPKVLA 60
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
E G L+ E+ ++G ++ ++ + + IA A L LH+
Sbjct: 61 SGESDGWSY---LLMEW---------IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 351 RILHRDIKSSNILLDEN 367
+ H D+ NIL+D+
Sbjct: 109 VLCHGDLHPGNILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 188
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE + D++S G ++ E+I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 13/81 (16%)
Query: 303 LVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
LV E++ G+++ L G E M + + VA+A L+YLH I+HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLHRHG---IIHRDLK 131
Query: 359 SSNILLDENLNAKITDLGMAK 379
N+L+ + K+TD G++K
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 181
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
Y APE + D++S G ++ E++ H+ + G + + W
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-----HKILFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 46/219 (21%)
Query: 234 GQGGSSYVYRGQL---TDGRIVA-------VKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
GQG + +Y+G L +D IV V + ++ + F T ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHKH 62
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAAR 339
+V L G C R ++V E++ G L L + V ++W ++ +A A
Sbjct: 63 LVKLYGVCV-----RDENIMVEEYVKFGPLDVFLHREKNNV---SLHW--KLDVAKQLAS 112
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL-DENLN------AKITDLGMAKRLKADGLPSCSSS 392
L YL + +++H ++ NIL+ LN K++D G+P S
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD---------PGIPITVLS 160
Query: 393 PARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLEL 429
+ APE G+ASL D +SFG LLE+
Sbjct: 161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+AI R ++YLHE RI+HRDIK+ NI ++ + + D G A + +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINA 237
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
+ GT APE D++S G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 17/82 (20%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEGMNWD------TRVAIAIGAARGLEYLHEAAAPRILHRD 356
L+ EF+P G+L L + +D TR +A +E +H+ +HRD
Sbjct: 78 LIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-ECVLAIEAVHKLG---FIHRD 126
Query: 357 IKSSNILLDENLNAKITDLGMA 378
IK NIL+D + K++D G++
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 399
L+ LH I+ RD+ +NILLD+ + ++T ++ SC M
Sbjct: 98 LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE----DSCDGEAVENM--- 147
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE + + D +S G +L EL+TG+
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 51/177 (28%)
Query: 303 LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
V +++P G++ L G+ E + R IA +E +H+ +HRDIK
Sbjct: 78 FVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIA-ELTCAVESVHKMG---FIHRDIKPD 130
Query: 361 NILLDENLNAKITDLGMAKRLK---------------------------------ADGLP 387
NIL+D + + K+TD G+ + D L
Sbjct: 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLK 190
Query: 388 SCSSSPARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
AR GT Y APE + + + D +S GV+L E++ G+ P
Sbjct: 191 PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 56/227 (24%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDT 329
E D+L+ + VV L Y S F+ K + V +++P G++ L V E +
Sbjct: 51 ERDILAEADNEWVVKL--YYS-FQDKDNL-YFVMDYIPGGDMMSLLIRMEVFPEVL---A 103
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM------------ 377
R IA +E +H+ +HRDIK NIL+D + + K+TD G+
Sbjct: 104 RFYIA-ELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 378 ---AKRLKADGL-PS----------CS------SSPARMQ----------GTFGYFAPEY 407
++ D + PS C A Q GT Y APE
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWTAT 453
+ + + D +S GV+L E++ G+ P + + T+ + ++ W T
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT 266
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 460 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.87 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.56 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.1 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.93 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.35 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.34 | |
| PLN02236 | 344 | choline kinase | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.12 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.1 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.96 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 96.59 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.54 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.51 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.36 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.32 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.21 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.2 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.98 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.64 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.6 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.54 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.28 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=404.47 Aligned_cols=236 Identities=53% Similarity=0.884 Sum_probs=208.7
Q ss_pred eeeeechHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012599 211 TIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (460)
Q Consensus 211 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 290 (460)
....|++.++..||++|+..+.||+|+||.||+|.+.++..||||++....... ..+|.+|++++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 457899999999999999999999999999999999999999999988765543 4559999999999999999999999
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcE
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
|.+... .++||||||++|+|.++|+......++|.+|++||.++|+||+|||+...|+|+||||||+|||||+++++
T Consensus 140 C~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 998332 57999999999999999987543378999999999999999999999988899999999999999999999
Q ss_pred EEEecCCcccccc-CCCCCCCCCCCcc-ccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHH
Q 012599 371 KITDLGMAKRLKA-DGLPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448 (460)
Q Consensus 371 kl~DFGla~~~~~-~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~ 448 (460)
||+|||+|+.... ... .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.++..++
T Consensus 217 KlsDFGLa~~~~~~~~~------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred EccCccCcccCCccccc------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999965543 211 1111 7899999999999999999999999999999999999999987766777899
Q ss_pred HHhhcccc
Q 012599 449 LWTATGIY 456 (460)
Q Consensus 449 ~~~~~~~~ 456 (460)
.|+.+.+.
T Consensus 291 ~w~~~~~~ 298 (361)
T KOG1187|consen 291 EWAKPLLE 298 (361)
T ss_pred HHHHHHHH
Confidence 99977654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=345.41 Aligned_cols=202 Identities=28% Similarity=0.466 Sum_probs=179.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..+|...+.||+|+|++||+|++.+ +..||||.+.... .++..+....|+.+|+.++|||||.|++++.+ +...
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~----~~~i 84 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED----DDFI 84 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec----CCeE
Confidence 3567777889999999999999864 8999999997764 44455567899999999999999999999887 5688
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC------CcEEEEec
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------LNAKITDL 375 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~------~~vkl~DF 375 (460)
+||||||.+|||.+||+.. ..+++.+...++.|+|.||++||+++ ||||||||.||||+.. -.+||+||
T Consensus 85 ~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999999865 46999999999999999999999999 9999999999999864 46899999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+|+.+.+.. .....+|++.|||||++....|+.|.|+||+|++|||+++|+.||+...
T Consensus 160 GfAR~L~~~~------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPGS------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhhhCCchh------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999887543 3456899999999999999999999999999999999999999998543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=371.68 Aligned_cols=217 Identities=29% Similarity=0.467 Sum_probs=186.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
+.+....+.||+|.||+||+|+.. +.+.||||.++.....+..++|.+|+++|+.++|||||+|+|+|.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~---- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE---- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----
Confidence 445556688999999999999864 3567999999998887788899999999999999999999999998
Q ss_pred cceEEEEEeecCCCCHHHHhcccc--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVL--------VEG----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
+...++|+|||..|||.+||+... ..+ ++..+.+.||.|||.||+||-++. +|||||.++|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 567799999999999999996532 122 888999999999999999999988 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcCc
Q 012599 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444 (460)
Q Consensus 366 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~~~ 444 (460)
++..|||+||||++.....++.. ...+..-+++|||||.+..++|+++||||||||+|||+++ |++||.....+
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk---~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-- 712 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYK---VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-- 712 (774)
T ss_pred cceEEEecccccchhhhhhhhhc---ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--
Confidence 99999999999999876655432 2223345689999999999999999999999999999998 99999988764
Q ss_pred hhHHHHhhc
Q 012599 445 ESLVLWTAT 453 (460)
Q Consensus 445 ~~l~~~~~~ 453 (460)
++++.++-
T Consensus 713 -EVIe~i~~ 720 (774)
T KOG1026|consen 713 -EVIECIRA 720 (774)
T ss_pred -HHHHHHHc
Confidence 44544443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=354.09 Aligned_cols=210 Identities=32% Similarity=0.470 Sum_probs=182.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++...+.++..+.||+|.||.||.|.+.....||+|.++... -..++|++|+++|++|+|+|||+++|+|.. +.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~----~~ 274 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTK----QE 274 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEec----CC
Confidence 333444555678899999999999999888899999998753 234569999999999999999999999987 44
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..+||||||+.|+|.+||+......+...+.+.++.|||.||+||++++ +|||||.++||||+++..+||+|||||+
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccc
Confidence 6899999999999999998756677999999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCc
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~ 442 (460)
...++.+... ....-+..|.|||.+..+.++.|||||||||+||||+| |+.||.++...
T Consensus 352 ~~~d~~Y~~~----~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 352 LIGDDEYTAS----EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred ccCCCceeec----CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 6655554322 22234578999999999999999999999999999999 99999887654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=346.03 Aligned_cols=205 Identities=34% Similarity=0.544 Sum_probs=175.7
Q ss_pred CcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
+...+.||+|+||+||+|.+.....||||++..... ....+.|.+|+.+|++++|||||+++|+|.+... ...+||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~iVt 119 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCIVT 119 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEEEE
Confidence 334456999999999999997555599999986532 2225679999999999999999999999987332 579999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCccccccC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLKAD 384 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~~~~~ 384 (460)
|||++|+|.++++......+++..++.++.|||+||+|||+++. |||||||++|||++.++ ++||+|||+++.....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999987545679999999999999999999999862 99999999999999997 9999999999876543
Q ss_pred CCCCCCCCCCccccCCcccCccccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
. .......||+.|||||++. ...|+.|+||||||++||||+||+.||.....
T Consensus 198 ~-----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 198 K-----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred c-----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 2 1223367999999999999 67999999999999999999999999988765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=325.49 Aligned_cols=205 Identities=29% Similarity=0.408 Sum_probs=180.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|+++++||+|+||+||.++..+ ++.+|+|.+++..- ....+...+|..+|.+++||.||+++-.+.+ ...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----EEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----CCe
Confidence 4678999999999999999997654 88999999986632 2335557899999999999999999976665 567
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+|||+||++||.|..+|++. ..+++..+..++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++.
T Consensus 100 LylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 89999999999999999854 45899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
...++ .....++||+.|||||++....|+..+|+||||+++|||++|.+||......
T Consensus 175 ~~~~~-----~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~ 231 (357)
T KOG0598|consen 175 DLKDG-----DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK 231 (357)
T ss_pred cccCC-----CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH
Confidence 65543 2445589999999999999999999999999999999999999999876543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=339.51 Aligned_cols=202 Identities=29% Similarity=0.500 Sum_probs=183.0
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..|...++||+|+|+.+|++++ ..|+.||+|++.+.. .+...+...+||++.++|+|||||++++++.+ ..+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED----s~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED----SNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec----CCce
Confidence 4578889999999999999998 779999999997642 33445568899999999999999999999988 5678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+|.|+|++++|.++++. .+.+++.++..+..||+.||.|||+.+ |+|||||..|+||++++++||+|||||..+
T Consensus 94 YivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 999999999999999984 467999999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..++ .....++||+.|.|||++.....+..+||||+||+||-|++|++||+...
T Consensus 169 e~~~-----Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 169 EYDG-----ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred cCcc-----cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 7653 35667899999999999999999999999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.56 Aligned_cols=212 Identities=29% Similarity=0.389 Sum_probs=184.2
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
++.++.||+|..|+|||+.+. +++.+|+|.+.....+...+++.+|++++++.+||+||.++|.|..... ...++|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~---~isI~m 157 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE---EISICM 157 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc---eEEeeh
Confidence 344678999999999999986 4888999999777777777889999999999999999999999987332 579999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||.+|+|++++... +.+++...-.|+.++++||.|||+ ++ ||||||||+||||+..++|||+|||.+..+...
T Consensus 158 EYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999999865 568999999999999999999996 65 999999999999999999999999999877543
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC--CCcCchhHHHHhhc
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS--ITKGEESLVLWTAT 453 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~--~~~~~~~l~~~~~~ 453 (460)
....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||-.. ...+-.+|..++..
T Consensus 233 -------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 -------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred -------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 235578999999999999999999999999999999999999999764 22344556666554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=314.53 Aligned_cols=207 Identities=25% Similarity=0.359 Sum_probs=176.6
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+|++++.||+|.||+|||+.. .+|..+|.|.+.... +....+....|+.+|++|+|||||++++.-. .++...++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f--~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF--IEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh--hccchhhH
Confidence 4577889999999999999964 579999999997543 3344566889999999999999999987322 22344579
Q ss_pred EEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 303 LVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPR--ILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~--ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
|||||+..|||.+.++... .+.+++.++++++.|+++||+++|+.- |+ |+||||||.||||+++|.|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 9999999999999996533 345999999999999999999999842 44 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+.+.... .......|||.||+||.+.+..|+.||||||+||++|||..-++||...
T Consensus 176 r~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~ 231 (375)
T KOG0591|consen 176 RFLSSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD 231 (375)
T ss_pred hHhcchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence 9876542 2345578999999999999999999999999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.95 Aligned_cols=204 Identities=27% Similarity=0.372 Sum_probs=172.0
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC------hhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
..+.|.+.+.||+|+||.|-+|... +|+.||||+++...... ......+|+++|++|+|||||++.+++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 4566778899999999999999765 59999999997653221 12224699999999999999999999987
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC---CcEEE
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKI 372 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~---~~vkl 372 (460)
....|+||||++||+|.+++-+. ..+.+..-.-++.|++.|+.|||++| |+||||||+|||+..+ ..+||
T Consensus 248 --~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 --PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred --CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 44669999999999999999654 44777778899999999999999999 9999999999999765 77999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
+|||+|+..... .-...++||+.|.|||++..+. +..++|+||+||+||-+++|.+||.....
T Consensus 321 tDFGlAK~~g~~------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 321 TDFGLAKVSGEG------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred cccchhhccccc------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 999999987643 3456789999999999997543 34488999999999999999999976543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=302.01 Aligned_cols=200 Identities=28% Similarity=0.364 Sum_probs=178.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||.|+||.|.+++.. +|..+|.|++..+.- ....+...+|..+|+.+.||+++++.+.+.+ ....
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d----~~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD----NSNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc----CCeE
Confidence 56788899999999999999876 488999999976532 2233446789999999999999999998877 5688
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||++||-|..+|++. +.+++.....+|.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||.|++.
T Consensus 120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999999865 56999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.. ..-..+||+.|+|||.+..+.++..+|.|||||++|||+.|.+||....+
T Consensus 195 ~~--------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 195 SG--------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred cC--------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 43 24567999999999999999999999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=323.85 Aligned_cols=212 Identities=28% Similarity=0.438 Sum_probs=188.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+.+.+...+.++||+|.||.|.++....+..||||+++.........+|.+|+++|.+++||||++|+|+|.. ++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~----De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ----DD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec----CC
Confidence 34556777888999999999999999988899999999999888888899999999999999999999999997 56
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.+++|+|||++|+|.+|+.+...........++|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccc
Confidence 7799999999999999998765555566777889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt--G~~Pf~~~~~ 441 (460)
.+...++. ....+..-+++|||||.+..++++.+||||+||++|||+++ .+.||.....
T Consensus 686 ~lysg~yy---~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 686 NLYSGDYY---RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ccccCCce---eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 76554432 33445567789999999999999999999999999999886 8999987654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.93 Aligned_cols=207 Identities=25% Similarity=0.409 Sum_probs=181.1
Q ss_pred CCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++.++||.|.||.|++|.++- ...||||.|+.....+...+|+.|..+|.+++||||++|.|+... ....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----s~Pv 705 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK----SKPV 705 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec----Ccee
Confidence 34567899999999999998863 457999999998888888899999999999999999999999886 5567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++|.|||+||+|+.||+.+.++ +++.+++.++++||.||.||-+++ +|||||.++|||++.+...|++|||+++.+
T Consensus 706 MIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999999987644 999999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCc
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~ 442 (460)
+++.... .....-.-+.+|.|||.+..+.++..|||||||++|||.++ |+.||=++...
T Consensus 782 edd~~~~--ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ 841 (996)
T KOG0196|consen 782 EDDPEAA--YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 841 (996)
T ss_pred ccCCCcc--ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH
Confidence 6654211 11111223478999999999999999999999999999987 99999877654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=317.15 Aligned_cols=215 Identities=27% Similarity=0.382 Sum_probs=181.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.+.|+.++.||+|.||.||+|++. +|+.||+|++..+... ....-..+||.+|++|+||||++|.+...+. ....+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~--~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK--LSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec--CCceE
Confidence 456777789999999999999764 5999999999876533 3334467999999999999999999998874 23578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|||+|||+. ||.-++... .-.|+..++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+.+
T Consensus 194 YlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999999955 898888753 245999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHH
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~ 449 (460)
..... ...+..+-|++|+|||++.+ ..|+...|+||.||||.||++|++.|....+-+....+.
T Consensus 269 ~~~~~----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf 333 (560)
T KOG0600|consen 269 TPSGS----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF 333 (560)
T ss_pred cCCCC----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH
Confidence 66542 22455678999999999886 679999999999999999999999998876654444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=308.73 Aligned_cols=196 Identities=33% Similarity=0.501 Sum_probs=162.8
Q ss_pred cccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccCccceEEEEE
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
+..++||+|+||.||||.+. ++.||||++... ..+.|.+|-++.+. ++|+||++++++-.-.......++||+
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 44578999999999999995 589999999754 33448888888875 489999999987554333355789999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------APRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~------~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
||.+.|+|.+||.. ..++|....+|+..+++||+|||+.- .|+|+|||||++||||.+|++..|+|||+|.
T Consensus 288 ~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999986 45899999999999999999999743 4689999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCC------CchhHHHHHHHHHHHHHhCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELITGRQ 434 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~sDVwSlGvll~elltG~~ 434 (460)
++.+... ........||.+|||||++.+... -.+.||||+|.+||||+++-.
T Consensus 365 ~~~p~~~---~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 365 RLEPGKP---QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred EecCCCC---CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 8875432 223444789999999999976432 236899999999999998543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=316.94 Aligned_cols=210 Identities=29% Similarity=0.400 Sum_probs=179.6
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 297 (460)
.-..+|...+.||+|+|++|++|+.. .++.+|||++.+..-- ...+-...|-+.|.+| .||.|++|+--+.+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD---- 145 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD---- 145 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----
Confidence 34578899999999999999999865 4899999999765322 1222256788999999 89999999987776
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
...+|+|+||+++|+|.++|++. ..+++.....++.+|+.||+|||++| ||||||||+|||||+|++++|.|||.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccc
Confidence 56789999999999999999875 56999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC----C----CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLP----S----CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~----~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+.+.+.... . .......++||..|.+||++..+..++.+|+|+|||+||+|+.|++||....
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9988654322 1 1111255899999999999999999999999999999999999999998654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=345.18 Aligned_cols=208 Identities=29% Similarity=0.481 Sum_probs=179.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC--Cc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD--GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~--g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++.+..+.||+|.||.||.|...+ +. .||||.++...+.+...+|++|..+|++++|||||+++|+|.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~---- 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD---- 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence 3445566899999999999998754 33 4999999988888888889999999999999999999999988
Q ss_pred cceEEEEEeecCCCCHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
....+|++|||++|||..||+..+ ...++..+.+.++.|||+|+.||++++ +|||||.++|+||++...|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI 843 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI 843 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence 446699999999999999998752 244889999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
+|||||+.+...++.+.... ..-+.+|||||.+..+.++.|+|||||||+|||++| |..||-....
T Consensus 844 aDFGlArDiy~~~yyr~~~~---a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n 910 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGE---AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN 910 (1025)
T ss_pred cccchhHhhhhchheeccCc---cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch
Confidence 99999996655444322211 234578999999999999999999999999999999 9999976544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=323.03 Aligned_cols=199 Identities=31% Similarity=0.495 Sum_probs=177.9
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
+.|+.+++....++.||.|+.|.||+|++. ++.||||+++.. -..+|..|++|+|+||+.+.|+|..
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtq---- 183 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQ---- 183 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecC----
Confidence 456777777788899999999999999995 678999988743 2467999999999999999999987
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
...++|||||++.|.|.+.|+.. +.++....+.+..+||.||.|||.+. |||||||+-||||..+..|||+|||.
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred CceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccc
Confidence 56789999999999999999864 56899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++..... +....+.||..|||||++...+.+.|+|||||||+||||+||..||.+..
T Consensus 259 S~e~~~~------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 259 SKELSDK------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hHhhhhh------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 9876543 34556899999999999999999999999999999999999999997643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=297.72 Aligned_cols=214 Identities=27% Similarity=0.380 Sum_probs=180.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+.|+.+.++|+|++|.|||++.++ |+.||||++....+ +...+..++|+++|++++|+|+|.|+.+|.. ...++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr----krklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR----KRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh----cceeE
Confidence 357777899999999999999875 99999999975543 4445557899999999999999999998876 55779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||+||+.. ++.+-|... ..+++.....++..|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.
T Consensus 78 LVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99999965 555555543 466999999999999999999999998 9999999999999999999999999999886
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhh
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTA 452 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~ 452 (460)
.. ....+....|.+|+|||++.+ ..|...+||||+||++.||++|++.|-..++-+..-+++-..
T Consensus 153 ~p-----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 153 AP-----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL 218 (396)
T ss_pred CC-----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence 43 234566778999999999987 789999999999999999999999998766554444444433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=303.74 Aligned_cols=210 Identities=25% Similarity=0.405 Sum_probs=186.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+.|+..+.||.|..++||+|... .++.||||++.-+......+.+.+|+..|+.++||||++++..|.. +..++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv----~~~LW 100 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV----DSELW 100 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----cceeE
Confidence 467888899999999999999754 5799999999887766667779999999999999999999988876 56889
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||+||.+|++.+.++......+++..+..|.+++++||.|||.+| .||||||+.||||+++|.|||+|||.+-.+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999998887788999999999999999999999999 9999999999999999999999999988777
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
..+ .+.......+.||+.|||||+++. ..|+.|+||||||++..||.+|+.||....+
T Consensus 178 ~~G-~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 178 DSG-DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP 237 (516)
T ss_pred ccC-ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh
Confidence 666 332333367899999999999654 5689999999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=321.66 Aligned_cols=209 Identities=30% Similarity=0.463 Sum_probs=180.3
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 293 (460)
.+.++|++..+++.+.+.||+|.||+||+|.+.. .||||+++... .++..+.|.+|+.++++-+|.||+-+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4457888889999999999999999999999853 39999998654 34456779999999999999999999999986
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
+ ...||+.|++|-+|+.+|+... ..++..+.+.||+|||+||.|||.++ |||||||+.|||+.+++.|||+
T Consensus 460 ----p-~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 460 ----P-PLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred ----C-ceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEe
Confidence 2 3389999999999999998754 56999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
|||++..-... ..........|...|||||++.. .+|+..+||||||+++|||+||..||.
T Consensus 531 DFGLatvk~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 531 DFGLATVKTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cccceeeeeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 99999765432 11222333457889999999864 578999999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=303.78 Aligned_cols=206 Identities=32% Similarity=0.495 Sum_probs=174.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++...+.||+|+||+||++...+ |+..|||.+.....+. .+.+.+|+.+|++++|||||+.+|....... ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEe
Confidence 446667899999999999998865 8999999997764333 4457899999999999999999997544222 46899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~~~ 382 (460)
.|||+++|+|.+++.+... .+++..+..+.+||++||+|||+++ |+||||||+||||+. ++.+||+|||++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999987654 7999999999999999999999998 999999999999999 7999999999998776
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ..........||+.|||||++..+ ...+++|||||||++.||+||+.||...
T Consensus 170 ~~~--~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 170 SKG--TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccc--ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 411 112234457899999999999854 3446999999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.58 Aligned_cols=209 Identities=23% Similarity=0.341 Sum_probs=178.7
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC--hhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 298 (460)
..++|..+++||+|+||+|+++.+.. ++.+|||.+++..--. +.+..+.|.+++... +||.+++|+..+.. .
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----~ 441 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----K 441 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----C
Confidence 34678899999999999999999864 7899999999875332 333467788888776 69999999988765 5
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+.||++..+.+ ...+++..+..+++.|+.||.|||+++ |||||||.+|||||.+|.+||+||||+
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 68899999999999554443 256999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchh
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~ 446 (460)
+..... ......++||+.|||||++.+..|+..+|.|||||+||||+.|+.||...++++-.+
T Consensus 516 Ke~m~~-----g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd 578 (694)
T KOG0694|consen 516 KEGMGQ-----GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD 578 (694)
T ss_pred cccCCC-----CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 875433 235678999999999999999999999999999999999999999998766554333
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.17 Aligned_cols=209 Identities=28% Similarity=0.406 Sum_probs=181.5
Q ss_pred ccceeeeeCcEEEEEEEEc-C----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 229 GSNIVGQGGSSYVYRGQLT-D----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
..++||.|+||+||+|.+- + .-+||+|.+.....++...++++|+..|.+++|||+++|+|+|... .+.|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s-----~~ql 774 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS-----TLQL 774 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc-----hHHH
Confidence 4578999999999999763 3 3579999999888888888899999999999999999999999852 3689
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|++|||.|+|.+|++..+ ..+.....+.+..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++.+..
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999998754 56889999999999999999999988 99999999999999999999999999998877
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcCchhHHH
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 449 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~~~~~l~~ 449 (460)
++..-. .....-.+.|||-|.+....++.++|||||||++|||+| |..|+++...++-.++.+
T Consensus 851 d~~ey~---~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 851 DEKEYS---APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred cccccc---ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 654321 122234578999999999999999999999999999999 999999988765555443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=284.20 Aligned_cols=221 Identities=24% Similarity=0.330 Sum_probs=183.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCCh-hHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|...+.||+|.||.||+|.+. .|+.||||+++.....+. ....++|+..|+.++|+||+.|++++.. ....-
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~----~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH----KSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC----CCceE
Confidence 35677789999999999999865 599999999986643322 3347899999999999999999998876 55678
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||+||| ..+|+..++... ..++..++..++.++++|++|||.+. |+||||||.|+||++++.+||+|||+++.+.
T Consensus 78 lVfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 999999 569999998743 56999999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhcccccCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIYLDH 459 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 459 (460)
.... ......-|.+|+|||++.+ +.|+..+||||.||++.||+-|.+-|.+.++-+....+..+...+.+|+
T Consensus 153 ~p~~-----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 153 SPNR-----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred CCCc-----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 5532 2223367889999999986 5689999999999999999998777777666555566666665555554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.57 Aligned_cols=228 Identities=24% Similarity=0.353 Sum_probs=186.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
..++|+.++.||+|+||.||+++-. .|..+|+|++++.. .....+..+.|-.+|...+.+.||+|+-.+.+ ..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----~~ 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----KE 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----CC
Confidence 4578999999999999999999765 49999999998653 22333447889999999999999999977766 66
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.+||||||+||||+...|... ..+++.....++.+++.||+-||+.| +|||||||+|+|||..|++||+||||+.
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 889999999999999999754 56999999999999999999999999 9999999999999999999999999985
Q ss_pred ccccC-----------------C-CCCCCC-----C-------------------CCccccCCcccCccccccCCCCchh
Q 012599 380 RLKAD-----------------G-LPSCSS-----S-------------------PARMQGTFGYFAPEYAMVGRASLMS 417 (460)
Q Consensus 380 ~~~~~-----------------~-~~~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~s 417 (460)
-+... . .+.... . .....|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 32210 0 000000 0 0124699999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCc-CchhHHHHhhcccccCC
Q 012599 418 DVFSFGVVLLELITGRQPIHRSITK-GEESLVLWTATGIYLDH 459 (460)
Q Consensus 418 DVwSlGvll~elltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~ 459 (460)
|+||||||+|||+.|.+||....+. .=..|+.|..-...|++
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~ 412 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE 412 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc
Confidence 9999999999999999999876653 23467888765555543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=297.79 Aligned_cols=211 Identities=28% Similarity=0.432 Sum_probs=172.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..+....+.||+|.||.||+|.++ |+.||||++.... +..+.+|.++... |+|+||+.+++.=....+.-.++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 455667789999999999999995 8889999997542 3347888888875 49999999998755555666789
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-----AAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-----~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
+||++|.++|||+|||.. ..++....++++.-+|.||+|||. ++.|.|.|||||+.|||+..++...|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 999999999999999976 568999999999999999999994 567899999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCC------CchhHHHHHHHHHHHHHh----------CCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELIT----------GRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~sDVwSlGvll~ellt----------G~~Pf~~~~ 440 (460)
+|-+...+.... ....+..+||.+|||||++.+... -..+||||||.++||+.- -++||....
T Consensus 362 LAv~h~~~t~~i-di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 362 LAVRHDSDTDTI-DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeEEecccCCcc-cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 998776653221 234555789999999999865432 225899999999999864 256887765
Q ss_pred CcC
Q 012599 441 TKG 443 (460)
Q Consensus 441 ~~~ 443 (460)
+.+
T Consensus 441 p~D 443 (513)
T KOG2052|consen 441 PSD 443 (513)
T ss_pred CCC
Confidence 443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.88 Aligned_cols=210 Identities=27% Similarity=0.438 Sum_probs=173.0
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEE------cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 294 (460)
.+.++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 4457788999999999999999974 235689999998654444455689999999999 899999999988642
Q ss_pred cCccceEEEEEeecCCCCHHHHhcccc-----------------------------------------------------
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------------------------------------- 321 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------- 321 (460)
....++||||+++|+|.+++....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 335789999999999999996421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCC
Q 012599 322 -------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394 (460)
Q Consensus 322 -------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 394 (460)
...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~ 234 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKG 234 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch---hccc
Confidence 124788899999999999999999998 999999999999999999999999999865432111 1112
Q ss_pred ccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
...++..|+|||++....++.++||||||++||||++ |..||....
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2345678999999998899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=310.99 Aligned_cols=200 Identities=29% Similarity=0.432 Sum_probs=176.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+....+ +.....+|++++++++||||+.+++.+.. ...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt----~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET----SAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc----cceEE
Confidence 46778889999999999999765 47899999997664433 44558899999999999999999988765 56789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|.||+.+ +|..+|... ..+++..+..|+.++..||.|||+.+ |+|||+||.|||++.++.+|++|||+|+.+.
T Consensus 78 vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99999965 999999753 56999999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. ......+.||+.|||||+..+.+|+..+|+||+||+||||++|++||...
T Consensus 152 ~~-----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 152 TN-----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred cC-----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 54 23456678999999999999999999999999999999999999999753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.34 Aligned_cols=211 Identities=28% Similarity=0.391 Sum_probs=177.3
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCC----cE-EEEEEecc--CCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDG----RI-VAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g----~~-vaVK~l~~--~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 290 (460)
..|+...++....+.||+|+||.||+|.+..+ .. ||||..+. ........+|++|.++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34555556666779999999999999987532 23 89999885 2344556679999999999999999999999
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcE
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
+.. ...+++|||+++||+|.+||+... ..++..+++.++.++|+||+|||+++ ++||||.++|+|++.++.+
T Consensus 230 a~~----~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v 301 (474)
T KOG0194|consen 230 AVL----EEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV 301 (474)
T ss_pred EcC----CCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence 987 567799999999999999998754 36999999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
||+|||+++....... ....-.-+.+|+|||.+....++.++|||||||++||+++ |..||.....
T Consensus 302 KISDFGLs~~~~~~~~-----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 302 KISDFGLSRAGSQYVM-----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred EeCccccccCCcceee-----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 9999999876541111 1111134578999999999999999999999999999998 8999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=306.60 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=175.2
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC----ChhHHHHHHHHHHHhcC-CCCccceeeeeeeccC
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 296 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 296 (460)
..++|...+.||+|+||+|++|... +++.||+|.+...... ...+.+.+|+.+++.++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence 3567888999999999999999764 5899999977654111 23344668999999998 9999999999876
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEEEEec
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDL 375 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vkl~DF 375 (460)
....++||||+.+|+|.+++.. ...+.+.....+++|++.|++|+|+.+ |+||||||+|||+|.+ +++||+||
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 3458999999999999999987 356888999999999999999999999 9999999999999999 99999999
Q ss_pred CCccccc-cCCCCCCCCCCCccccCCcccCccccccCC-C-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLK-ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-A-SLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~-~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|++.... .+ ......+||+.|+|||++.+.. | ..++||||+||+||.|++|+.||+...
T Consensus 166 G~s~~~~~~~------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 166 GLSAISPGED------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccccCCCC------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9998874 22 3456689999999999999877 7 478999999999999999999998743
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.33 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=178.7
Q ss_pred HhcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
....|...+.||+|..|.||.|.. ..++.||||++.....+. .+.+++|+.+|+..+|+|||+++.-+.. ...+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv----~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLV----GDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcc----ccee
Confidence 346677788999999999999965 458889999998655443 3347899999999999999999977665 3578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++|||||++|+|.+.+... .+++.++..|.+++++||+|||..+ |+|||||++|||++.++.+||+|||++..+
T Consensus 346 WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence 9999999999999999764 3899999999999999999999999 999999999999999999999999999887
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.... .......||+.|||||++....|.+|.||||||++++||+-|++||.+..+
T Consensus 420 ~~~~-----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 420 SEEQ-----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred cccc-----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh
Confidence 6653 245567899999999999999999999999999999999999999987544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.20 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=172.4
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.++++++|+||+++++++.+ ....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~----~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc----CCeEEE
Confidence 667789999999999999874 689999999865432 2233457899999999999999999988865 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999999998886544456899999999999999999999998 99999999999999999999999999976533
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.. ......|+..|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 155 GE------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred CC------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 21 12234688999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=307.26 Aligned_cols=207 Identities=23% Similarity=0.363 Sum_probs=173.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|+||+||++... +++.+|+|++.... .......+.+|+.++..++|+||+++++.+.+ ....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~----~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD----KLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCeE
Confidence 46888999999999999999875 48899999997532 12233457889999999999999999998876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCC------------------------------CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 382 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 382 ~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
....... .........||+.|+|||++....++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 3211000 0000123579999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 012599 432 GRQPIHRSI 440 (460)
Q Consensus 432 G~~Pf~~~~ 440 (460)
|+.||....
T Consensus 232 G~~Pf~~~~ 240 (363)
T cd05628 232 GYPPFCSET 240 (363)
T ss_pred CCCCCCCCC
Confidence 999997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.99 Aligned_cols=202 Identities=23% Similarity=0.348 Sum_probs=178.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCCh--hHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~--~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..+|++.+.||+|.+|.|-+|.. ..|+.||||.+++...+.. .-.+.+|+++|+.|+||||+.++.+|.. ...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN----kdK 127 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN----KDK 127 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC----Cce
Confidence 35677778999999999999976 5699999999987654433 3347899999999999999999988865 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
..|||||.++|.|++|+... +.+++.+...+++||..|+.|+|+++ ++|||||.+|||+|+|+++||+|||++..
T Consensus 128 IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 79999999999999999865 55999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+.... -...++|++.|.+||.+.+.+| .+.+|-|||||+||.|+.|..||+..+
T Consensus 203 y~~~k------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 203 YADKK------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred hcccc------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 76543 3456899999999999999998 789999999999999999999998653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=297.68 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=172.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD----QRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc----CCeE
Confidence 36788899999999999999876 58899999986432 12234458899999999999999999987765 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 152 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 152 RDR--------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred cCC--------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 332 123468899999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=304.06 Aligned_cols=205 Identities=26% Similarity=0.363 Sum_probs=178.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~ 301 (460)
-++|...+.||.|.||.||+|+-. .++.||||+++.....-++..=++|+..|++|+ ||||++|..++.+.. ..+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~---~~L 85 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND---RIL 85 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC---ceE
Confidence 467888899999999999999754 588999999987654444445689999999998 999999999887732 288
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||| ..+|++.++.. .+.+++.++..|+.||++||+|+|++| ++||||||+|||+..+..+||+|||+|+.+
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999999 77999999876 678999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
... ...+....|.+|+|||++. .+.|+.+.|||++|++++|+.+-++.|-+..+-
T Consensus 161 ~Sk------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 161 RSK------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred ccC------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 653 2345677889999999875 678899999999999999999999999776543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=285.96 Aligned_cols=211 Identities=25% Similarity=0.342 Sum_probs=178.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCCh-hHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|+.++.|++|.||.||+|++. +++.||+|+++-...... .-..++||.+|.+.+|||||.+-.+..-.. -...
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--~d~i 152 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--MDKI 152 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--ccee
Confidence 356778899999999999999875 488999999986543322 223689999999999999999998876433 2357
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+||||++ -||...++... +++...+...+..|+++|++|||.+. |+|||||++|+|+...|.+||+|||+|+.+
T Consensus 153 y~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999995 49999998643 78999999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchh
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~ 446 (460)
... ....+...-|++|+|||++.+ ..|++..|+||+||++.||+++++.|....+-+..+
T Consensus 228 gsp-----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~ 288 (419)
T KOG0663|consen 228 GSP-----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD 288 (419)
T ss_pred cCC-----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence 654 234566778999999999886 568999999999999999999999998776544333
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.94 Aligned_cols=206 Identities=23% Similarity=0.321 Sum_probs=171.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.|+..+.||+|+||+||+|... +++.+|+|++.... .......+.+|+++++.++|+||+++++++.+ ....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD----KDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec----CCEEE
Confidence 5788899999999999999875 47899999997542 22334558899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999999753 45889999999999999999999998 9999999999999999999999999976432
Q ss_pred cCCCCC------------------------------------------CCCCCCccccCCcccCccccccCCCCchhHHH
Q 012599 383 ADGLPS------------------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 420 (460)
Q Consensus 383 ~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVw 420 (460)
...... .........||+.|+|||.+....++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 110000 00011235699999999999888899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 012599 421 SFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 421 SlGvll~elltG~~Pf~~~~ 440 (460)
||||++|||++|+.||....
T Consensus 233 SlG~il~elltG~~Pf~~~~ 252 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPT 252 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCC
Confidence 99999999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=291.96 Aligned_cols=203 Identities=26% Similarity=0.418 Sum_probs=170.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|+..+.||+|+||.||+|... +++.||+|.++..........+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT----ERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC----CCeEEE
Confidence 46888899999999999999875 5889999999765444444567899999999999999999998765 446799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 81 VFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999996 5999998653 245789999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||.....
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 156 PT-----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred CC-----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 11233457889999998865 5689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.43 Aligned_cols=207 Identities=24% Similarity=0.357 Sum_probs=173.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +++.||||++.... .......+.+|++++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD----ENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCeE
Confidence 46888999999999999999886 48899999997532 12233457889999999999999999998876 5578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCC---------------------------------CCCCccccCCcccCccccccCCCCchhHHHHHHHHHHH
Q 012599 382 KADGLPSCS---------------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428 (460)
Q Consensus 382 ~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~e 428 (460)
......... .......||+.|+|||++....++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 322110000 00112468999999999998899999999999999999
Q ss_pred HHhCCCCCCCCC
Q 012599 429 LITGRQPIHRSI 440 (460)
Q Consensus 429 lltG~~Pf~~~~ 440 (460)
|++|+.||....
T Consensus 232 l~~G~~Pf~~~~ 243 (364)
T cd05599 232 MLVGYPPFCSDN 243 (364)
T ss_pred hhcCCCCCCCCC
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.42 Aligned_cols=199 Identities=26% Similarity=0.356 Sum_probs=172.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC--CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~ 105 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----ESY 105 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----CCE
Confidence 568888999999999999998643 3689999986432 22334558899999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 181 VDTR--------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred cCCC--------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 5322 223568999999999988889999999999999999999999997643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.55 Aligned_cols=199 Identities=26% Similarity=0.365 Sum_probs=172.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++.+. +++.||+|.+.... .......+.+|+.++++++||||+++++++.+ ....
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD----ENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----CCEE
Confidence 56788899999999999999886 48899999987532 22334458899999999999999999998876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999999753 45888999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 169 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 169 PDR--------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred CCC--------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 432 123468999999999999889999999999999999999999997543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.01 Aligned_cols=195 Identities=26% Similarity=0.339 Sum_probs=167.5
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.||+|+||.||++... +|+.+|+|.++... .......+++|++++++++||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----CCEEEEEEeC
Confidence 46999999999999875 58899999987542 22333457889999999999999999988876 4578999999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~ 387 (460)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 149 (323)
T cd05571 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--
Confidence 9999999999753 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 1223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.37 Aligned_cols=207 Identities=24% Similarity=0.330 Sum_probs=171.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +++.||+|.+.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD----AQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCee
Confidence 36888899999999999999875 58899999986432 22334557889999999999999999998876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999999753 45889999999999999999999998 999999999999999999999999999643
Q ss_pred ccCCCC-----------CC-------------------------------CCCCCccccCCcccCccccccCCCCchhHH
Q 012599 382 KADGLP-----------SC-------------------------------SSSPARMQGTFGYFAPEYAMVGRASLMSDV 419 (460)
Q Consensus 382 ~~~~~~-----------~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV 419 (460)
...... .. ........||+.|+|||++....++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 211000 00 000012468999999999998899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCC
Q 012599 420 FSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 420 wSlGvll~elltG~~Pf~~~~ 440 (460)
|||||++|||++|+.||....
T Consensus 232 wSlGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred EecchhhhhhhcCCCCCCCCC
Confidence 999999999999999997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=299.54 Aligned_cols=199 Identities=29% Similarity=0.419 Sum_probs=173.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|.+.+ ++.||+|+++.... ......+.+|++++..++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD----DEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc----CCEE
Confidence 368888999999999999999864 88999999975421 2234458899999999999999999998876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 152 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 152 VT--------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred cc--------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 33 1233568899999999998899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=284.95 Aligned_cols=209 Identities=25% Similarity=0.388 Sum_probs=175.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCC-ccceeeeeeecc--Cccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFR--GKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~--~~~~ 299 (460)
..|..++.||+|.||+||+|+.. +|+.||+|+++..... .......+|+.++++++|+| |++|.+++.... +...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 44556678999999999999865 5899999999866442 23334689999999999999 999999988643 2223
Q ss_pred eEEEEEeecCCCCHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
..++|+||+ ..+|..|++.... ..++...+..++.|+++||+|||+++ |+||||||.||||++++.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 678999999 6799999987553 36788899999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
|+...-. ........+|..|+|||++.+. .|++..||||+||++.||++++..|....+.
T Consensus 167 Ara~~ip-----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 167 ARAFSIP-----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred HHHhcCC-----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence 9965422 2235556789999999999875 7899999999999999999999999887664
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.71 Aligned_cols=206 Identities=23% Similarity=0.321 Sum_probs=170.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.|+..+.||+|+||.||+|... +++.+|+|.+.... .......+.+|++++++++|+||+++++.+.+ ....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~----~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe----CCEEE
Confidence 5788899999999999999875 47899999986532 12233457899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999999753 45788999999999999999999998 9999999999999999999999999975332
Q ss_pred cCCCC------------------------------------------CCCCCCCccccCCcccCccccccCCCCchhHHH
Q 012599 383 ADGLP------------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 420 (460)
Q Consensus 383 ~~~~~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVw 420 (460)
..... ..........||+.|+|||++....++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 10000 000011234689999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 012599 421 SFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 421 SlGvll~elltG~~Pf~~~~ 440 (460)
||||+||||++|+.||....
T Consensus 233 SlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred echHHHHHHHhCCCCCCCCC
Confidence 99999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.18 Aligned_cols=202 Identities=25% Similarity=0.426 Sum_probs=170.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|... +++.+|+|.+...........+.+|+++++.++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT----KETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec----CCeEE
Confidence 367888999999999999999986 5889999999765444444457899999999999999999998875 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+ .++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 80 lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999999 57898888653 245889999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 155 VPS-----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCC-----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 11223457899999998865 45789999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.39 Aligned_cols=208 Identities=22% Similarity=0.347 Sum_probs=174.2
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
.+....++|++.+.||+|+||.||++.... ++.+|+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-- 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-- 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 344456789999999999999999998864 7889999986421 22234457899999999999999999998875
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
+...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence 5578999999999999999965 34788999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|++......... ......||+.|+|||.+... .++.++||||||++||||++|+.||....
T Consensus 187 G~a~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 187 GTCMKMDETGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccceecccCCce----ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 999876433211 12345689999999998653 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=292.14 Aligned_cols=201 Identities=27% Similarity=0.366 Sum_probs=167.5
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-cceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~~~~~lV 304 (460)
|...+++|.|+||.||+|.+.+ ++.||||+.-.+..-. -+|+++|+.++|||||+|+-++....+. .....+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4455899999999999998865 6899999987654322 4789999999999999999888766555 3456799
Q ss_pred EeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEEEEecCCcccc
Q 012599 305 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRL 381 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vkl~DFGla~~~ 381 (460)
|||||. +|.++++.. ....++...+.-+..|+.+||.|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999965 999999742 2355888888999999999999999988 9999999999999966 89999999999988
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
.... .......|..|+|||++.+ ..|+.+.||||.||++.||+-|++-|.+.+..
T Consensus 177 ~~~e------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~ 232 (364)
T KOG0658|consen 177 VKGE------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV 232 (364)
T ss_pred ccCC------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH
Confidence 6543 2233455778999999886 56899999999999999999999999886544
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=288.18 Aligned_cols=197 Identities=22% Similarity=0.388 Sum_probs=167.7
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
...|++|++|.||+|.+ +|+.||||+++...... ..+.|.+|+.+|++++||||++++|++.+........++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46799999999999998 68899999997643222 1355789999999999999999999987643434567999999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
+++|+|.++++.. ..+++...+.++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999764 4689999999999999999999984 5 7899999999999999999999999987653321
Q ss_pred CCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 178 -------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 -------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred -------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 12357789999999875 688999999999999999999999998654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=295.50 Aligned_cols=196 Identities=26% Similarity=0.333 Sum_probs=167.1
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.||+|+||.||++... +|+.||+|.++... .......+.+|+++++.++||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCEEEEEEeC
Confidence 46999999999999875 58999999997542 22333457789999999999999999998876 4578999999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~ 387 (460)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-- 149 (323)
T cd05595 77 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--
Confidence 9999999988653 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 12233568999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=296.63 Aligned_cols=196 Identities=26% Similarity=0.336 Sum_probs=167.5
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.||+|+||.||++... +++.||+|++.... .......+.+|+.+++.++||||+++.+++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----KDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22334567899999999999999999988775 4577999999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~ 387 (460)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-- 149 (328)
T cd05593 77 VNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-- 149 (328)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--
Confidence 9999999998653 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 12233568999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.56 Aligned_cols=208 Identities=23% Similarity=0.325 Sum_probs=171.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+++.. +++.+|+|.+.... .......+.+|+++++.++|+||+++++.+.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD----KDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCEE
Confidence 36888999999999999999875 48899999986432 12233457899999999999999999988875 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999999999753 45888889999999999999999998 999999999999999999999999997533
Q ss_pred ccCCCC--------------------------------------CCCCCCCccccCCcccCccccccCCCCchhHHHHHH
Q 012599 382 KADGLP--------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFG 423 (460)
Q Consensus 382 ~~~~~~--------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlG 423 (460)
...... ..........||+.|+|||++....++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 110000 000011234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCC
Q 012599 424 VVLLELITGRQPIHRSIT 441 (460)
Q Consensus 424 vll~elltG~~Pf~~~~~ 441 (460)
|++|||++|+.||.....
T Consensus 232 vilyell~G~~Pf~~~~~ 249 (376)
T cd05598 232 VILYEMLVGQPPFLADTP 249 (376)
T ss_pred ceeeehhhCCCCCCCCCH
Confidence 999999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=294.35 Aligned_cols=193 Identities=25% Similarity=0.339 Sum_probs=165.8
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||.||++... +++.||+|.++... .......+.+|+.++++++||||+++++++.+ ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----PEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----CCeEEEEEcCCC
Confidence 689999999999876 47899999986432 23334557899999999999999999988865 457799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 147 (312)
T cd05585 77 GGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---- 147 (312)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC----
Confidence 99999999753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 1223456899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=293.53 Aligned_cols=202 Identities=28% Similarity=0.413 Sum_probs=174.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++... ++..+|+|.+...........+.+|++++++++||||+++++++.. +...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEEE
Confidence 467888999999999999999876 4788999998765444445568999999999999999999999876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999999753 45899999999999999999999853 39999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 156 DS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred cc-------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 1223468899999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=301.13 Aligned_cols=209 Identities=22% Similarity=0.336 Sum_probs=174.6
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 294 (460)
.++....++|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|+.+++.++||||+++++.+.+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~- 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence 344555689999999999999999999876 47889999986421 22233457889999999999999999988865
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEe
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~D 374 (460)
+...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 115 ---~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 ---DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred ---CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 4578999999999999999965 34788889999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||++......... ......||+.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 186 fG~a~~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 186 FGTCMKMNKEGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred CCceeEcCcCCcc----cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 9999876443211 12345689999999998643 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.58 Aligned_cols=205 Identities=24% Similarity=0.369 Sum_probs=171.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+|+||.||+|.+. .+..||+|.++..........|.+|+..+++++||||++++|++.. +.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 79 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----GN 79 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec----CC
Confidence 356788899999999999999763 3568999999876544555668999999999999999999999875 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.+.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 6799999999999999997542 46899999999999999999999998 9999999999999999999999999876
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 156 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 156 EDKSEAI----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cccccch----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 5422211 11112234578999999999999999999999999999885 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=290.60 Aligned_cols=219 Identities=26% Similarity=0.408 Sum_probs=175.7
Q ss_pred eechHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC---------C----hhHHHHHHHHHHHhc
Q 012599 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP---------N----ADSVFLTEVDMLSRL 279 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~---------~----~~~~f~~Ei~~l~~l 279 (460)
++.-.+-....++|++.+.||+|.||.|-+|... +++.||+|++.+.... . ..+...+||.+|+++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 3444444455688999999999999999999875 5899999999653211 0 123578999999999
Q ss_pred CCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 280 ~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
+|+|||+|+.+..+... ...|||+||+..|.+...=.. .. ++..+.+.+++++..||+|||.++ |||||||
T Consensus 166 ~H~nVV~LiEvLDDP~s--~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK 237 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPES--DKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK 237 (576)
T ss_pred CCcCeeEEEEeecCccc--CceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence 99999999998877553 478999999998877653322 33 899999999999999999999999 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQ 434 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvll~elltG~~ 434 (460)
|+|+||+++++|||+|||.+...................||+.|+|||...++. ...+-||||+||+||.|+.|+.
T Consensus 238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~ 317 (576)
T KOG0585|consen 238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL 317 (576)
T ss_pred hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence 999999999999999999987664332222222334478999999999887633 2567899999999999999999
Q ss_pred CCCCCC
Q 012599 435 PIHRSI 440 (460)
Q Consensus 435 Pf~~~~ 440 (460)
||....
T Consensus 318 PF~~~~ 323 (576)
T KOG0585|consen 318 PFFDDF 323 (576)
T ss_pred Ccccch
Confidence 998654
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=301.40 Aligned_cols=205 Identities=22% Similarity=0.344 Sum_probs=171.8
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
...++|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----~ 115 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----D 115 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 34578899999999999999999875 48899999986431 22233447789999999999999999988765 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccce
Confidence 578999999999999999865 34788888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......... ......||+.|+|||.+... .++.++|||||||++|||++|+.||....
T Consensus 190 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 190 MKMDANGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred eeccCCCcc----cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 876443211 12335689999999988643 47889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.15 Aligned_cols=203 Identities=26% Similarity=0.355 Sum_probs=170.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||.||++.+. +++.+|+|+++.... ......+.+|+++++.++|+||+++++++.. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR----RGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec----CCEEE
Confidence 36888899999999999999986 478899999975432 2334557899999999999999999998865 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||++++.|..+.+. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999988777655432 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 152 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 152 EGSN----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred cccc----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 3221 11223468899999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=292.85 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=166.0
Q ss_pred ceeeeeCcEEEEEEEEc----CCcEEEEEEeccCC---CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 231 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+.||+|+||.||++... +++.||+|.++... .......+.+|+++++.++||||+++++++.. +...++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT----GGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec----CCeEEE
Confidence 67999999999999763 57899999987532 22233457789999999999999999998876 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 78 ILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred EEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999999753 45788889999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 153 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 153 EG-----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred CC-----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 21 12233568999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=292.56 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=168.8
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+|.+.+.||+|+||.||+|.... ++.+|+|.++.... ......+..|..++..+ +|++|+++.+++.+ ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----MDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----CCEE
Confidence 47778999999999999998764 78999999875422 22233466788888777 68899999988765 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999998653 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......||+.|+|||++....++.++|||||||++|||+||+.||....
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 152 MWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CCCC-----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 3222 12234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=285.36 Aligned_cols=206 Identities=28% Similarity=0.427 Sum_probs=170.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc--CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhc---CCCCccceeeeeeecc-Cc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-GK 297 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~-~~ 297 (460)
++|++.+.||+|+||.||+|... +++.||+|.++...... ....+.+|+.+++.+ +||||+++++++.... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999873 46889999987543322 233466788777766 6999999999986432 23
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||++ ++|.+++.......+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 446799999995 69999997655566899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+....... ......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 157 ARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred eEeccCCc------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 97654321 2233468899999999988899999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=298.32 Aligned_cols=207 Identities=26% Similarity=0.357 Sum_probs=175.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||+||+|... +++.||+|+++... .......+.+|++++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD----EEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec----CCeE
Confidence 46888899999999999999886 58999999997542 22344568899999999999999999988765 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999999999764 56899999999999999999999988 999999999999999999999999999866
Q ss_pred ccCCC------------------------CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 382 KADGL------------------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 382 ~~~~~------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
..... ...........||+.|+|||.+....++.++|||||||+||||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 44320 000112233568999999999999999999999999999999999999997
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 232 ~~~ 234 (350)
T cd05573 232 SDT 234 (350)
T ss_pred CCC
Confidence 654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=299.94 Aligned_cols=208 Identities=24% Similarity=0.371 Sum_probs=173.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|+||.||++... +++.+|+|.++... .......+.+|+.++..++|+||+++++.+.+ ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD----KRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 46788899999999999999876 48899999997432 22334457889999999999999999988765 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCC------------------------------CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 382 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 382 ~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
....... .........||+.|+|||++....++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 3211000 0001123468999999999999999999999999999999999
Q ss_pred CCCCCCCCCC
Q 012599 432 GRQPIHRSIT 441 (460)
Q Consensus 432 G~~Pf~~~~~ 441 (460)
|+.||.....
T Consensus 232 G~~Pf~~~~~ 241 (360)
T cd05627 232 GYPPFCSETP 241 (360)
T ss_pred CCCCCCCCCH
Confidence 9999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.01 Aligned_cols=211 Identities=27% Similarity=0.393 Sum_probs=186.1
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
+++|+--..+.....+||.|.+|.||.|.+.. .-.||||.++.+.- ..++|+.|..+|+.++|||+|+|+|+|..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~-- 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTH-- 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhcc--
Confidence 46777777788888999999999999999875 56799999986543 45569999999999999999999999986
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
...+|||+|||.+|+|.+||+..+...++....+.+|.||+.||+||...+ +|||||.++|+|+.++..||++||
T Consensus 335 --EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 335 --EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred --CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 557799999999999999999988888899999999999999999999988 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
|+++.+..+.+... ....-++.|.|||.+....++.|+|||+|||+|||+.| |..||-..+
T Consensus 410 GLsRlMtgDTYTAH----AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAH----AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred chhhhhcCCceecc----cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 99999987765432 22234578999999999999999999999999999998 999986543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=289.48 Aligned_cols=206 Identities=29% Similarity=0.476 Sum_probs=169.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-----------------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l 287 (460)
++|.+.+.||+|+||.||++.+.+ +..||+|.+...........|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567788999999999999997642 336999998765444445668999999999999999999
Q ss_pred eeeeeeccCccceEEEEEeecCCCCHHHHhcccc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012599 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAP 350 (460)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~ 350 (460)
++++.+ ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+
T Consensus 85 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 85 LGVCVD----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred EEEEec----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999876 345799999999999999985421 123688899999999999999999998
Q ss_pred CeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHH
Q 012599 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430 (460)
Q Consensus 351 ~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ell 430 (460)
|+||||||+|||+++++.+||+|||+++........ .......++..|+|||++....++.++||||||+++|||+
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999865433211 1122334577899999998888999999999999999998
Q ss_pred h--CCCCCCCCC
Q 012599 431 T--GRQPIHRSI 440 (460)
Q Consensus 431 t--G~~Pf~~~~ 440 (460)
+ +..||....
T Consensus 235 ~~~~~~p~~~~~ 246 (304)
T cd05096 235 MLCKEQPYGELT 246 (304)
T ss_pred HccCCCCCCcCC
Confidence 6 677887543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.21 Aligned_cols=210 Identities=25% Similarity=0.401 Sum_probs=173.0
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEE------cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 293 (460)
....++|++.+.||+|+||.||+|.. ..+..||||+++........+.+.+|+.+++.+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 33456788889999999999999964 235689999997655444556688999999999 89999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhcccc----------------------------------------------------
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL---------------------------------------------------- 321 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------- 321 (460)
....++||||+++|+|.++++...
T Consensus 111 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 111 ----GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred ----CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 446799999999999999996422
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 322 ---------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 322 ---------------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCcccee
Confidence 124788899999999999999999988 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... .......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 264 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 264 IRNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ccCcccc---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 6433211 11112334567999999999999999999999999999998 899997643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.59 Aligned_cols=203 Identities=25% Similarity=0.362 Sum_probs=170.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +++.||+|.+.... .......+.+|+.++..++|+||+++++++.+ +...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD----ENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec----CCeE
Confidence 46888899999999999999875 48899999986421 22233457889999999999999999998876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999999653 245899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 153 LADGTV----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCCCc----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 443211 1222458999999998863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=291.38 Aligned_cols=207 Identities=23% Similarity=0.330 Sum_probs=170.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~~ 302 (460)
+|++.+.||+|+||.||+|... +++.||||++.... .......+.+|++++++++||||+++++++..... .....+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999875 58999999987432 22233458899999999999999999998764322 223579
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+ +++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 57999998753 45899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ........|+..|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 155 NDTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccCc--cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 32211 112234568899999998865 678999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=291.40 Aligned_cols=201 Identities=24% Similarity=0.336 Sum_probs=168.2
Q ss_pred CCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 297 (460)
+|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+..|+.+++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4778899999999999999763 57899999986432 122334578899999999 59999999988765
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 45679999999999999999653 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++....... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 152 SKEFLSEEK----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CccccccCC----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 976543321 122345689999999998764 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=270.77 Aligned_cols=203 Identities=25% Similarity=0.386 Sum_probs=179.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|-||.||.|+.+ ++..||+|++.+.. .......+.+|+++-+.|+||||+++++++.+ ...
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----~~r 96 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----SKR 96 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec----cce
Confidence 467888999999999999999865 47889999986542 12233458899999999999999999999987 557
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.||++||.++|.|...|+......+++.....+..|+|.|+.|+|... ++||||||+|+|++..+..||+|||-+..
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence 799999999999999999777777999999999999999999999888 99999999999999999999999998865
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.+. ......+||..|++||...+...+..+|+|++|++.||++.|.+||....
T Consensus 174 ~p~-------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 174 APS-------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred cCC-------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 431 23456899999999999999999999999999999999999999998765
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=290.68 Aligned_cols=201 Identities=25% Similarity=0.332 Sum_probs=167.8
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCC-CccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~~~~ 301 (460)
+|++.+.||+|+||.||+|...+ ++.||+|++.... .....+.+..|.+++..++|+ +|+++.+++.+ ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCEE
Confidence 47788999999999999998764 7789999987532 223344578899999999665 57788877765 4568
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999999653 45899999999999999999999998 999999999999999999999999998643
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......||+.|+|||++....++.++||||||+++|||+||+.||....
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 152 IFGG-----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred CCCC-----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2211 12234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=284.86 Aligned_cols=201 Identities=34% Similarity=0.564 Sum_probs=166.7
Q ss_pred ccceeeeeCcEEEEEEEEc-----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 229 GSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
..+.||.|.||.||+|.+. .+..|+||.++........+.|.+|++.+++++||||++++|++.. ....++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~----~~~~~l 78 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE----NEPLFL 78 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES----SSSEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc----cccccc
Confidence 3478999999999999987 2678999999765444456779999999999999999999999984 334799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.++|.......+++.++..++.|++.||.|||+.+ ++|+||+++|||+++++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999998865567999999999999999999999998 99999999999999999999999999987632
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
.... ...........|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 156 KSKY---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SSSE---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccc---cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2111 11122335678999999998889999999999999999999 78998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=283.91 Aligned_cols=202 Identities=28% Similarity=0.439 Sum_probs=172.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|+.+++.++|+||+++++.+.+ +...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC----CCeEE
Confidence 3677899999999999999875 588999999865322 2223457889999999999999999988765 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999986544456899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......|+..|+|||++....++.++||||||+++|||++|+.||....
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 154 EGE------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred CCC------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 321 1123467899999999988889999999999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=291.21 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=166.6
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHH---HhcCCCCccceeeeeeeccCccce
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDML---SRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
|++.+.||+|+||.||++... +++.||||.++... .....+.+.+|++++ +.++||||+++++++.. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~----~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT----EDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----CCE
Confidence 566789999999999999875 58899999997532 222334466666655 56689999999998875 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 8999999999999998864 45899999999999999999999998 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 151 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 151 GMGFG-----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CCCCC-----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 32221 12234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.18 Aligned_cols=196 Identities=27% Similarity=0.333 Sum_probs=166.3
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.||+|+||.||++... +++.||+|.++... .......+.+|++++..++||||+++.+++.. ....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----CCEEEEEEeC
Confidence 46999999999999874 58899999997542 22233457889999999999999999988765 4578999999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
+++|+|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~- 150 (325)
T cd05594 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 150 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence 9999999998653 458999999999999999999997 66 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 151 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred ----cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 11223568999999999998899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=290.07 Aligned_cols=201 Identities=24% Similarity=0.342 Sum_probs=168.2
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+|...+.||+|+||.||++... +++.||+|.+.... .......+..|..++..+. |++|+++.+++.+ ....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----VDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----CCEE
Confidence 3667789999999999999875 58899999987532 2233345778888888885 5778888887765 4467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999999999653 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 152 MVDG-----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred CCCC-----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 3322 12233568999999999998899999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=289.81 Aligned_cols=196 Identities=26% Similarity=0.382 Sum_probs=163.7
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|... +++.||+|.++... .....+.+..|..++... +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999875 47889999987532 122333456677777654 89999999988765 457899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 77 YLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 99999999999753 45899999999999999999999998 9999999999999999999999999997543221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 151 ----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 12234568999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.01 Aligned_cols=203 Identities=23% Similarity=0.339 Sum_probs=170.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.... .......+.+|+.++..++|+||+++++++.+ ....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~----~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD----ENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 46888899999999999999876 47889999986421 12233447889999999999999999998875 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999997532 45889999999999999999999998 999999999999999999999999999766
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... .......|++.|+|||++.. ..++.++||||||++||||++|+.||...
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 153 NQDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cCCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 44321 11223468999999998865 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.57 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=174.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
-|+..+.||+|+.|.|-+|++. .|+.+|||.+.... .......+.+|+-+|+.+.|||+++++++..+ ...+|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~----~~~ly 88 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN----KQHLY 88 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc----CceEE
Confidence 3667789999999999999875 59999999997652 22233447899999999999999999998876 66889
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|.||+++|-|++|+-.. .++.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||||....
T Consensus 89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999999754 56899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++ .....-+|++.|.+||++.+.+| ..++||||-||+||.|+||+.||++.
T Consensus 164 ~g------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 164 PG------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred CC------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 44 34456789999999999999888 78999999999999999999999854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=290.10 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=173.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++.+. ++..+|+|.+...........+.+|++++++++|+||+++++++.+ +...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE----CCEEE
Confidence 467889999999999999999886 4788999988765443444568999999999999999999999886 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++... ..+++.....++.|++.||.|||+.. +|+|+||||+|||+++++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999999753 45889999999999999999999742 39999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 156 DSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hhc-------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 321 123457889999999988889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=289.03 Aligned_cols=204 Identities=28% Similarity=0.466 Sum_probs=170.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|+..+.||+|+||.||+|.+. +++ .||+|.++..........+.+|+.+++.++|+||++++|+|.. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----C
Confidence 45888899999999999999864 333 4899999765545556678999999999999999999999875 2
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 3579999999999999997643 45889999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
......... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 158 LLGADEKEY---HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cccCCCcce---eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 765432110 1111234568999999999999999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=292.88 Aligned_cols=203 Identities=23% Similarity=0.341 Sum_probs=169.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++.... ++.+|+|.+.... .......+.+|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD----ENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CCEE
Confidence 468888999999999999998764 7789999986421 12233447889999999999999999988875 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999999997532 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 153 MEDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ccCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 43321 1122346899999999885 346789999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=289.55 Aligned_cols=196 Identities=27% Similarity=0.373 Sum_probs=166.1
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++... +++.||+|.+.... .......+..|..++..+ +||||+++++++.. ....++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----PDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----CCEEEEEEc
Confidence 36999999999999875 47899999987532 223344577888888876 79999999998865 457799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 y~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~- 150 (320)
T cd05590 77 FVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG- 150 (320)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence 99999999998754 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 151 ----KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ----CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 12234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.61 Aligned_cols=211 Identities=25% Similarity=0.412 Sum_probs=173.0
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
|....++|++.+.||+|+||.||++... ++..||+|+++..........+.+|+++++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3444567888999999999999998742 24579999998655444455688999999999 8999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhcccc---------------------------------------------------
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------------------------------------------- 321 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 321 (460)
. ....++||||+++|+|.++++...
T Consensus 113 ~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 113 H----GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred C----CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 6 446799999999999999985421
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 322 -----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 322 -----------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 123788899999999999999999988 999999999999999999999999999765432
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
... .......++..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 266 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 266 SNY---VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred cce---eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 210 11112234567999999988899999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=291.25 Aligned_cols=196 Identities=23% Similarity=0.350 Sum_probs=166.0
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|.... ++.||+|.++... .......+..|.+++..+ +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----KDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCeEEEEEe
Confidence 369999999999998764 7899999987542 223334577888888866 89999999998876 456799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 77 YVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 99999999998653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......|++.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 151 ----VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ----ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 12234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=287.64 Aligned_cols=196 Identities=27% Similarity=0.404 Sum_probs=164.6
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|.+.+ ++.||+|.++... .......+..|..++... +||||+++++++.+ ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----KENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----CCEEEEEEe
Confidence 369999999999998764 7899999997542 122334466778888764 99999999998876 456899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 y~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05619 77 YLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence 99999999999753 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 151 ----AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred ----CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 12234568999999999998899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=289.51 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=165.1
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++... +++.+|+|.++... .......+.+|+.++.++ +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----CCEEEEEEe
Confidence 46999999999999875 47899999997542 223334577888888877 89999999998876 457899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~- 150 (329)
T cd05618 77 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence 99999999988653 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.......||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 122345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=292.53 Aligned_cols=197 Identities=27% Similarity=0.407 Sum_probs=163.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|+..+.||+|+||.||++.+. +++.||||.+...........+.+|+++++.++|+||+++++++.+ ....++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 149 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH----NGEIQV 149 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc----CCeEEE
Confidence 34556788999999999999875 5899999999765444445668999999999999999999998865 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 150 v~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 150 LLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred EEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999999987532 2567788899999999999999998 99999999999999999999999999986643
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||...
T Consensus 221 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 221 TMD-----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred ccc-----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 221 1223468999999998743 23456899999999999999999999743
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.53 Aligned_cols=204 Identities=28% Similarity=0.386 Sum_probs=172.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +++.+|+|+++... .......+.+|+.+++.++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~----~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD----KDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCeE
Confidence 46888899999999999999875 58899999997542 22344557889999999999999999988765 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999997642 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 153 TANKMV----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred CCCCce----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 543211 122346889999999886 4567899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=281.92 Aligned_cols=207 Identities=29% Similarity=0.508 Sum_probs=172.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|++.+.||+|+||.||+|.... ...+++|.+...........|.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----E 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----C
Confidence 467888999999999999998643 257999998765544455668999999999999999999998875 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll 364 (460)
...+++|||+++++|.+++..... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 467999999999999999965321 44788999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 365 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
++++.++|+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred cCCCcEEECCCcceeeccccccc---cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999765332211 11222345788999999988899999999999999999998 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=289.08 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=165.7
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++... +++.||+|.++... .......+.+|..++..+ +||||+++++++.+ ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----CCEEEEEEe
Confidence 36999999999999875 48899999997542 222334578899999988 79999999998876 457799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 ~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 150 (329)
T cd05588 77 FVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence 99999999998653 46999999999999999999999998 9999999999999999999999999987432211
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.......||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 122345789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.31 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=174.4
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~ 292 (460)
++...++|.+.+.||+|+||.||+|.+.. +..||||+++........+.|.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34446788889999999999999998632 34699999976555445567999999999995 999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhcccc---------------------------------------------------
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------------------------------------------- 321 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 321 (460)
+ ....++||||+++|+|.++|....
T Consensus 112 ~----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 112 K----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred c----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 6 456799999999999999985421
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 322 -------------------------------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 322 -------------------------------------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
...+++.+++.++.|++.||.|||+.+ |+|||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dik 264 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLA 264 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCC
Confidence 124788889999999999999999988 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~ 437 (460)
|+|||+++++.+||+|||+++....... ........++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSN---YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceecccccc---ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 9999999999999999999986543221 111223346778999999988899999999999999999997 999997
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 342 ~~~ 344 (400)
T cd05105 342 GMI 344 (400)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=280.12 Aligned_cols=211 Identities=25% Similarity=0.312 Sum_probs=179.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+.|+.++.||.|.-|+||++++.+ +..+|+|++.+..- .+...+...|-++|+.++||.+..|++.+.. +...
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet----~~~~ 152 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET----DKYS 152 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec----ccee
Confidence 456677899999999999999875 58899999976532 2334456789999999999999999998876 6688
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++|||||+||+|...++++..+.+++..+..++.+++-||+|||-.| ||+|||||+||||.++|++.|+||.++...
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999999888888999999999999999999999999 999999999999999999999999987643
Q ss_pred ccC--------------------------------CCC-------------------CCCCCCCccccCCcccCcccccc
Q 012599 382 KAD--------------------------------GLP-------------------SCSSSPARMQGTFGYFAPEYAMV 410 (460)
Q Consensus 382 ~~~--------------------------------~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~ 410 (460)
... ... ........++||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 110 000 00012234679999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 411 GRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 411 ~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
...+..+|+|+|||+||||++|.-||.....+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 99999999999999999999999999886543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=289.17 Aligned_cols=196 Identities=25% Similarity=0.345 Sum_probs=163.3
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||+||+|... +++.||+|++.... .......+..|.. +++.++||||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----ADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----CCEEEEEEc
Confidence 46999999999999885 58999999986532 1222233555554 5678899999999988765 457799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (323)
T cd05575 77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS- 150 (323)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence 99999999999753 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 151 ----KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred ----CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 12334568999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=281.01 Aligned_cols=195 Identities=29% Similarity=0.420 Sum_probs=164.7
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||+||++... +++.+|+|.+...... ...+.+..|+++++.++|+||+++.+++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----KTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----CCeEEEEEeCCC
Confidence 689999999999875 5889999998654221 122457789999999999999999988765 456799999999
Q ss_pred CCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012599 310 NGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (460)
Q Consensus 310 ~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~ 387 (460)
+|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~- 152 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS- 152 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence 99999888432 2245899999999999999999999998 99999999999999999999999999976543321
Q ss_pred CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 153 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 153 ----KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ----cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 122346889999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.26 Aligned_cols=195 Identities=23% Similarity=0.279 Sum_probs=166.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
..+|++.+.||+|+||.||++.+. .++.||+|.... ..+.+|++++++++||||+++++++.. ....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTY----NKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEE----CCeeE
Confidence 367999999999999999999875 488999996542 236899999999999999999998876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|+|++ .++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999 57999998653 45899999999999999999999998 9999999999999999999999999997543
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ........||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 234 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 234 DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccc----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 211 11223456899999999999889999999999999999999999988643
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.04 Aligned_cols=195 Identities=26% Similarity=0.363 Sum_probs=165.6
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++... +++.+|+|+++.... ......+.+|+.++.++ +|+||+++++++.+ ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----TSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----CCEEEEEEe
Confidence 46999999999999875 478899999975432 22334578899999888 69999999998765 457899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 150 (327)
T cd05617 77 YVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG- 150 (327)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence 99999999988653 45999999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.......||+.|+|||++....++.++||||||++||||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 151 ----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ----CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 1223456899999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.67 Aligned_cols=203 Identities=24% Similarity=0.404 Sum_probs=170.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|...+.||+|+||.||+|... +++.+|+|.++..........+.+|++++++++|+||+++++++.. +...++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT----DKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee----CCeEEE
Confidence 56788899999999999999875 5788999999765544444557899999999999999999999876 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999996 58998886532 45889999999999999999999998 99999999999999999999999999875433
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.. .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.....
T Consensus 157 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 157 PT-----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred Cc-----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 21 11223457889999998764 5689999999999999999999999976544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=286.81 Aligned_cols=196 Identities=26% Similarity=0.384 Sum_probs=164.6
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++.+. +++.||+|.++.... ......+..|..++... +|+||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----CCEEEEEEC
Confidence 46999999999999886 488999999975421 22334466778787754 89999999998876 457899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05620 77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence 99999999998653 45899999999999999999999998 9999999999999999999999999987432211
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 151 ----NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred ----CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=278.31 Aligned_cols=203 Identities=26% Similarity=0.430 Sum_probs=173.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+ ....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK----EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCcEE
Confidence 46788889999999999999998888899999986532 234568999999999999999999988765 446799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+++++|.++++......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999997655566899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
.... ......++..|+|||++....++.++||||||+++|||+| |+.||...
T Consensus 156 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 156 NEYT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred Ccee----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 3211 1122335678999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=288.33 Aligned_cols=195 Identities=25% Similarity=0.339 Sum_probs=162.2
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|+.. +++.+|+|.+.... .......+..|.. +++.++||||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----AEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999885 58899999986432 1222334555554 5788899999999988765 457799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 77 YVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 99999999988653 45888999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 151 ----ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred ----CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 1223456899999999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=321.14 Aligned_cols=204 Identities=25% Similarity=0.509 Sum_probs=167.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
...|+..+.||+|+||.||+|.. .++..||||++...... ...|++.+++++||||++++|+|.+ ....+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~----~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS----EKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc----CCCCE
Confidence 34577788999999999999987 46899999998643321 2356889999999999999999976 34569
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.++++. ++|.++..++.|+|+||+|||....++|+||||||+||++++++.+++. ||......
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999953 8999999999999999999997655669999999999999999988876 66554322
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhh
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTA 452 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~ 452 (460)
.+ ....++..|+|||++....++.++|||||||++|||+||+.||+.... ....+++|++
T Consensus 834 ~~---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 893 (968)
T PLN00113 834 TD---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWAR 893 (968)
T ss_pred cC---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHH
Confidence 11 122578899999999999999999999999999999999999965433 2345666654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=279.54 Aligned_cols=207 Identities=29% Similarity=0.466 Sum_probs=173.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|.+.+.||+|+||.||+|...+ ++.||+|.++..........|.+|++++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE---- 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence 3457778999999999999998643 478999999866554455679999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
....++||||+++++|.++++... ...+++.++..++.|++.|+.|||+.+ ++||||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEc
Confidence 356799999999999999996532 134789999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 366 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.++.+||+|||++......... .......+++.|+|||++....++.++||||||+++|||++ |..||....
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred CCCeEEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999998765332211 11122345678999999999999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=280.18 Aligned_cols=209 Identities=28% Similarity=0.420 Sum_probs=171.7
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
...++|+..+.||+|+||.||+|.+. .+..+|+|.+...........|.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 45678999999999999999999753 2567999998654433344568899999999999999999998865
Q ss_pred CccceEEEEEeecCCCCHHHHhccccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLV--------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence 4567999999999999999965321 23678899999999999999999988 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+.++|+|||++.......... ......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCEEECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999987654322111 1112234678999999988889999999999999999999 788987543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=289.67 Aligned_cols=210 Identities=29% Similarity=0.445 Sum_probs=172.5
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 293 (460)
+.+.++|++.+.||+|+||.||+|... .++.||+|+++..........+..|++++.++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 344567899999999999999999642 24789999997554433445578899999999 89999999998864
Q ss_pred ccCccceEEEEEeecCCCCHHHHhcccc----------------------------------------------------
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL---------------------------------------------------- 321 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------- 321 (460)
. ....+++|||+++++|.+++....
T Consensus 83 ~---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 83 P---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred C---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 2 346789999999999999985421
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCC
Q 012599 322 -------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394 (460)
Q Consensus 322 -------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 394 (460)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.++|+|||++..+...... ....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~~~~ 233 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKG 233 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch---hhcc
Confidence 125899999999999999999999998 999999999999999999999999999876432211 1122
Q ss_pred ccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
...++..|+|||++....++.++|||||||+||||++ |+.||...
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~ 279 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence 2345678999999999999999999999999999998 99999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=288.66 Aligned_cols=196 Identities=27% Similarity=0.341 Sum_probs=163.5
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||+||++... +|+.+|+|++.... .......+..|.. +++.++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----TEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----CCEEEEEEc
Confidence 36999999999999875 58999999986532 2223334555654 4677899999999988875 457799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 149 (325)
T cd05604 77 FVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-- 149 (325)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--
Confidence 99999999998653 46899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
........|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 150 ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred ---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 112234568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.44 Aligned_cols=208 Identities=27% Similarity=0.397 Sum_probs=173.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|.+. .++.||+|++...... .....|.+|++++++++||||+++++++.+ ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d----~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD----GDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee----CCEE
Confidence 56888899999999999999876 4889999999754322 234568999999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 302 LLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEE
Confidence 99999999999999986421 133667888999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCC-------------CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLP-------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 373 ~DFGla~~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+|||++......... ..........||+.|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999866221100 0011122356999999999999999999999999999999999999999753
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=274.12 Aligned_cols=202 Identities=26% Similarity=0.425 Sum_probs=170.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|++.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++.+ ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc----CCCEEEE
Confidence 4577788999999999999999888889999886432 234568899999999999999999999876 4467999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999997533 35899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 154 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 154 EYT----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred cee----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 211 1122234568999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=277.92 Aligned_cols=201 Identities=29% Similarity=0.428 Sum_probs=170.9
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
|+..+.||+|+||+||++.+. +++.+|+|.+..... ......+.+|+++++.++|+|++++.+++.. +...++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----CCEEEE
Confidence 566789999999999999875 588999999865432 2223447889999999999999999988765 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999999999986544456999999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......|+..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 155 ~~------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 155 GE------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred CC------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1123468899999999988899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=274.82 Aligned_cols=205 Identities=29% Similarity=0.444 Sum_probs=174.0
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
..++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL----EEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec----CCCee
Confidence 456788889999999999999998778889999987543 234568999999999999999999998765 44679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.+++.......+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997655456899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
..... .......+..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 155 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 155 EDIYE----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred CCccc----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 32211 1111223457999999988899999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.89 Aligned_cols=196 Identities=24% Similarity=0.316 Sum_probs=161.7
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHH-HHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEV-DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++... +++.+|+|.+..... ......+..|. .+++.++|+||+++++++.+ ....++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----CCeEEEEEe
Confidence 36999999999999876 477899999864321 12223344444 45678899999999988865 456799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+.+.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~- 150 (325)
T cd05602 77 YINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 150 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence 99999999999753 45788888999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 151 ----GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred ----CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 12234568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=276.91 Aligned_cols=194 Identities=27% Similarity=0.439 Sum_probs=165.0
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||.||++... +|+.+|+|.+..... ......+..|++++++++||||+++.+++.. +...++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----KTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----CCeEEEEEecCC
Confidence 689999999999875 489999999864322 1223345679999999999999999988765 457799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 999999986655556899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
......|+..|+|||++....++.++||||||+++|||++|+.||...
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 112345788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=289.43 Aligned_cols=196 Identities=27% Similarity=0.360 Sum_probs=166.8
Q ss_pred ceeeeeCcEEEEEEEE----cCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 231 NIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~----~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
+.||+|+||.||++.. .+|+.+|+|++..... ......+..|++++++++||||+++++++.+ ....++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCEEEEEE
Confidence 5799999999999875 3578999999975432 2233446789999999999999999998876 45779999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999999653 45899999999999999999999998 9999999999999999999999999987653321
Q ss_pred CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 153 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 153 -----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred -----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 12233568899999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=277.71 Aligned_cols=201 Identities=29% Similarity=0.444 Sum_probs=171.2
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
|+..+.||+|+||.||++... +++.+|+|.+....... ....+.+|+.++++++|+|++++++.+.+ ....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec----CCEEEE
Confidence 667789999999999999875 58899999987543222 23447789999999999999999988865 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999999996554456899999999999999999999988 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......|+..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 155 GQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred Cc------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1123468899999999998899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=292.38 Aligned_cols=207 Identities=29% Similarity=0.490 Sum_probs=180.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.+.....++||+|.||.||+|...+ .-.||||..+.+.++...+.|+.|..+|++++||||++|+|+|.+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e----- 462 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE----- 462 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-----
Confidence 4445556889999999999998643 235899999988888888889999999999999999999999986
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++|||.++.|.|..||+... ..++..+...++.||+.||.|||+.. +|||||.++|||+.....|||+|||++
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 35699999999999999998643 56899999999999999999999988 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 443 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~~ 443 (460)
+.+..+.+.. .....-+..|||||.+.-++++..||||.|||.+||++. |..||+.....+
T Consensus 539 R~~ed~~yYk----aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 539 RYLEDDAYYK----ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred hhccccchhh----ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 9988776432 123345688999999999999999999999999999997 999999865543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=283.84 Aligned_cols=196 Identities=26% Similarity=0.374 Sum_probs=165.6
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++.+.. ++.+|+|.++... .......+..|++++..+ +||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----KDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 469999999999998764 7899999997542 223334567888888888 79999999998875 457899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 150 (318)
T cd05570 77 YVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG- 150 (318)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 151 ----VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ----CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 11233468899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=297.64 Aligned_cols=202 Identities=22% Similarity=0.261 Sum_probs=170.2
Q ss_pred CcccceeeeeCcEEEEEEEEcC--CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|.+.+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv 143 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS----DDKLLLI 143 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE----CCEEEEE
Confidence 7778999999999999997643 5778888765432 2333457889999999999999999999876 4578999
Q ss_pred EeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 305 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999988643 2245889999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ........||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 221 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 221 DSVS---LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred Cccc---cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 3221 11233456899999999999999999999999999999999999999754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.31 Aligned_cols=217 Identities=26% Similarity=0.354 Sum_probs=178.1
Q ss_pred hcCCcccceeeeeCcEEEEEEE-EcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~ 301 (460)
.++|.+.+.||+|||+.||+++ ..++..+|+|++.... .+..+..++|++..++++|||++++++++...+. .....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4567788999999999999998 4568889999998765 4455668999999999999999999998765433 45578
Q ss_pred EEEEeecCCCCHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
||+++|...|+|.+.+..... ..+++.+++.|+.++++||++||+.. |++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999965443 34999999999999999999999985 579999999999999999999999999987
Q ss_pred ccccCCCCC----CCCCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 380 RLKADGLPS----CSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 380 ~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
...-.-..+ .--.+.....|..|+|||++.- ...+.++|||||||+||+|+.|..||++....
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 553221100 0011223456889999999864 45688999999999999999999999876553
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=296.74 Aligned_cols=203 Identities=30% Similarity=0.438 Sum_probs=174.7
Q ss_pred cccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--CccceEEEE
Q 012599 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMRLLV 304 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~~~~lV 304 (460)
...+.||+|+||.||+|+.+ .|+.||||.++........++..+|+++|++++|+|||+++++-.+.. .......+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 33478999999999999965 599999999998887888888999999999999999999998744322 012356899
Q ss_pred EeecCCCCHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc--CCC--cEEEEecCCcc
Q 012599 305 FEFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENL--NAKITDLGMAK 379 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~--~~~--~vkl~DFGla~ 379 (460)
|||+++|||+..|+.. +..++++.+.+.+..+++.||.|||+++ |+||||||.||++- +++ .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999999763 3356999999999999999999999998 99999999999984 334 37999999999
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.+.++. ....+.||..|++||++. .+.|+..+|.|||||++|++.||..||.-.
T Consensus 173 el~d~s------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 173 ELDDNS------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cCCCCC------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 887654 345678999999999998 488999999999999999999999999643
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=277.41 Aligned_cols=204 Identities=25% Similarity=0.408 Sum_probs=167.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|+..+.||+|+||.||+|.+. +++ .+++|.+...........+..|+..+++++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence 45777899999999999999874 344 4788887644333344557788889999999999999998743 3
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 4578999999999999997533 45899999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 158 LLYPDDKK---YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred eccCCCcc---cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 66433211 11223446678999999988899999999999999999998 999997653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=277.48 Aligned_cols=224 Identities=25% Similarity=0.331 Sum_probs=185.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeee-ccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE-FRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~~~ 300 (460)
...|...+.||+|++|.|..+.+. +|+.||+|++... ......++.++|+.+|+.++|+||+.++++... ..+.-..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445666789999999999999875 5899999998733 333445668899999999999999999998865 3334456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.|+|+|+| +.+|.+.++.. +.++..+...++.|+++||.|+|+.+ ++||||||.|+|++.+..+||+|||+|+.
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 79999999 77999999763 44899999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhcccc
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIY 456 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~~~~ 456 (460)
.... ......+....|.+|.|||++. ...|+...||||.||+|.||++|++.|.+.+.-+...++....+.+.
T Consensus 175 ~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 175 LDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred cccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 8654 1122335567889999999875 57899999999999999999999999988776655566655555443
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=277.49 Aligned_cols=205 Identities=29% Similarity=0.482 Sum_probs=170.2
Q ss_pred cCCcccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|++.+.||+|+||.||+|.+ ..+..+++|.+...........|.+|+++++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----EQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CC
Confidence 4577789999999999999975 24678999999765444444568899999999999999999998765 34
Q ss_pred eEEEEEeecCCCCHHHHhcccc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVL---------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll 364 (460)
..++||||+++++|.+++.... ...+++.+.+.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEE
Confidence 6799999999999999985321 124788999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 365 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
++++.+||+|||++.......... ......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYR---VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cCCCcEEeccccccccccCCccee---cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999998764432111 1222335678999999988889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=270.38 Aligned_cols=203 Identities=30% Similarity=0.374 Sum_probs=174.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|++|.||++... +++.+++|.+.... .......+.+|+++++.++|||++++++++.+ ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----KGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----CCEEEE
Confidence 4677789999999999999875 58899999986532 23345568899999999999999999998876 457899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 999999999999998754567999999999999999999999988 99999999999999999999999999886644
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......+++.|+|||++....++.++|+||||+++|||++|+.||....
T Consensus 154 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 154 NTN-----FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred ccc-----hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1223457789999999998889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=275.18 Aligned_cols=208 Identities=26% Similarity=0.435 Sum_probs=173.9
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccC--c
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG--K 297 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~--~ 297 (460)
.+++.|+..+.||+|+||.||+|... +++.+|+|.+.... .....+..|+.+++++ +|+||+++++++..... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45677888899999999999999875 47889999987543 3344588999999998 79999999999875432 1
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 346799999999999999998654456899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+....... .......|+..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 158 SAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred ceeccccc-----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 87653321 1223356888999999885 345788999999999999999999999654
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=289.38 Aligned_cols=205 Identities=26% Similarity=0.307 Sum_probs=168.6
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-cceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~~~~~ 302 (460)
+|+..+.||+|+||.||++... +++.||+|++.... .......+.+|+++++.++|+||+++++++...... ....+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 68999999986532 222344588999999999999999999998753311 12679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888888643 45899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 155 PDES----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cCcc----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 3221 11223357889999998876 457999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.80 Aligned_cols=216 Identities=26% Similarity=0.291 Sum_probs=177.1
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
.+.....++|.+.+.||+|+||+||++... +++.||||.+..... ......+.+|+..+..++|+|++++...+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344455678999999999999999999864 689999999875432 233445789999999999999999887665422
Q ss_pred C----ccceEEEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 296 G----KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 296 ~----~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
. .....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 1 1124689999999999999996432 345899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+||+|||+++....... ........||+.|+|||++....++.++||||||++||||++|+.||...
T Consensus 182 vkL~DFGls~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVS---DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred EEEEecccCeecccccc---ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999986543211 11223456899999999999999999999999999999999999999754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.02 Aligned_cols=203 Identities=24% Similarity=0.359 Sum_probs=180.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
..|+..+.||+|.||.||||.+. .++.||+|++..+......+++.+|+.++.+++++||.+++|.+.. +..+++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~----g~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK----GTKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee----cccHHH
Confidence 34666689999999999999875 4889999999988877777889999999999999999999998876 567799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+.+|++.+.|+.. ..+++..+..++++++.|+.|||.++ .+|||||+.|||+.+++.+||+|||.+-.+..
T Consensus 89 iMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999999753 33588888899999999999999998 99999999999999999999999999987765
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.. .....+.||+.|||||++....|+.|+||||||++.+||.+|.+|+.+..+
T Consensus 164 ~~-----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 164 TV-----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred hh-----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 43 234678999999999999998999999999999999999999999987654
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=274.51 Aligned_cols=202 Identities=29% Similarity=0.442 Sum_probs=171.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.+|+..+.||+|++|.||+|...+ ++.+|+|.+... ......+.+|+++++.++|+||+++++++.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcC----CCCcEE
Confidence 456777899999999999998754 788999998743 2234568999999999999999999998875 446799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999997655556899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
.... .......+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 157 DTYT----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred ceee----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 3211 1112234567999999988899999999999999999998 99998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=274.34 Aligned_cols=203 Identities=31% Similarity=0.486 Sum_probs=171.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|.+.+.||+|+||.||+|.+.+...||+|+++.... ..+.|.+|+++++.++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCcEE
Confidence 456888899999999999999987777899999975332 33468999999999999999999987643 34689
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999997654456899999999999999999999988 99999999999999999999999999976644
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.... ......++..|+|||+.....++.++||||||+++|||+| |+.||....
T Consensus 155 ~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred cccc----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 3211 1122345678999999988899999999999999999999 888987543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=275.60 Aligned_cols=206 Identities=30% Similarity=0.444 Sum_probs=176.8
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.+..+|+..+.||+|+||.||+|...++..+++|.+..... .....+.+|+.+++.++|+||+++++++.+ ....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSV----GEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEec----CCCe
Confidence 45567888899999999999999998899999999875432 234458899999999999999999998876 4467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||.+...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999998765567899999999999999999999998 999999999999999999999999999766
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
..... ......++..|+|||.+....++.++||||||+++|+|++ |+.||....
T Consensus 155 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 155 KEDVY-----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred CCccc-----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 43321 1112335678999999988899999999999999999998 899997644
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=272.76 Aligned_cols=205 Identities=26% Similarity=0.436 Sum_probs=174.5
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
...++|++.+.||+|+||.||+|...+++.+|+|.+..... ....|.+|+.++++++|+|++++++++.. ...
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-----EPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-----CCc
Confidence 34567888899999999999999998899999999875432 34568999999999999999999987642 357
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+++|||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 99999999999999997655567899999999999999999999988 999999999999999999999999999766
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
...... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 153 ~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 153 EDNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred CCCCcc----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 532211 1122335678999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=273.38 Aligned_cols=204 Identities=30% Similarity=0.470 Sum_probs=172.6
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
..++|++.+.||+|+||.||++...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++.+ ...+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-----EPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-----CCcE
Confidence 3457888899999999999999988888899999875432 23458999999999999999999988642 3468
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
++|||+++++|.+++.......+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 9999999999999997655556899999999999999999999998 9999999999999999999999999997654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
..... ......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 154 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 154 DNEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred Ccccc----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 33211 1112234567999999988889999999999999999999 899996543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=273.15 Aligned_cols=205 Identities=27% Similarity=0.441 Sum_probs=172.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|+..+.||+|+||.||+|.+.. ...||+|.++..........|.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----SRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec----CCc
Confidence 568888999999999999998743 457999998765555555678999999999999999999998765 446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++.... ..+++..++.++.|++.|++|||+.+ |+|+||||+|||+++++.++|+|||++..
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 799999999999999997643 36899999999999999999999988 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... .......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 156 LEDSEAT---YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccccccc---eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 7521111 11112234578999999988899999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.03 Aligned_cols=214 Identities=23% Similarity=0.312 Sum_probs=174.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCC-cEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeee-eeec--cCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGY-CSEF--RGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~~~--~~~~ 298 (460)
..+.++.+.|.+|||+.||.|.+..+ ..+|+|++... +....+...+|+++|++|+ |+|||.+++. .... ....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 34556778999999999999998876 99999999876 5667777899999999996 9999999983 3222 1223
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
.+.+|.||||++|.|-+++.......|++.++++|+.|+++|+++||... |||||||||.+||||+.+++.||+|||.+
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 57899999999999999998766666999999999999999999999985 77999999999999999999999999998
Q ss_pred cccccCCC-CC---CCCCCCccccCCcccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGL-PS---CSSSPARMQGTFGYFAPEYA---MVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~-~~---~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
......-. .. .........-|+-|+|||.+ .+...++|+|||+|||+||-|++...||...
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 74322110 00 00011123467899999976 4567899999999999999999999999865
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=292.65 Aligned_cols=208 Identities=19% Similarity=0.236 Sum_probs=168.4
Q ss_pred eechHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC------CCccc
Q 012599 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH------CHVVP 286 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~ 286 (460)
....+++...+++|++.+.||+|+||+||+|.+. .++.||||+++... .....+..|+.+++.++| .++++
T Consensus 118 ~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 118 VVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred EecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 3444556667889999999999999999999875 47889999996432 223345677877777754 45788
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEc
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~ 365 (460)
+++++... ....++|||++ +++|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++
T Consensus 196 i~~~~~~~---~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~ 266 (467)
T PTZ00284 196 IQRYFQNE---TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILME 266 (467)
T ss_pred eEEEEEcC---CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEe
Confidence 88877542 34678999988 78999998653 458999999999999999999997 47 99999999999998
Q ss_pred CCC----------------cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHH
Q 012599 366 ENL----------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 429 (460)
Q Consensus 366 ~~~----------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~el 429 (460)
.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||+||||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc--------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 765 499999998754321 12345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 012599 430 ITGRQPIHRSI 440 (460)
Q Consensus 430 ltG~~Pf~~~~ 440 (460)
++|+.||....
T Consensus 339 ltG~~pf~~~~ 349 (467)
T PTZ00284 339 YTGKLLYDTHD 349 (467)
T ss_pred HhCCCCCCCCC
Confidence 99999997644
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=270.89 Aligned_cols=203 Identities=25% Similarity=0.316 Sum_probs=174.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+|++.+.||+|+||.||++... +++.+|+|.++........+.+.+|+.+++.++|+||+++++.+.+ ....+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA----DGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE----CCEEEEE
Confidence 4677899999999999999875 5889999998755444455568899999999999999999998865 4578999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999987655556899999999999999999999998 999999999999999999999999998766433
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......++..|+|||++....++.++|+||||+++|+|++|+.||....
T Consensus 154 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 154 GA-----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cc-----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 21 1223457888999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=272.44 Aligned_cols=202 Identities=25% Similarity=0.404 Sum_probs=170.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|++.+.||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++||||+++++++.+ ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK----QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc----CCCcEEE
Confidence 3567778999999999999998777789999987432 234568999999999999999999999865 3456999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999997543 36899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
... ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 154 ~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 206 (256)
T cd05113 154 EYT----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN 206 (256)
T ss_pred cee----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 211 1112235578999999988889999999999999999999 999997543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=284.90 Aligned_cols=204 Identities=23% Similarity=0.285 Sum_probs=169.6
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~ 298 (460)
..++|+..+.||+|+||.||++... .++.||+|.+.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999875 48899999997542 22334557899999999999999999998864322 12
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 35799999995 56777664 24788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 171 RTACTNF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cccccCc------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 7543221 1233467899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=292.72 Aligned_cols=203 Identities=24% Similarity=0.334 Sum_probs=164.6
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeec----cCc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF----RGK 297 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----~~~ 297 (460)
...+|++.+.||+|+||.||+|... .++.||||++.... ....+|+.+|+.++|+||+++++++... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999875 58899999886432 1245799999999999999999876432 122
Q ss_pred cceEEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEe
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITD 374 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~D 374 (460)
....++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 235679999996 5787777532 2355899999999999999999999998 99999999999999664 799999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||+++...... ......+|+.|+|||++.+ ..++.++|||||||+||||++|++||....
T Consensus 215 FGla~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 215 FGSAKNLLAGQ------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred cccchhccCCC------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998764322 1223467899999998865 468999999999999999999999997654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=273.28 Aligned_cols=228 Identities=24% Similarity=0.311 Sum_probs=192.1
Q ss_pred chHHHHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceee
Q 012599 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289 (460)
Q Consensus 216 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g 289 (460)
...++.....++....++-+|.||.||+|.+. +.+.|.||.++...++-....++.|.-++..+.|||++++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34566667778888899999999999999654 356789999998888877888999999999999999999999
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEE
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIl 363 (460)
++.+. ...++++|+++.-|+|..||... ..+.++..+.+.++.|++.||+|||+++ +||.||.++|++
T Consensus 355 V~ie~---~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 355 VSIED---YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred EEeec---cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 99873 34679999999999999999732 2345888899999999999999999999 999999999999
Q ss_pred EcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCc
Q 012599 364 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (460)
Q Consensus 364 l~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~ 442 (460)
||+..++||+|=.+++.+.+.++..-+.. ...+..||+||.+....|+..+|||||||+||||+| |+.|+...++
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDn---EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP- 504 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDN---ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP- 504 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCC---CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-
Confidence 99999999999999999888766543322 335689999999999999999999999999999999 9999976544
Q ss_pred CchhHHHHhhccc
Q 012599 443 GEESLVLWTATGI 455 (460)
Q Consensus 443 ~~~~l~~~~~~~~ 455 (460)
.++.-+...+.
T Consensus 505 --fEm~~ylkdGy 515 (563)
T KOG1024|consen 505 --FEMEHYLKDGY 515 (563)
T ss_pred --HHHHHHHhccc
Confidence 34444444443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=269.99 Aligned_cols=199 Identities=30% Similarity=0.457 Sum_probs=165.7
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
+.||+|+||.||+|.+. +++.+|+|.+...........|.+|++++++++|+||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CCCeEEEEeecc
Confidence 36899999999999875 6889999988755444445668999999999999999999999875 446799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++... ...+++.+++.++.|++.||.|||+.+ ++|+||||+|||+++++.+||+|||++..........
T Consensus 77 ~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~- 151 (252)
T cd05084 77 GGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS- 151 (252)
T ss_pred CCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccc-
Confidence 99999999653 245899999999999999999999998 9999999999999999999999999987654321110
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.......+..|+|||.+..+.++.++||||||+++|||++ |..||....
T Consensus 152 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 152 --TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred --cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 0111123457999999988889999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.30 Aligned_cols=204 Identities=27% Similarity=0.428 Sum_probs=168.6
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhc---CCCCccceeeeeeeccC-ccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-~~~ 299 (460)
+|++.+.||+|+||.||+|... +++.||+|.++...... ....+.+|+++++.+ +||||+++++++..... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 58899999987543222 223456777777665 79999999998865332 234
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 6789999996 59999997655556899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 157 IYSCQM------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccCcc------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 654321 122345788999999998889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=275.50 Aligned_cols=208 Identities=29% Similarity=0.429 Sum_probs=170.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
.+++|++.+.||+|++|.||+|.+.+ +..|++|.+...........|.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 35678889999999999999998753 567899988755444445568999999999999999999998776
Q ss_pred ccceEEEEEeecCCCCHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC---
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL--- 368 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~--- 368 (460)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCc
Confidence 3456899999999999999965432 24899999999999999999999998 99999999999998754
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 369 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.+||+|||+++......... .......+..|+|||++....++.++||||||+++|||++ |+.||....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 157 VAKIADFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred ceEeccCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 59999999998763322111 1111223467999999998999999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=271.55 Aligned_cols=201 Identities=26% Similarity=0.403 Sum_probs=168.9
Q ss_pred CCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
+|++.+.||+|+||.||++.+.++..+|+|.+..... ....|.+|+++++.++|+||+++++++.+ ....++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTK----QRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcC----CCceEEEE
Confidence 4677889999999999999987777899999864322 23458899999999999999999998765 44679999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
||+++++|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999999997543 35899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.. ......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 155 ~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 155 YT----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred cc----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 11 1111223457999999998899999999999999999999 899997543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=272.48 Aligned_cols=195 Identities=27% Similarity=0.399 Sum_probs=168.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|+..+.||+|+||.||+|.+. +++.+|+|.+...........+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV----ENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----CCEEEE
Confidence 35777899999999999999864 5889999998765444445568899999999999999999999876 456789
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999999997653 3678889999999999999999998 99999999999999999999999999976533
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
. ......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 148 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 148 S-------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred c-------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 2 122346788999999999889999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=276.91 Aligned_cols=209 Identities=28% Similarity=0.423 Sum_probs=171.4
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 294 (460)
+...++|++.+.||+|+||.||+|...+ +..||+|.+...........+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 4457789999999999999999997542 457999998755444444568899999999999999999998765
Q ss_pred cCccceEEEEEeecCCCCHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
....++||||+++|+|.+++.... ....++..+..++.|++.||.|||+.+ |+||||||+||++++
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~ 154 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH 154 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence 345799999999999999996422 123567888999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 367 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
++.++|+|||+++......... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred CCcEEECcCCcccccccccccc---ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999988654332111 1112234677999999988899999999999999999998 78899754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.84 Aligned_cols=199 Identities=28% Similarity=0.404 Sum_probs=171.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||.||++... ++..+|+|.+...........+.+|++++++++||||+++++++.+ +...++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS----DGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCEEEE
Confidence 36888899999999999999875 4788999988754433344558899999999999999999999876 457899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||||+++++|.++++.. ..+++..+..++.|++.||.|||+ .+ ++|+||||+|||+++++.+||+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999999754 558999999999999999999997 45 9999999999999999999999999987553
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 152 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 152 DSM-------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ccc-------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 221 22346788999999988888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=270.44 Aligned_cols=205 Identities=32% Similarity=0.482 Sum_probs=174.9
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
...++|.+.+.||+|+||.||+|.+.+++.+|||.+.... .....+.+|+.++++++|+|++++++++.. ....
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE----EEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeec----CCce
Confidence 3457888899999999999999998888899999987543 234568999999999999999999998765 3467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++.......+++.++..++.|++.|+.|||+.+ ++|+||||+||++++++.++|+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence 99999999999999998755566999999999999999999999998 999999999999999999999999998766
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
...... .......+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 154 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 154 EDDEYT----AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred cchhhh----hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432211 1112234567999999998889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.58 Aligned_cols=204 Identities=21% Similarity=0.269 Sum_probs=170.3
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Ccc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~ 298 (460)
..++|+..+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999875 47889999997543 2333455789999999999999999999875432 122
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 45799999995 578887753 4788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 174 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cccCCCC------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 7653321 1223467899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=269.86 Aligned_cols=197 Identities=26% Similarity=0.451 Sum_probs=164.0
Q ss_pred eeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||.||+|.+. .+..||+|.+.........+.|.+|+.++++++|+||+++++++.. ...++||||++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----~~~~lv~e~~~ 77 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----EALMLVMEMAS 77 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----CCeEEEEEeCC
Confidence 899999999999764 3557999999766554455668999999999999999999998743 35689999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++... ...+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 151 (257)
T cd05115 78 GGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-- 151 (257)
T ss_pred CCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc--
Confidence 99999999753 246899999999999999999999998 999999999999999999999999999765433211
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
........++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 203 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC
Confidence 111111223578999999988889999999999999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.59 Aligned_cols=202 Identities=26% Similarity=0.422 Sum_probs=169.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.++++++|+||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec----CCeEEE
Confidence 46788899999999999999875 4789999998765444444557899999999999999999999875 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 999996 6999998753 245889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 157 PT-----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred CC-----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11222346789999998765 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=271.60 Aligned_cols=199 Identities=29% Similarity=0.402 Sum_probs=160.2
Q ss_pred eeeeeCcEEEEEEEEcC---CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeec
Q 012599 232 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~---g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.||+|+||.||+|...+ ...+++|.+...........|.+|+..++.++|+||+++++.+.. ....++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----SIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC----CCceEEEEEeC
Confidence 58999999999997643 356888887655444445568899999999999999999998875 44679999999
Q ss_pred CCCCHHHHhccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 309 PNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 309 ~~gsL~~~l~~~~~---~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
++|+|.+++..... ...++...+.++.|++.||+|||+.+ |+||||||+|||+++++++||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 99999999976432 23567888999999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCCccccCCcccCccccc-------cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
... ......++..|+|||++. ...++.++||||||+++|||++ |..||....
T Consensus 155 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 155 YYI---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred hee---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 111 112233567799999864 2456889999999999999999 888887543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=270.11 Aligned_cols=203 Identities=32% Similarity=0.485 Sum_probs=171.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|.+.+.||+|++|.||++.+..+..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-----EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCcEE
Confidence 35577788999999999999998877789999886533 234568999999999999999999988643 34689
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999999997655456899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.... ......++..|+|||......++.++||||||+++|||+| |+.||....
T Consensus 155 ~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 208 (260)
T cd05069 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV 208 (260)
T ss_pred Cccc----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 3211 1112235678999999988899999999999999999999 999997643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=283.41 Aligned_cols=203 Identities=21% Similarity=0.270 Sum_probs=169.9
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~ 298 (460)
..++|+..+.||+|+||.||++... .++.+|||++..... ......+.+|+.+++.++|+||+++++++..... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 488999999875432 2334557889999999999999999998764321 22
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 35799999995 578777753 4788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 167 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccCCCcc------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 7653321 123346789999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=273.55 Aligned_cols=202 Identities=30% Similarity=0.423 Sum_probs=168.5
Q ss_pred cccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 228 SGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+..+.||+|+||+||++.. .++..||+|.++..........|.+|++++++++||||+++++++.... ....+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 84 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG--GKGLQ 84 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--CceEE
Confidence 7789999999999988653 3577899999976544444566889999999999999999999876532 34678
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++....
T Consensus 85 lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999965 35899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... ........++..|+|||.+....++.++||||||+++|||+||..||...
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 159 EGHEY--YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred Ccchh--hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 32211 01112223556799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=266.82 Aligned_cols=197 Identities=31% Similarity=0.484 Sum_probs=166.6
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCC
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~ 310 (460)
++||+|+||.||+|...+++.+|+|.+...........|.+|+++++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec----CCccEEEEECCCC
Confidence 368999999999999888999999998765444444568899999999999999999999875 3467999999999
Q ss_pred CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012599 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (460)
Q Consensus 311 gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 390 (460)
++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 149 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--- 149 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc---
Confidence 99999996543 45899999999999999999999988 999999999999999999999999998754322111
Q ss_pred CCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
......++..|+|||++....++.++||||||+++|||++ |..||...
T Consensus 150 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 150 -SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred -cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1111234567999999988889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.34 Aligned_cols=199 Identities=23% Similarity=0.293 Sum_probs=168.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..+|.+.+.||+|+||.||++... .+..||+|.+.... .+.+|++++++++|+||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee----CCE
Confidence 457899999999999999999753 35789999886432 25689999999999999999988765 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++|||++ .++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++..
T Consensus 161 ~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 79999999 5799999843 356899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
...... ........||+.|+|||++....++.++|||||||++|||++|+.||.....
T Consensus 235 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 235 LDAHPD---TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cCcccc---cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 544321 1122345689999999999999999999999999999999999999976543
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.16 Aligned_cols=199 Identities=28% Similarity=0.404 Sum_probs=162.2
Q ss_pred eeeeeCcEEEEEEEEcC---CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeec
Q 012599 232 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~---g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.||+|+||.||+|...+ +..+|+|.++..........|.+|+.+++.++||||+++++++.+ ....++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE----VTPYLLVMEFC 77 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----CCCcEEEEECC
Confidence 58999999999998653 457999998766554445568899999999999999999998876 34569999999
Q ss_pred CCCCHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 309 PNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 309 ~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
++|+|.+++.... ....++..+..++.|++.||+|||+.+ ++|+||||+||++++++++||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999999996532 124677888899999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCCccccCCcccCccccccC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
. ........++..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 155 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 155 Y---YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred e---eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1 1112234567889999987532 35789999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.13 Aligned_cols=204 Identities=28% Similarity=0.454 Sum_probs=169.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|+..+.||+|+||+||+|.+. +++ .||+|.++..........+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence 356778899999999999999853 344 4899999766555556678899999999999999999999864
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence 24579999999999999997532 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+........ .......++..|+|||......++.++||||||+++|||++ |..||...
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 157 RLLDIDETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred eecccccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 876432211 01111234578999999988899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=274.19 Aligned_cols=207 Identities=29% Similarity=0.431 Sum_probs=174.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|++.+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++|+||+++++++.+. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---G 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---C
Confidence 4678888999999999999998865 6889999987655445556688999999999999999999987653 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLV------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
...++++||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 456899999999999999965422 45899999999999999999999988 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+|||+++.+....... ......++..|+|||++....++.++||||||+++||+++ |+.||...
T Consensus 159 ~d~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 159 TDNALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 9999998664432211 1112345678999999988889999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=274.07 Aligned_cols=208 Identities=28% Similarity=0.417 Sum_probs=172.7
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
..++|.+.+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--- 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC---
Confidence 34678888999999999999998743 467999998755444445568899999999999999999999876
Q ss_pred ccceEEEEEeecCCCCHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~ 368 (460)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~ 156 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence 356799999999999999996532 123788999999999999999999988 99999999999999999
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 369 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CEEECCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999999999866443221 11122345678999999988889999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=276.50 Aligned_cols=207 Identities=24% Similarity=0.375 Sum_probs=173.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccC
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 296 (460)
.++|...+.||+|+||.||++... .+..+|||+++........+.+.+|+++++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 456888899999999999999752 24579999987654444455689999999999 79999999998876
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 346799999999999999997654445899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++......... .......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 187 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 187 LARDIMNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccccCCCce---eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 98765433211 11122345678999999999999999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=277.43 Aligned_cols=206 Identities=28% Similarity=0.434 Sum_probs=169.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 294 (460)
.++|.+.+.||+|+||.||++... +...+|+|.++..........+.+|+++++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 467888999999999999999753 23569999998654444445688999999999 79999999999876
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCC
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~ 360 (460)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 4467999999999999999975321 24889999999999999999999988 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 361 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|||+++++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999998765432111 01111224468999999988889999999999999999998 88898654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=269.68 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=174.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|+..+.||.|++|.||+|.+. +++.+|+|.+...........+.+|+++++.++|+|++++++++.+ +...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK----GSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE----CCeEEE
Confidence 35777889999999999999876 5889999999765544555668899999999999999999998876 457899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999999753 6899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. .......++..|+|||++.+..++.++||||||+++|||+||+.||...
T Consensus 151 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 151 TM-----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred cc-----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 32 1222345778899999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=266.02 Aligned_cols=204 Identities=27% Similarity=0.408 Sum_probs=171.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|+..+.||+|++|.||++... +++.+|+|.+...... .....+.+|++++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD----DE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc----CC
Confidence 56888999999999999999875 5899999998644221 123457889999999999999999999876 44
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 789999999999999999754 45889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
........ ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 153 RLQTICSS--GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred eccccccc--cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 65432111 11112345778899999999888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=267.24 Aligned_cols=206 Identities=26% Similarity=0.385 Sum_probs=170.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|++.+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++++++|+||+++++++.+.. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--ER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC--Cc
Confidence 46888899999999999999875 4889999988643211 12345788999999999999999999875532 23
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.++++|||+++++|.+++... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 678999999999999999753 34788899999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
........ ........++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 155 RLQTICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred cccccccc--ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 65432111 11223345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=268.11 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=169.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|... +++.+|+|++..... .....+.+|+.++++++|+||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~----~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS----REKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe----CCEEE
Confidence 357888999999999999999874 588899999875432 233457889999999999999999999875 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++....
T Consensus 83 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999999999998643 45899999999999999999999988 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 158 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 158 ATI-----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ccc-----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 321 1122345788999999874 455788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=274.18 Aligned_cols=205 Identities=27% Similarity=0.400 Sum_probs=168.2
Q ss_pred CCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
+|.+.+.||+|+||.||+|...+ ++.||+|+++..........|.+|+.++..++||||+++++++.+ ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK----EQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CC
Confidence 35667889999999999998642 578999999865433334568899999999999999999999876 34
Q ss_pred eEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
..++++||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 5789999999999999985311 134788899999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 366 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+++.+||+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred CCCceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999998865433211 11122335678999999988889999999999999999998 888987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=275.03 Aligned_cols=200 Identities=25% Similarity=0.352 Sum_probs=161.4
Q ss_pred cceeeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 230 SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
.+.||+|+||.||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++.... +...+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHA--DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCC--CcEEEEEEe
Confidence 357999999999999865 46789999986532 2234789999999999999999999876532 346789999
Q ss_pred ecCCCCHHHHhcccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE----cCCCcEEEEec
Q 012599 307 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDL 375 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll----~~~~~vkl~DF 375 (460)
|+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 568988875321 124889999999999999999999998 9999999999999 45678999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+++.......+ ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCcc--ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 999876433211 112234568899999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=280.86 Aligned_cols=208 Identities=28% Similarity=0.445 Sum_probs=170.4
Q ss_pred HhcCCcccceeeeeCcEEEEEEEE------cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 295 (460)
..++|++.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 356788999999999999999974 347889999997654444455688999999999 789999999988642
Q ss_pred CccceEEEEEeecCCCCHHHHhccccC-----------------------------------------------------
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLV----------------------------------------------------- 322 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------- 322 (460)
....++||||+++|+|.+++.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 3356899999999999999864210
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012599 323 ------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (460)
Q Consensus 323 ------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 390 (460)
..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY--- 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence 23678888999999999999999998 999999999999999999999999998765332110
Q ss_pred CCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
.......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 285 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence 11112235677999999988899999999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.25 Aligned_cols=211 Identities=26% Similarity=0.406 Sum_probs=173.3
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~ 292 (460)
++...++|.+.+.||+|+||.||+|.+. .++.||+|+++..........+.+|+++|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4555667888899999999999999864 246799999986544444456889999999997 999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccC--------------------------------------------------
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-------------------------------------------------- 322 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------- 322 (460)
. ....++||||+++|+|.++++....
T Consensus 112 ~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 112 K----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred c----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 6 3467999999999999999964311
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012599 323 ----------------------------------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356 (460)
Q Consensus 323 ----------------------------------------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~D 356 (460)
..+++..++.++.|++.||+|||+.+ ++|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence 23677888999999999999999887 99999
Q ss_pred cCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCC
Q 012599 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435 (460)
Q Consensus 357 Lk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~P 435 (460)
|||+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |+.|
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999865432211 11122346788999999988889999999999999999998 8999
Q ss_pred CCCCC
Q 012599 436 IHRSI 440 (460)
Q Consensus 436 f~~~~ 440 (460)
|....
T Consensus 342 ~~~~~ 346 (401)
T cd05107 342 YPELP 346 (401)
T ss_pred CCCCC
Confidence 96543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=272.65 Aligned_cols=205 Identities=27% Similarity=0.419 Sum_probs=168.3
Q ss_pred CCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
+|.+.+.||+|+||.||+|... ....+++|.+...........+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CC
Confidence 4677789999999999999863 2357889988765444444568899999999999999999998875 34
Q ss_pred eEEEEEeecCCCCHHHHhcccc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
..++++||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 5799999999999999986421 134789999999999999999999988 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 012599 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 436 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf 436 (460)
||+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccch---hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999765433211 11122345678999999988889999999999999999998 99999
Q ss_pred CCCC
Q 012599 437 HRSI 440 (460)
Q Consensus 437 ~~~~ 440 (460)
....
T Consensus 231 ~~~~ 234 (290)
T cd05045 231 PGIA 234 (290)
T ss_pred CCCC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=268.69 Aligned_cols=203 Identities=24% Similarity=0.349 Sum_probs=171.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|... +++.||||.++... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE----DNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE----CCeE
Confidence 56888899999999999999875 68899999886432 23334458899999999999999999998876 3467
Q ss_pred EEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 302 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
++|+||+++++|.+++.... ...++...+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence 99999999999999885422 244788999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
....... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eccchhH-----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 6543221 112345778899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=275.96 Aligned_cols=211 Identities=28% Similarity=0.435 Sum_probs=173.6
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
++...++|+..+.||+|+||.||++...+ ...+|+|.+...........+.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34455678888999999999999998642 3679999987654444445688999999999 8999999999887
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
. ....+++|||+++|+|.++++.. ....+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 87 ~----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlk 159 (293)
T cd05053 87 Q----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLA 159 (293)
T ss_pred C----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence 5 44679999999999999999642 2345899999999999999999999988 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~ 437 (460)
|+|||+++++.+||+|||+++......... ......++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYR---KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred eeeEEEcCCCeEEeCcccccccccccccee---ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 999999999999999999998764432111 1111234567999999988899999999999999999998 999987
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 237 ~~~ 239 (293)
T cd05053 237 GIP 239 (293)
T ss_pred CCC
Confidence 543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=273.50 Aligned_cols=209 Identities=25% Similarity=0.360 Sum_probs=175.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|++|.||++...+ ++.+|+|.+....... ....+.+|+++++.++|+||+++++.+.+ ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT----ETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec----CCEE
Confidence 367888999999999999998865 8999999997653332 34458899999999999999999998765 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999999999997655566899999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCC------------------------CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 382 KADGLPS------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 382 ~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
....... .........|+..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3321100 0011223467889999999998889999999999999999999999997
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 234 ~~~ 236 (316)
T cd05574 234 GSN 236 (316)
T ss_pred CCc
Confidence 543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=273.40 Aligned_cols=203 Identities=28% Similarity=0.467 Sum_probs=166.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-C--cEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g--~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+|.+.+ + ..+++|.++........+.|.+|+++++++ +||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN----RGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----CCc
Confidence 568888999999999999998754 3 347888887544344445688999999999 79999999998865 346
Q ss_pred EEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
.++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECC
Confidence 799999999999999996432 124889999999999999999999988 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 367 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++.+||+|||++....... .......+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 155 ~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 155 NLASKIADFGLSRGEEVYV------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred CCeEEECCcCCCcccccee------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999986432110 1111123457999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=269.35 Aligned_cols=207 Identities=28% Similarity=0.431 Sum_probs=169.0
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-C---cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.|++.+.||+|+||.||+|.+.. + ..||+|.+...........|..|+.+++.++||||+++++++.+ ....
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 80 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SRPV 80 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC----CCce
Confidence 46677899999999999998753 3 36999998765444445679999999999999999999998765 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 99999999999999997543 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.................+..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 43221110111111112457999999998899999999999999999987 999997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=274.81 Aligned_cols=208 Identities=28% Similarity=0.435 Sum_probs=171.1
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 293 (460)
..++|.+.+.||+|+||.||++... ++..+|+|.+...........+.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3566778899999999999999742 24579999987554444456688999999999 89999999998876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCC
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~ 359 (460)
....++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+ ++||||||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 165 (304)
T cd05101 93 ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAA 165 (304)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeeccccc
Confidence 446799999999999999996532 134788999999999999999999998 99999999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 012599 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438 (460)
Q Consensus 360 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~ 438 (460)
+||++++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred ceEEEcCCCcEEECCCccceeccccccc---ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999876443211 11122335678999999988889999999999999999998 8888865
Q ss_pred CC
Q 012599 439 SI 440 (460)
Q Consensus 439 ~~ 440 (460)
..
T Consensus 243 ~~ 244 (304)
T cd05101 243 IP 244 (304)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=269.39 Aligned_cols=205 Identities=23% Similarity=0.357 Sum_probs=169.7
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++++|.+.+.||+|+||.||+|... +++.+|+|.+...........+.+|+++++.++|+||+++.+++.. ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 78 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT----KETL 78 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec----CCeE
Confidence 3577888999999999999999875 5889999999765444444457899999999999999999998865 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||++ ++|.+++.... ..+.+..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++..
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99999995 78888775432 45788889999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 154 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 154 SIPSQ-----TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCC-----CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 33211 1122346789999998875 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=265.71 Aligned_cols=203 Identities=26% Similarity=0.382 Sum_probs=172.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|+||.||+|... +++.+|+|.++... .......+.+|++++++++|+|++++++++.+ ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~----~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE----NNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec----CCeE
Confidence 57888899999999999999987 68999999886432 22334568899999999999999999999876 3567
Q ss_pred EEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 302 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
++||||+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence 99999999999999986432 244899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eccCCCc-----ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 6543211 122345778899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=275.96 Aligned_cols=203 Identities=28% Similarity=0.483 Sum_probs=166.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-Cc--EEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+|.+.+ +. .+++|.++..........+.+|++++.++ +|+||+++++++.+ ...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----CCC
Confidence 567888999999999999998753 43 46777776544444455688999999999 89999999999865 446
Q ss_pred EEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
.++||||+++++|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 799999999999999996432 124789999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 367 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++.+||+|||++...... ........+..|+|||.+....++.++||||||+++|||+| |..||....
T Consensus 160 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred CCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 999999999998643211 01111223567999999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=272.33 Aligned_cols=200 Identities=26% Similarity=0.430 Sum_probs=171.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.+|+..+.||+|+||.||+|... +++.+++|.+...... ....+.+|+.+++.++|+|++++++.+.. ....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe----CCEEEE
Confidence 56788899999999999999864 5889999998764433 34558899999999999999999998875 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999999864 34789999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......+++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 169 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 169 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred ccc-----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 1123457889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=268.61 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=170.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+|.+. .+..+|+|.++..........|.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCc
Confidence 46778899999999999999864 2347999998765444445568999999999999999999999865 446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 799999999999999997543 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... ........++..|+|||.+....++.++|+||||+++||+++ |+.||....
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 156 LEDDPEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cccccce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 6443211 111112223567999999988889999999999999999887 999997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=276.12 Aligned_cols=210 Identities=26% Similarity=0.432 Sum_probs=171.2
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeee
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~ 291 (460)
+...++|.+.+.||+|+||.||++... ....+|+|.++..........+.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344567888899999999999999752 24579999987654444455688999999999 699999999988
Q ss_pred eeccCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 292 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
.+ ....+++|||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+ ++||||
T Consensus 88 ~~----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dl 160 (314)
T cd05099 88 TQ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDL 160 (314)
T ss_pred cc----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence 75 346799999999999999996532 134889999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 012599 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 436 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf 436 (460)
||+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 161 AARNVLVTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred cceeEEEcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999865432110 01111223467999999988899999999999999999999 89998
Q ss_pred CCCC
Q 012599 437 HRSI 440 (460)
Q Consensus 437 ~~~~ 440 (460)
....
T Consensus 238 ~~~~ 241 (314)
T cd05099 238 PGIP 241 (314)
T ss_pred CCCC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=267.23 Aligned_cols=206 Identities=26% Similarity=0.375 Sum_probs=166.1
Q ss_pred cccceeeeeCcEEEEEEEEcCC-c--EEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccceE
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDG-R--IVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMR 301 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g-~--~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~ 301 (460)
.+.+.||+|+||.||+|.+.+. . .+|+|.++... .....+.+.+|+++++.++|+||+++++++..... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999987653 2 58999887542 22334568899999999999999999998764332 12356
Q ss_pred EEEEeecCCCCHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 302 LLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
+++|||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999988421 2234899999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+.......... ......+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 159 SKKIYNGDYYR---QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred ccccCccccee---cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 98764432111 1122235678999999998999999999999999999999 89999653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=271.01 Aligned_cols=205 Identities=31% Similarity=0.457 Sum_probs=169.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 56788899999999999999752 34568999886533 2334568999999999999999999999875 4
Q ss_pred ceEEEEEeecCCCCHHHHhcccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
...++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 56799999999999999996432 134899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+.++|+|||++......... .......++..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred CcEEeccCCccccccCCcee---ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999865433211 11122335678999999988899999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=285.95 Aligned_cols=196 Identities=22% Similarity=0.271 Sum_probs=166.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
...|.+.+.||+|+||.||++.+.. ++.||||.... ..+.+|++++++++|+||+++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 4578899999999999999998864 78899996432 126789999999999999999998876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|||++ .++|.+++.... ..+++.+++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999 579999986532 46999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.... ........||..|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 312 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 312 GSWS---TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccc---cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 3211 1112235689999999999999999999999999999999998877654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=279.22 Aligned_cols=203 Identities=27% Similarity=0.343 Sum_probs=178.3
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 298 (460)
....|++.+.||.|.||.||++.... |+.+|+|.+.+..... ......+|+.+|+++. ||||+.+.+.+.+ .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~----~ 108 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED----P 108 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc----C
Confidence 34567778999999999999999876 9999999997664332 3356899999999998 9999999999887 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC----CcEEEEe
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITD 374 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~----~~vkl~D 374 (460)
...++|||++.||.|.+.+... .+++.+...++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 5779999999999999999765 3999999999999999999999998 9999999999999633 4799999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
||++...... ......+||+.|+|||++....|+..+||||+||++|.|++|..||.....
T Consensus 183 FGla~~~~~~------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 183 FGLAKFIKPG------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred CCCceEccCC------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 9999987652 234567899999999999999999999999999999999999999987654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=268.39 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=167.7
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|++|.||+|... +++.||+|.++.... ......+.+|+.++++++||||+++++++.+ +...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----ESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----CCeEEE
Confidence 4677889999999999999875 588999999875432 2233457899999999999999999999876 457799
Q ss_pred EEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 999996 799999865432 55899999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 153 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 153 IPV-----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCc-----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 221 11222346788999998765 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=266.88 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=172.7
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
...++|++.+.||+|+||.||++.+.++..+++|.+.... .....|.+|+++++.++|+|++++.+++.+ ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-----EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-----CCe
Confidence 3456788889999999999999998888889999887532 234568899999999999999999988764 356
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+++|||+++++|.+++.......+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence 89999999999999997655556899999999999999999999988 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
...... ......++..|+|||++....++.++|+||||+++||++| |+.||...
T Consensus 153 ~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 153 EDNEYT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred cCCCcc----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 432211 1122335577999999988889999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=269.69 Aligned_cols=201 Identities=27% Similarity=0.434 Sum_probs=168.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||.||++... +++.+|+|.++..........+.+|++++++++|+||+++++.+.. ....++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI----EGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec----CCeEEE
Confidence 35778899999999999999886 6899999998765443444568899999999999999999998776 457899
Q ss_pred EEeecCCCCHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
||||+++++|.++++... ...+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.++|+|||++...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999987532 23689999999999999999999974 6 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccC------CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......++..|+|||.+... .++.++|+||||+++|||++|+.||...
T Consensus 154 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 154 VAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred cCC-------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 322 11223467889999988543 3588999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=265.02 Aligned_cols=206 Identities=28% Similarity=0.469 Sum_probs=172.2
Q ss_pred CCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+|+..+.||+|+||.||+|...+++.+|+|.+...... .....+.+|+++++.++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD----DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec----CCe
Confidence 46778899999999999999888999999998754321 112347889999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 79999999999999999653 45889999999999999999999988 99999999999999999999999999876
Q ss_pred cccCCCCC-CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPS-CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
........ .........++..|+|||++....++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 53321110 0111223457889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=269.27 Aligned_cols=202 Identities=25% Similarity=0.433 Sum_probs=168.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++.+ ....++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT----KKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec----CCeEEE
Confidence 56888899999999999999876 5889999998765433333457889999999999999999999875 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ ++|.+++.... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999997 59999987543 36899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 156 PSK-----TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred CCc-----cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 211 1112245788999998865 557899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=267.15 Aligned_cols=206 Identities=27% Similarity=0.461 Sum_probs=170.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-C---cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|+..+.||+|+||.||+|.+.. + ..+++|.++........+.+..|++++++++|+|++++.+++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK----FK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc----CC
Confidence 3467778999999999999998753 3 37999998765444445668999999999999999999999875 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 6799999999999999997533 45899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
......... ........+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~ 214 (268)
T cd05063 156 VLEDDPEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214 (268)
T ss_pred ecccccccc--eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 664322111 11111223457999999988889999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=277.84 Aligned_cols=203 Identities=23% Similarity=0.339 Sum_probs=169.6
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--c
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--K 297 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~ 297 (460)
...++|+..+.||+|+||.||++... +++.||||.+..... ......+.+|+.+++.++|+||+++++++..... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 44678999999999999999999874 578999999875422 2233457789999999999999999988754321 1
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 23568999988 8899988864 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+...... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 165 ARQADDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ceecCCC--------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9865332 123467899999998876 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=272.26 Aligned_cols=199 Identities=25% Similarity=0.349 Sum_probs=160.5
Q ss_pred ceeeeeCcEEEEEEEEcC---CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
..||+|+||.||+|...+ +..+|+|.+.... ....+.+|++++++++||||+++++++.... +...++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHS--DRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--CCeEEEEEee
Confidence 579999999999998753 5789999886532 2234789999999999999999999886532 3467999999
Q ss_pred cCCCCHHHHhccc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE----cCCCcEEEEecC
Q 012599 308 MPNGNLRDCLDGV-------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLG 376 (460)
Q Consensus 308 ~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll----~~~~~vkl~DFG 376 (460)
++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 85 5888887432 1234889999999999999999999998 9999999999999 567789999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+++........ ........+|+.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 158 ~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCccc--ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99866443211 112233567899999998876 457999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=281.96 Aligned_cols=194 Identities=26% Similarity=0.308 Sum_probs=159.2
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhc---CCCCccceeeeeeeccCccceEEEEEe
Q 012599 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
||+|+||+||+|... +++.||+|++..... ......+..|..++... +||||+++++++.+ ....++|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----DSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----CCeEEEEEc
Confidence 689999999999875 489999999864321 12222345666666655 69999999988776 456799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......||+.|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 151 ----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ----CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 122345689999999988754 47999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=264.89 Aligned_cols=196 Identities=28% Similarity=0.445 Sum_probs=163.0
Q ss_pred eeeeeCcEEEEEEEEc---CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEee
Q 012599 232 IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
.||+|+||.||+|.+. ++..+|+|+++.... ....+.+.+|+.+++.++|+||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCcEEEEec
Confidence 5899999999999753 478899999875432 2334568899999999999999999998743 346899999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~ 387 (460)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999999753 45899999999999999999999998 999999999999999999999999999876443211
Q ss_pred CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 388 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 152 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 152 Y--KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred e--eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11122234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=266.01 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=171.7
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++.. .+++.++||.+..... ......+.+|+.+++.++|+||+++++++.+ +...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe----CCeE
Confidence 4677889999999999999986 4689999998864322 2233568899999999999999999998876 4577
Q ss_pred EEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
+++|||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 9999999999999998642 2245899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
....... ......++..|+|||.+....++.++||||||+++|||++|..||...
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 155 FFSSKTT-----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ccccCCc-----ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 6543221 122345788999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=272.46 Aligned_cols=207 Identities=26% Similarity=0.414 Sum_probs=169.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC---------------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcccee
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD---------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~ 288 (460)
.++|.+.+.||+|+||.||++...+ ...||+|.++..........|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987642 2358999987654444455689999999999999999999
Q ss_pred eeeeeccCccceEEEEEeecCCCCHHHHhcccc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 289 g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
+++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+|||
T Consensus 84 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 156 (295)
T cd05097 84 GVCVS----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA 156 (295)
T ss_pred EEEcC----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence 99865 446799999999999999995431 123688999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPI 436 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt--G~~Pf 436 (460)
|+||++++++.+||+|||++......... .......++..|+|||.+..+.++.++||||||+++|||++ |..||
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcce---eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999998765432211 11122345678999999988889999999999999999998 77788
Q ss_pred CCCC
Q 012599 437 HRSI 440 (460)
Q Consensus 437 ~~~~ 440 (460)
....
T Consensus 234 ~~~~ 237 (295)
T cd05097 234 SLLS 237 (295)
T ss_pred cccC
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=263.94 Aligned_cols=197 Identities=29% Similarity=0.450 Sum_probs=167.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|++.+.||+|+||.||++... +..+++|.++... ..+.|.+|+.++++++|+|++++++++... ....+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC---CCceEEE
Confidence 46788899999999999999874 7789999886432 244688999999999999999999976542 3457999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999997655455899999999999999999999988 999999999999999999999999998764332
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
. .....+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 156 ~--------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 156 Q--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred C--------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11234567999999988889999999999999999998 99999653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=282.82 Aligned_cols=215 Identities=25% Similarity=0.340 Sum_probs=183.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce-E
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM-R 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~-~ 301 (460)
++|..++.+|+|+||.++..+.+ ++..+++|.+.-.. +.........|+.++++++|||||.+.+.+.+ +.. .
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCceE
Confidence 56778899999999999998765 47789999987553 22333457899999999999999999988776 334 8
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+|||+|++||+|.+.|.......+++..+..++.|++.|+.|||+.. |+|||||+.|||++.+..|||+|||+|+.+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhc
Confidence 99999999999999998877677999999999999999999999887 999999999999999999999999999998
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhcc
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATG 454 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~~ 454 (460)
.++. .......||+.|+.||.+.+.+|+.|+|||||||++|||++-+.+|...+ ...|+.-+.+.
T Consensus 157 ~~~~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~ 221 (426)
T KOG0589|consen 157 NPED-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRG 221 (426)
T ss_pred CCch-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhc
Confidence 7653 13345789999999999999999999999999999999999999997543 34455444433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.48 Aligned_cols=229 Identities=25% Similarity=0.391 Sum_probs=190.0
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceee
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 289 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g 289 (460)
.|+...++.++.+.||+|.||.|++|... ....||||+++......+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56666777777789999999999999753 14579999999887777778899999999999 7999999999
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhcccc------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL------------V--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~ 355 (460)
+|.. +...++|+||+..|+|.+||+..+ . ..++..+.+.++.|||.||+||++.. ++||
T Consensus 370 ~~t~----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 370 ACTQ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred eecc----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 9987 557799999999999999997654 0 13888999999999999999999987 9999
Q ss_pred CcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCC
Q 012599 356 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQ 434 (460)
Q Consensus 356 DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~ 434 (460)
||.++|||+.++..+||+|||+++.....+......... . -+..|||||.+....|+.|||||||||+||||+| |..
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~-~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAG-T-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCC-c-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 999999999999999999999999766554332111111 1 3567999999999999999999999999999999 999
Q ss_pred CCCCCCCcCchhHHHHhhcccccC
Q 012599 435 PIHRSITKGEESLVLWTATGIYLD 458 (460)
Q Consensus 435 Pf~~~~~~~~~~l~~~~~~~~~~~ 458 (460)
||..... ..++.++.+.+..++
T Consensus 521 PYp~~~~--~~~l~~~l~~G~r~~ 542 (609)
T KOG0200|consen 521 PYPGIPP--TEELLEFLKEGNRME 542 (609)
T ss_pred CCCCCCc--HHHHHHHHhcCCCCC
Confidence 9976332 345677777766544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=267.07 Aligned_cols=199 Identities=32% Similarity=0.517 Sum_probs=169.4
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhH-HHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS-VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~-~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|+..+.||+|+||+||++.... ++.+|+|.+.......... ...+|+.++++++|+||+++++++.+ ....++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----ccccccc
Confidence 4567899999999999999875 5689999998764332221 23569999999999999999999877 5577899
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 77 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999999983 356899999999999999999999998 999999999999999999999999998764111
Q ss_pred CCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
........++..|+|||.+. ...++.++||||||+++|+|++|..||...
T Consensus 152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 -----NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp -----TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11233456788999999988 888999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=263.92 Aligned_cols=198 Identities=30% Similarity=0.432 Sum_probs=165.3
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|.... +..+|+|.+.........+.+.+|+.+++.++|+||+++++++.. ...++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-----EPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----CceEEEEE
Confidence 469999999999997532 268999999866544455678999999999999999999998653 35689999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 76 LAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred eCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999999754 36899999999999999999999988 99999999999999999999999999987644322
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.. .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 151 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 151 YY--RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cc--ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 11 11112234567999999988899999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=269.07 Aligned_cols=199 Identities=28% Similarity=0.394 Sum_probs=172.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|+||.||++... +++.+|+|.+.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----DSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCeE
Confidence 36788899999999999999876 48999999986432 22334558899999999999999999998875 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||+++++.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999754 56899999999999999999999988 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....+++.|+|||.+.....+.++||||||+++|||++|+.||....
T Consensus 152 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 152 KGR--------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCC--------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 223457889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=270.35 Aligned_cols=201 Identities=25% Similarity=0.410 Sum_probs=173.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
..+|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCEEE
Confidence 467888899999999999999874 689999999875433 334558899999999999999999999876 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999864 45889999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......+++.|+|||.+....++.++||||||+++|+|++|+.||....
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 167 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CCcc-----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 1223457789999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=269.15 Aligned_cols=216 Identities=26% Similarity=0.351 Sum_probs=177.2
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 334667778899999999999999999999875 47889999886432 2334578899999999 7999999999886
Q ss_pred ecc-CccceEEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 293 EFR-GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 293 ~~~-~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
... ..+...++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 432 2345789999999999999988642 2245889999999999999999999988 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++|+|||++........ ......|+..|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 163 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEEccCCceeecccCCC-----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999876643221 122335788999999875 3457889999999999999999999997543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=301.61 Aligned_cols=213 Identities=23% Similarity=0.368 Sum_probs=173.0
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
+.+...++|.+.+.||+|+||+||++.+.. ++.+|+|.+..... ......|..|+.+++.|+||||+++++++....
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~- 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA- 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-
Confidence 334556789999999999999999998764 67899998875432 233456889999999999999999999876532
Q ss_pred ccceEEEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCcCCCCEEEcCC---
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAA----PRILHRDIKSSNILLDEN--- 367 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~----~~ivH~DLk~~NIll~~~--- 367 (460)
...++|||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 346799999999999999996532 2458999999999999999999998542 349999999999999642
Q ss_pred --------------CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHh
Q 012599 368 --------------LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 368 --------------~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~ellt 431 (460)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||+||||+|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 348999999998654322 1223468999999998854 458999999999999999999
Q ss_pred CCCCCCCC
Q 012599 432 GRQPIHRS 439 (460)
Q Consensus 432 G~~Pf~~~ 439 (460)
|+.||...
T Consensus 239 Gk~PF~~~ 246 (1021)
T PTZ00266 239 GKTPFHKA 246 (1021)
T ss_pred CCCCCCcC
Confidence 99999754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=263.96 Aligned_cols=201 Identities=25% Similarity=0.387 Sum_probs=174.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|+..+.||+|+||.||++...+ ++.+++|.+..... .+.+.+|++++++++|+||+++++++.+ ....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFK----NTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeec----CCcEE
Confidence 3678888999999999999999875 78999999875432 5568999999999999999999999876 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 9999999999999996532 56899999999999999999999998 9999999999999999999999999988664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 151 ~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 151 DTMA-----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred cCcc-----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 3321 1223446788999999988899999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=262.75 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=173.7
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|+||.||.++.. +++.+++|.+.... .......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----DNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----CCeEEE
Confidence 4778899999999999999865 48889999986543 33445568899999999999999999999876 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+++++|.+++.......+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999876644
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 154 ~~~-----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 154 EYS-----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred ccc-----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 321 122345788999999998888899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=263.57 Aligned_cols=208 Identities=27% Similarity=0.412 Sum_probs=176.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||.|+||+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV----GDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee----CCEEEE
Confidence 46888899999999999999865 5788999999765444455678999999999999999999998766 457799
Q ss_pred EEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||||+++++|.++++.... ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999976433 46899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... .......++..|+|||.+... .++.++|+||||+++|||++|+.||....
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 211 (267)
T cd06610 154 DGGDRTR-KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211 (267)
T ss_pred cCccccc-cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC
Confidence 5432210 122334678899999998766 78999999999999999999999997654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.90 Aligned_cols=198 Identities=25% Similarity=0.320 Sum_probs=171.1
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC------CCCccceeeeeeeccCcc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH------HCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~~~~~~~~~ 298 (460)
+|.+.+.||+|.||+|-++.+.. ++.||||+++... .....-..|+.+|..|+ .-|+|++++++.. +
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f----r 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF----R 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc----c
Confidence 78899999999999999998764 9999999998553 33344567899999886 3589999999886 6
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC--CcEEEEecC
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLG 376 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~--~~vkl~DFG 376 (460)
...+||+|.+ ..||+++|+.+...+++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 6889999999 679999999988889999999999999999999999998 9999999999999753 379999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.+......-. ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.++
T Consensus 337 SSc~~~q~vy--------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRVY--------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcce--------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9987544321 23455679999999999999999999999999999999888877654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=273.75 Aligned_cols=204 Identities=21% Similarity=0.321 Sum_probs=165.5
Q ss_pred ccceeeee--CcEEEEEEEEc-CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 229 GSNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 229 ~~~~LG~G--~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+.++||+| +|++||++... +|+.||+|++....... ....+.+|+++++.++||||+++++++.. +...++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCEEEEE
Confidence 34789999 78999999875 58999999997654332 23446789999999999999999999876 4577999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+++.||+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999999999997654456899999999999999999999998 999999999999999999999999875543222
Q ss_pred CCCC--CCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPS--CSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+... .........++..|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 1110 0011122346678999999875 46899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=262.22 Aligned_cols=203 Identities=24% Similarity=0.337 Sum_probs=171.9
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.|++.+.||+|++|.||++.... ++.+|+|.+..... ....+.+.+|++++++++|+|++++++.+.. .+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG---EDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC---CCCEEEE
Confidence 37788999999999999998754 78899999875432 2334458899999999999999999887542 2345789
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+++++|.+++.......+++.+++.++.|++.|+++||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999999997655566899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......+++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 155 QCD-----MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred cCC-----ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 321 223345788999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=268.43 Aligned_cols=216 Identities=27% Similarity=0.433 Sum_probs=178.3
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
.++.++..+.+.|+..+.||+|+||.||+|.+. +++.+|+|.+.... .....+..|+.+++++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 345666677889999999999999999999875 47889999886432 2334578899999998 7999999999886
Q ss_pred ecc--CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcE
Q 012599 293 EFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 293 ~~~--~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
... ......+++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 432 23457799999999999999997655566889999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 161 ~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 161 KLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EEeeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999999987653221 1223345788999999875 3567889999999999999999999997543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=267.17 Aligned_cols=201 Identities=24% Similarity=0.371 Sum_probs=172.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
..|+..+.||+|+||.||+|.+. +++.+|+|.+...........+.+|+.+++.++|+||+++++++.+ +...++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----GTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEEEE
Confidence 34667788999999999999875 4889999998765444445668899999999999999999999876 457899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.++++. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999999964 45889999999999999999999988 99999999999999999999999999976644
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 154 ~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 154 TQI-----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred Ccc-----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 321 1122356788999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=270.15 Aligned_cols=199 Identities=25% Similarity=0.384 Sum_probs=170.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
.|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|++++++++|+||+++++++.. +...++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 80 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK----GTKLWII 80 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc----CCceEEE
Confidence 3556678999999999999875 4788999998755444445568899999999999999999998875 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 81 MEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999999999864 45899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. ......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 155 QI-----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred ch-----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 21 112235778899999999888999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=262.31 Aligned_cols=198 Identities=31% Similarity=0.475 Sum_probs=171.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|+..+.||.|+||.||++... ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++.+ ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ----GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC----CCCeEE
Confidence 356778899999999999999874 78899999976543 44568999999999999999999999875 446799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.++++......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||.++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999999997655446899999999999999999999998 99999999999999999999999999987632
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
... ....+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~--------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 155 GQD--------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ccc--------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 211 1223567999999988889999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=263.71 Aligned_cols=206 Identities=26% Similarity=0.401 Sum_probs=171.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|+..+.||+|+||.||+|... .+..+++|++...... .....+.+|+.+++.++|+||+++++++.+.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--EK 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--CC
Confidence 36888899999999999999875 4889999998644221 22345788999999999999999999876422 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++++||+++++|.+++... ..+++...+.++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 678999999999999999753 34889999999999999999999988 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
........ ........++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 155 RLQTICMS--GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccc--CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 65432111 11122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=266.59 Aligned_cols=202 Identities=26% Similarity=0.395 Sum_probs=170.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|+..+.||+|++|.||+|.+. +++.+|+|++..... ....+.+.+|+.+++.++|+|++++++++.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR----KRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee----CCEEE
Confidence 46788899999999999999986 488999999865432 2334457899999999999999999999876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||++++.|..++... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999998888877543 45899999999999999999999988 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 152 GPGD-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred CCcc-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 1122346788999998865 567899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=269.93 Aligned_cols=205 Identities=29% Similarity=0.454 Sum_probs=169.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.+|...+.||+|+||.||++... ++..+++|.+.... ......+.+|++.+++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----C
Confidence 45677789999999999999753 34568888886432 2233458899999999999999999999875 4
Q ss_pred ceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll 364 (460)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 46799999999999999996532 134889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 365 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++++.++|+|||++......... .......++..|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee---ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999765433211 11223345788999999998899999999999999999999 999986644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=264.61 Aligned_cols=207 Identities=27% Similarity=0.401 Sum_probs=168.5
Q ss_pred CcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccc
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~ 299 (460)
|++.+.||+|+||.||+|.+.. +..+|+|+++..... .....+.+|++.++.++|+||+++++++.+... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998743 367999998764322 234568899999999999999999998865332 223
Q ss_pred eEEEEEeecCCCCHHHHhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
..+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 4689999999999999985432 235899999999999999999999988 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|+++......... ......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 158 g~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 158 GLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred cceeecccccccc---ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9998765433211 1112234578999999988889999999999999999999 88998653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=261.11 Aligned_cols=199 Identities=33% Similarity=0.519 Sum_probs=171.1
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||++.... +..+++|.+...........+.+|++.++.++|+|++++++++.. ....++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC----CCceEEEEE
Confidence 468999999999998864 788999999866544445668999999999999999999998876 457799999
Q ss_pred ecCCCCHHHHhcccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 307 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccc
Confidence 999999999997642 256899999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
....... ........++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 154 DVYDDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 7654432 112233456788999999988889999999999999999999 69999765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=262.47 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=173.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|+..+.||+|+||.||++... +++.+++|.+...... ....+.+|++++++++||||+++++++.+ ....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe----CCEEE
Confidence 467888899999999999999875 4788999998765332 44568899999999999999999998866 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
++|||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999999987532 45899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .......++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 153 ~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 153 ATI-----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred hhh-----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 321 112234577889999998766 78999999999999999999999997643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=268.75 Aligned_cols=216 Identities=27% Similarity=0.399 Sum_probs=177.6
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
++..++..++++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|+|++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 445666778899999999999999999999874 58899999986432 2334578899999999 8999999999987
Q ss_pred eccC-ccceEEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 293 EFRG-KRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 293 ~~~~-~~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
.... .....++||||+++++|.++++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 6432 234679999999999999998642 2345899999999999999999999988 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 167 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred EEEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999886543221 11223577889999987543 36889999999999999999999997653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=266.38 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=169.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|+..+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~----~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR----RDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEE
Confidence 46777789999999999999875 588999999875432 233457889999999999999999998765 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999998653 45899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......|+..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 159 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 159 TI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred cc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 21 1223346889999999874 4568899999999999999999999996543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=263.40 Aligned_cols=206 Identities=25% Similarity=0.378 Sum_probs=171.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC----CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|.+.+.||+|+||.||+|.+. +++.+|+|.+.... .......+.+|++++++++|+||+++++++.+.. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE--EK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC--CC
Confidence 46888899999999999999875 48899999875321 2233446889999999999999999999876532 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 678999999999999999753 34789999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
........ ........++..|+|||.+....++.++|+||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 155 RIQTICMS--GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccccccc--CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 65432111 11122345788999999998888999999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=268.59 Aligned_cols=205 Identities=30% Similarity=0.460 Sum_probs=168.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.+|...+.||+|+||.||++... ++..+++|.+.... ......|.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec----C
Confidence 45667789999999999999642 35678999876432 3344568999999999999999999998876 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLV-------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
...+++|||+++++|.+++..... ..+++..++.++.|++.|++|||+.+ ++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 457999999999999999965321 24789999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 366 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+++.+||+|||++......... .......+++.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 9999999999998765432211 11122334678999999998899999999999999999998 999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=270.98 Aligned_cols=207 Identities=27% Similarity=0.429 Sum_probs=169.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-----------------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-----------------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 286 (460)
.++|++.+.||+|+||.||++... ++..+|+|++...........|.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998542 234689999876544445567899999999999999999
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhccccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
+++++.. ....++||||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 84 LLAVCIT----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 9998866 3457999999999999999965321 23778899999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCC
Q 012599 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 435 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt--G~~P 435 (460)
||+|||+++++.++|+|||++......... .......++..|+|||....+.++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999865433211 11122234578999999888889999999999999999998 7889
Q ss_pred CCCCC
Q 012599 436 IHRSI 440 (460)
Q Consensus 436 f~~~~ 440 (460)
|....
T Consensus 234 ~~~~~ 238 (296)
T cd05095 234 YSQLS 238 (296)
T ss_pred ccccC
Confidence 86543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=263.02 Aligned_cols=205 Identities=27% Similarity=0.496 Sum_probs=170.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--------hhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
+|.+...||+|++|.||+|... +++.+|+|.+....... ..+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 3667789999999999999875 47889999886543221 12357889999999999999999998876
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 78 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 78 -ADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred -CCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 44678999999999999999754 45889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCC-CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPS-CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+++......... .........++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 998775332111 111122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=270.55 Aligned_cols=206 Identities=27% Similarity=0.452 Sum_probs=170.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|+..+.||+|+||.||++... ++..+|+|.+...........|.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 467888899999999999999863 4678999998765444445668999999999999999999998875
Q ss_pred cceEEEEEeecCCCCHHHHhcccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVL--------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 345799999999999999996421 124788899999999999999999988 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 012599 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 436 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf 436 (460)
||+|||+++++.++|+|||++......... ........+..|+|||.+....++.++||||||+++|||++ |..||
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998755332211 11112234567999999988899999999999999999998 88898
Q ss_pred CCC
Q 012599 437 HRS 439 (460)
Q Consensus 437 ~~~ 439 (460)
...
T Consensus 234 ~~~ 236 (288)
T cd05050 234 YGM 236 (288)
T ss_pred CCC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=268.94 Aligned_cols=200 Identities=25% Similarity=0.428 Sum_probs=172.4
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.+|+..+.||.|++|.||+|.. .+++.|++|.+..... .....+.+|+.+++.++|+|++++++++.. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLV----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEec----CceEEE
Confidence 4578889999999999999986 4689999999875433 334568899999999999999999999875 457899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999864 35899999999999999999999998 99999999999999999999999999876544
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 168 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred ccc-----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 1123457889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=270.29 Aligned_cols=206 Identities=29% Similarity=0.460 Sum_probs=172.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-----------------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 286 (460)
.++|.+.+.||+|+||.||++.+.+ +..||+|.+.........+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678889999999999999997643 24689999886655555567899999999999999999
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhcccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
+++++.. +...+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 84 LLGVCTV----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 9999876 346799999999999999996543 125899999999999999999999998 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh--CCCC
Q 012599 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 435 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt--G~~P 435 (460)
||+||++++++.++|+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999999999999998765433211 11223345678999999988889999999999999999998 7788
Q ss_pred CCCC
Q 012599 436 IHRS 439 (460)
Q Consensus 436 f~~~ 439 (460)
|...
T Consensus 234 ~~~~ 237 (296)
T cd05051 234 YEHL 237 (296)
T ss_pred CCCc
Confidence 8654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=264.17 Aligned_cols=200 Identities=28% Similarity=0.454 Sum_probs=160.7
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|.+.+ +..+|+|++...........+.+|+.+++.++|||++++++++... +...++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS---EGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC---CCCcEEEEe
Confidence 468999999999998642 3579999886544334455688999999999999999999987642 234689999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++.... ...++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999997543 34678888999999999999999988 99999999999999999999999999976543221
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHR 438 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG-~~Pf~~ 438 (460)
.. ........++..|+|||.+....++.++||||||+++|||++| .+||..
T Consensus 154 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 205 (262)
T cd05058 154 YS-VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205 (262)
T ss_pred ee-ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 11 0111223456789999999888899999999999999999995 556653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=268.42 Aligned_cols=201 Identities=25% Similarity=0.373 Sum_probs=173.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||+||++... +++.+|+|.+...........+.+|+++++.++|+||+++++++.. ...+++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN----ENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec----CCEEEE
Confidence 56777899999999999999875 4889999998765555556678999999999999999999999876 357899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||||+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++|+||+|+||++++++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999998753 458999999999999999999997 45 9999999999999999999999999986543
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
... .....++..|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 156 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 156 NSI-------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred hhc-------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 221 1234688999999999888899999999999999999999999986443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.85 Aligned_cols=194 Identities=23% Similarity=0.300 Sum_probs=163.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
...+|.+.+.||+|+||.||+|.... ++.||+|...... ...|+.++++++|+||+++++++.+ ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVS----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEe----CCee
Confidence 34679999999999999999998764 6789999754321 4579999999999999999999876 4467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+ .++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 133 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999999 57999998653 356899999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
... .......||..|+|||++....++.++||||||+++|||+++..|+..
T Consensus 208 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 208 VVA------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccC------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 221 112235688999999999999999999999999999999996666543
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.39 Aligned_cols=203 Identities=26% Similarity=0.431 Sum_probs=169.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|.+.+.||+|+||.||+|.+.+ ...+++|...........+.+.+|+.+++.++|+||+++++++.+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----NP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----CC
Confidence 457778899999999999998643 246899988765544455678999999999999999999998764 24
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 589999999999999997542 35899999999999999999999988 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
........ .....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 157 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 157 LEDESYYK----ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccccccee----cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 54432111 112234567999999988889999999999999999996 999997654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=263.22 Aligned_cols=199 Identities=30% Similarity=0.414 Sum_probs=167.7
Q ss_pred ceeeeeCcEEEEEEEEcC--C--cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--g--~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|++|.||+|.+.+ + ..+|+|.+.........+.|.+|+.++++++|+||+++++++.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-----CeEEEEEE
Confidence 368999999999998753 2 36899999765543455678999999999999999999998765 46799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999997644346899999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
. ........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 153 ~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 153 H--YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred c--eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 111123456788999999988899999999999999999998 99999654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=263.72 Aligned_cols=206 Identities=28% Similarity=0.420 Sum_probs=170.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++.+++++.....||+|+||.||+|.+. ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE----N 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc----C
Confidence 4556777777789999999999999865 47789999887543 2334568899999999999999999999876 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEec
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDL 375 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DF 375 (460)
...++|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 57799999999999999997532 234 78888999999999999999988 999999999999986 679999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|++....... .......++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 154 g~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 154 GTSKRLAGIN-----PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred hhheecccCC-----CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 9987654321 112223578899999988654 3788999999999999999999999753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=266.75 Aligned_cols=205 Identities=30% Similarity=0.423 Sum_probs=167.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|++.+.||+|+||.||++... +++.||+|.+.... ......|.+|+++++.++||||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--CC
Confidence 46778899999999999999742 47889999987543 233456889999999999999999999876432 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 5789999999999999996532 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
......... .......++..|+|||.+....++.++||||||+++|||++|..|+..
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 157 VLPQDKEYY--KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cccCCCcce--eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 764432110 011112234569999999888999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=268.61 Aligned_cols=204 Identities=27% Similarity=0.441 Sum_probs=170.4
Q ss_pred CCcccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.|++.+.||+|+||.||++.. .++..||+|.++..........+.+|+++++.++|+|++++.+++.+.. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--CCc
Confidence 467789999999999999974 2478899999976654555567899999999999999999999886532 245
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 789999999999999996532 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
....... ........++..|+|||.+....++.++||||||+++|||+|++.|+.
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 159 IETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 6433211 111223456778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=266.64 Aligned_cols=204 Identities=28% Similarity=0.464 Sum_probs=170.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-Cc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|+..+.||+|+||.||+|.+.+ ++ .+|+|.+...........+.+|+..+++++|+||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----S 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 457778999999999999998643 32 5899988765544445668899999999999999999999875 3
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 5689999999999999997643 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
......... ......++..|+|||.+....++.++|+||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 158 LLDVDEKEY---HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred cccCcccce---ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence 765322111 1111223567999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=264.93 Aligned_cols=196 Identities=29% Similarity=0.499 Sum_probs=161.2
Q ss_pred ceeeeeCcEEEEEEEEcC-Cc--EEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|.+.+ +. .+++|.++..........+.+|++++.++ +||||+++++++.. ....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----CCCceEEEE
Confidence 368999999999998754 33 47888887544444455688999999999 89999999999876 346799999
Q ss_pred ecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 307 FMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
|+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEE
Confidence 999999999996532 124789999999999999999999988 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+|||++....... .......+..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 154 ~dfgl~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 154 ADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred CCCCCccccchhh------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 9999986322110 1111223567999999988889999999999999999997 99999654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=264.55 Aligned_cols=203 Identities=29% Similarity=0.385 Sum_probs=172.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|...+.||.|++|.||++.+. +++.+|+|.+...........+.+|++++++++|+||+++++++.+.. ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES--SSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--CCeEEE
Confidence 35777899999999999999985 478899999886554445566899999999999999999999986533 346799
Q ss_pred EEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 99999999999987542 2345889999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... .....++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 156 VNSL-------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc-------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 3321 12334678899999998889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=270.89 Aligned_cols=204 Identities=28% Similarity=0.488 Sum_probs=168.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|+..+.||+|+||.||+|.+. +++ .+|+|.+...........+.+|+.+++.++|+||++++|++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----P 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----C
Confidence 45677889999999999999864 343 5789988765544444568899999999999999999998864 2
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 3478999999999999997532 35889999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 158 LLEGDEKE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccCcccc---cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 66432211 11112335678999999988899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=259.98 Aligned_cols=202 Identities=30% Similarity=0.436 Sum_probs=175.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|++|.||++.... ++.+++|++...........+.+|+..+.+++|+|++++++++.. ....++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK----EGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----CCeEEE
Confidence 367788999999999999998875 899999999766544445668999999999999999999999876 457899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||||+++++|.+++... ..+++..++.++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999999754 568999999999999999999999 88 9999999999999999999999999988764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 152 NTLDQ-----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cCCCc-----ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 43211 123457788999999988899999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=284.78 Aligned_cols=212 Identities=25% Similarity=0.404 Sum_probs=173.3
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEe---ccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRF---KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vaVK~l---~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
..||+|+|-+||||.+.. |..||=-.+ .....+...+.|..|+++|+.|+|+||++++.+..+... ...-+|+|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in~iTE 123 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTINFITE 123 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceeeeeee
Confidence 579999999999998753 655653322 222344555779999999999999999999988776443 56789999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCccccccCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~~~ 385 (460)
.|..|+|+.|+++. +.++...+..+++||++||.|||++. |||||||||-+||||+ ..|.|||+|+|+|.......
T Consensus 124 L~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999875 45888999999999999999999985 7899999999999997 45899999999999876432
Q ss_pred CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhccccc
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIYL 457 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 457 (460)
.....|||.|||||... ..|+..+||||||+.++||+|+..||..-.. ...+...+.-+..|
T Consensus 201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKP 262 (632)
T ss_pred -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCH
Confidence 23367999999999776 8899999999999999999999999975433 34555555554443
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=261.23 Aligned_cols=205 Identities=27% Similarity=0.458 Sum_probs=170.9
Q ss_pred CCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
+|+..+.||+|++|.||++.. .+++.+|+|.+...... .....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE----DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc----CC
Confidence 477788999999999999986 45889999998743321 123458899999999999999999999875 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMA 378 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla 378 (460)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 679999999999999999753 45889999999999999999999998 99999999999998775 5999999998
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......... ........++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 152 ARLAAKGTGA-GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccccC-CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 8765432111 111223457889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=263.22 Aligned_cols=198 Identities=24% Similarity=0.345 Sum_probs=157.5
Q ss_pred eeeeeCcEEEEEEEEcCC---cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeec
Q 012599 232 IVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.||+|+||.||++...++ ..+++|.+...........|.+|+.+++.++||||+++++.+.+ ....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE----AIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC----CCccEEEEecC
Confidence 589999999999976443 34667776655444455679999999999999999999999876 34679999999
Q ss_pred CCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 309 PNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 309 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
++|+|.+++.... ....++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999999997532 234667778899999999999999988 99999999999999999999999999864322211
Q ss_pred CCCCCCCCccccCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
. .......++..|+|||++.. ..++.++||||||+++|||++ |..||...
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 155 I---ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred h---hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 0 11223457788999998743 345789999999999999997 57788643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=274.83 Aligned_cols=208 Identities=27% Similarity=0.420 Sum_probs=169.9
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcC--------CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
....+|++.+.||+|+||.||++.... +..+|+|.++..........+.+|+++++++ +|+||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 334568888999999999999997521 2368999887554444455689999999999 8999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
. ....+++|||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|||||
T Consensus 89 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlk 161 (334)
T cd05100 89 Q----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLA 161 (334)
T ss_pred c----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccc
Confidence 6 446799999999999999996532 234789999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~ 437 (460)
|+|||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||.
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred cceEEEcCCCcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999765432111 01112234567999999999999999999999999999998 889986
Q ss_pred CC
Q 012599 438 RS 439 (460)
Q Consensus 438 ~~ 439 (460)
..
T Consensus 239 ~~ 240 (334)
T cd05100 239 GI 240 (334)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=273.92 Aligned_cols=206 Identities=28% Similarity=0.410 Sum_probs=177.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
-+.|...++||+|+||.||-.... .|+.+|.|.+.+.. ....+...++|-.+|.+++.+.||.+--.+.. ...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT----kd~ 259 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET----KDA 259 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC----CCc
Confidence 356788899999999999999765 48999999886442 22344557899999999999999988644443 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+++|+..|.||||.-+|.......+++..++.++.+|+.||++||+.. ||+|||||+|||+|++|+++|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence 899999999999999998776678999999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
+..... .....||.+|||||++....|+...|.|||||+||||+.|+.||.+..++
T Consensus 337 i~~g~~------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 337 IPEGKP------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred cCCCCc------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 765432 22347999999999999999999999999999999999999999865544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=266.27 Aligned_cols=202 Identities=24% Similarity=0.383 Sum_probs=169.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+.|++.+.||.|+||.||+|.+.. ++.+++|.+.... ......+.+|+.+++.++|+|++++++++.. +...+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW----DGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----CCeEE
Confidence 3668888999999999999998865 7889999987542 3344568899999999999999999998865 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|..++.... ..+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999998886533 45899999999999999999999988 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......++..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 162 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 162 KTL-----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred ccc-----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 221 1122345778899999884 345688999999999999999999999654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=260.14 Aligned_cols=199 Identities=30% Similarity=0.484 Sum_probs=167.1
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCC
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~ 310 (460)
+.||+|+||.||++.+.+++.|++|.+...........+.+|++++++++|+||+++++++.+ ....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCCeEEEEEcCCC
Confidence 368999999999999877999999998765444345568999999999999999999998876 4467999999999
Q ss_pred CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012599 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (460)
Q Consensus 311 gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 390 (460)
++|.+++.... ..+++..++.++.+++.||.|||+++ ++||||+|+|||++.++.++|+|||++..........
T Consensus 77 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-- 150 (251)
T cd05041 77 GSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-- 150 (251)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee--
Confidence 99999996532 45889999999999999999999998 9999999999999999999999999987654221110
Q ss_pred CCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.......+..|+|||.+....++.++|+||||+++|||+| |..||....
T Consensus 151 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 151 -SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred -ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 1111223567999999988889999999999999999999 899986554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=262.55 Aligned_cols=199 Identities=25% Similarity=0.390 Sum_probs=170.7
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
-|+..+.||+|+||.||+|... +++.+|+|.+...........+.+|+..+++++|+||+++++++.+ +...++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----CCeEEEE
Confidence 3667789999999999999864 5889999998755444445668899999999999999999999876 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 999999999999864 35899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. ......++..|+|||.+....++.++|+||||+++|||++|..||...
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 155 QI-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred hh-----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 21 122245778899999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=265.28 Aligned_cols=200 Identities=24% Similarity=0.363 Sum_probs=166.9
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
|++.+.||+|+||.||++.... +..+++|.+.... ......+.+|+++++.++|+|++++++++.. ....++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee----CCEEEEEE
Confidence 5667889999999999998864 6778888886432 2334568899999999999999999998876 45779999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
||+++++|..++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999988643 246899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......++..|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 158 -----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred -----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 1122345788999999873 3457889999999999999999999997543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=284.23 Aligned_cols=197 Identities=30% Similarity=0.418 Sum_probs=171.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
-|+.++.||.|+||.||-|.+. +.+.||||++....... .-.+++.|+.+|++++|||++.+.|++.. ....+
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr----e~TaW 102 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR----EHTAW 102 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----cchHH
Confidence 3566788999999999999864 57899999997654332 33468999999999999999999999876 45669
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
|||||| -|+-.|.|.-. .+++.+.++..|..+.+.||+|||+.+ .||||||+.|||+++.+.|||+|||.|....
T Consensus 103 LVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence 999999 77888887643 367999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+. ..+.||+.|||||++. .+.|+-++||||||++..||.-.++|.+++.
T Consensus 178 PA---------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN 229 (948)
T KOG0577|consen 178 PA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 229 (948)
T ss_pred ch---------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence 43 4578999999999884 5889999999999999999999999998875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=285.98 Aligned_cols=205 Identities=27% Similarity=0.405 Sum_probs=174.4
Q ss_pred CCcccceeeeeCcEEEEEEEEcC--Cc--EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD--GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~--g~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+....++||+|.||.|++|.+.. |+ .||||.++.........+|++|+.+|.+|+|+|+++|+|+..+ ...
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-----qp~ 185 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-----QPA 185 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-----chh
Confidence 34456889999999999998863 43 5899999987655567789999999999999999999999875 355
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
.+|||.++.|+|.+.|++.....+-....-.++.|||.||.||..++ +|||||.++|+|+-....|||+|||+++-+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 89999999999999998754456778888899999999999999888 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
...+.. +.-.....-.+.|.|||.+....++.+||||+|||++||||| |+.||-...
T Consensus 263 g~ned~--Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 263 GENEDM--YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred CCCCcc--eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 654321 111222334578999999999999999999999999999998 999998654
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=266.96 Aligned_cols=203 Identities=25% Similarity=0.357 Sum_probs=171.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||.|+||.||++.+. +++.+|+|.+.... ....+.|.+|++++++++|+||+++++++.. +...+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec----CCeEE
Confidence 466888899999999999999875 58899999987542 2334568899999999999999999998875 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999999987532 45899999999999999999999998 9999999999999999999999999887653
Q ss_pred cCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .......++..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 155 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 155 STL-----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ccc-----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 321 1122345788999999874 3456789999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.68 Aligned_cols=203 Identities=32% Similarity=0.460 Sum_probs=172.8
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCCh-------hHHHHHHHHHHHhc-CCCCccceeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRL-HHCHVVPLVGY 290 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~-------~~~f~~Ei~~l~~l-~H~nIv~l~g~ 290 (460)
-+...++|...+.||.|..+.|-+.... .|...|+|++........ .+.-.+|+.+|+++ .||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 3455677888899999999999998765 478899998864432211 22356799999999 69999999998
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcE
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
+.. +...++|+|.|+.|.|.+||... -.+++....+|++|+..|++|||... |+||||||+|||+|++.++
T Consensus 92 yes----~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 92 YES----DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI 162 (411)
T ss_pred ccC----cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence 876 66889999999999999999764 45899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
||+|||.+..+++.. .....+||++|+|||.+. ...|+..+|+|+.||+||.|+.|.+||-
T Consensus 163 ~isDFGFa~~l~~Ge------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred EEeccceeeccCCch------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 999999999887643 456789999999999874 2457889999999999999999999984
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=265.18 Aligned_cols=204 Identities=26% Similarity=0.412 Sum_probs=170.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|+..+.||+|+||.||+|... +.+.+++|.+...........+.+|++++++++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----A 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----C
Confidence 56788899999999999999864 2467999988654433345669999999999999999999998865 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLV-------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 467999999999999999975431 15899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
++|||++........ .......++..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 158 l~~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~ 222 (275)
T cd05046 158 VSLLSLSKDVYNSEY----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222 (275)
T ss_pred EcccccccccCcccc----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999875432211 12223345678999999988888999999999999999999 88898653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=260.77 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=172.0
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|+||.+|++... +++.+|+|.+.... .......+.+|+.++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----NGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----CCeEEE
Confidence 4778899999999999999875 58899999987532 22334568899999999999999999998765 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.......+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999999997654456899999999999999999999988 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......+++.|+|||++.+..++.++|+||||++++||++|+.||...
T Consensus 154 ~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 154 TVE-----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred chh-----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 221 112234778899999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=263.05 Aligned_cols=200 Identities=26% Similarity=0.418 Sum_probs=170.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.|+..+.||+|+||.||+|.+. +++.+|+|.+...........+.+|+.++++++ |+|++++++++.+ ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----GPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----CCEE
Confidence 4677789999999999999874 588999999876555555566889999999996 9999999998875 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.++++. ..+++...+.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999999865 36899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||....
T Consensus 152 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 152 NQNS-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred CCCc-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 11233457889999998865 456889999999999999999999997543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.65 Aligned_cols=199 Identities=26% Similarity=0.423 Sum_probs=167.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
.|.....||+|+||.||++... ++..||+|.+.... ....+.+.+|+..++.++|+||+++++.+.. ....++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV----GDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec----CCeEEEE
Confidence 3444467999999999999875 58899999986533 2334558899999999999999999998765 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999999999854 34899999999999999999999998 999999999999999999999999998754322
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
. .......++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 172 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 172 V-----PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred c-----ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11223457889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=260.01 Aligned_cols=190 Identities=25% Similarity=0.416 Sum_probs=159.1
Q ss_pred ceeeeeCcEEEEEEEEcCCc-----------EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 231 NIVGQGGSSYVYRGQLTDGR-----------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~-----------~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-----D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-----C
Confidence 36899999999999986533 5778877644322 5568999999999999999999999875 2
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-------cEEE
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-------NAKI 372 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-------~vkl 372 (460)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 3489999999999999997643 26899999999999999999999988 99999999999999887 7999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+|||++...... ....++..|+|||++... .++.++||||||+++|||++ |..||....
T Consensus 150 ~Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 150 SDPGIPITVLSR---------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred CCCCcccccccc---------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 999998865431 123356779999998776 78999999999999999999 688886654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=257.77 Aligned_cols=202 Identities=25% Similarity=0.381 Sum_probs=171.3
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|++|.||++... +++.+|+|.+.... .......+.+|+++++.++|+|++++++.+.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----DKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----CCEEEE
Confidence 4777899999999999999875 58889999987543 23344568899999999999999999988764 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vkl~DFGla~~~~ 382 (460)
||||+++++|.+++.......+++..+..++.|++.||.|||+++ ++|+||+|+||+++++ ..++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999998755556899999999999999999999998 9999999999999855 468999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......++..|+|||.+....++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 154 SKS------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred CCc------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 332 1223457789999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=263.50 Aligned_cols=208 Identities=27% Similarity=0.446 Sum_probs=173.9
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc--Cc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR--GK 297 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~--~~ 297 (460)
.++++|++.+.||+|++|.||+|... +++.+++|.+..... ....+.+|+++++++ +|+||+++++++.+.. ..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 45688999999999999999999985 478899999875432 345689999999999 7999999999987644 23
Q ss_pred cceEEEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 456899999999999999986543 356899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 158 GVSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred ccceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9987653321 11223457889999998753 34678999999999999999999999754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=259.42 Aligned_cols=201 Identities=29% Similarity=0.503 Sum_probs=169.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
.+|+..+.||+|+||.||++.+.++..+|+|.+..... ....|.+|++++++++|||++++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTE----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEcc----CCceEEE
Confidence 45677789999999999999987788999998874322 33458999999999999999999998765 4467999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.... ..+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999997533 35789999999999999999999998 999999999999999999999999998765332
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
.. .......++..|+|||.+..+.++.++||||||+++|||++ |+.||...
T Consensus 154 ~~----~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 154 QY----TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred cc----cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 11 11112234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=263.71 Aligned_cols=201 Identities=25% Similarity=0.428 Sum_probs=168.2
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|++|.||+|... +++.+|||++..... ......+.+|++++++++||||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----CCcEEE
Confidence 4778899999999999999875 588999999875432 2233458899999999999999999998765 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999995 68999997655567899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus 153 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 153 PV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred Cc-----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 1122234678899999886644 588999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=262.34 Aligned_cols=202 Identities=26% Similarity=0.422 Sum_probs=169.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+|+..+.||+|++|.||+|... +++.||+|.++..........+.+|++++++++|+||+++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT----ENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee----CCcEEEE
Confidence 4778899999999999999986 5889999999866544445567899999999999999999999876 3467999
Q ss_pred EeecCCCCHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 305 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99997 58999886533 245899999999999999999999998 99999999999999999999999999875533
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......++..|++||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 153 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 153 PV-----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred Cc-----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11122346788999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=265.48 Aligned_cols=206 Identities=23% Similarity=0.326 Sum_probs=170.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|+||.||++.... ++.|++|.+..... ......+.+|+++++.++|+||+++++.+.. +...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET----KRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec----CCEE
Confidence 367888999999999999998764 78899999875432 2233457899999999999999999988765 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998642
Q ss_pred ccCCCCC----------CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPS----------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
....... .........++..|+|||.+....++.++|+||||+++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1111000 000111245778899999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=264.73 Aligned_cols=199 Identities=29% Similarity=0.476 Sum_probs=164.5
Q ss_pred ceeeeeCcEEEEEEEEcC-------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 231 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+.||+|+||.||+|+..+ ++.+++|.+...........+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----NEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC----CCCeEE
Confidence 368999999999998643 257999988765444455668999999999999999999999865 346799
Q ss_pred EEeecCCCCHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-----cEEEE
Q 012599 304 VFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-----NAKIT 373 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-----~vkl~ 373 (460)
||||+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEEC
Confidence 999999999999996532 233789999999999999999999988 99999999999999877 89999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|||++.......... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 154 dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 154 DFGLARDIYKSDYYR---KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred Ccccccccccccccc---cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999997654332111 1122345678999999998999999999999999999998 99999643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=260.36 Aligned_cols=196 Identities=31% Similarity=0.459 Sum_probs=166.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|++.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++|+|++++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-----NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CCcEEE
Confidence 4578889999999999999975 67789999986532 33468899999999999999999998754 235899
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999999999997655456899999999999999999999988 999999999999999999999999998754321
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
. .....+..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 154 ~--------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 154 V--------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred C--------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 1 11223467999999988899999999999999999998 999997553
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=257.31 Aligned_cols=200 Identities=30% Similarity=0.446 Sum_probs=170.3
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC----CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+|+..+.||+|++|.||+|... +++.|++|.+..... ....+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE----EDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec----CCe
Confidence 3666789999999999999886 689999999865332 2234568899999999999999999998865 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 79999999999999999754 45889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 152 ~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 152 VVEFS------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ccccc------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 54332 122345788899999887666 8999999999999999999999996543
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=265.08 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=168.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|+..+.||+|+||.||+|.+. +++.+|+|++...... ...+.+.+|+++++.++|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----KKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----CCeEE
Confidence 36778899999999999999986 4889999998654332 234568899999999999999999999865 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999998877543 34899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 152 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 152 APG-----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CCc-----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 332 11223456788999998865 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=264.72 Aligned_cols=200 Identities=24% Similarity=0.377 Sum_probs=165.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|+||.||+|... +|+.+|+|.++.... ......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----DKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----CCceEE
Confidence 4777889999999999999885 588999999875432 2223457889999999999999999998765 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|+||++ ++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 999996 68988886532 45899999999999999999999998 99999999999999999999999999876533
Q ss_pred CCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. .......++..|+|||.+.+. .++.++||||||+++|||+||..||...
T Consensus 152 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 152 PV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CC-----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 21 112223467889999988664 4789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=263.28 Aligned_cols=200 Identities=27% Similarity=0.393 Sum_probs=164.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHH-HHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||.||++.+. +|+.||+|+++..........+..|+.. ++.++|+|++++++++.. +...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR----EGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec----CCcEE
Confidence 46788899999999999999876 5899999999765443344456667665 566799999999999875 44679
Q ss_pred EEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 303 LVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
++|||++ |+|.+++.... ...+++..++.++.|++.||+|||++ + ++||||||+||++++++.+||+|||++.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999995 78988886432 24589999999999999999999986 6 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc----CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
...... ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||..
T Consensus 153 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 153 YLVDSV------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cccccc------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 653321 1122457788999998754 4568899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=262.58 Aligned_cols=199 Identities=30% Similarity=0.426 Sum_probs=173.3
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+|+..+.||+|++|.||++.+. +++.+++|.+...........+.+|++++++++|+||+++++.+.. ....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN----NGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec----CCEEEEE
Confidence 5677789999999999999886 5889999998776555555678999999999999999999998876 4578999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999997643 568999999999999999999999 77 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~-------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 154 SLA-------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHh-------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1155778899999998889999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=255.96 Aligned_cols=201 Identities=32% Similarity=0.526 Sum_probs=170.8
Q ss_pred CcccceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
|++.+.||.|+||.||++...+ +..+|+|.+...........+..|++++..++|+||+++++++.+ ....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE----EEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC----CCee
Confidence 3456889999999999998864 488999999765544355678999999999999999999998876 3567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999997644333899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~ 438 (460)
........ ....++..|+|||.+....++.++||||||++++||++ |+.||..
T Consensus 154 ~~~~~~~~----~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 154 YDDDYYKK----KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred cccccccc----ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 55422111 12236788999999988889999999999999999998 8888865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=267.54 Aligned_cols=196 Identities=24% Similarity=0.404 Sum_probs=167.3
Q ss_pred cccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+....||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++|||++++++++.. ....++|||
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~iv~e 98 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV----GEELWVLME 98 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee----CCeEEEEEe
Confidence 33457999999999999875 588999999865433 334558899999999999999999998876 457799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~- 171 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence 9999999998854 45899999999999999999999998 9999999999999999999999999987543321
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.......++..|+|||++....++.++||||||+++|||++|+.||...
T Consensus 172 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 172 ----PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred ----ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=270.68 Aligned_cols=207 Identities=24% Similarity=0.333 Sum_probs=170.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~ 301 (460)
.++|++.+.||+|+||.||+|... +++.||+|.+...........+.+|+.++++++|+||+++++++..... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468899999999999999999864 5899999998754444445568899999999999999999988764321 22357
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588888754 45899999999999999999999998 999999999999999999999999998865
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 157 DPEHDHT--GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccccccc--CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4432111 12233467889999998654 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=261.47 Aligned_cols=195 Identities=30% Similarity=0.435 Sum_probs=165.2
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||+||++... +|+.+|+|.+.... .......+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----KDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----CCeEEEEEecCC
Confidence 689999999999765 58899999986432 22234457889999999999999999988765 456799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---- 149 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence 999999997654456899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......++..|+|||.+....++.++||||||+++|+|++|+.||....
T Consensus 150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 1122346788999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=263.81 Aligned_cols=201 Identities=26% Similarity=0.390 Sum_probs=168.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+|+..+.||+|++|.||+|... +++.|++|.+...... .....+..|++++++++|+||+++++++.+ ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----KSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec----CCE
Confidence 4677789999999999999875 5889999999765432 223446789999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+ +++|.+++.... ..+++..++.++.|+++||.|||+.+ ++|+||+|+|||++.++.++|+|||++..
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 79999999 999999997643 36899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......++..|+|||.+.+ ..++.++||||||+++|||++|..||....
T Consensus 152 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 152 FGSPNR-----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred ccCCCc-----cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 644321 1122345678999998854 567899999999999999999988876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=261.20 Aligned_cols=201 Identities=29% Similarity=0.376 Sum_probs=173.3
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+|++.+.||.|+||.||++.+. +++.+|+|.+..... ....+.+.+|++++++++||||+++++++.+ ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD----EENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC----CCeEE
Confidence 4778899999999999999886 488999999975432 2345568999999999999999999988764 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999999764 46899999999999999999999998 9999999999999999999999999987664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
... ......++..|+|||.+....++.++|+||||+++|+|++|+.||.....
T Consensus 152 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 152 PDT------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCc------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 432 12234577889999999888899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=261.25 Aligned_cols=201 Identities=22% Similarity=0.327 Sum_probs=170.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|++.+.||+|++|.||+|.+. +++.+++|++..... ......+.+|+.++++++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----GSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----CCeeEE
Confidence 4777889999999999999875 589999999976543 2334568999999999999999999998876 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+ +++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.....
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99999 999999987543 56999999999999999999999998 99999999999999999999999999887644
Q ss_pred CCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......++..|+|||.+... .++.++||||||+++|||++|++||...
T Consensus 152 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 152 EEP----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CCC----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 321 112234578899999988654 4689999999999999999998887543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=260.25 Aligned_cols=191 Identities=24% Similarity=0.385 Sum_probs=156.6
Q ss_pred ceeeeeCcEEEEEEEEcC-------------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 231 NIVGQGGSSYVYRGQLTD-------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
+.||+|+||.||+|.... ...+++|.+.... ......|.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~---- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR---- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 368999999999998532 2358888876533 2334468889999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc-------E
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-------A 370 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~-------v 370 (460)
....++||||+++|+|..++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCcee
Confidence 345689999999999999986532 45899999999999999999999988 999999999999987664 8
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCC
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELI-TGRQPIHRS 439 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~ell-tG~~Pf~~~ 439 (460)
+++|||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.||...
T Consensus 152 ~l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 152 KLSDPGIPITVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred EeCCCCCCccccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998654322 1234677899999886 567899999999999999998 588888654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=256.88 Aligned_cols=204 Identities=29% Similarity=0.450 Sum_probs=172.0
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|+||.||++... +++.+++|.++..... ...+.+.+|+++++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----REKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----CCEEEE
Confidence 4777899999999999999875 5889999998765432 345668999999999999999999998765 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999999753 34788999999999999999999998 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... ........++..|+|||++.... .+.++||||||+++|||++|+.||...
T Consensus 152 ~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 152 NTTTM-GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred CCCcc-cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 43221 11012245778999999987766 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=262.28 Aligned_cols=211 Identities=20% Similarity=0.212 Sum_probs=159.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhH----------HHHHHHHHHHhcCCCCccceee
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADS----------VFLTEVDMLSRLHHCHVVPLVG 289 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~----------~f~~Ei~~l~~l~H~nIv~l~g 289 (460)
.++|++.+.||+|+||.||+|...+ +..+|+|...........+ ....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678888999999999999998754 3456666543322211111 1122333455668999999998
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
++..........++++|+. ..++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 7665443334567888887 45777776543 33578889999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCC--CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++|+|||+++.....+.... ........||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999987654322111 112223468999999999999999999999999999999999999998663
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=261.69 Aligned_cols=202 Identities=28% Similarity=0.393 Sum_probs=170.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|+..+.||+|+||.||+|.+. +++.|++|.++... .......+.+|+++++.++|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR----KGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE----CCEEE
Confidence 36788899999999999999886 47899999987543 23334568899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||++++.|..++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 999999887776665432 45899999999999999999999998 9999999999999999999999999988765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... .......++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 152 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 152 ARPA----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CCcc----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 112234567889999999887 8899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=275.82 Aligned_cols=204 Identities=29% Similarity=0.382 Sum_probs=177.3
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.-...|.+.+.||+|.|+.|.+|... .+..||+|.+.+.. .....+.+.+|+++|..++|||||+++.+... ..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t----~~ 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET----EA 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----cc
Confidence 34567888999999999999999875 48899999987653 33333458899999999999999999998776 56
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.+|+||||+.+|.+++||.+. ..+.......++.|+.+|++|||++. |+|||||++||||+.+.++||+|||++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 889999999999999999764 33666888999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.+.... .....+|++.|.|||++.+..| .++.|+||+|++||-|+.|..||+...
T Consensus 204 ~~~~~~------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 204 FFDYGL------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred eecccc------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 876432 3456789999999999988666 889999999999999999999998654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=256.07 Aligned_cols=204 Identities=25% Similarity=0.323 Sum_probs=171.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|++.+.||.|+||.||++... +++.+|+|.+..... ....+.+.+|++++++++|+||+++++++.... ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS--NQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC--CCEEEE
Confidence 4677889999999999999865 578899999875432 233455888999999999999999998876432 346789
Q ss_pred EEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLH-----EAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH-----~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
+|||+++++|.+++.... ...+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999996532 346899999999999999999999 655 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++........ ......++..|+|||.+....++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 156 LAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred ccccccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 9987654321 112235788999999998888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=259.95 Aligned_cols=194 Identities=28% Similarity=0.391 Sum_probs=157.7
Q ss_pred eeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHh---cCCCCccceeeeeeeccCccceEEEEE
Q 012599 232 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSR---LHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~---l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
.||+|+||.||++... +++.+|+|.+...... .....+.+|..+++. .+|+|++.+.+++.. ....++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----PDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----CCeEEEEE
Confidence 4899999999999875 4889999998654322 222334555544443 479999999988775 34679999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.....|+..|+|||.+. +..++.++||||||+++|||++|+.||.....
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 152 -------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred -------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 12235889999999886 45689999999999999999999999975443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=263.33 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=171.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++... ++..+++|.+..... ...+.+.+|+.++++++|||++++++++.. ....+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLV----GDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeee----CCcEE
Confidence 367888899999999999999864 578899999864432 334568899999999999999999998876 44679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 99999999999999965 34789999999999999999999998 9999999999999999999999999887654
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......+++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 167 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred cccc-----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 1122357788999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=269.23 Aligned_cols=209 Identities=23% Similarity=0.319 Sum_probs=171.1
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
..++|++.+.||+|+||.||+|.+. +++.+|+|++.... .......+.+|+.+++++ +|+||+++++++.... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--DK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC--Cc
Confidence 4567888899999999999999876 47889999886432 223334577899999999 9999999999876522 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 6799999996 6999998753 6889999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..................++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 7654332111122334567889999998754 567889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=258.49 Aligned_cols=202 Identities=27% Similarity=0.457 Sum_probs=167.0
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--C-------hhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--N-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
+|...+.||+|+||.||+|... +++.+|+|.++..... . ..+.+.+|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 3666789999999999999764 5889999988642111 0 12347789999999999999999998875
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
....++||||+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 --EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred --CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 45679999999999999999764 46899999999999999999999988 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|++......... .......++..|+|||.+.... ++.++|+||||+++|||++|..||...
T Consensus 153 ~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 153 GISKKSDDIYDN---DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred cccccccccccc---cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 998765332111 1122345788999999887654 789999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=260.64 Aligned_cols=206 Identities=23% Similarity=0.326 Sum_probs=166.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccC-ccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG-KRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~-~~~~ 300 (460)
++|+..+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.+++.+ +|+||+++++++..... ....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999875 5889999998654322 2334578899999999 56999999998875432 2234
Q ss_pred EEEEEeecCCCCHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEecC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLG 376 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DFG 376 (460)
.++||||+++ +|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8999886432 235899999999999999999999998 999999999999998 8899999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++|..||...
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 987653321 11122345788999998765 55799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=260.69 Aligned_cols=209 Identities=25% Similarity=0.287 Sum_probs=177.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+.+++||+|.||+|.+++-. .++.+|+|+++++..-. ....-+.|-++|..-+||.+..|--.+.. ...+
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt----~drl 243 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT----QDRL 243 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc----CceE
Confidence 56788899999999999999765 58999999998764332 22335789999999999999877643333 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||..||.|.-+|... +.+++.....+-..|..||.|||+.+ ||.||||.+|.|+|.+|++||.|||+++.-
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999988754 55888888889999999999999988 999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhH
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l 447 (460)
-.. ......++||+.|+|||++....|...+|.|.+||++|||+.|+.||.+...+....|
T Consensus 319 I~~-----g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 319 IKY-----GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred ccc-----cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 433 2356679999999999999999999999999999999999999999998766544443
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=261.56 Aligned_cols=191 Identities=25% Similarity=0.396 Sum_probs=155.3
Q ss_pred eeeeeCcEEEEEEEEcC-------------------------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccc
Q 012599 232 IVGQGGSSYVYRGQLTD-------------------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~-------------------------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~ 286 (460)
.||+|+||.||+|.+.. ...|++|.+..... .....|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999997521 23588898865322 23345888999999999999999
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
+++++.+ ....++||||+++|+|..++... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 81 ~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~ 152 (274)
T cd05076 81 VHGVCVR----GSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEEe----CCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEec
Confidence 9999876 44679999999999999999653 245889999999999999999999988 999999999999976
Q ss_pred CC-------cEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHH-hCCCCCC
Q 012599 367 NL-------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELI-TGRQPIH 437 (460)
Q Consensus 367 ~~-------~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~ell-tG~~Pf~ 437 (460)
++ .+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||.
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred cCcccCccceeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 43 3899999987643221 11246678999998865 56899999999999999995 6999997
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 224 ~~~ 226 (274)
T cd05076 224 ERT 226 (274)
T ss_pred ccC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=261.67 Aligned_cols=211 Identities=24% Similarity=0.324 Sum_probs=169.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC----c
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 297 (460)
-++|+..+.||+|+||.||+|... +++.||||.+...... .....+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356888899999999999999875 5889999998654322 223346789999999999999999999876432 1
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 345699999995 58988886532 35899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+.......... ........++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 166 ARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred cccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 98664432111 1112234567889999987654 47889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=258.78 Aligned_cols=200 Identities=25% Similarity=0.422 Sum_probs=167.2
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|+..+.||+|++|.||+|... +|..||+|++...... .....+.+|+++++.++|+|++++++++.+ ....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----ENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----CCeEEEE
Confidence 566789999999999999875 6899999998754322 233458899999999999999999999875 4577999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+ +++|.+++.......+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 9999 579999997654456899999999999999999999988 999999999999999999999999998765332
Q ss_pred CCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. ......++..|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 153 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 153 VR-----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred cc-----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 11222457889999987654 5789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-34 Score=264.60 Aligned_cols=199 Identities=24% Similarity=0.371 Sum_probs=175.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
-|.++++||+|++|.||+|.++ .|+.+|+|.+..+. ..+++..|+.+|.+.+.+++|+++|.+.. ...+++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK----~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK----HSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc----CCceEee
Confidence 4677889999999999999876 49999999998654 34568899999999999999999998765 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
||||..|++.+.++.. .+++++.++..+++..++||+|||... -+|||||+.|||++.++.+||+|||.+-.+...
T Consensus 107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 9999999999999864 478999999999999999999999987 899999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
-.......||+-|||||++.+-.|+.+.||||||+...||..|++||....
T Consensus 183 -----MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 183 -----MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred -----HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 122345679999999999999999999999999999999999999997643
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=260.71 Aligned_cols=204 Identities=26% Similarity=0.425 Sum_probs=175.2
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..++.|+..+.||+|++|.||++.+. +++.+++|.+..... ....+.+|+++++.++|+|++++++++.. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE----CCE
Confidence 45677888899999999999999987 588999999976443 44568899999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 799999999999999998643 36999999999999999999999988 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 166 LTKEKS-----KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hccchh-----hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 543211 1122346788999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=260.77 Aligned_cols=203 Identities=23% Similarity=0.360 Sum_probs=166.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|+..+.||+|.+|.||+|... +++.+|+|.+...... .....+.+|++++++++|+||+++++++.+ ....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec----CCeEE
Confidence 46888899999999999999876 5889999998654322 233458899999999999999999999875 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEecCCcccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 381 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~~ 381 (460)
+||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++...
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999995 68988886544445788889999999999999999988 999999999999985 567999999999765
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......+++.|+|||.+.+ ..++.++||||||+++|||+||+.||....
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 154 GIPV-----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred CCCc-----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3321 11122346788999998865 457899999999999999999999997543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=260.15 Aligned_cols=208 Identities=29% Similarity=0.418 Sum_probs=172.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
..|+..+.||+|+||.||++... .+..+|||.+...........|.+|++.++.++|+||+++++++.... ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG--GR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC--CC
Confidence 35667789999999999999864 367899999986544334566999999999999999999999876532 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 6799999999999999997643 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......... .......++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 158 VLPEDKDYY--YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccccCCcce--eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 765322110 11111234567999999988889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=258.42 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=166.6
Q ss_pred CCcccceeeeeCcEEEEEEEE----cCCcEEEEEEeccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 297 (460)
+|++.+.||+|+||.||++.. .+|+.||+|+++... .....+.+.+|+.+++.+ +|+||+++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 467788999999999999986 368899999987532 122334578899999999 69999999988765
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
+...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 45678999999999999999754 45889999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 152 SKEFHEDEV----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ceecccccc----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 976543321 11223457889999998865 3467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=266.95 Aligned_cols=204 Identities=26% Similarity=0.342 Sum_probs=171.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChh--HHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD--SVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~--~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
..+|..+.+||+|+||.|.+|.-+. .+.+|||+++++..-+.. +--+.|-++|+.. +.|.++++..++.. -.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----mD 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----MD 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----hh
Confidence 3567888999999999999997653 567999999876432222 1235677777766 67888888877665 34
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.+|+||||+.+|+|.-++++. ..+.+..++.+|..||-||-+||+.+ |+.||||.+|||+|.++++||.|||+++
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred heeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 679999999999999999865 45888999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.--.++ .....++||+.|+|||.+...+|...+|.|||||+||||+.|++||+..++
T Consensus 499 Eni~~~-----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 499 ENIFDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ccccCC-----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 644332 345678999999999999999999999999999999999999999987654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=267.54 Aligned_cols=210 Identities=22% Similarity=0.335 Sum_probs=173.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||++... +++.||+|++..... ......+.+|+.+++.++|+||+++++++..........
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999875 489999999875432 233445778999999999999999999876554445678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998653 45899999999999999999999998 999999999999999999999999999766
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 158 SSSPTEH-KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cccCcCC-CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 4432211 111223467889999998765 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=257.92 Aligned_cols=207 Identities=27% Similarity=0.395 Sum_probs=166.6
Q ss_pred CcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc--c
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR--A 299 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~--~ 299 (460)
|.+.+.||+|+||.||+|.+. .++.+|+|++..... ....+.+.+|+.+++.++||||+++++++....... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999864 368899999875432 233456889999999999999999999886543222 2
Q ss_pred eEEEEEeecCCCCHHHHhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
..++++||+++|+|.+++.... ...+++...+.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999998874321 124788999999999999999999988 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|+++........ .......+++.|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 158 g~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 158 GLSKKIYSGDYY---RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred cccccccCCcce---ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 999865432211 11112234578999999988889999999999999999999 88998654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=261.10 Aligned_cols=198 Identities=29% Similarity=0.421 Sum_probs=166.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.+.|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+|+++++.++|||++++.+++.+ ...
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----~~~ 89 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----EHT 89 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----CCe
Confidence 355788899999999999999875 5889999998644322 223458899999999999999999999876 446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCccee
Confidence 799999995 68888775432 45899999999999999999999998 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ....++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 165 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 165 VSPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred cCCC---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 4322 1235678899999874 466889999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=258.46 Aligned_cols=198 Identities=24% Similarity=0.413 Sum_probs=168.1
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
.|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.. ....+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~----~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV----GDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc----CCeEEEE
Confidence 3455679999999999999864 58899999886432 2334458899999999999999999998765 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
+||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999999999976 45899999999999999999999998 999999999999999999999999988755332
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
. .......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 169 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 169 V-----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred C-----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 1 1112245788999999998888999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=250.54 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=173.0
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+|++++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEEE
Confidence 3667789999999999999986 588999999976543 344568999999999999999999998876 3567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999999997643 46899999999999999999999988 999999999999999999999999998876543
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. .....++..|+|||.+.....+.++||||||+++|+|++|+.||...
T Consensus 152 ~~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 152 KA------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred cc------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 21 23345778999999998888999999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-34 Score=255.31 Aligned_cols=202 Identities=26% Similarity=0.364 Sum_probs=172.0
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.+++|++.+.||+|.|+.||+.... .|+.+|+|.+.... .....+.+.+|+.+-+.|+||||++|.....+ ..+
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----~~~ 84 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESF 84 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----cce
Confidence 3567888899999999999998654 58889998886442 23345568899999999999999999976655 668
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGl 377 (460)
.++|+|+|.|++|..-|-+. .-+++...-..++||+.+|.|+|.++ |||||+||+|+++.. .--+||+|||+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccce
Confidence 89999999999997766433 44788888899999999999999998 999999999999953 34599999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|..+. + ...+..+.||+.|||||++...+|+..+|||+-||+||-|+.|.+||...
T Consensus 160 Ai~l~-~-----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 160 AIEVN-D-----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred EEEeC-C-----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 99886 3 34566678999999999999999999999999999999999999999873
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=266.50 Aligned_cols=202 Identities=23% Similarity=0.343 Sum_probs=172.4
Q ss_pred CcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|...+.||+|.|..|-+|++ -.|+.||||++.+..-. .....+..|++.|+.++|||||+|+.+... ...+|||
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT----QTKlyLi 95 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT----QTKLYLI 95 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc----cceEEEE
Confidence 55668899999999999965 36999999999754322 223347789999999999999999987654 5678999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCcccccc
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~ 383 (460)
+|.=.+|+|++||-+.. ..+.+....+++.||+.|+.|+|+.. +|||||||+||.+- .-|-|||.|||++..+.+
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999997643 56999999999999999999999998 99999999998875 557899999999987765
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
.. .....+|++.|-|||.+.+..| -+.+|||||||+||.|+.|+.||+...+.
T Consensus 172 G~------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS 225 (864)
T KOG4717|consen 172 GK------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS 225 (864)
T ss_pred cc------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch
Confidence 43 4566789999999999998887 56899999999999999999999987654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=254.05 Aligned_cols=193 Identities=28% Similarity=0.392 Sum_probs=166.4
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||.|++|.||++.+.. ++.+++|.+..... ....+.+.+|+.+++.++|+||+++++++.+ +...+++|||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----KKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----CCccEEEEecCC
Confidence 6899999999999864 88999999875432 2344568899999999999999999998765 456799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 77 GGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred CCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 99999999754 44899999999999999999999988 9999999999999999999999999998764432
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......++..|+|||.+....++.++|+||||+++|||++|..||....
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 1123457788999999988889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=235.98 Aligned_cols=220 Identities=24% Similarity=0.344 Sum_probs=181.1
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..++||+|.+|+||+|+..+ ++.||+|+++-+.+. ......++|+-+++.++|+|||+++++... +..+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----dkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----CceeEE
Confidence 45566889999999999998765 789999999865433 334457999999999999999999987655 567789
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|+||+ ..+|..|++..+ ..++......++.|+++|+.++|+++ +.||||||.|.||+.+++.|++|||+++...-
T Consensus 79 vfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99999 779999998755 45999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcCchhHHHHhhcccccCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWTATGIYLDH 459 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 459 (460)
. ........-|..|.+|.++.+ +.|++..|+||-||++.|+.. |++.|...+..+...-+.|....++.|+
T Consensus 154 p-----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 154 P-----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred c-----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 2 122333456899999999886 457999999999999999997 7777777766655566666666665553
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=254.75 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=170.3
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|+||.||++.... +..+|+|.+..... ....+.+.+|+++++.++|+||+++++.+.+ ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----NGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----CCeEEE
Confidence 46778999999999999998864 78899999865422 2234457899999999999999999998765 457799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~~~ 382 (460)
|+||+++++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999999997654456899999999999999999999998 99999999999999885 46999999987664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 154 ~~~~-----~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 154 DSME-----LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred CCcc-----cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3321 112235788899999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=259.50 Aligned_cols=210 Identities=27% Similarity=0.395 Sum_probs=171.3
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc----
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR---- 295 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---- 295 (460)
...++|++.+.||+|+||.||+|... +++.||+|+++.... ......+.+|+++++.++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 488999999975432 233345788999999999999999999887643
Q ss_pred --CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 296 --GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 296 --~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
......++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 112367999999965 788877653 346899999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 159 DFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred cccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999986644321 11122235678999998764 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=253.89 Aligned_cols=199 Identities=21% Similarity=0.263 Sum_probs=163.5
Q ss_pred HHHHHHhcCCccccee--eeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012599 218 SALEHATDKFSGSNIV--GQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 293 (460)
.+.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3444556677777776 99999999999875 57889999986542211 122222222 79999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEE
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKI 372 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl 372 (460)
....++||||+++++|.+++... ..+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|
T Consensus 81 ----~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 81 ----LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred ----CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEE
Confidence 34789999999999999999754 36899999999999999999999998 99999999999999998 9999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+|||++...... ....++..|+|||++....++.++||||||+++|||++|+.||....
T Consensus 152 ~dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 152 CDYGLCKIIGTP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ecCccceecCCC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999998765322 12357889999999998889999999999999999999999998543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=259.42 Aligned_cols=204 Identities=25% Similarity=0.360 Sum_probs=168.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|+..+.||+|+||.||+|... +++.+++|.++..... .....+.+|++++++++||||+++++++.... ....+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--LDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--CCcEE
Confidence 46788899999999999999986 4889999999754322 22334678999999999999999999886532 25789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.++|+|||++....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999996 59999987543 35899999999999999999999998 9999999999999999999999999988664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||....
T Consensus 158 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 158 SPLK-----PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CCcc-----ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 11223467889999988654 46899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=265.99 Aligned_cols=203 Identities=22% Similarity=0.296 Sum_probs=169.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~ 298 (460)
..++|+..+.||+|+||.||++... +++.||+|.+.... .......+.+|+.+++.++|+||+++++++..... ..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 58899999986432 23334457789999999999999999998764321 22
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++ ++|.+++.. .++...+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35699999994 689888863 2788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+...... ......++..|+|||.+....++.++||||||+++|+|++|+.||...
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 166 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred eeCCCCC------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 8654321 122345778999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=256.42 Aligned_cols=203 Identities=27% Similarity=0.399 Sum_probs=168.8
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|++.+.||+|++|.||+|...+ ++.+|+|.+.... .......+.+|+++++.++|+|++++++++.+.. ....++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CCcEEEE
Confidence 5667899999999999998764 8899999998654 2333456889999999999999999999987632 2578999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 79 FEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99996 58999886542 46899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 ~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 154 NS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred Cc----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11222345778999997764 467999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-31 Score=260.34 Aligned_cols=208 Identities=25% Similarity=0.331 Sum_probs=168.1
Q ss_pred CCcccceeeeeCcEEEEEEEEcC---CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+|.+.+.||+|+||.||+|.... ++.+|+|.+.... .......+.+|+.+++.++||||+++++++.+.. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--DKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--Cce
Confidence 36778899999999999998754 7899999997632 1222345788999999999999999999987632 247
Q ss_pred EEEEEeecCCCCHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC----CCcEEEE
Q 012599 301 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKIT 373 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~----~~~vkl~ 373 (460)
.++||||++ ++|.+++.... ...++...+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence 899999996 57877774322 135889999999999999999999998 999999999999999 9999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
|||++......... ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 155 DLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred CCccccccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99999865443211 112233457888999998765 4578999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=259.92 Aligned_cols=205 Identities=28% Similarity=0.389 Sum_probs=168.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|.+. +|+.||+|.++..... .....+.+|+.++++++|+|++++++++.... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--LDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--CCeE
Confidence 467888999999999999999885 4899999998754322 22234678999999999999999999876522 2457
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999995 58999887533 56899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~ 213 (309)
T cd07845 159 GLPAK-----PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213 (309)
T ss_pred CCccC-----CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 44321 1122234678999998865 557899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=255.20 Aligned_cols=201 Identities=22% Similarity=0.382 Sum_probs=166.9
Q ss_pred CCcccceeeeeCcEEEEEEEEcC--CcEEEEEEeccCC---------CCChhHHHHHHHHHHHh-cCCCCccceeeeeee
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG---------GPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSE 293 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~l~~~~---------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~ 293 (460)
+|++.+.||+|+||.||++.+.. ++.+|+|.+.... .......+.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999999865 6889999886431 11223346778888875 699999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcE
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
+...+++|||+++++|.+++... ....+++..++.++.|++.||.|||+ .+ ++|+||+|+||++++++.+
T Consensus 81 ----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 ----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred ----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 45779999999999999988542 23458999999999999999999996 55 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+|+|||++....... ......++..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 154 ~l~dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 154 TITDFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred EEecccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 999999997654332 123345788999999999888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=255.86 Aligned_cols=193 Identities=28% Similarity=0.402 Sum_probs=157.3
Q ss_pred eeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHH---HHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 232 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDM---LSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~---l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
.||+|+||.||++... +++.||+|.+...... .....+..|..+ ++..+|+||+++++++.+ ....++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----CCEEEEEE
Confidence 4899999999999875 4889999998754322 222224445443 344579999999988775 45679999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-
Confidence 999999999998643 45899999999999999999999988 999999999999999999999999998755322
Q ss_pred CCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......|+..|+|||.+..+ .++.++||||||+++|||++|+.||....
T Consensus 151 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 151 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 11234688999999998754 68999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=255.44 Aligned_cols=200 Identities=24% Similarity=0.302 Sum_probs=164.1
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|++.+.||+|+||.||+|... +++.+|+|.++............+|+..++++. |+|++++++++.+.. ....++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK--TGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC--CCcEEEE
Confidence 456788999999999999875 588999999876533333334568999999885 999999999987632 2467999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99996 68988886532 46899999999999999999999998 999999999999999 99999999999866432
Q ss_pred CCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .....++..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 153 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 153 PP------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred CC------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 21 12234678899999764 4567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=276.18 Aligned_cols=196 Identities=30% Similarity=0.449 Sum_probs=167.7
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
-+||+|.+|+||-|++.+ ...+|||.+....+.. .+-..+||.+-+.|+|.|||+++|.+.+ ++++.+.||.+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~-~QPLhEEIaLH~~LrHkNIVrYLGs~se----nGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE-VQPLHEEIALHSTLRHKNIVRYLGSVSE----NGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchh-hccHHHHHHHHHHHhhHhHHHHhhccCC----CCeEEEEeecCC
Confidence 469999999999998865 4568999987654433 3337889999999999999999999876 567889999999
Q ss_pred CCCHHHHhccccCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCccccccCCC
Q 012599 310 NGNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l--~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~~~~ 386 (460)
||+|.+.|+... .++ ++.++-.+..||+.||.|||++. |||||||-+||||+ -.|.+||+|||-++++..-
T Consensus 656 GGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-- 729 (1226)
T KOG4279|consen 656 GGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-- 729 (1226)
T ss_pred CCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--
Confidence 999999998754 445 78888899999999999999998 99999999999996 5789999999999876422
Q ss_pred CCCCCCCCccccCCcccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.+....+.||+.|||||++..+ .|....|||||||++.||.||++||....
T Consensus 730 ---nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 730 ---NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred ---CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 3456678899999999999764 48999999999999999999999997543
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.34 Aligned_cols=204 Identities=19% Similarity=0.225 Sum_probs=158.0
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcC--CcEEEEEE--------------ecc--CCCCChhHHHHHHHHHHHhcCCCC
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKR--------------FKT--QGGPNADSVFLTEVDMLSRLHHCH 283 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~--------------l~~--~~~~~~~~~f~~Ei~~l~~l~H~n 283 (460)
...++|++.+.||+|+||+||++.+.. +...++|. +.. .........+.+|+++|++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999987542 22222221 100 011223345789999999999999
Q ss_pred ccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCC
Q 012599 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (460)
Q Consensus 284 Iv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~ 360 (460)
|+++++++.. ....++|+|++ .++|.+++..... ..........++.|++.||+|||+.+ |+||||||+
T Consensus 225 Iv~l~~~~~~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~ 296 (501)
T PHA03210 225 ILKIEEILRS----EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLE 296 (501)
T ss_pred cCcEeEEEEE----CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 9999999876 34668999998 5688888754221 22345667889999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 361 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
|||++.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 297 NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 297 NIFLNCDGKIVLGDFGTAMPFEKERE----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred HEEECCCCCEEEEeCCCceecCcccc----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999987644321 11223568999999999999999999999999999999999876543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=263.13 Aligned_cols=209 Identities=25% Similarity=0.350 Sum_probs=172.8
Q ss_pred chHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012599 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (460)
Q Consensus 216 ~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 293 (460)
...++...+++|++.+.||+|+||.||++... +++.||+|++.... .......+.+|++++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34567778899999999999999999999864 58899999987532 22234457889999999999999999998764
Q ss_pred ccC--ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEE
Q 012599 294 FRG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 294 ~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
... .....+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 322 123467888887 8899988864 35899999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|+|||++...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 161 l~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 161 ILDFGLARHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred Eeccccccccccc--------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998764321 123456788999998765 56889999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=259.91 Aligned_cols=200 Identities=29% Similarity=0.394 Sum_probs=162.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|...+.||+|+||.||++... +++.+|+|.+...........+.+|+.++.++. |+||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----EGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----CCcEEE
Confidence 3455678999999999999875 488999999876544444556889999999995 9999999998765 346689
Q ss_pred EEeecCCCCHHHHh---ccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 304 VFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 304 V~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
+|||++ ++|.++. .......+++..+..++.|++.||+|||+. + ++||||||+||++++++.++|+|||++.
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence 999985 4665543 222235689999999999999999999974 6 9999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... ......++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 157 QLVDSI------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred HhccCC------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 654321 11223578889999998765 6899999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=253.81 Aligned_cols=199 Identities=31% Similarity=0.431 Sum_probs=166.2
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||.||++...+ ++.+++|.+..... ......+.+|++++++++|+||+++++.+.. ....+++|||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----KKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----CcEEEEEEecCC
Confidence 5889999999999875 89999999865432 2344568899999999999999999987764 457799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC--
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-- 387 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~-- 387 (460)
+++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.........
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99999999764 36899999999999999999999998 999999999999999999999999998765433210
Q ss_pred -CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 388 -SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 388 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..........++..|+|||.......+.++||||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 00112233457788999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=259.25 Aligned_cols=212 Identities=27% Similarity=0.389 Sum_probs=169.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccC----c
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~ 297 (460)
.++|++.+.||+|+||.||+|... +++.+|+|++....... ....+.+|+++++.++|+||+++++++.+... .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999875 58899999986543322 22347789999999999999999988765332 2
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+. ++|.+.+... ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 346799999995 5788877643 246999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCC------CCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSC------SSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+........... ........+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~ 231 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence 986544321111 111223456788999998765 457899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=255.06 Aligned_cols=200 Identities=27% Similarity=0.367 Sum_probs=168.3
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|++.+.||+|++|.||+|...+ ++.+++|++.............+|+..+++++ |+|++++++++.+ +...++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE----NDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc----CCcEEEE
Confidence 5567899999999999999864 78899999876544333444678999999998 9999999998876 4577999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+ +|+|.+++.......+++..++.++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999 889999997654456899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
. ......++..|+|||.+. ...++.++|+||||+++|||++|+.||....
T Consensus 153 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 153 P------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred C------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 2 112245678899999875 4557899999999999999999999996553
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=261.97 Aligned_cols=201 Identities=23% Similarity=0.351 Sum_probs=165.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~ 299 (460)
.++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++|+||+++++++..... ...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478888999999999999999875 58999999987532 22233457899999999999999999998865321 223
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5689999995 47877653 35899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 166 HADAE--------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCCCC--------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54321 123356788999998876 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=255.94 Aligned_cols=190 Identities=24% Similarity=0.388 Sum_probs=155.8
Q ss_pred ceeeeeCcEEEEEEEEcC--------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 231 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++|||++++++++.. +...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC----GDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe----CCCcE
Confidence 368999999999997642 2348888875432 3334568899999999999999999999876 34568
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc--------EEEEe
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--------AKITD 374 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~--------vkl~D 374 (460)
+||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++++|
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecc
Confidence 9999999999999997643 35899999999999999999999998 999999999999987765 69999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCC-CCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGR-QPIHR 438 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~-~Pf~~ 438 (460)
||++...... ....++..|+|||++.. ..++.++||||||+++|||++|. .||..
T Consensus 152 ~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 152 PGISITVLPK---------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccccccCCc---------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 9988654321 22456788999999876 45799999999999999999985 55544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=252.59 Aligned_cols=208 Identities=25% Similarity=0.335 Sum_probs=170.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
..|+....||+|.+|.||+|.-.+ ...+|+|+++.+.+.. ......+|+.+++.++|||++.|..++... +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---D 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---C
Confidence 457888999999999999996433 2368999998664322 234478999999999999999999888764 4
Q ss_pred ceEEEEEeecCCCCHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC----CcEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAK 371 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~----~~vk 371 (460)
...++++||.+. +|.+.|+-. ..+.++......|+.||+.|+.|||++. |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 567999999955 899888432 2345888999999999999999999998 9999999999999876 8999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
|+|||+++.+...-.+-. ......-|..|+|||++.+ ..|++..|||+.||++.||+|-++.|....+
T Consensus 177 IaDlGlaR~~~~plkpl~--s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLA--SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred eecccHHHHhhccccccc--cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 999999998866543321 2334567899999999886 5689999999999999999999988876543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=257.10 Aligned_cols=193 Identities=25% Similarity=0.435 Sum_probs=165.4
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
..||+|+||.||++... +++.+|+|++.... ......+.+|+.+++.++|+|++++++++.. ....++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe----CCEEEEEEecCC
Confidence 57999999999999874 68899999886432 3344568899999999999999999998876 457799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---- 170 (292)
T cd06657 101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 170 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----
Confidence 9999998854 34899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.......++..|+|||.+....++.++|+||||+++|||++|..||...
T Consensus 171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1122345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=247.88 Aligned_cols=205 Identities=26% Similarity=0.392 Sum_probs=174.4
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||+|++|.||+|... +++.+++|.+..... ....+.+.+|++++++++|+||+++++.+.+.. ....++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--KNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--CCeEEE
Confidence 3667789999999999999987 588999999875532 234556899999999999999999999887632 257799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
++||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999997643 6899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......++..|+|||.+.....+.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETG---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccc---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4210 01223457789999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=259.00 Aligned_cols=203 Identities=20% Similarity=0.257 Sum_probs=164.1
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeec
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.+.+|.|+++.||++.. +++.+|||++... ........+.+|+++++.++|+||+++++++.+ ....+++|||+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----~~~~~~~~e~~ 81 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----DSELYVVSPLM 81 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----CCeEEEEEecc
Confidence 34455666666666665 6899999999765 234445568999999999999999999998875 45679999999
Q ss_pred CCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCC-
Q 012599 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 387 (460)
Q Consensus 309 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~- 387 (460)
++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+......+..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999998655556899999999999999999999998 999999999999999999999999988765432211
Q ss_pred -CCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 388 -SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 388 -~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..........++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01111223456778999998865 357899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=289.57 Aligned_cols=209 Identities=24% Similarity=0.339 Sum_probs=178.4
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 294 (460)
.++.-..++|.++++||+|+||.|..++... ++.+|.|++++-. ......-|..|-++|..-+.+=|++|.-.+.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD- 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD- 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence 3455567899999999999999999998864 8899999997521 12233448888999988888888888765555
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEe
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~D 374 (460)
+.++|+|||||+||||...+.... .+++.-+..++..|.-||.-||+.| +|||||||+|||||.+|++||+|
T Consensus 147 ---~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ---ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ---ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 678999999999999999998764 6888888999999999999999999 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccc----c-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM----V-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
||.+-.+..++... ....+|||.|.+||++. + +.|.+..|.||+||++|||+.|.-||+..
T Consensus 219 FGsClkm~~dG~V~----s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad 284 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVR----SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD 284 (1317)
T ss_pred chhHHhcCCCCcEE----eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH
Confidence 99999888776432 34467999999999884 2 67899999999999999999999999854
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=253.15 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=167.4
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC-hhHHHHHHHHHHHhc---CCCCccceeeeeeeccC-ccce
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRAM 300 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-~~~~ 300 (460)
|++.+.||+|+||.||+|+... ++.+|+|+++...... ....+.+|+.+++++ +|+|++++++++..... ....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 8999999997543322 233466788777666 69999999999876432 2224
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+++|||++ ++|.+++.......+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 799999996 58999987654446899999999999999999999998 99999999999999999999999999877
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .....++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 157 YSFEMA------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred ccCCcc------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 644321 122346788999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=248.66 Aligned_cols=208 Identities=25% Similarity=0.392 Sum_probs=172.2
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEE-EcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 294 (460)
++++-..|+ +.||+|+++.|--++ +.+|..+|||++.++.. .......+|++++... .|+||++|+.++.+
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEd- 147 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-HSRSRVFREVETFYQCQGHKNILQLIEFFED- 147 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCc-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-
Confidence 455555554 489999999999886 46799999999987743 4455678999999998 59999999999877
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc---EE
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AK 371 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~---vk 371 (460)
+..+|||||-|.||.|..+|++. ..+++.++.++..+||.||.|||+++ |.||||||+|||-.+-.. +|
T Consensus 148 ---d~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 ---DTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred ---cceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCcee
Confidence 66789999999999999999864 55999999999999999999999999 999999999999865443 89
Q ss_pred EEecCCccccccCC--CCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 372 ITDLGMAKRLKADG--LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 372 l~DFGla~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|+||.+..-+.... .+...+.....+|+..|||||+.. ...|+.+.|.|||||+||-|++|.+||...
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 99999886544332 233333444567999999999763 345789999999999999999999999865
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=256.68 Aligned_cols=200 Identities=28% Similarity=0.469 Sum_probs=164.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|...+ ++.+|||.++..........+..|+.++.+. .|+||+++++++.+ ....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~ 89 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT----DSDV 89 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec----CCeE
Confidence 4667888999999999999999875 8899999997654444445577788777777 49999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+++|||+ .++|.+++.... ..+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++..
T Consensus 90 ~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 90 FICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999998 457877775432 468999999999999999999997 46 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
..... ......++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 165 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 165 LVDSK------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred ccCCC------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 54321 112234678899999886543 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=259.47 Aligned_cols=208 Identities=23% Similarity=0.297 Sum_probs=168.3
Q ss_pred CCcccceeeeeCcEEEEEEEEcC---CcEEEEEEeccCCC-CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+|++.+.||+|+||.||++.... +..+|+|++..... ......+.+|+++++++ +|+||+++++.+.........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46777899999999999998753 67899999875432 22345578899999999 599999999876543333446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++++||++ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999985 7999998643 56899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
........ ........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 155 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 155 FSENPGEN-AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cccccccc-cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 65432211 112233568899999998765 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=256.64 Aligned_cols=195 Identities=29% Similarity=0.436 Sum_probs=163.9
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
|+..+.||+|+||.||++... +++.+|+|.+...... .....+.+|+++++.++|+|++++++++.+ ....++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 102 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----EHTAWL 102 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----CCeEEE
Confidence 666789999999999999875 5889999998754322 223458899999999999999999999876 446799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ |+|.+++... ...+++.++..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 999996 5888877543 355899999999999999999999998 99999999999999999999999999865432
Q ss_pred CCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
. ....++..|+|||.+. .+.++.++||||||+++|||++|+.||...
T Consensus 178 ~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 A---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred c---------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 1 2235778899999873 466899999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=247.26 Aligned_cols=202 Identities=27% Similarity=0.386 Sum_probs=173.2
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|+..+.||.|+||.||++... +++.+++|++..... ......+.+|+++++.++|+|++++++.+.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----KGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----CCEEEE
Confidence 4677889999999999999886 488999999876433 2445568899999999999999999998765 357799
Q ss_pred EEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+||+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence 999999999999997643 356899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... .......+++.|+|||.+....++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 154 SSTV-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred ccCc-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 4432 1122345788899999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=253.02 Aligned_cols=207 Identities=29% Similarity=0.440 Sum_probs=173.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|...+.||+|+||.||++... +++.+++|.+.... .......+.+|.+++++++ |+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----EEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----Cce
Confidence 46788899999999999999876 58999999987532 2233455889999999998 9999999988765 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 79999999999999999764 36999999999999999999999998 99999999999999999999999999886
Q ss_pred cccCCCCCC---------------CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSC---------------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......... ........++..|+|||.+....++.++||||||++++++++|+.||....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 644322100 122233457889999999888889999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=249.44 Aligned_cols=192 Identities=26% Similarity=0.376 Sum_probs=158.4
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHH-HhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDML-SRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|... +++.||+|.+..... ......+..|..++ ...+|+|++++++++.. +...++|||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----KDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----CCeEEEEEe
Confidence 56899999999999875 488999999864321 11122244454444 44589999999999875 457899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++++|.++++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 78 YLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999999999753 45889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 123357788999999988888999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=245.55 Aligned_cols=200 Identities=29% Similarity=0.481 Sum_probs=171.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|++.+.||+|++|.||++... +++.+++|.+...... .....+.+|++++++++|+|++++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----SDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----CCEEEE
Confidence 4677899999999999999875 5788999999765432 234568899999999999999999998775 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 99999999999999754 56899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......++..|+|||.+.....+.++||||||+++|+|++|+.||...
T Consensus 152 ~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~ 202 (254)
T cd06627 152 VSK-----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202 (254)
T ss_pred Ccc-----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence 321 123345788999999988777899999999999999999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=260.40 Aligned_cols=207 Identities=26% Similarity=0.341 Sum_probs=172.2
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc-CccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~~~~~ 302 (460)
+|++.+.||+|++|.||++.... ++.+|+|++..... ....+.+.+|+++++.++|+||+++++++.... ......+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778999999999999999764 88999999876432 334456889999999999999999999887643 1223679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
++|||++ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 5899998753 36999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ........++..|+|||.+... .++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 155 PDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 43211 0112234578889999999877 78999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=258.94 Aligned_cols=204 Identities=24% Similarity=0.335 Sum_probs=169.3
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK- 297 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~- 297 (460)
....++|++.+.||+|+||.||++... +++.||||++..... ......+.+|+++++.++|+||+++++++......
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999865 589999999864322 22334578999999999999999999988653221
Q ss_pred -cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 298 -RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 298 -~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 13468999999 7899988864 45899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++...... .....++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...
T Consensus 164 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 98765332 122356788999998865 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.44 Aligned_cols=205 Identities=25% Similarity=0.353 Sum_probs=168.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~ 300 (460)
.++|++.+.||+|+||+||++... +++.||||.+.... .......+.+|+.+++.++|+||+++++++..... ....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999875 58899999987532 22233457789999999999999999998765322 1235
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7999998753 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 158 TSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred cCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 54321 11122356788999998764 56889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=263.27 Aligned_cols=204 Identities=24% Similarity=0.358 Sum_probs=170.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEecc-CCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKT-QGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~-~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
...|++++.||.||.+.||++...+.+.+|+|++.. ..+.....-|.+|+.+|.+| .|.+|++|++|-.. +..+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----d~~l 435 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----DGYL 435 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----CceE
Confidence 345778899999999999999998888888888754 34555556699999999999 59999999998665 6789
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+||||= ..||..+|++.......| .+..+..||+.++.++|.++ |||.||||.|+|+-. |.+||+|||+|..+
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999976 779999998766554555 78889999999999999999 999999999999875 58999999999988
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGR-----------ASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..+... -.....+||+.||+||.+.... .+++|||||+||+||+|+.|+.||....
T Consensus 510 ~~DTTs---I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 510 QPDTTS---IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred Cccccc---eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 776432 1233468999999999885322 4678999999999999999999997543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=247.23 Aligned_cols=201 Identities=29% Similarity=0.372 Sum_probs=170.6
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+|++.+.||+|++|.||++... +++.+++|.+.... .......+.+|++++++++|+||+++.+++.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----GNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----CCEEEE
Confidence 4677889999999999999765 57899999987543 22334457889999999999999999988765 357799
Q ss_pred EEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999999999986522 245899999999999999999999998 999999999999999999999999999776
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .....++..|+|||.+....++.++|+||||+++|||++|+.||....
T Consensus 154 ~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 154 KKNM-------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ccCC-------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5431 112346788999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=257.20 Aligned_cols=202 Identities=25% Similarity=0.351 Sum_probs=168.4
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
..++++|+..+.||+|+||.||++... +++.+|+|++.... .......+.+|+++++.++||||+++.+++... .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP---L 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---C
Confidence 346788999999999999999999865 68999999886432 223345578999999999999999999987642 2
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++++||+ +++|.++++. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 3568999999 6799998864 34788888999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 156 RIQDPQ--------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cccCCC--------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 754321 122346788999998765 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=257.56 Aligned_cols=203 Identities=25% Similarity=0.350 Sum_probs=162.7
Q ss_pred ceeeee--CcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G--~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
..||+| +||+||++.+. +++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----GSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----CCceEEEEe
Confidence 346666 99999999875 6899999998754322 233557889999999999999999999876 446799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 999999999998755556899999999999999999999988 99999999999999999999999986544322211
Q ss_pred CCC--CCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSC--SSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ........++..|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 110 011112234567999999875 347899999999999999999999997653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=252.55 Aligned_cols=200 Identities=26% Similarity=0.339 Sum_probs=165.5
Q ss_pred CCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 297 (460)
+|++.+.||+|++|.||++... +++.+|||.++... .......+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 3677789999999999999753 57889999986432 122334578999999999 69999999987754
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
+...++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence 45678999999999999998653 45889999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
++....... .......++..|+|||.+.... .+.++||||||+++|||++|..||..
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 152 SKEFLAEEE----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccc----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 876543321 1122345788999999887654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=256.10 Aligned_cols=206 Identities=25% Similarity=0.362 Sum_probs=165.2
Q ss_pred cCCc-ccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-------------hhHHHHHHHHHHHhcCCCCccceee
Q 012599 225 DKFS-GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------------ADSVFLTEVDMLSRLHHCHVVPLVG 289 (460)
Q Consensus 225 ~~f~-~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-------------~~~~f~~Ei~~l~~l~H~nIv~l~g 289 (460)
++|. +.+.||+|+||.||+|.+. +++.||||.++...... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999875 58999999986543222 1124678999999999999999999
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
++.. ....++||||++ |+|.+++... ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.
T Consensus 88 ~~~~----~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 88 VYVE----GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEec----CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 9875 457799999996 6999999653 45899999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCC---------CCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLP---------SCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~---------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++|+|||++......... ..........++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999866522111 001111223467889999988754 4689999999999999999999999755
Q ss_pred C
Q 012599 440 I 440 (460)
Q Consensus 440 ~ 440 (460)
.
T Consensus 238 ~ 238 (335)
T PTZ00024 238 N 238 (335)
T ss_pred C
Confidence 4
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=249.73 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=168.2
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|+..+.||+|++|.||++... +++.+++|.+...... .....+.+|++++++++|+||+++++++.. ....++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----KGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----CCCEEEE
Confidence 456788999999999999875 5889999998765332 334568899999999999999999998775 4577999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||.+......
T Consensus 77 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 77 FEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 99996 49999887643 46899999999999999999999998 999999999999999999999999998776543
Q ss_pred CCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......++..|+|||.+... .++.++|+||||+++|+|+||+.||....
T Consensus 152 ~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 152 VR-----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred cc-----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11223467789999988766 78999999999999999999999997644
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=251.01 Aligned_cols=195 Identities=30% Similarity=0.454 Sum_probs=163.6
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
|...+.||+|+||.||+|... +++.+++|.+...... .....+.+|+++++.++|+|++++++++.+ ....++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK----EHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCEEEE
Confidence 555678999999999999875 5889999998754332 223457889999999999999999999876 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ |+|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 99 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 99 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 999995 6888887643 245899999999999999999999998 99999999999999999999999998864321
Q ss_pred CCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12345788999999874 466888999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=259.29 Aligned_cols=206 Identities=22% Similarity=0.334 Sum_probs=165.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc------
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK------ 297 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~------ 297 (460)
.+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 67888899999999999999875 488999999875543 3345588999999999999999999876543221
Q ss_pred ----cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEE
Q 012599 298 ----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKI 372 (460)
Q Consensus 298 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl 372 (460)
....++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ ++..++|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 125689999996 699988864 35889999999999999999999998 99999999999997 5667899
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+|||++.......... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 157 ~dfg~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 157 GDFGLARIVDPHYSHK--GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CCcccceecCCccccc--cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999997654321111 11122346788999997654 567889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=281.32 Aligned_cols=207 Identities=29% Similarity=0.420 Sum_probs=165.8
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeee------
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE------ 293 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------ 293 (460)
.+...+|+.+++||+|+||.|||++.. ||+.+|||++...........+.+|+.++++|+|||||+++....+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 566778899999999999999999875 7999999999876655555668899999999999999998744311
Q ss_pred -------------------------------------------------c---------c--------------------
Q 012599 294 -------------------------------------------------F---------R-------------------- 295 (460)
Q Consensus 294 -------------------------------------------------~---------~-------------------- 295 (460)
. .
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0 0
Q ss_pred ------------------------C-------ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH
Q 012599 296 ------------------------G-------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344 (460)
Q Consensus 296 ------------------------~-------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yL 344 (460)
. ....+||=||||+.-.|+++++.+.... .....++++++|+.||.|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 0 0134688899999988888887643211 4677899999999999999
Q ss_pred HhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc----c--------CCCCCCC-CCCCccccCCcccCccccccC
Q 012599 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK----A--------DGLPSCS-SSPARMQGTFGYFAPEYAMVG 411 (460)
Q Consensus 345 H~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~----~--------~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 411 (460)
|+++ ||||||||.|||+|++..|||+|||+|.... . ....... ...+...||.-|+|||++...
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998722 0 0111111 234557899999999998653
Q ss_pred ---CCCchhHHHHHHHHHHHHHh
Q 012599 412 ---RASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 412 ---~~~~~sDVwSlGvll~ellt 431 (460)
.|+.|+|+|||||+|+||+.
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc
Confidence 59999999999999999974
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=248.87 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=167.5
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|+..+.||+|.+|.||+|+..+ ++.+++|.+.... .......+..|+++++.++|+|++++++++.+ ....++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----ERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----CCceEEE
Confidence 4556789999999999998864 8999999998653 22334557889999999999999999998876 3577999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||.+......
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 99997 69999997643 45899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......++..|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 152 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 152 LR-----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred cc-----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 21 11223356789999988766 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=246.89 Aligned_cols=203 Identities=26% Similarity=0.312 Sum_probs=173.4
Q ss_pred HhcCCccc-ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 223 ATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 223 ~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+++|++. ++||-|-.|.|..+..+ .|+.+|+|++... +. ..+|+++--.- .|+|||.+++++........
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PK----ARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HH----HHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45666654 67999999999999765 5889999998743 22 56788765444 79999999999988777788
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc---CCCcEEEEecC
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLG 376 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~---~~~~vkl~DFG 376 (460)
.+++|||.|+||.|.+.++......+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 8999999999999999999887788999999999999999999999999 99999999999996 45579999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+|+...... .....+-|+.|.|||++-...|+...|+||+||++|-|+.|.+||....
T Consensus 210 FAK~t~~~~------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 210 FAKETQEPG------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred cccccCCCc------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 998765432 2334567899999999988889999999999999999999999998654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=258.98 Aligned_cols=208 Identities=25% Similarity=0.333 Sum_probs=172.7
Q ss_pred ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeec
Q 012599 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
+.||.|.||+||-|+.+ +|+.||||++.+...+ ..+....+|+.+|.+++||.||.|---|.. .+..++|||-+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET----~ervFVVMEKl 645 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET----PERVFVVMEKL 645 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC----CceEEEEehhh
Confidence 78999999999999876 5999999999765433 344568899999999999999999876655 55679999999
Q ss_pred CCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCCccccccCC
Q 012599 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 309 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGla~~~~~~~ 385 (460)
+|+..+.|-......+++.....+..||+.||.|||..+ |+|+||||+|||+.+ --++||+|||.|+.+.+..
T Consensus 646 -~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 646 -HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred -cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 778777775544456888888899999999999999998 999999999999964 3479999999999987654
Q ss_pred CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhcc
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATG 454 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~~ 454 (460)
. .....||+.|+|||++..+.|+..-|+||.||++|--++|..||.... +-.+-++.|...
T Consensus 722 F------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFM 782 (888)
T KOG4236|consen 722 F------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFM 782 (888)
T ss_pred h------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccc
Confidence 3 334689999999999999999999999999999999999999996432 233344444433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=257.86 Aligned_cols=212 Identities=30% Similarity=0.399 Sum_probs=174.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCCh------hHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNA------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
.++|-.+.+||+|+|+.||+|.+ ...+.||||+-.....+.+ .+...+|.++-+.|+||.||++++|+.-.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec--
Confidence 35677789999999999999965 4588999998654433322 22356889999999999999999998753
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc---CCCcEEEE
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKIT 373 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~---~~~~vkl~ 373 (460)
...++-|+||++|-+|+-||+.. +.+++.++..|+.||+.||.||.+.. |||||-||||.|||+. .-|.+||.
T Consensus 540 -tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 -TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred -cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 34568999999999999999875 45999999999999999999999874 7799999999999995 45789999
Q ss_pred ecCCccccccCCCCC--CCCCCCccccCCcccCccccccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 374 DFGla~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
|||+++.+..+.+.. .........||.+|++||.+..+ ..+.|+||||.||++|+.++|+.||.....
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 999999988765442 22344557899999999988643 458899999999999999999999976543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=251.91 Aligned_cols=197 Identities=28% Similarity=0.425 Sum_probs=164.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..|+..+.||+|+||.||+|... +++.+++|.+..... ......+.+|+++++.++|+|++++++++.. ....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 90 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTA 90 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCee
Confidence 34666788999999999999875 478899999864322 2233457889999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+. |+|.+++.... ..+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence 99999996 68888775432 45899999999999999999999988 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ....++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 166 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 166 APA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred cCc---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 332 1235778899999874 356788999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=240.58 Aligned_cols=194 Identities=32% Similarity=0.429 Sum_probs=165.7
Q ss_pred eeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
||+|+||.||++... +++.+++|.+....... ....+.+|++++++++|+||+++++.+.. +...++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----EEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----CCeeEEEEecCC
Confidence 689999999999876 48899999987653322 34468899999999999999999988764 557799999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~ 389 (460)
+++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---- 147 (250)
T cd05123 77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---- 147 (250)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----
Confidence 99999999754 35899999999999999999999988 9999999999999999999999999987664431
Q ss_pred CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 390 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.......++..|+|||.......+.++|+||||+++|||++|+.||....
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 11233457788999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=244.74 Aligned_cols=200 Identities=24% Similarity=0.297 Sum_probs=162.2
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC----CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+|.+.+.||+|+||.||++.... +..+++|.++... .......+..|+.+++.++||||+++++++.+ ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE----RDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc----CCc
Confidence 47778899999999999998754 3445566554321 22233446789999999999999999988765 346
Q ss_pred EEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 301 RLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
.++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||.+
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence 79999999999999998642 2356899999999999999999999998 999999999999976 56999999998
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
........ ......++..|+|||.+....++.++|+||||+++|+|++|+.||..
T Consensus 153 ~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 153 RLLMGSCD-----LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred eecCCCcc-----cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76543221 12234577889999998888889999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=267.13 Aligned_cols=202 Identities=23% Similarity=0.362 Sum_probs=166.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcE-EEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~-vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+.|.++..||-|+||.||+|...+... .|.|.+... .....++|+-||++|+..+||+||+|++.+.. ...+++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~----enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYF----ENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc----cCceEE
Confidence 345566779999999999998876443 455666543 34455679999999999999999999976654 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+.|||+||-....+-. ..+.+++.++..+..|++.||.|||++. |||||||+.|||++-+|.++|+|||.+-....
T Consensus 107 liEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh
Confidence 9999999998887754 3467999999999999999999999998 99999999999999999999999998765432
Q ss_pred CCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
. .-....+.||++|||||+.+ ..+|+.++||||||++|.||..+.+|-+...
T Consensus 183 t-----~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 183 T-----RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred H-----HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 1 11233477999999999874 5789999999999999999999999987654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=287.68 Aligned_cols=225 Identities=29% Similarity=0.377 Sum_probs=180.6
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
+...+-++.....||.|.||.||.|... +|+-.|+|.++.+.. ......+.+|+.++..|+|||+|+.+|+-..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH---- 1305 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH---- 1305 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec----
Confidence 4445667777899999999999999764 589999999876533 2333447899999999999999999998765
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
+...+|.||||++|+|.+.++.. ...++.....+..|++.|+.|||+++ ||||||||.||||+.++.+|++|||.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence 45668999999999999999753 33566666778899999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhcc
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATG 454 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~~ 454 (460)
|..+....... ........||+-|||||++.+. .-.-+.||||+||++.||+||+.||...+.+ -.+...+..+
T Consensus 1381 a~ki~~~~~~~-~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1381 AVKIKNNAQTM-PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAG 1457 (1509)
T ss_pred eeEecCchhcC-CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhcc
Confidence 99876552111 1233457899999999999753 3466899999999999999999999877543 4455555444
Q ss_pred cc
Q 012599 455 IY 456 (460)
Q Consensus 455 ~~ 456 (460)
..
T Consensus 1458 h~ 1459 (1509)
T KOG4645|consen 1458 HK 1459 (1509)
T ss_pred CC
Confidence 33
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=238.87 Aligned_cols=201 Identities=28% Similarity=0.457 Sum_probs=166.1
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
.+.+..||.|.-|+|+++.... |...|||.+......+..++++..+.++.+-+ .|.||+.+||+.. +...++.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~----n~dV~Ic 169 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT----NTDVFIC 169 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee----CchHHHH
Confidence 3446789999999999998865 88999999998877777778888888887664 8999999999987 3344788
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
||.| ..-++..|+. ..+++++.-+-++...+.+||.||.++. +|+|||+||+|||+|+.|++||+|||++-++-+.
T Consensus 170 MelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 170 MELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9988 3344555543 3466888888889999999999998765 5999999999999999999999999999877553
Q ss_pred CCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
....+..|.+.|||||.+. ...|+..+||||||+.|+||.||+.||.....
T Consensus 246 ------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 246 ------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred ------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 2344556889999999985 45688999999999999999999999987544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=244.59 Aligned_cols=198 Identities=26% Similarity=0.376 Sum_probs=161.1
Q ss_pred ccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEEe
Q 012599 229 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
.+..||.|.||+|+|-.++ .|+..|||+++......+..+++.|.+...+- +-||||+++|.+.. .+-.++.||
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~----EGdcWiCME 143 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS----EGDCWICME 143 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc----CCceeeeHH
Confidence 3568999999999999876 48999999999887767777888888866554 79999999998765 345699999
Q ss_pred ecCCCCHHHHhc---cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 307 FMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 307 ~~~~gsL~~~l~---~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
.| .-+|..+-+ ......+++.-.-.|..-...||.||.+.- .|||||+||+|||+|..|.+||+|||++-.+..
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99 667765542 222344777777788888999999998654 599999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCcccCccccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+ -......|...|||||.+. ...|+.+|||||||++|||+.||+.|+..-
T Consensus 221 S------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 221 S------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred H------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 2 2334456778899999985 345899999999999999999999998754
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=253.67 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=167.4
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--cc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~ 298 (460)
..++|+..+.||+|++|.||+|... +++.+|+|++.... .......+.+|+.++++++|+|++++++++..... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4677888999999999999999886 47899999986532 22233457789999999999999999987654221 12
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 3479999999 6799999875 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 166 RHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred cccccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 765332 122346788999998765 46789999999999999999999999654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=261.82 Aligned_cols=217 Identities=27% Similarity=0.417 Sum_probs=185.3
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
..++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++....+.+ +++..|.++++.. +|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 345556667888999999999999999999764 58899999998665433 4477888999888 7999999999886
Q ss_pred ec-cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEE
Q 012599 293 EF-RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 293 ~~-~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
.. ...+.+++||||||.+|+..|.+++.....+.|..+..|.+.+++|+.|||++. ++|||||=.|||+++++.||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 43 345678999999999999999999888888999999999999999999999988 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
|.|||.+..+... ........||+.|||||++. ...|+..+|+||||++..||--|.+|+..+.+
T Consensus 164 LvDFGvSaQldsT-----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDST-----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred Eeeeeeeeeeecc-----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999998766432 23445567999999999985 34577889999999999999999999987654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=266.91 Aligned_cols=146 Identities=26% Similarity=0.356 Sum_probs=127.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||.||+|.+. +++.||+|+++.... ......+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS----ANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE----CCEE
Confidence 56888899999999999999886 588999999975432 2223457889999999999999999988765 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999753 45889999999999999999999988 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=236.70 Aligned_cols=180 Identities=21% Similarity=0.227 Sum_probs=151.4
Q ss_pred eCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHH
Q 012599 236 GGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLR 314 (460)
Q Consensus 236 G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~ 314 (460)
|.+|.||++.+. +++.+|+|+++... .+.+|...+....|||++++++++.+ ....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec----CCeEEEEEecCCCCCHH
Confidence 899999999875 58899999987542 13455555566679999999998765 45679999999999999
Q ss_pred HHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCC
Q 012599 315 DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394 (460)
Q Consensus 315 ~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~ 394 (460)
+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++|||.+....... .
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--------~ 140 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--------D 140 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc--------c
Confidence 999653 35899999999999999999999998 9999999999999999999999999876553321 1
Q ss_pred ccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 395 ~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
...++..|+|||.+....++.++||||+|+++|||++|+.||..
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 22345679999999888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=253.93 Aligned_cols=221 Identities=22% Similarity=0.314 Sum_probs=175.9
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.-|..++.||-|+||.|.++.- +....+|.|.|.+..-. ........|-++|+.-+.+=||+|+-.+.+ ...+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD----kdnL 704 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNL 704 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc----CCce
Confidence 4466778899999999999964 34667899988754321 222335678899999999999999976665 5678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+||+|++||++-..|-+. .-|.+..+..++.+++.|+++.|++| +|||||||+|||||.+|++||.||||+.-+
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999999998653 44888888889999999999999999 999999999999999999999999997632
Q ss_pred cc--------CCCCCCC-----------------------------CCCCccccCCcccCccccccCCCCchhHHHHHHH
Q 012599 382 KA--------DGLPSCS-----------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGV 424 (460)
Q Consensus 382 ~~--------~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGv 424 (460)
.- .+.+... .......||+.|+|||++....++...|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 10 1111000 0011246999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCc-CchhHHHHhhcc
Q 012599 425 VLLELITGRQPIHRSITK-GEESLVLWTATG 454 (460)
Q Consensus 425 ll~elltG~~Pf~~~~~~-~~~~l~~~~~~~ 454 (460)
+||||+.|+.||....+. ....+++|-..+
T Consensus 860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l 890 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGETQYKVINWRNFL 890 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcceeeeeehhhcc
Confidence 999999999999876654 345678886643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=226.93 Aligned_cols=210 Identities=26% Similarity=0.356 Sum_probs=169.3
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 295 (460)
..++.+.+.......||+|++|.|=+-++ .+|+..|||++...-..+.....+.|+++..+- ..|.+|.++|....
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-- 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-- 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--
Confidence 33455556666678899999999988876 469999999998776666666788888876654 79999999996554
Q ss_pred CccceEEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
....++.||.| ..+|..|-+.. ....+++.-+-+||..+..||.|||++- .++|||+||+||||+.+|++|++
T Consensus 117 --egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 117 --EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred --cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence 34568999999 67888776442 2355888889999999999999999875 49999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccc----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||.+-.+.++- ..+...|...|||||.+. ...|+-+|||||||+.+.||.+++.||..-.
T Consensus 192 DFGIsG~L~dSi------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 192 DFGISGYLVDSI------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ccccceeehhhh------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999998765431 222245778899999885 3478999999999999999999999997644
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=228.85 Aligned_cols=200 Identities=30% Similarity=0.418 Sum_probs=169.3
Q ss_pred CcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
|...+.||+|++|.||++...+ ++.+++|.+...........+.+|++.+++++|+|++++++++.. ....++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED----PEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec----CCceEEEE
Confidence 4556889999999999999876 889999999865433245568899999999999999999998765 34679999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
||+++++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+++||+++.++.++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999976432 1799999999999999999999997 9999999999999999999999999988765432
Q ss_pred CCCCCCCCCccccCCcccCcccc-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
. .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 A----ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c----ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 012234567889999988 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=255.85 Aligned_cols=208 Identities=23% Similarity=0.348 Sum_probs=154.5
Q ss_pred HhcCCcccceeeeeCcEEEEEEEE-----------------cCCcEEEEEEeccCCCCC-------------hhHHHHHH
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQL-----------------TDGRIVAVKRFKTQGGPN-------------ADSVFLTE 272 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vaVK~l~~~~~~~-------------~~~~f~~E 272 (460)
..++|++.++||+|+||.||+|.+ .+++.||||++....... ..+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 235689999987532211 11123456
Q ss_pred HHHHHhcCCCCc-----cceeeeeeeccC----ccceEEEEEeecCCCCHHHHhccccC---------------------
Q 012599 273 VDMLSRLHHCHV-----VPLVGYCSEFRG----KRAMRLLVFEFMPNGNLRDCLDGVLV--------------------- 322 (460)
Q Consensus 273 i~~l~~l~H~nI-----v~l~g~~~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 322 (460)
+.++.+++|.++ ++++++|..... .....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777866654 678888764321 12457999999999999999864211
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCc
Q 012599 323 -EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401 (460)
Q Consensus 323 -~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~ 401 (460)
..+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~ 375 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----FNPLYGMLDPR 375 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc----cCccccCCCcc
Confidence 12467888999999999999999998 99999999999999999999999999976533211 11112234789
Q ss_pred ccCccccccCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCC
Q 012599 402 YFAPEYAMVGRA----------------------SLMSDVFSFGVVLLELITGRQ-PIH 437 (460)
Q Consensus 402 y~aPE~~~~~~~----------------------~~~sDVwSlGvll~elltG~~-Pf~ 437 (460)
|+|||.+..... ..+.||||+||+++||++|.. ||.
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 999998753221 234799999999999999886 765
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=238.01 Aligned_cols=211 Identities=24% Similarity=0.361 Sum_probs=171.3
Q ss_pred CCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccC----ccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~~ 299 (460)
.|....+||+|.||.||+|+..+ |+.||+|++.-+..+. .....++|+.+|..++|+|++.++..|..... ...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 34556789999999999998764 7788998765433222 23346899999999999999999998865332 234
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.+++||.+++ -+|.-.|.... ..++..++..++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+++
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 5899999995 48998887543 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
.+....... .....+..-|+.|++||.+.+ +.|+++.|||.-||++.||+||.+-|+...+.
T Consensus 173 ~fs~~~n~~-kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 173 AFSTSKNVV-KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred ceecccccC-CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 765543222 233556677999999998875 66899999999999999999998888766543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=234.96 Aligned_cols=202 Identities=24% Similarity=0.344 Sum_probs=172.1
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 298 (460)
..++|..+++||+|++.+|..+++.. .+.+|+|+++++- ..+...-...|..+..+- +||.+|-|..++.. .
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----e 323 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----E 323 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----c
Confidence 35789999999999999999998764 6789999998652 222222356777777665 89999998877654 5
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
..+++|.||+++|+|.-++++. +.+++..+..+...|..||.|||+.+ |+.||||.+|||||..+++||.|||++
T Consensus 324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchh
Confidence 5789999999999998777654 56899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+.--.+ ......++||+.|.|||.+.+..|...+|.|+|||+++||+.|+.||+-
T Consensus 399 ke~l~~-----gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 399 KEGLGP-----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hcCCCC-----CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 865433 3356678999999999999999999999999999999999999999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=250.53 Aligned_cols=199 Identities=22% Similarity=0.294 Sum_probs=168.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChh----H---HHHHHHHHHHhcC---CCCccceeeeee
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD----S---VFLTEVDMLSRLH---HCHVVPLVGYCS 292 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~----~---~f~~Ei~~l~~l~---H~nIv~l~g~~~ 292 (460)
..+|+.++.+|+|+||.|+.+.++. ...|+||.+.+..-.... . ..-.||.+|+.++ |+||+++++++.
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4568889999999999999998865 567899998765321110 0 0335999999997 999999999998
Q ss_pred eccCccceEEEEEeec-CCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEE
Q 012599 293 EFRGKRAMRLLVFEFM-PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
+ +.++||+||-. ++-+|.+||... ..+++.+...|+.|++.|+++||+.+ |||||||-+||.++.+|-+|
T Consensus 640 d----dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 640 D----DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred c----CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence 7 67889999876 456999999764 45999999999999999999999999 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
|+|||.+...... ..-.+.||..|.|||++.+..| ...-|||++|++||.++..+.||.+
T Consensus 711 lidfgsaa~~ksg-------pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSG-------PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCC-------CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999998765443 2345789999999999998777 6678999999999999999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=251.94 Aligned_cols=202 Identities=22% Similarity=0.317 Sum_probs=175.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCc-EEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..+++.+..||-|+||.|=++...... .+|+|.+++.+ .....+....|-++|...+.+.||+++--+.+ ..+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----~ky 494 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----SKY 494 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----chh
Confidence 455666778999999999999876544 38889887653 23334457889999999999999999976665 668
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.|+.||-|-||.|...|+.. ..++..+...++..++.|++|||.++ ||+|||||+|.++|.+|-+||.|||+|+.
T Consensus 495 vYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHH
Confidence 89999999999999999864 55899999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+.... ..-.++||+.|.|||.+..+..+..+|.||||+++|||++|.+||...+
T Consensus 570 i~~g~------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d 623 (732)
T KOG0614|consen 570 IGSGR------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD 623 (732)
T ss_pred hccCC------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence 87653 4456899999999999999999999999999999999999999997654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=223.25 Aligned_cols=187 Identities=33% Similarity=0.489 Sum_probs=162.7
Q ss_pred CcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHHH
Q 012599 237 GSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD 315 (460)
Q Consensus 237 ~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~ 315 (460)
+||.||+|...+ ++.+++|++...........+.+|++.+++++|+|++++++++.. ....++++||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED----EDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee----CCEEEEEEeCCCCCCHHH
Confidence 589999999874 899999999865544335679999999999999999999999876 357799999999999999
Q ss_pred HhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCc
Q 012599 316 CLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395 (460)
Q Consensus 316 ~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~ 395 (460)
++.... .+++..++.++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 77 ~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~ 145 (244)
T smart00220 77 LLKKRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTT 145 (244)
T ss_pred HHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------cccc
Confidence 997643 2899999999999999999999998 9999999999999999999999999998765432 1223
Q ss_pred cccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 396 ~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
..++..|++||.+....++.++||||||+++|+|++|..||..
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4567889999999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=254.80 Aligned_cols=203 Identities=22% Similarity=0.272 Sum_probs=142.1
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeee-eec-c
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC-SEF-R 295 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~-~ 295 (460)
..++|+..+.||+|+||.||+|.+.+ +..||+|++..... .+.+..| .+....+.++..++..+ ... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45789999999999999999998854 68999998764321 1112211 12222233333322111 111 1
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVE------------------GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
......++||||+++++|.+++...... ......+..++.|++.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 2345779999999999999998643210 0123345679999999999999998 999999
Q ss_pred CCCCEEEcC-CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC----------------------CCC
Q 012599 358 KSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----------------------RAS 414 (460)
Q Consensus 358 k~~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 414 (460)
||+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+... .++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999986 57999999999986543221 123446788999999965322 234
Q ss_pred chhHHHHHHHHHHHHHhCCCCCC
Q 012599 415 LMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 415 ~~sDVwSlGvll~elltG~~Pf~ 437 (460)
.++|||||||+||||+++..|+.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCc
Confidence 46799999999999999877654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=237.40 Aligned_cols=211 Identities=22% Similarity=0.266 Sum_probs=172.0
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC--CCC----ccceeeeeee
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH----VVPLVGYCSE 293 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--H~n----Iv~l~g~~~~ 293 (460)
...+.+|.+..++|+|.||.|-...+.. +..||||+++... ...+..+-|++++.++. -|+ ++.+.+++..
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3448899999999999999999998765 6899999998543 33344678999999993 222 4455555544
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-------
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE------- 366 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~------- 366 (460)
.+..++|+|.+ |-|+.+||..+...+++..++..|+.|++.+++|||+.+ ++|-||||+|||+.+
T Consensus 163 ----rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 163 ----RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred ----cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 55679999998 779999999888888999999999999999999999998 999999999999932
Q ss_pred -------------CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC
Q 012599 367 -------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433 (460)
Q Consensus 367 -------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~ 433 (460)
+..++|+|||.|+...... .....|..|+|||++.+-.++..+||||+||+|.||.||.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc--------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 3358999999998754432 3456788999999999999999999999999999999999
Q ss_pred CCCCCCCCcCchhHHH
Q 012599 434 QPIHRSITKGEESLVL 449 (460)
Q Consensus 434 ~Pf~~~~~~~~~~l~~ 449 (460)
..|+.-...+-..+.+
T Consensus 307 ~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMME 322 (415)
T ss_pred eecccCCcHHHHHHHH
Confidence 9998755443333333
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=243.94 Aligned_cols=196 Identities=23% Similarity=0.302 Sum_probs=163.4
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+++.|.....+|.|+|+.|-++... +++..+||++...... -.+|+.++... +|+|++++.+++.+ ...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~----~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYED----GKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecC----Cce
Confidence 4677888888999999999999765 4788999999765221 24567666555 89999999999877 567
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE-cCCCcEEEEecCCcc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-DENLNAKITDLGMAK 379 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll-~~~~~vkl~DFGla~ 379 (460)
.++|||.+.++-|.+.+.... .+. ..+..|+.+|+.|+.|||.++ ++||||||+|||+ ++.++++|+|||.++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence 799999999998888876532 233 778889999999999999998 9999999999999 689999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
..+.+- ...+-|..|.|||++....|++.+|+||||++||+|++|+.||..-..
T Consensus 465 ~~~~~~--------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 465 ELERSC--------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred hCchhh--------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 776551 112456789999999999999999999999999999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-30 Score=233.38 Aligned_cols=216 Identities=24% Similarity=0.295 Sum_probs=171.0
Q ss_pred cccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccceEEEE
Q 012599 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMRLLV 304 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~~~lV 304 (460)
+..+.||-|.||.||...+. +|+.||.|++.... .....+.+.+|+.+|..++|.|++..+++..-... --.+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 44578999999999999874 69999999886432 22234558899999999999999998876532211 11245788
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
+|.| ..+|...|-. .+.++...+.-+..||++||.|||+.+ |.||||||.|.|++.|-..||+|||+++..+.+
T Consensus 136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 8888 5678777743 467899999999999999999999998 999999999999999999999999999987665
Q ss_pred CCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhc
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTAT 453 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~ 453 (460)
+ ........-|..|+|||.+++ +.|+...||||.||++.||+-.+..|+...+-...+++.-...
T Consensus 210 ~----~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG 275 (449)
T KOG0664|consen 210 D----RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG 275 (449)
T ss_pred h----hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC
Confidence 4 222333456789999999987 5689999999999999999999999987666555555544433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=248.44 Aligned_cols=200 Identities=31% Similarity=0.443 Sum_probs=159.9
Q ss_pred cccceeeeeCcEE-EEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEE
Q 012599 228 SGSNIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 228 ~~~~~LG~G~fG~-Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
...+.+|.|..|+ ||+|.. +|+.||||++-... .....+|+..|+.- +||||+++++.-.+ +...|+..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d----~qF~YIal 582 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQD----RQFLYIAL 582 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccC----CceEEEEe
Confidence 3346788988865 899988 57899999986432 23367999999888 79999999865333 66889999
Q ss_pred eecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-----CCcEEEEecCCc
Q 012599 306 EFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMA 378 (460)
Q Consensus 306 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-----~~~vkl~DFGla 378 (460)
|.| ..+|.++++.. ......-...+.+..|++.||+|||+.+ ||||||||.||||+- ...++|+|||++
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999 67999999873 1111222456788999999999999998 999999999999975 257999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCc
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~ 442 (460)
+++..+... ........||-+|+|||.+....-+..+||+||||++|+.++ |..||......
T Consensus 659 Kkl~~~~sS--~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 659 KKLAGGKSS--FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cccCCCcch--hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 988665321 233555779999999999999888999999999999999998 59999876544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=214.64 Aligned_cols=208 Identities=20% Similarity=0.301 Sum_probs=170.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.+|+|-++.||.|.. .++++++||++++... +.+.+|+.+|..|. ||||++|+++..+... ..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~S--ktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDPES--KTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCccc--cCc
Confidence 46788899999999999999974 4688999999986533 34889999999996 9999999999888654 367
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEecCCccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKR 380 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~ 380 (460)
.||+||+.+.+..... +.++..++...+.+++.||.|+|++| |.|||+||.|++||. .-..+|+|+|+|..
T Consensus 111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 8999999988777654 45788899999999999999999999 999999999999995 45699999999988
Q ss_pred cccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhh
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTA 452 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~ 452 (460)
+.+.. .......+..|--||++.. ..|+..-|+|||||+|.+|+..+.||+.-.+. .+.|+..|.
T Consensus 183 YHp~~------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIak 248 (338)
T KOG0668|consen 183 YHPGK------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAK 248 (338)
T ss_pred cCCCc------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHH
Confidence 76543 2233345567889998864 56788899999999999999999999865443 345555543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=217.25 Aligned_cols=208 Identities=19% Similarity=0.367 Sum_probs=162.1
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..+.|.+.+.||+|.||.+-+++++. ++.+++|.+.... ....+|.+|...--.| .|.||+.-+++-.+. ...
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt---~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT---SDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhc---Cce
Confidence 34678889999999999999999875 6778889887543 3455699998765555 699999888654432 236
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc--CCCcEEEEecCCc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMA 378 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~--~~~~vkl~DFGla 378 (460)
+++++||+|.|+|.+-+.. .++.+.....++.|+++||+|+|+.+ +||||||.+||||- +...+||+|||+.
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccc
Confidence 7899999999999987754 55788888999999999999999998 99999999999993 4457999999998
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHH
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~ 450 (460)
+....- -....-+..|.+||..... ...+.+|+|.||++++.++||..||+.... .+....+|
T Consensus 171 ~k~g~t--------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~ 238 (378)
T KOG1345|consen 171 RKVGTT--------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEW 238 (378)
T ss_pred cccCce--------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHH
Confidence 765321 1122334568999976432 247789999999999999999999996543 33444444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-25 Score=200.76 Aligned_cols=184 Identities=35% Similarity=0.542 Sum_probs=156.7
Q ss_pred eeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCC
Q 012599 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~g 311 (460)
||+|.+|.||++...+ ++.+++|++...........+.+|+..++.++|++++++++++.. ....++++||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED----ENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec----CCeEEEEEecCCCC
Confidence 6889999999999865 899999999865443234568999999999999999999998876 35779999999999
Q ss_pred CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEecCCccccccCCCCCCC
Q 012599 312 NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCS 390 (460)
Q Consensus 312 sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~~~~~~~~~~~ 390 (460)
+|.+++.... ..+++..+..++.++++++.+||+.+ ++|+||+|+||++++ ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999997542 35899999999999999999999998 999999999999999 89999999999986644321
Q ss_pred CCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHH
Q 012599 391 SSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLEL 429 (460)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~el 429 (460)
......+...|++||..... ..+.++|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 12224466789999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=210.07 Aligned_cols=198 Identities=25% Similarity=0.327 Sum_probs=160.7
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC-CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccceE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMR 301 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~ 301 (460)
+|..+..+|.|.- .|-.+.+. .++.||+|++... ..........+|..++..++|+|+++++.++.-... .-...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555567888887 55555443 4788999988544 223334457899999999999999999988764221 12346
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+|||+| ..+|.+.+. ..++..++..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++..
T Consensus 97 y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 8999999 779999887 34788999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
..+ ...+....|..|.|||++.+..+.+.+||||.||++.||++|+..|..
T Consensus 169 ~~~------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 169 DTD------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred Ccc------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 443 123445677889999999988899999999999999999999999973
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=216.19 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=169.5
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 293 (460)
.+....+.|...++||+|.|++||++.+.. ++.||+|.+.....+. ...+|+++|..+ -+.||+++.+++..
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhcc
Confidence 345566788899999999999999998654 6789999997655444 478999999999 69999999988765
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEE
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKI 372 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl 372 (460)
+....+|+||++..+-.++... ++...+...+..+..||.++|..| ||||||||.|+|.+. -+.-.|
T Consensus 107 ----nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 107 ----NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred ----CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence 4567999999999999888854 678899999999999999999999 999999999999984 456899
Q ss_pred EecCCccccccCC----------------------------------CCC-----CCCCCCccccCCcccCcccccc-CC
Q 012599 373 TDLGMAKRLKADG----------------------------------LPS-----CSSSPARMQGTFGYFAPEYAMV-GR 412 (460)
Q Consensus 373 ~DFGla~~~~~~~----------------------------------~~~-----~~~~~~~~~gt~~y~aPE~~~~-~~ 412 (460)
.|||+|....... +.. .........||++|.|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 9999988221100 000 0011123569999999999875 55
Q ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 413 ASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 413 ~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
.++++||||-||+++-+++++.||.+...+
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccc
Confidence 689999999999999999999999987653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=207.26 Aligned_cols=208 Identities=24% Similarity=0.313 Sum_probs=167.3
Q ss_pred CCcccceeeeeCcEEEEEEEEcCC--cEEEEEEeccCCCCChhHHHHHHHHHHHhcCC----CCccceeeeeeeccCccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDG--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH----CHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~~~~~~~~~ 299 (460)
+|++.+.||+|+||.||++...+. ..+|+|........... .+..|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCc
Confidence 788899999999999999997653 47888888765433332 47788888888863 57778876653 2245
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-----CcEEEEe
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-----LNAKITD 374 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-----~~vkl~D 374 (460)
..++||+.+ |.+|.+.......+.++..+.+.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 679999988 899999886655577999999999999999999999999 9999999999999855 4699999
Q ss_pred cCCccccc--cCCCC--CCCCC-CCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 375 LGMAKRLK--ADGLP--SCSSS-PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 375 FGla~~~~--~~~~~--~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
||+++... ..... ..... ...+.||..|.+++.+.+...+++.|+||++.++.|++.|..||.....
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 99999433 22211 11111 2346699999999999999999999999999999999999999976553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=210.84 Aligned_cols=170 Identities=22% Similarity=0.209 Sum_probs=129.6
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc--CCcEEEEEEeccCC----CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~l~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
...++|...+.||+|+||+||+|.+. +++.+|||++.... .......|.+|+++|++++|+|+++.+...
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 44577899999999999999999875 57888999875331 122345589999999999999998643211
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc-CCCCEEEcCCCcEEEEe
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITD 374 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL-k~~NIll~~~~~vkl~D 374 (460)
...++||||+++++|.. +.. .. ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 23599999999999973 211 11 1467889999999999998 999999 99999999999999999
Q ss_pred cCCccccccCCCCCC---CCCCCccccCCcccCcccccc
Q 012599 375 LGMAKRLKADGLPSC---SSSPARMQGTFGYFAPEYAMV 410 (460)
Q Consensus 375 FGla~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~ 410 (460)
||+++.....+.... ...-....+++.|+|||.+..
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999997765431111 112235678889999998854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=205.37 Aligned_cols=135 Identities=26% Similarity=0.345 Sum_probs=119.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-----C---CCccceeeeeeecc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----H---CHVVPLVGYCSEFR 295 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----H---~nIv~l~g~~~~~~ 295 (460)
.+|.+.++||=|.|++||++.+. +.+.||+|+.+.. ....+..+.||.+|++++ | .+||+|++.|.-..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 67888999999999999999875 4788999999853 334445789999999883 2 46999999999888
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll 364 (460)
..+...++|+|++ |-+|..+|.....+.++...+.+|++||+.||.|||... +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 8888999999999 889999998888889999999999999999999999876 69999999999999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-25 Score=215.37 Aligned_cols=211 Identities=25% Similarity=0.287 Sum_probs=171.4
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC------CCCccce
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH------HCHVVPL 287 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l 287 (460)
|.+.--+....+|.+....|+|-|++|.+|.+.. |+.||||++..... ....=+.|+++|++|+ -.|.++|
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 4444445567889999999999999999998765 78999999985432 2233478999999994 4578888
Q ss_pred eeeeeeccCccceEEEEEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
+-.|.. ...++||+|-+ ..+|.+.|+.... -++.......++.|+.-||.+|-+.+ |+|.||||+|||+++
T Consensus 500 ~r~F~h----knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 500 FRHFKH----KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNE 571 (752)
T ss_pred HHHhhh----cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEecc
Confidence 866554 55789999988 6799999976532 34888899999999999999999998 999999999999997
Q ss_pred C-CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 367 N-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 367 ~-~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
. ..+||+|||.|........+ ...-+--|.|||.+.+-+|+...|+||.||.||||.||+..|......
T Consensus 572 ~k~iLKLCDfGSA~~~~eneit-------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEIT-------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred CcceeeeccCcccccccccccc-------HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 6 45899999999877654421 123345699999999999999999999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-24 Score=219.90 Aligned_cols=202 Identities=27% Similarity=0.408 Sum_probs=170.4
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+.++|+.+..+|.|.+|.|||+++. .++..|||.++-..... ......|+-+++.-+|+||+.++|-+.. +...
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr----~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLR----RDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhh----hcCc
Confidence 4567888899999999999999875 58889999998664432 2336788999999999999999998765 4467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+++|||+.+|+|++.-+.. .++++.++..+.+..++|+.|||+++ -+|||||-.|||+++.+.+|++|||.+-.+
T Consensus 88 wicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh
Confidence 9999999999999977654 56899999999999999999999998 899999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... ......+.||+.|||||+.. .+.|..++|||+.|+...|+---+.|.++.
T Consensus 163 tat-----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl 218 (829)
T KOG0576|consen 163 TAT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL 218 (829)
T ss_pred hhh-----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc
Confidence 432 23345678999999999874 577899999999999999988777775543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=183.90 Aligned_cols=207 Identities=22% Similarity=0.276 Sum_probs=169.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC-CCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~ 301 (460)
..+|..++.||.|+||.+|.|.. .+|+.||+|.-+...... ...-|..+.+.|++ ..|..+..|..+ ...-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp---qL~yEskvY~iL~~g~GiP~i~~y~~e----~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP---QLLYESKVYRILQGGVGIPHIRHYGTE----KDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc---chhHHHHHHHHhccCCCCchhhhhccc----cccc
Confidence 46788899999999999999974 579999999876554322 26788999999975 455555555544 4455
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC---CcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~---~~vkl~DFGla 378 (460)
.+||+.+ |-+|++.+.-.. +.++..+.+.++-|++.-++|+|..+ ++||||||+|+|+.-+ ..+.++|||++
T Consensus 87 vlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccch
Confidence 8999999 889999886543 56999999999999999999999998 9999999999999643 46899999999
Q ss_pred cccccCC--CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 379 KRLKADG--LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 379 ~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
+.+.+.. .+.+........||.+|.+-..+.+...+...|+-|+|.+|....-|..||+.....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 9875532 333455566788999999988888888899999999999999999999999987654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=186.46 Aligned_cols=204 Identities=21% Similarity=0.279 Sum_probs=168.8
Q ss_pred CCcccceeeeeCcEEEEEEE-EcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.|.+.++||+|+||.++.|+ +-+++.||||.-..... .-.+..|....+.| ..+.|..++-+-.+ +..-.|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqe----G~~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQE----GKYNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccc----cchhhh
Confidence 57888999999999999997 45799999997654322 22367888888888 56788877744333 345589
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-----CCcEEEEecCCc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMA 378 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-----~~~vkl~DFGla 378 (460)
|+|.+ |-+|+|.++-+ .+.++..+...+|.|++.-|+|+|++. +|.|||||+|+||.. ...+.|+|||+|
T Consensus 102 VidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99999 88999988754 366999999999999999999999998 999999999999963 335899999999
Q ss_pred cccccCC--CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 379 KRLKADG--LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
+.+.+.. .+.+........||.+||+-..+.+++.+...|+-|||-++++.+-|..||+....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 9886654 23345566678899999999999999999999999999999999999999998654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-23 Score=227.65 Aligned_cols=156 Identities=18% Similarity=0.157 Sum_probs=114.8
Q ss_pred hcCC-CCccceeeeeeecc---CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 012599 278 RLHH-CHVVPLVGYCSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 353 (460)
Q Consensus 278 ~l~H-~nIv~l~g~~~~~~---~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~iv 353 (460)
.++| +||+++++++.... .....+++++||+ +++|.++|+.. ...+++.+++.++.||++||.|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 4445 58888888763322 1223567888988 67999999753 355999999999999999999999998 99
Q ss_pred ecCcCCCCEEEcCCCc-------------------EEEEecCCccccccCCC-------C-C---CCCCCCccccCCccc
Q 012599 354 HRDIKSSNILLDENLN-------------------AKITDLGMAKRLKADGL-------P-S---CSSSPARMQGTFGYF 403 (460)
Q Consensus 354 H~DLk~~NIll~~~~~-------------------vkl~DFGla~~~~~~~~-------~-~---~~~~~~~~~gt~~y~ 403 (460)
||||||+||||+..+. +|++|||+++....... . . .........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999965444 45555555543211000 0 0 000111245788999
Q ss_pred CccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 404 aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
|||++.+..++.++|||||||+||||++|..|+..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 99999999999999999999999999999998753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-21 Score=186.67 Aligned_cols=205 Identities=33% Similarity=0.486 Sum_probs=169.9
Q ss_pred CcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCC-CccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~~~~~l 303 (460)
|...+.||.|+||.||++... ..+++|.+....... ....|.+|+.+++.+.|+ +++++.+++.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec----CCEEEE
Confidence 556688999999999999987 789999998765554 366799999999999888 79999988843 333699
Q ss_pred EEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~~ 381 (460)
+++++.+++|.+++..... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||.+...
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999999977765321 25889999999999999999999998 99999999999999988 7999999999865
Q ss_pred ccCCCCCCC-CCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCS-SSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......... .......++..|+|||.+.. .......|+||+|++++++++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 443322111 12355678999999999987 678999999999999999999999976554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-23 Score=189.20 Aligned_cols=228 Identities=22% Similarity=0.323 Sum_probs=173.5
Q ss_pred cccccccccCCceeecceeeeechHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccC-CCCChhHHHHHH
Q 012599 194 CFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTE 272 (460)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~-~~~~~~~~f~~E 272 (460)
.+..+++.+.+..+..+++.+|+.-+.. +.....+|.+...|..|+|+++ |..+++|+++.. .+.....+|.+|
T Consensus 163 pfkdt~wkgtktr~rdatlsr~~gid~~----~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfnee 237 (448)
T KOG0195|consen 163 PFKDTTWKGTKTRTRDATLSRYTGIDVS----SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEE 237 (448)
T ss_pred cccccccccccccccccccccccCcchh----hhhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcchhhcchhhhh
Confidence 3444555556666666777776654432 2334467889999999999996 556778888654 344555679999
Q ss_pred HHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012599 273 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (460)
Q Consensus 273 i~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~i 352 (460)
.-.|+.+.||||++++|.|.. ...+.++..|||.|+|+..|+....-..+..+.++++.++|+||+|||+.. |-|
T Consensus 238 fp~lrifshpnilpvlgacns----ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~i 312 (448)
T KOG0195|consen 238 FPALRIFSHPNILPVLGACNS----PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMI 312 (448)
T ss_pred CcceeeecCCchhhhhhhccC----CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhh
Confidence 999999999999999999987 456789999999999999998766556888999999999999999999986 445
Q ss_pred EecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCC---CchhHHHHHHHHHHHH
Q 012599 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA---SLMSDVFSFGVVLLEL 429 (460)
Q Consensus 353 vH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwSlGvll~el 429 (460)
.-.-|.++.|+||++.+++|+- +-++.... . ....-.+.||+||.+..++. -...|+|||+++||||
T Consensus 313 pr~~lns~hvmidedltarism-ad~kfsfq--e-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel 382 (448)
T KOG0195|consen 313 PRFYLNSKHVMIDEDLTARISM-ADTKFSFQ--E-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL 382 (448)
T ss_pred hhhhcccceEEecchhhhheec-ccceeeee--c-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence 5667999999999999988762 11111110 0 01122477999999876543 4578999999999999
Q ss_pred HhCCCCCCCCCC
Q 012599 430 ITGRQPIHRSIT 441 (460)
Q Consensus 430 ltG~~Pf~~~~~ 441 (460)
.|.+.||....+
T Consensus 383 ~trevpfadlsp 394 (448)
T KOG0195|consen 383 NTREVPFADLSP 394 (448)
T ss_pred hccccccccCCc
Confidence 999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5e-21 Score=174.77 Aligned_cols=140 Identities=17% Similarity=0.180 Sum_probs=107.9
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC-h-------hHHH-----------------HHHHHHHHhcCCCCc
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-A-------DSVF-----------------LTEVDMLSRLHHCHV 284 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~-~-------~~~f-----------------~~Ei~~l~~l~H~nI 284 (460)
...||+|+||.||+|...+|+.||||+++...... . ...| ..|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999998889999999997542111 1 0112 348999999988876
Q ss_pred cceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCcCCCCEE
Q 012599 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILHRDIKSSNIL 363 (460)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yL-H~~~~~~ivH~DLk~~NIl 363 (460)
.....+.. ...++||||+++++|...... ...++..+...++.|++.+|.+| |+.+ |+||||||+|||
T Consensus 82 ~~p~~~~~------~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILL------KSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEe------cCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 43332211 123899999988877654322 24588999999999999999999 6888 999999999999
Q ss_pred EcCCCcEEEEecCCcccc
Q 012599 364 LDENLNAKITDLGMAKRL 381 (460)
Q Consensus 364 l~~~~~vkl~DFGla~~~ 381 (460)
+++ +.++|+|||++...
T Consensus 151 i~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YHD-GKLYIIDVSQSVEH 167 (190)
T ss_pred EEC-CcEEEEEccccccC
Confidence 984 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=178.04 Aligned_cols=177 Identities=12% Similarity=0.128 Sum_probs=135.9
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChh--HH------HHHHHHHHHhcCCCCccceeeeeee
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--SV------FLTEVDMLSRLHHCHVVPLVGYCSE 293 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~--~~------f~~Ei~~l~~l~H~nIv~l~g~~~~ 293 (460)
....+|...+++|.|+||.||+... ++..+|+|.+......... .. +.+|+..+.++.|++|..+..+...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4478999999999999999999766 5778999999765432221 12 5789999999999999999888654
Q ss_pred ccCc----cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 294 FRGK----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 294 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
.... ....++||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||.||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3211 235789999999999988742 222 24569999999999998 99999999999999988
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHH
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ell 430 (460)
++|+|||.......+.. ...+.....+..+.|+||||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a-----------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA-----------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh-----------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998865532210 011345566778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-20 Score=168.32 Aligned_cols=140 Identities=22% Similarity=0.226 Sum_probs=110.1
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC---------------------h----hHHHHHHHHHHHhcCCCCc
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---------------------A----DSVFLTEVDMLSRLHHCHV 284 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~---------------------~----~~~f~~Ei~~l~~l~H~nI 284 (460)
...||+|++|+||+|.+.+|+.||||+++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998889999999998652110 0 1123578899999999987
Q ss_pred cceeeeeeeccCccceEEEEEeecCCCCHHHH-hccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCE
Q 012599 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 362 (460)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NI 362 (460)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.+||+ .+ |+||||||+||
T Consensus 82 ~~p~~~~~~------~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 82 PVPEPILLK------KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCceEEEec------CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 544433221 23899999988865433 332 347788899999999999999999 88 99999999999
Q ss_pred EEcCCCcEEEEecCCccccc
Q 012599 363 LLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 363 ll~~~~~vkl~DFGla~~~~ 382 (460)
|++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=169.96 Aligned_cols=108 Identities=25% Similarity=0.242 Sum_probs=94.8
Q ss_pred CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012599 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (460)
Q Consensus 311 gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 390 (460)
|+|.++++.. ...+++.+++.++.|++.||.|||+.+ ||+|||+++++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7899999753 356999999999999999999999875 999999999999999 99987654321
Q ss_pred CCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..|++.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 247899999999999999999999999999999999999997543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4e-20 Score=168.17 Aligned_cols=193 Identities=16% Similarity=0.053 Sum_probs=140.6
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh---hHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEE
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA---DSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~---~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+...|+.|+||+||.+.. .+.+++.+.+........ ...|.+|+++|++++ |+++.+++++. ..+++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~lv 76 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHLD 76 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEEE
Confidence 457899999999998776 678888887775433211 225789999999994 58899998751 24899
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc-CCCCEEEcCCCcEEEEecCCcccccc
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL-k~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|||+.|.+|.+.+.. ....++.|++.+|+++|+.+ |+|||| ||.|||+++++.++|+|||++.....
T Consensus 77 meyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 77 RSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred EeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999999998764321 11357789999999999999 999999 79999999999999999999985443
Q ss_pred CCCCCCCCC--------CCccccCCcccCcccccc-CCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 384 DGLPSCSSS--------PARMQGTFGYFAPEYAMV-GRAS-LMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 384 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~-~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
......... ......++.|++|+.... ...+ ...+.++-|.-+|.++|++.|+....+.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 221000000 011224567777774322 2233 5679999999999999999998765543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-19 Score=161.80 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=106.5
Q ss_pred cccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-----CCCCccceeeeeeeccCccceEE
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-----HHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+..+.||+|+||.||. .-.++. .+||+...... ...+.+.+|+.+++.+ +||||++++|++.+..+......
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcC-eEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 222344 47998865432 2345689999999999 57999999999887543333345
Q ss_pred EEEee--cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCcCCCCEEEcC----CCcEEEEe-
Q 012599 303 LVFEF--MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL-EYLHEAAAPRILHRDIKSSNILLDE----NLNAKITD- 374 (460)
Q Consensus 303 lV~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l-~yLH~~~~~~ivH~DLk~~NIll~~----~~~vkl~D- 374 (460)
+|+|| .++|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 89999 5579999999652 25544 35677888777 9999998 999999999999973 34799999
Q ss_pred cCCcc
Q 012599 375 LGMAK 379 (460)
Q Consensus 375 FGla~ 379 (460)
||...
T Consensus 154 ~G~~~ 158 (210)
T PRK10345 154 IGEST 158 (210)
T ss_pred CCCcc
Confidence 55433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.5e-19 Score=190.15 Aligned_cols=200 Identities=22% Similarity=0.246 Sum_probs=156.6
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeecc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFR 295 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~ 295 (460)
+.+.-...|.+.+.||+|++|+||+|...+|+.||+|.-+.....+ |.--.+++.+|+ -+-|..+...+..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~-- 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF-- 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc--
Confidence 3444567788889999999999999999899999999988776554 443445556665 1222232222221
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-------CCC
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-------ENL 368 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-------~~~ 368 (460)
...-+||+||.+.|+|.+++. ..+.|+|.-.+.+..|+++.+++||..+ |||+||||+|+||. ++.
T Consensus 766 --~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 --QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred --CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 223489999999999999998 3467999999999999999999999999 99999999999994 334
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC
Q 012599 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ 434 (460)
Q Consensus 369 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~ 434 (460)
-++|+|||.+-.+..-.. ........+|-.+--+|...++.++.+.|.|.|+-+++-|+.|+.
T Consensus 839 ~l~lIDfG~siDm~lfp~---~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPD---GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceEEEecccceeeeEcCC---CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 589999999876644221 123344567888999999999999999999999999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-18 Score=154.96 Aligned_cols=145 Identities=20% Similarity=0.141 Sum_probs=111.8
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC---------------------ChhHHHHHHHHHHH
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---------------------NADSVFLTEVDMLS 277 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~---------------------~~~~~f~~Ei~~l~ 277 (460)
++......|...+.||+|+||.||++...+|+.||||++...... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 444444457778999999999999999888999999987643210 00112567888899
Q ss_pred hcCCCC--ccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012599 278 RLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (460)
Q Consensus 278 ~l~H~n--Iv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~ 355 (460)
.+.|++ +.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ |+|+
T Consensus 89 ~l~~~~i~v~~~~~~--------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~ 149 (198)
T cd05144 89 ALYEEGFPVPKPIDW--------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHG 149 (198)
T ss_pred HHHHcCCCCCceeec--------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcC
Confidence 998774 4444432 234899999999998765431 234678899999999999988 9999
Q ss_pred CcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 356 DIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 356 DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
||||+||++++++.++|+|||++....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.6e-18 Score=160.61 Aligned_cols=202 Identities=21% Similarity=0.286 Sum_probs=131.1
Q ss_pred ccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCC----------CCccceeeeeee--
Q 012599 229 GSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHH----------CHVVPLVGYCSE-- 293 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H----------~nIv~l~g~~~~-- 293 (460)
..+.||.|+++.||.+++.+ ++.+|||.+..... ....+.+.+|......+.+ -.++--++....
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 35789999999999999875 89999999865432 2334456666654444322 112211222111
Q ss_pred ------ccC--ccc---eEEEEEeecCCCCHHHHhccc---cC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCc
Q 012599 294 ------FRG--KRA---MRLLVFEFMPNGNLRDCLDGV---LV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (460)
Q Consensus 294 ------~~~--~~~---~~~lV~e~~~~gsL~~~l~~~---~~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DL 357 (460)
... ... ..+++|+-+ .+||.+++..- .. ..+....++.+..|+.+.+++||+.+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 000 111 347888888 77998886431 11 12345566778899999999999999 999999
Q ss_pred CCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc--------CCCCchhHHHHHHHHHHHH
Q 012599 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--------GRASLMSDVFSFGVVLLEL 429 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlGvll~el 429 (460)
+|+|+|++++|.++|+||+........... ...+..|.+||.... ..++.+.|.|+||+++|.|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG--------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec--------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999887665432110 123467999997643 2468899999999999999
Q ss_pred HhCCCCCCCCCCc
Q 012599 430 ITGRQPIHRSITK 442 (460)
Q Consensus 430 ltG~~Pf~~~~~~ 442 (460)
+.|..||......
T Consensus 244 WC~~lPf~~~~~~ 256 (288)
T PF14531_consen 244 WCGRLPFGLSSPE 256 (288)
T ss_dssp HHSS-STCCCGGG
T ss_pred HHccCCCCCCCcc
Confidence 9999999876544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-19 Score=186.94 Aligned_cols=204 Identities=23% Similarity=0.289 Sum_probs=154.1
Q ss_pred cccceeeeeCcEEEEEEEEcC-CcEEEEEEecc----CCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 228 SGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKT----QGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~----~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.....+|.|.+|.|+...... .+..+.|.... ... ......+..|+-+-..++|+|++..+..+.+... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----I 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc----c
Confidence 345789999999887775432 33344443321 111 1111114456666678899999888766655322 2
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+-+|||+++ +|..++... ..++..++-.++.|+..|+.|+|+.+ |.|||||++|++++.++.+||+|||.+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence 334999999 999999753 35888999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASL-MSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
..+.... ......+.|+..|+|||.+....|.+ ..||||.|+++..|.+|+.||......
T Consensus 471 ~~~~e~~-~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 471 RYPWEKN-IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred ccCcchh-hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 5543221 23445578999999999999998865 589999999999999999999876544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-17 Score=153.26 Aligned_cols=135 Identities=20% Similarity=0.315 Sum_probs=110.5
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh-------hHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+.||+|++|.||+|.. .|..+++|.......... ...+.+|++++..++|+++.....++.. ....++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD----PENFII 76 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe----CCCCEE
Confidence 5799999999999987 677899998764332111 1347789999999999998776666554 234589
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+|||+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999998642 22 78899999999999999998 99999999999999 78999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=157.16 Aligned_cols=149 Identities=19% Similarity=0.148 Sum_probs=112.4
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEE--EcCCcEEEEEEeccCCCCC-----------------------hhHHHHHHHH
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPN-----------------------ADSVFLTEVD 274 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~--~~~g~~vaVK~l~~~~~~~-----------------------~~~~f~~Ei~ 274 (460)
|..-..-|++.+.||+|+||.||+|. ..+|+.||+|.++...... ....+..|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33333457788999999999999998 5679999999987542110 0123568999
Q ss_pred HHHhcCCCC--ccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012599 275 MLSRLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (460)
Q Consensus 275 ~l~~l~H~n--Iv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~i 352 (460)
.+.++.+.. +.+++++. ..++||||+++.+|..+.... ..+...+...++.|++.++++||+.+ +|
T Consensus 103 ~L~~L~~~~i~~p~~~~~~--------~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~i 170 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAWR--------RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--EL 170 (237)
T ss_pred HHHHHHhcCCCCCeeeEec--------CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence 999997533 33444321 238999999998887765321 23566667899999999999999886 49
Q ss_pred EecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 353 LHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 353 vH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+||||||+||+++ ++.++|+|||.+...
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.1e-17 Score=150.83 Aligned_cols=132 Identities=22% Similarity=0.328 Sum_probs=103.9
Q ss_pred eeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh-------hHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+||+|+||.||+|.. ++..+++|.......... ...+.+|++++..++|+++.....++.. ....++|
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD----PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----CCCCEEE
Confidence 489999999999986 578899998654322111 2346789999999988875544434333 2245899
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|||+++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++...
T Consensus 76 ~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999999875421 1 78999999999999998 99999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=174.15 Aligned_cols=143 Identities=19% Similarity=0.279 Sum_probs=111.5
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEe-ccCCCC------ChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRF-KTQGGP------NADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l-~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 292 (460)
.......|...+.||+|+||.||+|.+.... +++|+. ...... ...+.+.+|+++++.++|++++....++.
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 3334455566789999999999999886544 444433 221111 11245789999999999999988776665
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
+ ....++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|
T Consensus 407 ~----~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 407 D----PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred e----CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 4 234589999999999999885 35678999999999999998 9999999999999 6779999
Q ss_pred EecCCcccc
Q 012599 373 TDLGMAKRL 381 (460)
Q Consensus 373 ~DFGla~~~ 381 (460)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.3e-19 Score=178.38 Aligned_cols=186 Identities=27% Similarity=0.310 Sum_probs=150.3
Q ss_pred eeeeCcEEEEEEE----EcCCcEEEEEEeccCCCCChhH-HHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEEEe
Q 012599 233 VGQGGSSYVYRGQ----LTDGRIVAVKRFKTQGGPNADS-VFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 233 LG~G~fG~Vy~~~----~~~g~~vaVK~l~~~~~~~~~~-~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+|+|.||.|++.. .+.+..+|.|.+++........ ....|..++...+ ||.++++.-.+.. +...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----DGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----ccchhHhhh
Confidence 6899999999763 2346778888887654332221 3456778888886 9999998754443 445689999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|..+|+|...+... ..++..........+|-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999999888653 34677777778888999999999999 99999999999999999999999999987644321
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.+||..|||||.+. ......|.||||++++||+||..||..
T Consensus 153 ---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 17899999999887 667789999999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-18 Score=182.18 Aligned_cols=202 Identities=23% Similarity=0.207 Sum_probs=149.2
Q ss_pred CCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHH--HhcCCCCccceeeeeeeccCccceEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDML--SRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l--~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++...+.||.+.|=+|.+|++++|. |+||++-.+...-..+.|.++++-+ ..++|||.+++.-+-.. +...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t----~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT----DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh----hHHHHH
Confidence 5566688999999999999999998 8999987665444444565555444 44589999998755332 445578
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc-c
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-K 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~-~ 382 (460)
|-+|. .-+|+|.|... .-+...+...|+.|++.||..+|+.+ |+|||||.+||||+.-.=+.|+||..-+-. -
T Consensus 99 vRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 99 VRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 88888 45899988653 33777888999999999999999999 999999999999999888999999764321 1
Q ss_pred cCCCCCCCCCC-CccccCCcccCccccccC-----------CCCchhHHHHHHHHHHHHHh-CCCCCCC
Q 012599 383 ADGLPSCSSSP-ARMQGTFGYFAPEYAMVG-----------RASLMSDVFSFGVVLLELIT-GRQPIHR 438 (460)
Q Consensus 383 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwSlGvll~ellt-G~~Pf~~ 438 (460)
+.+.|....-. -.-.....|.|||.+... ..+++.||||+||++.||++ |++||.-
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 12222211000 000122469999987431 26889999999999999998 8888863
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=158.10 Aligned_cols=152 Identities=22% Similarity=0.293 Sum_probs=116.9
Q ss_pred CCCCccceeeeeee-----------------------ccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHH
Q 012599 280 HHCHVVPLVGYCSE-----------------------FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336 (460)
Q Consensus 280 ~H~nIv~l~g~~~~-----------------------~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 336 (460)
+|||||++.+.+.+ ..+.+..+|+||.-. ..+|.+|+.. +..+......++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHH
Confidence 49999999987744 112345689999988 5599999975 44677788889999
Q ss_pred HHHHHHHHHhCCCCCeEecCcCCCCEEEc--CCC--cEEEEecCCccccccCCCCCCCC-CCCccccCCcccCccccccC
Q 012599 337 AARGLEYLHEAAAPRILHRDIKSSNILLD--ENL--NAKITDLGMAKRLKADGLPSCSS-SPARMQGTFGYFAPEYAMVG 411 (460)
Q Consensus 337 ia~~l~yLH~~~~~~ivH~DLk~~NIll~--~~~--~vkl~DFGla~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 411 (460)
+++|+.|||+++ |.|||+|++||||. +|. ..+|+|||.+---+..+..-... ..-...|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 99999999999983 443 47899999876444433322222 22334577889999987542
Q ss_pred C------CCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 412 R------ASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 412 ~------~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+ .-.|.|.|+.|-+.||+++...||..
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 2 24589999999999999999999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=140.98 Aligned_cols=137 Identities=24% Similarity=0.265 Sum_probs=97.6
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC-hhHH----------------------HHHHHHHHHhcCCC--Cc
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-ADSV----------------------FLTEVDMLSRLHHC--HV 284 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~-~~~~----------------------f~~Ei~~l~~l~H~--nI 284 (460)
.+.||+|+||+||+|.+.+++.||||++....... .... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987532111 1111 12455566666433 24
Q ss_pred cceeeeeeeccCccceEEEEEeecCCCCHHHH-hccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCE
Q 012599 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 362 (460)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NI 362 (460)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+|+||||+||
T Consensus 82 ~~~~~~--------~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDL--------NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CceEec--------CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 444432 134899999998543321 11110 11 5678899999999999998 77 99999999999
Q ss_pred EEcCCCcEEEEecCCccccc
Q 012599 363 LLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 363 ll~~~~~vkl~DFGla~~~~ 382 (460)
+++ ++.++|+|||.+....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-16 Score=161.69 Aligned_cols=166 Identities=22% Similarity=0.386 Sum_probs=131.3
Q ss_pred HHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012599 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (460)
Q Consensus 276 l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~ 355 (460)
|+.+.|.|+.+++|.+.+. ...++|.+|++.|+|.+.+.. ....++|.....+.++++.||+|||+.. -..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~----~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG----PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC----CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence 3568899999999999983 567999999999999999976 3356999999999999999999999754 23999
Q ss_pred CcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-------CCCchhHHHHHHHHHHH
Q 012599 356 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLE 428 (460)
Q Consensus 356 DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwSlGvll~e 428 (460)
.+++.|+++|..+.+||+|||+.......... .......-...|.|||.+... ..+.+.||||||++++|
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~---~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP---EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccc---cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999999999999999998776431110 111112234679999988653 24777999999999999
Q ss_pred HHhCCCCCCCCCCcCc-hhHHHHh
Q 012599 429 LITGRQPIHRSITKGE-ESLVLWT 451 (460)
Q Consensus 429 lltG~~Pf~~~~~~~~-~~l~~~~ 451 (460)
+++.+.||.......+ ..++.++
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~ 174 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRV 174 (484)
T ss_pred HHhccCccccccccCChHHHHHHH
Confidence 9999999987543322 4555553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-15 Score=131.64 Aligned_cols=135 Identities=21% Similarity=0.194 Sum_probs=111.1
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccceEEEEEe
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.+++++... ....+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES----DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----CCccEEEEE
Confidence 34679999999999999855 7799998865433 3458899999999976 588888876654 246799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
|++++.+..+ +......++.+++.++++||....++++|+|++|+||++++++.++++|||.+..
T Consensus 74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9988766643 5567788899999999999986545699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.7e-15 Score=140.32 Aligned_cols=139 Identities=17% Similarity=0.196 Sum_probs=106.0
Q ss_pred ceee-eeCcEEEEEEEEcCCcEEEEEEeccCC------------CCChhHHHHHHHHHHHhcCCCCc--cceeeeeeecc
Q 012599 231 NIVG-QGGSSYVYRGQLTDGRIVAVKRFKTQG------------GPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEFR 295 (460)
Q Consensus 231 ~~LG-~G~fG~Vy~~~~~~g~~vaVK~l~~~~------------~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~ 295 (460)
..|| .|+.|+||++... +..++||++.... .......+.+|++++..++|+++ .+.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8999999999885 6779999885321 11223457889999999988875 66776644322
Q ss_pred CccceEEEEEeecCC-CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEe
Q 012599 296 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~D 374 (460)
......++|||++++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 212233699999997 699998864 234443 3578999999999999 99999999999999988999999
Q ss_pred cCCccc
Q 012599 375 LGMAKR 380 (460)
Q Consensus 375 FGla~~ 380 (460)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.1e-16 Score=164.10 Aligned_cols=173 Identities=23% Similarity=0.376 Sum_probs=122.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|..+++|..|++|.||..++.. .+.+|.| +++++. ++ +||+.+.+ ..+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l------il-----------Rnilt~a~----------npf 133 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL------IL-----------RNILTFAG----------NPF 133 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch------hh-----------hccccccC----------Ccc
Confidence 3678888999999999999998764 4556663 222211 11 12333321 223
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+| ||-...++.. ..+.- +++.+++|||+.+ |+|||+||+|.+|+.-+++|+.|||+++..-
T Consensus 134 vv------gDc~tllk~~--g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 134 VV------GDCATLLKNI--GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ee------chhhhhcccC--CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhh
Confidence 33 4444444432 22221 2278899999998 9999999999999999999999999987532
Q ss_pred cCCCC--------C--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcC
Q 012599 383 ADGLP--------S--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443 (460)
Q Consensus 383 ~~~~~--------~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~ 443 (460)
...-+ . ........+||+.|.|||++....|...+|+|++|+++||.+.|..||+...+++
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 11100 0 1112334689999999999999999999999999999999999999999885544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.6e-16 Score=157.15 Aligned_cols=126 Identities=25% Similarity=0.375 Sum_probs=108.3
Q ss_pred eEEEEEeecCCCCHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 300 MRLLVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
.+++.|+++...+|.+||.. ......++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999963 344668899999999999999999 56 999999999999999999999999999
Q ss_pred cccccCCCCCC-CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 379 KRLKADGLPSC-SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 379 ~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
..........+ ........||..||+||.+.+..|+.|+||||||++|+||++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87765542111 123344679999999999999999999999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.1e-14 Score=144.52 Aligned_cols=151 Identities=23% Similarity=0.231 Sum_probs=105.7
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh------------------------------------
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA------------------------------------ 265 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~------------------------------------ 265 (460)
.....|+ .+.||.|++|+||+|++.+|+.||||+.+.......
T Consensus 115 ~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 193 (437)
T TIGR01982 115 ELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKT 193 (437)
T ss_pred HHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHH
Confidence 3444555 368999999999999999999999999875421100
Q ss_pred ---hHHHHHHHHHHHhc----CCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHH
Q 012599 266 ---DSVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338 (460)
Q Consensus 266 ---~~~f~~Ei~~l~~l----~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia 338 (460)
+-+|.+|...+.++ +|.+-+.+..++.+.. ...+|||||++|++|.++..... ... .+..++.+++
T Consensus 194 l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~ 266 (437)
T TIGR01982 194 LRRELDLRREAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLA 266 (437)
T ss_pred HHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHH
Confidence 00244455555544 2344444444444322 23589999999999998765321 122 2345666666
Q ss_pred H-HHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 339 R-GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 339 ~-~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
. .+..+|..+ ++|+|++|.||+++++++++++|||++..+..
T Consensus 267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 467889888 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9e-15 Score=154.84 Aligned_cols=209 Identities=27% Similarity=0.327 Sum_probs=160.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC--CcEEEEEEeccCC-CCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~ 300 (460)
..|...+.||+|.|+.|-...... ...+|+|.+.... ..........|..+-..+. |+|++.+++...+ ...
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----~~~ 95 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----PRS 95 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----Ccc
Confidence 345566779999999999887643 4456666665443 1222222344666666775 9999999977655 556
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRILHRDIKSSNILLDENL-NAKITDLGMA 378 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH-~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla 378 (460)
.+++++|..++++.+-+.......++....-..+.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 799999999999998883222224667777888999999999999 877 99999999999999999 9999999999
Q ss_pred ccccc-CCCCCCCCCCCcccc-CCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcC
Q 012599 379 KRLKA-DGLPSCSSSPARMQG-TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKG 443 (460)
Q Consensus 379 ~~~~~-~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~ 443 (460)
..+.. .+. .......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.......
T Consensus 173 t~~~~~~g~---~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 173 TAYRNKNGA---ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccccCCc---ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 88766 332 223334566 9999999988874 55778999999999999999999998776543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-12 Score=134.42 Aligned_cols=153 Identities=18% Similarity=0.199 Sum_probs=99.6
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC---------------------------------h
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN---------------------------------A 265 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~---------------------------------~ 265 (460)
++.....|+. +.||.|++|+||+|++.+ |+.||||+.++.-.+. .
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 4445567776 789999999999999987 9999999997542100 0
Q ss_pred h------HHHHHHHHHHHhc----CCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHH
Q 012599 266 D------SVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335 (460)
Q Consensus 266 ~------~~f~~Ei~~l~~l----~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 335 (460)
. -+|.+|...+.++ .+.+.+.+-.++.+. ....+|||||++|+.|.++-.- .....+... ++.
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~---la~ 266 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAAL-RAAGTDMKL---LAE 266 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHH-HhcCCCHHH---HHH
Confidence 0 1244455445444 244555555555443 2245899999999999875321 112222221 121
Q ss_pred HHH-HHHHHHHhCCCCCeEecCcCCCCEEEcCCC----cEEEEecCCcccccc
Q 012599 336 GAA-RGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKITDLGMAKRLKA 383 (460)
Q Consensus 336 qia-~~l~yLH~~~~~~ivH~DLk~~NIll~~~~----~vkl~DFGla~~~~~ 383 (460)
..+ .-+..+...+ ++|+|+||.||+++.++ .++++|||++..+..
T Consensus 267 ~~v~~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 267 RGVEVFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 111 1123344566 99999999999999888 999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.3e-12 Score=112.68 Aligned_cols=130 Identities=17% Similarity=0.103 Sum_probs=95.7
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceEEEEEeecC
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
+.|+.|.++.||++... +..+++|........ ...+..|..+++.+.+.+++ +++++.. ...++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~------~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP------ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC------CCCeEEEEecC
Confidence 56888999999999875 778999987654321 22367899999988665554 4444322 12379999999
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~--~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+.++.+. . . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 75 G~~l~~~------~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE------D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc------c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9877643 0 1 11345678999999999876 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.4e-11 Score=109.11 Aligned_cols=146 Identities=21% Similarity=0.233 Sum_probs=109.9
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccceEEEEEeec
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
+.|+.|.++.||++...+|+.+++|.............+..|.+++..+.+ .++.+++.+..... .....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCceEEEEEe
Confidence 568899999999999877788999997654332233457899999999965 34567777654321 112458999999
Q ss_pred CCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012599 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 348 (460)
Q Consensus 309 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~---------------------------------------- 348 (460)
++.++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99888775532 34677788888889999999998531
Q ss_pred -------------CCCeEecCcCCCCEEEcC--CCcEEEEecCCccc
Q 012599 349 -------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (460)
Q Consensus 349 -------------~~~ivH~DLk~~NIll~~--~~~vkl~DFGla~~ 380 (460)
...++|+|++++||++++ +..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.2e-10 Score=104.19 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=97.7
Q ss_pred ceeeeeCcEEEEEEEEcC-------CcEEEEEEeccCCC---------------------CChhHHHH----HHHHHHHh
Q 012599 231 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGG---------------------PNADSVFL----TEVDMLSR 278 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------g~~vaVK~l~~~~~---------------------~~~~~~f~----~Ei~~l~~ 278 (460)
..||.|-.+.||.|...+ +..+|||+.+.... ......+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47899998864311 01122233 78999998
Q ss_pred cCC--CCccceeeeeeeccCccceEEEEEeecCCCCHHH-HhccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEe
Q 012599 279 LHH--CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-CLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILH 354 (460)
Q Consensus 279 l~H--~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~qia~~l~yL-H~~~~~~ivH 354 (460)
+.. -++.+++++- ..+|||||+.+..+.. .++. ..++..+...+..+++.+|..| |+.+ |+|
T Consensus 83 l~~~Gv~vP~pi~~~--------~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVLK--------KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHcCCCCCeEEEec--------CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 853 4566666541 2389999997654422 2222 1244556677889999999998 8888 999
Q ss_pred cCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 355 RDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 355 ~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+||++.|||+++ +.+.|+|||.+-..
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 999999999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.6e-10 Score=98.77 Aligned_cols=145 Identities=17% Similarity=0.222 Sum_probs=102.5
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEec-cCCCC-C-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGGP-N-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~-~~~~~-~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.+.++-+|+.+.|+++.+ .|+..+||.-. +.... . .....++|...+.+.+--.|.--.=++.+.. .-
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----GG 85 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC----CC
Confidence 457899999999999998 47776776433 22111 1 1223667888888886444432222333422 23
Q ss_pred EEEEeecCC-CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC---cEEEEecCC
Q 012599 302 LLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGM 377 (460)
Q Consensus 302 ~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~---~vkl~DFGl 377 (460)
.|+|||+++ -++.+|+...............++.+|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||+
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence 799999965 38899987655444444444788999999999999998 99999999999996554 468999999
Q ss_pred cccc
Q 012599 378 AKRL 381 (460)
Q Consensus 378 a~~~ 381 (460)
+...
T Consensus 163 s~~s 166 (229)
T KOG3087|consen 163 SSVS 166 (229)
T ss_pred hhcc
Confidence 8654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-10 Score=118.08 Aligned_cols=166 Identities=19% Similarity=0.259 Sum_probs=120.6
Q ss_pred EcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCC
Q 012599 246 LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 325 (460)
Q Consensus 246 ~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l 325 (460)
..++.+|.|...+.... .......+-++.|+.++||||++++..... ....|||+|-+ .-|..+++..
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----~~~~ylvTErV--~Pl~~~lk~l----- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE----EGTLYLVTERV--RPLETVLKEL----- 101 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc----cCceEEEeecc--ccHHHHHHHh-----
Confidence 34577888888776544 333446788899999999999999976655 45789999987 3577777542
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCc
Q 012599 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405 (460)
Q Consensus 326 ~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aP 405 (460)
.....-.-+.||+.||.|||+.+ .++|++|..+-|++++.|+.||++|.++........+... ..--..|..|
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~-----~~~~~s~~~P 174 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS-----LYLIESFDDP 174 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc-----chhhhcccCh
Confidence 34455567789999999999765 4999999999999999999999999988654332211100 0111236666
Q ss_pred cccccCCCCchhHHHHHHHHHHHHHhC
Q 012599 406 EYAMVGRASLMSDVFSFGVVLLELITG 432 (460)
Q Consensus 406 E~~~~~~~~~~sDVwSlGvll~elltG 432 (460)
+.+.... -..|.|-||+++||++.|
T Consensus 175 ~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCccc--cchhhhhHHHHHHHHhCc
Confidence 6443222 345999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-11 Score=122.44 Aligned_cols=203 Identities=23% Similarity=0.270 Sum_probs=153.5
Q ss_pred cCCcccceeee--eCcEEEEEEEE---cCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012599 225 DKFSGSNIVGQ--GGSSYVYRGQL---TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 225 ~~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 297 (460)
..|.+.+-+|. |.+|.||.+.. .++..+|+|+-+.... +.....-++|+...+++ .|+|.++.......
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~---- 189 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG---- 189 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----
Confidence 34556678999 99999999987 3578899998543322 22222345677777777 49999985544333
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKI 372 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~----~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vkl 372 (460)
....++-+|++ +.+|.++..... ..+.....+....+... |+.++|+.. ++|-|+||.||++.++ ...++
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 44557777777 689999887532 33666777777777777 999999988 9999999999999999 88999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
+|||+...+.............+..+...|++||+. .+.++..+|+|++|.+..+..++..++.
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence 999999988877655544444454677889999954 5778889999999999999888766543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.2e-11 Score=111.85 Aligned_cols=159 Identities=19% Similarity=0.304 Sum_probs=117.4
Q ss_pred HHHhcCCCCccceeeeeeeccC-ccceEEEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012599 275 MLSRLHHCHVVPLVGYCSEFRG-KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (460)
Q Consensus 275 ~l~~l~H~nIv~l~g~~~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ 351 (460)
-+-.+.|.|||++..|..+... ......++.|||+-|+|.++|++.. ...+......++..||..||.|||+.. |+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 4445679999999988776544 3445678999999999999997643 234677778899999999999999985 77
Q ss_pred eEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 352 ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
|+|+++..+.|++..++-+|+.--- .......-............+-++|.+||+-.....+..+|||+||+..+||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999988888875311 111110000000111222345688999998777778889999999999999988
Q ss_pred CCCC
Q 012599 432 GRQP 435 (460)
Q Consensus 432 G~~P 435 (460)
+..-
T Consensus 278 lEiq 281 (458)
T KOG1266|consen 278 LEIQ 281 (458)
T ss_pred heec
Confidence 7764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.6e-09 Score=103.86 Aligned_cols=146 Identities=18% Similarity=0.142 Sum_probs=103.8
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC----------hhHHHHHHHHHHHhcCCC--CccceeeeeeeccCc-
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGK- 297 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~----------~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~- 297 (460)
+.+-+-....|++..+ +|+.+.||+........ ....+.+|...+..+... ...+++++.......
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455445555778766 67889999775433111 111377899988888433 344556665432111
Q ss_pred cceEEEEEeecCCC-CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-------CCc
Q 012599 298 RAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-------NLN 369 (460)
Q Consensus 298 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-------~~~ 369 (460)
...-+||+|++++- +|.+++........+......++.+++..+.-||..+ |+|+|+++.|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23458999999876 8999986433344566777899999999999999999 999999999999975 568
Q ss_pred EEEEecCCccc
Q 012599 370 AKITDLGMAKR 380 (460)
Q Consensus 370 vkl~DFGla~~ 380 (460)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.1e-09 Score=96.86 Aligned_cols=131 Identities=24% Similarity=0.354 Sum_probs=93.7
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEec-cCCC-CChh-----HHHHHHHHHHHhcCCCCc--cceeeeeeeccCccceE
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGG-PNAD-----SVFLTEVDMLSRLHHCHV--VPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~-~~~~-~~~~-----~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~~~~ 301 (460)
..+++|+-+.+|.+.+. |.++++|.=. +... +..+ ..-.+|..++++.+--.| ..++.+ + ....
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D----~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D----PDNG 74 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c----CCCC
Confidence 35788999999999774 4446666432 2221 2221 124578888888854433 333332 3 2344
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
.++|||+++..|.+++... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+...
T Consensus 75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 8999999999999998653 2556777778888899999 99999999999998775 999999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.6e-09 Score=95.22 Aligned_cols=126 Identities=26% Similarity=0.281 Sum_probs=81.2
Q ss_pred EEEEEEEcCCcEEEEEEeccCCC------------CC--------h-----hHHHHHHHHHHHhcCCC--Cccceeeeee
Q 012599 240 YVYRGQLTDGRIVAVKRFKTQGG------------PN--------A-----DSVFLTEVDMLSRLHHC--HVVPLVGYCS 292 (460)
Q Consensus 240 ~Vy~~~~~~g~~vaVK~l~~~~~------------~~--------~-----~~~f~~Ei~~l~~l~H~--nIv~l~g~~~ 292 (460)
.||.|...+|..+|||..+.... .. . .....+|.+.|.++... ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999999999999998875311 00 0 11256799999999765 456666442
Q ss_pred eccCccceEEEEEeecC--CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 293 EFRGKRAMRLLVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY-LHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~y-LH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
...|||||++ +..+....... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .
T Consensus 80 -------~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 -------RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp -------TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred -------CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 1289999998 54444333221 1234456677777775555 57887 9999999999999988 9
Q ss_pred EEEEecCCcccc
Q 012599 370 AKITDLGMAKRL 381 (460)
Q Consensus 370 vkl~DFGla~~~ 381 (460)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=7.6e-08 Score=88.00 Aligned_cols=143 Identities=21% Similarity=0.153 Sum_probs=106.1
Q ss_pred eeeCcEEEEEEEEcCCcEEEEEEeccC--CC---CChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccceEEEEEe
Q 012599 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQ--GG---PNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 234 G~G~fG~Vy~~~~~~g~~vaVK~l~~~--~~---~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
|+||.+.|++-.+. |+.+-+|+-... .+ +.....|.+|+..+..+.. -.+.+++............-+||+|
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 55888899998774 457888877522 11 4455679999999999853 3345555222222222345689999
Q ss_pred ecCC-CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc--EEEEecCCccc
Q 012599 307 FMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 380 (460)
Q Consensus 307 ~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~--vkl~DFGla~~ 380 (460)
-+++ -+|.+++......+.+...+..++.+++..+.-||..+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7753 58999987654455678888899999999999999999 999999999999986666 99999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=9.8e-10 Score=112.25 Aligned_cols=198 Identities=22% Similarity=0.220 Sum_probs=146.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc--CCcEEEEEEeccCCCCChhHH-HHHHHHHHHhc-CCCCccceeeeeeecc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~l~~~~~~~~~~~-f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 295 (460)
....+.+|..+..||.|.|+.|++...+ ++..+++|.+.........+. -+.|+.+...+ .|.++++......+.
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~- 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL- 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-
Confidence 4455678899999999999999998644 577899998876543333222 35666666666 588888766443332
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEEEEe
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITD 374 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vkl~D 374 (460)
...++=-||++++++...+. ....++...++.+..|++.++.++|+.. ++|+|++|+||++..+ +.-+++|
T Consensus 339 ---r~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 339 ---RQGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ---ccccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 23468889999998887762 3345788889999999999999999888 9999999999999876 7889999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCccc--CccccccCCCCchhHHHHHHHHHHHHHhCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYF--APEYAMVGRASLMSDVFSFGVVLLELITGRQ 434 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDVwSlGvll~elltG~~ 434 (460)
||....+.... .......+++ +|+......+..+.|++|||.-+.|..++..
T Consensus 411 ~~~~t~~~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 411 FGCWTRLAFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccccceec--------ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 99886532211 1111223344 5555567788999999999999999888665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.1e-08 Score=98.74 Aligned_cols=172 Identities=19% Similarity=0.260 Sum_probs=130.5
Q ss_pred CcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCC-CCHH
Q 012599 237 GSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN-GNLR 314 (460)
Q Consensus 237 ~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~-gsL~ 314 (460)
...+.||+.. .||..+++|++.........+ .-.-+++++++.|.|+|++..++......+..+++||+|.|+ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK-DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCccc-chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467888864 479999999994332222111 234578899999999999999887555556788999999986 4777
Q ss_pred HHhcccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 315 DCLDGVL-------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 315 ~~l~~~~-------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++--... ....++..++.++.|++.||.++|+.| +.-+-|.+++|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 6652211 123667889999999999999999999 999999999999999999999999988876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ 434 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~ 434 (460)
..+.. |-+ .-..+-|.=.||.++..|.||..
T Consensus 444 ~~d~~-------------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 444 QEDPT-------------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cCCCC-------------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 55431 000 11336799999999999999854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.7e-08 Score=91.11 Aligned_cols=109 Identities=28% Similarity=0.304 Sum_probs=86.5
Q ss_pred HHHHHHHHHHHhcC--CCCccceeeeeeeccCccceEEEEEeecCCC-CHHHHhccccCCCCCHHHHHHHHHHHHHHHHH
Q 012599 267 SVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343 (460)
Q Consensus 267 ~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~y 343 (460)
....+|...+..+. .-.+.+.+++..........-++|+|++++- +|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 34778888888874 3345677777665333334558999999874 89999976332 5667788999999999999
Q ss_pred HHhCCCCCeEecCcCCCCEEEcCCC---cEEEEecCCccc
Q 012599 344 LHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKR 380 (460)
Q Consensus 344 LH~~~~~~ivH~DLk~~NIll~~~~---~vkl~DFGla~~ 380 (460)
||..+ |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.7e-08 Score=103.22 Aligned_cols=153 Identities=20% Similarity=0.225 Sum_probs=101.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChh---------------------------------
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--------------------------------- 266 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~--------------------------------- 266 (460)
++....+|+. +.|+.++-|+||+|++.+|+.||||+.++.-.+...
T Consensus 121 iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 121 IEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred HHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 4444555553 679999999999999999999999988764221100
Q ss_pred ------HHHHHHHHHHHhc----CCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHH
Q 012599 267 ------SVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336 (460)
Q Consensus 267 ------~~f~~Ei~~l~~l----~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q 336 (460)
-++.+|...+.++ ++..-+.+-.++++.. ....|+|||++|-.+.+...-.. ..++...+. ..
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t---~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~ 272 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT---TRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---EL 272 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc---CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HH
Confidence 0134444444444 3333444555555432 24589999999998888753222 445633333 33
Q ss_pred HHHH-HHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 337 AARG-LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 337 ia~~-l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
++++ +..+-..+ ++|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus 273 ~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 273 LVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3222 22333346 99999999999999999999999999886644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2e-09 Score=115.78 Aligned_cols=208 Identities=22% Similarity=0.247 Sum_probs=134.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+.|.+.+-+-.|.++.++.+.-.. |...+.|...... .....+....+-.++-..++|-++...-- .......
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s----~~~rsP~ 879 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS----FPCRSPL 879 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC----CCCCCCc
Confidence 344555667778888888775332 3222333222110 00001111122222222234444433321 1224567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+|+++|..+++|..-|+... ..+..-.......+..+.+|||... +.|+|++|.|.++..++..++.|||.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999887643 3454455556667888999999876 899999999999999999999999843321
Q ss_pred ccC----CC------------C------C----CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 012599 382 KAD----GL------------P------S----CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435 (460)
Q Consensus 382 ~~~----~~------------~------~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~P 435 (460)
..- +. . . .........+|+.|.+||...+.......|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0 0 00113335689999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 012599 436 IHRSIT 441 (460)
Q Consensus 436 f~~~~~ 441 (460)
|.....
T Consensus 1035 ~na~tp 1040 (1205)
T KOG0606|consen 1035 FNAETP 1040 (1205)
T ss_pred CCCcch
Confidence 987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-07 Score=88.48 Aligned_cols=134 Identities=22% Similarity=0.202 Sum_probs=93.4
Q ss_pred cccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC---------------C------ChhHHHHHHHHHHHhcCCC--Cc
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---------------P------NADSVFLTEVDMLSRLHHC--HV 284 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~---------------~------~~~~~f~~Ei~~l~~l~H~--nI 284 (460)
.+.+.||.|--+.||.|..++|.++|||.=+...+ . .......+|.++|..|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45578999999999999999999999996442211 0 0112356788999988654 66
Q ss_pred cceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE
Q 012599 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (460)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll 364 (460)
.+.+++ +...+||||+++--|...- ++....-.++..|+.-+..+-..| |||+|+..-||++
T Consensus 174 P~P~~~--------nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 174 PKPIAW--------NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCcccc--------ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 666643 2348999999775544321 122233334444555555555667 9999999999999
Q ss_pred cCCCcEEEEecCCcc
Q 012599 365 DENLNAKITDLGMAK 379 (460)
Q Consensus 365 ~~~~~vkl~DFGla~ 379 (460)
++|+.+.++||-.+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.7e-07 Score=89.91 Aligned_cols=196 Identities=15% Similarity=0.161 Sum_probs=126.8
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee---eccCccceEEEEE
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS---EFRGKRAMRLLVF 305 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~---~~~~~~~~~~lV~ 305 (460)
...||+|+.+.+|-..-- ...+.|+.....-... ...++.|.+. .||-+-.=+.+-. ...+.....-+.|
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 467999999999965321 1134566654332211 2234445555 4654433111100 0111122356788
Q ss_pred eecCCCC-HHHHhc----cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 306 EFMPNGN-LRDCLD----GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 306 e~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+.+++.. +..+++ .......+|...+++++.+|.+.+-||+.| .+-+|+.++|+|+.++..+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8887652 233331 112234889999999999999999999999 89999999999999999999998543222
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITG-RQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG-~~Pf~~~~ 440 (460)
...+ ....-..|...|++||+.. +-.-+..+|.|.|||++++|+.| +.||....
T Consensus 167 ~~ng------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 167 NANG------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ccCC------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 2111 1222345778899999765 23457789999999999999885 99998643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.4e-07 Score=94.84 Aligned_cols=151 Identities=19% Similarity=0.237 Sum_probs=97.6
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh-----------------------------------
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------------------------------- 265 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~----------------------------------- 265 (460)
+.....|+ .+.||..+.|+||+|++.+|+.||||+-++.-....
T Consensus 158 e~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 158 EDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 33344444 267999999999999999999999998775422110
Q ss_pred -hHHHHHHHHHHHh----cCCCCc---cceeeeeeeccCccceEEEEEeecCCCCHHHH--hccccCCCCCHHHHHHHHH
Q 012599 266 -DSVFLTEVDMLSR----LHHCHV---VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC--LDGVLVEGMNWDTRVAIAI 335 (460)
Q Consensus 266 -~~~f~~Ei~~l~~----l~H~nI---v~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~ 335 (460)
+-+|.+|.+...+ +.|-++ |.+-.++++. ...+.|+||||+|..+.+. |++ ..++...+..-+.
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~ 310 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLV 310 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHH
Confidence 0125555544433 345562 2233444432 2356999999999876554 333 4466665555444
Q ss_pred HHHHHHHHHHhCCCCCeEecCcCCCCEEEcC----CCcEEEEecCCcccccc
Q 012599 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDLGMAKRLKA 383 (460)
Q Consensus 336 qia~~l~yLH~~~~~~ivH~DLk~~NIll~~----~~~vkl~DFGla~~~~~ 383 (460)
++..-+-+ ..| ++|.|-+|.||+++. ++++.+-|||+...+..
T Consensus 311 ~~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 311 EAYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 43332222 235 999999999999984 67899999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.7e-06 Score=80.74 Aligned_cols=145 Identities=21% Similarity=0.249 Sum_probs=85.4
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC--CccceeeeeeeccCccceEEEEEeec
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+... .......+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~-~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTS-DEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE-TEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeeccc-ccccccceEEEEEe
Confidence 578999999999999977 68999987543 2344577899999888533 35566665433 22233478999999
Q ss_pred CCCCHHH----------------Hh---cccc--CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 012599 309 PNGNLRD----------------CL---DGVL--VEGMNWDT---------RVAI------------AIGAAR-GLEYLH 345 (460)
Q Consensus 309 ~~gsL~~----------------~l---~~~~--~~~l~~~~---------~~~i------------~~qia~-~l~yLH 345 (460)
++..+.. .+ +... ...+.+.. .... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 1110 01111111 0000 112222 333443
Q ss_pred h----CCCCCeEecCcCCCCEEEc-CCCcEEEEecCCccc
Q 012599 346 E----AAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKR 380 (460)
Q Consensus 346 ~----~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~ 380 (460)
+ ...+.++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1345699999999999999 566667999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=4.6e-06 Score=78.26 Aligned_cols=139 Identities=13% Similarity=0.167 Sum_probs=81.6
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeeeccCccceEEEEEeec
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~----~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVED----GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEec----CCeeeeeeeec
Confidence 57899999999984 24457888876433 2233688999999886443 3566666544 23357899999
Q ss_pred CCCC-HHHHh---------------------ccccCCCCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeE
Q 012599 309 PNGN-LRDCL---------------------DGVLVEGMNWDTRVA-IAI----------GAAR-GLEYLHEA-AAPRIL 353 (460)
Q Consensus 309 ~~gs-L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------qia~-~l~yLH~~-~~~~iv 353 (460)
+|.+ +.+.+ +.............. +.. .+.. ...+|... ..+.++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 21111 111001111111100 000 0111 12222211 134579
Q ss_pred ecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 354 HRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 354 H~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.7e-06 Score=76.52 Aligned_cols=154 Identities=22% Similarity=0.287 Sum_probs=101.9
Q ss_pred eechHHHHHHhcCCcccceee---eeCcEEEEEEEEcCCcEEEEEEeccCCCCChh--------HH--------------
Q 012599 214 RFSYSALEHATDKFSGSNIVG---QGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--------SV-------------- 268 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG---~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~--------~~-------------- 268 (460)
..+++.+....+...+....| .|--..||+|...++..+|||+++........ ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 455666777777777666655 56677899999888999999999754321110 00
Q ss_pred -HHHHHHHHHhcC--CCCccceeeeeeeccCccceEEEEEeecCCCCH-HHHhccccCCCCCHHHHHHHHHHHHHHHHHH
Q 012599 269 -FLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344 (460)
Q Consensus 269 -f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qia~~l~yL 344 (460)
...|...|.++. +-.+.+-+++. .-.|||||++...+ .-.|+. -++...+...+..++++.|.-|
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~--------~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR--------NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec--------CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHH
Confidence 234556666653 33344444332 22799999955311 001111 1123335677788888888888
Q ss_pred Hh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 345 HE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 345 H~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
-. .+ +||+||+.-|||+. ++.+.|+|||.+....
T Consensus 183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 77 55 99999999999999 7899999999886543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.2e-06 Score=76.98 Aligned_cols=143 Identities=15% Similarity=0.199 Sum_probs=93.6
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHH---------HHHHHHHHhcCC---CCccceee
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF---------LTEVDMLSRLHH---CHVVPLVG 289 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f---------~~Ei~~l~~l~H---~nIv~l~g 289 (460)
....+|+..+++-......|.+-.. +|..+++|..+..... ..+.| .+.+..+.+++. .....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3467788888888888888888877 5788999988765422 22222 233333444432 22233222
Q ss_pred eeeec-cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC
Q 012599 290 YCSEF-RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368 (460)
Q Consensus 290 ~~~~~-~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~ 368 (460)
+..-. ..-....+++|||++|..|.++.. ++. .++..++.++.-||+.| ++|+|.+|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22111 111234568999999988776542 222 24566778899999999 9999999999999865
Q ss_pred cEEEEecCCccc
Q 012599 369 NAKITDLGMAKR 380 (460)
Q Consensus 369 ~vkl~DFGla~~ 380 (460)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.3e-06 Score=77.80 Aligned_cols=103 Identities=22% Similarity=0.265 Sum_probs=83.3
Q ss_pred HHHHHHHHhcCC-CCccceeeeeeeccCccceEEEEEeecCCCCHHHH---hccccCCCCCHHHHHHHHHHHHHHHHHHH
Q 012599 270 LTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC---LDGVLVEGMNWDTRVAIAIGAARGLEYLH 345 (460)
Q Consensus 270 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~qia~~l~yLH 345 (460)
..|.-++..+++ +++.+++|+|-. ++|.||.+.+++... +... -..+|..+.+||.++++.+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHh
Confidence 467888888865 699999999965 789999987765421 1111 23689999999999999999999
Q ss_pred hCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 346 ~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+.....+.-.|++++|+-+++++++|++|...+....
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8554459999999999999999999999998776443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.8e-07 Score=97.39 Aligned_cols=100 Identities=27% Similarity=0.509 Sum_probs=76.3
Q ss_pred HHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc-CCCCCCC---CCCCccccCCcccCcccccc
Q 012599 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-DGLPSCS---SSPARMQGTFGYFAPEYAMV 410 (460)
Q Consensus 335 ~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~-~~~~~~~---~~~~~~~gt~~y~aPE~~~~ 410 (460)
.+++.|+.|+|... ++||++|.|++|.++.++.+||..|+.+..... ..++... ..+.-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999765 699999999999999999999999998765433 1122111 11111234567999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCC
Q 012599 411 GRASLMSDVFSFGVVLLELITGRQPI 436 (460)
Q Consensus 411 ~~~~~~sDVwSlGvll~elltG~~Pf 436 (460)
...+.++|++|+|+++|.+..|..+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i 209 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSI 209 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcch
Confidence 88999999999999999998655553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.25 E-value=2.3e-05 Score=87.32 Aligned_cols=82 Identities=13% Similarity=0.209 Sum_probs=57.9
Q ss_pred cceeeeeCcEEEEEEEEcCC---cEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCc--cceeeeeeeccCccceEEE
Q 012599 230 SNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHV--VPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~~~~~~~~~l 303 (460)
.+.++.|.++.+|+....++ ..+++|+............+.+|.++|+.+. |.++ .+++++|.+... ....++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceE
Confidence 46688899999999887654 4677887654333233345889999999995 6665 777887765322 234689
Q ss_pred EEeecCCCC
Q 012599 304 VFEFMPNGN 312 (460)
Q Consensus 304 V~e~~~~gs 312 (460)
||||+++..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=74.07 Aligned_cols=139 Identities=22% Similarity=0.174 Sum_probs=82.1
Q ss_pred eeeeCc-EEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEEEeecCC
Q 012599 233 VGQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (460)
Q Consensus 233 LG~G~f-G~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~ 310 (460)
|..|.. ..||+.... +..++||+..... .....+|+++++.+. +--+.+++++... ....++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSD----DGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEec----CCccEEEEEeeCC
Confidence 444555 889999764 4778888876442 223678999988884 4344566665543 1345899999998
Q ss_pred CCHHHHh-------------------ccccCC--CCC--HHHHHHHHH--------------------HHHHHHHHHHh-
Q 012599 311 GNLRDCL-------------------DGVLVE--GMN--WDTRVAIAI--------------------GAARGLEYLHE- 346 (460)
Q Consensus 311 gsL~~~l-------------------~~~~~~--~l~--~~~~~~i~~--------------------qia~~l~yLH~- 346 (460)
.+|.+.. +..... ++. ....+.... .+...+..|-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776431 111000 111 001110000 01111222211
Q ss_pred ---CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 347 ---AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 347 ---~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
...+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1235699999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.10 E-value=9.5e-05 Score=72.37 Aligned_cols=82 Identities=12% Similarity=0.072 Sum_probs=57.5
Q ss_pred CcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC---CCccceeeeeeeccCccceEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH---CHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~~~~~l 303 (460)
....+.||+|..+.||+....+++ +++|..+... ....|..|.+.|+.+.. -.+.++++++..... ....++
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-~g~~~L 90 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGN-PMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-PGPDVL 90 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCC-EEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc-CCCeEE
Confidence 334567999999999999876664 6677754311 12358899999998853 367788887754221 234699
Q ss_pred EEeecCCCCH
Q 012599 304 VFEFMPNGNL 313 (460)
Q Consensus 304 V~e~~~~gsL 313 (460)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999988754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00013 Score=68.56 Aligned_cols=73 Identities=15% Similarity=0.145 Sum_probs=48.0
Q ss_pred ceeeeeCcEEEEEEEEcC--CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.|..|-...+|+....+ +..+++|......... ....+|+.+++.+....+. ++++... ..++|||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--~d~~~E~~~~~~l~~~gl~P~v~~~~~--------~~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--IDRERELRIHKLLSKHGLAPKLYATFQ--------NGLIYEF 73 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--ecHHHHHHHHHHHHhCCCCCeEEEEeC--------CcEEEEe
Confidence 457778889999998764 6788899775432211 1235788888888544443 4443321 1479999
Q ss_pred cCCCCH
Q 012599 308 MPNGNL 313 (460)
Q Consensus 308 ~~~gsL 313 (460)
+++.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00031 Score=64.32 Aligned_cols=130 Identities=20% Similarity=0.271 Sum_probs=88.6
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEeccCC---------------CCChhHHHHHHHHHHHhcC------CCCccce
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---------------GPNADSVFLTEVDMLSRLH------HCHVVPL 287 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~---------------~~~~~~~f~~Ei~~l~~l~------H~nIv~l 287 (460)
....||+|+.-.||.- ++.....||+..... ......++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999965 344557889887655 1122445777777666665 8899999
Q ss_pred eeeeeeccCccceEEEEEeecCC------CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCC
Q 012599 288 VGYCSEFRGKRAMRLLVFEFMPN------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (460)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~N 361 (460)
+|+..... ..-+|+|.+.+ .+|.++++. ..++. .....+ -.-..||-+.+ |+.+||+|+|
T Consensus 83 ~G~veT~~----G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~N 148 (199)
T PF10707_consen 83 YGFVETNL----GLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHN 148 (199)
T ss_pred eEEEecCC----ceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHH---HHHHHHHHHcC---CeecCCCccc
Confidence 99987633 44677777643 268888854 33554 333333 34445666666 9999999999
Q ss_pred EEEcCCC----cEEEEe
Q 012599 362 ILLDENL----NAKITD 374 (460)
Q Consensus 362 Ill~~~~----~vkl~D 374 (460)
|++..+. .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 9996332 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.9e-07 Score=91.74 Aligned_cols=184 Identities=17% Similarity=0.155 Sum_probs=125.4
Q ss_pred cccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC-ccceeeeeeeccCccceEEEEEe
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~~lV~e 306 (460)
...+-+++++.+++||.+....+....+.+... ....-++++|.+.+||| .+..+ .+. +.+....++++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~---~d~-~~E~~~~i~~~ 314 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYL---EDY-DGEDYLWIPMR 314 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCccccc---ccC-Ccccccchhhh
Confidence 333456789999999987654444445555432 22456899999999999 33333 222 22446688999
Q ss_pred ecCCC-CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCC
Q 012599 307 FMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 307 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~ 385 (460)
++..+ +-..-.. .....+...+...+.+.-++++++||+.. =+|+| ||+..+ ...+..||+....+....
T Consensus 315 i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 99776 2111110 00111444555566777788999999864 48898 777766 688999999887664432
Q ss_pred CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf 436 (460)
......+++.|+|||+.....+..+.|+|++|+--.++--|-+|-
T Consensus 386 ------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 344567899999999999999999999999998766666666653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=9.6e-05 Score=65.33 Aligned_cols=128 Identities=18% Similarity=0.177 Sum_probs=86.6
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceEEEEEee
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
..+.|++|.+|.||++.+.. ..+|+|.-+.++. ...+..|.++|..++-.++. +++.|-.+ ++.|||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~--------~i~me~ 93 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-GEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED--------FIRMEY 93 (201)
T ss_pred hhhhhhcccccEEEEeeccC-ceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh--------hhhhhh
Confidence 45789999999999999864 5788887665432 33488999999999766665 45555333 566999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC-CCCEEEcCCCcEEEEecCCccc
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK-SSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk-~~NIll~~~~~vkl~DFGla~~ 380 (460)
+.|-.|.+.-.. .+..+...++ ..---|-..+ |-|+.|. |...+|..+..+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~-----~~rk~l~~vl----E~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG-----GDRKHLLRVL----EKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc-----ccHHHHHHHH----HHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 988788776542 1334444333 3323344445 8888885 4444554555999999998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00016 Score=65.76 Aligned_cols=130 Identities=26% Similarity=0.403 Sum_probs=91.6
Q ss_pred cCCcccceeeeeCc-EEEEEEEEcCCcEEEEEEecc---CCC-------C----------ChhHHHHHHHHHHHhcC---
Q 012599 225 DKFSGSNIVGQGGS-SYVYRGQLTDGRIVAVKRFKT---QGG-------P----------NADSVFLTEVDMLSRLH--- 280 (460)
Q Consensus 225 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vaVK~l~~---~~~-------~----------~~~~~f~~Ei~~l~~l~--- 280 (460)
.+++.++.||.|.- |.||+++. +|+.+|+|.++. ... . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888899999999 99999999 577999999321 100 0 11123778888887774
Q ss_pred CCCc--cceeeeeeecc--------------CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH
Q 012599 281 HCHV--VPLVGYCSEFR--------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344 (460)
Q Consensus 281 H~nI--v~l~g~~~~~~--------------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yL 344 (460)
+.++ |+.+||..-.. .....+.||.||++... .++.. -+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHH
Confidence 5566 89999975432 11223467888876532 12222 345677778889
Q ss_pred HhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 345 H~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9998 999999999985 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00048 Score=69.78 Aligned_cols=76 Identities=21% Similarity=0.195 Sum_probs=53.3
Q ss_pred ceeeeeCcEEEEEEEEcCC-cEEEEEEeccC------CCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCccce
Q 012599 231 NIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQ------GGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g-~~vaVK~l~~~------~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~ 300 (460)
+.||.|.+..||++.+.+| +.++||.-... ..+-..+.+..|.+.|..+. ..++.+++.+-. ..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------EL 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC------CC
Confidence 5689999999999999877 58999985422 11223445677888888762 345677776622 34
Q ss_pred EEEEEeecCCCC
Q 012599 301 RLLVFEFMPNGN 312 (460)
Q Consensus 301 ~~lV~e~~~~gs 312 (460)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 589999998643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00017 Score=68.05 Aligned_cols=32 Identities=22% Similarity=0.433 Sum_probs=26.7
Q ss_pred CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 ~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+.++|+|+.+.|||++++...-|+||+.+..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 34599999999999999776667999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=68.75 Aligned_cols=138 Identities=14% Similarity=0.056 Sum_probs=79.2
Q ss_pred eeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccceEEEEEeecCCC
Q 012599 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFMPNG 311 (460)
Q Consensus 233 LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~lV~e~~~~g 311 (460)
+..|-.+.+|+... +++.+++|........-. ....+|.++++.+....+ .++++... ..+||||++|.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~--------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE--------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC--------CEEEEEeccCc
Confidence 45578889999874 567788887654322211 125788899988864434 34444321 26899999886
Q ss_pred CHHHH-----------------hcccc--CCCCCHHHH-HHHHHH---------HHHHHHHHHhCC-----CCCeEecCc
Q 012599 312 NLRDC-----------------LDGVL--VEGMNWDTR-VAIAIG---------AARGLEYLHEAA-----APRILHRDI 357 (460)
Q Consensus 312 sL~~~-----------------l~~~~--~~~l~~~~~-~~i~~q---------ia~~l~yLH~~~-----~~~ivH~DL 357 (460)
.+..- |+... ..+++.... .....+ +...+..+-... .+.++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 11111 111222211 111111 112222222221 235899999
Q ss_pred CCCCEEEcCCCcEEEEecCCcccc
Q 012599 358 KSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 358 k~~NIll~~~~~vkl~DFGla~~~ 381 (460)
.+.||++++++ +.|+||..+..-
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCcC
Confidence 99999999876 789999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0003 Score=68.65 Aligned_cols=146 Identities=14% Similarity=0.116 Sum_probs=84.3
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeee--ccCccceEEEEE
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVF 305 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~--~~~~~~~~~lV~ 305 (460)
.+.+..|....+|+....+ ..+++|+.... .......|++++..+.+.. +.+++..... ........++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 4567778888999987654 46888887641 2233667888888885433 4444431100 001123458999
Q ss_pred eecCCCCHHH-----------Hh---ccc----cC-----CCCCHHHHH----------HHHHHHHHHHHHHHhC----C
Q 012599 306 EFMPNGNLRD-----------CL---DGV----LV-----EGMNWDTRV----------AIAIGAARGLEYLHEA----A 348 (460)
Q Consensus 306 e~~~~gsL~~-----------~l---~~~----~~-----~~l~~~~~~----------~i~~qia~~l~yLH~~----~ 348 (460)
+|++|..+.. .| +.. .. ....|.... .....+..++.++.+. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876422 01 110 00 011222211 0112234445555431 2
Q ss_pred CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 ~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
...++|+|+.|.||+++++..+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23599999999999999987778999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00064 Score=66.58 Aligned_cols=141 Identities=22% Similarity=0.256 Sum_probs=83.4
Q ss_pred ceeeeeCcEEEEEEEEcC-------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccceEE
Q 012599 231 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~ 302 (460)
+.+..|-...+|+....+ ++.+++|+...... ......+|.+++..+....+ .+++++... .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--------~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN--------G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC--------C
Confidence 345667788999998765 57899998765332 11235688888888854333 355554421 3
Q ss_pred EEEeecCCCCHHHH-----------------hccccCC-------CCC--HHHHHH------------------------
Q 012599 303 LVFEFMPNGNLRDC-----------------LDGVLVE-------GMN--WDTRVA------------------------ 332 (460)
Q Consensus 303 lV~e~~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~~~------------------------ 332 (460)
+|+||++|..+... ++..... ... |..+..
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 58999988765431 1111111 000 111100
Q ss_pred --HHHHHHHHHHHHHh------CCCCCeEecCcCCCCEEEcCC----CcEEEEecCCcccc
Q 012599 333 --IAIGAARGLEYLHE------AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRL 381 (460)
Q Consensus 333 --i~~qia~~l~yLH~------~~~~~ivH~DLk~~NIll~~~----~~vkl~DFGla~~~ 381 (460)
+...+...+..|.. .....++|+|+.+.|||++++ +.+.++||..+...
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 11222233444432 123468999999999999985 78999999988643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0011 Score=65.08 Aligned_cols=146 Identities=14% Similarity=0.144 Sum_probs=81.6
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeee--ccCccceEEEEE
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVF 305 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~--~~~~~~~~~lV~ 305 (460)
.+.++.|....+|+....++ .+++|+...... ......|.+++..|.... +.+++..... .....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 35567777789999886555 577887654221 223456677777774322 3444432110 001124568999
Q ss_pred eecCCCCHH-----------HHh---ccccC---C-------CCCHHHHH------------HHHHHHHHHHHHHHh---
Q 012599 306 EFMPNGNLR-----------DCL---DGVLV---E-------GMNWDTRV------------AIAIGAARGLEYLHE--- 346 (460)
Q Consensus 306 e~~~~gsL~-----------~~l---~~~~~---~-------~l~~~~~~------------~i~~qia~~l~yLH~--- 346 (460)
||++|..+. ..+ +.... . .-.|.... .....+.+.+++|..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999875431 111 11000 0 01121110 011223445555543
Q ss_pred -CCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 347 -AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 347 -~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
...+.++|+|+++.||+++++....|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0048 Score=60.88 Aligned_cols=145 Identities=15% Similarity=0.170 Sum_probs=75.9
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC--ccceeeeeee--ccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~--~~~~~~~~~lV~e 306 (460)
+.|..|....+|+....+| .+++|+.. .... .....|+.++..|.... +.+.+..... ........++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 4566677789999987666 58888875 2111 22334556666553222 3333321000 0011234689999
Q ss_pred ecCCCCHH-----------HHh---cccc---------CCCCCH-HHHHH------------HH-HHHHHHHHHHHhC--
Q 012599 307 FMPNGNLR-----------DCL---DGVL---------VEGMNW-DTRVA------------IA-IGAARGLEYLHEA-- 347 (460)
Q Consensus 307 ~~~~gsL~-----------~~l---~~~~---------~~~l~~-~~~~~------------i~-~qia~~l~yLH~~-- 347 (460)
|++|..+. +.| +... ...+.| ..... .. ..+...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 111 1100 001112 11111 11 1111222333211
Q ss_pred --CCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 348 --AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 348 --~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
-...++|+|+++.||+++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999776568999998753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0031 Score=61.80 Aligned_cols=149 Identities=17% Similarity=0.214 Sum_probs=83.3
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEecc-CCCCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~-~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.+..|..-.+|..... ++.+++. ... ...........+|..+|+.+.- --+-..+++|.+.. -...+.||+|
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~--~g~pf~v~~~ 106 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY--LGTPFYVMEW 106 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC--CCCceEEEEE
Confidence 33433544556665554 7778888 332 2222233345678888887743 23445567766533 2466999999
Q ss_pred cCCCCHHHHhccccC-----------------------------------CC-CCHHHHHHH--------HHHHHHHHHH
Q 012599 308 MPNGNLRDCLDGVLV-----------------------------------EG-MNWDTRVAI--------AIGAARGLEY 343 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~-----------------------------------~~-l~~~~~~~i--------~~qia~~l~y 343 (460)
.++..+.+.+..... .. ..|...... .-....-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 987433222110000 00 011111100 0012223444
Q ss_pred HHhCC-----CCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 344 LHEAA-----APRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 344 LH~~~-----~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
|+.+. .+.++|+|+++.|++++++..+-|.||+++..-.+
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 44332 35799999999999999988899999999876443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0061 Score=60.94 Aligned_cols=141 Identities=17% Similarity=0.140 Sum_probs=81.2
Q ss_pred ceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceEEEE
Q 012599 231 NIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lV 304 (460)
+.|-.|-...+|+....+ ++.+++|....... .. -+..+|..+++.+...++- ++++.... ..|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF-FDRDDEIRTFECMSRHGQGPRLLGRFPN--------GRV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee-echHHHHHHHHHHHHcCCCCceEEEECC--------ceE
Confidence 345558889999987543 36788998765432 21 1236788888888654444 55554321 257
Q ss_pred EeecCCCCHHHH-----------------hccccC---C-CCCHHHHHHHHHH-----------------HHHHHHHH--
Q 012599 305 FEFMPNGNLRDC-----------------LDGVLV---E-GMNWDTRVAIAIG-----------------AARGLEYL-- 344 (460)
Q Consensus 305 ~e~~~~gsL~~~-----------------l~~~~~---~-~l~~~~~~~i~~q-----------------ia~~l~yL-- 344 (460)
++|+++.+|..- ++.... . ..-|.++..+..+ +...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999977665321 111110 0 1112222222211 11122222
Q ss_pred --Hh-CCCCCeEecCcCCCCEEEcC-CCcEEEEecCCcccc
Q 012599 345 --HE-AAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 381 (460)
Q Consensus 345 --H~-~~~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~~ 381 (460)
.. .....++|+|+++.|||+++ +..+.++||..+...
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 21 11235899999999999986 468999999987643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.005 Score=59.60 Aligned_cols=32 Identities=28% Similarity=0.418 Sum_probs=26.5
Q ss_pred CCeEecCcCCCCEEEcCCCc-EEEEecCCcccc
Q 012599 350 PRILHRDIKSSNILLDENLN-AKITDLGMAKRL 381 (460)
Q Consensus 350 ~~ivH~DLk~~NIll~~~~~-vkl~DFGla~~~ 381 (460)
+.++|+|+++.|||+++++. .-|+||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 469999988654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00086 Score=64.90 Aligned_cols=133 Identities=17% Similarity=0.102 Sum_probs=89.8
Q ss_pred CcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCC-------------------CCCh--hHHHHHHHHHHHhcC-C-CC
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-------------------GPNA--DSVFLTEVDMLSRLH-H-CH 283 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~-------------------~~~~--~~~f~~Ei~~l~~l~-H-~n 283 (460)
++..+.||-|--+-||.+.+.+|++.++|.-+-.. ++-. .-...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 46678999999999999999999998888432110 0000 112456888888884 2 33
Q ss_pred ccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEE
Q 012599 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363 (460)
Q Consensus 284 Iv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIl 363 (460)
+.+.+++. ..++|||++.+-.|.+.-+- .+..++ ...+..-+--|.++| +||+|..-=||+
T Consensus 174 VPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v-----~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 174 VPKPIDHN--------RHCVVMELVDGYPLRQVRHV-----EDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCccccc--------ceeeHHHhhcccceeeeeec-----CChHHH---HHHHHHHHHHHHHcC---ceecccchheeE
Confidence 44555443 34899999988776653221 223332 233333445566677 999999999999
Q ss_pred EcCCCcEEEEecCCc
Q 012599 364 LDENLNAKITDLGMA 378 (460)
Q Consensus 364 l~~~~~vkl~DFGla 378 (460)
++++..++++||--+
T Consensus 235 v~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQM 249 (465)
T ss_pred EecCCCEEEeechHh
Confidence 999999999999754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.016 Score=57.65 Aligned_cols=80 Identities=23% Similarity=0.158 Sum_probs=50.1
Q ss_pred eeeeeCcEEEEEEEEcCC-cEEEEEEeccC------CCCChhHHHHHHHHHHHhcC--CC-CccceeeeeeeccCccceE
Q 012599 232 IVGQGGSSYVYRGQLTDG-RIVAVKRFKTQ------GGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g-~~vaVK~l~~~------~~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~~~~ 301 (460)
.||.|....||++...+| +.|+||.-... ..+-...+..-|.+.|+... -| .+.+++.+- +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D------~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD------TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc------cccc
Confidence 478899999999998754 57999975321 22333344556777776652 23 455566542 3355
Q ss_pred EEEEeecCCC-CHHHHh
Q 012599 302 LLVFEFMPNG-NLRDCL 317 (460)
Q Consensus 302 ~lV~e~~~~g-sL~~~l 317 (460)
.+|||+++.. .|++.|
T Consensus 76 ~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGL 92 (370)
T ss_pred eehHhhCccchHHHHHH
Confidence 7999999654 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0032 Score=61.11 Aligned_cols=138 Identities=23% Similarity=0.264 Sum_probs=69.9
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCccceEEEEEe
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
.+.++.|....+|+.. .+++.+.||.-... ....|..|.+-|+.|. .-.+.+++++.... ...+||||
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~----~~~fLlle 92 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD----DDAFLLLE 92 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S----SCCEEEEE
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec----CCceEEEE
Confidence 4568889999999988 57888999987622 2234889999888883 34566777776542 23389999
Q ss_pred ecCCCC--------HHHH---hcc-ccCC-------------------CCCHHHHH-----HHHHH-----------HHH
Q 012599 307 FMPNGN--------LRDC---LDG-VLVE-------------------GMNWDTRV-----AIAIG-----------AAR 339 (460)
Q Consensus 307 ~~~~gs--------L~~~---l~~-~~~~-------------------~l~~~~~~-----~i~~q-----------ia~ 339 (460)
|++.+. |... |+. .... .-+|.+.. ....+ +.+
T Consensus 93 ~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~ 172 (288)
T PF03881_consen 93 FLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELER 172 (288)
T ss_dssp --------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHH
T ss_pred eecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHH
Confidence 997761 1111 122 1100 12333221 11111 111
Q ss_pred HHHH----HHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 340 GLEY----LHEA-AAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 340 ~l~y----LH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
.++- |+.. -.|.++|+||-+.|++.+.++.+.|.|-.
T Consensus 173 l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 173 LVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 1222 2211 14679999999999999999999999954
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0019 Score=71.76 Aligned_cols=156 Identities=21% Similarity=0.193 Sum_probs=110.3
Q ss_pred HHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012599 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349 (460)
Q Consensus 270 ~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~ 349 (460)
.-|++.+.++.|+|++.+++|-.+.....-...+..++++.-++...+... ...+..+.+.+..++..|+.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 346667778899999999988766443321233456788888888877654 44778888899999999999999885
Q ss_pred CCeEecCcCCC---CEEEcCCCcEEEE--ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCc--hhHHHHH
Q 012599 350 PRILHRDIKSS---NILLDENLNAKIT--DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASL--MSDVFSF 422 (460)
Q Consensus 350 ~~ivH~DLk~~---NIll~~~~~vkl~--DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDVwSl 422 (460)
..|.-|..+ +.-.+..+.+.++ ||+.+......... ....-+..|.+||......+.. ..|+|.+
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS------FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccc------hhhcCccccccccccccccchhhhhhHHHHH
Confidence 666666555 4455666667776 88887765443211 1122345688888877666544 4799999
Q ss_pred HHHHHHHHhCCCCC
Q 012599 423 GVVLLELITGRQPI 436 (460)
Q Consensus 423 Gvll~elltG~~Pf 436 (460)
|.++..+..|..+-
T Consensus 379 gll~~~~~~~~~i~ 392 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDIS 392 (1351)
T ss_pred HHHHhhhhhcCccc
Confidence 99999998876653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.019 Score=58.16 Aligned_cols=81 Identities=20% Similarity=0.179 Sum_probs=52.4
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC------CChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCccce
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~------~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~ 300 (460)
.+.||.|....||+.... +..++||+-..... +....+-..|.+.|+.+. ..++.+++.++.+ .
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------M 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------C
Confidence 357899999999998874 45689998652211 112223344566666553 3578889888764 3
Q ss_pred EEEEEeecCC--CCHHHHh
Q 012599 301 RLLVFEFMPN--GNLRDCL 317 (460)
Q Consensus 301 ~~lV~e~~~~--gsL~~~l 317 (460)
.+++|||+++ ..+++.+
T Consensus 110 ~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CEEEEeecCCcceehhhhh
Confidence 4889999976 3444433
|
|
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0073 Score=70.24 Aligned_cols=53 Identities=21% Similarity=0.459 Sum_probs=31.9
Q ss_pred cCcccceEEeccCCCCCcccccccCCCcCcccCCCC-CCCCCCeeEeeecCCCCCc
Q 012599 30 SGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPAV-GGSSEGKWTCICAADGLPK 84 (460)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~c~~~~-~~~~~~~~~c~~~~~g~~~ 84 (460)
++..+|.|.|.+-|-||-==+--.+|.+ =.|+.|. ..-+.+.+-|.| .+|+-+
T Consensus 3881 ~~~ggy~CkCpsqysG~~CEi~~epC~s-nPC~~GgtCip~~n~f~CnC-~~gyTG 3934 (4289)
T KOG1219|consen 3881 QPKGGYKCKCPSQYSGNHCEIDLEPCAS-NPCLTGGTCIPFYNGFLCNC-PNGYTG 3934 (4289)
T ss_pred CCCCceEEeCcccccCcccccccccccC-CCCCCCCEEEecCCCeeEeC-CCCccC
Confidence 4457999999999999764443346653 3454432 111555666776 445444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.029 Score=55.72 Aligned_cols=141 Identities=16% Similarity=0.169 Sum_probs=79.5
Q ss_pred ceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceEEEEE
Q 012599 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~lV~ 305 (460)
+.|..|-...+|+....+ +..+++|....... ..-+..+|..+++.+...++- +++++... .+|.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--------G~i~ 89 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFGN--------GMIQ 89 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeCC--------cEee
Confidence 345558888999987643 23788887765332 112246788888888655553 55554321 2488
Q ss_pred eecCCCCHHH-------H----------hccccC---CCC-CHHHHHHHHHHH----------------------HHHHH
Q 012599 306 EFMPNGNLRD-------C----------LDGVLV---EGM-NWDTRVAIAIGA----------------------ARGLE 342 (460)
Q Consensus 306 e~~~~gsL~~-------~----------l~~~~~---~~l-~~~~~~~i~~qi----------------------a~~l~ 342 (460)
+|+++..|.. . |+.... ... -|..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 9987665421 0 111110 001 122222222111 11122
Q ss_pred HHH----hCC-CCCeEecCcCCCCEEEcC-CCcEEEEecCCcccc
Q 012599 343 YLH----EAA-APRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 381 (460)
Q Consensus 343 yLH----~~~-~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~~ 381 (460)
.+. ..+ ...++|+|+.+.|||+++ ++.++++||..|...
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 221 111 234799999999999975 578999999987643
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.045 Score=55.27 Aligned_cols=76 Identities=20% Similarity=0.134 Sum_probs=49.8
Q ss_pred cceeeeeCcEEEEEEEEcC-CcEEEEEEeccC-----CCCChhHHHHHHHHHHHhcC--CC-CccceeeeeeeccCccce
Q 012599 230 SNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQ-----GGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~-----~~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~~~ 300 (460)
.+.||-|.-..||++.+.+ ++.|+||.-... ..+-..++..-|.+.|+... -| ++.+++.+= ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cHH
Confidence 3578999999999999853 567999874321 22333445566777777662 23 555666542 335
Q ss_pred EEEEEeecCCC
Q 012599 301 RLLVFEFMPNG 311 (460)
Q Consensus 301 ~~lV~e~~~~g 311 (460)
..+|||+++..
T Consensus 108 ~~~vMEdL~~~ 118 (409)
T PRK12396 108 NCCVMEDLSDH 118 (409)
T ss_pred hhHHHHhCccc
Confidence 57899999653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.0094 Score=58.74 Aligned_cols=75 Identities=16% Similarity=0.208 Sum_probs=59.2
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
...+.|++|++. |++|.- ...-.|.+.+.|+.+.+..+.-|...- ++-|||+...||||+ +|++-|+||-
T Consensus 297 e~~y~yl~~kdh-gt~is~------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeee------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 345667888876 555542 133578999999999888888777654 589999999999999 9999999999
Q ss_pred Ccccc
Q 012599 377 MAKRL 381 (460)
Q Consensus 377 la~~~ 381 (460)
+++.-
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99843
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.068 Score=52.34 Aligned_cols=29 Identities=24% Similarity=0.360 Sum_probs=25.3
Q ss_pred CCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 350 PRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 350 ~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
+.++|+|+.+.||++++ +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999988 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.00068 Score=76.84 Aligned_cols=161 Identities=12% Similarity=-0.028 Sum_probs=108.5
Q ss_pred HHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 012599 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEA 347 (460)
Q Consensus 270 ~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~~l~yLH~~ 347 (460)
+.|.+.++...|+++.....-... ......+.+++|+..|++.+.|-+... ..++..-......+......-.|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~p--s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPP--SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCC--CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 344455566789888766543322 223355889999999999999854322 2233332222223323343443332
Q ss_pred --CCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHH
Q 012599 348 --AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVV 425 (460)
Q Consensus 348 --~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvl 425 (460)
...--+|++||+.|.+|..+..++++++|+.+...+.. .......+++.|++|+....-.++.++|+|..+..
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-----sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-----SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchH-----hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 22346999999999999999999999999998332221 11223456778999998888889989999999999
Q ss_pred HHHHHhCCCCCC
Q 012599 426 LLELITGRQPIH 437 (460)
Q Consensus 426 l~elltG~~Pf~ 437 (460)
+|++.-|..||-
T Consensus 1430 ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHhcccHHHH
Confidence 999888877753
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.012 Score=54.41 Aligned_cols=30 Identities=27% Similarity=0.449 Sum_probs=21.3
Q ss_pred CeEecCcCCCCEEE-cCCCcEEEEecCCccc
Q 012599 351 RILHRDIKSSNILL-DENLNAKITDLGMAKR 380 (460)
Q Consensus 351 ~ivH~DLk~~NIll-~~~~~vkl~DFGla~~ 380 (460)
.++|+|+.+.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.061 Score=53.24 Aligned_cols=144 Identities=21% Similarity=0.306 Sum_probs=84.3
Q ss_pred eeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC------ccceeeeeeeccCccceEEEEE
Q 012599 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~~~~~lV~ 305 (460)
.|.+ .-..+|+....+|+. ++|..... . ...+...|+.+|..|.-.. +..+=|-....-......+-++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~--~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-W--TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC-C--CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 567899999888876 88888765 2 2233566777777773211 1222222111111113668899
Q ss_pred eecCCCCHHH------------Hh-------cccc---C---CCCCHHH-------------HHHHHHHHHHHHHHHHhC
Q 012599 306 EFMPNGNLRD------------CL-------DGVL---V---EGMNWDT-------------RVAIAIGAARGLEYLHEA 347 (460)
Q Consensus 306 e~~~~gsL~~------------~l-------~~~~---~---~~l~~~~-------------~~~i~~qia~~l~yLH~~ 347 (460)
+|++|..+.. +| ++.. . ....|.. ......++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999887762 11 1111 0 0133331 012344455555555543
Q ss_pred CC----C-C--eEecCcCCCCEEEcCCCc-EEEEecCCccc
Q 012599 348 AA----P-R--ILHRDIKSSNILLDENLN-AKITDLGMAKR 380 (460)
Q Consensus 348 ~~----~-~--ivH~DLk~~NIll~~~~~-vkl~DFGla~~ 380 (460)
-. . + +||+|+.+.||+++++.. +.++||+-+..
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 21 1 2 899999999999999885 89999998763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.063 Score=53.24 Aligned_cols=139 Identities=19% Similarity=0.212 Sum_probs=90.7
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC---------------------CChhHH----HHHHHHHHHhcCCCCcc
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---------------------PNADSV----FLTEVDMLSRLHHCHVV 285 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~---------------------~~~~~~----f~~Ei~~l~~l~H~nIv 285 (460)
..|..|--..||.+.-.+|..+|||+++..-- ...... ...|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 45778999999999999999999998874200 000111 23567777777654432
Q ss_pred ceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 286 ~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
----+.. ....|||+|+. ++=+-.=. ...-.++...+..+-.|++.-|.-|.+.. ++||.||.--|+|+-
T Consensus 230 ~PePIlL------k~hVLVM~FlG-rdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 230 CPEPILL------KNHVLVMEFLG-RDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCceee------ecceEeeeecc-CCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 1110000 12379999994 32111100 01123677778888888888888887655 599999999999996
Q ss_pred CCCcEEEEecCCccc
Q 012599 366 ENLNAKITDLGMAKR 380 (460)
Q Consensus 366 ~~~~vkl~DFGla~~ 380 (460)
+ |.+.|+|-+-+..
T Consensus 300 d-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVE 313 (520)
T ss_pred C-CEEEEEEcccccc
Confidence 5 4889999886654
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.062 Score=54.44 Aligned_cols=74 Identities=16% Similarity=0.217 Sum_probs=44.9
Q ss_pred ceeeeeCcEEEEEEEEcCC--cE-----EEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceEE
Q 012599 231 NIVGQGGSSYVYRGQLTDG--RI-----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g--~~-----vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~~ 302 (460)
+.|..|-...+|++...++ .. |.++.... . ....-+-.+|+++++.+...++- ++++.+.. .
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--------g 125 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-Y-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--------F 125 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-C-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC--------E
Confidence 4555588899999976543 22 44443221 1 11111235789999999766555 45554432 6
Q ss_pred EEEeecCCCCHH
Q 012599 303 LVFEFMPNGNLR 314 (460)
Q Consensus 303 lV~e~~~~gsL~ 314 (460)
+++||+++..|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 899999887653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.073 Score=52.31 Aligned_cols=31 Identities=19% Similarity=0.265 Sum_probs=27.6
Q ss_pred CCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 350 PRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 350 ~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
..++|+|+.++|||+++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.1 Score=59.65 Aligned_cols=145 Identities=20% Similarity=0.287 Sum_probs=77.8
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC--CCC--cccee----eee-e--eccCccc
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH--VVPLV----GYC-S--EFRGKRA 299 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--H~n--Iv~l~----g~~-~--~~~~~~~ 299 (460)
+.|+ |..-.+|+....+|..+++|+.+..... .....|..+|..|. ++. +.+++ |-. . ...+...
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 3454 5568899998888888999998764322 22334555555442 122 22222 110 1 1111112
Q ss_pred eEEEEEeecCCCCHHHH--------------h-------cccc----CCCCCHHH-----------------HHHHHHHH
Q 012599 300 MRLLVFEFMPNGNLRDC--------------L-------DGVL----VEGMNWDT-----------------RVAIAIGA 337 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~--------------l-------~~~~----~~~l~~~~-----------------~~~i~~qi 337 (460)
..+-+++|++|..|.+. + +... ...+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 45678999999777551 0 1110 01123321 11222222
Q ss_pred HHHHH-----HHHhCCCCCeEecCcCCCCEEEcCCC--cEE-EEecCCccc
Q 012599 338 ARGLE-----YLHEAAAPRILHRDIKSSNILLDENL--NAK-ITDLGMAKR 380 (460)
Q Consensus 338 a~~l~-----yLH~~~~~~ivH~DLk~~NIll~~~~--~vk-l~DFGla~~ 380 (460)
....+ .|.+ -...+||+|+.+.|||++.+. ++. |+|||.+..
T Consensus 187 ~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22222 1211 123599999999999999875 554 999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.27 Score=48.69 Aligned_cols=73 Identities=22% Similarity=0.242 Sum_probs=44.5
Q ss_pred eCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC--Ccccee---eeeeeccCccceEEEEEeecCC
Q 012599 236 GGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLV---GYCSEFRGKRAMRLLVFEFMPN 310 (460)
Q Consensus 236 G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~---g~~~~~~~~~~~~~lV~e~~~~ 310 (460)
+....||+....++..+++|..+... ........|.+.+..|... .++..+ |-... ..+...+.++++++|
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~--~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH--EHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE--EECCEEEEEEeeeCC
Confidence 55678999998888889999876432 2334467788888777321 222212 10000 012356889999987
Q ss_pred CC
Q 012599 311 GN 312 (460)
Q Consensus 311 gs 312 (460)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.008 Score=39.16 Aligned_cols=29 Identities=31% Similarity=0.402 Sum_probs=12.8
Q ss_pred EEEehHHHHHHHHHHH-HHHHHHhhhhcCC
Q 012599 120 VVIVLLLCVILTTIAF-LMLVLCYVYRKGK 148 (460)
Q Consensus 120 ~~iv~~~~~~~~~l~~-l~~~~~~~~rr~k 148 (460)
+.|...+.+.++++++ ++++++++|||+|
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR~k 40 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRRKK 40 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEeccC
Confidence 3333333344444433 3344444566553
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.2 Score=46.68 Aligned_cols=75 Identities=25% Similarity=0.291 Sum_probs=46.7
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC---CccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.+-.|.--.-|...+ ...++.||+-. ......|..|+.-|+.|... ++.+++.+-.+ ...-|+||||
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~----~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGAS----RDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCC----CCeeEEEEee
Confidence 3444455555555544 45678888643 23345588888877777544 45555544333 4566999999
Q ss_pred cCCCCHH
Q 012599 308 MPNGNLR 314 (460)
Q Consensus 308 ~~~gsL~ 314 (460)
++-|.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9987654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.075 Score=53.37 Aligned_cols=59 Identities=14% Similarity=0.094 Sum_probs=42.2
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
.++-+|+++-++..+++.. ..++.-...++.-.++|+-.+--.. .++|.|++|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 5677888888999988653 2344556666766666665544333 299999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 460 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-38 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-30 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-109
Identities = 97/242 (40%), Positives = 146/242 (60%), Gaps = 10/242 (4%)
Query: 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF 269
G + RFS L+ A+D FS NI+G+GG VY+G+L DG +VAVKR K + + F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNW 327
TEV+M+S H +++ L G+C RLLV+ +M NG++ CL ++W
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 328 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387
R IA+G+ARGL YLH+ P+I+HRD+K++NILLDE A + D G+AK L
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDT 189
Query: 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
++ ++GT G+ APEY G++S +DVF +GV+LLELITG++ + ++ +
Sbjct: 190 HVTT---AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 448 VL 449
+L
Sbjct: 247 ML 248
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 312 bits (803), Expect = e-104
Identities = 98/239 (41%), Positives = 135/239 (56%), Gaps = 13/239 (5%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 273
R LE AT+ F ++G G VY+G L DG VA+KR F TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT-PESSQGIEEFETEI 86
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRV 331
+ LS H H+V L+G+C E R +L++++M NGNL+ L G M+W+ R+
Sbjct: 87 ETLSFCRHPHLVSLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
I IGAARGL YLH A I+HRD+KS NILLDEN KITD G++K + + S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLS 198
Query: 392 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
+ ++GT GY PEY + GR + SDV+SFGVVL E++ R I +S+ + +L W
Sbjct: 199 T--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 2e-95
Identities = 85/247 (34%), Positives = 129/247 (52%), Gaps = 24/247 (9%)
Query: 214 RFSYSALEHATDKFS------GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-- 265
FS+ L++ T+ F G N +G+GG VY+G + + VAVK+
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 266 -DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVE 323
F E+ ++++ H ++V L+G+ S+ LV+ +MPNG+L D L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
++W R IA GAA G+ +LHE +HRDIKS+NILLDE AKI+D G+A+ +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443
+S R+ GT Y APE + G + SD++SFGVVLLE+ITG + +
Sbjct: 186 FAQTVMTS---RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--RE 239
Query: 444 EESLVLW 450
+ L+
Sbjct: 240 PQLLLDI 246
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-71
Identities = 67/240 (27%), Positives = 94/240 (39%), Gaps = 21/240 (8%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV 268
H + + L + + +G V++ QL VAVK F Q
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQ 64
Query: 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD 328
EV L + H +++ +G L+ F G+L D L ++W+
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 329 TRVAIAIGAARGLEYLHEAAA-------PRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
IA ARGL YLHE P I HRDIKS N+LL NL A I D G+A +
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPI 436
+A + GT Y APE A L D+++ G+VL EL +
Sbjct: 182 EAGKSAGDTHGQV---GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-58
Identities = 59/243 (24%), Positives = 93/243 (38%), Gaps = 27/243 (11%)
Query: 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 272
+ + S D ++G+G VY+G L D R VAVK F F+ E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINE 55
Query: 273 VDM--LSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 329
++ + + H ++ + M LV E+ PNG+L L +W +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVS 112
Query: 330 RVAIAIGAARGLEYLHEAAA------PRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+A RGL YLH P I HRD+ S N+L+ + I+D G++ RL
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 384 DGLPSCSSSPARM---QGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGR 433
+ L GT Y APE A D+++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 434 QPI 436
+
Sbjct: 233 TDL 235
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-56
Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 17/209 (8%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
+G G V+R + G VAVK Q +A+ V FL EV ++ RL H ++V +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
G + + L +V E++ G+L L E ++ R+++A A+G+ YLH
Sbjct: 101 GAVT-----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
P I+HR++KS N+L+D+ K+ D G++ RLKA S S+ GT + APE
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAA----GTPEWMAPE 209
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQP 435
++ SDV+SFGV+L EL T +QP
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 3e-53
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+ + S +++G+ G + VK K + F E L H +V+P++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C L+ +MP G+L + L ++ V A+ ARG+ +LH
Sbjct: 75 ACQSPPAPHPT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
P I + S ++++DE++ A+I+ + ++ G + APE A+
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG----------RMYAPAWVAPE-AL 180
Query: 410 VGRASLM----SDVFSFGVVLLELITGRQP 435
+ +D++SF V+L EL+T P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-52
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+VG+G V + + + VA+K+ +++ + F+ E+ LSR++H ++V L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C LV E+ G+L + L G + ++ + ++G+ YLH
Sbjct: 70 CLN------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 350 PRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
++HRD+K N+LL KI D G A ++ + +G+ + APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNKGSAAWMAPEVF 175
Query: 409 MVGRASLMSDVFSFGVVLLELITGRQP 435
S DVFS+G++L E+IT R+P
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-52
Identities = 72/216 (33%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPL 287
I+G GG VYR G VAVK + + E + + L H +++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
G C K LV EF G L L G + + D V A+ ARG+ YLH+
Sbjct: 72 RGVCL----KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 348 AAPRILHRDIKSSNILLDE--------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
A I+HRD+KSSNIL+ + N KITD G+A R ++ G
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHR------TTKMSAAGA 177
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ + APE S SDV+S+GV+L EL+TG P
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-51
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCH 283
+G+GG V++G+ + D +VA+K + F EV ++S L+H +
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+V L G +V EF+P G+L L + W ++ + + A G+EY
Sbjct: 85 IVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 344 LHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ P I+HRD++S NI L + AK+ D G++ + + G
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLL-------G 188
Query: 399 TFGYFAPEYAMVGRASL---MSDVFSFGVVLLELITGRQP 435
F + APE + +D +SF ++L ++TG P
Sbjct: 189 NFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 22/218 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 288
VG+G V+RG G VAVK F ++ + + E ++ L H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
R L+ + G+L D L + ++ + + I + A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 349 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
P I HRD+KS NIL+ +N I DLG+A + + GT Y
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE + D+++FG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-50
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G VY+G+ VAVK P F EV +L + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ +V ++ +L L + IA ARG++YLH A
Sbjct: 90 TA-----PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE---YA 408
I+HRD+KS+NI L E+ KI D G+A + G+ + APE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQ 197
Query: 409 MVGRASLMSDVFSFGVVLLELITGRQP 435
S SDV++FG+VL EL+TG+ P
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 22/218 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 288
+G+G V+RG+ G VAVK F ++ + + E ++ L H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFI 102
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
++ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 349 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
P I HRD+KS NIL+ +N I DLG+A R + + R GT Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE + +D+++ G+V E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 288
+G+G V+ G+ G VAVK F T ++ + E ++ + H +++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFI 97
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
+ G L+ ++ NG+L D L ++ + + +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 349 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
P I HRD+KS NIL+ +N I DLG+A + +D R+ GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
PE ++ +M+D++SFG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-48
Identities = 55/218 (25%), Positives = 87/218 (39%), Gaps = 25/218 (11%)
Query: 231 NIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
++G+G + G ++ +K + FL EV ++ L H +V+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-FLKEVKVMRCLEHPNVLKFIG 74
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
+ KR + E++ G LR + D W RV+ A A G+ YLH
Sbjct: 75 VLY--KDKRLN--FITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIASGMAYLHS 126
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--------- 397
I+HRD+ S N L+ EN N + D G+A+ + + +
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
G + APE DVFSFG+VL E+I
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-47
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 25/217 (11%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
++G+G VY G+ G VA++ + N D + F EV + H +VV +
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
G C L ++ L + + ++ + IA +G+ YLH
Sbjct: 96 GACM-----SPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLH-- 147
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
A ILH+D+KS N+ D ITD G+ G + APE
Sbjct: 148 -AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 408 AMVGRASLM---------SDVFSFGVVLLELITGRQP 435
SDVF+ G + EL P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVG 289
+G+G VY+G VA + + ++ F E +ML L H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLH 345
+ +LV E M +G L+ L V+ + +W ++ +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146
Query: 346 EAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
P I+HRD+K NI + + KI DLG+A +A + + GT + A
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMA 198
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
PE DV++FG+ +LE+ T P
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-36
Identities = 44/206 (21%), Positives = 81/206 (39%), Gaps = 21/206 (10%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+ GG ++Y + +GR V +K G A ++ + E L+ + H +V + +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 291 CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+V E++ +L+ L +A + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----PVAEAIAYLLEILPALSYLHSI-- 201
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+++ D+K NI+L E K+ DLG R+ + G + GT G+ APE
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY---------LYGTPGFQAPEIVR 250
Query: 410 VGRASLMSDVFSFGVVLLELITGRQP 435
++ +D+++ G L L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+GG SYV + L DG A+KR E DM +H +++ LV YC
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGLEYLHEAAA 349
RG + L+ F G L + ++ + +G + +G RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------GTFGYF 403
HRD+K +NILL + + DLG + S +Q T Y
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH--VEGSRQALTLQDWAAQRCTISYR 210
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE + ++ +DV+S G VL ++ G P
Sbjct: 211 APELFSVQSHCVIDER---TDVWSLGCVLYAMMFGEGP 245
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 62/215 (28%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 234 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
G+G G V G +VAVK K GP S + E+D+L L+H H++
Sbjct: 40 GEGHFGK--VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
G C + LV E++P G+LRD L + + A G+ YLH
Sbjct: 98 YKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA 152
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTFG 401
+HRD+ + N+LLD + KI D G+AK +
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----- 204
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE + SDV+SFGV L EL+T
Sbjct: 205 --APECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 231 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+G+G G V + G VAVK K + G N + E+++L L+H +
Sbjct: 27 RDLGEGHFGK--VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 340
+V G C+E G L+ EF+P+G+L++ L + N ++ A+ +G
Sbjct: 85 IVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKI----NLKQQLKYAVQICKG 138
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 395
++YL + +HRD+ + N+L++ KI D G+ K ++ D
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE M + + SDV+SFGV L EL+T
Sbjct: 196 Y-------APECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 241 VYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
V+ G+L VAVK + P+ + FL E +L + H ++V L+G C+ ++
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT----QKQ 185
Query: 300 MRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
+V E + G+ L +G + T + + AA G+EYL +HRD+
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF-----APEYAMVGR 412
+ N L+ E KI+D GM++ A G APE GR
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG-------VYAASGGL-RQVPVKWTAPEALNYGR 291
Query: 413 ASLMSDVFSFGVVLLELIT-GRQP 435
S SDV+SFG++L E + G P
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-34
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ VG+G V+R + G AVK+ + + E+ + L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSP 110
Query: 283 HVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA- 338
+VPL G + G + +F E + G+L + G L E R +G A
Sbjct: 111 RIVPLYG--AVREGPW---VNIFMELLEGGSLGQLIKQMGCLPE-----DRALYYLGQAL 160
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
GLEYLH RILH D+K+ N+LL + A + D G A L+ DGL + +
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT + APE M D++S ++L ++ G P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 234 GQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
G+G GS V + G +VAVK+ + GP+ F E+ +L LH +V
Sbjct: 32 GKGNFGS--VELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
G + LV E++P+G LRD L L + + + +G+EY
Sbjct: 89 YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHRARL----DASRLLLYSSQICKGMEY 142
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 398
L R +HRD+ + NIL++ + KI D G+AK L D P +
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE S SDV+SFGVVL EL T +
Sbjct: 198 -----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 34/232 (14%)
Query: 231 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+G+G GS V + G +VAVK+ + F E+++L L H +
Sbjct: 47 QQLGKGNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDN 103
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 340
+V G C + L+ E++P G+LRD L + + + +G
Sbjct: 104 IVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKG 157
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 395
+EYL R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
APE + S+ SDV+SFGVVL EL T + + +
Sbjct: 215 Y-------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-33
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
+G GG S V+ + L D R VAVK + + F E + L+H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 347
+ +V E++ LRD ++ M + + A + L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRD----IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
I+HRD+K +NI++ K+ D G+A+ + G ++ + GT Y +PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQ 190
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
A SDV+S G VL E++TG P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 32/227 (14%)
Query: 234 GQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
G GS V + G +VAVK+ + F E+++L L H ++V
Sbjct: 21 GNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 345
G C + L+ E++P G+LRD L + + + +G+EYL
Sbjct: 78 GVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKGMEYLG 131
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTF 400
R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
APE + S+ SDV+SFGVVL EL T + + +
Sbjct: 185 ---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 234 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
C + M LV E G L L + + + G++YL E
Sbjct: 79 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 129
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+HRD+ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 184
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S SDV+S+GV + E ++ G++P
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 31/219 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L+G C G L+V +M +G+LR+ + + + A+G++Y
Sbjct: 91 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKY 143
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L A+ + +HRD+ + N +LDE K+ D G+A+ + + G
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-------DKEYYSVHNKTGAK 193
Query: 404 ------APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
A E + + SDV+SFGV+L EL+T G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 35/225 (15%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVV 285
I+G+G V G L VAVK K + FL+E + H +V+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 286 PLVGYCSEFRGKRAMRLLV-FEFMPNGNL----RDCLDGVLVEGMNWDTRVAIAIGAARG 340
L+G C E + + +V FM G+L + + T + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 392
+EYL + LHRD+ + N +L +++ + D G++K R
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK-----M 211
Query: 393 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + + A E + SDV++FGV + E+ T G P
Sbjct: 212 PVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G+ D A+K FL E ++ L+H +V+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 344
L+G G + ++ +M +G+L + N + ++ + ARG+EYL
Sbjct: 87 LIGIMLPPEG---LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 403
A + +HRD+ + N +LDE+ K+ D G+A+ + + Q
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR------EYYSVQQHRHARLP 191
Query: 404 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
A E R + SDV+SFGV+L EL+T G P
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
+G GG S VY + VA+K +++ F EV S+L H ++V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 348
E LV E++ L + ++ G ++ DT + G+++ H+
Sbjct: 79 VDEE----DDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
RI+HRDIK NIL+D N KI D G+AK L L + + GT YF+PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQA 184
Query: 409 MVGRASLMSDVFSFGVVLLELITGRQP 435
+D++S G+VL E++ G P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 36/226 (15%)
Query: 231 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVV 285
++G+G V QL VAVK K ++D FL E + H HV
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 286 PLVGYCSEFRGKRAMR--LLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAAR 339
LVG R K + +++ FM +G+ L G + T V + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSS 391
G+EYL ++ +HRD+ + N +L E++ + D G+++ R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK----- 200
Query: 392 SPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + + A E ++ SDV++FGV + E++T G+ P
Sbjct: 201 LPVKWL-------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 22/209 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL-- 287
VG+GG VY + RIVA+K + E RL HVVP+
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 346
G E G + + +L L +G + VAI L+ H
Sbjct: 102 FG---EIDG---QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
A HRD+K NIL+ + A + D G+A + L + GT Y APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL----TQLGNTVGTLYYMAPE 205
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQP 435
A+ +D+++ VL E +TG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 232 IVGQGGSSYVYRGQLTDGRI-----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G L VA+K K FL E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L G S + K M ++ E+M NG L L DG + V + G A G++Y
Sbjct: 111 LEGVIS--KYKPMM--IITEYMENGALDKFLREKDGEF----SVLQLVGMLRGIAAGMKY 162
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 398
L +HRD+ + NIL++ NL K++D G+++ L+ D + ++S P R
Sbjct: 163 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-- 217
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE + + SDV+SFG+V+ E++T G +P
Sbjct: 218 -----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 344
L+G C G L+V +M +G+LR+ + E N + + + A+G+++L
Sbjct: 155 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 403
A+ + +HRD+ + N +LDE K+ D G+A+ + T
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-----DKEFDSVH-NKTGAKLP 259
Query: 404 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
A E + + SDV+SFGV+L EL+T G P
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 231 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L+G C L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT---STVQ--LITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YL + R++HRD+ + N+L+ + KITD G+AK L A+ G
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEG-GK 180
Query: 403 F-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGE 444
A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
I+G G S V G+L VA+K K FL+E ++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L G + RG+ AM +V E+M NG+L L DG V + G G+ Y
Sbjct: 115 LEGVVT--RGRLAM--IVTEYMENGSLDTFLRTHDGQF----TIMQLVGMLRGVGAGMRY 166
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 398
L + +HRD+ + N+L+D NL K++D G+++ L+ D + +++ +
Sbjct: 167 LSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE S SDV+SFGVV+ E++ G +P
Sbjct: 222 -----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+ +G G VY G + VAVK K + + FL E ++ + H ++V L+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C+ R ++ EFM GNL D L + ++ + +A + +EYL
Sbjct: 77 VCT--REPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPE 406
+HRD+ + N L+ EN K+ D G+++ + D + + + P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-------APE 182
Query: 407 YAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S+ SDV++FGV+L E+ T G P
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
Y + E + +G G V G+ VA+K K G ++ F+ E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAK 71
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRV 331
++ L H +V L G C+ K+ ++ E+M NG L + L +
Sbjct: 72 VMMNLSHEKLVQLYGVCT----KQRPIFIITEYMANGCLLNYLREMRHRF----QTQQLL 123
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+ +EYL + + LHRD+ + N L+++ K++D G+++ + D S
Sbjct: 124 EMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 392 S--PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
S P R PE M + S SD+++FGV++ E+ + G+ P
Sbjct: 181 SKFPVRWS-------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 234 GQGGSSYVYRGQLTDGRI---VAVKRFKT-QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G G+ V +G ++ VAVK K P L E +++ +L + ++V ++G
Sbjct: 28 GNFGT--VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C + M LV E G L L + + + + G++YL E+
Sbjct: 86 ICE---AESWM--LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW--PVKWYAPECIN 193
Query: 410 VGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S SDV+SFGV++ E + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 6e-31
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 234 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
C + M LV E G L L + + + G++YL E
Sbjct: 405 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 455
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+HR++ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 456 ---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 510
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S SDV+S+GV + E ++ G++P
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G G V+ G + VA+K + G ++ F+ E +++ +L H +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
C ++A LV EFM +G L D L G+ +T + + + G+ YL
Sbjct: 72 CL----EQAPICLVTEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYL--- 120
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFA 404
++HRD+ + N L+ EN K++D GM + + D S + + P + +
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-------S 173
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
PE R S SDV+SFGV++ E+ + G+ P
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 36/220 (16%)
Query: 231 NIVGQG--GSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
++G G G+ V++G V +K + + G + + + L H H
Sbjct: 19 KVLGSGVFGT--VHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 340
+V L+G C LV +++P G+L D + G L + + A+G
Sbjct: 77 IVRLLGLCPG---SSLQ--LVTQYLPLGSLLDHVRQHRGAL----GPQLLLNWGVQIAKG 127
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-M 396
+ YL E ++HR++ + N+LL ++ D G+A L D S P + M
Sbjct: 128 MYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
A E G+ + SDV+S+GV + EL+T G +P
Sbjct: 185 -------ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-31
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G V G+ VAVK K G ++ F E + +L H +V G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
S K +V E++ NG L + L L + + G+ +L
Sbjct: 73 S----KEYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEMCYDVCEGMAFL---E 121
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAP 405
+ + +HRD+ + N L+D +L K++D GM + + D S + P + AP
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-------AP 174
Query: 406 EYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
E + S SDV++FG+++ E+ + G+ P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 232 IVGQGGSSYVYRGQLTDGRI----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
I+G+G VY G T+ + VAVK K + F++E ++ L H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
+G E ++ E P G L L L T V ++ + + YL
Sbjct: 79 IGIIEE-----EPTWIIMELYPYGELGHYLERNKNSL----KVLTLVLYSLQICKAMAYL 129
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 401
+HRDI NIL+ K+ D G+++ ++ + S + P + M
Sbjct: 130 ESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----- 181
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+PE R + SDV+ F V + E+++ G+QP
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 231 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+ +G G VY G + VAVK K FL E ++ + H ++V L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C+ ++ EFM GNL D L + ++ + +A + +EYL +
Sbjct: 284 VCTR--EPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF--APEY 407
+HR++ + N L+ EN K+ D G+++ + D + A F APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPES 390
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S+ SDV++FGV+L E+ T G P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +G G V+ VAVK K G + FL E +++ L H +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKL 245
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L ++ + ++ EFM G+L D L + + A G+ ++
Sbjct: 246 VKLHAVVTK---EPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 402
+ +HRD++++NIL+ +L KI D G+A+ ++ + + + P + +
Sbjct: 301 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------W 351
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE G ++ SDV+SFG++L+E++T GR P
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+VG G V G+L VA+K K FL E ++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L G + + K M +V E+M NG+L L D V + G A G++Y
Sbjct: 111 LEGVVT--KSKPVM--IVTEYMENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKY 162
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 398
L + +HRD+ + NIL++ NL K++D G+ + L+ D + ++ P R
Sbjct: 163 LSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+PE + + SDV+S+G+VL E+++ G +P
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G G V+ G VAVK K G + FL E +++ +L H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
+ + + ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 77 VT----QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 407
+HRD++++NIL+ + L+ KI D G+A+ ++ + + + P + APE
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-------APEA 181
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
G ++ SDV+SFG++L E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 19/224 (8%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQ 231
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++ +L H +V L SE + +V E+M G+L D L G + + V +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-- 392
A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + + APE A+ GR ++ SDV+SFG++L EL T GR P
Sbjct: 344 PIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 273
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEA 313
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
++ +L H +V L SE + +V E+M G+L D L G + + V +
Sbjct: 314 QVMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 392
A A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 369 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 393 -PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + + APE A+ GR ++ SDV+SFG++L EL T GR P
Sbjct: 426 FPIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 232 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
+G +E ++ E G LR L L + + A + L YL
Sbjct: 82 IGVITE---NPVW--IIMELCTLGELRSFLQVRKYSLDLA----SLILYAYQLSTALAYL 132
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 401
R +HRDI + N+L+ N K+ D G+++ ++ S P + M
Sbjct: 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE R + SDV+ FGV + E++ G +P
Sbjct: 185 --APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 63/231 (27%), Positives = 93/231 (40%), Gaps = 47/231 (20%)
Query: 231 NIVGQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+GQG G VY G VA+K FL E ++ +
Sbjct: 31 RELGQGSFGM--VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTRVAIA 334
HVV L+G S + L++ E M G+L+ L + ++ + + +A
Sbjct: 89 HVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 386
A G+ YL A + +HRD+ + N ++ E+ KI D GM + R GL
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 387 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P R M +PE G + SDV+SFGVVL E+ T QP
Sbjct: 202 -----LPVRWM-------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G V G G VAVK K A FL E ++++L H ++V L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV 82
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 83 IVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGN 136
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 407
+HRD+ + N+L+ E+ AK++D G+ K + + + P + APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEA 185
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S SDV+SFG++L E+ + GR P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L+G C + L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-MQG 398
YL + R++HRD+ + N+L+ + KITD G+AK L A+ + P + M
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-- 186
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
A E + + SDV+S+GV + EL+T G +P
Sbjct: 187 -----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 60/214 (28%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 232 IVGQGGSSYVYRGQLTDGRI----VAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVV 285
+G G V RG+ VAVK K P A F+ EV+ + L H +++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L G +V E P G+L D L G T A+ A G+
Sbjct: 85 RLYGVVLT---PPMK--MVTELAPLGSLLDRLRKHQGHF----LLGTLSRYAVQVAEGMG 135
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YL R +HRD+ + N+LL KI D G+ + L + ++ F +
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAW 190
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE S SD + FGV L E+ T G++P
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 25/199 (12%)
Query: 241 VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300
V G G VAVK K A FL E ++++L H ++V L+G E +G
Sbjct: 209 VMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL-- 262
Query: 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
+V E+M G+L D L + D + ++ +EYL +HRD+ +
Sbjct: 263 -YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAAR 318
Query: 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEYAMVGRASLMS 417
N+L+ E+ AK++D G+ K + + + P + APE + S S
Sbjct: 319 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEALREKKFSTKS 367
Query: 418 DVFSFGVVLLELIT-GRQP 435
DV+SFG++L E+ + GR P
Sbjct: 368 DVWSFGILLWEIYSFGRVP 386
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 40/237 (16%)
Query: 221 EHATDKFSGSN-----IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
H DK G + ++G GG V++ + DG+ +KR K N + EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKA--EREVK 56
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRL------------LVFEFMPNGNLRDCLD---- 318
L++L H ++V G F + EF G L ++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 319 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
L + + + + +G++Y+H ++++RD+K SNI L + KI D G+
Sbjct: 117 EKLDKVLALE----LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
LK DG R +GT Y +PE D+++ G++L EL+
Sbjct: 170 TSLKNDGK------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 41/221 (18%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
VY+G L VA+K K + F E + +RL H +VV L+G +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-- 82
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR------VAIAIGAARG 340
K ++F + +G+L + L G + + V + A G
Sbjct: 83 --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
+EYL ++ ++H+D+ + N+L+ + LN KI+DLG+ + + ++ ++ G
Sbjct: 141 MEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-------AADYYKLLGN- 189
Query: 401 GYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE M G+ S+ SD++S+GVVL E+ + G QP
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 50/225 (22%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
V+ + + +VAVK K A F E ++L+ L H H+V G C
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-- 87
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR---------VAIAIGAARG 340
++VFE+M +G+L L D +++ + IA A G
Sbjct: 88 --DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 392
+ YL A+ +HRD+ + N L+ NL KI D GM++ R+ +
Sbjct: 146 MVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM-----L 197
Query: 393 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P R M PE M + + SDV+SFGV+L E+ T G+QP
Sbjct: 198 PIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 20/216 (9%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-- 289
+G+GG V+ + D A+KR + A + EV L++L H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 290 -----YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLE 342
+ L + + NL+D ++G +E + I + A +E
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----- 397
+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 133 FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 398 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
GT Y +PE S D+FS G++L EL+
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 67/231 (29%), Positives = 103/231 (44%), Gaps = 49/231 (21%)
Query: 234 GQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
G+G V+ + + +VAVK K + +A F E ++L+ L H H+V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRF 108
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR--------VAIA 334
G C+ + L+VFE+M +G+L L D L+ G +A+A
Sbjct: 109 FGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 386
A G+ YL A +HRD+ + N L+ + L KI D GM++ R+ +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 387 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P R M PE + + + SDV+SFGVVL E+ T G+QP
Sbjct: 222 -----LPIRWM-------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
+++G+G V + ++ A+KR K + F E+++L +L HH +++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTR--------VA 332
L+G C R L E+ P+GNL D L + + T +
Sbjct: 91 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-----RLKADGLP 387
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ K G
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 202
Query: 388 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P R M A E + SDV+S+GV+L E+++ G P
Sbjct: 203 ----LPVRWM-------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 43/229 (18%)
Query: 231 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAAR 339
V +G + R ++ E M G+L+ L + + +A A
Sbjct: 96 VRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 388
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-- 206
Query: 389 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + M PE M G + +D +SFGV+L E+ + G P
Sbjct: 207 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 232 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
+G +E ++ E G LR L L + + A + L YL
Sbjct: 457 IGVITE---NPVW--IIMELCTLGELRSFLQVRKFSLDLA----SLILYAYQLSTALAYL 507
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 402
R +HRDI + N+L+ N K+ D G+++ ++ S P + +
Sbjct: 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------W 558
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
APE R + SDV+ FGV + E++ G +P
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
F +G+G S VYR L DG VA+K+ + +A + + E+D+L +L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 335
+V+ Y + F + +V E G+L + ++ E W +
Sbjct: 92 PNVI---KYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFV 143
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
LE++H R++HRDIK +N+ + K+ DLG+ + S ++ A
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAH 194
Query: 396 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ GT Y +PE + SD++S G +L E+ + P
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 43/230 (18%)
Query: 234 GQG--GSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 284
G+G G V R VAVK K + ++E+ +L + HH +V
Sbjct: 36 GRGAFGQ--VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTR 330
V L+G C++ G +++ EF GNL L + + + + +
Sbjct: 94 VNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LP 387
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 388 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ P + M APE ++ SDV+SFGV+L E+ + G P
Sbjct: 208 GDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 23/235 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHC 282
+ + +G G + + +DG+I+ K A+ L +EV++L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 283 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--AR 339
++V Y + L +V E+ G+L + E D + +
Sbjct: 66 NIV---RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 340 GLEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D + +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-----FV 177
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
GT Y +PE + SD++S G +L EL P + I +G+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 49/224 (21%), Positives = 88/224 (39%), Gaps = 23/224 (10%)
Query: 224 TDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRL 279
+ ++G+G V + G V V+R + N FL E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 280 HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+H ++VP + L +V FM G+ +D + ++GMN I G
Sbjct: 84 NHPNIVPY--RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARM 396
+ L+Y+H +HR +K+S+IL+ + ++ L + + G P
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 397 QGTFGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQP 435
+ +PE V + +L SD++S G+ EL G P
Sbjct: 196 VKVLPWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 48/233 (20%)
Query: 234 GQG--GSSYVYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 282
G+G G V + VAVK K S ++E++M+ + H
Sbjct: 44 GEGAFGQ--VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWD 328
+++ L+G C+ + ++ E+ GNLR+ L + V E M +
Sbjct: 102 NIINLLGACT----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 329 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
V+ ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ +
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--- 211
Query: 389 CSSSPARMQGTFGYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ T G APE + SDV+SFGV++ E+ T G P
Sbjct: 212 -----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 57/233 (24%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
V++ + +VAVK K + + + F E +++ + ++V L+G C+
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR--------------VA 332
L+FE+M G+L + L + ++ R +
Sbjct: 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKAD 384
IA A G+ YL + + +HRD+ + N L+ EN+ KI D G+++ + +
Sbjct: 179 IARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 235
Query: 385 GLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P R M PE R + SDV+++GVVL E+ + G QP
Sbjct: 236 DA-----IPIRWM-------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 43/229 (18%)
Query: 231 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTR--VAIAIGAAR 339
V +G + R ++ E M G+L+ L + + + +A A
Sbjct: 137 VRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 388
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM-- 247
Query: 389 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + M PE M G + +D +SFGV+L E+ + G P
Sbjct: 248 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHC 282
+K+ +G+G + DGR +K + + EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAA 338
++V Y F ++ +V ++ G+L + + E D +
Sbjct: 84 NIV---QYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQIC 135
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
L+++H+ +ILHRDIKS NI L ++ ++ D G+A+ L + + + G
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-----CIG 187
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y +PE + SD+++ G VL EL T +
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 53/218 (24%), Positives = 80/218 (36%), Gaps = 27/218 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HH 281
F + +G G V++ + DGR+ AVKR + D L EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGA 337
V L + G L L E +L+ + L E W
Sbjct: 117 PCCVRL--EQAWEEGGI---LYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDT 166
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
L +LH ++H D+K +NI L K+ D G+ L G +
Sbjct: 167 LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV------QE 217
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
G Y APE + G +DVFS G+ +LE+ +
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
++G+G VY G L++ +A+K + + + E+ + L H ++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-HEEIALHKHLKHKNIVQYLGS 87
Query: 291 CSEFRGKRAMRLLVF-EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLEYLHEAA 348
SE + +F E +P G+L L + + + GL+YLH+
Sbjct: 88 FSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 349 APRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+I+HRDIK N+L++ + KI+D G +KRL G+ C+ + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTET---FTGTLQYMAPEI 194
Query: 408 AMVGR--ASLMSDVFSFGVVLLELITGRQP 435
G +D++S G ++E+ TG+ P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 234 GQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
G+G G V + + VAVK K P+ L+E ++L +++H HV+
Sbjct: 32 GEGEFGK--VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------------------DGVLVE 323
L G CS + LL+ E+ G+LR L D
Sbjct: 90 KLYGACS----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+ ++ A ++G++YL A +++HRD+ + NIL+ E KI+D G+++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 384 DG---LPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ S P + M A E + SDV+SFGV+L E++T G P
Sbjct: 203 EDSYVKRSQGRIPVKWM-------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 29/255 (11%), Positives = 65/255 (25%), Gaps = 46/255 (18%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV---------------------- 268
++GQ G V P ++++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 269 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM--PNGNLRDCLDGVL 321
F+ D++ ++ + E R ++ M + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 322 VEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379
+ R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQ 434
R A + A G+ + D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGF----APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 435 PIHRSITKGEESLVL 449
P G +
Sbjct: 316 PNTDDAALGGSEWIF 330
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 52/228 (22%)
Query: 241 VYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
V + VAVK K S ++E++M+ + H +++ L+G C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGA 337
+ + ++ E+ GNLR+ L + V E M + V+
Sbjct: 157 T----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSC 389
ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ + +G
Sbjct: 213 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR--- 266
Query: 390 SSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + M APE + SDV+SFGV++ E+ T G P
Sbjct: 267 --LPVKWM-------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293
V VAVK K+ + ++E+ ++S L H ++V L+G C+
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120
Query: 294 FRGKRAMRLLVFEFMPNGNLRDCL----------DGVLVEGMNWDTR--VAIAIGAARGL 341
L++ E+ G+L + L + TR + + A+G+
Sbjct: 121 ---HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSSP 393
+L A+ +HRD+ + N+LL AKI D G+A+ +K + P
Sbjct: 178 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR-----LP 229
Query: 394 AR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ M APE ++ SDV+S+G++L E+ + G P
Sbjct: 230 VKWM-------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 54/223 (24%), Positives = 90/223 (40%), Gaps = 42/223 (18%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293
V VAVK K ++E+ +LS L +H ++V L+G C+
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT- 97
Query: 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR----------------VAIAIGA 337
L++ E+ G+L + L + T ++ +
Sbjct: 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPA 394
A+G+ +L A+ +HRD+ + NILL KI D G+A+ +K D + + P
Sbjct: 155 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 395 R-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ M APE + SDV+S+G+ L EL + G P
Sbjct: 212 KWM-------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 56/237 (23%)
Query: 234 GQG--GSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 282
G+G G V + VAVK K+ S ++E++M+ + H
Sbjct: 78 GEGAFGQ--VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR------------ 330
+++ L+G C+ + ++ E+ GNLR+ L G+ +
Sbjct: 136 NIINLLGACT----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 331 --VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------R 380
V+ A ARG+EYL A+ + +HRD+ + N+L+ E+ KI D G+A+ +
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 381 LKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+G P + M APE + SDV+SFGV+L E+ T G P
Sbjct: 249 KTTNGR-----LPVKWM-------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 46/224 (20%), Positives = 84/224 (37%), Gaps = 44/224 (19%)
Query: 234 GQGGSSYVYRGQLTDGRI--------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
GQG + +++G + V +K + N F M+S+L H H+V
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
G C +LV EF+ G+L L + N ++ +A A +
Sbjct: 76 LNYGVCV----CGDENILVQEFVKFGSLDTYLKKNKNCI----NILWKLEVAKQLAAAMH 127
Query: 343 YLHEAAAPRILHRDIKSSNILLD--------ENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+L ++H ++ + NILL K++D G++ + +
Sbjct: 128 FL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI 181
Query: 395 R-MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELIT-GRQP 435
+ PE + +L +D +SFG L E+ + G +P
Sbjct: 182 PWV-------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 70/216 (32%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL--VGY 290
G GG YV R G VA+K+ + + P + E+ ++ +L+H +VV V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIA-IGAARGLEYL 344
+ + LL E+ G+LR L L EG R ++ I +A L YL
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG---PIRTLLSDISSA--LRYL 137
Query: 345 HEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
HE RI+HRD+K NI+L + L KI DLG AK L L C+ GT
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEF----VGTLQ 188
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + ++ D +SFG + E ITG +P
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-27
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 338
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 392
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 393 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP 435
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 287
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
Y + + +V E N +L L + + D + + +H
Sbjct: 94 YDY---EITDQYI-YMVMECG-NIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 197
Query: 406 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
E + S SDV+S G +L + G+ P
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/233 (27%), Positives = 97/233 (41%), Gaps = 41/233 (17%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 338
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 392
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 393 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP 435
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 32/221 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHC-HVVPL 287
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
Y + + +V E N +L L + + D + + +H
Sbjct: 122 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ I+H D+K +N L+ + K+ D G+A +++ D S G Y P
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GAVNYMPP 225
Query: 406 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
E + S SDV+S G +L + G+ P
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 24/219 (10%)
Query: 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 284
F +++G G + + D R VAVKR + AD EV +L H +V
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
+ +C+E R + + E L++ ++ + + + GL +L
Sbjct: 81 IRY--FCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHL 134
Query: 345 HEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
H I+HRD+K NIL+ + A I+D G+ K+L S GT
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV--PGT 189
Query: 400 FGYFAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP 435
G+ APE + D+FS G V +I+
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 32/221 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 287
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
Y + + +V E N +L L + + D + + +H
Sbjct: 75 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 178
Query: 406 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
E + S SDV+S G +L + G+ P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 55/232 (23%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSV----FLTEVDMLSRL-HHCHVVPLVG 289
V VAVK K ADS ++E+ M+++L H ++V L+G
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLK----EKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL---------DGVLVEGMNWDTR---------- 330
C+ L+FE+ G+L + L D + E
Sbjct: 117 ACT----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 331 --VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-- 386
+ A A+G+E+L +HRD+ + N+L+ KI D G+A+ + +D
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 387 -PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ P + M APE G ++ SDV+S+G++L E+ + G P
Sbjct: 230 VRGNARLPVKWM-------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 17/222 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
D + ++G G ++ V VA+KR + + L E+ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTR---VAIAI---G 336
+V Y S L LV + + G++ D + ++ +G + IA
Sbjct: 75 IVSY--YTSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
GLEYLH+ +HRD+K+ NILL E+ + +I D G++ L G + +
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 397 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 437
GT + APE R +D++SFG+ +EL TG P H
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 59/252 (23%), Positives = 92/252 (36%), Gaps = 42/252 (16%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
F ++GQG V + + D R A+K+ + S L+EV +L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQ 62
Query: 283 HVVPLVG-YCSEFRGKRAMRL--------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+VV + + M + E+ NG L D ++ R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD----LIHSENLNQQRDEY 118
Query: 334 A-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
I L Y+H I+HRD+K NI +DE+ N KI D G+AK +
Sbjct: 119 WRLFRQI--LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 389 CSSSPARMQ---------GTFGYFAPE-YAMVGRASLMSDVFSFGVVLLELITG------ 432
S GT Y A E G + D++S G++ E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 433 RQPIHRSITKGE 444
R I + +
Sbjct: 234 RVNILKKLRSVS 245
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 28/235 (11%), Positives = 56/235 (23%), Gaps = 42/235 (17%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
+ G S V+ + A+K F + + +RL
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 289 GYCSEFRGKRAMRL----------------------LVFEFMP--NGNLRDCLDGVLVEG 324
A+ + L+ L LD V V
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 325 MNWDTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382
+ + A R L ++H N+ + + + D+ ++
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
G S Y E+ A + + + G+ + + P
Sbjct: 246 TRGPASS--------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 24/217 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ F+ +G+G V++G ++VA+K + + E+ +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAI---GAA 338
+V Y S + + ++ E++ G+ D L G L E IA
Sbjct: 81 YVTKY--YGSYLKDTKLW--IIMEYLGGGSALDLLEPGPLDETQ-------IATILREIL 129
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+GL+YLH + +HRDIK++N+LL E+ K+ D G+A +L + + G
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-----FVG 181
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T + APE +D++S G+ +EL G P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 22/221 (9%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290
+ +GG ++VY Q + GR A+KR + ++ + EV + +L H ++V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-IQEVCFMKKLSGHPNIVQFCSA 94
Query: 291 CSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 346
S + L+ + G L + L + G ++ DT + I R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-------GT 399
P I+HRD+K N+LL K+ D G A + S S+ + T
Sbjct: 155 QKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 400 FGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQP 435
Y PE ++ S D+++ G +L L + P
Sbjct: 214 PMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNP 77
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 338
++V + S G +V E++ G+L D + + EG IA
Sbjct: 78 NIVNYLD--SYLVGDELW--VVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECL 126
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ LE+LH +++HRDIKS NILL + + K+TD G ++ + S + M G
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVG 178
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T + APE D++S G++ +E+I G P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 54/242 (22%), Positives = 84/242 (34%), Gaps = 51/242 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-H 280
T +F +G G V++ DG I A+KR K + D L EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCL------DGVLVEGMNWDTRVAI 333
H HVV + + +L+ E+ G+L D + E D +
Sbjct: 70 HSHVVRY--FSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----L 120
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-------------------LNAKITD 374
+ RGL Y+H ++H DIK SNI + + KI D
Sbjct: 121 LLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
LG R+ SSP +G + A E +D+F+ + ++
Sbjct: 178 LGHVTRI---------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
Query: 434 QP 435
Sbjct: 229 PL 230
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+G+G + V + GR VAVK + + +F EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHF 102
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 338
+VV + S G+ ++ EF+ G L D + L E IA
Sbjct: 103 NVVEMYK--SYLVGEELW--VLMEFLQGGALTDIVSQVRLNEEQ-------IATVCEAVL 151
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ L YLH A ++HRDIKS +ILL + K++D G ++ D + G
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVG 203
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T + APE + D++S G++++E++ G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 5e-24
Identities = 33/248 (13%), Positives = 72/248 (29%), Gaps = 59/248 (23%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV---------------------- 268
++GQ G V P ++++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 269 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD----- 318
F+ D++ ++ + E R ++ M NL+ +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 196
Query: 319 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
+ + R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 379 KRLKADGLPSCSSSPARMQGTFGYFAPEY--------AMVGRASLMS---DVFSFGVVLL 427
R + + G+ PE R +LM+ D ++ G+V+
Sbjct: 254 VRD---------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 428 ELITGRQP 435
+ P
Sbjct: 305 WIWCADLP 312
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G V++ G ++A K + P + + E+ +L + ++V Y
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF--YG 98
Query: 292 SEFRGKR---AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHE 346
+ + M E M G LD VL + ++ ++I +GL YL E
Sbjct: 99 AFYSDGEISICM-----EHMDGG----SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 405
+I+HRD+K SNIL++ K+ D G++ +L S A GT Y +P
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANSFVGTRSYMSP 199
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
E S+ SD++S G+ L+E+ GR PI
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 32/224 (14%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ + +G G VY+ + G + A K +T+ + ++ E+++L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 336
++V L+G + + + ++ EF P G + LD L E I +
Sbjct: 77 YIVKLLG--AYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQ 125
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
L +LH RI+HRD+K+ N+L+ + ++ D G++ + S
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----F 177
Query: 397 QGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 435
GT + APE M D++S G+ L+E+ P
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ F +G+G VY+ G+IVA+K+ + + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSP 84
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 336
HVV G S F+ +V E+ G++ D + L E IA
Sbjct: 85 HVVKYYG--SYFKNTDLW--IVMEYCGAGSVSDIIRLRNKTLTEDE-------IATILQS 133
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
+GLEYLH R +HRDIK+ NILL+ +AK+ D G+A +L + +
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-----V 185
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT + APE + ++D++S G+ +E+ G+ P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 64/241 (26%), Positives = 98/241 (40%), Gaps = 47/241 (19%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 283
+ I+G G S V GR VAVKR + + L E+ +L+ H +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPN 70
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGM-NWDTRVAIAI--GA 337
V+ YCSE L + E N NL+D ++ V E + I++
Sbjct: 71 VIRY--YCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLD-------------ENLNAKITDLGMAKRLKAD 384
A G+ +LH +I+HRD+K NIL+ ENL I+D G+ K+L +
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 385 GLPSCSSSPARMQ---GTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQ 434
SS + GT G+ APE R + D+FS G V +++ +
Sbjct: 182 Q----SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 435 P 435
Sbjct: 238 H 238
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 234 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
F + +V E +L + L E + R G +YLH
Sbjct: 110 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 160
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 405
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 210
Query: 406 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
E ++ + S DV+S G ++ L+ G+ P + I K E
Sbjct: 211 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 40/248 (16%), Positives = 87/248 (35%), Gaps = 55/248 (22%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVK--------RFKTQGGPNADSVFLT--------EVDMLS 277
QG + + + + A+K + + N D + + E+ +++
Sbjct: 40 NQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA 334
+ + + + G + +++E+M N ++ + VL + + +
Sbjct: 99 DIKNEYCLTCEGI---ITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 335 IGAAR----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SC 389
+ Y+H I HRD+K SNIL+D+N K++D G ++ + + S
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 390 SSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQP---------I 436
GT+ + PE D++S G+ L + P +
Sbjct: 212 --------GTYEFMPPE--FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 437 HRSITKGE 444
+I
Sbjct: 262 FNNIRTKN 269
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 19/231 (8%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTE 272
SAL F +VG G VY+G+ + G++ A+K G + E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQE 70
Query: 273 VDMLSRL-HHCHVVPLVG-YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 329
++ML + HH ++ G + + +L LV EF G++ D + + +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389
I RGL +LH+ +++HRDIK N+LL EN K+ D G++ +L
Sbjct: 131 IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 435
+ GT + APE + D++S G+ +E+ G P
Sbjct: 188 T-----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 32/208 (15%), Positives = 58/208 (27%), Gaps = 50/208 (24%)
Query: 233 VGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
G ++ D R VA+ QG D + L+ LSR+ V +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ RA L+V E++ G+L++ D + + A + H A
Sbjct: 97 LDVVHT----RAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ S + + + + +
Sbjct: 149 G---VALSIDHPSRVRVSIDGDVVL-------------------------AYPATMPD-- 178
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
A+ D+ G L L+ R P
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWP 201
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 39/229 (17%)
Query: 234 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
F + +V E +L + L E + R G +YLH
Sbjct: 84 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 134
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 405
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 184
Query: 406 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
E ++ + S DV+S G ++ L+ G+ P + I K E
Sbjct: 185 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-23
Identities = 65/232 (28%), Positives = 92/232 (39%), Gaps = 44/232 (18%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+G + VYR + + G VA+K K EV + +L H ++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 291 CSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEYLH 345
F + LV E NG + L E + R + I G+ YLH
Sbjct: 80 ---FEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSE---NEARHFMHQI--ITGMLYLH 129
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGY 402
ILHRD+ SN+LL N+N KI D G+A +LK C GT Y
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--------GTPNY 178
Query: 403 FAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
+PE + R+ L SDV+S G + L+ GR P + +
Sbjct: 179 ISPE--IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 60/228 (26%), Positives = 86/228 (37%), Gaps = 44/228 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL--TEVDMLSRLH 280
FS +G G VY + + + +VA+K+ G + + EV L +L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI-- 335
H + + G R A LV E+ G+ D L E IA
Sbjct: 113 HPNTIQYRG--CYLREHTAW--LVMEYCL-GSASDLLEVHKKPLQEVE-------IAAVT 160
Query: 336 -GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG----MAKRLKADGLPSCS 390
GA +GL YLH ++HRD+K+ NILL E K+ D G MA
Sbjct: 161 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------- 207
Query: 391 SSPARMQGTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQP 435
GT + APE + DV+S G+ +EL + P
Sbjct: 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 62/237 (26%), Positives = 93/237 (39%), Gaps = 39/237 (16%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 281
+ F +G+G VY + I+A+K FK Q + EV++ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAA 338
+++ L GY F R+ L+ E+ P G + L E T I A
Sbjct: 69 PNILRLYGY---FHDAT--RVYLILEYAPLGTVYRELQKLSKFDE---QRTATYIT-ELA 119
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPARMQ 397
L Y H R++HRDIK N+LL KI D G + + C
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------- 168
Query: 398 GTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
GT Y PE M+ D++S GV+ E + G+ P ++ I++ E
Sbjct: 169 GTLDYLPPE--MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 21/213 (9%)
Query: 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 290
+G+G V + + G+I+AVKR + L ++D+ R C V Y
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF--Y 72
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHEAA 348
+ FR + E M + +L V+ +G + IA+ + LE+LH
Sbjct: 73 GALFREGDVW--ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-- 406
++HRD+K SN+L++ K+ D G++ L + G Y APE
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DVAKDIDAGCKPYMAPERI 181
Query: 407 --YAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
S+ SD++S G+ ++EL R P
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 290
+G+G V + G+I+AVKR ++ L ++D++ R C ++V Y
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF--Y 87
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV-------AIAIGAARGLEY 343
+ FR + E M + D + V I + + L +
Sbjct: 88 GALFREGDCW--ICMELM-ST----SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L E +I+HRDIK SNILLD + N K+ D G++ +L S + R G Y
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDAGCRPYM 192
Query: 404 APEYAMVGRA----SLMSDVFSFGVVLLELITGRQPIH 437
APE + + SDV+S G+ L EL TGR P
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 21/210 (10%)
Query: 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 290
+G G V++ + G ++AVK+ + G + L ++D++ + H C ++V +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC--F 90
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
+ + E M G + L + + + + + L YL E
Sbjct: 91 GTFITNTDVF--IAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-- 144
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
++HRD+K SNILLDE K+ D G++ RL + R G Y APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD------DKAKDRSAGCAAYMAPERIDP 198
Query: 411 GRA-----SLMSDVFSFGVVLLELITGRQP 435
+ +DV+S G+ L+EL TG+ P
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 65/257 (25%), Positives = 102/257 (39%), Gaps = 33/257 (12%)
Query: 203 SKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRF-KTQ 260
+ T F S H ++ + +G G V A+K KT
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 261 GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV 320
+++S L EV +L L H +++ L + + KR L V E G L D
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED---KRNYYL-VMECYKGGELFD----E 126
Query: 321 LVEGMNWDTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDL 375
++ M ++ A I G+ YLH+ I+HRD+K N+LL +++ KI D
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
G++ + GT Y APE + + DV+S GV+L L+ G P
Sbjct: 184 GLSAVFENQ------KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
Query: 436 --------IHRSITKGE 444
I R + KG+
Sbjct: 237 FGGQTDQEILRKVEKGK 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 223 ATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDM 275
AT ++ +G G +Y VY+ + G VA+K + G + EV +
Sbjct: 7 ATSRYEPVAEIGVG--AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 276 LSRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV 331
L RL H +VV L+ C+ R R +++ LVFE + +LR LD G+ +T
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+ RGL++LH I+HRD+K NIL+ K+ D G+A+ S
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---------S 171
Query: 392 SPARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
+ T Y APE + + D++S G + E+ +
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 12/164 (7%)
Query: 277 SRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI 335
R+ VG K + + + NL+D ++ +E + I I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYL-YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
A +E+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 172 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 396 MQ-------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 432
GT Y +PE S D+FS G++L EL+
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 34/237 (14%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 280
+D++ G ++G+G V G+ AVK + L EV +L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAA 338
H +++ L + + + LV E G L D ++ + A I
Sbjct: 85 HPNIMKLYEFFED----KGYFYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVL 136
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+ Y+H+ +I+HRD+K N+LL ++ N +I D G++ +A
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS------KKMKD 187
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
GT Y APE + G DV+S GV+L L++G P I + + KG+
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 43/239 (17%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 281
D F +G+G VY + + I+A+K FK+Q + E+++ S L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGA- 337
+++ + Y F ++ R+ L+ EF P G L L G E + +
Sbjct: 74 PNILRMYNY---FHDRK--RIYLMLEFAPRGELYKELQKHGRFDE------QRSATFMEE 122
Query: 338 -ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPAR 395
A L Y HE +++HRDIK N+L+ KI D G + + C
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------ 173
Query: 396 MQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
GT Y PE M+ + D++ GV+ E + G P HR I +
Sbjct: 174 --GTLDYLPPE--MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLH 280
K+ +GQG V++ + G+ VA+K+ + + +T E+ +L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 281 HCHVVPL----VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
H +VV L S + + LVF+F + D L G+L + V +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLL-------SNVLVKFT 122
Query: 337 AA----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
+ GL Y+H +ILHRD+K++N+L+ + K+ D G+A+ L
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF---SL 176
Query: 387 PSCSSSPARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 436
+S P R T Y PE + R D++ G ++ E+ T PI
Sbjct: 177 AK-NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 233 VGQGGSSYVYRGQ---LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
VG+G +VY+ + D + A+K+ + G + E+ +L L H +V+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85
Query: 290 YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA---------- 338
F ++ L+F++ + +L + + + + +
Sbjct: 86 V---FLSHADRKVWLLFDYAEH-DLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA----KITDLGMAKRLKADGLPSCSSSPA 394
G+ YLH +LHRD+K +NIL+ KI D+G A RL L +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDP 194
Query: 395 RMQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+ TF Y APE Y + D+++ G + EL+T PI
Sbjct: 195 VVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE-PI 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 45/226 (19%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 277
+K+ +VG+G SY V + + GRIVA+K+F + D + + E+ +L
Sbjct: 25 EKYENLGLVGEG--SYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLK 79
Query: 278 RLHHCHVVPLVGYCSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
+L H ++V L+ E + K+ R LVFEF+ + + D L+ + G+++
Sbjct: 80 QLRHENLVNLL----EVCKKKK--RWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLF 131
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+ + H I+HRDIK NIL+ ++ K+ D G A R A A
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 396 MQGTFGYFAPE-------YAM-VGRASLMSDVFSFGVVLLELITGR 433
T Y APE Y V DV++ G ++ E+ G
Sbjct: 187 ---TRWYRAPELLVGDVKYGKAV-------DVWAIGCLVTEMFMGE 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 38/238 (15%), Positives = 76/238 (31%), Gaps = 35/238 (14%)
Query: 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEV 273
+ + +++G+G + VY D + +K K P + +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLM 118
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTR 330
+ L + F+ LV E G L + ++ + M
Sbjct: 119 ERLKPSMQHMFMKFY-SAHLFQNGSV---LVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----------DENLNAKITDLGMAK 379
++ A+ +E +H+ I+H DIK N +L D + + DLG +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP 435
+K + ++ T G+ E M+ D F + ++ G
Sbjct: 232 DMKLFPKGTIFTAKC---ETSGFQCVE--MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 224 TDKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLH 280
++ ++G G S+ V++ +L + VA+K+ D F E+ ++ +
Sbjct: 39 EIAYTNCKVIGNG--SFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIMRIVK 90
Query: 281 HCHVVPLVGY-CSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGVLVEGMNWDT 329
H +VV L + S K + L LV E++P L+ + +L++ +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 388
R L Y+H I HRDIK N+LLD K+ D G AK L A G P+
Sbjct: 151 --------LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GEPN 198
Query: 389 ----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQPI 436
CS R Y APE + G A+ + D++S G V+ EL+ G QP+
Sbjct: 199 VSYICS----RY-----YRAPE-LIFG-ATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 51/234 (21%)
Query: 224 TDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL 279
++ + ++G G S+ VY+ +L D G +VA+K+ D F E+ ++ +L
Sbjct: 53 EVSYTDTKVIGNG--SFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKL 104
Query: 280 HHCHVVPLVGY-CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG- 336
HC++V L + S K + L LV +++P + + + +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH------YSRAKQTLPVIY 157
Query: 337 -------AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 388
R L Y+H I HRDIK N+LLD + K+ D G AK+L P+
Sbjct: 158 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PN 213
Query: 389 ----CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPI 436
CS R Y APE + G + DV+S G VL EL+ G QPI
Sbjct: 214 VSYICS----RY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNW 327
E+ ++ L H +V L Y F+ + M +V + + G+LR L + E
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YS--FQDEEDM-FMVVDLLLGGDLRYHLQQNVHFKEE--- 115
Query: 328 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
++ I + A L+YL RI+HRD+K NILLDE+ + ITD +A L +
Sbjct: 116 TVKLFICELVMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 387 PS--CSSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 435
+ GT Y APE M D +S GV EL+ GR+P
Sbjct: 171 ITTMA--------GTKPYMAPE--MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 277
+K+ +G+G SY V++ + G+IVA+K+F D V L E+ ML
Sbjct: 3 EKYEKIGKIGEG--SYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLK 57
Query: 278 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
+L H ++V L V FR KR + LVFE+ + + LD G+ +I
Sbjct: 58 QLKHPNLVNLLEV-----FRRKRRL-HLVFEYCDH-TVLHELDRYQR-GVPEHLVKSITW 109
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ + + H+ +HRD+K NIL+ ++ K+ D G A RL A
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA- 164
Query: 396 MQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGR 433
T Y +PE Y DV++ G V EL++G
Sbjct: 165 ---TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 58/248 (23%), Positives = 89/248 (35%), Gaps = 46/248 (18%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV------------FL 270
+ + +G G V + A+K K
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 271 TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 329
E+ +L L H +++ L + LV EF G L + ++ +D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFE----QIINRHKFDE 145
Query: 330 RVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 384
A I G+ YLH+ I+HRDIK NILL + LN KI D G++ D
Sbjct: 146 CDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------I 436
GT Y APE + + + DV+S GV++ L+ G P I
Sbjct: 203 ------YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
Query: 437 HRSITKGE 444
+ + KG+
Sbjct: 256 IKKVEKGK 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 62/240 (25%)
Query: 234 GQGGSSYVYRG--QLTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+G + V LT GR VA+K KTQ P + EV ++ L+H ++V L +
Sbjct: 24 GKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR--------G 340
E L+ E+ G + D L G + E AR
Sbjct: 81 --EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE------------ARSKFRQIVSA 126
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQG 398
++Y H+ RI+HRD+K+ N+LLD ++N KI D G + G C + P
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----- 178
Query: 399 TFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
Y APE Y G DV+S GV+L L++G P + + +G+
Sbjct: 179 ---YAAPELFQGKKYD--GPE---VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 42/224 (18%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 278
+K+ VG+G +Y VY+ + + GRIVA+KR + +G P S + E+ +L
Sbjct: 21 EKYQKLEKVGEG--TYGVVYKAKDSQGRIVALKRIRLDAEDEGIP---STAIREISLLKE 75
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
LHH ++V L+ +R + LVFEFM +L+ LD + + +
Sbjct: 76 LHHPNIVSLI---DVIHSERCL-TLVFEFMEK-DLKKVLD---------ENKTGLQDSQI 121
Query: 339 --------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
RG+ + H+ RILHRD+K N+L++ + K+ D G+A +A G+P S
Sbjct: 122 KIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA---RAFGIPVRS 175
Query: 391 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
+ + T Y AP+ M + S D++S G + E+ITG+
Sbjct: 176 YTHEVV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 281
D F ++G+GG V+ Q+ G++ A K+ + + E +L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 338
+V L Y F K L LV M G++R + V + + AI A
Sbjct: 245 RFIVSLA-YA--FETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GLE+LH+ I++RD+K N+LLD++ N +I+DLG+A LKA + G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAG 351
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T G+ APE + D F+ GV L E+I R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 277
K+ +G+G +Y V++ + IVA+KR + +G P S L E+ +L
Sbjct: 2 QKYEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLK 56
Query: 278 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
L H ++V L V + + LVFEF +L+ D ++ + +
Sbjct: 57 ELKHKNIVRLHDV-----LHSDKKL-TLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLF 108
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+GL + H +LHRD+K N+L++ N K+ + G+A +A G+P S
Sbjct: 109 QLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA---RAFGIPVRCYSAEV 162
Query: 396 MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 436
+ T Y P+ + S D++S G + EL +P+
Sbjct: 163 V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ + + +G+G + VY+G +VA+K + + A + EV +L L H +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 284 VVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+V L + ++++ LVFE++ +L+ LD +N RGL
Sbjct: 62 IVTLHDI-----IHTEKSL-TLVFEYLDK-DLKQYLD-DCGNIINMHNVKLFLFQLLRGL 113
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H ++LHRD+K N+L++E K+ D G+A +A +P+ + + T
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYDNEVV--TLW 165
Query: 402 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
Y P+ + S D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 40/239 (16%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
D + +G G V+R + GR+ K T + +V E+ ++++LHH
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHP 108
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--- 339
++ L F K M +L+ EF+ G L D + E I R
Sbjct: 109 KLINLHDA---FEDKYEM-VLILEFLSGGEL---FDRIAAEDYKMSEAEVINY--MRQAC 159
Query: 340 -GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
GL+++HE I+H DIK NI+ + + KI D G+A +L D +
Sbjct: 160 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------T 210
Query: 397 QGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
T + APE VG +D+++ GV+ L++G P +++ + +
Sbjct: 211 TATAEFAAPEIVDREPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 266
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 49/273 (17%), Positives = 74/273 (27%), Gaps = 57/273 (20%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV----FLTEVDMLSR 278
K+ +GQG V + I A+K + TEV ++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-------------------CLDG 319
LHH ++ L + LV E G+L D
Sbjct: 85 LHHPNIARLYEVYED----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 320 VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR----------------ILHRDIKSSNIL 363
E +I E I HRDIK N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 364 L--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE--YAMVGRASLMSDV 419
+++ K+ D G++K GT + APE D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLN-NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 420 FSFGVVLLELITGRQP--------IHRSITKGE 444
+S GV+L L+ G P + +
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 51/249 (20%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 277
D + ++G+G S V R G+ AVK +F + G + + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICH 81
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIA 334
L H H+V L+ S M +VFEFM +L ++ VA
Sbjct: 82 MLKHPHIVELLETYSS----DGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASH 134
Query: 335 IGAAR----GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 387
R L Y H+ I+HRD+K +LL + + K+ G+A +L G
Sbjct: 135 Y--MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-- 187
Query: 388 SCSSSPARMQ---GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP------- 435
GT + APE +V R DV+ GV+L L++G P
Sbjct: 188 ------LVAGGRVGTPHFMAPE--VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
Query: 436 IHRSITKGE 444
+ I KG+
Sbjct: 240 LFEGIIKGK 248
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 61/264 (23%), Positives = 93/264 (35%), Gaps = 82/264 (31%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---------------RFKTQGGPNADSVFLTEVDMLS 277
G+G V D A+K R +G A + +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 278 R----------LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMN 326
+ L H +VV L +VFE + G + + L E
Sbjct: 82 QVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 327 WDTRVAIAIGAAR--------GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
AR G+EYLH +I+HRDIK SN+L+ E+ + KI D G++
Sbjct: 138 ----------QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 379 KRLK-ADGLPSCSS-SPARMQGTFGYFAPE--------YAMVGRASLMSDVFSFGVVLLE 428
K +D L S + +PA + APE ++ G+A DV++ GV L
Sbjct: 185 NEFKGSDALLSNTVGTPA-------FMAPESLSETRKIFS--GKA---LDVWAMGVTLYC 232
Query: 429 LITGRQP--------IHRSITKGE 444
+ G+ P +H I
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQA 256
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 59/251 (23%), Positives = 104/251 (41%), Gaps = 33/251 (13%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 266
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 267 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 326
S L EV++L +L H +++ L + + + V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED---SSSFYI-VGELYTGGELFD----EIIKRKR 117
Query: 327 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 381
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ + GT Y APE + G DV+S GV+L L++G P
Sbjct: 175 QQNTKMK------DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 436 --IHRSITKGE 444
I + + G+
Sbjct: 228 YDILKRVETGK 238
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 222 HATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
++ +F +G G +Y VY+G T G VA+K K S + E+ ++
Sbjct: 2 SSSSQFKQLEKLGNG--TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 279 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPN---GNLRDCLDGVLVEGMNWDTRVAI 333
L H ++V L V + + LVFEFM N + G G+ +
Sbjct: 60 LKHENIVRLYDV-----IHTENKL-TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
+GL + HE +ILHRD+K N+L+++ K+ D G+A +A G+P + S
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA---RAFGIPVNTFSS 167
Query: 394 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
+ T Y AP+ M R S D++S G +L E+ITG+
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 53/251 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 275
D++ S +G G V + + VA++ +F AD TE+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 276 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 330
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 242
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 387
++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 243 -LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 388 S--CSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------- 435
C GT Y APE + D +S GV+L ++G P
Sbjct: 299 RTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350
Query: 436 --IHRSITKGE 444
+ IT G+
Sbjct: 351 VSLKDQITSGK 361
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL-- 287
G+G V AVK + K + PN ++ E+ +L RL H +V+ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 339
V Y E + +V E+ G +++ LD V + A
Sbjct: 74 VLYNEE----KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ--------AHGYFCQLID 120
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA---KRLKADGLPSCSSSPARM 396
GLEYLH + I+H+DIK N+LL KI+ LG+A AD C +S
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT--CRTS---- 171
Query: 397 QGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQP 435
QG+ + PE A + D++S GV L + TG P
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ--LTDGRIVAVKRFK----TQGGPNADSVFLTEVDML 276
++ +G+G +Y V++ + GR VA+KR + +G P + EV +L
Sbjct: 11 QQYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVL 65
Query: 277 SRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
L H +VV L C+ R R +L LVFE + +L LD V G+ +T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+ RGL++LH R++HRD+K NIL+ + K+ D G+A+ S
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---------SF 172
Query: 393 PARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
+ T Y APE + + D++S G + E+ +
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-18
Identities = 66/250 (26%), Positives = 99/250 (39%), Gaps = 49/250 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--------FLTEVD 274
+ + I+G+G SS V R + AVK GG + + L EVD
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 275 MLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRV 331
+L ++ H +++ L LVF+ M G L D L E +TR
Sbjct: 76 ILRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKVTLSEK---ETRK 128
Query: 332 AI-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-- 388
+ A+ + LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 129 IMRAL--LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 389 CSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP------- 435
C GT Y APE D++S GV++ L+ G P
Sbjct: 184 C--------GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235
Query: 436 -IHRSITKGE 444
+ R I G
Sbjct: 236 LMLRMIMSGN 245
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-18
Identities = 62/238 (26%), Positives = 93/238 (39%), Gaps = 39/238 (16%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
F ++G G S V+ Q G++ A+K K S+ E+ +L ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-NEIAVLKKIKHE 66
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAARG 340
++V L + LV + + G L D GV E D + I
Sbjct: 67 NIVTLEDI---YESTTHY-YLVMQLVSGGELFDRILERGVYTEK---DASLVIQQ-VLSA 118
Query: 341 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
++YLHE I+HRD+K N+L +EN ITD G++K + M
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----------NGIMS 165
Query: 398 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
GT GY APE S D +S GV+ L+ G P + I +G
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
I+G+G S V + R A+K + + + V E D++SRL H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLEYL 344
Y + F+ +L + NG L + G E TR A I +A LEYL
Sbjct: 96 -YFT-FQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYL 146
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT Y +
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQYVS 200
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
PE A SD+++ G ++ +L+ G P I + I K E
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 47/242 (19%), Positives = 96/242 (39%), Gaps = 41/242 (16%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+ +K+ + +G+G V+R + + + K K +G E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIA 58
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +++ L F + +++FEF+ ++ + + + R ++
Sbjct: 59 RHRNILHLHES---FESMEEL-VMIFEFISGLDI---FERINTSAFELNEREIVSY--VH 109
Query: 340 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 393
L++LH I H DI+ NI+ + KI + G A++LK
Sbjct: 110 QVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---- 162
Query: 394 ARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 442
+ Y+APE + +V A +D++S G ++ L++G P I +I
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTA---TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 443 GE 444
E
Sbjct: 218 AE 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHHCHVVPLV 288
++G+GG V Q+ G++ A K+ + + L E +L +++ VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
Y + K L LV M G+L+ + + G V A GLE LH
Sbjct: 251 -YA--YETKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
RI++RD+K NILLD++ + +I+DLG+A + +G GT GY APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKG-----RVGTVGYMAPEV 356
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
R + D ++ G +L E+I G+ P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 59/244 (24%)
Query: 221 EHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKR-FKTQGGPNADSVF----LTE 272
D+F + GQG ++ V G+ G VA+K+ D F L
Sbjct: 19 RKEMDRFQVERMAGQG--TFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQI 69
Query: 273 VDMLSRLHHCHVVPL--VGYCSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGV 320
+ L+ LHH ++V L Y R +R + L +V E++P + +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 321 LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 379
L++ + R + LH + + HRDIK N+L++ + K+ D G AK
Sbjct: 130 LIKVFLFQL--------IRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 380 RLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITG 432
+L P+ CS R Y APE + G + D++S G + E++ G
Sbjct: 181 KLSPSE-PNVAYICS----RY-----YRAPEL-IFG-NQHYTTAVDIWSVGCIFAEMMLG 228
Query: 433 RQPI 436
+PI
Sbjct: 229 -EPI 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 281
+ FS I+G+GG VY + D G++ A+K + L E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 282 CH---VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA- 334
+V + Y K L + + M G+L L GV E D R A
Sbjct: 249 GDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAE 300
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSP 393
I GLE++H +++RD+K +NILLDE+ + +I+DLG+A +
Sbjct: 301 I--ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 394 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
GT GY APE G A +D FS G +L +L+ G P + TK + +
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 278
+K+ G +G+G +Y VY+ Q G A+K+ + +G P S + E+ +L
Sbjct: 2 EKYHGLEKIGEG--TYGVVYKAQNNYGETFALKKIRLEKEDEGIP---STTIREISILKE 56
Query: 279 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
L H ++V L V K+ + +LVFE + +L+ LD V G+ T + +
Sbjct: 57 LKHSNIVKLYDV-----IHTKKRL-VLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQ 108
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
G+ Y H+ R+LHRD+K N+L++ KI D G+A +A G+P + +
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA---RAFGIPVRKYTHEIV 162
Query: 397 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
T Y AP+ M + S D++S G + E++ G
Sbjct: 163 --TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 38/172 (22%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNA-DSVFLT---EVDMLS 277
++ + +G+G + VY+ + +IVA+K+ K A D + T E+ +L
Sbjct: 10 KRYEKLDFLGEG--QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 337
L H +++ L+ F K + LVF+FM D L+ ++ + + + +
Sbjct: 68 ELSHPNIIGLLDA---FGHKSNI-SLVFDFME----TD-LEVII-KDNS------LVLTP 111
Query: 338 A----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379
+ +GLEYLH+ ILHRD+K +N+LLDEN K+ D G+AK
Sbjct: 112 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 48/249 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-------RFKTQGGPNADSVFLTEVDM 275
K+ +++G+G SS V R G AVK R + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 276 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVA 332
L ++ H H++ L+ + LVF+ M G L D L E +TR
Sbjct: 153 LRQVAGHPHIITLIDSYES----SSFMFLVFDLMRKGELFDYLTEKVALSEK---ETRSI 205
Query: 333 I-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--C 389
+ ++ + +LH I+HRD+K NILLD+N+ +++D G + L+ C
Sbjct: 206 MRSL--LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 390 SSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-------- 435
GT GY APE D+++ GV+L L+ G P
Sbjct: 261 --------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
Query: 436 IHRSITKGE 444
+ R I +G+
Sbjct: 313 MLRMIMEGQ 321
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 54/240 (22%), Positives = 84/240 (35%), Gaps = 61/240 (25%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLT----EVDMLSRLHHCHVV 285
G G +V+ + V VK + K + L E+ +LSR+ H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGN-LRDCLD--GVLVEGMNWDTRVAIAIGAAR--- 339
++ + + LV E +G L +D L E + A
Sbjct: 93 KVL----DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------------ASYIF 136
Query: 340 -----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS 392
+ YL I+HRDIK NI++ E+ K+ D G A L+ L C
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 393 PARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--RSITKGE 444
GT Y APE Y G +++S GV L L+ P +
Sbjct: 191 -----GTIEYCAPEVLMGNPYR--GPE---LEMWSLGVTLYTLVFEENPFCELEETVEAA 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 51/247 (20%), Positives = 91/247 (36%), Gaps = 53/247 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 281
T+++ +G+G S V R ++ G+ A T+ D E + L H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI--GA 337
++V L SE L+F+ + G L + E A
Sbjct: 70 PNIVRLHDSISE----EGHHYLIFDLVTGGELFEDIVAREYYSE------ADASHCIQQI 119
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+ + H+ ++HR++K N+LL + K+ D G+A ++ +
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--------Q 168
Query: 395 RMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IH 437
GT GY +PE Y G+ D+++ GV+L L+ G P ++
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPY---GKP---VDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 438 RSITKGE 444
+ I G
Sbjct: 223 QQIKAGA 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 55/237 (23%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLHHC--HV 284
G GG VY G ++D VA+K PN V + EV +L ++ V
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGV 110
Query: 285 VPLVGYCSEFRGKRAMRLLVFEF-MPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAAR-- 339
+ L+ ++ + +L+ E P +L D + G L E + AR
Sbjct: 111 IRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------ARSF 154
Query: 340 ------GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGL--PSCS 390
+ + H +LHRDIK NIL+D N K+ D G LK D +
Sbjct: 155 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD- 209
Query: 391 SSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIH--RSITKGE 444
GT Y PE+ R + V+S G++L +++ G P I +G+
Sbjct: 210 -------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 49/221 (22%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL-- 76
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 339
Y + +V E++ G L D C G + E AR
Sbjct: 77 Y--QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM------------EARRLFQQILS 122
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 397
++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 175
Query: 398 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 435
Y APE ++ A D++S GV+L L+ G P
Sbjct: 176 ----YAAPE--VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 39/254 (15%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 266
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 267 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 326
S L EV++L +L H +++ L + + +V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED----SSSFYIVGELYTGGELFD----EIIKRKR 117
Query: 327 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 381
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 382 KADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--- 435
+ + +M+ GT Y APE + G DV+S GV+L L++G P
Sbjct: 175 QQNT---------KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 436 -----IHRSITKGE 444
I + + G+
Sbjct: 225 KNEYDILKRVETGK 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
S + I+G G V++ + G +A K KT+G + + V E+ ++++L H ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVMNQLDHANL 148
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----G 340
+ L F K + +LV E++ G L D ++ E N I + G
Sbjct: 149 IQLYDA---FESKNDI-VLVMEYVDGGEL---FDRIIDESYNLTELDTILF--MKQICEG 199
Query: 341 LEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ ++H+ ILH D+K NIL + KI D G+A+R K G
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NFG 250
Query: 399 TFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
T + APE Y V +D++S GV+ L++G P +I
Sbjct: 251 TPEFLAPEVVNYDFVSFP---TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 46/245 (18%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+H D + +G G V+R + G A K T + ++V E+ +S L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVL 211
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +V L F M ++++EFM G L + V E A+ R
Sbjct: 212 RHPTLVNLHDA---FEDDNEM-VMIYEFMSGGEL---FEKVADEHNKMSEDEAVEY--MR 262
Query: 340 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 393
GL ++HE +H D+K NI+ + K+ D G+ L
Sbjct: 263 QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-------- 311
Query: 394 ARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRS 439
++ T G + APE VG +D++S GV+ L++G P R+
Sbjct: 312 -SVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
Query: 440 ITKGE 444
+ +
Sbjct: 368 VKSCD 372
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 50/222 (22%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 341
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 396
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 397 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 435
GT Y APE ++ R + DV+S G+VL ++ G P
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 62/252 (24%), Positives = 99/252 (39%), Gaps = 55/252 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 275
D++ S +G G V + + VA+K +F AD TE+++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 276 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 330
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 117
Query: 331 VAI-AIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGL 386
+ + ++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 118 LYFYQM--LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 387 --PSCSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
C GT Y APE + D +S GV+L ++G P
Sbjct: 173 MRTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
Query: 436 ---IHRSITKGE 444
+ IT G+
Sbjct: 225 QVSLKDQITSGK 236
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 50/222 (22%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 341
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 396
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 397 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 435
GT Y APE ++ R + DV+S G+VL ++ G P
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 57/251 (22%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLS 277
D + +G G + V + + + G A K K + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 335
++ H +++ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHPNIITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 336 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 387
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 388 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 436 --IHRSITKGE 444
+IT
Sbjct: 224 QETLANITAVS 234
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 223 ATDKFSGS---------NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTE 272
+TD FSG +++G+G + V L + AVK + Q G VF E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 273 VDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDT 329
V+ML + H +V+ L+ + E LVFE M G++ E
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEE----EDRFYLVFEKMRGGSILSHIHKRRHFNE------ 110
Query: 330 RVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 384
A + A L++LH I HRD+K NIL ++ KI D + +K +
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 385 GLPSCSSSPARMQ--GTFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQ 434
G S S+P + G+ Y APE V A D++S GV+L L++G
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPE---VVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 435 P 435
P
Sbjct: 225 P 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 63/224 (28%), Positives = 91/224 (40%), Gaps = 55/224 (24%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKL-- 81
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 339
Y + + +V E++ G L D C +G L E +R
Sbjct: 82 Y--QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------------ESRRLFQQILS 127
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 397
G++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 180
Query: 398 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE YA G D++S GV+L L+ G P
Sbjct: 181 ----YAAPEVISGRLYA--GPE---VDIWSSGVILYALLCGTLP 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 8e-16
Identities = 58/251 (23%), Positives = 95/251 (37%), Gaps = 57/251 (22%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 277
D + +G G + V + Q G+ A K R + + EV++L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAI 335
+ H +++ L F K + +L+ E + G L D L L E A
Sbjct: 64 EIRHPNIITLHDI---FENKTDV-VLILELVSGGELFDFLAEKESLTE--------DEAT 111
Query: 336 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 387
+ G+ YLH RI H D+K NI+L N K+ D G+A +++A
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166
Query: 388 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 167 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGETK 216
Query: 436 --IHRSITKGE 444
+I+
Sbjct: 217 QETLTNISAVN 227
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 57/251 (22%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 277
D + +G G + V + + + G A K + + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 335
++ H +V+ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHHNVITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 336 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 387
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 388 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 436 --IHRSITKGE 444
+IT
Sbjct: 224 QETLANITSVS 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 37/224 (16%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 277
D++ +G+G +Y VY+ VA+KR + +G P + EV +L
Sbjct: 34 DRYRRITKLGEG--TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLK 88
Query: 278 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
L H +++ L V + L+FE+ N +L+ +D ++ +
Sbjct: 89 ELQHRNIIELKSV-----IHHNHRL-HLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLY 139
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAKRLKADGLPSCS 390
G+ + H R LHRD+K N+LL + + KI D G+A +A G+P
Sbjct: 140 QLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGIPIRQ 193
Query: 391 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
+ + T Y PE + R S D++S + E++
Sbjct: 194 FTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
++G+G V +L + ++ A+K F E D+L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEY 343
+ + F+ L LV ++ G+L L + L E M R +A + A ++
Sbjct: 140 -HYA-FQDDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVIA--IDS 190
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H+ +HRDIK NIL+D N + ++ D G +L DG S GT Y
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV----AVGTPDYI 243
Query: 404 APE-----YAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE GR D +S GV + E++ G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 34/253 (13%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS 267
H + R + D F +G G V+ + + G +K
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 268 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 327
E+++L L H +++ + F M + V E G L + + G
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEV---FEDYHNMYI-VMETCEGGELLERIVSAQARGKAL 121
Query: 328 DTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 382
+ L Y H ++H+D+K NIL + KI D G+A+ K
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 383 ADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---- 435
+D GT Y APE + D++S GVV+ L+TG P
Sbjct: 179 SD---------EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 436 ----IHRSITKGE 444
+ + T E
Sbjct: 229 SLEEVQQKATYKE 241
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 50/217 (23%), Positives = 81/217 (37%), Gaps = 31/217 (14%)
Query: 229 GSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
++G G + V G+ A+K EVD + H+V
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVC 86
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGL 341
++ + L++ E M G L + G T + IG A +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTA--I 141
Query: 342 EYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
++LH I HRD+K N+L +++ K+TD G AK + L +P
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC---Y 191
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y APE + D++S GV++ L+ G P
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 71/246 (28%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLH----HC 282
G+GG V+ G LTD VA+K ++ + L EV +L ++ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHP 98
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-----GVLVEGMNWDTRVAIAIGA 337
V+ L+ ++ + +LV E +D D G L EG
Sbjct: 99 GVIRLL----DWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGP------------ 140
Query: 338 AR--------GLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL-- 386
+R +++ H ++HRDIK NIL+D AK+ D G L D
Sbjct: 141 SRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYT 196
Query: 387 PSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--R 438
GT Y PE Y + V+S G++L +++ G P +
Sbjct: 197 DFD--------GTRVYSPPEWISRHQYH--ALP---ATVWSLGILLYDMVCGDIPFERDQ 243
Query: 439 SITKGE 444
I + E
Sbjct: 244 EILEAE 249
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 49/239 (20%), Positives = 91/239 (38%), Gaps = 55/239 (23%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHCHVVPLVGY 290
G+G + V + + G+ A K K + + L E+ +L V+ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRD-CLD---GVLVEGMNWDTRVAIAIGAAR----GLE 342
+ + +L+ E+ G + CL ++ E I + G+
Sbjct: 98 ---YENTSEI-ILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVY 145
Query: 343 YLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
YLH+ I+H D+K NILL + KI D GM++++ ++
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---------ELREI 193
Query: 400 FG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
G Y APE Y + A +D+++ G++ L+T P + +I++
Sbjct: 194 MGTPEYLAPEILNYDPITTA---TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 57/259 (22%), Positives = 91/259 (35%), Gaps = 50/259 (19%)
Query: 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-S 267
G F +A +D + +G+G S V R T G A K T+ D
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 268 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 327
E + +L H ++V L E + LVF+ + G L + +V +
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQE----ESFHYLVFDLVTGGELFE----DIVAREFY 125
Query: 328 DTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 382
A + Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 126 SEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 383 ADGLPSCSSSPARMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGR 433
GT GY +PE Y + D+++ GV+L L+ G
Sbjct: 183 DSE---------AWHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGY 227
Query: 434 QP--------IHRSITKGE 444
P ++ I G
Sbjct: 228 PPFWDEDQHRLYAQIKAGA 246
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 63/237 (26%), Positives = 95/237 (40%), Gaps = 37/237 (15%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+D F + +G+G +S VYR Q + A+K K + TE+ +L RL H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAAR 339
+++ L LV E + G L D G E D A+ I
Sbjct: 109 NIIKLKEIFET----PTEISLVLELVTGGELFDRIVEKGYYSER---DAADAVKQI--LE 159
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
+ YLHE I+HRD+K N+L + KI D G++K ++ L +
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK------TV 210
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---------IHRSITKGE 444
GT GY APE D++S G++ L+ G +P + R I E
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 5e-15
Identities = 56/246 (22%), Positives = 87/246 (35%), Gaps = 52/246 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 281
+D + +G+G S V R T G A K T+ D E + +L H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAA 338
++V L E + LVF+ + G L + E D I I
Sbjct: 65 PNIVRLHDSIQE----ESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQI--L 115
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---------A 163
Query: 396 MQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 438
GT GY +PE Y + D+++ GV+L L+ G P ++
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGYPPFWDEDQHRLYA 217
Query: 439 SITKGE 444
I G
Sbjct: 218 QIKAGA 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 34/220 (15%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
++G+G V + + T G++ A+K V F E D+L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQT-GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLE 342
+ + F+ + L LV E+ G+L L + M R +A I A ++
Sbjct: 127 --HFA-FQDEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMA--ID 176
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+H +HRDIK NILLD + ++ D G +L+ADG GT Y
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVGTPDY 229
Query: 403 FAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE G D ++ GV E+ G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 59/265 (22%), Positives = 98/265 (36%), Gaps = 62/265 (23%)
Query: 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGP 263
GT+ R E+ D + +G G + V + + + G A K R K+
Sbjct: 1 GTVFR-----QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 264 NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVL 321
+ EV +L + H +V+ L + K + +L+ E + G L D L L
Sbjct: 56 VSREDIEREVSILKEIQHPNVITLHEV---YENKTDV-ILILELVAGGELFDFLAEKESL 111
Query: 322 VEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKIT 373
E A + G+ YLH +I H D+K NI+L KI
Sbjct: 112 TE--------EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 374 DLGMAKRLKADGLPSCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLL 427
D G+A ++ + FG + APE Y +G +D++S GV+
Sbjct: 161 DFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITY 208
Query: 428 ELITGRQP--------IHRSITKGE 444
L++G P +++
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVN 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 61/224 (27%), Positives = 86/224 (38%), Gaps = 56/224 (25%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G+G V + VA+K R + V E+ L L H H++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL-- 74
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 339
Y + ++V E+ G L D + E R
Sbjct: 75 Y--DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED------------EGRRFFQQIIC 119
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 397
+EY H +I+HRD+K N+LLD+NLN KI D G++ + SC SP
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPN--- 172
Query: 398 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE YA G DV+S G+VL ++ GR P
Sbjct: 173 ----YAAPEVINGKLYA--GPE---VDVWSCGIVLYVMLVGRLP 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-15
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
++G+G G + R + T ++ A+K F E D+++ + VV L
Sbjct: 76 VIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIA-IGAARGLEYL 344
+ + F+ R L +V E+MP G+L + + + E R A + A L+ +
Sbjct: 135 --FYA-FQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKW---ARFYTAEVVLA--LDAI 184
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H +HRD+K N+LLD++ + K+ D G ++ +G+ C + GT Y +
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT----AVGTPDYIS 237
Query: 405 PE-------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 447
PE GR D +S GV L E++ G P + I + SL
Sbjct: 238 PEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 53/221 (23%), Positives = 79/221 (35%), Gaps = 51/221 (23%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G G + +VAVK + ++V E+ L H ++V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQ-REIINHRSLRHPNIVRF--K- 82
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 341
E ++ E+ G L + C G E AR G+
Sbjct: 83 -EVILTPTHLAIIMEYASGGELYERICNAGRFSED------------EARFFFQQLLSGV 129
Query: 342 EYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKRLKADGLP--SCSSSPARMQ 397
Y H + +I HRD+K N LLD + KI D G +K P +
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-------- 178
Query: 398 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 435
GT Y APE ++ R ++DV+S GV L ++ G P
Sbjct: 179 GTPAYIAPE--VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 49/238 (20%), Positives = 83/238 (34%), Gaps = 39/238 (16%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
++ N +G+G V Q A K+ + D E++++ L H
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-QEIEIMKSLDHP 66
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARG 340
+++ L + LV E G L + +V + A I
Sbjct: 67 NIIRLYETFED----NTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKDVLSA 118
Query: 341 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ Y H+ + HRD+K N L + K+ D G+A R K M+
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---------MMR 166
Query: 398 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
GT Y +P+ + G D +S GV++ L+ G P + I +G
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 51/215 (23%), Positives = 77/215 (35%), Gaps = 36/215 (16%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
G G + V + A+K + EV++ R H+V +V
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVY 124
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGLEYLHE 346
R L+V E + G L + G T + +IG A ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS 179
Query: 347 AAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTF 400
I HRD+K N+L N K+TD G AK + + T
Sbjct: 180 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTP 227
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE + D++S GV++ L+ G P
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 391 SS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
P + + APE ++ SDV+SFGV+L E+ + G P
Sbjct: 253 GDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 10/94 (10%)
Query: 231 NIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 283
+G+G V R VAVK K + ++E+ +L + HH +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL 317
VV L+G C++ G +++ EF GNL L
Sbjct: 88 VVNLLGACTKPGGP---LMVIVEFCKFGNLSTYL 118
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 44/220 (20%), Positives = 87/220 (39%), Gaps = 30/220 (13%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 278
++ +G G V R VA+K+ P + E+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 117
Query: 279 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
++H +++ L+ + + + LV E M + L V+ ++ + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----N-LCQVIQMELDHERMSYLLYQ 172
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
G+++LH A I+HRD+K SNI++ + KI D G+A+ + M
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---------M 220
Query: 397 QG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
T Y APE + D++S G ++ E++ +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 46/221 (20%), Positives = 87/221 (39%), Gaps = 32/221 (14%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 278
++ +G G V R VA+K+ P + E+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 80
Query: 279 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAI 335
++H +++ L+ + + + +V E M D L V+ ++ + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLCQVIQMELDHERMSYLLY 134
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+++LH A I+HRD+K SNI++ + KI D G+A+ +
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--------- 182
Query: 396 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
M T Y APE + D++S G ++ E+I G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 59/264 (22%), Positives = 98/264 (37%), Gaps = 71/264 (26%)
Query: 220 LEHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDM 275
LE ++ K+S +G G S+ V + G+ A+K+ D + E+D+
Sbjct: 2 LETSSKKYSLGKTLGTG--SFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDI 53
Query: 276 LSRLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---- 329
+ L H +++ L Y + + + G + +N
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 330 ------------RVAIAIGAA-----------------RGLEYLHEAAAPRILHRDIKSS 360
+V + + R + ++H I HRDIK
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 361 NILLDENLNA-KITDLGMAKRLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASL 415
N+L++ N K+ D G AK+L PS CS R Y APE M+G A+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICS----RF-----YRAPEL-MLG-ATE 218
Query: 416 MS---DVFSFGVVLLELITGRQPI 436
+ D++S G V ELI G +P+
Sbjct: 219 YTPSIDLWSIGCVFGELILG-KPL 241
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 61/228 (26%), Positives = 90/228 (39%), Gaps = 45/228 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 281
TD + +G G S R AVK + E+++L R H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SKRDPT-EEIEILLRYGQH 75
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGA-- 337
+++ L + +V E M G L D E R A A+
Sbjct: 76 PNIITLKDVYDD----GKYVYVVTELMKGGELLDKILRQKFFSE------REASAVLFTI 125
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILL-DENLNA---KITDLGMAKRLKADGLPSCSSSP 393
+ +EYLH ++HRD+K SNIL DE+ N +I D G AK+L+A+ +P
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTP 180
Query: 394 ARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
T + APE Y A D++S GV+L ++TG P
Sbjct: 181 C---YTANFVAPEVLERQGY---DAA---CDIWSLGVLLYTMLTGYTP 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 9/98 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
LE+LH+ I++RDIK NILLD N + +TD G++K AD GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGT 223
Query: 400 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
Y AP+ G + D +S GV++ EL+TG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 52/238 (21%), Positives = 83/238 (34%), Gaps = 51/238 (21%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKR-FKTQGGPNADSVF---------LT 271
++ + G V G ++G VA+KR F T ++ L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 272 EVDMLSRLHHCHVVPLV-----GYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGM 325
E+ +L+ HH +++ L LV E M L V+ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKL----YLVTELM------RTDLAQVIHDQR 128
Query: 326 NWDTRVAIA-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ I I GL LHEA ++HRD+ NILL +N + I D +A+
Sbjct: 129 IVISPQHIQYFMYHI--LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 381 LKADGLPSCSSSPARMQG---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGR 433
AD Y APE ++ D++S G V+ E+ +
Sbjct: 184 DTADA---------NKTHYVTHRWYRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 46/244 (18%), Positives = 84/244 (34%), Gaps = 78/244 (31%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 281
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 282 CHVVPL---VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------------VLVEGMN 326
+++ L V LVFE + N + + +L
Sbjct: 91 PNIITLADIVKDPVSRT-----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----- 140
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 385
+ L+Y H I+HRD+K N+++D E+ ++ D G+A+
Sbjct: 141 ------------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------ 179
Query: 386 LPSCSSSPAR-MQG---TFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITG 432
P + + + PE Y++ D++S G +L +I
Sbjct: 180 ----FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFR 227
Query: 433 RQPI 436
++P
Sbjct: 228 KEPF 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
G+G S + + AVK + ++ E+ L H ++V L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLHEAAA 349
+ + LV E + G L + + + ++ A I + ++H+
Sbjct: 76 HD----QLHTFLVMELLNGGEL---FERIKKKK-HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 350 PRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYF 403
++HRD+K N+L ++NL KI D G A+ D P C T Y
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--------FTLHYA 176
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE D++S GV+L +++G+ P
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 49/189 (25%), Positives = 77/189 (40%), Gaps = 37/189 (19%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 324
L E +L ++ +V L F+ L +V E++ G +LR G E
Sbjct: 89 LNEKRILQAVNFPFLVKLEFS---FKDNS--NLYMVMEYVAGGEMFSHLRRI--GRFSEP 141
Query: 325 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
R A I EYLH +++RD+K N+L+D+ ++TD G AKR+K
Sbjct: 142 H---ARFYAAQIVLT--FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-------- 435
C GT APE + + D ++ GV++ E+ G P
Sbjct: 194 RTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 436 IHRSITKGE 444
I+ I G+
Sbjct: 246 IYEKIVSGK 254
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 54/233 (23%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 273
E D++ +++G+G V + + VA+K F Q EV
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--------QIEV 101
Query: 274 DMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 325
+L + ++ V L + FR + VFE + + NL D L G+
Sbjct: 102 RLLELMNKHDTEMKYYI--VHLKRH-FMFRNHLCL---VFEML-SYNLYDLLRNTNFRGV 154
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKA 383
+ + A L +L I+H D+K NILL + KI D G +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS----- 208
Query: 384 DGLPSCSSSPAR---MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
C +Q F Y +PE + L D++S G +L+E+ TG
Sbjct: 209 -----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 35/224 (15%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 276
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLL 77
Query: 277 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
+ H +V+ L+ + R LV FM +L+ + E + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSE----EKIQYLV 132
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+GL+Y+H A ++HRD+K N+ ++E+ KI D G+A+ A+
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---------- 179
Query: 395 RMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 433
M G T Y APE ++ + D++S G ++ E++TG+
Sbjct: 180 -MTGYVVTRWYRAPE-VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 28/119 (23%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L +LH+ I++RD+K NI+L+ + K+TD G+ K DG + + GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-----FCGT 184
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
Y APE + RA D +S G ++ +++TG P I K +
Sbjct: 185 IEYMAPEILMRSGH---NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 28/119 (23%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L++LH I++RD+K NILLDE + K+TD G++K + S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-----FCGT 189
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
Y APE + ++ +D +SFGV++ E++TG P I K +
Sbjct: 190 VEYMAPEVVNRRGH---TQS---ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 19/102 (18%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L+YLH +++RD+K N++LD++ + KITD G+ K DG + GT
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGT 312
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE Y GRA D + GVV+ E++ GR P
Sbjct: 313 PEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLP 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 40/105 (38%), Positives = 55/105 (52%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-- 397
LEYLH +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTF 165
Query: 398 -GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y GRA D + GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLP 204
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 49/195 (25%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 324
E MLS + H ++ + + + F+ + ++ ++ +++ G LR
Sbjct: 54 NDERLMLSIVTHPFIIRM--WGT-FQDAQ--QIFMIMDYIEGGELFSLLRKS--QRFPNP 106
Query: 325 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+ + A + A LEYLH I++RD+K NILLD+N + KITD G AK +
Sbjct: 107 V---AKFYAAEVCLA--LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 384 DGLPSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-- 435
C GT Y APE Y ++ D +SFG+++ E++ G P
Sbjct: 159 VTYTLC--------GTPDYIAPEVVSTKPY---NKS---IDWWSFGILIYEMLAGYTPFY 204
Query: 436 ------IHRSITKGE 444
+ I E
Sbjct: 205 DSNTMKTYEKILNAE 219
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L +LH+ I++RD+K N+LLD + K+ D GM K +G+ + + GT
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGT 187
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE Y G A D ++ GV+L E++ G P
Sbjct: 188 PDYIAPEILQEMLY---GPA---VDWWAMGVLLYEMLCGHAP 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 26/109 (23%), Positives = 49/109 (44%), Gaps = 25/109 (22%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
R ++ LH + ++HRD+K SN+L++ N + K+ D G+A+ + + + +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 399 TFGYF------APEYAMVGRASLMS--------DVFSFGVVLLELITGR 433
+ APE +++ DV+S G +L EL R
Sbjct: 180 V-EFVATRWYRAPEV-------MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 33/105 (31%), Positives = 43/105 (40%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
L YLH I++RD+K NILLD + +TD G+ K + C
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC------- 200
Query: 397 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y R D + G VL E++ G P
Sbjct: 201 -GTPEYLAPEVLHKQPY---DRT---VDWWCLGAVLYEMLYGLPP 238
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 26/112 (23%), Positives = 51/112 (45%), Gaps = 20/112 (17%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ ++YLH +LHRD+K SNILL+ + K+ D G+++ + + + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 399 TFGYFAPEYAMVG-------RA--SLMS--------DVFSFGVVLLELITGR 433
T + + + RA L+ D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 276
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLL 78
Query: 277 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVL-VEGMNWDTRVA 332
+ H +V+ L+ + LV FM L ++ E + D
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDRIQF 132
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+ +GL Y+H A I+HRD+K N+ ++E+ KI D G+A++ ++
Sbjct: 133 LVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-------- 181
Query: 393 PARMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 433
M G T Y APE ++ R + D++S G ++ E+ITG+
Sbjct: 182 ---MTGYVVTRWYRAPE-VILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 14/99 (14%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPS--CSSSPARM 396
GL++LH I++RD+K NILLD++ + KI D GM K + D + C
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC------- 179
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE + + + D +SFGV+L E++ G+ P
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 184
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++FGV+L E++ G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 9e-11
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 171
Query: 397 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 172 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 214
Query: 397 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 215 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 252
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 14/100 (14%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A +LHRD+K SN+LL+ + KI D G+A+ D +
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-----HDHTGFLTE 190
Query: 399 ---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGR 433
T Y APE M+ D++S G +L E+++ R
Sbjct: 191 YVATRWYRAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 20/100 (20%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTADEMTG 188
Query: 399 ---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 433
T Y APE M+ + D++S G ++ EL+TGR
Sbjct: 189 YVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 505
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++FGV+L E++ G+ P
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 41/165 (24%), Positives = 61/165 (36%), Gaps = 24/165 (14%)
Query: 225 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 282
D S ++G G + V + A+K + EV++ R
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCP 71
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGA 337
H+V +V R L+V E + G L + G T + +IG
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 379
A ++YLH I HRD+K N+L N K+TD G AK
Sbjct: 129 A--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 2e-10
Identities = 37/224 (16%), Positives = 63/224 (28%), Gaps = 57/224 (25%)
Query: 201 CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVK--RFK 258
C K + FS+ T+K +G+G V++ D VA+K +
Sbjct: 5 CSQKG------PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIE 54
Query: 259 TQGGPNADS-----VFLTEVDML-----------------SRLHHCHVV------PLVGY 290
N L E+ + L+ H V L+
Sbjct: 55 GPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKA 114
Query: 291 CSEFRGKRAMRL------------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+ + +V EF G L+ + + + T +I
Sbjct: 115 WDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLT 171
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382
L + R HRD+ N+LL + K+ K
Sbjct: 172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 53/235 (22%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 273
+H ++ ++G+G V + + VA+K RF Q E+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEI 144
Query: 274 DMLSRL------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMN 326
+L L + +V+ ++ FR + + FE + + NL + + +G +
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLEN-FTFRN----HICMTFELL-SMNLYELIKKNKFQGFS 198
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKAD 384
A + L+ LH+ RI+H D+K NILL + + K+ D G
Sbjct: 199 LPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG-------- 247
Query: 385 GLPSCSSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
SS +Q F Y APE + R + D++S G +L EL+TG
Sbjct: 248 -----SSCYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 58/224 (25%)
Query: 222 HATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVD 274
D++ +++G G SY V + R+VA+K+ D + L E+
Sbjct: 50 QIPDRYEIRHLIGTG--SYGHVCEAYDKLEKRVVAIKKI---LRVFEDLIDCKRILREIA 104
Query: 275 MLSRLHHCHVVPLV-----GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWD 328
+L+RL+H HVV ++ +F L +V E D
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDE-----LYVVLEIAD-----------------SD 142
Query: 329 TRVAIAIGAA--------------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374
+ G++Y+H A ILHRD+K +N L++++ + K+ D
Sbjct: 143 FKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCD 199
Query: 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
G+A R S P + ++
Sbjct: 200 FGLA-RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 15/101 (14%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + S +
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH-----YSHKGHLS 182
Query: 398 G---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGR 433
T Y +P ++ + D+++ G + E++TG+
Sbjct: 183 EGLVTKWYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 37/123 (30%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
G ++HE+ I+HRD+K +N LL+++ + K+ D G+A+ + ++ + + +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 399 TFG-----------------YFAPEYAMVGRASLMS---------DVFSFGVVLLELITG 432
Y APE L+ D++S G + EL+
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPE--------LILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 433 RQP 435
Q
Sbjct: 249 LQS 251
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 48/227 (21%), Positives = 86/227 (37%), Gaps = 45/227 (19%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEVDMLSRLHHC-- 282
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--------EDEIKLLQRVNDADN 77
Query: 283 ---------HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
H++ L+ + +G + + +VFE + NL + G+
Sbjct: 78 TKEDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE------NLNAKITDLGMAKRLKADGL 386
I+ GL+Y+H I+H DIK N+L++ + KI DLG A
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
S + Y +PE + +D++S ++ ELITG
Sbjct: 194 NSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 27/214 (12%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G +Y G + VA+K + L E + L +P V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 292 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ V + + P+ +L + ++ T + +A +E++H +
Sbjct: 72 GVEGDYNVL---VMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 350 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 404
LHRDIK N L+ A I D G+AK+ + + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 405 PEYAMVGRASLMS---DVFSFGVVLLELITGRQP 435
+G S D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVK--RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G + G+ L VA+K K++ E +L +P V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVY 71
Query: 290 YCSEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
Y AM V E + P+ +L D D + T + IAI +EY+H
Sbjct: 72 YFGPCGKYNAM---VLELLGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHSK 124
Query: 348 AAPRILHRDIKSSNILL--DENLNAK---ITDLGMAKR 380
+++RD+K N L+ N + I D +AK
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 41/241 (17%), Positives = 78/241 (32%), Gaps = 49/241 (20%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRG--QLTDGRIVAVK------RFKTQGGPNADSVFLTE 272
+ +++ +G+G V VA+K +++ E
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLE 66
Query: 273 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVE 323
+++L ++ C V + F G + + FE + N + L +
Sbjct: 67 INVLKKIKEKDKENKFLC--VLMSD-WFNFHG----HMCIAFELL-GKNTFEFLKENNFQ 118
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+A L +LHE ++ H D+K NIL + + + + K+
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 384 DGLPSC------SSSPARMQGT------FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
S S++ T Y PE + + DV+S G +L E
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 432 G 432
G
Sbjct: 235 G 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 23/212 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G +Y G + G VA+K + E + + +P + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 292 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
M V E + P+ +L + + T + +A +EY+H
Sbjct: 74 GAEGDYNVM---VMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 350 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 404
+HRD+K N L+ I D G+AK+ + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 405 PEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 435
+G S D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 42/230 (18%), Positives = 81/230 (35%), Gaps = 39/230 (16%)
Query: 233 VGQGGSSYVYRGQ---------LTDGRIVAVKRFKTQGGPNADSVFLT------EVDMLS 277
+ +Y + ++K G + F +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 278 RLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIA 334
+L+ + +P + K R LV + G +L+ LD ++ + + +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK--YRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG--LPSCS 390
LE+LHE +H ++ + NI +D +++T G A R G +
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 391 SSPARMQGTFGYFAPEYAMV----GRA-SLMSDVFSFGVVLLELITGRQP 435
S + +G E+ + G S SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 42/214 (19%), Positives = 76/214 (35%), Gaps = 25/214 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 292 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ + V + + P+ +L D + T A ++ +HE +
Sbjct: 75 GQEGLHNVL---VIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 350 PRILHRDIKSSNILLDENLNAK-----ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGY 402
+++RDIK N L+ + + D GM K + + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 403 FAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 435
+GR S D+ + G V + + G P
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 46/259 (17%), Positives = 83/259 (32%), Gaps = 71/259 (27%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G S V+ + + VA+K K+ ++ E+ +L + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD-------- 94
Query: 292 SEFRGKRAMRLLVFEFM---PNG------------NLRDCLDGVLVEGMNWDTRVAIAIG 336
+ + L+ +F NG +L + +G+ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSP 393
+GL+YLH RI+H DIK NILL ++ + + +R A + S
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 394 ARMQG--------------------------------------TFGYFAPEYAMVGRA-S 414
A T Y + E ++G +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE-VLIGSGYN 271
Query: 415 LMSDVFSFGVVLLELITGR 433
+D++S + EL TG
Sbjct: 272 TPADIWSTACMAFELATGD 290
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 45/240 (18%), Positives = 83/240 (34%), Gaps = 47/240 (19%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVK------RFKTQGGPNADSVFLTE 272
+ + ++ + +G+G V GR VAVK R+ +E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSE 61
Query: 273 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG 324
+ +L L C V ++ E G + VFE + + D +
Sbjct: 62 IQVLEHLNTTDPNSTFRC--VQMLE-WFEHHGHICI---VFELL-GLSTYDFIKENGFLP 114
Query: 325 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384
D +A + + +LH ++ H D+K NIL ++ + + + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 385 GLPSC------SSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 432
P S++ + Y APE + S DV+S G +L+E G
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 49/250 (19%), Positives = 80/250 (32%), Gaps = 63/250 (25%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 273
+ F +G G V Q + + + AVK ++ E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--------KIEA 82
Query: 274 DMLSRL-------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGM 325
D+L ++ ++ V G + + L+FE + +L + + G
Sbjct: 83 DILKKIQNDDINNNNI--VKYHG-KFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGF 134
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
+ + I + L YL + + H D+K NILLD+ K
Sbjct: 135 HIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 386 LPSCSSSPARMQGTFG-----------------YFAPE------YAMVGRASLMSDVFSF 422
+ S FG Y APE + + SD++SF
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSF 245
Query: 423 GVVLLELITG 432
G VL EL TG
Sbjct: 246 GCVLAELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 2e-06
Identities = 80/515 (15%), Positives = 132/515 (25%), Gaps = 144/515 (27%)
Query: 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRS----------CDCSPA-- 64
++ I + + S L D K N SR + PA
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 65 -----VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKV 119
V GS GK T + A D SY C + + + V
Sbjct: 153 VLIDGVLGS--GK-TWV-ALD-----VCLSYKVQC-----KMDFKIFWLNLKNCNSPETV 198
Query: 120 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESCNSATNLISHRITSVPE 179
+ ++ L + + RS S+ K +S + + S P
Sbjct: 199 LEMLQKLLYQID---------------PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 180 TR----------VEVVSPIDLATGC-FLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFS 228
+ + +L C L TT R K T + ++ +L+H + +
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNL--SCKILLTT--RFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV-DMLSRLHH-CHVVP 286
+ Y+ D R + R P S+ + D L+ + HV
Sbjct: 300 PDEVKSL-LLKYL------DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV-- 350
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN---------WD------- 328
C + L V E P R D V + W
Sbjct: 351 ---NCDKLTTIIESSLNVLE--PA-EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 329 --------TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ + ++ ++K + + L+ I D
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPS------IYLELK-VKLENEYALHRSIVD----HY 453
Query: 381 LKADGLPSCSSSPARMQGTF----GYFAPEYAMVGRASLMSDVF-SFGVVLLELITGRQP 435
S P + F G+ R +L VF F + Q
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL-------EQK 506
Query: 436 IHRSITKGEESLVLWTATG----------IYLDHI 460
I T W A+G Y +I
Sbjct: 507 IRHDST-------AWNASGSILNTLQQLKFYKPYI 534
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 48/231 (20%), Positives = 76/231 (32%), Gaps = 44/231 (19%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV------- 284
+G GG +Y A K + + +E+ R+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE--YQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 285 -------VPLVGYCSEFRGK-RAMRLLVFEFM-PN-GNLRDC-----LDGVLVEGMNWDT 329
+PL K R+ R +V E + + + VL
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ------- 155
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG-- 385
+ I LEY+HE +H DIK++N+LL ++ D G++ R +G
Sbjct: 156 ---LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
+ GT F A G A S SDV G +L + G+ P
Sbjct: 210 KQYQENPRKGHNGTI-EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 13/102 (12%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG----LPSCSSSPA 394
LEY+HE +H DIK+SN+LL+ ++ D G+A R +G +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC- 220
Query: 395 RMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
GT F A G A S D+ G +++ +TG P
Sbjct: 221 -HDGTI-EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 460 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.03 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.31 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.19 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.48 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.44 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.98 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 89.54 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 88.81 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 87.26 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 86.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.27 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 84.8 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 84.67 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 83.51 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 83.45 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 82.49 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=388.56 Aligned_cols=214 Identities=27% Similarity=0.401 Sum_probs=180.0
Q ss_pred CCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
+++..+.||+|+||+||+|.+. +++.||||+++........+.|.+|+.+|++++|||||+++|+|.+ +.
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~ 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----DQ 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----CC
Confidence 3455688999999999999863 4678999999876666666789999999999999999999999986 44
Q ss_pred eEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
..+|||||+++|+|.++|.... ...++|.+++.|+.|||+||+|||+.+ |+||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 6799999999999999996432 235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcCc
Q 012599 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444 (460)
Q Consensus 366 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~~~ 444 (460)
+++++||+|||+++........ .......||+.|||||++..+.++.++|||||||+||||+| |+.||.....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--- 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB---CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---
T ss_pred CCCCEEECCcccceeccCCCce---eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999876544321 22344678999999999999999999999999999999999 8999986543
Q ss_pred hhHHHHhh
Q 012599 445 ESLVLWTA 452 (460)
Q Consensus 445 ~~l~~~~~ 452 (460)
..+...+.
T Consensus 254 ~~~~~~i~ 261 (308)
T 4gt4_A 254 QDVVEMIR 261 (308)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 34444443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=384.89 Aligned_cols=205 Identities=31% Similarity=0.457 Sum_probs=174.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|.+.+.||+|+||+||+|++. +++.||||+++... ....+.|.+|+++|++++|||||+++|+|.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEee----C
Confidence 56777899999999999999874 47889999997542 3345679999999999999999999999986 4
Q ss_pred ceEEEEEeecCCCCHHHHhcccc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
...+|||||+++|+|.++|+... ...++|.+++.++.|||+||+|||+++ |+||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 56799999999999999996532 346999999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+.+||+|||+++........ .......||+.|||||++....++.++|||||||+||||+| |+.||....
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CcEEECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999876543221 12233568999999999999999999999999999999999 999998654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=385.02 Aligned_cols=205 Identities=30% Similarity=0.459 Sum_probs=169.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|.+.+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----C
Confidence 45667789999999999999874 4788999999753 33445679999999999999999999999986 4
Q ss_pred ceEEEEEeecCCCCHHHHhcccc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVL-------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
...+|||||+++|+|.++|+... ..+++|.+++.|+.|||+||+|||+.+ |+||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 56799999999999999996532 235899999999999999999999998 99999999999999
Q ss_pred CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 366 ~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+++.+||+|||+++........ .......||+.|||||++....++.++|||||||+||||+| |+.||....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp TTTEEEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred CCCcEEEcccccceeccCCCcc---eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999876543321 12334578999999999999999999999999999999999 999998654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=382.97 Aligned_cols=207 Identities=31% Similarity=0.443 Sum_probs=171.4
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
|+...+++.+.+.||+|+||+||+|++.+ .||||+++... .....+.|.+|+++|++++|||||+++|++.+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----- 103 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----- 103 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----
Confidence 44556788889999999999999998753 59999997543 23344669999999999999999999999864
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
..++|||||+++|+|.++|+... ..++|.+++.|+.|||.||+|||+++ |+||||||+||||++++++||+|||+|
T Consensus 104 ~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 104 DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCc
Confidence 24699999999999999997543 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+....... ........||+.|||||++.. +.|+.++|||||||+||||+||+.||....
T Consensus 180 ~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 180 TVKSRWSG---SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp BC---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eecccCCc---ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 87643221 112344679999999999853 468999999999999999999999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=384.75 Aligned_cols=204 Identities=24% Similarity=0.311 Sum_probs=173.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++++.||+|+||+||+|+.. +|+.||||++..... ....+.|.+|+++|++++|||||++++++.+ +...|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----~~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----NGSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 57899999999999999999875 589999999976532 2334568999999999999999999999876 56789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
|||||+++|+|.++|.......+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999997655566899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||....
T Consensus 177 ~~~-----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 177 STV-----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp HHH-----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc-----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 321 11223579999999999999999999999999999999999999997643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=378.17 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=178.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+.|+..+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+ ....|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 356889999999999999999986 589999999975433 334458899999999999999999999887 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
|||||+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+.
T Consensus 148 ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 221 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221 (346)
T ss_dssp EEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence 99999999999999975 45999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......+||+.|||||++....|+.++|||||||+||||++|+.||....
T Consensus 222 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 222 KEV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp SSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCC-----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 432 22345689999999999999999999999999999999999999997643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=373.35 Aligned_cols=204 Identities=27% Similarity=0.402 Sum_probs=179.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+++|++++|||||++++++.+ +...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 46889999999999999999875 58999999996431 23345568999999999999999999999876 5578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
|+||||+++|+|.++++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+|+.+
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999999764 45999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .......+||+.|||||++.+..|+.++|||||||+||||+||+.||....
T Consensus 183 ~~~~~---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 238 (311)
T 4aw0_A 183 SPESK---QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238 (311)
T ss_dssp CTTTT---CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCC---cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 54321 122345689999999999999999999999999999999999999997543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=368.18 Aligned_cols=201 Identities=27% Similarity=0.386 Sum_probs=171.5
Q ss_pred cccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
+..+.||+|+||+||+|.+. +++.||+|++.... .....+.|.+|+++|++++|||||++++++.+........+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34467999999999999876 48899999997543 23334569999999999999999999999876555556789999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCccccccC
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~~ 384 (460)
||+++|+|.++++.. ..+++..+..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 999999999999764 56999999999999999999999875 4599999999999998 4889999999999754321
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
......||+.|||||++.+ .|+.++|||||||+||||+||+.||...
T Consensus 186 -------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 186 -------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp -------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2234679999999998764 6999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=376.16 Aligned_cols=202 Identities=27% Similarity=0.334 Sum_probs=171.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+.|+..+.||+|+||.||+|++. +|+.||||+++.... +.+|+.+|++++|||||++++++.+ ....+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~----~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE----GPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 45777889999999999999985 489999999976432 3579999999999999999999876 557899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 382 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~~~ 382 (460)
||||+++|+|.++|+.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+|+...
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999764 45999999999999999999999998 99999999999999887 69999999999876
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.++...........+||+.|||||++.+..++.++|||||||+||||+||+.||.....
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 65433222233446799999999999999999999999999999999999999986544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=380.55 Aligned_cols=219 Identities=26% Similarity=0.407 Sum_probs=186.1
Q ss_pred eechHHHHHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccc
Q 012599 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVP 286 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~ 286 (460)
.++..+|+...++|++.+.||+|+||+||+|.+.. ++.||||+++........+.|.+|+++|++++ |||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34556788888999999999999999999998643 36899999987655555667999999999995 589999
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~i 352 (460)
++|+|.+. ....++|||||++|+|.++|+... ...+++.+++.++.|||+||+|||+++ |
T Consensus 133 l~g~~~~~---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 133 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp EEEEECCT---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEEec---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 99998752 235699999999999999996532 234899999999999999999999998 9
Q ss_pred EecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-
Q 012599 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 431 (460)
Q Consensus 353 vH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt- 431 (460)
|||||||+|||+++++.+||+|||+|+....+... .......||+.|||||++.+..++.++|||||||+||||+|
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~ 283 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 283 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhC
Confidence 99999999999999999999999999876543221 12334578999999999999999999999999999999998
Q ss_pred CCCCCCCCCC
Q 012599 432 GRQPIHRSIT 441 (460)
Q Consensus 432 G~~Pf~~~~~ 441 (460)
|+.||.....
T Consensus 284 G~~Pf~~~~~ 293 (353)
T 4ase_A 284 GASPYPGVKI 293 (353)
T ss_dssp SCCSSTTCCC
T ss_pred CCCCCCCCCH
Confidence 9999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=379.41 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=178.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+.|+..+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+ ....|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEE----CCEEE
Confidence 467999999999999999999986 589999999976543 334558999999999999999999999887 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
|||||+++|+|.++++. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999999965 45999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......+||+.|||||++....|+.++|||||||+||||++|+.||....
T Consensus 299 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 299 KEV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp SSC-----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCC-----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 432 22345689999999999999999999999999999999999999997643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=369.48 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=169.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|++.+.||+|+||+||+|+.. .++.||||+++... .......+.+|+++|++++|||||++++++.+ +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----EG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE----TT
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CC
Confidence 56889999999999999999863 47899999997542 11222348899999999999999999999886 56
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.++|... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 789999999999999999764 46999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......+||+.|||||++....++.++|||||||+||||+||+.||....
T Consensus 175 ~~~~~~-----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 175 ESIDHE-----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp C----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCC-----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 654332 22345689999999999999999999999999999999999999997643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=367.61 Aligned_cols=205 Identities=27% Similarity=0.356 Sum_probs=164.5
Q ss_pred CCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
+|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.......++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 466678999999999999998 58999999996432 112223345555678899999999999987655455789999
Q ss_pred eecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-----~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
||+++|+|.++|+. ..++|..+++++.|+|+||+|||++ ..++|+||||||+||||++++++||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 99999999999975 4589999999999999999999986 234599999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccC------CCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
........ ........||+.|||||++.+. .++.++|||||||+||||+||..||.
T Consensus 158 ~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 158 HDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EETTTTEE-SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred ccCCCCce-eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 65443211 1223346799999999998754 46789999999999999999987664
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=355.79 Aligned_cols=199 Identities=26% Similarity=0.357 Sum_probs=161.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||+||+|... +|+.||||++.... .......+.+|+++|++++||||+++++++.+ ....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS----KDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEE
Confidence 57999999999999999999875 58999999997543 23344568999999999999999999999876 5578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+..
T Consensus 89 ~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999999 78999999754 56999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ......||+.|||||++.+..+ +.++|||||||+||||+||+.||...
T Consensus 163 ~~~~------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 163 TDGN------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCC------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 4432 2334679999999999988776 68999999999999999999999754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=355.70 Aligned_cols=208 Identities=25% Similarity=0.384 Sum_probs=164.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-------
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------- 296 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------- 296 (460)
++|++.+.||+|+||+||+|+.. +|+.||||+++........+.+.+|+++|++++|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999875 5899999999765544455668999999999999999999999875332
Q ss_pred -ccceEEEEEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEe
Q 012599 297 -KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (460)
Q Consensus 297 -~~~~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~D 374 (460)
.....++||||+++|+|.+++..... ...++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 12357899999999999999975432 33667788999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCC-------CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 375 LGMAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 375 FGla~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
||+|+.......... .......+||+.|||||++.+..|+.++|||||||+||||++ ||..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999988765432111 112234579999999999999999999999999999999996 8864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=353.45 Aligned_cols=210 Identities=23% Similarity=0.343 Sum_probs=175.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Cccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~~ 300 (460)
++|++.+.||+|+||+||+|.+. +|+.||||+++..... ...+.+++|+++|+.++|||||++++++.... .....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999875 5999999999754332 23345889999999999999999999876532 23457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.||||||++ |+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 7899999754 56999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
+....... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 208 ~~~~~~~~-~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 208 LCTSPAEH-QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp C--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cccCcccc-ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 64432111 2233457899999999998764 569999999999999999999999976543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=345.15 Aligned_cols=208 Identities=21% Similarity=0.332 Sum_probs=172.5
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
+.+....++|++.+.||+|+||+||+|+.. .++.||+|.+.... ....+.+|+++|+.+ +||||+++++++.
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 344456788999999999999999999863 46789999986542 334578999999998 7999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEE
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAK 371 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vk 371 (460)
+ ....++||||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 91 ~----~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 91 K----NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp E----TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEE
T ss_pred E----CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEE
Confidence 6 557899999999999999984 4899999999999999999999999 9999999999999877 7999
Q ss_pred EEecCCccccccCCCCC-----------------------CCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHH
Q 012599 372 ITDLGMAKRLKADGLPS-----------------------CSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLL 427 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~ 427 (460)
|+|||+|+......... ........+||+.|+|||++.+. .++.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 99999998654322110 00112335799999999998765 5899999999999999
Q ss_pred HHHhCCCCCCCCC
Q 012599 428 ELITGRQPIHRSI 440 (460)
Q Consensus 428 elltG~~Pf~~~~ 440 (460)
||++|+.||....
T Consensus 239 ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 239 SLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHTCSSSSCCS
T ss_pred HHHHCCCCCCCCC
Confidence 9999999997654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=362.95 Aligned_cols=208 Identities=27% Similarity=0.395 Sum_probs=174.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHH---HHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... .......+.+| +.+++.++|||||++++++.+ .
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----C
Confidence 67999999999999999999886 48999999996431 11222234444 556667799999999999876 5
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...||||||++||+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 6789999999999999999764 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHH
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~ 448 (460)
+..... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+...+.
T Consensus 340 ~~~~~~-------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~ 403 (689)
T 3v5w_A 340 CDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403 (689)
T ss_dssp EECSSC-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred eecCCC-------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 876443 2345689999999999975 57999999999999999999999999865544433333
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.40 Aligned_cols=202 Identities=25% Similarity=0.334 Sum_probs=176.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+++|+.++|||||++++++.+ ....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 367999999999999999999885 58999999997543 2234558899999999999999999999876 56789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC--CcEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~--~~vkl~DFGla~~ 380 (460)
|||||+++|+|.++|.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999999996532 45899999999999999999999998 9999999999999854 8999999999998
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+.... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||....
T Consensus 307 ~~~~~------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~ 360 (573)
T 3uto_A 307 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360 (573)
T ss_dssp CCTTS------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ccCCC------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 75432 2234579999999999999999999999999999999999999997643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.44 Aligned_cols=220 Identities=43% Similarity=0.776 Sum_probs=188.5
Q ss_pred ceeeeechHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceee
Q 012599 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289 (460)
Q Consensus 210 ~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g 289 (460)
+....|++.+++.+.++|+..+.||+|+||.||+|...+++.||||++...........+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34578999999999999999999999999999999988899999999987654444446899999999999999999999
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
++.+ ....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+...++|+||||||+|||++++
T Consensus 95 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 95 FCMT----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp EECC----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred EEec----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 9876 3456899999999999999976432 349999999999999999999999922239999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
+.+||+|||++........ .......||+.|+|||.+....++.++||||||+++|||++|+.||.
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDT----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCEEECCCSSCEECCSSSS----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCEEeccCccccccCcccc----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999999987644321 12233458999999999988889999999999999999999999996
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=324.43 Aligned_cols=228 Identities=43% Similarity=0.714 Sum_probs=192.0
Q ss_pred eeechHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012599 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (460)
Q Consensus 213 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 292 (460)
.++++.+++.++++|+..+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4555667778899999999999999999999998889999999987643 345566899999999999999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcE
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
+ ....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 106 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~ 178 (321)
T 2qkw_B 106 E----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178 (321)
T ss_dssp C----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCE
T ss_pred C----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCE
Confidence 5 4467999999999999999975432 34899999999999999999999998 9999999999999999999
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHH
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~ 450 (460)
||+|||++........ ........||+.|+|||.+....++.++||||||+++|||++|+.||....+.+...+..|
T Consensus 179 kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 179 KITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp EECCCTTCEECSSSSC---CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred EEeecccccccccccc---cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 9999999986543221 1122334689999999999888999999999999999999999999987766555555555
Q ss_pred h
Q 012599 451 T 451 (460)
Q Consensus 451 ~ 451 (460)
.
T Consensus 256 ~ 256 (321)
T 2qkw_B 256 A 256 (321)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.36 Aligned_cols=201 Identities=26% Similarity=0.429 Sum_probs=176.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|+..+.||+|+||+||+|.+ .+++.||||++...... ..+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----CCEEE
Confidence 46799999999999999999986 45899999999755433 34568999999999999999999999876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999999975 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 168 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp STTC-----CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred Cccc-----ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 2234568999999999999999999999999999999999999997643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=334.85 Aligned_cols=214 Identities=22% Similarity=0.313 Sum_probs=181.5
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 291 (460)
+.+.++....++|++.+.||+|+||+||+|++.+ ++.||+|+++... .......+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666778899999999999999999999875 7889999986421 111222388999999999999999999998
Q ss_pred eeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEE
Q 012599 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 292 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
.+ ....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 144 ~~----~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 144 QD----DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp EC----SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEE
Confidence 76 55789999999999999999763 256999999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+|||+++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 216 L~DFGla~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp ECCCTTCEECCTTSC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EcchhhhhhcccCCC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987654321 1223357999999999986 4678999999999999999999999997644
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.03 Aligned_cols=211 Identities=23% Similarity=0.379 Sum_probs=183.3
Q ss_pred eeechHHHHHHhcC----------CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC
Q 012599 213 IRFSYSALEHATDK----------FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH 281 (460)
Q Consensus 213 ~~~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H 281 (460)
..|+++++..+++. |+..+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 35778888888765 677789999999999999986 69999999997654 3344568899999999999
Q ss_pred CCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCC
Q 012599 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (460)
Q Consensus 282 ~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~N 361 (460)
|||+++++++.. ....++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 102 ~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 102 FNVVEMYKSYLV----GEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp TTBCCEEEEEEE----TTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCcceEEEEEEE----CCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999886 4567999999999999999975 45899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 362 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
||++.++.+||+|||++....... .......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEECCCCcEEEeeeeeeeecccCc-----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998765432 1223456899999999999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=322.07 Aligned_cols=207 Identities=28% Similarity=0.438 Sum_probs=176.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 294 (460)
.++|++.+.||+|+||.||+|.+. ++..||||+++........+.+.+|+++++.+ +||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 467888999999999999999863 35679999998665444456689999999999 89999999999876
Q ss_pred cCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCC
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~ 360 (460)
....++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+.+ |+||||||+
T Consensus 159 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 232 (370)
T 2psq_A 159 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232 (370)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred ---CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh
Confidence 446799999999999999997543 134899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 361 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|||+++++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTT---CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEECCCCCEEEccccCCcccCcccce---ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999876543221 12233456789999999999999999999999999999999 99999765
Q ss_pred C
Q 012599 440 I 440 (460)
Q Consensus 440 ~ 440 (460)
.
T Consensus 310 ~ 310 (370)
T 2psq_A 310 P 310 (370)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=317.10 Aligned_cols=202 Identities=26% Similarity=0.330 Sum_probs=175.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|+..+.||+|+||.||++... +++.||+|+++... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe----CCEE
Confidence 56888899999999999999886 58999999997531 23344568899999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC-----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 3322 12344679999999999999999999999999999999999999997643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=316.21 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=175.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----EKTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEE
Confidence 46788899999999999999998 468999999997543 22334558899999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS-LMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......||+.|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 165 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 165 TVGG------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp SSSC------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCC------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 4432 22345789999999999887764 89999999999999999999997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.23 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=174.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCeEE
Confidence 467889999999999999999886 6899999999765544444558899999999999999999999876 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999999753 45999999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.... ........||+.|+|||++....+ +.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp ETTE---ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cCCc---ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 3321 112234578999999999987765 7899999999999999999999986544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=328.60 Aligned_cols=209 Identities=22% Similarity=0.339 Sum_probs=177.8
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 294 (460)
.++....++|++.+.||+|+||+||++.... ++.||+|+++... .......+.+|+.+++.++||||+++++++.+
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 140 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence 4555667899999999999999999999864 8899999986421 11122337899999999999999999999876
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEe
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~D 374 (460)
....++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 141 ---~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 ---DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp ---SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEec
Confidence 5578999999999999999975 35899999999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||+++....... .......||+.|+|||++.... ++.++||||||++||||++|+.||....
T Consensus 212 FG~a~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 212 FGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CTTCEECCTTSE----EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeEeeccCCc----ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 999987654321 1123457999999999987655 7899999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=307.37 Aligned_cols=204 Identities=29% Similarity=0.451 Sum_probs=171.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||++.+. +++.||+|.+....... ..+.|.+|+.++++++||||+++++++.+ ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 85 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----DDC 85 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC----SSE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee----CCe
Confidence 367888999999999999999875 58899999986543333 23568899999999999999999999875 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 79999999999999999754 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 161 LSETSL----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp C-----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccccc----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 644321 12234568999999999999999999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=319.28 Aligned_cols=203 Identities=26% Similarity=0.361 Sum_probs=171.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+|+||.||+|+.. +++.||||+++... .......+.+|..+++.+ +||||+++++++.+ ..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 97 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----PD 97 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----CC
Confidence 468899999999999999999876 48999999997531 122344578899999988 79999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 789999999999999999764 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 173 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 173 EGICNG-----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CSCC--------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccCC-----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 543322 22344679999999999998899999999999999999999999997654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.52 Aligned_cols=206 Identities=32% Similarity=0.412 Sum_probs=173.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.+........++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 356788899999999999999885 7899999996432 2333466788889999999999999999875554556799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA----------AAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~----------~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
||||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||+++++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999975 4589999999999999999999988 6 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
|||+++........ .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||.....
T Consensus 174 DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 174 DFGLALKFEAGKSA---GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CCTTCEEECTTSCC---CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred cCCcccccccccCc---cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999876544321 12333568999999999876 3456789999999999999999999976543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.46 Aligned_cols=202 Identities=25% Similarity=0.367 Sum_probs=173.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+|+||.||+++... ++.||+|+++... .......+.+|..++.++ +||||+++++++.+ ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ES 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----SS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----CC
Confidence 3578889999999999999999864 7889999997542 222334478899999887 89999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 789999999999999999754 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 202 ~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 202 EGLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCCCTT-----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ecccCC-----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 633221 2234567999999999999999999999999999999999999999643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=313.17 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=176.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|++.+.||+|+||.||++... +|+.||+|.++...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN---- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe----
Confidence 467888999999999999999886 48999999997654322 24568999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC----cEEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~----~vkl~ 373 (460)
....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++ .+||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence 45789999999999999999753 46999999999999999999999998 99999999999998877 79999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|||++....... ......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 162 DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~ 221 (361)
T 2yab_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (361)
T ss_dssp CCSSCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ecCCceEcCCCC------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999998765432 233457999999999999989999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=306.92 Aligned_cols=207 Identities=25% Similarity=0.407 Sum_probs=174.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|...+.||+|+||+||+|.+. +++.||+|.+... .....+.|.+|++++++++||||+++++++.+ +...++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK----DKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec----CCeeEE
Confidence 56778899999999999999985 4899999988543 33445568999999999999999999999886 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999999763 356999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCC---------CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSC---------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ........||+.|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 332110 011124578999999999999999999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=306.85 Aligned_cols=205 Identities=29% Similarity=0.444 Sum_probs=172.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||+||+|.+.+++.||+|++..... ......+.+|++++++++||||+++++++.+ ....+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 95 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS----ERCLT 95 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC----SSCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc----CCEEE
Confidence 467888899999999999999998899999999975432 2334568899999999999999999999875 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 96 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 96 LVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999996 58988887533 45899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 171 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 171 IPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp SCC-----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred CCc-----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 322 12233467899999999876 56899999999999999999999999865543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.05 Aligned_cols=207 Identities=28% Similarity=0.444 Sum_probs=174.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+|+||.||+|.+. .+..||||.++........+.|.+|+.++++++||||+++++++.+ ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----GR 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CC
Confidence 356788899999999999999984 3556999999866555555679999999999999999999999875 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.++++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 6799999999999999996532 46999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
......... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 200 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 200 VLEDDPDAA--YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp ECC----CC--EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred ccccCccce--eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC
Confidence 765432211 11222345778999999998899999999999999999999 999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=314.30 Aligned_cols=212 Identities=30% Similarity=0.423 Sum_probs=169.4
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
.+++...++|++.+.||+|+||+||+|.. +++.||||++...... ...+.|.+|++++++++||||+++++++.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 105 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--- 105 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE---
Confidence 33444567888999999999999999987 6888999999765432 233468899999999999999999999876
Q ss_pred ccceEEEEEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||+++++.+||+||
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 106 -PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred -CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence 3457999999999999999975321 23899999999999999999999875 34999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+++...... .......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 184 g~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 184 GLSRLKASTF-----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp C----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred CCCccccccc-----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9997544321 12234568999999999999999999999999999999999999997654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=327.30 Aligned_cols=214 Identities=24% Similarity=0.320 Sum_probs=181.3
Q ss_pred echHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012599 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 291 (460)
+.+.++....++|++.+.||+|+||.||+++.. +++.||+|+++... .......+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566667899999999999999999999985 58999999996421 111223378999999999999999999998
Q ss_pred eeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEE
Q 012599 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 292 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
.+ ....++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++|
T Consensus 131 ~~----~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 131 QD----ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EC----SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence 76 457899999999999999997532 46999999999999999999999998 99999999999999999999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCccccc-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+|||+++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 203 L~DFGla~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 203 LADFGSCLKLRADGT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp ECCCTTCEECCTTSC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred EeechhheeccCCCc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 999999987654321 1123457999999999987 3568999999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.09 Aligned_cols=212 Identities=24% Similarity=0.343 Sum_probs=175.5
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-----
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----- 296 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 296 (460)
..++|++.+.||+|+||.||+|.+. +++.||||+++........+.+.+|++++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3467888999999999999999986 6899999999876666666779999999999999999999999865332
Q ss_pred ------------------------------------------------ccceEEEEEeecCCCCHHHHhccccC-CCCCH
Q 012599 297 ------------------------------------------------KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNW 327 (460)
Q Consensus 297 ------------------------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~-~~l~~ 327 (460)
.....++||||+++|+|.+++..... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 12247999999999999999975432 33677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCC-------CCCCCccccCC
Q 012599 328 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC-------SSSPARMQGTF 400 (460)
Q Consensus 328 ~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~-------~~~~~~~~gt~ 400 (460)
..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........... ........||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 789999999999999999998 99999999999999999999999999987755421110 12233456999
Q ss_pred cccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 401 ~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
.|+|||.+....++.++||||||+++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999988764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=317.93 Aligned_cols=208 Identities=28% Similarity=0.390 Sum_probs=177.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++.... ++.||+|.+.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 90 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD----EEDM 90 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCEE
Confidence 568888999999999999998764 8899999986432 22334568899999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999753 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhH
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l 447 (460)
.... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||..........+
T Consensus 166 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 228 (384)
T 4fr4_A 166 PRET------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228 (384)
T ss_dssp CTTC------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH
T ss_pred cCCC------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 4332 2344679999999999863 4589999999999999999999999986544433333
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=310.61 Aligned_cols=203 Identities=26% Similarity=0.380 Sum_probs=166.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEE----cCCcEEEEEEeccCCC---CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG---PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~l~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
.++|++.+.||+|+||.||++.. .+++.||+|+++.... ......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 35788889999999999999987 4689999999976431 2233457889999999999999999999876
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 45679999999999999999754 45899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+++...... .......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 167 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 167 LCKESIHDG-----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CC---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCC-----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 997643332 12234578999999999999999999999999999999999999997643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=310.48 Aligned_cols=199 Identities=28% Similarity=0.352 Sum_probs=174.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +|+.||+|.++... .....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe----CCEE
Confidence 56888899999999999999886 58999999997531 12334557899999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 157 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 157 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCc--------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 332 234578999999999999999999999999999999999999997543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=314.51 Aligned_cols=205 Identities=25% Similarity=0.389 Sum_probs=175.5
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 297 (460)
...++|.+.+.||+|+||.||+|+.. +++.||+|+++... .......+..|..++..+ +||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---- 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---- 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence 34578899999999999999999986 48899999997532 123344578899999877 99999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChh
Confidence 45789999999999999999754 45899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 165 a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 165 CKENMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CBCCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhcccCC-----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 98643221 12345679999999999999999999999999999999999999997643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=308.32 Aligned_cols=205 Identities=28% Similarity=0.421 Sum_probs=175.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|.+.+.||+|+||+||+|.+.. ++.||||++.........+.+.+|++++++++||||+++++++.... ....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC--CceEEE
Confidence 567888999999999999999865 89999999986554455566889999999999999999999887533 336799
Q ss_pred EEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE----cCCCcEEEEecCCc
Q 012599 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 378 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll----~~~~~vkl~DFGla 378 (460)
||||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976432 33999999999999999999999998 9999999999999 78888999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccc--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM--------VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCTTC------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eecCCCC------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765432 122346899999999886 5778999999999999999999999997543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=310.20 Aligned_cols=210 Identities=27% Similarity=0.404 Sum_probs=171.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||++.+ .+++.||||+++...... ....+.+|++++++++||||+++++++.........
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999997 468999999997654332 234588999999999999999999998775544456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.++++.. ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 69999999999999999754 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 166 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc--cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 6543221 112233568999999999999999999999999999999999999997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=306.91 Aligned_cols=204 Identities=27% Similarity=0.415 Sum_probs=162.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|... +++.||+|.++..........+.+|++++++++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT----ENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC----TTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE----CCeEE
Confidence 467888999999999999999875 4899999999866555555678999999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhcccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 303 LVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999997 69999986532 245899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 156 RAFGIPV-----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp EETTSCC-----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecCCCc-----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764322 12233468999999999876 468999999999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=330.84 Aligned_cols=210 Identities=26% Similarity=0.413 Sum_probs=180.3
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
...++...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--- 254 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--- 254 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---
Confidence 344566678899999999999999999999888999999998643 345679999999999999999999999752
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
...++||||+++|+|.++++......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 255 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 255 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp --SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTT
T ss_pred --CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCC
Confidence 35699999999999999998654446899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+++....... .......+++.|+|||.+....++.++||||||++||||+| |+.||....
T Consensus 330 ~a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 330 LARVIEDNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp GGGGBCCHHH----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CceEcCCCce----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 9987643221 11122346788999999998999999999999999999999 999997643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=316.11 Aligned_cols=204 Identities=17% Similarity=0.186 Sum_probs=172.4
Q ss_pred HHhcCCcccceeeeeCcEEEEEEE------EcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeee
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQ------LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCS 292 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~ 292 (460)
...++|.+.+.||+|+||.||+|. ..+++.||||+++.. ....+..|+++++.++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345778889999999999999994 446889999999753 3445888999988886 999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--- 366 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~--- 366 (460)
. ....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||||+.
T Consensus 138 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 138 F----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp C----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred c----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence 6 45679999999999999999642 2356999999999999999999999998 999999999999998
Q ss_pred --------CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 367 --------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 367 --------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPK---GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCT---TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred CccccccccCCEEEeeCchhhhhhccCC---CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999976543211 1122345689999999999999999999999999999999999999964
Q ss_pred C
Q 012599 439 S 439 (460)
Q Consensus 439 ~ 439 (460)
.
T Consensus 288 ~ 288 (365)
T 3e7e_A 288 N 288 (365)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=322.41 Aligned_cols=208 Identities=29% Similarity=0.442 Sum_probs=175.5
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
...++|.+.+.||+|+||.||+|.+. +++.||||.++..........|.+|+++|++++||||+++++++.+ ...
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 186 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQP 186 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS----SSS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec----CCC
Confidence 34567888899999999999999986 6899999999765433334458899999999999999999999875 346
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 799999999999999997532 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... .......+++.|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 263 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 263 EADGVYA---ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp CTTSEEE---CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred cCCCcee---ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 4332111 11112235678999999998899999999999999999998 999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.94 Aligned_cols=218 Identities=37% Similarity=0.610 Sum_probs=185.9
Q ss_pred eeeechHHHHHHhcCCccc------ceeeeeCcEEEEEEEEcCCcEEEEEEeccCC---CCChhHHHHHHHHHHHhcCCC
Q 012599 212 IIRFSYSALEHATDKFSGS------NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHC 282 (460)
Q Consensus 212 ~~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H~ 282 (460)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4679999999999999988 8999999999999987 68899999987542 233456689999999999999
Q ss_pred CccceeeeeeeccCccceEEEEEeecCCCCHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCC
Q 012599 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (460)
Q Consensus 283 nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~N 361 (460)
||+++++++.+ ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 91 ~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 91 NLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp TBCCEEEEECS----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CeEEEEEEEec----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 99999999876 346699999999999999996533 345999999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 362 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
||+++++.+||+|||++......... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQT---VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSC---EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred EEEcCCCcEEEeeccccccccccccc---ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99999999999999999865432211 11233568999999998764 578999999999999999999999986543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=315.14 Aligned_cols=213 Identities=26% Similarity=0.445 Sum_probs=179.9
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeee
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~ 291 (460)
..++...++|++.+.||+|+||.||+|.+.+ ++.||||.++..........|.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445567889999999999999999998853 4789999998665444556789999999999999999999998
Q ss_pred eeccCccceEEEEEeecCCCCHHHHhcccc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 012599 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAA 349 (460)
Q Consensus 292 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~~l~yLH~~~~ 349 (460)
.+ ....++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+
T Consensus 120 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~- 194 (343)
T 1luf_A 120 AV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 194 (343)
T ss_dssp CS----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred cc----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 76 446799999999999999997632 146899999999999999999999998
Q ss_pred CCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHH
Q 012599 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 429 (460)
Q Consensus 350 ~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~el 429 (460)
|+||||||+|||+++++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||
T Consensus 195 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 195 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --eecCCCCcceEEECCCCeEEEeecCCCcccccCccc---cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence 999999999999999999999999999876443211 122334578899999999989999999999999999999
Q ss_pred Hh-CCCCCCCCC
Q 012599 430 IT-GRQPIHRSI 440 (460)
Q Consensus 430 lt-G~~Pf~~~~ 440 (460)
++ |+.||....
T Consensus 270 ~t~g~~p~~~~~ 281 (343)
T 1luf_A 270 FSYGLQPYYGMA 281 (343)
T ss_dssp HTTTCCTTTTSC
T ss_pred HhcCCCcCCCCC
Confidence 99 999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=319.92 Aligned_cols=219 Identities=27% Similarity=0.425 Sum_probs=184.3
Q ss_pred eeechHHHHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCcc
Q 012599 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 285 (460)
Q Consensus 213 ~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv 285 (460)
..++...++...++|++.+.||+|+||.||+|.+. +++.||||+++........+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 45666778888999999999999999999999742 36789999998655444556699999999999 899999
Q ss_pred ceeeeeeeccCccceEEEEEeecCCCCHHHHhccccC-------------------------------------------
Q 012599 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV------------------------------------------- 322 (460)
Q Consensus 286 ~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------- 322 (460)
++++++.+. ....++||||+++|+|.++++....
T Consensus 90 ~~~~~~~~~---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 90 NLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp CEEEEECST---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred eeeeeeecC---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 999998763 2346999999999999999976432
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 323 ---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 323 ---------------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 11889999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
..... ........+|+.|+|||++....++.++||||||+++|||+| |+.||....
T Consensus 244 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 244 YKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp TSCTT---CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccc---chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 44321 112233567889999999999999999999999999999998 999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.20 Aligned_cols=208 Identities=19% Similarity=0.228 Sum_probs=176.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|.. .+++.||||.+...... ..+.+|+++++++ +|+||+++++++.+ ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPC----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEE----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEec----CCcc
Confidence 36788889999999999999987 46899999998754332 2388999999999 99999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc-----EEEEecC
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 376 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~-----vkl~DFG 376 (460)
++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999 99999999764 356999999999999999999999998 999999999999998887 9999999
Q ss_pred CccccccCCCC--CCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcC
Q 012599 377 MAKRLKADGLP--SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443 (460)
Q Consensus 377 la~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~ 443 (460)
+++........ ..........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 99876543321 11122345679999999999999999999999999999999999999998765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=313.42 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=175.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+|+||.||++.... ++.||+|+++... .......+..|..++..+ +||||+++++++.+ ..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~ 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MD 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----CC
Confidence 4678999999999999999999865 7889999997532 223345578899999988 89999999998876 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 789999999999999999754 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 170 ENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCC-----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 643322 12344679999999999999999999999999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=311.16 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=173.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+++.. +++.||+|+++...... ....+.+|..++.++ +||||+++++++.+ ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~~ 84 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESR 84 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----CCE
Confidence 56888899999999999999986 48899999997653222 234578899999988 89999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
..... .......||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 160 GLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp SCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCC-----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 43221 123446799999999999999999999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=305.72 Aligned_cols=202 Identities=25% Similarity=0.366 Sum_probs=175.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|.+.+.||+|+||.||++... +++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 356888899999999999999986 48999999997653321 34568999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC----cEEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~----~vkl~ 373 (460)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++ .+||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 45779999999999999999753 56999999999999999999999998 99999999999999887 89999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||++....... ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 161 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 161 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp CCTTCEECCTTS------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ECCCCeECCCCC------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 999998764332 2234568999999999998999999999999999999999999997543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.53 Aligned_cols=207 Identities=27% Similarity=0.426 Sum_probs=164.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+|+||.||+|.+. ++..||||.++........+.|.+|+.++++++||||+++++++.+ ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----SK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CC
Confidence 357889999999999999999875 4778999999865544455679999999999999999999999876 44
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 679999999999999999753 346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
......... .......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 196 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 196 VLEDDPEAA--YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ccccCCccc--eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 765432111 11122335678999999999999999999999999999998 999997543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=304.29 Aligned_cols=205 Identities=27% Similarity=0.388 Sum_probs=172.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.+........
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999988 6899999998643 33456777777776 79999999999987765556678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH--------~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999964 46899999999999999999999 666 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccC------CCCchhHHHHHHHHHHHHHhC----------CCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITG----------RQPIH 437 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwSlGvll~elltG----------~~Pf~ 437 (460)
|||+++......... ........||+.|+|||.+... .++.++||||||+++|||++| +.||.
T Consensus 156 Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCTTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eCCCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998665433211 1122334689999999998776 455799999999999999999 88987
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 235 ~~~ 237 (301)
T 3q4u_A 235 DVV 237 (301)
T ss_dssp TTS
T ss_pred ccC
Confidence 643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=322.96 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=175.2
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++...++|++.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+.+|++++||||+++++++.+. ..
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT---TS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC---CC
Confidence 3345677888999999999999999985 7899999998643 345699999999999999999999998762 23
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.++++......+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 337 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence 5799999999999999998755445899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
...... ....++..|+|||.+....++.++||||||++||||+| |+.||.....
T Consensus 338 ~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 338 EASSTQ--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp ECC--------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred cccccc--------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 543221 12246788999999999999999999999999999998 9999986544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=312.63 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=175.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||++... +|+.||+|++.... .....+.+.+|+++++.++||||+++++++.+ ....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 116 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----CCEE
Confidence 57888899999999999999986 58999999986432 22334568899999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 192 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC--------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 432 234578999999999999999999999999999999999999997543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=311.04 Aligned_cols=203 Identities=24% Similarity=0.340 Sum_probs=175.5
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
...++|++.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+ ..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~ 101 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ES 101 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SS
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CC
Confidence 34567999999999999999999875 5899999999765322 233558899999999999999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC---CcEEEEecC
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLG 376 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~---~~vkl~DFG 376 (460)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence 779999999999999999753 45899999999999999999999998 9999999999999865 459999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++....... ......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 177 ~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 177 LAIEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233 (362)
T ss_dssp TCBCCTTCC------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cceEecCCc------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 998765332 223457899999999999989999999999999999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=300.81 Aligned_cols=203 Identities=30% Similarity=0.468 Sum_probs=175.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|+..+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+ ....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCceEE
Confidence 35678889999999999999999889999999997543 234568999999999999999999999876 446799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999997533 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
... .......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 159 DQY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp HHH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 321 11223446778999999998999999999999999999999 999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.49 Aligned_cols=211 Identities=20% Similarity=0.314 Sum_probs=178.9
Q ss_pred hcCCcccceeeee--CcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|++.+.||+| +||.||+|... +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 99 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DN 99 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TT
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----CC
Confidence 3568888999999 99999999986 5899999999765332 233557889999999999999999999886 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 7899999999999999998765567999999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCC--CCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 380 RLKADGLP--SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.....+.. ..........||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 65433211 11122333578899999999987 6789999999999999999999999976543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=299.17 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=175.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|++.+.||+|+||.||++.+.++..||+|+++.... ....+.+|++++++++||||+++++++.+ ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSK----EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCceEE
Confidence 467888899999999999999998888999999975432 34568999999999999999999999865 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999999764 245899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 157 DQYV----SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp TCEE----ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred hhhh----cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 3321 1223346678999999988889999999999999999999 999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.48 Aligned_cols=201 Identities=21% Similarity=0.311 Sum_probs=175.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEec----CCEEE
Confidence 467889999999999999999886 4889999998743 2344558899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC--CCcEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~--~~~vkl~DFGla~~ 380 (460)
+||||+++|+|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999999753 245899999999999999999999998 999999999999987 78999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 207 (321)
T 1tki_A 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCCC------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence 64432 1233568999999999988889999999999999999999999997643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=309.22 Aligned_cols=205 Identities=27% Similarity=0.454 Sum_probs=168.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-Cc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|+..+.||+|+||+||+|.+.. ++ +||+|.+...........|.+|+.++++++||||+++++++.+ .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----S
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 567888999999999999998643 33 4689988766555666779999999999999999999999875 2
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 3589999999999999997643 56999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 166 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 166 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp HHTTTCC----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred EccCCccc---ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 76543321 12223456789999999999999999999999999999999 9999986544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=308.83 Aligned_cols=204 Identities=26% Similarity=0.323 Sum_probs=174.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC----CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|++.+.||+|+||.||++... +++.||||++... ......+.+.+|+.+++.++||||+++++++.+ .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----D 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----T
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----C
Confidence 356888999999999999999875 5899999998632 122234568999999999999999999999876 4
Q ss_pred ceEEEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc---EEEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKIT 373 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~---vkl~ 373 (460)
...++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence 57899999999999998885432 234899999999999999999999998 999999999999986654 9999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|||++........ ......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 176 Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 176 GFGVAIQLGESGL-----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTCEECCTTSC-----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCcceeEecCCCe-----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 9999987654321 123456899999999999989999999999999999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=313.06 Aligned_cols=211 Identities=25% Similarity=0.305 Sum_probs=181.7
Q ss_pred eeeechHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-----CCCcc
Q 012599 212 IIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----HCHVV 285 (460)
Q Consensus 212 ~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv 285 (460)
+..+++.+.....++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......+..|+++++.+. ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345566666667789999999999999999999984 5889999999742 223445788999999986 99999
Q ss_pred ceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc
Q 012599 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (460)
Q Consensus 286 ~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~ 365 (460)
++++++.. ....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 100 ~~~~~~~~----~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 100 KYHGKFMY----YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp CEEEEEEE----TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred cccceeeE----CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 99999876 45779999999 999999998765566999999999999999999999998 99999999999997
Q ss_pred C-------------------------CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHH
Q 012599 366 E-------------------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 420 (460)
Q Consensus 366 ~-------------------------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVw 420 (460)
+ ++.+||+|||++...... .....||+.|+|||++.+..++.++|||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--------HGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------CCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--------CcCccCcccccCcHHHcCCCCCCccchH
Confidence 6 789999999999864322 2345689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 012599 421 SFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 421 SlGvll~elltG~~Pf~~~~ 440 (460)
|||+++|||++|+.||....
T Consensus 244 slG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHHHCCCCCCCCc
Confidence 99999999999999997654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=308.60 Aligned_cols=212 Identities=27% Similarity=0.412 Sum_probs=178.3
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 293 (460)
++...++|.+.+.||+|+||.||+|... +++.||||++.........+.+.+|++++++++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3344677888999999999999999862 3578999999865544455668999999999999999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV----------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ 351 (460)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+
T Consensus 98 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--- 170 (314)
T 2ivs_A 98 ----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170 (314)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ----CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4457999999999999999975432 23889999999999999999999998
Q ss_pred eEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 352 ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
|+||||||+|||+++++.+||+|||++......... .......+++.|+|||.+....++.++||||||+++|||++
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999876443211 11223456788999999998889999999999999999999
Q ss_pred -CCCCCCCCCC
Q 012599 432 -GRQPIHRSIT 441 (460)
Q Consensus 432 -G~~Pf~~~~~ 441 (460)
|+.||.....
T Consensus 248 ~g~~p~~~~~~ 258 (314)
T 2ivs_A 248 LGGNPYPGIPP 258 (314)
T ss_dssp TSCCSSTTCCG
T ss_pred CCCCCCCCCCH
Confidence 9999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.84 Aligned_cols=209 Identities=27% Similarity=0.415 Sum_probs=177.9
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
...++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34567888899999999999999863 24679999998765555556789999999999 9999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
+ ....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+|||||
T Consensus 146 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk 218 (382)
T 3tt0_A 146 Q----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218 (382)
T ss_dssp S----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred c----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence 6 4457999999999999999976431 34899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~ 437 (460)
|+|||+++++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTT---CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cceEEEcCCCcEEEcccCccccccccccc---ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999876543221 12333457789999999999999999999999999999999 999997
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 296 ~~~ 298 (382)
T 3tt0_A 296 GVP 298 (382)
T ss_dssp TCC
T ss_pred CCC
Confidence 543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.85 Aligned_cols=202 Identities=26% Similarity=0.369 Sum_probs=167.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-------------------------ChhHHHHHHHHHHHh
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------------------NADSVFLTEVDMLSR 278 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-------------------------~~~~~f~~Ei~~l~~ 278 (460)
++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57888899999999999999875 5889999999754311 112458899999999
Q ss_pred cCCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 279 l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
++||||+++++++.+.. ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPN--EDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSS--SSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCC--CCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 99999999999987532 3467999999999999887643 46999999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 435 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvll~elltG~~P 435 (460)
|+|||++.++.+||+|||++........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999987654321 122346899999999987655 37899999999999999999999
Q ss_pred CCCC
Q 012599 436 IHRS 439 (460)
Q Consensus 436 f~~~ 439 (460)
|...
T Consensus 240 f~~~ 243 (298)
T 2zv2_A 240 FMDE 243 (298)
T ss_dssp SCCS
T ss_pred CCCc
Confidence 9754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.25 Aligned_cols=209 Identities=27% Similarity=0.415 Sum_probs=180.3
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++...++|++.+.||+|+||.||+|.+.. +..||||.++... ...+.|.+|+.+|++++||||+++++++.+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---- 287 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 287 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEec----
Confidence 344456778889999999999999999875 8899999997543 235669999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+++|+|.++++......+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccc
Confidence 346799999999999999998755567999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++....... .......++..|+|||.+....++.++||||||++||||++ |+.||....
T Consensus 365 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 365 SRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp EECCTTCCE----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeccCCce----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 987644321 11223346788999999998899999999999999999999 999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.51 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=178.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|...+.||+|+||.||++... +|+.||+|++.... .......+.+|+++|+.++||||+++++++.+ ...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 258 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDA 258 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----CCE
Confidence 467899999999999999999886 58999999996431 22334558899999999999999999998876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 899999999999999997655556999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 336 ~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 336 VPEGQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp CCTTC------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred cccCc------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 64432 12234799999999999988899999999999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.84 Aligned_cols=199 Identities=27% Similarity=0.353 Sum_probs=172.0
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 84 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----PTDI 84 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 6788899999999999999997 468999999986431 12233458899999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+ +|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999 78999999754 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ......||+.|+|||.+.+..+ ++++||||||+++|||++|+.||...
T Consensus 159 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 159 TDGN------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TTSB------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred cCCc------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 4432 2234568999999999987776 78999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=308.15 Aligned_cols=206 Identities=24% Similarity=0.405 Sum_probs=172.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-Cc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|++.+.||+|+||.||+|.+.. ++ +||+|.+...........+.+|+.++++++||||+++++++.. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-----S 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----S
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence 567888999999999999998753 43 3888888655544444557899999999999999999998853 3
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 5789999999999999997642 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCc
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~ 442 (460)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 224 (325)
T 3kex_A 164 LLPPDDKQ---LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224 (325)
T ss_dssp GSCCCTTC---CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred ccCccccc---ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence 77544321 12234567789999999999999999999999999999999 99999875543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=309.78 Aligned_cols=211 Identities=25% Similarity=0.425 Sum_probs=175.3
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
++...++|.+.+.||+|+||.||+|.+. +++.||||.+.........+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445678889999999999999999862 45689999998665555556799999999999 8999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ 351 (460)
. ....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+
T Consensus 120 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 192 (344)
T 1rjb_A 120 L----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 192 (344)
T ss_dssp S----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred e----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6 3467999999999999999976432 23799999999999999999999998
Q ss_pred eEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 352 ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
|+||||||+|||++.++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||+|
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccc---eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence 999999999999999999999999999876543211 11223456788999999999999999999999999999998
Q ss_pred -CCCCCCCCC
Q 012599 432 -GRQPIHRSI 440 (460)
Q Consensus 432 -G~~Pf~~~~ 440 (460)
|+.||....
T Consensus 270 ~g~~p~~~~~ 279 (344)
T 1rjb_A 270 LGVNPYPGIP 279 (344)
T ss_dssp TSCCSSTTCC
T ss_pred CCCCCcccCC
Confidence 999997654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.40 Aligned_cols=203 Identities=26% Similarity=0.328 Sum_probs=166.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC--CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||++... +++.||||+++.. ........+.+|+.+++.++||||+++++++.+ ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~ 222 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDR 222 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE----TTE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee----CCE
Confidence 467888999999999999999875 5899999999753 223333457889999999999999999999876 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||||+.++.+||+|||+++
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 79999999999999999754 468999999999999999999998 77 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .......||+.|+|||++....++.++||||||++||||++|+.||....
T Consensus 298 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 298 EGIKDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp TTCC----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCCC-----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 643322 12334679999999999999999999999999999999999999997653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.45 Aligned_cols=208 Identities=31% Similarity=0.476 Sum_probs=174.0
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 250 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 250 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 3445567788899999999999999999888889999998643 234569999999999999999999999864
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.++++......+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccc
Confidence 34689999999999999998654466999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+........ ......++..|+|||.+....++.++||||||++||||++ |+.||....
T Consensus 328 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 328 RLIEDNEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp C------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eecCCCcee----cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 876543211 1223346788999999999999999999999999999999 999997643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=301.11 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=169.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||.||+|...+++.||+|++..... ......+.+|++++++++||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc----CCeEEE
Confidence 46888899999999999999998899999999975432 2233568899999999999999999999876 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 78 VFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 999996 59999997543 56899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (288)
T 1ob3_A 153 PV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (288)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11233467899999999875 458999999999999999999999997643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.32 Aligned_cols=205 Identities=24% Similarity=0.405 Sum_probs=173.7
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
...++|++.+.||+|+||.||++.+.++..||+|+++.... ..+.+.+|++++++++|+||+++++++.+ ....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEec----CCCe
Confidence 34567888899999999999999999888999999985432 34568999999999999999999999875 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence 99999999999999997633 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
..... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 171 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 171 LDDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp CCHHH----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccccc----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 43321 11223346788999999998899999999999999999998 999997644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=316.91 Aligned_cols=207 Identities=28% Similarity=0.389 Sum_probs=175.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|++.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++.+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 467888899999999999999853 4678999999765555555668999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC---c
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 369 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~---~ 369 (460)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 3456999999999999999976432 34899999999999999999999998 99999999999999554 5
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+||+|||+++........ .......+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 223 ~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp EEECCCHHHHHHHHHSSC---TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCcccccccccccc---ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999866443221 12334567889999999999999999999999999999998 999997643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=313.71 Aligned_cols=202 Identities=24% Similarity=0.304 Sum_probs=166.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCC--CChhHHHHHHHHH-HHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~--~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+++... ++.||+|+++.... ......+.+|..+ ++.++||||+++++++.+ ...
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----~~~ 113 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADK 113 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----CCE
Confidence 568888999999999999999864 88999999975432 2223345667766 467899999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 189 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 189 NIEHN-----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp GBCCC-----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred cccCC-----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 43321 23345679999999999999999999999999999999999999997643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=296.91 Aligned_cols=202 Identities=24% Similarity=0.375 Sum_probs=171.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||+||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++.+ ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe----CCEEE
Confidence 56888999999999999999986 489999999976543 3334668899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 78 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 78 LVFEFCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 9999996 5777776543 256999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .......||+.|+|||.+.+.. ++.++||||||+++|||++|..||....
T Consensus 153 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~ 206 (292)
T 3o0g_A 153 IPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_dssp SCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred Ccc-----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC
Confidence 322 2233456889999999987665 7999999999999999999999875443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=312.96 Aligned_cols=212 Identities=20% Similarity=0.291 Sum_probs=171.9
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCCh----------hHHHHHHHHHHHhcCCCCccc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNA----------DSVFLTEVDMLSRLHHCHVVP 286 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~----------~~~f~~Ei~~l~~l~H~nIv~ 286 (460)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++........ ...+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578888999999999999998865 47899999875431100 011334445566678999999
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD- 365 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~- 365 (460)
+++++..........++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9999987555456789999999 99999999763 356999999999999999999999998 99999999999999
Q ss_pred -CCCcEEEEecCCccccccCCCCCC--CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 366 -ENLNAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 366 -~~~~vkl~DFGla~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.++.+||+|||+++.+........ ........||+.|+|||++.+..++.++||||||++||||+||+.||...
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 889999999999987755432211 11223456999999999999999999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.17 Aligned_cols=201 Identities=24% Similarity=0.305 Sum_probs=165.2
Q ss_pred cCCccc-ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHh-cCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+. +.||+|+||+||++.+. +++.||||++... ..+.+|++++.+ .+||||+++++++..........
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456655 68999999999999886 5889999999632 347789988754 48999999999987644445678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGla 378 (460)
++||||+++|+|.+++.......+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999998755456999999999999999999999998 999999999999997 789999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+...... ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 212 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 212 KETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp EECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccCCCC------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 8654322 2234568999999999999999999999999999999999999997654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=300.45 Aligned_cols=207 Identities=27% Similarity=0.448 Sum_probs=177.5
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
+++...++|++.+.||+|+||.||+|...+++.||||.+.... ...+.+.+|++++++++||||+++++++.+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----- 79 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----
Confidence 3444567888899999999999999999888899999997543 234568999999999999999999998753
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccc
Confidence 24689999999999999997654346999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
......... ......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 157 RLIEDNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp EECSSSCEE----CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccCcccc----cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 876543211 1223446788999999988889999999999999999999 99999754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=302.65 Aligned_cols=206 Identities=24% Similarity=0.381 Sum_probs=164.7
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.........+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 35678888999999999999998753 457999998765544455668999999999999999999998743
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence 3468999999999999999753 245899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
......... ......+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 164 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 164 RYMEDSTYY----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cccCccccc----ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 876543211 1223346778999999998999999999999999999997 9999976543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=300.69 Aligned_cols=208 Identities=28% Similarity=0.415 Sum_probs=173.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC----CChhHHHHHHHHHHHhcC---CCCccceeeeeeec
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEF 294 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~----~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~ 294 (460)
..++|++.+.||+|+||+||+|.+. +++.||||++..... ......+.+|+++++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 589999999874321 122335778888887774 99999999998764
Q ss_pred cCc-cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 295 RGK-RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 295 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
... ....++||||++ ++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 432 235789999996 69999998765556999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 163 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 163 DFGLARIYSYQM------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp SCSCTTTSTTCC------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred eCccccccCCCc------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998654322 2344678999999999999999999999999999999999999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.02 Aligned_cols=205 Identities=29% Similarity=0.446 Sum_probs=177.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|...+.||+|+||.||++... +|+.||+|++.... .......+.+|++++++++||||+++++++.+ ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----KTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee----CCE
Confidence 367888899999999999999986 58999999996432 12334568899999999999999999998876 456
Q ss_pred EEEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
.++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence 899999999999999997543 345999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 337 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 337 VELKAGQ-----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp EECCTTC-----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred eeccCCC-----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 8765432 12233579999999999999999999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=307.11 Aligned_cols=201 Identities=26% Similarity=0.352 Sum_probs=160.8
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
...++|++.+.||+|+||.||+|.+.. ++.||||+++... ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 122 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET----PTE 122 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec----CCe
Confidence 346789999999999999999999864 7899999997543 23457899999999999999999999876 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGl 377 (460)
.++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 79999999999999999753 45899999999999999999999998 999999999999975 88999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 198 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 198 SKIVEHQV------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp ---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred ccccCccc------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 98664332 1233568999999999999999999999999999999999999997543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.64 Aligned_cols=204 Identities=22% Similarity=0.301 Sum_probs=174.6
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
...++|++.+.||+|+||.||++... +|+.+|+|.+...... ...+.+.+|+++++.++||||+++++++.+ ..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~ 83 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE----EG 83 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC----SS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE----CC
Confidence 34677999999999999999999875 5899999999765322 234458899999999999999999999876 55
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc---CCCcEEEEecC
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLG 376 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~---~~~~vkl~DFG 376 (460)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ +++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 779999999999999999754 45999999999999999999999998 99999999999998 56789999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++....... .......||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 159 ~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 159 LAIEVEGEQ-----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 216 (444)
T ss_dssp SCBCCCTTC-----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred eeEEecCCC-----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence 998765432 1223457999999999999989999999999999999999999999654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=293.67 Aligned_cols=207 Identities=18% Similarity=0.231 Sum_probs=176.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+..++.+ +|+|++++++++.+ ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCC----Ccee
Confidence 46788899999999999999986 46899999998754332 2378999999999 89999999998865 5577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc-----EEEEecC
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 376 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~-----vkl~DFG 376 (460)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999 99999999754 345999999999999999999999998 999999999999987776 9999999
Q ss_pred CccccccCCCCC--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 377 MAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 377 la~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
++.......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 998775543211 112344567999999999999999999999999999999999999999875543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=304.23 Aligned_cols=209 Identities=25% Similarity=0.399 Sum_probs=177.5
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEE------cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 294 (460)
...++|+..+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+.+++++ +||||+++++++.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-
Confidence 3456788889999999999999985 246789999998655444556789999999999 99999999999876
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLV----------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred ---CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 3456999999999999999976432 24899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~ 437 (460)
|+|||+++++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||+| |+.||.
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cceEEEcCCCCEEEccccccccccccccc---eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999876543211 11223456788999999999999999999999999999999 999997
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 250 ~~~ 252 (313)
T 1t46_A 250 GMP 252 (313)
T ss_dssp TCC
T ss_pred ccc
Confidence 654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.99 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=175.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|++.+.||+|+||.||++... +++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 456888899999999999999986 58999999997654322 34568999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC----cEEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~----~vkl~ 373 (460)
....++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++ .+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 45779999999999999999753 45899999999999999999999998 99999999999999888 79999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|||++....... ......||+.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 162 Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp CCTTCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCccceecCccc------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 999998765432 223456899999999999999999999999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=297.72 Aligned_cols=202 Identities=23% Similarity=0.323 Sum_probs=170.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|.+.+.||+|+||.||++... +++.+|+|++.........+.+.+|++++++++||||+++++++.+ ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED----YHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec----CCeEEE
Confidence 56788899999999999999875 5889999999876655556779999999999999999999999876 456799
Q ss_pred EEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCCc
Q 012599 304 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGla 378 (460)
||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999999543 2356999999999999999999999998 9999999999999 45678999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 175 ELFKSDE------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp CC----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCcc------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 8664432 123456889999999875 578999999999999999999999997654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=307.93 Aligned_cols=202 Identities=25% Similarity=0.362 Sum_probs=174.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++.+ ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe----CCEEE
Confidence 467899999999999999999886 58899999987543 2234458899999999999999999999876 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC--CCcEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~--~~~vkl~DFGla~~ 380 (460)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999999753 245899999999999999999999998 999999999999974 56799999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 201 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 201 LNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp CCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cCCCc------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 65432 1223468999999999999999999999999999999999999997643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=302.51 Aligned_cols=209 Identities=28% Similarity=0.421 Sum_probs=180.3
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
+++...++|++.+.||+|+||.||+|.+.. ++.||+|.+... ....+.+.+|++++++++||||+++++++.+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 80 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 80 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 344456778889999999999999999875 888999999753 3345668999999999999999999999875
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcc
Confidence 456799999999999999998766667999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+........ .......+++.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 158 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~ 217 (288)
T 3kfa_A 158 SRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217 (288)
T ss_dssp GGTSCSSSS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeccCCcc----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 987654321 11223456788999999998999999999999999999999 999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.17 Aligned_cols=216 Identities=25% Similarity=0.394 Sum_probs=163.0
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcCC----cEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g----~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 293 (460)
++....++|++.+.||+|+||.||+|.+... ..||||+++... .....+.+.+|++++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3444567899999999999999999987543 279999997653 23345668999999999999999999999876
Q ss_pred ccCcc--ceEEEEEeecCCCCHHHHhccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 294 FRGKR--AMRLLVFEFMPNGNLRDCLDGVLV----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 294 ~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
..... ...++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 33211 234899999999999999964321 25899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+.+||+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp SCEEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCEEEeeccccccccccccc---cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 99999999999876543321 11223346778999999999999999999999999999999 999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=301.53 Aligned_cols=199 Identities=24% Similarity=0.298 Sum_probs=165.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|+..+.||+|+||+||+|.+. +++.||||++...... .....+..|+..+.++ +|+||+++++++.+ ...
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----~~~ 131 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----GGI 131 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----CCE
Confidence 367899999999999999999987 6899999998654322 2233456666666665 89999999999876 557
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 89999999 789999987643 56999999999999999999999998 99999999999999999999999999887
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|..||..
T Consensus 207 ~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 207 LGTAG------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CC------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred cccCC------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 64432 1233458999999998875 789999999999999999999777654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.05 Aligned_cols=201 Identities=24% Similarity=0.390 Sum_probs=177.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+.|+..+.||+|+||.||+|... +++.||+|.+.........+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEE
Confidence 356888899999999999999875 5889999999876655666779999999999999999999999876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 97 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp EEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999999974 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 222 (303)
T 3a7i_A 171 DTQI-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222 (303)
T ss_dssp TTBC-----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cccc-----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence 4321 223356889999999999999999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=305.62 Aligned_cols=203 Identities=26% Similarity=0.410 Sum_probs=165.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|.+.+.||+|+||.||+|... +++.||+|++...........+.+|++++++++||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee----CCEEEE
Confidence 56888999999999999999986 6899999999765433333336689999999999999999999876 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 78 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred Eecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999996 6999999764 345899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.. .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (324)
T 3mtl_A 153 PT-----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Cc-----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22 12233467899999999876 6689999999999999999999999976543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=291.91 Aligned_cols=202 Identities=35% Similarity=0.503 Sum_probs=164.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC---ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|+..+.||+|+||.||+|.+. ++.+|||+++..... ...+.+.+|+++++.++||||+++++++.+ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK----EPN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC----C--
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----CCc
Confidence 367888899999999999999985 889999998754322 234568899999999999999999999876 446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC--------CCcEEE
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------NLNAKI 372 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~--------~~~vkl 372 (460)
.++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+..+|+||||||+|||+++ ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 7999999999999999964 46899999999999999999999987666899999999999986 678999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+|||++....... .....|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 158 ~Dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 158 TDFGLAREWHRTT-------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp CCCCC--------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccCCccccccccc-------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999998654332 123468899999999999999999999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.48 Aligned_cols=207 Identities=28% Similarity=0.363 Sum_probs=178.2
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++|++.+.||+|+||.||+|... +++.||||.+.........+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 80 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQ 80 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc----CCEE
Confidence 3467888999999999999999986 5899999999765555566778999999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
..... ........|++.|+|||.+....+ +.++||||||+++|||++|+.||.....
T Consensus 156 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 156 RYNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp EETTE---ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred CCCcc---hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 44321 112233568899999999987665 7899999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.80 Aligned_cols=207 Identities=29% Similarity=0.413 Sum_probs=169.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|++.+.||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--C
Confidence 35678889999999999999984 258899999997542 233456899999999999999999999986532 2
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35689999999999999997643 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
......... ........++..|+|||.+....++.++||||||+++|||+||..||...
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 162 KVLPQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp C---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccccCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 876543211 11222334677899999999999999999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=310.45 Aligned_cols=207 Identities=28% Similarity=0.451 Sum_probs=162.4
Q ss_pred CcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
|...+.||+|+||.||+|.+.+ +..||||.++........+.|.+|+.++++++||||+++++++.+. ....+
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~~ 167 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPL 167 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---SSCCE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---CCCeE
Confidence 5566899999999999998642 2468999987655555567799999999999999999999987642 23568
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 168 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999999753 345899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
...... ........+|+.|+|||.+....++.++||||||+++|||+| |.+||.....
T Consensus 244 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 244 DKEFDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred cccccc-ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 432211 112233457788999999999999999999999999999999 7777765443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=305.19 Aligned_cols=214 Identities=26% Similarity=0.286 Sum_probs=173.4
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC----CCCChhHHHHHHHHHHHhcCCCCccceeeeeee
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~----~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~ 293 (460)
++....++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45667788999999999999999999875 5889999998643 234555679999999999999999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccC--------------------------------------CCCCHHHHHHHHH
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------------------------------EGMNWDTRVAIAI 335 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------~~l~~~~~~~i~~ 335 (460)
....++||||+++|+|.+++..... ..+++..+..++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 4578999999999999999953111 1135677889999
Q ss_pred HHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC--cEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc--C
Q 012599 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENL--NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--G 411 (460)
Q Consensus 336 qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~--~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~ 411 (460)
|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++.......... ........||+.|+|||.+.. .
T Consensus 176 qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc-cccccccCCCccccCchhhccCCC
Confidence 9999999999998 99999999999998776 89999999998764432111 112334568999999999865 6
Q ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 412 RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 412 ~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.++.++||||||+++|||++|+.||....
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVN 280 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 78999999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=295.37 Aligned_cols=205 Identities=25% Similarity=0.410 Sum_probs=171.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+.........+.+.+|+.++++++||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----E 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----C
Confidence 4678888999999999999998653 346999999866544455678999999999999999999998754 2
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 348999999999999999753 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
....... .......+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 162 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 162 YIEDEDY----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp CC-------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred ccccccc----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 7654321 11223456788999999998999999999999999999998 9999975443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.15 Aligned_cols=193 Identities=22% Similarity=0.319 Sum_probs=149.9
Q ss_pred cceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEEEee
Q 012599 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
.+.||+|+||.||++.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----CCEEEEEEEc
Confidence 378999999999999986 5899999999643 3445789999999996 9999999999876 4577999999
Q ss_pred cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC---cEEEEecCCccccccC
Q 012599 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKRLKAD 384 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~---~vkl~DFGla~~~~~~ 384 (460)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 88 LNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999764 56999999999999999999999998 99999999999997665 8999999999865443
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 163 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 163 NQ-----PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CC-----cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 21 2233467899999999999999999999999999999999999997643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.77 Aligned_cols=216 Identities=24% Similarity=0.302 Sum_probs=176.3
Q ss_pred eechHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh----------hHHHHHHHHHHHhcCCCC
Q 012599 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------DSVFLTEVDMLSRLHHCH 283 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~----------~~~f~~Ei~~l~~l~H~n 283 (460)
+....++....++|.+.+.||+|+||.||+|...+++.||||++........ .+.+.+|++++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3445788999999999999999999999999998899999999965432221 256899999999999999
Q ss_pred ccceeeeeeecc-CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCE
Q 012599 284 VVPLVGYCSEFR-GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 362 (460)
Q Consensus 284 Iv~l~g~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NI 362 (460)
|+++++++.... ......++||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999999986643 23446799999996 7999988753 246999999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 363 LLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 363 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|++.++.+||+|||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp EECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEcCCCCEEEEecCccccccccc------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999997544332 2233568899999998876 778999999999999999999999997643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=303.32 Aligned_cols=207 Identities=28% Similarity=0.442 Sum_probs=174.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeec
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~ 294 (460)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+++++++ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 467888899999999999999873 46789999998665444556689999999999 89999999999876
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCC
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~ 360 (460)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 113 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 113 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ---SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred ---CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 4467999999999999999976432 24899999999999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 361 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|||++.++.+||+|||++......... .......+++.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999999876543211 11223456788999999988889999999999999999999 99999764
Q ss_pred C
Q 012599 440 I 440 (460)
Q Consensus 440 ~ 440 (460)
.
T Consensus 264 ~ 264 (334)
T 2pvf_A 264 P 264 (334)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=329.03 Aligned_cols=209 Identities=31% Similarity=0.476 Sum_probs=179.1
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
..|+...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++|+||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---- 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee----
Confidence 34455567788899999999999999999888889999998643 234569999999999999999999999864
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
...++||||+++|+|.++|+......+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccc
Confidence 34699999999999999998654456999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++....... .......++..|+|||.+....++.++||||||++||||++ |+.||....
T Consensus 410 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 410 ARLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp TTTCCCHHH----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred ceecCCCce----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 987643211 11122346788999999999999999999999999999999 999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.51 Aligned_cols=203 Identities=25% Similarity=0.354 Sum_probs=169.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||.||+|.+.. ++.||+|++....... ..+.+.+|++++++++||||+++++++.+ ....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR----KRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec----CCeEE
Confidence 678889999999999999999864 8999999986543322 24557899999999999999999999876 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999999988653 55899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.... ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 154 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 208 (311)
T 4agu_A 154 GPSD-----YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Cccc-----ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 3321 1233468899999999875 6789999999999999999999999976544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=306.06 Aligned_cols=201 Identities=24% Similarity=0.305 Sum_probs=163.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEee----CCEEE
Confidence 467888999999999999999986 689999999975433 23458899999999999999999999876 45689
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc--EEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~--vkl~DFGla~~ 380 (460)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999653 45999999999999999999999998 999999999999987765 99999999975
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM-SDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
..... ......||+.|+|||++....++.+ +||||||+++|||++|+.||.....
T Consensus 168 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 168 SVLHS------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ccccC------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 43221 2233568999999999988877665 8999999999999999999986543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=306.61 Aligned_cols=213 Identities=28% Similarity=0.421 Sum_probs=179.2
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 290 (460)
.++++...++|++.+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455666788999999999999999999764 3678999999865544455568999999999999999999999
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCE
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 362 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NI 362 (460)
+.+ ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 97 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 97 VSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp ECS----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred Ecc----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 875 345699999999999999996532 145799999999999999999999998 99999999999
Q ss_pred EEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 363 LLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 363 ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
|++.++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EEcCCCeEEECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999999999999866443211 11122346788999999998999999999999999999999 89999764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.50 Aligned_cols=207 Identities=28% Similarity=0.439 Sum_probs=169.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.+|++.+.||+|+||.||+|.+.+ ...+|+|.+.........+.+.+|+.++++++||||+++++++.+. +..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---CCc
Confidence 346677899999999999998643 2368999998655545556789999999999999999999987653 345
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.++++.. ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 68999999999999999753 356899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
........ ........+|+.|+|||.+....++.++||||||+++|||++ |.+||...
T Consensus 178 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 236 (298)
T 3f66_A 178 MYDKEYYS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236 (298)
T ss_dssp CSCGGGCB-C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred ccccchhc-cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence 65432211 122333457789999999999999999999999999999999 55555544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=293.40 Aligned_cols=203 Identities=31% Similarity=0.475 Sum_probs=155.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|... +++.||||.+.... .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----SNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC----SSEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc----CCeE
Confidence 56888899999999999999874 68999999986432 12234568899999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999999753 356899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 163 KMPHE-----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp C---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cCCCC-----cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 43221 1223568899999999998889999999999999999999999997543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.33 Aligned_cols=206 Identities=27% Similarity=0.452 Sum_probs=169.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-Cc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|++.+.||+|+||.||+|.+.. ++ +||+|.+...........+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 3678889999999999999998753 43 4688888766666667789999999999999999999999875
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 23689999999999999997643 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
......... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 165 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 165 KLLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred eEccCcccc---ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 876443221 11223446788999999999999999999999999999999 9999986543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=294.34 Aligned_cols=205 Identities=27% Similarity=0.413 Sum_probs=173.3
Q ss_pred cCCcccc-eeeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|.+.+ .||+|+||.||+|.+. +++.||||.++........+.+.+|++++++++||||+++++++.. ..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 83 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 83 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----CC
Confidence 4455555 8999999999999864 5788999999876544456678999999999999999999999842 35
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 79999999999999999753 355999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... ........+|+.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 218 (287)
T 1u59_A 160 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218 (287)
T ss_dssp CTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred eccCcce--eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 6543211 112223446789999999988889999999999999999998 999997654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.19 Aligned_cols=200 Identities=26% Similarity=0.345 Sum_probs=170.4
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..++|++.+.||+|+||.||++... +++.||||.+...... +.+|++++.++ +||||+++++++.+ ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDD----GKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEEC----SSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEc----CCE
Confidence 4567899999999999999999886 4889999999764321 45788888888 79999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC----CcEEEEecC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLG 376 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~----~~vkl~DFG 376 (460)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+.++ +.+||+|||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 89999999999999999753 45999999999999999999999998 9999999999998543 359999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
++....... .......||+.|+|||++....++.++||||||+++|||++|+.||.....
T Consensus 166 ~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 166 FAKQLRAEN-----GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp TCEECBCTT-----CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred CcccCcCCC-----CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 998765432 122345689999999999888899999999999999999999999986443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=308.18 Aligned_cols=210 Identities=23% Similarity=0.333 Sum_probs=165.3
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 298 (460)
...++|++.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.+++.+. ||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--D 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT--S
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC--C
Confidence 45678999999999999999999875 589999999865422 233445789999999996 999999999987532 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++ ++|.++++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 46799999996 699999975 46899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC----------------CCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLP----------------SCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~----------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+........ ..........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 865431110 01112334579999999999876 678999999999999999999999997654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=311.75 Aligned_cols=205 Identities=28% Similarity=0.420 Sum_probs=174.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|.+.+.||+|+||.||+|.+.. ++.||||++.........+.+.+|++++++++||||+++++++.+.. ....++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC--CCeeEE
Confidence 457788999999999999999865 89999999986554455566889999999999999999999987633 336799
Q ss_pred EEeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE----cCCCcEEEEecCCc
Q 012599 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 378 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll----~~~~~vkl~DFGla 378 (460)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976432 33999999999999999999999998 9999999999999 77888999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--------GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 8764432 1223568999999998864 567889999999999999999999997543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=291.19 Aligned_cols=202 Identities=24% Similarity=0.340 Sum_probs=174.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc----CCEE
Confidence 578899999999999999999876 488999999975432 2234558899999999999999999999875 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc---EEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~---vkl~DFGla 378 (460)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++
T Consensus 81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999999998754 45899999999999999999999998 999999999999986655 999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ......||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 156 IEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp EECCSSC------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEcccCc------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 7664432 1233568999999999999999999999999999999999999996543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=291.56 Aligned_cols=202 Identities=29% Similarity=0.456 Sum_probs=174.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|+..+.||+|+||.||++...+++.||+|.+..... ..+.+.+|++++++++||||+++++++.+ ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCCeEE
Confidence 356788899999999999999998889999999986432 33568999999999999999999999876 345799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999997542 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
... .......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 157 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 157 DQY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp HHH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccc----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 211 11223446788999999998899999999999999999999 89999754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=302.56 Aligned_cols=199 Identities=28% Similarity=0.418 Sum_probs=170.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.+.|+..+.||+|+||.||+|.. .+++.||||++....... ..+.+.+|++++++++||||+++++++.+ ...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 128 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHT 128 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCe
Confidence 35588889999999999999987 468999999997543222 23458899999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||++ |+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 799999996 7898888643 256999999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ....||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 204 ~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 204 MAPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp SSSB---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCCC---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 2346899999999884 5678999999999999999999999997643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.71 Aligned_cols=218 Identities=27% Similarity=0.425 Sum_probs=182.8
Q ss_pred eechHHHHHHhcCCcccceeeeeCcEEEEEEEE------cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccc
Q 012599 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~ 286 (460)
.+....++...++|.+.+.||+|+||.||+|.+ .+++.||||.++..........+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 455566777788999999999999999999975 246889999998665444555689999999999 7999999
Q ss_pred eeeeeeeccCccceEEEEEeecCCCCHHHHhccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012599 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (460)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~i 352 (460)
+++++... +...++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |
T Consensus 96 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 96 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp EEEEECCT---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEecC---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 99998652 2357999999999999999976432 12789999999999999999999998 9
Q ss_pred EecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-
Q 012599 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 431 (460)
Q Consensus 353 vH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt- 431 (460)
+||||||+|||++.++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||+|
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccc---eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999866443211 11223457889999999999999999999999999999998
Q ss_pred CCCCCCCCC
Q 012599 432 GRQPIHRSI 440 (460)
Q Consensus 432 G~~Pf~~~~ 440 (460)
|+.||....
T Consensus 247 g~~p~~~~~ 255 (316)
T 2xir_A 247 GASPYPGVK 255 (316)
T ss_dssp SCCSSTTCC
T ss_pred CCCCCcccc
Confidence 999997654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=289.20 Aligned_cols=201 Identities=21% Similarity=0.263 Sum_probs=173.4
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++|++.+.||+|+||.||+|.... +..+|+|++..... ...+.+.+|++++++++||||+++++++.+ ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFED----NTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCeE
Confidence 34678889999999999999998865 77899999876443 334568999999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGla 378 (460)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999999999754 45899999999999999999999998 9999999999999 78899999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 157 ARFKPGK------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp EECCTTS------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCcc------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 8765432 1233468899999998765 48999999999999999999999997643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=329.97 Aligned_cols=204 Identities=25% Similarity=0.322 Sum_probs=176.0
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCcc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 298 (460)
..++|++.+.||+|+||.||+|... +++.||||+++... .....+.+..|..++..+ +|+||+++++++.+ .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----~ 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----M 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----S
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----C
Confidence 4578999999999999999999876 48889999997431 223344578899999988 79999999988765 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||++
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 5789999999999999999764 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+.....+ .......||+.|+|||++....++.++||||||++||||++|+.||....
T Consensus 490 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 490 KENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp EECCCTT-----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccCC-----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 8643332 22345679999999999999999999999999999999999999997643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=292.30 Aligned_cols=201 Identities=28% Similarity=0.506 Sum_probs=169.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChh------HHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~------~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
++|++.+.||+|+||.||+|.+. +++.||+|++......... +.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 95 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--- 95 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence 66788899999999999999985 6899999999765433221 5688999999999999999999987541
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc-----EEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKI 372 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~-----vkl 372 (460)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred ---CeEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 27999999999999998653 356999999999999999999999875 34999999999999988776 999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
+|||+++..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 171 ~Dfg~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 171 ADFGLSQQSVHS--------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCBCCSSC--------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCcccccccc--------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 999999754321 22356889999999983 45678999999999999999999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=306.73 Aligned_cols=196 Identities=26% Similarity=0.367 Sum_probs=164.8
Q ss_pred cceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEeec
Q 012599 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.+.||+|+||.||+|... +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFES----KNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEEEEEeCC
Confidence 568999999999999875 589999999976432 344568999999999999999999999876 45679999999
Q ss_pred CCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE--cCCCcEEEEecCCccccccCCC
Q 012599 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 309 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll--~~~~~vkl~DFGla~~~~~~~~ 386 (460)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999986532 45899999999999999999999998 9999999999999 577899999999998765432
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 244 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 244 -----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp -----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223468999999999998899999999999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=306.72 Aligned_cols=204 Identities=26% Similarity=0.345 Sum_probs=171.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEE----cCCcEEEEEEeccCC---CCChhHHHHHHHHHHHhc-CCCCccceeeeeeecc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 295 (460)
.++|++.+.||+|+||.||++.. .+++.||||+++... .......+.+|+++++.+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 36788899999999999999988 368999999986432 122334477899999999 69999999998876
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred --CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 45679999999999999999754 45899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+++....... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||....
T Consensus 204 G~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 204 GLSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp SEEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CCCeecccCCC----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 99986543321 12234578999999999875 457899999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=315.73 Aligned_cols=203 Identities=21% Similarity=0.263 Sum_probs=167.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Cccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~ 299 (460)
.++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++.... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467899999999999999999875 48899999997542 2233456889999999999999999999986533 2234
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999964 67777753 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 213 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 213 TAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp ----CC------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCc------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764432 2334678999999999999999999999999999999999999997644
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.19 Aligned_cols=206 Identities=26% Similarity=0.405 Sum_probs=170.1
Q ss_pred cCCcccc-eeeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
+++.+.+ .||+|+||.||+|.+. ++..||||+++........+.|.+|+++|++++||||+++++++.. ..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----CC
Confidence 3344444 7999999999999874 4667999999876555566779999999999999999999999864 24
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 79999999999999999754 356999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
....... ........+++.|+|||++....++.++||||||++||||++ |+.||.....
T Consensus 486 ~~~~~~~--~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 486 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp CC----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred ccCCCce--eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 6443211 111122345688999999999999999999999999999998 9999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=300.13 Aligned_cols=217 Identities=27% Similarity=0.430 Sum_probs=174.4
Q ss_pred eechHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeee
Q 012599 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291 (460)
Q Consensus 214 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~ 291 (460)
.+++.++..+.++|++.+.||+|+||.||+|.+. +++.||||++.... .....+.+|+.+++++ +||||+++++++
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3444555667888999999999999999999984 68999999997543 2345689999999999 899999999998
Q ss_pred eeccC--ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 292 SEFRG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 292 ~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
..... .....++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 76431 1357799999999999999998655567999999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+||+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 168 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EEECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEEeeCcCceecCcCc-----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999998654321 1123346889999999986 5678999999999999999999999997543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=311.79 Aligned_cols=202 Identities=23% Similarity=0.325 Sum_probs=156.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeecc-Cccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~~~ 300 (460)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ...+.+.+|+++|+.++||||+++++++.... .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999876 5899999999654322 23456889999999999999999999986532 23356
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+ +++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 68999999753 55999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC----------------------CCCCCccccCCcccCcccc-ccCCCCchhHHHHHHHHHHHHHh
Q 012599 381 LKADGLPSC----------------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 381 ~~~~~~~~~----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvll~ellt 431 (460)
......... ........||+.|+|||++ ....++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 653321100 0122345789999999976 46679999999999999999999
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=297.11 Aligned_cols=205 Identities=28% Similarity=0.429 Sum_probs=171.5
Q ss_pred cCCcccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
.+|++.+.||+|+||.||++.+ .+++.||||++.........+.+.+|++++++++||||+++++++.+.. ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--Cc
Confidence 3477789999999999999984 3588999999987665566677999999999999999999999987632 24
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 5789999999999999996533 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
........ ........+|..|+|||.+....++.++||||||+++|||++|..|+.
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 76544321 112333457888999999998899999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=291.77 Aligned_cols=203 Identities=23% Similarity=0.341 Sum_probs=171.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|.+. ++.+|||+++.... ....+.|.+|+.++++++||||+++++++.+.. ....+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--APHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--SSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--CCCeE
Confidence 356888899999999999999985 88899999986542 233456899999999999999999999987632 24679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ ++|+||||||+|||+++++.++|.|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999998755456999999999999999999999875 459999999999999999999999999875432
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCC---CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA---SLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
. ....+|+.|+|||.+....+ +.++||||||+++|||++|+.||....
T Consensus 165 ~----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 165 S----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp C----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred c----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 2 22457899999999876544 348999999999999999999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=289.29 Aligned_cols=201 Identities=25% Similarity=0.391 Sum_probs=172.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|.+.+.||+|+||.||++... +++.||+|.++...... ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~ 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----K 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----S
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----C
Confidence 56888899999999999999986 58999999987653221 35568999999999999999999999876 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC----cEEEEe
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKITD 374 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~----~vkl~D 374 (460)
...++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++ .+||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred CeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 5679999999999999999753 45899999999999999999999998 99999999999999877 899999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||++....... ......+++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 156 fg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 156 FGIAHKIEAGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp CTTCEECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccceeccCCC------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 99998764432 1233468899999999998999999999999999999999999997643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.45 Aligned_cols=211 Identities=22% Similarity=0.323 Sum_probs=176.8
Q ss_pred hHHHHHHhcCCccc-ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 217 YSALEHATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 217 ~~~l~~~~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
+...+...+.|.+. +.||+|+||.||+|... +++.||+|++..... ......+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34455667778777 88999999999999886 489999999975432 23345689999999999 5799999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCc
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 369 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~ 369 (460)
+ ....++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 100 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 100 N----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp C----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred e----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 5 456799999999999999997655567999999999999999999999998 999999999999998 789
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+||+|||++....... ......||+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 173 ~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp EEECCGGGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEeeCccccccCCcc------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999998764432 1233568999999999999999999999999999999999999997543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=291.63 Aligned_cols=202 Identities=25% Similarity=0.396 Sum_probs=174.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||.||++.+.+ ++.+|+|.+...... ...+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 90 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDFV 90 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----CCEE
Confidence 567788999999999999999864 788999998754322 234568899999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999998753 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 166 EYDGE-----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CSTTC-----CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCcc-----ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 53321 2233568899999999998889999999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.96 Aligned_cols=208 Identities=23% Similarity=0.318 Sum_probs=175.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc-CccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|... +++.||||++...........+.+|++++++++||||+++++++.... ......
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888999999999999999875 588899999976544444466899999999999999999999987533 223467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||++ |+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 699999965 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 179 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 179 DPDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp CGGGCB--CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCCc--cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 543221 112234578999999998754 558999999999999999999999997654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=299.88 Aligned_cols=211 Identities=24% Similarity=0.344 Sum_probs=174.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC----cc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~ 298 (460)
++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+++++.++||||+++++++..... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 56888899999999999999984 689999999865533 2334568899999999999999999999876322 13
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++ ++|.+.+.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46799999996 58888886543 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.......... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 172 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EECCCCSSSS-CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccc-ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 8765432211 223344568999999998875 5689999999999999999999999986543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.83 Aligned_cols=201 Identities=26% Similarity=0.461 Sum_probs=174.7
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc------
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 295 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 295 (460)
...+|+..+.||+|+||.||+|.+. +++.||+|.+.... ..+.+|++++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567888999999999999999986 68999999997542 23789999999999999999999875421
Q ss_pred ------CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc
Q 012599 296 ------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (460)
Q Consensus 296 ------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~ 369 (460)
......++||||+++++|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 12345799999999999999997665567999999999999999999999998 999999999999999999
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
+||+|||++....... ......+++.|+|||.+....++.++||||||+++|||++|..||.
T Consensus 161 ~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCS------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheeccccc------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 9999999998765432 1233468899999999999999999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=295.51 Aligned_cols=207 Identities=27% Similarity=0.365 Sum_probs=167.0
Q ss_pred hcCCccc-ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.+.|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|++++.++ +||||+++++++.+ ...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----EDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----CCE
Confidence 3557664 78999999999999865 58999999997653 33455689999999985 79999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc---EEEEecCC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 377 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~---vkl~DFGl 377 (460)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 89999999999999999764 45899999999999999999999998 999999999999998776 99999999
Q ss_pred ccccccCCCCC--CCCCCCccccCCcccCcccccc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+......+... .........||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 98664332111 1112233468999999999865 567899999999999999999999997654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.15 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=174.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 91 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----PSDI 91 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 56888899999999999999986 68999999996432 12334568899999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999999753 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 167 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 167 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp CTTC------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccc------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 5432 1233568999999999987765 789999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=304.61 Aligned_cols=201 Identities=26% Similarity=0.405 Sum_probs=175.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++.+. +++.||+|++...........+.+|+.+++.++||||+++++++.+ ....+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----TTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----CCEEE
Confidence 357888899999999999999986 5899999999876544455678999999999999999999999886 45689
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999764 4589999999999999999999985 7 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 183 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 183 IDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HHHC-----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred cccc-------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 223468899999999999999999999999999999999999997643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=303.41 Aligned_cols=210 Identities=24% Similarity=0.377 Sum_probs=177.1
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeee
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~ 293 (460)
+...++|+..+.||+|+||.||+|.... ...||+|.+.........+.+.+|+.+++.+ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345788889999999999999998743 2479999998665444556689999999999 89999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCC
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~N 361 (460)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 346799999999999999996532 245899999999999999999999998 9999999999
Q ss_pred EEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 362 Ill~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
||+++++.+||+|||++......... .......+|+.|+|||.+....++.++||||||+++|||+| |..||....
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCTTS---EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEECCCCeEEECccccccccccccce---eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 99999999999999999876543211 11233456788999999998999999999999999999999 999997654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=309.18 Aligned_cols=204 Identities=25% Similarity=0.368 Sum_probs=164.9
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-------CCChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-------GPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-------~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 292 (460)
....++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+++|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 355789999999999999999999875 47899999986532 1111223789999999999999999999874
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC---Cc
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LN 369 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~---~~ 369 (460)
. ...++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.+ ..
T Consensus 211 ~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 211 A-----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp S-----SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred c-----CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence 3 3468999999999999998753 56999999999999999999999998 9999999999999754 45
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+||+|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 281 ~kl~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 281 IKITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp EEECCSSTTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred EEEeecccceecCCCc------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 9999999998764432 223457899999999885 3678899999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.86 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=175.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|.+.+.||+|+||.||++.+.+ ++.+|+|.+...... ...+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 115 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDF 115 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCe
Confidence 3567888999999999999999864 789999998754322 234568899999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 79999999999999998753 46899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... ......|+..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 191 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 244 (335)
T 2owb_A 191 VEYDGE-----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244 (335)
T ss_dssp CCSTTC-----CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccCcc-----cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence 654321 223356899999999999888999999999999999999999999764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.08 Aligned_cols=208 Identities=22% Similarity=0.242 Sum_probs=168.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCCCCC----------hhHHHHHHHHHHHhcCCCCccceeee
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCHVVPLVGY 290 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~~~~----------~~~~f~~Ei~~l~~l~H~nIv~l~g~ 290 (460)
++|.+.+.||+|+||.||+|.+. .+..+|+|++....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999986 57789999987543211 11236678888899999999999999
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC--
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-- 368 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-- 368 (460)
+.+........++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 887555566889999999 999999997643 6999999999999999999999998 99999999999999887
Q ss_pred cEEEEecCCccccccCCCCCC--CCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 369 NAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 369 ~vkl~DFGla~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.+||+|||+++.+........ ........||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999987754432111 1112345789999999999999999999999999999999999999965
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.30 Aligned_cols=202 Identities=24% Similarity=0.345 Sum_probs=166.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||++...+++.||||++...... ...+.+.+|+.++++++| +||+++++++.+ ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----CCE
Confidence 3568888999999999999999988999999999755322 233568899999999976 999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++|||+ .+++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 8999995 588999999763 56899999999999999999999998 99999999999997 57899999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 157 MQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp C---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCcccc---cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 654321 112234568999999999864 67899999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=302.23 Aligned_cols=202 Identities=25% Similarity=0.338 Sum_probs=174.0
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-------hhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 294 (460)
..++|++.+.||+|+||.||+|.+. +++.||||++....... ....+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4578999999999999999999864 58899999997653211 22347789999999999999999999876
Q ss_pred cCccceEEEEEeecCCC-CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 295 RGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
....++||||+.+| +|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 45779999999777 999999754 45999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|||++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 173 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 173 DFGSAAYLERGK------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CCTTCEECCTTC------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred ecccceECCCCC------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 999998765432 2234568999999999988776 88999999999999999999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.94 Aligned_cols=206 Identities=27% Similarity=0.435 Sum_probs=167.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|+..+.||+|+||.||+|.+.. +..||||.++..........+.+|+.++++++||||+++++++.+ .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----Y 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----C
Confidence 3567778999999999999998753 245999999865544445568999999999999999999999865 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 5679999999999999999753 356999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
......... ........+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 195 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 254 (333)
T 1mqb_A 195 RVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhhcccccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence 876543211 111222345778999999998999999999999999999999 99999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.81 Aligned_cols=201 Identities=24% Similarity=0.402 Sum_probs=170.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||+|.... ++.||+|++.... .......+.+|+.++++++||||+++++++.+ ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 83 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATR 83 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec----CCE
Confidence 4678889999999999999998764 7789999986431 12234458899999999999999999999876 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 79999999999999999754 45899999999999999999999998 99999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 159 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 159 APSSR-------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp C---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCccc-------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 43321 233468899999999999999999999999999999999999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=300.17 Aligned_cols=214 Identities=26% Similarity=0.398 Sum_probs=157.3
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
+....++|.+.+.||+|+||.||+|... +++.||||.+...........+.+|+.++++++||||+++++++.. .
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 85 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV----K 85 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES----S
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee----c
Confidence 3445678999999999999999999864 5889999998765444445568899999999999999999999876 3
Q ss_pred ceEEEEEeecCCCCHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGV------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
...++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEE
Confidence 4679999999999999999642 2345899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+|||++...................||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 99999876654322111222334568999999998865 568999999999999999999999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=290.90 Aligned_cols=204 Identities=26% Similarity=0.403 Sum_probs=169.4
Q ss_pred CcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
|...+.||+|+||.||+|.+.+ +..+|+|.+.........+.+.+|+.++++++||||+++++++.+. +...+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 99 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---EGLPH 99 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSCCE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---CCCcE
Confidence 4455889999999999998643 2379999998655444556789999999999999999999998752 23448
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999999763 356899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
...... ........+++.|+|||.+....++.++||||||+++|||++|..||..
T Consensus 176 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~ 230 (298)
T 3pls_A 176 DREYYS-VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230 (298)
T ss_dssp TGGGGC-SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred CCcccc-cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc
Confidence 432111 1223345678899999999999999999999999999999996666544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=289.99 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=171.6
Q ss_pred CcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
|.+.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++..........++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 566688999999999999875 47889999987543 2334456889999999999999999999987765556778999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCcccccc
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~ 383 (460)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||||+|||++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999754 45899999999999999999999875 3599999999999998 889999999999975432
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
. ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus 185 ~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 185 S-------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp T-------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c-------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 122346889999999776 56899999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=287.23 Aligned_cols=208 Identities=20% Similarity=0.289 Sum_probs=171.6
Q ss_pred HhcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++|++.+.||+|+||.||+|.+ .+++.||||++....... .+.+|+++++.++|++++..++.+... ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAE---GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC---CHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch---HHHHHHHHHHHhcCCCCCCeeeeecCC---CCce
Confidence 457899999999999999999997 468899999876543322 378999999999999888888776542 4467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGla 378 (460)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999999 99999999743 246999999999999999999999998 9999999999999 78999999999999
Q ss_pred cccccCCCCC--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 379 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 8775543211 11233456789999999999999999999999999999999999999987544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=286.38 Aligned_cols=207 Identities=20% Similarity=0.293 Sum_probs=174.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+|+.+++.++|++++..+.++... ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCC---CCceE
Confidence 46788999999999999999997 56899999998765432 2488999999999998888777766542 44679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCCcc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 379 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGla~ 379 (460)
+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++.
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999999 99999999743 256999999999999999999999998 9999999999999 588899999999998
Q ss_pred ccccCCCCC--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 380 RLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
......... .........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 765543211 11223456789999999999999999999999999999999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=298.88 Aligned_cols=208 Identities=27% Similarity=0.453 Sum_probs=177.7
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-------hhHHHHHHHHHHHhc-CCCCccce
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRL-HHCHVVPL 287 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-------~~~~f~~Ei~~l~~l-~H~nIv~l 287 (460)
+.......++|++.+.||+|+||.||+|.+. +|+.||||++....... ..+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445666788999999999999999999986 69999999997654221 133478899999999 89999999
Q ss_pred eeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
++++.. ....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++++
T Consensus 166 ~~~~~~----~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 166 IDSYES----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEB----SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEEee----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999875 45779999999999999999753 45899999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+.+||+|||++....... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...
T Consensus 237 ~~ikl~DfG~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp CCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCEEEEecCcccccCCCc------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 999999999998765432 2234578999999998853 35788999999999999999999999753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.89 Aligned_cols=203 Identities=31% Similarity=0.444 Sum_probs=173.0
Q ss_pred CcccceeeeeCcEEEEEEEEc-----CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
|++.+.||+|+||.||++... +++.||||+++..........+.+|++++++++||||+++++++.+.. ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--AASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--TTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--CceE
Confidence 377899999999999998653 588999999987655455567899999999999999999999987633 3467
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999999975 34899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... ........+|..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 185 PEGHEY--YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CTTCSE--EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccc--cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 543211 11223345778899999999888999999999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=292.27 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=161.5
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++|++.+.||+|+||.||+|.+. ..+|||+++..... ...+.|.+|+.++++++|+||+++++++.. ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 94 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----PQL 94 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SSC
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-----Ccc
Confidence 3567888999999999999999864 35999999765432 334568999999999999999999997543 346
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 89999999999999996543 55999999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ........||+.|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 171 SRWSG---SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccc---cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 43221 11223456899999999886 6678999999999999999999999997643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.00 Aligned_cols=206 Identities=24% Similarity=0.341 Sum_probs=167.9
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc---
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--- 295 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--- 295 (460)
++...++|++.+.||+|+||.||+|.+. +++.||||++...... ..+|+++++.++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456788999999999999999999874 6899999998754322 347999999999999999999986532
Q ss_pred -------------------------------CccceEEEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHH
Q 012599 296 -------------------------------GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLE 342 (460)
Q Consensus 296 -------------------------------~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~ 342 (460)
......++||||++ |+|.+.+... ....+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 22345789999997 6888887542 2356999999999999999999
Q ss_pred HHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHH
Q 012599 343 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVF 420 (460)
Q Consensus 343 yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVw 420 (460)
|||+.+ |+||||||+|||++ +++.+||+|||+++...... ......+|..|+|||.+.+. .++.++|||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999998 99999999999998 68899999999998764432 12334678999999988764 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 012599 421 SFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 421 SlGvll~elltG~~Pf~~~~ 440 (460)
|||+++|||++|+.||....
T Consensus 227 slG~il~ell~g~~pf~~~~ 246 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGET 246 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSS
T ss_pred hHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=295.09 Aligned_cols=211 Identities=27% Similarity=0.412 Sum_probs=169.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc--CCCCccceeeeeeeccCc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL--HHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~~~~~~ 297 (460)
-....++|++.+.||+|+||.||+|... ++.||||++... ....+..|.+++..+ +||||+++++++.+....
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445678999999999999999999985 899999998643 233456666666655 899999999998875544
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCcCCCCEEEcCCCcEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-----APRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~-----~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
....++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.. .++|+||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 4678999999999999999965 35899999999999999999999880 112999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCch------hHHHHHHHHHHHHHhC----------CCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM------SDVFSFGVVLLELITG----------RQPI 436 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwSlGvll~elltG----------~~Pf 436 (460)
+|||++.......... ........||+.|+|||.+.....+.+ +||||||+++|||+|| +.||
T Consensus 184 ~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEV-DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeCCCceeeccccccc-cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999997665432211 111234578999999999987666554 9999999999999999 7777
Q ss_pred CCC
Q 012599 437 HRS 439 (460)
Q Consensus 437 ~~~ 439 (460)
...
T Consensus 263 ~~~ 265 (337)
T 3mdy_A 263 HDL 265 (337)
T ss_dssp TTT
T ss_pred hhh
Confidence 654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=287.82 Aligned_cols=200 Identities=25% Similarity=0.326 Sum_probs=170.3
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~ 299 (460)
..++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+..+..+ +||||+++++++.+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----~~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----DD 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----TT
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----CC
Confidence 4567889999999999999999986 689999999986533 33445688999999999 99999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-----------
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----------- 366 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~----------- 366 (460)
..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccc
Confidence 77999999999999999975422 55899999999999999999999998 999999999999984
Q ss_pred --------CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 367 --------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 367 --------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
...+||+|||++....... ...||+.|+|||.+... .++.++||||||+++|||++|..|+.
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccccccCCceEEEEcccccccccCCcc---------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4479999999998764332 23488999999998765 56789999999999999999998764
Q ss_pred C
Q 012599 438 R 438 (460)
Q Consensus 438 ~ 438 (460)
.
T Consensus 233 ~ 233 (289)
T 1x8b_A 233 N 233 (289)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=294.22 Aligned_cols=198 Identities=28% Similarity=0.470 Sum_probs=163.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|++.+.||+|+||.||++... ++.||||.+... ...+.|.+|++++++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------CcEEE
Confidence 56778899999999999999985 788999998642 345668999999999999999999998763 35899
Q ss_pred EeecCCCCHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc-EEEEecCCccccc
Q 012599 305 FEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLK 382 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~-vkl~DFGla~~~~ 382 (460)
|||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||+++++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999975432 24789999999999999999999933233999999999999998886 7999999997653
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .....||+.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 158 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 158 TH--------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cc--------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 32 123358899999999999999999999999999999999999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.35 Aligned_cols=203 Identities=18% Similarity=0.270 Sum_probs=171.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC---------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccc---------
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP--------- 286 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~--------- 286 (460)
++|.+.+.||+|+||.||+|.+.. ++.||+|.+... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 568888999999999999998864 789999999754 23889999999999999988
Q ss_pred ------eeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCC
Q 012599 287 ------LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (460)
Q Consensus 287 ------l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~ 360 (460)
+++++.. .....++||||+ +++|.+++.......+++.+++.++.|++.||.|||+.+ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~---~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVH---QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEE---TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhcccc---CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 4555543 245779999999 999999998654467999999999999999999999998 999999999
Q ss_pred CEEEcCCC--cEEEEecCCccccccCCCCC--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 012599 361 NILLDENL--NAKITDLGMAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (460)
Q Consensus 361 NIll~~~~--~vkl~DFGla~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf 436 (460)
|||++.++ .+||+|||+++......... .........||+.|+|||.+.+..++.++||||||++||||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999998765543211 111223457899999999999999999999999999999999999999
Q ss_pred CCCC
Q 012599 437 HRSI 440 (460)
Q Consensus 437 ~~~~ 440 (460)
....
T Consensus 269 ~~~~ 272 (352)
T 2jii_A 269 TNCL 272 (352)
T ss_dssp GGGT
T ss_pred ccCC
Confidence 8754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.21 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=164.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||++.+. +++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+ ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----DGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----CCe
Confidence 478899999999999999999986 58899999997543222 23568899999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 79999999999999999754 45899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... .......+++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 184 TTDEKL----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccc----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 644321 1223346889999999999999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.71 Aligned_cols=201 Identities=23% Similarity=0.340 Sum_probs=166.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcC--CCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.+|++.+.||+|+||.||++...+++.||||++..... ....+.+.+|+.++++++ |+||+++++++.. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----CCEE
Confidence 45888899999999999999988899999999976432 233456899999999995 5999999999876 4468
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 132 ~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99999 5689999999764 46899999999999999999999998 99999999999996 579999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... .......||+.|+|||++.. ..++.++||||||++||||++|+.||...
T Consensus 205 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 205 QPDTTS---VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cCCCcc---ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 543211 12234569999999998864 46899999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=296.89 Aligned_cols=205 Identities=27% Similarity=0.383 Sum_probs=166.0
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC----hhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
...++|++.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34578999999999999999999986 48999999997543221 12357899999999999999999999875
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 84 -~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 -KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp -TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred -CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 4467999999965 8999987532 45889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||....
T Consensus 158 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 158 LAKSFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp GGSTTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceeccCCc-----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 998764332 12334568999999999865 458999999999999999999999987643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=302.40 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=166.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~ 299 (460)
.++|+..+.||+|+||.||+|.+. +|+.||||++...... ...+.+.+|+++++.++||||+++++++..... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999985 5899999999654322 234558899999999999999999999875322 123
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+ +++|.++++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 8899999975 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....+|..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 177 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 177 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc--------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 75432 233568899999999876 779999999999999999999999997654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.80 Aligned_cols=195 Identities=21% Similarity=0.311 Sum_probs=168.7
Q ss_pred cCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+|+.++++++ ||||+++++++.+.. ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC--CCceE
Confidence 6788889999999999999987 46899999998743 3456899999999996 999999999987632 34679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCcccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 381 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~~ 381 (460)
+||||+++++|.+++.. +++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999999853 789999999999999999999998 99999999999999776 8999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 182 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 182 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCC------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 5432 2233468899999999876 67899999999999999999999999643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=288.82 Aligned_cols=200 Identities=25% Similarity=0.384 Sum_probs=173.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+++++.++||||+++++++.+ ....
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 89 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----RKRI 89 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----CCEE
Confidence 56888899999999999999886 47889999986431 12234568899999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .....|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 165 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 165 PSLR-------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SSSC-------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccc-------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 4321 223468899999999999899999999999999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=296.39 Aligned_cols=206 Identities=29% Similarity=0.462 Sum_probs=164.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHH--HhcCCCCccceeeeeeec-cCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDML--SRLHHCHVVPLVGYCSEF-RGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l--~~l~H~nIv~l~g~~~~~-~~~~~~ 300 (460)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++ ..++|+||+++++.+... ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788889999999999999987 6899999999743 223355555554 457999999999876543 223446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCcCCCCEEEcCCCcEE
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA---------AAPRILHRDIKSSNILLDENLNAK 371 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~---------~~~~ivH~DLk~~NIll~~~~~vk 371 (460)
.++||||+++|+|.+++.. ...++..++.++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 7899999999999999965 3458999999999999999999998 6 99999999999999999999
Q ss_pred EEecCCccccccCCCCC---CCCCCCccccCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+|||++.......... .........||+.|+|||++.+ ..++.++||||||+++|||++|..||....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 99999998765433211 1122234568999999999876 456778999999999999999988876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=296.21 Aligned_cols=203 Identities=29% Similarity=0.488 Sum_probs=168.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcE--EEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+|.+. ++.. +|+|.++........+.+.+|+++++++ +||||+++++++.+ ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----CCc
Confidence 56888899999999999999875 4554 4999998655555556689999999999 99999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 899999999999999997542 246899999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 367 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
++.+||+|||+++...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp GGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCeEEEcccCcCccccccc------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999987543221 1223346788999999988889999999999999999998 999997543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=294.48 Aligned_cols=217 Identities=24% Similarity=0.366 Sum_probs=167.1
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 292 (460)
.++....++|.+.+.||+|+||.||+|.+.. ++.||+|.++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4444556788889999999999999997643 458999999765332 23456889999999999999999999987
Q ss_pred eccCc-cceEEEEEeecCCCCHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC
Q 012599 293 EFRGK-RAMRLLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 293 ~~~~~-~~~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~ 367 (460)
+.... ....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 64322 12469999999999999999432 2345999999999999999999999998 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+.+||+|||++......... .......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp SCEEECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcEEEeecCcceeccccccc---CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99999999999876543211 11223456788999999999999999999999999999999 899997654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=290.16 Aligned_cols=199 Identities=29% Similarity=0.438 Sum_probs=165.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|++.+.||+|+||.||++.. +++.||||.++... ..+.+.+|++++++++||||+++++++.+. ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CCceEE
Confidence 46788889999999999999988 48899999987543 345689999999999999999999987652 235699
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999997654334899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.. ....+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 170 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 219 (278)
T 1byg_A 170 TQ--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cc--------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 21 12346788999999998999999999999999999998 999997653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=308.14 Aligned_cols=205 Identities=17% Similarity=0.209 Sum_probs=161.9
Q ss_pred HhcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCC--CCChhHHHHHHHH---HHHhcCCCCcccee-------e
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG--GPNADSVFLTEVD---MLSRLHHCHVVPLV-------G 289 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~--~~~~~~~f~~Ei~---~l~~l~H~nIv~l~-------g 289 (460)
..++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|++ .+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356788889999999999999996 458999999997542 3344566889994 55556899999998 4
Q ss_pred eeeeccC--------cc-----ceEEEEEeecCCCCHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012599 290 YCSEFRG--------KR-----AMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (460)
Q Consensus 290 ~~~~~~~--------~~-----~~~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~~l~yLH~~~~~~ 351 (460)
++.+... .. ...++||||+ +|+|.+++..... ..+++..++.++.||+.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4433211 00 0368999999 7899999975321 11335888899999999999999998
Q ss_pred eEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-----------CCCchhHHH
Q 012599 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVF 420 (460)
Q Consensus 352 ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVw 420 (460)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++|||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999999999999999999999985322 1223456 899999999877 899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 012599 421 SFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 421 SlGvll~elltG~~Pf~~~~ 440 (460)
|||++||||++|+.||....
T Consensus 298 SlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp HHHHHHHHHHHSSCCC----
T ss_pred HHHHHHHHHHHCCCCCcccc
Confidence 99999999999999997644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.14 Aligned_cols=210 Identities=23% Similarity=0.338 Sum_probs=172.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeec-cCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF-RGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|... +|+.||||.+...........+.+|++++++++||||+++++++... .......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999986 58899999997554444455688999999999999999999987652 1223567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 699999875 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCC-----CCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSC-----SSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
........ ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 54321110 111233568999999998764 778999999999999999999999997643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.16 Aligned_cols=209 Identities=28% Similarity=0.428 Sum_probs=174.7
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEE--cCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhc---CCCCccceeeeeeecc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQL--TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR 295 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~ 295 (460)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999998 3588999999875432 22223467888887776 8999999999986322
Q ss_pred -CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEe
Q 012599 296 -GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (460)
Q Consensus 296 -~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~D 374 (460)
......++||||++ |+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 23457899999996 79999998765556999999999999999999999998 99999999999999999999999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||++....... ......+++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 164 fg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (326)
T 1blx_A 164 FGLARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223 (326)
T ss_dssp CCSCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CcccccccCCC------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998654321 1223467899999999999999999999999999999999999997644
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.22 Aligned_cols=209 Identities=22% Similarity=0.291 Sum_probs=168.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~ 300 (460)
.++|.+.+.||+|+||.||+|.+. +++.||||++...... .....+.+|+.+|+.++|+||+++++++..... ....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467888999999999999999875 4788999999754322 234568899999999999999999999875321 1246
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 799999995 6999999753 55999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC-----------------CCCCCccccCCcccCcccc-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 381 LKADGLPSC-----------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 381 ~~~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
......... ........||+.|+|||++ ....++.++|||||||++|||++|..||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 654321100 0122456789999999986 566799999999999999999987666543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=301.21 Aligned_cols=204 Identities=25% Similarity=0.254 Sum_probs=173.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC--------CCCccceeeeeeec
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--------HCHVVPLVGYCSEF 294 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~~~ 294 (460)
.++|++.+.||+|+||+||+|... +++.||||+++.. ....+.+.+|+.+++.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 367899999999999999999875 5889999999743 223456889999999985 78899999998755
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCC-----
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENL----- 368 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~----- 368 (460)
.......++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 44466789999999 77888877655546699999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------cEEEEecCCccccccCCCCCCCCCCCccccCCcccC
Q 012599 369 --------------------------------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404 (460)
Q Consensus 369 --------------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~a 404 (460)
.+||+|||++...... .....||+.|+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~~y~a 261 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCGGGCC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccCCCCCcccC
Confidence 7999999999876432 223468999999
Q ss_pred ccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 405 PE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
||++.+..++.++||||||++||||++|+.||.....
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999999999999999999999999999999976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=290.16 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=171.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|.+.+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++++++||||+++++++.+ ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYES----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhccc----CCEEE
Confidence 456888899999999999999986 589999999985432 233458899999999999999999999876 45779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCCcc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 379 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGla~ 379 (460)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||++.
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999999654 45899999999999999999999998 9999999999999 788999999999987
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... ......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 158 MEQNG-------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp CCCCB-------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ecCCC-------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 54322 122346889999999999999999999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=290.21 Aligned_cols=202 Identities=26% Similarity=0.410 Sum_probs=170.0
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
...++|++.+.||+|+||.||+|.... |+.||+|.+.... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCE
Confidence 446789999999999999999998864 8999999997643 23458999999999999999999999876 456
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 79999999999999999743 356899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... .......|++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 175 LTDTM-----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp CBTTB-----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred hhhhc-----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 64331 1223346889999999999889999999999999999999999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=290.08 Aligned_cols=203 Identities=25% Similarity=0.357 Sum_probs=162.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 107 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 107 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCcE
Confidence 56888899999999999999874 689999999975432 2234568899999999999999999999886 4577
Q ss_pred EEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999642 2355899999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... .......+++.|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 185 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 185 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred eecCCC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 654432 1223346889999999999999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=295.46 Aligned_cols=203 Identities=28% Similarity=0.445 Sum_probs=168.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||++.... ++.||||++....... ....+.+|+.++++++||||+++++++.+ ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 99 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----KKRW 99 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec----CCEE
Confidence 3568888999999999999999864 8999999987554332 23457899999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 100 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999998887543 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 175 AAPGE-----VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCcc-----ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 44321 22334688999999998765 78999999999999999999999997654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=290.99 Aligned_cols=197 Identities=24% Similarity=0.376 Sum_probs=166.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-C-------cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-G-------RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
.++|.+.+.||+|+||.||+|.+.. + ..||+|.+.... ....+.+.+|++++++++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC-- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence 3567888999999999999998653 3 479999986533 3344568999999999999999999999876
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc------
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN------ 369 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~------ 369 (460)
....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccc
Confidence 345699999999999999997642 34899999999999999999999998 999999999999998887
Q ss_pred --EEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 370 --AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 370 --vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+||+|||++...... ....+++.|+|||.+.. ..++.++||||||+++|||++|..|+..
T Consensus 158 ~~~kl~Dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp CEEEECCCCSCTTTSCH---------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ceeeeccCcccccccCc---------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 999999998754322 22457889999999987 7799999999999999999996555543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=292.86 Aligned_cols=205 Identities=26% Similarity=0.409 Sum_probs=168.5
Q ss_pred hcCCcccc-eeeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|.+.+ .||+|+||.||+|.+. .++.||||+++...... ..+.+.+|+++++.++||||+++++++. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----C
Confidence 45667777 8999999999999653 36789999997654322 3556899999999999999999999983 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 4568999999999999999763 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.......... .......+++.|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 165 KALRADENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp EECCTTCSEE--EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred eeeccCCCcc--cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 8765432111 11222346788999999988889999999999999999999 999997643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.38 Aligned_cols=210 Identities=22% Similarity=0.322 Sum_probs=172.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||++... +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--GTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--CceE
Confidence 357888899999999999999886 589999999976542 233456889999999999999999999876532 3467
Q ss_pred EEEEeecCCCCHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 302 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qia~~l~yLH~~~--~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+|||+++++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997532 234899999999999999999999876 23499999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+........ ......|++.|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 163 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 163 ARILNHDTS-----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp HHHC---CH-----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred heeeccccc-----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 976543210 1122457899999999998899999999999999999999999997653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=308.64 Aligned_cols=202 Identities=26% Similarity=0.337 Sum_probs=170.9
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCC------------ChhHHHHHHHHHHHhcCCCCccceee
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP------------NADSVFLTEVDMLSRLHHCHVVPLVG 289 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~------------~~~~~f~~Ei~~l~~l~H~nIv~l~g 289 (460)
..++|.+.+.||+|+||+||+|.... ++.||+|++...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35778999999999999999999864 789999999754321 33456889999999999999999999
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL- 368 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~- 368 (460)
++.+ ....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFED----KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEC----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEc----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9876 55789999999999999999754 45999999999999999999999998 99999999999998775
Q ss_pred --cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 369 --NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 369 --~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||....
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp CSSEEECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccEEEEECCCCEEcCCCC------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 69999999998765432 223356899999999876 568999999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=286.04 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=165.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+.+.||+|+||.||+|.+. +++.||||.+.... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----PTDF 86 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----CCeE
Confidence 57888899999999999999986 68999999986432 22344568899999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ......+++.|+|||.+....+ +.++||||||+++|||++|+.||...
T Consensus 162 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 162 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CC-------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCc------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 4432 1223468899999999987765 68999999999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=304.80 Aligned_cols=199 Identities=22% Similarity=0.291 Sum_probs=171.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhc------CCCCccceeeeeeeccC
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL------HHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~ 296 (460)
..+|++.+.||+|+||.||+|.+.. ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence 4568889999999999999998764 889999999743 22334577888888877 57799999999876
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc--EEEEe
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITD 374 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~--vkl~D 374 (460)
....++||||++ ++|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECC
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEee
Confidence 457799999995 79999998766567999999999999999999999998 999999999999999887 99999
Q ss_pred cCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||++...... .....||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 246 FG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR--------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC--------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc--------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999764322 223568899999999999999999999999999999999999997654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=296.61 Aligned_cols=203 Identities=22% Similarity=0.332 Sum_probs=163.6
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
..++|++.+.||+|+||+||+|... +++.||||+++..... .....+.+|++++++++||||+++++++.+ ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----NHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----TTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----CCE
Confidence 3567889999999999999999875 5889999999755332 223457899999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE-----cCCCcEEEEec
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----DENLNAKITDL 375 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll-----~~~~~vkl~DF 375 (460)
.++||||++ |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+||
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 899999996 5999999754 45899999999999999999999998 9999999999999 45556999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|++....... .......+|+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 182 g~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 242 (329)
T 3gbz_A 182 GLARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242 (329)
T ss_dssp THHHHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCccccCCcc-----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 9998764321 122334678999999998764 58999999999999999999999997643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=297.36 Aligned_cols=206 Identities=27% Similarity=0.387 Sum_probs=169.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEE------cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|++.+.||+|+||.||+|.+ .+++.||||.+...........+.+|+.++++++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 46788899999999999999984 24778999999765444455668999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCc
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 369 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~ 369 (460)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 3456999999999999999976432 34899999999999999999999998 999999999999984 456
Q ss_pred EEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 370 vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+||+|||++......... .......+++.|+|||.+....++.++||||||+++|||+| |+.||...
T Consensus 182 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 249 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249 (327)
T ss_dssp EEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEECcccccccccccccc---ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence 999999999865443211 12233457889999999998999999999999999999998 99999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=285.55 Aligned_cols=202 Identities=28% Similarity=0.432 Sum_probs=168.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|.....||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE----NGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----CCcEEE
Confidence 34556679999999999999974 58899999997653 3344568999999999999999999999876 457799
Q ss_pred EEeecCCCCHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~DFGla~~~ 381 (460)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++. ++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999999997643 234678999999999999999999998 999999999999987 899999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... .......|++.|+|||.+.... ++.++||||||+++|||++|+.||...
T Consensus 174 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 174 AGIN-----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CC----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred CCCC-----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 4321 1123456889999999987643 899999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=296.16 Aligned_cols=206 Identities=30% Similarity=0.399 Sum_probs=174.3
Q ss_pred cCCcccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|++.+.||+|+||.||++.+ .+++.||||++.... ....+.+.+|++++++++|+||+++++++.... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG--RQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--SC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--Cc
Confidence 5678889999999999999984 358899999997542 333455899999999999999999999886422 44
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6799999999999999997633 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
........ ........+|..|+|||.+....++.++||||||+++|||++|+.||...
T Consensus 176 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 176 LLPLDKDY--YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp ECCTTCSE--EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ecccCCcc--ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 76543211 11223345788899999999888999999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=295.45 Aligned_cols=211 Identities=28% Similarity=0.381 Sum_probs=171.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++..........+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 45788899999999999999997 468999999986532 3344568899999999999999999999876544456789
Q ss_pred EEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+||||+++|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999753 2356999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCC----CCCCCccccCCcccCccccccCC---CCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 381 LKADGLPSC----SSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 381 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
......... ........||+.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 432110000 00011234688999999887543 68999999999999999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.41 Aligned_cols=200 Identities=26% Similarity=0.368 Sum_probs=164.9
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~~ 302 (460)
+|+..+.||+|+||.||+|.+. +++.||||++...... +.+|+++|+.++|+||+++++++..... .....+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4777899999999999999986 4899999998754321 3479999999999999999999865432 234567
Q ss_pred EEEeecCCCCHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-CcEEEEecCCcc
Q 012599 303 LVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAK 379 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~-~~vkl~DFGla~ 379 (460)
+||||+++ +|.+.+.. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999965 77776643 12356999999999999999999999998 9999999999999955 678999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......+|+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 206 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 206 QLVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp ECCTTC------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccCC------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 764332 12335689999999998764 78999999999999999999999997654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.02 Aligned_cols=203 Identities=21% Similarity=0.270 Sum_probs=164.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc--Cccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~ 299 (460)
.++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999875 588999999975432 223455889999999999999999999987533 1223
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6799999996 58988885 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 176 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 176 TAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 654321 1233568999999999999999999999999999999999999997643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=310.31 Aligned_cols=201 Identities=27% Similarity=0.412 Sum_probs=174.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||.||++... +++.||||++..... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 100 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----KGY 100 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCE
Confidence 457888999999999999999986 689999999965432 3345668999999999999999999999876 457
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGM 377 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGl 377 (460)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 89999999999999999753 45999999999999999999999998 9999999999999 5678999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||....
T Consensus 176 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 231 (484)
T 3nyv_A 176 STHFEASK------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN 231 (484)
T ss_dssp HHHBCCCC------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEccccc------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence 98764432 1233568999999998865 68999999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.95 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=168.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||+||+|... +++.+|+|++.... .......+.+|+.+++.++||||+++++++.+ ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 111 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED----KRNY 111 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 456888999999999999999986 58899999997543 23335568999999999999999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGla 378 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999998654 45899999999999999999999998 999999999999976 445999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ......||+.|+|||++. ..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~~------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 187 AVFENQK------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp EECBTTB------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eECCCCc------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765432 123356899999999876 568999999999999999999999997644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.05 Aligned_cols=203 Identities=20% Similarity=0.328 Sum_probs=174.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh----------------hHHHHHHHHHHHhcCCCCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------------DSVFLTEVDMLSRLHHCHVVPL 287 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~----------------~~~f~~Ei~~l~~l~H~nIv~l 287 (460)
.++|.+.+.||+|+||.||+|.. +++.||||.+........ ...+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788999999999999999999 899999999875422111 1668999999999999999999
Q ss_pred eeeeeeccCccceEEEEEeecCCCCHHHH------hccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCC
Q 012599 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSS 360 (460)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~ 360 (460)
++++.+ ....++||||+++|+|.++ +.......+++..++.++.|++.||.|||+ .+ |+||||||+
T Consensus 109 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 109 EGIITN----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp SEEEES----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred EEEEee----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999876 4577999999999999999 655435679999999999999999999999 87 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-CCCc-hhHHHHHHHHHHHHHhCCCCCCC
Q 012599 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASL-MSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 361 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwSlGvll~elltG~~Pf~~ 438 (460)
|||++.++.+||+|||++...... ......|+..|+|||.+... .++. ++||||||+++|||++|+.||..
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876433 12234688999999999876 6666 99999999999999999999976
Q ss_pred CCC
Q 012599 439 SIT 441 (460)
Q Consensus 439 ~~~ 441 (460)
...
T Consensus 255 ~~~ 257 (348)
T 2pml_X 255 KIS 257 (348)
T ss_dssp SSC
T ss_pred CCc
Confidence 543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.37 Aligned_cols=201 Identities=25% Similarity=0.370 Sum_probs=171.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|.+.+.||+|+||+||++... +++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc----CCEE
Confidence 467888999999999999999986 58999999986432 22345568999999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc---CCCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~---~~~~vkl~DFGla 378 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999998654 45999999999999999999999998 99999999999995 5667999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 172 TCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp TTBCCC----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eECCCCC------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8664432 2233568999999998865 59999999999999999999999997643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.01 Aligned_cols=211 Identities=27% Similarity=0.399 Sum_probs=175.2
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHh--cCCCCccceeeeeeecc
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~~~ 295 (460)
..-....++|.+.+.||+|+||.||+|.. +++.||||.+... ....+.+|.+++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34455678899999999999999999998 5899999998643 34457889999887 68999999999988754
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCcCCCCEEEcCC
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDEN 367 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH--------~~~~~~ivH~DLk~~NIll~~~ 367 (460)
......++||||+++|+|.+++.. ..+++.+++.++.|++.||+||| +.+ |+||||||+|||++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 444478999999999999999975 35899999999999999999999 666 9999999999999999
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCC------CCchhHHHHHHHHHHHHHhC---------
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITG--------- 432 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvll~elltG--------- 432 (460)
+.+||+|||++.......... ........||+.|+|||.+.... ++.++||||||+++|||+||
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCEEEEECCCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999998765433111 01223456899999999987652 34789999999999999999
Q ss_pred -CCCCCCCC
Q 012599 433 -RQPIHRSI 440 (460)
Q Consensus 433 -~~Pf~~~~ 440 (460)
+.||....
T Consensus 263 ~~~p~~~~~ 271 (342)
T 1b6c_B 263 YQLPYYDLV 271 (342)
T ss_dssp CCCTTTTTS
T ss_pred cccCccccC
Confidence 88997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=291.29 Aligned_cols=200 Identities=23% Similarity=0.296 Sum_probs=171.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEE--cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC------ccceeeeeeecc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL--TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 295 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~--~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~ 295 (460)
.++|++.+.||+|+||.||+|.+ .+++.||||+++.. ......+.+|+++++.++|+| ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--
Confidence 46788899999999999999987 35889999999743 223455889999999887654 8999998876
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---------
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------- 366 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~--------- 366 (460)
....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence 45789999999 899999998765557899999999999999999999998 999999999999987
Q ss_pred ----------CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 012599 367 ----------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (460)
Q Consensus 367 ----------~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf 436 (460)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH--------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC--------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc--------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 678999999999764322 23356899999999999999999999999999999999999999
Q ss_pred CCCCC
Q 012599 437 HRSIT 441 (460)
Q Consensus 437 ~~~~~ 441 (460)
.....
T Consensus 235 ~~~~~ 239 (339)
T 1z57_A 235 PTHDS 239 (339)
T ss_dssp CCSCH
T ss_pred CCCCh
Confidence 76543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.88 Aligned_cols=201 Identities=25% Similarity=0.321 Sum_probs=165.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~~~ 302 (460)
.+|+..+.||+|+||.||+|.+.++..+|+|++...... ..+|+++++.++||||+++++++..... .....+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 357788999999999999999987777999988654322 2479999999999999999999876432 233478
Q ss_pred EEEeecCCCCHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCcc
Q 012599 303 LVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 379 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~ 379 (460)
+||||++++ +.+.+.. .....+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999764 4444321 12356999999999999999999999998 99999999999999 79999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 191 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 191 ILIAGE------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp ECCTTC------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCC------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764432 12335678999999988764 58999999999999999999999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=320.05 Aligned_cols=199 Identities=28% Similarity=0.437 Sum_probs=164.8
Q ss_pred ceeeeeCcEEEEEEEEc---CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||.||+|.+. .++.||||+++.... ....+.|.+|+++|++++||||+++++++.. ...++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEEEE
Confidence 47999999999999764 367899999976432 2334679999999999999999999999853 24689999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999999753 56899999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
. ........+|+.|+|||++....++.++||||||++||||++ |+.||.....
T Consensus 525 ~--~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 525 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred c--cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1 112223346788999999999999999999999999999998 9999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.72 Aligned_cols=201 Identities=24% Similarity=0.322 Sum_probs=156.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHH-HHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~-f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||++... +++.||+|+++.......... +.++...++.++||||+++++++.+ ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----~~~~ 81 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----EGDV 81 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSSE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----cCCE
Confidence 467888999999999999999974 689999999976543333333 3444455778899999999999876 4467
Q ss_pred EEEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
++||||++ |+|.+++... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999996 6998888542 235699999999999999999999997 8 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
....... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 158 GYLVDDV------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccccccc------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 8764432 12223588999999996 566789999999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=287.17 Aligned_cols=207 Identities=23% Similarity=0.366 Sum_probs=165.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc-------
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------- 295 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 295 (460)
.++|.+.+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3678889999999999999999875 8999999987542 334456889999999999999999999875321
Q ss_pred ---CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEE
Q 012599 296 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAK 371 (460)
Q Consensus 296 ---~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vk 371 (460)
......++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 22457799999996 699999964 45899999999999999999999998 99999999999997 577999
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+|||++......... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 162 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSH--KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp ECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EccCccccccCCCccc--ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999876433211 112233457889999998865 778999999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-35 Score=282.23 Aligned_cols=202 Identities=29% Similarity=0.425 Sum_probs=172.9
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--------ChhHHHHHHHHHHHhcC-CCCccceeeeee
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--------NADSVFLTEVDMLSRLH-HCHVVPLVGYCS 292 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--------~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~ 292 (460)
..++|++.+.||+|+||.||+|... +++.||||.+...... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578889999999999999999986 5889999999765321 11345789999999995 999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
. ....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 95 ~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 T----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp C----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred c----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 5 45789999999999999999753 45899999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCCCCCCCCCCccccCCcccCccccc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+|||++....... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 166 ~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 166 TDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp CCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecccchhhcCCCc------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9999998765432 123346889999999885 456789999999999999999999999654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.92 Aligned_cols=204 Identities=11% Similarity=0.025 Sum_probs=154.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhc--CCCCcccee-------eee
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL--HHCHVVPLV-------GYC 291 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~ 291 (460)
..+|+..+.||+|+||.||+|.+. +++.||||++...... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345778899999999999999975 6899999999875432 2234467785555555 699988755 333
Q ss_pred eeccC-------------ccceEEEEEeecCCCCHHHHhccccCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 012599 292 SEFRG-------------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR------VAIAIGAARGLEYLHEAAAPRI 352 (460)
Q Consensus 292 ~~~~~-------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qia~~l~yLH~~~~~~i 352 (460)
..... .....++||||++ |+|.+++.... ..+.+..+ +.++.|++.||+|||+++ |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 32111 0134799999998 89999997642 23455666 788899999999999998 9
Q ss_pred EecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHH
Q 012599 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELI 430 (460)
Q Consensus 353 vH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~ell 430 (460)
+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.. ..++.++||||||++||||+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999865322 113456799999999987 77999999999999999999
Q ss_pred hCCCCCCCCC
Q 012599 431 TGRQPIHRSI 440 (460)
Q Consensus 431 tG~~Pf~~~~ 440 (460)
+|+.||....
T Consensus 288 tg~~Pf~~~~ 297 (371)
T 3q60_A 288 CLFLPFGLVT 297 (371)
T ss_dssp HSSCSTTBCC
T ss_pred hCCCCCCCcC
Confidence 9999998763
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.20 Aligned_cols=204 Identities=21% Similarity=0.364 Sum_probs=169.3
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ......+.+|+++++.++||||+++++++.. ....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH----DGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----C-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----CCeE
Confidence 34678889999999999999999864 8899999987643 3345568999999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 92 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999998653 255999999999999999999999998 999999999999999999999999987643
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccc-----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYA-----MVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .......|++.|+|||.+ ....++.++||||||+++|||++|+.||....
T Consensus 168 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 168 LKTL-----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHH-----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccc-----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 2211 011234588999999988 36778999999999999999999999997643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=284.84 Aligned_cols=208 Identities=27% Similarity=0.355 Sum_probs=171.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC---CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
..++|.+.+.||+|+||.||++... +++.+|+|.++... .......+.+|++++++++|+||+++++++... ..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~ 80 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE--EK 80 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC--CC
Confidence 3478999999999999999999875 58899999996432 234456689999999999999999999998542 23
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++++ |.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 4679999999766 888887655567999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCC--CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
......... .......|++.|+|||.+.... ++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 157 EALHPFAAD---DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp EECCTTCSS---CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCccccc---cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 876432211 1122345889999999987644 378999999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.20 Aligned_cols=207 Identities=22% Similarity=0.287 Sum_probs=171.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCcc-ceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~~~~ 301 (460)
.++|++.+.||+|+||.||+|.+ .+++.||||++....... .+..|+++++.++|++.+ .+..++.+ ....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGVE----GDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEee----CCEE
Confidence 46789999999999999999997 458999999987554322 378999999999775544 44444433 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE---cCCCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll---~~~~~vkl~DFGla 378 (460)
++||||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||| ++++.+||+|||++
T Consensus 79 ~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 9999999 99999999753 356999999999999999999999998 9999999999999 68899999999999
Q ss_pred cccccCCCCC--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 379 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 379 ~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
+......... .........||+.|+|||.+.+..++.++||||||++||||++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 8776543211 122334567999999999999999999999999999999999999999876543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.18 Aligned_cols=204 Identities=25% Similarity=0.341 Sum_probs=155.1
Q ss_pred CCcc-cceeeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 226 KFSG-SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 226 ~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.|.+ .++||+|+||.||+|... +++.||||++.... ....+.+|+.+|++++||||+++++++.... ....
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHA--DRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT--TTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC--CCeE
Confidence 3554 457999999999999975 47889999997543 2235889999999999999999999986532 4477
Q ss_pred EEEEeecCCCCHHHHhcccc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE----cCCCcE
Q 012599 302 LLVFEFMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNA 370 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll----~~~~~v 370 (460)
++||||++ |+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||| ++++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 99999995 68988885321 124899999999999999999999998 9999999999999 778899
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
||+|||+++........ ........||+.|+|||++.+ ..++.++||||||++||||++|+.||....
T Consensus 172 kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEECCCceecCCCCcc--cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999876543211 112334578999999999887 458999999999999999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.96 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=167.2
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-------CChhHHHHHHHHHHHhcCCCCccceeeeeeec
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~ 294 (460)
..++|.+.+.||+|+||.||+|.+. +++.||||.+..... ......+.+|++++++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 3567899999999999999999875 478999999865421 1122347899999999999999999999754
Q ss_pred cCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc---EE
Q 012599 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AK 371 (460)
Q Consensus 295 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~---vk 371 (460)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred ----CceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 2369999999999999999753 56899999999999999999999998 999999999999987654 99
Q ss_pred EEecCCccccccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 372 l~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|+|||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....
T Consensus 158 l~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 158 ITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp ECCCTTCEECCCCH------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred EccCccceeccccc------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999998654321 112345889999999874 5678999999999999999999999997644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.37 Aligned_cols=203 Identities=23% Similarity=0.289 Sum_probs=171.3
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-----------CCCccceeeee
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYC 291 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~ 291 (460)
.++|.+.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.++++++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357888899999999999999874 5889999999743 223455889999999886 89999999998
Q ss_pred eeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEc-----
Q 012599 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLD----- 365 (460)
Q Consensus 292 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~----- 365 (460)
..........++||||+ +++|.+++.......+++..++.++.||+.||+|||++ + |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 87554455789999999 99999999876556699999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 366 -ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 366 -~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999876432 223468999999999999999999999999999999999999998543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=299.41 Aligned_cols=202 Identities=26% Similarity=0.359 Sum_probs=155.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~ 299 (460)
.++|++.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++..... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 377899999999999999999875 588999999975432 2234568899999999999999999999865321 224
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++|+|++ +++|.++++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 569999999 7899999865 46999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 181 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 181 HTADE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccc--------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65332 233568999999999876 678999999999999999999999997654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=289.90 Aligned_cols=201 Identities=23% Similarity=0.289 Sum_probs=149.9
Q ss_pred hcCCccc-ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHH-HHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEV-DMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|.+. +.||+|+||.||+|.+. +++.||||++... . ...+|+ ..++.++||||+++++++.........
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~-~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----P-KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----H-HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----H-HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4567774 46999999999999986 5899999998642 1 133344 345667999999999998875555567
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGl 377 (460)
.++||||+++|+|.+++.......+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998765567999999999999999999999998 999999999999986 45599999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+....... .....+|+.|+|||++....++.++||||||+++|||++|+.||....
T Consensus 178 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 178 AKETTQNA-------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeccccc-------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 98654322 223467899999999988889999999999999999999999996543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=292.39 Aligned_cols=201 Identities=23% Similarity=0.349 Sum_probs=166.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-hhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc--c
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR--A 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~--~ 299 (460)
.++|...+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++....... .
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888899999999999999875 58999999997643222 2456889999999999999999999987643211 1
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 3489999996 79988874 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....+|+.|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 193 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp ---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccC--------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65432 223467899999999877 788999999999999999999999997643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=289.60 Aligned_cols=211 Identities=24% Similarity=0.319 Sum_probs=162.7
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccC
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 296 (460)
.......++|++.+.||+|+||.||+|.+. +++.||||++..... ....+.++++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 456677889999999999999999999985 589999999865432 22346788889999999999999999876432
Q ss_pred ---ccceEEEEEeecCCCCHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCcCCCCEEEcC-CC
Q 012599 297 ---KRAMRLLVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLH--EAAAPRILHRDIKSSNILLDE-NL 368 (460)
Q Consensus 297 ---~~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qia~~l~yLH--~~~~~~ivH~DLk~~NIll~~-~~ 368 (460)
.....++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 22347899999965 66555432 12355899999999999999999999 877 999999999999996 89
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 369 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEEECCCTTCBCCCTTS------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEeeCCCceecCCCC------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 99999999998765432 22335688999999998654 48999999999999999999999998654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.16 Aligned_cols=206 Identities=29% Similarity=0.416 Sum_probs=172.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEE-----cCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--R 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--C
Confidence 35678889999999999999984 35889999999764 2334456899999999999999999999886532 2
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 35689999999999999997642 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.......... .......++..|+|||.+....++.++||||||+++|||+||..||..
T Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 193 KVLPQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp EECCSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhcccccccc--ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 8765432110 112233467789999999888899999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=314.66 Aligned_cols=208 Identities=24% Similarity=0.379 Sum_probs=173.0
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
++...++|++.+.||+|+||.||+|.+.. +..||+|.++........+.|.+|+.++++++||||+++++++.+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 33445778889999999999999998743 467999998765444445679999999999999999999999853
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
...++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 463 ---~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 463 ---NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred ---CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEec
Confidence 3468999999999999999753 245899999999999999999999998 999999999999999999999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
|+++....... .......+|+.|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 536 G~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 536 GLSRYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp CCCCSCCC--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCeecCCCcc----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99987644321 11223456788999999998999999999999999999997 999997643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=288.91 Aligned_cols=213 Identities=24% Similarity=0.329 Sum_probs=157.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeec----cCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEF----RGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~----~~~ 297 (460)
..+|.+.+.||+|+||.||++.+. +++.||||++.... ......+.+|+.++.++. ||||+++++++... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346788899999999999999975 58999999986542 233456889999999995 99999999998532 123
Q ss_pred cceEEEEEeecCCCCHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....++||||+ +|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||||+|||+++++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45679999999 589999986532 345999999999999999999999875 359999999999999999999999999
Q ss_pred CccccccCCCCCC-------CCCCCccccCCcccCcccc---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 377 MAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYA---MVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 377 la~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++........... ........+|+.|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9987654321110 0111234588999999988 5677899999999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=292.85 Aligned_cols=213 Identities=23% Similarity=0.301 Sum_probs=170.2
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeecc
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~ 295 (460)
..+++...++|++.+.||+|+||.||+|...+ .+|+|.++.... ....+.+.+|+.++++++|+||+++++++.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 100 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-- 100 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--
Confidence 34555567889999999999999999998854 499999875432 2233447889999999999999999999886
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEec
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DF 375 (460)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++ ++.+||+||
T Consensus 101 --~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 101 --PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp --SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCC
T ss_pred --CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeec
Confidence 44679999999999999999763 246899999999999999999999998 99999999999998 679999999
Q ss_pred CCccccccCCCCCCCCCCCccccCCcccCcccccc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---------GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|++...................|++.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876543222222223334568899999998864 457999999999999999999999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=286.88 Aligned_cols=202 Identities=28% Similarity=0.388 Sum_probs=151.2
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHH-HHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|+..+.||+|+||.||+|... +++.||||+++..........+..|+. +++.++||||+++++++.+ ....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR----EGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----CCce
Confidence 467888899999999999999985 589999999986544444445666666 6677899999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 302 LLVFEFMPNGNLRDCLDG---VLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
++||||++ |+|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99999996 588888753 2235689999999999999999999998 8 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCcccc----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+....... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 173 SGQLVDSI------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp SCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred ceeccccc------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 98764332 12233688999999998 4567899999999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=279.49 Aligned_cols=203 Identities=25% Similarity=0.358 Sum_probs=172.7
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
...++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++++.+ ..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 94 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SS 94 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----CC
Confidence 34578999999999999999999986 58999999986543 23445668999999999999999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC---CcEEEEecC
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLG 376 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~---~~vkl~DFG 376 (460)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+|+||||+||+++.+ +.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 779999999999999998654 45899999999999999999999998 9999999999999754 479999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++....... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 170 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 170 LSTCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp GGGTBCCCS------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceeecCCC------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 998664332 1223457889999998765 48999999999999999999999997643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.18 Aligned_cols=201 Identities=23% Similarity=0.328 Sum_probs=166.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc--cc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~--~~ 299 (460)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888899999999999999875 5899999999764322 2245688999999999999999999998763321 12
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||++ ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 4599999996 68888875 34899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....+|+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 175 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp C----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred CCCCC--------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65332 223467899999998876 678999999999999999999999997643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=285.31 Aligned_cols=204 Identities=29% Similarity=0.386 Sum_probs=161.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEc--CCc--EEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT--DGR--IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|++.+.||+|+||.||+|.+. +++ .||||.++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 56788899999999999999864 233 68999987543 233455689999999999999999999998752
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 3689999999999999997642 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
......... ........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 228 (291)
T 1u46_A 169 RALPQNDDH--YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228 (291)
T ss_dssp EECCC-CCE--EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccc--hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence 876543211 111223456778999999988889999999999999999999 99999754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.80 Aligned_cols=200 Identities=20% Similarity=0.258 Sum_probs=169.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcC-C-cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC------ccceeeeeeecc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTD-G-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 295 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~-g-~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~ 295 (460)
.++|++.+.||+|+||.||+|.... + +.||+|+++.. ......+.+|+++++.++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence 4678889999999999999998753 3 68999999743 233455888999999997665 8888888766
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE-----------
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----------- 364 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll----------- 364 (460)
....++||||+ +++|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECC
T ss_pred --CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccc
Confidence 45779999999 778888887655567999999999999999999999998 9999999999999
Q ss_pred --------cCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 012599 365 --------DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (460)
Q Consensus 365 --------~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf 436 (460)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH--------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCcEEEeecCcccccccc--------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 66889999999999764322 23356899999999999999999999999999999999999999
Q ss_pred CCCCC
Q 012599 437 HRSIT 441 (460)
Q Consensus 437 ~~~~~ 441 (460)
.....
T Consensus 240 ~~~~~ 244 (355)
T 2eu9_A 240 QTHEN 244 (355)
T ss_dssp CCSSH
T ss_pred CCCCH
Confidence 86543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.48 Aligned_cols=202 Identities=25% Similarity=0.290 Sum_probs=169.2
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCC-----ccceeeeeeecc
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCH-----VVPLVGYCSEFR 295 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~n-----Iv~l~g~~~~~~ 295 (460)
..++|++.+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.+++.++ |+| ++++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 4578999999999999999999876 5789999999743 223345778888988884 554 8999998876
Q ss_pred CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc--CCCcEEEE
Q 012599 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKIT 373 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~--~~~~vkl~ 373 (460)
....++||||++ |+|.+++.......+++..+..++.|++.||.|||.+. .+|+||||||+|||++ .++.+||+
T Consensus 128 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 --RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp --TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred --CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence 457899999995 69999998765566999999999999999999999521 2399999999999994 57889999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 204 DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR--------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc--------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876432 233568899999999999999999999999999999999999998654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=281.82 Aligned_cols=203 Identities=29% Similarity=0.397 Sum_probs=162.8
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc------
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 295 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 295 (460)
..++|++.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3567889999999999999999975 6899999999642 233456889999999999999999999886532
Q ss_pred ---CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEE
Q 012599 296 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (460)
Q Consensus 296 ---~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl 372 (460)
......++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 22457899999999999999997532 45788999999999999999999998 999999999999999999999
Q ss_pred EecCCccccccCCC---------CCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHh
Q 012599 373 TDLGMAKRLKADGL---------PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 373 ~DFGla~~~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~ellt 431 (460)
+|||++........ +..........|++.|+|||.+... .++.++||||||+++|||++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999986643210 0111223345688999999998754 78999999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=286.92 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=166.7
Q ss_pred HHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcC--CCCccceeeeeeeccCc
Q 012599 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 221 ~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~ 297 (460)
....++|++.+.||+|+||.||++...+++.||||.+..... ......+.+|++++++++ |+||+++++++.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~---- 99 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT---- 99 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC----
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec----
Confidence 334567888999999999999999998899999999975432 223456889999999996 5999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||| +.+++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 456899999 5589999999754 46899999999999999999999998 999999999999975 7999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCcccccc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+........ ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 173 ANQMQPDTT---SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp SCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccccCccc---cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 987654321 111233468999999998865 47889999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=283.35 Aligned_cols=203 Identities=25% Similarity=0.361 Sum_probs=163.7
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhc----CCCCccceee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRL----HHCHVVPLVG 289 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l----~H~nIv~l~g 289 (460)
.+...++|++.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455688999999999999999999874 58899999997543221 122356799999998 8999999999
Q ss_pred eeeeccCccceEEEEEee-cCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CC
Q 012599 290 YCSEFRGKRAMRLLVFEF-MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-EN 367 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~ 367 (460)
++.+ ....++|||| +++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ ++
T Consensus 106 ~~~~----~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 106 WFET----QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEec----CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9876 3456899999 7899999999763 45899999999999999999999998 99999999999999 88
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+.+||+|||++....... .....|+..|+|||++....+ +.++||||||+++|||++|+.||..
T Consensus 177 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP-------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp TEEEECCCSSCEECCSSC-------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CeEEEEEcchhhhcccCc-------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999999998765432 223458899999999877666 4589999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.81 Aligned_cols=198 Identities=22% Similarity=0.407 Sum_probs=168.0
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc--CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc-cce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~~~ 300 (460)
.++|++.+.||+|+||.||++.+. +++.||||++...........+.+|++++++++||||+++++++...... ...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999986 58999999987654444555689999999999999999999998874432 223
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+.+ |+||||||+|||++++ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988753 5899999999999999999999998 9999999999999986 999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ....||+.|+|||++.... +.++||||||++||||++|..||...
T Consensus 231 ~~~~---------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 231 INSF---------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp TTCC---------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred cccC---------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccc
Confidence 5432 3356899999999887654 89999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=286.21 Aligned_cols=204 Identities=24% Similarity=0.352 Sum_probs=170.8
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhcC--CCCccceeee
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLH--HCHVVPLVGY 290 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~--H~nIv~l~g~ 290 (460)
+.+...++|++.+.||+|+||.||+|... +++.||||.+....... ....+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34455678999999999999999999864 58899999997543221 1233678999999995 5999999999
Q ss_pred eeeccCccceEEEEEeecCC-CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCC
Q 012599 291 CSEFRGKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENL 368 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~ 368 (460)
+.. ....++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ +++
T Consensus 117 ~~~----~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 117 FER----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEC----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred Eec----CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 876 4567999999976 8999999753 45899999999999999999999998 99999999999999 789
Q ss_pred cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 369 ~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
.+||+|||++....... .....||+.|+|||.+....+ +.++||||||+++|||++|+.||..
T Consensus 188 ~~kL~Dfg~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV-------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp EEEECCCTTCEECCSSC-------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CEEEeeCcccccccccc-------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99999999998765332 223468999999999877665 7889999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=279.21 Aligned_cols=201 Identities=25% Similarity=0.395 Sum_probs=150.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHH-HHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~-f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.++|+..+.||+|+||.||+|.+. +++.||||++........... +.++..+++.++||||+++++++.+ ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----NTDV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcE
Confidence 467888899999999999999986 589999999986543333333 3444456778899999999999876 4577
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
++||||+ ++.+..+... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 100 ~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999 5555555443 345689999999999999999999985 7 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 175 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 175 LVDDK------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCc------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 54432 122346889999999984 566889999999999999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=292.10 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=154.6
Q ss_pred CcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEEEE
Q 012599 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+ ....++||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~~~lv~ 88 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETT----DRFLYIAL 88 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----SSEEEEEE
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEec----CCeEEEEE
Confidence 3445789999999998777778999999998653 234578999999887 89999999998765 45789999
Q ss_pred eecCCCCHHHHhccccCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCC-------------
Q 012599 306 EFMPNGNLRDCLDGVLVEG-----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------------- 367 (460)
Q Consensus 306 e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~------------- 367 (460)
||++ |+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCc
Confidence 9995 79999997543211 133356789999999999999998 9999999999999754
Q ss_pred CcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccccc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 368 ~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+.+||+|||++.......... ........||+.|+|||++.+ ..++.++||||||+++|||+| |+.||...
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp CEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred eEEEEcccccceecCCCCccc-eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 489999999998765432111 111234579999999999865 678999999999999999999 99999754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=282.28 Aligned_cols=197 Identities=16% Similarity=0.111 Sum_probs=162.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCC-------CChhHHHHHHHHHHHhcC---------CCCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLH---------HCHVVPL 287 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~---------H~nIv~l 287 (460)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ....+.+.+|+.+++.++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688889999999999999998 689999999986532 223356899999999886 8888877
Q ss_pred eeeeeecc--------------------------CccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHH
Q 012599 288 VGYCSEFR--------------------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341 (460)
Q Consensus 288 ~g~~~~~~--------------------------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l 341 (460)
.+++.... ......++||||+++|++.+.+.. ..+++..+..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77643210 014578999999999987777643 4589999999999999999
Q ss_pred HHHH-hCCCCCeEecCcCCCCEEEcCCC--------------------cEEEEecCCccccccCCCCCCCCCCCccccCC
Q 012599 342 EYLH-EAAAPRILHRDIKSSNILLDENL--------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400 (460)
Q Consensus 342 ~yLH-~~~~~~ivH~DLk~~NIll~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~ 400 (460)
+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~ 241 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCD 241 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEee
Confidence 9999 888 99999999999999887 8999999999876432 346899
Q ss_pred cccCccccccCCCCchhHHHHHHHH-HHHHHhCCCCCCC
Q 012599 401 GYFAPEYAMVGRASLMSDVFSFGVV-LLELITGRQPIHR 438 (460)
Q Consensus 401 ~y~aPE~~~~~~~~~~sDVwSlGvl-l~elltG~~Pf~~ 438 (460)
.|+|||++.+.. +.++|||||+.+ .+++++|..||..
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999999988666 899999998777 7788899999953
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=291.28 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=157.0
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+ ....++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~----~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKD----RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEE----TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEec----CCEEEE
Confidence 45777789999999997666666899999999965332 2257899999999 89999999998876 557799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-----CCcEEEEecCCc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMA 378 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-----~~~vkl~DFGla 378 (460)
||||++ |+|.+++.... ....+..++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||++
T Consensus 96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999995 69999997643 23455567889999999999999998 999999999999953 346889999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccc---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~ 439 (460)
+........ ........||+.|+|||++. ...++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 171 KKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp ECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred eeccCCCcc--eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 876543211 11233456899999999987 4667889999999999999999 99999654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=304.87 Aligned_cols=205 Identities=29% Similarity=0.464 Sum_probs=173.5
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--CccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~~~ 301 (460)
++|.+.+.||+|+||.||+|.+. +|+.||||+++........+.+.+|++++++++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999874 588999999976555555567899999999999999999999875422 124566
Q ss_pred EEEEeecCCCCHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCc---EEEEecCC
Q 012599 302 LLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 377 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~---vkl~DFGl 377 (460)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 235899999999999999999999998 999999999999997665 99999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 171 AKELDQGE------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCBTTSCC------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 98765432 22345689999999999999999999999999999999999999964
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=266.98 Aligned_cols=179 Identities=23% Similarity=0.332 Sum_probs=153.3
Q ss_pred cCCccc-ceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHH-HhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDML-SRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|.+. +.||+|+||.||++... +++.||+|++... ..+.+|++++ +.++||||+++++++..........
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 78999999999999874 5899999999642 3478899888 5559999999999987654455678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCCc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 378 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGla 378 (460)
++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998765557999999999999999999999998 999999999999998 788999999998
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.... ...++.++||||||+++|||++|+.||...
T Consensus 168 ~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 168 KETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp EECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 6532 134577999999999999999999999654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=267.38 Aligned_cols=174 Identities=18% Similarity=0.145 Sum_probs=150.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|.+.. ++.||||++....... ....|.+|+..+++++||||+++++++.+ ....
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~~ 106 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----RAGG 106 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE----CCcE
Confidence 568888999999999999999865 8999999998654432 23568999999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++++|.++++. .....++..++.|++.||+|||+.+ |+||||||+|||+++++.+||++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999999964 2466678999999999999999998 9999999999999999999998443
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
|++| ++.++||||||+++|||+||+.||.....
T Consensus 175 --------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 --------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp --------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred --------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3333 58899999999999999999999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=282.97 Aligned_cols=206 Identities=17% Similarity=0.161 Sum_probs=156.5
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC--ChhHHHHHHHHHHHhcCC-CCcccee---------
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHH-CHVVPLV--------- 288 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H-~nIv~l~--------- 288 (460)
..+.+|...+.||+|+||.||+|.+. +|+.||||++...... ...+.|.+|+.+++.++| +|...+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34455777789999999999999965 5899999998744322 234568999999999977 3321111
Q ss_pred eee------------eec-cCccceEEEEEeecCCCCHHHHhcc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012599 289 GYC------------SEF-RGKRAMRLLVFEFMPNGNLRDCLDG-----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350 (460)
Q Consensus 289 g~~------------~~~-~~~~~~~~lV~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~ 350 (460)
... ... .......+++|+++ +++|.++++. .....+++..++.++.|++.||+|||+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 111 100 00122457777766 7899999852 12234788899999999999999999998
Q ss_pred CeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCcccc----------ccCCCCchhHHH
Q 012599 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA----------MVGRASLMSDVF 420 (460)
Q Consensus 351 ~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDVw 420 (460)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999998865433 223456 899999998 555688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC
Q 012599 421 SFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 421 SlGvll~elltG~~Pf~~~~ 440 (460)
|||+++|||++|+.||....
T Consensus 302 SlGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTG
T ss_pred HHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-30 Score=270.63 Aligned_cols=186 Identities=19% Similarity=0.155 Sum_probs=128.0
Q ss_pred eeeeCcEEEEEEE-EcCCcEEEEEEeccCCCC---------ChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccceE
Q 012599 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGP---------NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 233 LG~G~fG~Vy~~~-~~~g~~vaVK~l~~~~~~---------~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
.+.|++|.+..+. ..-|+.+++|.+...... ...++|.+|+++|+++ +|+||+++++++.+ +...
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----~~~~ 317 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----AQSG 317 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC----SSEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE----CCEE
Confidence 4556666666543 224788999999765321 1224589999999999 79999999999876 5678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
||||||++|++|.++|... ..++.. .|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+++..
T Consensus 318 yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 9999999999999999764 446654 58899999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf 436 (460)
..+. .......||+.|+|||++.+ .+..++|+||+|+++++|.++..||
T Consensus 390 ~~~~-----~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDC-----SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C--------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCC-----ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 5432 23345679999999998865 4667899999999988776654443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=247.40 Aligned_cols=190 Identities=15% Similarity=0.164 Sum_probs=143.7
Q ss_pred cccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCCh-------hHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
...+.||+|+||.||++.. .++.+++|+......... .+.|.+|++++++++||||+++..++.. ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----LDN 413 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE----TTT
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe----CCc
Confidence 3457899999999999954 578899998755332211 2347899999999999999965555554 234
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++.. ++.++.|++.||+|||+++ |+||||||+|||+++ .+||+|||+++.
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 5999999999999999975 5689999999999999998 999999999999999 999999999987
Q ss_pred cccCCCCCC--CCCCCccccCCcccCcccccc--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 012599 381 LKADGLPSC--SSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 381 ~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
......... ........||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 644211000 001124679999999999976 667888999999999999888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4e-24 Score=206.40 Aligned_cols=153 Identities=14% Similarity=0.055 Sum_probs=121.1
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCC-----------------hhHHHHHHHHHHHhcC
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-----------------ADSVFLTEVDMLSRLH 280 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~-----------------~~~~f~~Ei~~l~~l~ 280 (460)
..+......|.+.+.||+|+||.||+|.+.+|+.||+|.++...... ....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 34455566677779999999999999999779999999996432111 2345889999999999
Q ss_pred CCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCC
Q 012599 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (460)
Q Consensus 281 H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~ 360 (460)
| +++.+++.. ...++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+
T Consensus 163 --~-~~v~~~~~~-----~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~ 222 (282)
T 1zar_A 163 --G-LAVPKVYAW-----EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 222 (282)
T ss_dssp --T-SSSCCEEEE-----ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred --C-CCcCeEEec-----cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHH
Confidence 5 666665432 34599999999999998 532 224579999999999999998 999999999
Q ss_pred CEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccc
Q 012599 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409 (460)
Q Consensus 361 NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 409 (460)
|||++ ++.+||+|||+++.. ..++|||++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~~------------------~~~~a~e~l~ 252 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVEV------------------GEEGWREILE 252 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEET------------------TSTTHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeEC------------------CCCCHHHHHH
Confidence 99999 999999999999743 3478999763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=171.95 Aligned_cols=137 Identities=20% Similarity=0.231 Sum_probs=106.1
Q ss_pred CcccceeeeeCcEEEEEEEE-cCCcE--EEEEEeccCCCCC-----------------------hhHHHHHHHHHHHhcC
Q 012599 227 FSGSNIVGQGGSSYVYRGQL-TDGRI--VAVKRFKTQGGPN-----------------------ADSVFLTEVDMLSRLH 280 (460)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~-~~g~~--vaVK~l~~~~~~~-----------------------~~~~f~~Ei~~l~~l~ 280 (460)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++...... ....+.+|+..|..++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 9999876432110 0124789999999998
Q ss_pred CCCc--cceeeeeeeccCccceEEEEEeecCC-C----CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 012599 281 HCHV--VPLVGYCSEFRGKRAMRLLVFEFMPN-G----NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRI 352 (460)
Q Consensus 281 H~nI--v~l~g~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH-~~~~~~i 352 (460)
|+++ ..++++ ...+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |
T Consensus 129 ~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 129 EAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred hCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 8864 334432 134899999942 4 77776532 234567789999999999999 888 9
Q ss_pred EecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 353 LHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 353 vH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+||||||.|||+++ .++|+|||++...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=4e-17 Score=162.58 Aligned_cols=136 Identities=13% Similarity=0.135 Sum_probs=98.1
Q ss_pred CCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC-------------ChhHHH--------HHHHHHHHhcCCCCc
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------NADSVF--------LTEVDMLSRLHHCHV 284 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-------------~~~~~f--------~~Ei~~l~~l~H~nI 284 (460)
-|.+.+.||+|+||.||+|...+|+.||||+++..... ...... ..|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38889999999999999999999999999987643110 001111 235555555544333
Q ss_pred c--ceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCE
Q 012599 285 V--PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 362 (460)
Q Consensus 285 v--~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NI 362 (460)
. ..++. ...+|||||+++++|.++... .....++.|++.+|.+||+.+ ||||||||.||
T Consensus 176 ~vp~p~~~--------~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 176 PVPEPIAQ--------SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp SCCCEEEE--------ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred CCCeeeec--------cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 2 11211 122799999999888765421 123567899999999999998 99999999999
Q ss_pred EEcCCC----------cEEEEecCCccc
Q 012599 363 LLDENL----------NAKITDLGMAKR 380 (460)
Q Consensus 363 ll~~~~----------~vkl~DFGla~~ 380 (460)
|+++++ .+.|+||+-+..
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccccccccceEEEEeCCccc
Confidence 998876 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.8e-11 Score=115.77 Aligned_cols=148 Identities=16% Similarity=0.107 Sum_probs=111.6
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCcc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 298 (460)
+......|.....++.|+.+.||+.... ++.+++|+...... .....+.+|.++++.+. +.++.+++++... .
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH----D 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE----T
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec----C
Confidence 3444567877788888889999999864 68899999875211 11223889999999984 6778889888765 3
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------ 348 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~------------------------------ 348 (460)
...++||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 467999999999999876321 1223478889999999999821
Q ss_pred --------------------------CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 --------------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 --------------------------~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14499999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=2.3e-11 Score=114.42 Aligned_cols=129 Identities=17% Similarity=0.126 Sum_probs=94.7
Q ss_pred eeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc--cceeeeeeeccCccceEEEEEeecCCC
Q 012599 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFMPNG 311 (460)
Q Consensus 234 G~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~~~~~~~~~lV~e~~~~g 311 (460)
+.|..+.||+....+|+.+++|...... ...+.+|+.+++.+.+.++ .+++++... ....++||||++|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVPGQ 100 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCSSE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC----CCCCEEEEEecCCc
Confidence 4556699999988778889999976531 1237889999999965454 457776554 23569999999998
Q ss_pred CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 012599 312 NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------------- 348 (460)
Q Consensus 312 sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~------------------------------------------- 348 (460)
+|. ... .+ ...++.++++.|..||+..
T Consensus 101 ~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 101 DLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp ETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 884 211 12 2356778888888888643
Q ss_pred ------------CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 ------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 ------------~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.7e-10 Score=113.04 Aligned_cols=146 Identities=15% Similarity=0.180 Sum_probs=106.5
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEec--cCCCCChhHHHHHHHHHHHhcC--CCCccceeeeeeeccCccceEEEE
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~--~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
..+.|+.|.++.||+....+ ..+++|+.. ..........+.+|..+++.+. +..+.++++++.+... ....++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-IGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-TSSCEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-cCCeEEE
Confidence 35678899999999998754 678888776 3322122334788999999996 4567888888765321 1346899
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------ 348 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~------------------------------------ 348 (460)
|||++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988775421 234788888999999999999999831
Q ss_pred -------------------CCCeEecCcCCCCEEEcCCCc--EEEEecCCccc
Q 012599 349 -------------------APRILHRDIKSSNILLDENLN--AKITDLGMAKR 380 (460)
Q Consensus 349 -------------------~~~ivH~DLk~~NIll~~~~~--vkl~DFGla~~ 380 (460)
.+.++|+|+++.|||+++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-10 Score=112.13 Aligned_cols=187 Identities=21% Similarity=0.229 Sum_probs=123.0
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCC--ccceeeeeeeccCccceEEEEEe
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCH--VVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~~~~~~~~lV~e 306 (460)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++..... .......|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~-~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP-SETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-CSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-CCCCCcceEEEc
Confidence 4568999999999874 45888886432 23455889999999883 333 3344443222 111124488999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-------------------------------------- 348 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~-------------------------------------- 348 (460)
+++|.+|.+... ..++..++..++.++++.+..||+..
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988865332 23677888888999999999998621
Q ss_pred -----------------CCCeEecCcCCCCEEEcC--CCcEEEEecCCccccccCCCCCCCCCCCccccCCcc---cCcc
Q 012599 349 -----------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY---FAPE 406 (460)
Q Consensus 349 -----------------~~~ivH~DLk~~NIll~~--~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y---~aPE 406 (460)
.+.++|+|+++.||++++ +..+.|+||+.+....+... +.....+ ..|+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---------l~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---------FISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---------HHTTCCTTTSCCHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---------HHHHHhhccccCHH
Confidence 245899999999999998 45678999999875432110 0000001 1222
Q ss_pred ccc----c-CCC---------CchhHHHHHHHHHHHHHhCCCCCC
Q 012599 407 YAM----V-GRA---------SLMSDVFSFGVVLLELITGRQPIH 437 (460)
Q Consensus 407 ~~~----~-~~~---------~~~sDVwSlGvll~elltG~~Pf~ 437 (460)
... . +.. ....+.|+++.++|++.+|..||.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 111 0 111 123689999999999999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=6.7e-07 Score=86.49 Aligned_cols=138 Identities=17% Similarity=0.167 Sum_probs=94.7
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC---CccceeeeeeeccCccceEEEEEe
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
.+.++.|....||+. +..+++|+... ......+.+|.++|+.+.+. .+.+++.+... .....++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~---~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR---SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC---TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc---CCCceEEEEe
Confidence 356788888999998 45688887431 22344588999999999643 34556655542 1345689999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA--------------------------------------- 347 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~--------------------------------------- 347 (460)
|++|..|.+..- ..++..+...++.++++.|..||+.
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999988876321 2245555556666666666666643
Q ss_pred ------------------CCCCeEecCcCCCCEEEcC---CCc-EEEEecCCcccc
Q 012599 348 ------------------AAPRILHRDIKSSNILLDE---NLN-AKITDLGMAKRL 381 (460)
Q Consensus 348 ------------------~~~~ivH~DLk~~NIll~~---~~~-vkl~DFGla~~~ 381 (460)
..+.++|+|+++.|||+++ ++. +.|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2235799999999999997 455 489999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.2e-07 Score=84.26 Aligned_cols=135 Identities=19% Similarity=0.132 Sum_probs=94.9
Q ss_pred eeeeeCcE-EEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEEEEEeec
Q 012599 232 IVGQGGSS-YVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 232 ~LG~G~fG-~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+ ....++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE----CCeEEEEEEee
Confidence 44556555 69988765 3567899986532 3345788999999884 3346677887765 34569999999
Q ss_pred CCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012599 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 348 (460)
Q Consensus 309 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~---------------------------------------- 348 (460)
++.++.+..... ......+..+++..|..||...
T Consensus 103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 998887765321 1223445666777777777432
Q ss_pred ---------------CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 ---------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 ---------------~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12489999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.9e-06 Score=84.95 Aligned_cols=83 Identities=6% Similarity=-0.104 Sum_probs=54.5
Q ss_pred cee-eeeCcEEEEEEEEc-------CCcEEEEEEeccCCC--CChhHHHHHHHHHHHhcC-C--CCccceeeeeeeccCc
Q 012599 231 NIV-GQGGSSYVYRGQLT-------DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLH-H--CHVVPLVGYCSEFRGK 297 (460)
Q Consensus 231 ~~L-G~G~fG~Vy~~~~~-------~g~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~ 297 (460)
+.| +.|....+|+.... +++.+++|+...... ......+.+|..+++.+. + -.+.++++++.+...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~- 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV- 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence 567 77889999998764 266788987654320 001123778999988884 3 356778877654211
Q ss_pred cceEEEEEeecCCCCHH
Q 012599 298 RAMRLLVFEFMPNGNLR 314 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~ 314 (460)
....++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 13458999999887654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.8e-05 Score=75.54 Aligned_cols=79 Identities=24% Similarity=0.326 Sum_probs=56.8
Q ss_pred CCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC---CccceeeeeeeccCccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~~~~~ 302 (460)
.....+.+|.|..+.||+.++.||+.++||+..... ......|..|...|+.|... -+.+++++.. .+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--------~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--------RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--------TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--------ce
Confidence 344457789999999999999999999999876443 33334588999999988422 3445554421 27
Q ss_pred EEEeecCCCCH
Q 012599 303 LVFEFMPNGNL 313 (460)
Q Consensus 303 lV~e~~~~gsL 313 (460)
+||||++.+..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.9e-05 Score=78.94 Aligned_cols=76 Identities=20% Similarity=0.178 Sum_probs=48.4
Q ss_pred cceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC------CChhHHHHHHHHHHHhcCC--CC-ccceeeeeeeccCccc
Q 012599 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLHH--CH-VVPLVGYCSEFRGKRA 299 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~------~~~~~~f~~Ei~~l~~l~H--~n-Iv~l~g~~~~~~~~~~ 299 (460)
.+.||.|.++.||++... +++.++||....... +.....+..|.++++.+.. +. +.+++.+ + ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d----~~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D----TE 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E----TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c----CC
Confidence 457899999999999764 467899998653211 1123346789999988742 33 3355543 2 12
Q ss_pred eEEEEEeecCCC
Q 012599 300 MRLLVFEFMPNG 311 (460)
Q Consensus 300 ~~~lV~e~~~~g 311 (460)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 348999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.03 E-value=1.7e-05 Score=77.20 Aligned_cols=141 Identities=16% Similarity=0.244 Sum_probs=79.3
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC--CCCccceeee-----eeeccCccceEEE
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCHVVPLVGY-----CSEFRGKRAMRLL 303 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~-----~~~~~~~~~~~~l 303 (460)
+.|+.|..+.||+....+| .+++|+.... ...+..|..+++.+. .-.+.+++.. +.. .....++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~---~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK---HGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE---ETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE---ECCEEEE
Confidence 4465577899999987655 4889988642 123445566665553 1123344321 111 1345689
Q ss_pred EEeecCCCCHH-----------HH---hcccc-----C-------CCCCHHHHH--------------------------
Q 012599 304 VFEFMPNGNLR-----------DC---LDGVL-----V-------EGMNWDTRV-------------------------- 331 (460)
Q Consensus 304 V~e~~~~gsL~-----------~~---l~~~~-----~-------~~l~~~~~~-------------------------- 331 (460)
+|||++|..+. .. ++... . ....|....
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999986542 11 11110 0 001232210
Q ss_pred -----HHHHHHHHHHHHHHh----------CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 332 -----AIAIGAARGLEYLHE----------AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 332 -----~i~~qia~~l~yLH~----------~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+..++..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224446667763 1235699999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.9e-05 Score=72.48 Aligned_cols=138 Identities=17% Similarity=0.176 Sum_probs=89.4
Q ss_pred ccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC---CCCccceeeeeeeccCccceEEEEE
Q 012599 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVF 305 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~~~~~lV~ 305 (460)
..+.|+.|....+|+... ++..+++|+.... ....|..|.+.|+.|. ...+.+++++... ....++||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS----QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----SSEEEEEE
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----CCceEEEE
Confidence 346688899999999986 4677889987642 2455889999998884 3567788877654 24579999
Q ss_pred eecCCCCHH--------HH---hccccC-C-------------------CCCHHHHH---HHHH----------------
Q 012599 306 EFMPNGNLR--------DC---LDGVLV-E-------------------GMNWDTRV---AIAI---------------- 335 (460)
Q Consensus 306 e~~~~gsL~--------~~---l~~~~~-~-------------------~l~~~~~~---~i~~---------------- 335 (460)
||+++..+. +. |+.... . .-+|.... ++..
T Consensus 111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~ 190 (312)
T 3jr1_A 111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID 190 (312)
T ss_dssp ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 999987642 11 222111 0 02454332 1111
Q ss_pred HHH-HHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 336 GAA-RGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 336 qia-~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
.+. .....|.. ...|.++|+|+.+.|++++.++ +.|+|+.
T Consensus 191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 11223422 2356799999999999999887 8999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00024 Score=68.02 Aligned_cols=71 Identities=8% Similarity=-0.009 Sum_probs=44.2
Q ss_pred cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccceEEEEEeec
Q 012599 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFM 308 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~lV~e~~ 308 (460)
.+.|+.|....+|+. ..+++|+......... ...+|..+++.+....+ .+++++..+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~--~r~~E~~~l~~l~~~g~~P~~~~~~~~------~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYI--NRANEAVAAREAAKAGVSPEVLHVDPA------TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CC--CHHHHHHHHHHHHHTTSSCCEEEECTT------TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcccee--CHHHHHHHHHHHHHcCCCCceEEEECC------CCEEEEeec
Confidence 577888999999999 4588888765322211 13578888877743333 456654321 227899999
Q ss_pred -CCCCH
Q 012599 309 -PNGNL 313 (460)
Q Consensus 309 -~~gsL 313 (460)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 55444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00023 Score=71.65 Aligned_cols=77 Identities=10% Similarity=0.094 Sum_probs=46.1
Q ss_pred CCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccc--cCCcccCccccccC---CCCchhHHHHHH
Q 012599 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--GTFGYFAPEYAMVG---RASLMSDVFSFG 423 (460)
Q Consensus 349 ~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDVwSlG 423 (460)
.+.++|+|+++.|||++++. ++|+||+.+....+...- .... -...|.+|+..... ......++.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl------a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI------GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTI 303 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH------HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH------HHHHHHHHHHHHhcccccccccchHHHHHHHHHHH
Confidence 45699999999999999876 999999988754321000 0000 01235555544311 112235556777
Q ss_pred HHHHHHHhC
Q 012599 424 VVLLELITG 432 (460)
Q Consensus 424 vll~elltG 432 (460)
..+|+.+++
T Consensus 304 ~~~~~~y~~ 312 (420)
T 2pyw_A 304 EQTWNLFNK 312 (420)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777777664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00052 Score=66.10 Aligned_cols=162 Identities=9% Similarity=0.100 Sum_probs=87.9
Q ss_pred echHHHHHHhcCCcc-----cceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC--ccce
Q 012599 215 FSYSALEHATDKFSG-----SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPL 287 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l 287 (460)
++.+++.....+|.. .+.|+.|....+|+....++ .+++|........ ..+..|..+++.+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 444556666566654 23456688899999988666 5888988653222 23567888887774222 2333
Q ss_pred eeeeee--ccCccceEEEEEeecCCCCHHH-----------H---hccc----cCC---C---CCHHHHHH---------
Q 012599 288 VGYCSE--FRGKRAMRLLVFEFMPNGNLRD-----------C---LDGV----LVE---G---MNWDTRVA--------- 332 (460)
Q Consensus 288 ~g~~~~--~~~~~~~~~lV~e~~~~gsL~~-----------~---l~~~----~~~---~---l~~~~~~~--------- 332 (460)
+..... ........+++|+|++|..+.. . ++.. ... . ..|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321000 0001234689999998765311 0 1111 000 0 11322111
Q ss_pred ---HHHHHHHHHHHHHhC----CCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 333 ---IAIGAARGLEYLHEA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 333 ---i~~qia~~l~yLH~~----~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
+...+...++.|... ..+.++|+|+++.|||++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666532 134599999999999999876668999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00057 Score=66.33 Aligned_cols=141 Identities=15% Similarity=0.125 Sum_probs=74.0
Q ss_pred ceeeeeCcEE-EEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC--CCccceeeeeeeccCccceEEEEEee
Q 012599 231 NIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 231 ~~LG~G~fG~-Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+ .. +++||+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~----~g--~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA----RG--LLLIED 93 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT----TT--EEEECC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC----CC--EEEEee
Confidence 3455555544 6677654467777776543221 124567777777632 234566655221 12 689999
Q ss_pred cCCCCHHHHhccccC------------------------CCCCHHHHH-------H-------------HHHHHHHHHHH
Q 012599 308 MPNGNLRDCLDGVLV------------------------EGMNWDTRV-------A-------------IAIGAARGLEY 343 (460)
Q Consensus 308 ~~~gsL~~~l~~~~~------------------------~~l~~~~~~-------~-------------i~~qia~~l~y 343 (460)
+++..+.+++..... ..++..... . ....+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 977777655432100 012211100 0 00111222333
Q ss_pred HHh---CCCCCeEecCcCCCCEEEcCC----CcEEEEecCCcccc
Q 012599 344 LHE---AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRL 381 (460)
Q Consensus 344 LH~---~~~~~ivH~DLk~~NIll~~~----~~vkl~DFGla~~~ 381 (460)
|.. ...+.++|+|+.+.|||++++ ..+.|+||+.+..-
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 311 123469999999999999875 67999999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00098 Score=67.89 Aligned_cols=74 Identities=11% Similarity=0.047 Sum_probs=47.7
Q ss_pred cceeeeeCcEEEEEEEEcC-CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccceEEEEEee
Q 012599 230 SNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEF 307 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~~~lV~e~ 307 (460)
.+.|+.|-...+|+....+ +..+++|+......... +..+|..+++.+...++ .++++++. + .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i--dR~~E~~vl~~L~~~gl~P~ll~~~~-----~---G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII--NREREKKISCILYNKNIAKKIYVFFT-----N---GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS--CHHHHHHHHHHHTTSSSBCCEEEEET-----T---EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc--CHHHHHHHHHHHHhcCCCCCEEEEeC-----C---eEEEEe
Confidence 3567778899999998865 47788888754321111 12588999998865555 46666652 1 359999
Q ss_pred cCCCCH
Q 012599 308 MPNGNL 313 (460)
Q Consensus 308 ~~~gsL 313 (460)
+++.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0011 Score=66.95 Aligned_cols=73 Identities=19% Similarity=0.283 Sum_probs=49.5
Q ss_pred cceeeeeCcEEEEEEEEcC--------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccce
Q 012599 230 SNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAM 300 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~ 300 (460)
.+.|+.|....+|+....+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG------- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-------
Confidence 4567788899999998753 478999987432 111346689999988853344 566665432
Q ss_pred EEEEEeecCCCCH
Q 012599 301 RLLVFEFMPNGNL 313 (460)
Q Consensus 301 ~~lV~e~~~~gsL 313 (460)
.+|+||+++.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999976443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0031 Score=60.79 Aligned_cols=144 Identities=17% Similarity=0.164 Sum_probs=82.2
Q ss_pred ceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC--Cccceeeeeeecc---CccceEEEEE
Q 012599 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFR---GKRAMRLLVF 305 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~---~~~~~~~lV~ 305 (460)
..++ |....||+....+|+.+++|....... ....+..|..+++.+... .+.+++.. +.. ......+++|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEE
Confidence 4566 888899998877787899999864321 234467788888877422 23444432 110 0123557899
Q ss_pred eecCCCCHH-----H------H---hccc----c---CCCCCHHHH----HHH---------------HHHHHHHHHHHH
Q 012599 306 EFMPNGNLR-----D------C---LDGV----L---VEGMNWDTR----VAI---------------AIGAARGLEYLH 345 (460)
Q Consensus 306 e~~~~gsL~-----~------~---l~~~----~---~~~l~~~~~----~~i---------------~~qia~~l~yLH 345 (460)
+|++|..+. . . ++.. . ....++... ..+ ...+...++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999875431 1 1 1110 0 011222211 001 111112233333
Q ss_pred hC----CCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 346 EA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 346 ~~----~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
.. ..+.++|+|+++.|||++ + .+.|+||+.+...
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 21 234589999999999999 4 8999999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0011 Score=65.67 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=81.6
Q ss_pred ceeeeeCcEEEEEEEEc--------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC-ccceeeeeeeccCccceE
Q 012599 231 NIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~--------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~ 301 (460)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.+...+ ..++++++.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence 45666888999999874 2478999986332 123344678999998884323 3566665432
Q ss_pred EEEEeecCCCCHHH--------------H---hcccc---CCCCC--HHHHHHHHHHHH-------------------HH
Q 012599 302 LLVFEFMPNGNLRD--------------C---LDGVL---VEGMN--WDTRVAIAIGAA-------------------RG 340 (460)
Q Consensus 302 ~lV~e~~~~gsL~~--------------~---l~~~~---~~~l~--~~~~~~i~~qia-------------------~~ 340 (460)
.+||||++|.+|.. . |+... .+... |.++.++..++. ..
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999998765431 1 11111 11122 344444443332 12
Q ss_pred HHHH----HhCC-CCCeEecCcCCCCEEEcCC----CcEEEEecCCccc
Q 012599 341 LEYL----HEAA-APRILHRDIKSSNILLDEN----LNAKITDLGMAKR 380 (460)
Q Consensus 341 l~yL----H~~~-~~~ivH~DLk~~NIll~~~----~~vkl~DFGla~~ 380 (460)
++.| .... ...++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3333 2222 2358999999999999876 7899999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0008 Score=66.36 Aligned_cols=73 Identities=10% Similarity=0.114 Sum_probs=43.4
Q ss_pred ceeeeeCcEEEEEEEEcC---------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccce
Q 012599 231 NIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAM 300 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~ 300 (460)
+.|+.|....+|+....+ +..+++|+...... .......|.++++.+...++ .++++...
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-------- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTFN-------- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEET--------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEecC--------
Confidence 457778889999998754 26788887654221 11123678888888853343 46665431
Q ss_pred EEEEEeecCCCCH
Q 012599 301 RLLVFEFMPNGNL 313 (460)
Q Consensus 301 ~~lV~e~~~~gsL 313 (460)
-++||||+++..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 1689999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0039 Score=60.77 Aligned_cols=32 Identities=22% Similarity=0.248 Sum_probs=28.2
Q ss_pred CCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 350 ~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
+.++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0073 Score=60.73 Aligned_cols=73 Identities=11% Similarity=0.115 Sum_probs=47.8
Q ss_pred ceeeeeCcEEEEEEEEcC--------CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCC-ccceeeeeeeccCccceE
Q 012599 231 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~~~~ 301 (460)
+.+..|-...+|+....+ ++.+++|+......... +..+|..+++.+...+ ..++++.+. -
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i--dR~~E~~~l~~L~~~gi~P~l~~~~~--------~ 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY--DSKVELDVFRYLSNINIAPNIIADFP--------E 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC--CHHHHHHHHHHHHHTTSSCCEEEEET--------T
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc--CHHHHHHHHHHHHhcCCCCCEEEEcC--------C
Confidence 456668889999998763 57899998654321111 2467888888884333 345665332 1
Q ss_pred EEEEeecCCCCH
Q 012599 302 LLVFEFMPNGNL 313 (460)
Q Consensus 302 ~lV~e~~~~gsL 313 (460)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.19 E-value=0.081 Score=52.57 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=25.0
Q ss_pred eEecCcCCCCEEE------cCCCcEEEEecCCccc
Q 012599 352 ILHRDIKSSNILL------DENLNAKITDLGMAKR 380 (460)
Q Consensus 352 ivH~DLk~~NIll------~~~~~vkl~DFGla~~ 380 (460)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998874
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.48 E-value=0.024 Score=37.04 Aligned_cols=27 Identities=15% Similarity=0.122 Sum_probs=11.6
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhhcCC
Q 012599 122 IVLLLCVILTTIAFLMLVLCYVYRKGK 148 (460)
Q Consensus 122 iv~~~~~~~~~l~~l~~~~~~~~rr~k 148 (460)
|++.+++.+++++++++.++++.||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444444434444444444444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.44 E-value=0.026 Score=36.86 Aligned_cols=28 Identities=14% Similarity=0.066 Sum_probs=11.8
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhhcCCC
Q 012599 122 IVLLLCVILTTIAFLMLVLCYVYRKGKF 149 (460)
Q Consensus 122 iv~~~~~~~~~l~~l~~~~~~~~rr~k~ 149 (460)
|++.+++.+++++++++.++++.|||+.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3443444344444444444444444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.43 E-value=0.023 Score=37.05 Aligned_cols=27 Identities=15% Similarity=0.208 Sum_probs=10.6
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhhcCC
Q 012599 122 IVLLLCVILTTIAFLMLVLCYVYRKGK 148 (460)
Q Consensus 122 iv~~~~~~~~~l~~l~~~~~~~~rr~k 148 (460)
|+++++++++++++++.+++|++||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 333333333333333333444444443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.98 E-value=0.28 Score=44.19 Aligned_cols=103 Identities=13% Similarity=0.089 Sum_probs=67.6
Q ss_pred CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCC
Q 012599 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (460)
Q Consensus 311 gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~ 390 (460)
-+|.+.|+.. ..++++.+++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3799999865 47899999999999999998776221111 1333456889999999988764 1110
Q ss_pred CCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC
Q 012599 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435 (460)
Q Consensus 391 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~P 435 (460)
.....+.|||... ...+.+.=|||||+++|.-+-=..|
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0113467888653 4557889999999999998874554
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=89.54 E-value=0.067 Score=40.62 Aligned_cols=50 Identities=22% Similarity=0.621 Sum_probs=28.5
Q ss_pred CcccceEEeccCCCCCcccccccCCCcCcccCC-------CCCCCCCCeeEeeecCCCCC
Q 012599 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSP-------AVGGSSEGKWTCICAADGLP 83 (460)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~c~~-------~~~~~~~~~~~c~~~~~g~~ 83 (460)
..++|+|.|..||++++ +.- .+|..+=+|.. +.-....|+|+|.| ..||-
T Consensus 21 ~~g~y~C~C~~Gy~~~~-~~g-~~C~dideC~~~~~~C~~~~C~n~~g~y~C~C-~~G~~ 77 (86)
T 1lmj_A 21 TPGDFECKCDEGYESGF-MMM-KNCMDIDECQRDPLLCRGGVCHNTEGSYRCEC-PPGHQ 77 (86)
T ss_dssp ETTEEEECCCSSEEECT-TTS-SSEEECCHHHHCSSTTTTSEEEEETTEEEEES-CTTSC
T ss_pred CCCCEEeeCCCCcCccC-CCC-CccCCcccccCCCCcCCCCEeEcCCCCEEEEC-cCCcc
Confidence 34689999999998764 211 24544433322 11122456778877 44554
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=88.81 E-value=0.17 Score=40.61 Aligned_cols=55 Identities=27% Similarity=0.553 Sum_probs=30.5
Q ss_pred hhhhccccccccCcccceEEeccCCCCCccccccc-----CCCc-CcccCCCCCCCCCCeeEeeecCCCCC
Q 012599 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKL-----NCSR-SCDCSPAVGGSSEGKWTCICAADGLP 83 (460)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~c~c~~~~~~~~~~~~~c~~~~~g~~ 83 (460)
.++.|.+ ..++|+|.|..||.|+. |.. .|.. ...|.. .-....|+|+|.| .+||-
T Consensus 24 ~~g~C~~-----~~~~y~C~C~~G~~G~~---C~~~~~~~~C~~~~~~C~~-~C~n~~g~y~C~C-~~G~~ 84 (114)
T 1aut_L 24 GHGTCID-----GIGSFSCDCRSGWEGRF---CQREVSFLNCSLDNGGCTH-YCLEEVGWRRCSC-APGYK 84 (114)
T ss_dssp TSEEECC-----CSSCCCEEECTTEESTT---SCEECCSSSSSSGGGGCSS-EEEECSSSEEEEC-CTTEE
T ss_pred CcCCCCC-----CCCCcEeeCCCCCcCCC---cCcCCcCCcCcCCCCCCCC-EeECCCCCEEeEC-CCCee
Confidence 3455644 45789999999999864 211 1221 011111 1112467899998 55654
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.26 E-value=0.11 Score=39.53 Aligned_cols=45 Identities=20% Similarity=0.536 Sum_probs=26.1
Q ss_pred CcccceEEeccCCCCCcccccccCCCcCcccCC----CCCCCCCCeeEeeec
Q 012599 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSP----AVGGSSEGKWTCICA 78 (460)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~c~~----~~~~~~~~~~~c~~~ 78 (460)
..++|+|.|..||++|+ +- ..|..+-+|.+ +.-....|+|+|.|.
T Consensus 21 ~~g~y~C~C~~G~~~~~-~g--~~C~dideC~~~~C~~~C~n~~g~y~C~C~ 69 (87)
T 1z6c_A 21 IPGDFECECPEGYRYNL-KS--KSCEDIDECSENMCAQLCVNYPGGYTCYCD 69 (87)
T ss_dssp BTTBCCCSSSTTCEEET-TT--TEEECCCHHHHSCCSSEECCCSSSCCEECC
T ss_pred CCCCEEEECCCCceECC-CC--CcCCCcCeeCCCCCCCEEEccCCCEEEECC
Confidence 34689999999999765 11 13333322221 112235677888885
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=86.82 E-value=0.42 Score=30.14 Aligned_cols=16 Identities=25% Similarity=0.403 Sum_probs=6.7
Q ss_pred HHHHHHHHHHHhhhhc
Q 012599 131 TTIAFLMLVLCYVYRK 146 (460)
Q Consensus 131 ~~l~~l~~~~~~~~rr 146 (460)
+.+++++.+.++++||
T Consensus 22 ~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 22 LGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHeec
Confidence 3333333444444444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.27 E-value=2 Score=38.51 Aligned_cols=119 Identities=8% Similarity=0.044 Sum_probs=78.1
Q ss_pred CCCCccceeeeeeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCC
Q 012599 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359 (460)
Q Consensus 280 ~H~nIv~l~g~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~ 359 (460)
.||++++.- +-.+ .....+. |-...+...|-. .+.++...+++++.+|+....+++. =+|--|+|
T Consensus 43 ~~~~Fl~~~-I~e~----eD~v~~~--y~~~~~~~~f~~---ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDAE-LTEL----RDSFQIH--YDINDNHTPFDN---IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp CCTTBCCEE-EEEC----SSEEEEE--ECCCTTSEEGGG---GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred cCCcccceE-EEEc----ccEEEEE--EEcCcccCCHHH---HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 588888652 2222 2233444 443333333332 2447899999999999998866653 37889999
Q ss_pred CCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 360 ~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
+|++++.++.+++.=.|+...+ +|. ..+...=.-.+=+++..+++++..|...
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l----------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVV----------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTB----------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred ceEEEcCCCCEEEEEccCccCC----------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 9999999999999877764432 221 2233344556777888889998888654
Q ss_pred C
Q 012599 440 I 440 (460)
Q Consensus 440 ~ 440 (460)
.
T Consensus 161 ~ 161 (215)
T 4ann_A 161 V 161 (215)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.80 E-value=0.26 Score=31.58 Aligned_cols=9 Identities=22% Similarity=0.394 Sum_probs=3.8
Q ss_pred HHHhhhhcC
Q 012599 139 VLCYVYRKG 147 (460)
Q Consensus 139 ~~~~~~rr~ 147 (460)
++++++||+
T Consensus 32 ~~~~~~rRr 40 (41)
T 2k9y_A 32 VGFFIHRRR 40 (41)
T ss_dssp HHHSSSSSC
T ss_pred HheeEeeec
Confidence 334444443
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
Probab=84.67 E-value=0.21 Score=44.24 Aligned_cols=56 Identities=27% Similarity=0.675 Sum_probs=13.5
Q ss_pred hhhhhccccccccCcccceEEeccCCCCCccccccc---C-CCcC-cccCCCCCCCCCCeeEeeecCCCCC
Q 012599 18 IQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKL---N-CSRS-CDCSPAVGGSSEGKWTCICAADGLP 83 (460)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~-c~c~~~~~~~~~~~~~c~~~~~g~~ 83 (460)
..++.|.+ ..++|+|.|..||.|.. |.. + |... +.|.. .-....|+|+|.| ..||-
T Consensus 51 ~ngg~C~n-----~~g~y~C~C~~Gf~G~~---Ce~~i~deC~~~~~~C~~-~C~n~~gsy~C~C-~~Gy~ 111 (195)
T 1nfu_B 51 QNQGKCKD-----GLGEYTCTCLEGFEGKN---CELFTRKLCSLDNGDCDQ-FCHEEQNSVVCSC-ARGYT 111 (195)
T ss_dssp --------------------------------------CCGGGTGGGGCSS-EEEEETTEEEEEC-CTTEE
T ss_pred CCCCEeEC-----CCCCeeEeCCCCceecc---ccccccccccCCCCCCCC-EeECCCCCeEEEC-CCCce
Confidence 34456654 44689999999999853 211 1 4321 22322 1122467899998 45554
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=83.51 E-value=0.62 Score=34.77 Aligned_cols=15 Identities=13% Similarity=0.468 Sum_probs=12.5
Q ss_pred CcccceEEeccCCCC
Q 012599 31 GQKNWKCTCSSSLQG 45 (460)
Q Consensus 31 ~~~~~~~~~~~~~~~ 45 (460)
..++|+|.|..||+|
T Consensus 22 ~~g~y~C~C~~Gy~~ 36 (82)
T 1emn_A 22 TDGSYRCECPFGYIL 36 (82)
T ss_dssp CSSCCCEECCTTEEE
T ss_pred cCCCEEEECCCCeEC
Confidence 346899999999974
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=83.45 E-value=0.25 Score=39.20 Aligned_cols=47 Identities=21% Similarity=0.569 Sum_probs=15.9
Q ss_pred CcccceEEeccCCCCCcccccccCCCcCcccCC-----CCCCCCCCeeEeeecCCCC
Q 012599 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSP-----AVGGSSEGKWTCICAADGL 82 (460)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~c~~-----~~~~~~~~~~~c~~~~~g~ 82 (460)
..++|+|.|..||+|+.. ..|..+-+|.. +.-....|+|+|.| .+||
T Consensus 46 ~~g~y~C~C~~Gy~g~~g----~~C~dideC~~~~~C~~~C~n~~gsy~C~C-~~Gy 97 (107)
T 2w2n_E 46 LKIGYECLCPDGFQLVAQ----RRCEDIDECQDPDTCSQLCVNLEGGYKCQC-EEGF 97 (107)
T ss_dssp CSBSCEEECCTTCEEETT----TEEEC------------------------------
T ss_pred CCCCeEEECCCCccccCC----CccccccccCCCCCcCCeeecCCCCEEEEC-CCCc
Confidence 346899999999998531 23433333321 11222456667766 3444
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=82.49 E-value=0.59 Score=39.23 Aligned_cols=50 Identities=20% Similarity=0.552 Sum_probs=28.3
Q ss_pred CcccceEEeccCCCCCcccccccCCCcC-cccCCCCC-CCCCCeeEeeecCCCCC
Q 012599 31 GQKNWKCTCSSSLQGDQSNILKLNCSRS-CDCSPAVG-GSSEGKWTCICAADGLP 83 (460)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-c~c~~~~~-~~~~~~~~c~~~~~g~~ 83 (460)
..++|+|.|..||.|.. =.-.+-|... +.|.. .- ....|+|+|.| .+|+-
T Consensus 65 ~~~~y~C~C~~G~~G~~-C~~~deC~~~~~~C~~-~C~~n~~g~y~C~C-~~Gy~ 116 (146)
T 1x7a_L 65 DINSYECWCQVGFEGKN-CELDATCNIKNGRCKQ-FCKTGADSKVLCSC-TTGYR 116 (146)
T ss_dssp CSSCEEEECCSSEESTT-TCEECCTTSGGGSCSS-BCCCCSSSCCCCBC-CTTEE
T ss_pred CCCCEEEecCCCCcCCc-CCCCccccCCCCCCcC-CCCCCCCCCEEeEc-CCCcE
Confidence 34689999999999843 0000223321 22322 22 23568899998 55654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 460 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-45 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 6e-57
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 16/219 (7%)
Query: 220 LEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
+E D F + +G G V++ G ++A K + P + + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+ ++V G + E M G+L L + ++I
Sbjct: 61 CNSPYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 114
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L S G
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 165
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
T Y +PE S+ SD++S G+ L+E+ GR PI
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-54
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCH 283
+ + +G G VY+G+ VAVK T P F EV +L + H +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
++ +GY + +V ++ +L L + + IA A+G++Y
Sbjct: 66 ILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDY 119
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH I+HRD+KS+NI L E+L KI D G+A S S ++ G+ +
Sbjct: 120 LHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW---SGSHQFEQLSGSILWM 173
Query: 404 APEYAMV---GRASLMSDVFSFGVVLLELITGRQPIH 437
APE + S SDV++FG+VL EL+TG+ P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (442), Expect = 1e-51
Identities = 57/243 (23%), Positives = 108/243 (44%), Gaps = 21/243 (8%)
Query: 215 FSYSALEHATDKFSGS---------NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG 261
F++ A +F+ ++G G V G L VA+K K+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 262 GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL 321
FL+E ++ + H +V+ L G ++ +++ EFM NG+L D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STPVMIITEFMENGSL-DSFLRQN 121
Query: 322 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
V + G A G++YL + +HRD+ + NIL++ NL K++D G+++ L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
+ D +S + + APE + + SDV+S+G+V+ E+++ + + +T
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 442 KGE 444
+
Sbjct: 239 NQD 241
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-51
Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +G G V+ G VAVK K G + FL E +++ +L H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L ++ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 71 VRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
E +HRD++++NIL+ + L+ KI D G+A+ ++ + + + + A
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK----FPIKWTA 178
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
PE G ++ SDV+SFG++L E++T + + +T E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-49
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 13/217 (5%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
+ + +G G + + +DG+I+ K + ++EV++L L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARG 340
++V + +V E+ G+L + E ++ + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 341 LEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D +S G
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-----TSFAKAFVG 176
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y +PE + SD++S G +L EL P
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-49
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +G+G V G G VAVK K A FL E ++++L H ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 62
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L+G E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 63 VQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
+HRD+ + N+L+ E+ AK++D G+ K SS+ + + A
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTA 168
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
PE + S SDV+SFG++L E+ + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV 199
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-49
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +GQG V+ G VA+K K G + FL E ++ +L H +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L SE +V E+M G+L D L G + + V +A A G+ Y+
Sbjct: 75 VQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
+HRD++++NIL+ ENL K+ D G+A+ ++ + + + + A
Sbjct: 130 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG----AKFPIKWTA 182
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
PE A+ GR ++ SDV+SFG++L EL T + + + E
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 2e-49
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 24/220 (10%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 280
FS +G G VY + + + +VA+K+ G + + + EV L +L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H + + G LV E+ V + + A+ GA +G
Sbjct: 74 HPNTIQYRGCYLR----EHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLH ++HRD+K+ NILL E K+ D G A + GT
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------SFVGTP 175
Query: 401 GYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 437
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-49
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 12/216 (5%)
Query: 230 SNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
+ ++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 345
L+G C G L+V +M +G+LR+ + + A+G+++L
Sbjct: 92 SLLGICLRSEGSP---LVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ +HRD+ + N +LDE K+ D G+A+ + S + + A
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK-LPVKWMAL 203
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
E + + SDV+SFGV+L EL+T P + +
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-49
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G+G V+RG+ G VAVK F ++ E+ L H +++ + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA--- 349
+ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 350 --PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
P I HRD+KS NIL+ +N I DLG+A R + + +P GT Y APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT-DTIDIAPNHRVGTKRYMAPEV 183
Query: 408 ------AMVGRASLMSDVFSFGVVLLELITGRQP 435
+ +D+++ G+V E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-48
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 14/217 (6%)
Query: 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
+G+G VY+G T+ VA + + F E +ML L H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
+ +LV E M +G L+ L + M + +GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 349 APRILHRDIKSSNILL-DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
P I+HRD+K NI + + KI DLG+A + +S + GT + APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAPEM 184
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ DV++FG+ +LE+ T P +
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-48
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 14/220 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ + +G G V+ G + VA+K + G ++ F+ E +++ +L H +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L G C E +A LVFEFM +G L D +T + + + G+ YL
Sbjct: 63 VQLYGVCLE----QAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
E ++HRD+ + N L+ EN K++D GM + + D S + + + +
Sbjct: 118 EE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----TKFPVKWAS 170
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
PE R S SDV+SFGV++ E+ + + + + + E
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-47
Identities = 53/214 (24%), Positives = 80/214 (37%), Gaps = 19/214 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F +G+G VY + I+A+K A EV++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+++ L GY + L+ E+ P G + L + + A L
Sbjct: 66 PNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H R++HRDIK N+LL KI D G + SS + GT
Sbjct: 120 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTTLCGTLD 169
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y PE D++S GV+ E + G+ P
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 6e-47
Identities = 54/257 (21%), Positives = 104/257 (40%), Gaps = 38/257 (14%)
Query: 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVF 269
+LE+ + +G+G V++ + +VAVK K + + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------------ 317
E +++ + ++V L+G C+ L+FE+M G+L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 318 ----------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
++ ++ IA A G+ YL E + +HRD+ + N L+ EN
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLL 427
+ KI D G+++ + + + A + PE R + SDV+++GVVL
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDA---IPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 428 ELITGRQPIHRSITKGE 444
E+ + + + E
Sbjct: 234 EIFSYGLQPYYGMAHEE 250
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-46
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 20/220 (9%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
D + +G G VY+ Q + + A K T+ + ++ E+D+L+ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHP 69
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V L+ ++ EF G + + L + + L
Sbjct: 70 NIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALN 124
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH+ +I+HRD+K+ NIL + + K+ D G++ + S GT +
Sbjct: 125 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYW 176
Query: 403 FAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQPIH 437
APE M + +DV+S G+ L+E+ P H
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH 216
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-46
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 15/220 (6%)
Query: 220 LEHATDKFSGSNIV-GQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLTEVDM 275
L D ++I G G V +G VA+K K + E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
+ +L + ++V L+G C +LV E G L L G E + +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLH 116
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ G++YL E +HRD+ + N+LL AKI+D G++K L AD + S
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--A 171
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ ++APE + S SDV+S+GV + E ++ Q
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 3e-46
Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 14/232 (6%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTE 272
+Y E + + +G G VY G VAVK K + FL E
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63
Query: 273 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
++ + H ++V L+G C+ ++ EFM GNL D L + ++ +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTR----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+A + +EYL + +HRD+ + N L+ EN K+ D G+++ + D + + +
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ APE + S+ SDV++FGV+L E+ T + I +
Sbjct: 177 K----FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-46
Identities = 58/236 (24%), Positives = 90/236 (38%), Gaps = 15/236 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ + +G+G V VAVK + + E+ + L+H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
VV G+ + ++ L E+ G L D ++ GM G+ Y
Sbjct: 65 VVKFYGHRR----EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH I HRDIK N+LLDE N KI+D G+A + + + M GT Y
Sbjct: 119 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK---MCGTLPYV 172
Query: 404 APEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIYLD 458
APE + DV+S G+VL ++ G + + W YL+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLN 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-45
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 16/218 (7%)
Query: 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVP 286
+G G V +G + VAVK K + P L E +++ +L + ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
++G C +LV E G L L + + + + G++YL E
Sbjct: 73 MIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 180
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ S SDV+SFGV++ E + Q +R + E
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-45
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V + +V E++ G+L D + M+ A+ + LE
Sbjct: 78 NIVNYLDSYLVGD----ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYW 182
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE D++S G++ +E+I G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-45
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 14/214 (6%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G G V G+ VA+K K G ++ F+ E ++ L H +V L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
C++ + ++ E+M NG L + L + + + +EYL
Sbjct: 68 CTK----QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
+ LHRD+ + N L+++ K++D G+++ + D S + + PE M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG----SKFPVRWSPPEVLMY 175
Query: 411 GRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ S SD+++FGV++ E+ + + + T E
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-45
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 15/225 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+ ++G G VY+G L VA+K K FL E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +++ L G S+++ +++ E+M NG L L + V + G A
Sbjct: 67 SHHNIIRLEGVISKYKP----MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAA 121
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G++YL +HRD+ + NIL++ NL K++D G+++ L+ D P + + + +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSGGKIP 176
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ APE + + SDV+SFG+V+ E++T + + ++ E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-44
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 17/225 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+F ++G G VY+G VA+K + P A+ L E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
+ HV L+G C + L+ + MP G L D + + + + + A+
Sbjct: 69 DNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+ YL + R++HRD+ + N+L+ + KITD G+AK L A+ + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG---GKVP 176
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ A E + + SDV+S+GV + EL+T + I E
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (388), Expect = 5e-44
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 10/217 (4%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR 278
H +D++ I+G GG S V+ + L R VAVK + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
L+H +V + + +V E++ LRD + M + + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 121
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ L + H+ I+HRD+K +NI++ K+ D G+A+ + G + + A + G
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIG 176
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y +PE A SDV+S G VL E++TG P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-44
Identities = 51/249 (20%), Positives = 99/249 (39%), Gaps = 38/249 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
+ ++G G V VAVK K + + ++E+ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 279 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-------------------- 317
L H ++V L+G C+ L+FE+ G+L + L
Sbjct: 97 LGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 318 -DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376
+ + + ++ + A A+G+E+L +HRD+ + N+L+ KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+A+ + +D S + + APE G ++ SDV+S+G++L E+ +
Sbjct: 210 LARDIMSD---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 437 HRSITKGEE 445
+ I
Sbjct: 267 YPGIPVDAN 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 31/238 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-H 280
+ +++G+G V + ++ A+KR K + F E+++L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMN 326
H +++ L+G C R L E+ P+GNL D L ++
Sbjct: 70 HPNIINLLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
+ A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------G 176
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ + A E + SDV+S+GV+L E+++ + +T E
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-43
Identities = 52/244 (21%), Positives = 94/244 (38%), Gaps = 33/244 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
++ S +G G V VAVK K ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 279 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-------------- 323
L +H ++V L+G C+ L++ E+ G+L + L
Sbjct: 83 LGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 324 --GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
++ + ++ + A+G+ +L +HRD+ + NILL KI D G+A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
K D S + + APE + SDV+S+G+ L EL + + +
Sbjct: 196 KND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 442 KGEE 445
+
Sbjct: 253 VDSK 256
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-43
Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 23/234 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F I+G+G S V + L R A+K + + + V E D++SRL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
V L + + NG L + + + L
Sbjct: 68 PFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 121
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQ 175
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 447
Y +PE A SD+++ G ++ +L+ G P I + I K E
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF 229
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 17/224 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 280
++ +G+G V++G VA+K K + FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H H+V L+G +E ++ E G LR V ++ + + A +
Sbjct: 67 HPHIVKLIGVITEN-----PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTA 120
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YL R +HRDI + N+L+ N K+ D G+++ ++ S + +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----KGKLPI 173
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ APE R + SDV+ FGV + E++ + + +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (381), Expect = 3e-42
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 18/214 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
D + +G G V+R GR+ K T P E+ ++++LHH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPK 87
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
++ L + + +L+ EF+ G L D + M+ + A GL++
Sbjct: 88 LINLHDAFED----KYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKH 142
Query: 344 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
+HE I+H DIK NI+ + + + KI D G+A +L D + T
Sbjct: 143 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------TTATAE 193
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ APE +D+++ GV+ L++G P
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (379), Expect = 6e-42
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 18/218 (8%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+H D + +G G V+R G A K T + ++ E+ +S L
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVL 80
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +V L + ++++EFM G L + + M+ D V +
Sbjct: 81 RHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCK 135
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
GL ++HE +H D+K NI+ + K+ D G+ L S
Sbjct: 136 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTT 186
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT + APE A +D++S GV+ L++G P
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (376), Expect = 2e-41
Identities = 63/239 (26%), Positives = 100/239 (41%), Gaps = 23/239 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH- 280
+ FS I+G+GG VY + D G++ A+K + +++ L E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 281 --HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+V + + + M G+L L + A
Sbjct: 64 GDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEII 117
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GLE++H +++RD+K +NILLDE+ + +I+DLG+A P G
Sbjct: 118 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVG 167
Query: 399 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTATGIY 456
T GY APE G A +D FS G +L +L+ G P + TK + + T T
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-40
Identities = 56/209 (26%), Positives = 82/209 (39%), Gaps = 17/209 (8%)
Query: 233 VGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVP 286
+G G V RG+ VAVK K +++ F+ EV+ + L H +++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
L G +V E P G+L D L T A+ A G+ YL
Sbjct: 76 LYGVVLTPP-----MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
R +HRD+ + N+LL KI D G+ + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 184
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQP 435
S SD + FGV L E+ T Q
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 141 bits (357), Expect = 2e-39
Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 31/227 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--------FLTEVDM 275
+ + I+G+G SS V R + AVK GG + + L EVD+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 276 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
L ++ H +++ L LVF+ M G L D L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIM 116
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+ LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 117 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLR 167
Query: 395 RMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELITGRQP 435
+ GT Y APE D++S GV++ L+ G P
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-39
Identities = 55/234 (23%), Positives = 97/234 (41%), Gaps = 24/234 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
+K + S +GQG VY G VA+K FL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR 330
+ HVV L+G S + L++ E M G+L+ L + ++ +
Sbjct: 80 FNCHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ +A A G+ YL+ + +HRD+ + N ++ E+ KI D GM + +
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ + +PE G + SDV+SFGVVL E+ T + ++ ++ +
Sbjct: 193 G---KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 47/216 (21%), Positives = 89/216 (41%), Gaps = 10/216 (4%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+++ + +G+G V + VA+K+ L E+ +L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+++ + ++ + + + +L L + ++ D RGL+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
Y+H A +LHRD+K SN+LL+ + KI D G+A+ D + T Y
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH--DHTGFLTEYVATRWY 178
Query: 403 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 437
APE + + S D++S G +L E+++ R
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP 214
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-39
Identities = 48/211 (22%), Positives = 76/211 (36%), Gaps = 20/211 (9%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 289
++G G + V + A+K + EV++ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 72
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
R L+V E + G L + + I ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 350 PRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
I HRD+K N+L N K+TD G AK + +S T Y APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH------NSLTTPCYTPYYVAPE 183
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ D++S GV++ L+ G P +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (356), Expect = 6e-39
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
+G G V+ + +GR A+K K + V E MLS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
G + ++ +++ G L L + A LEYLH
Sbjct: 70 WGTFQD----AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS- 122
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
I++RD+K NILLD+N + KITD G AK + + GT Y APE
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------PDVTYTLCGTPDYIAPEV 172
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ D +SFG+++ E++ G P +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-39
Identities = 58/242 (23%), Positives = 101/242 (41%), Gaps = 30/242 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRG------QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
D+ +G+G V + R VAVK K + ++E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 279 -LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVE 323
HH +VV L+G C++ G +++ EF GNL L + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+ + + + A+G+E+L + +HRD+ + NILL E KI D G+A+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443
D + + APE ++ SDV+SFGV+L E+ + + +
Sbjct: 187 DPDYVRKGD---ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 444 EE 445
EE
Sbjct: 244 EE 245
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 2e-38
Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 19/225 (8%)
Query: 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDM 275
+ E D + +++G G S V + ++VA+K + + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
L ++ H ++V L L+ + + G L D + +
Sbjct: 61 LHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIF 114
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSS 392
++YLH+ I+HRD+K N+L DE+ I+D G++K + S
Sbjct: 115 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--- 168
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT GY APE S D +S GV+ L+ G P +
Sbjct: 169 ---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-38
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV----FLTEVDMLSRLHHCHVV 285
+ +G+G + VY+ + +IVA+K+ K A L E+ +L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 345
L+ ++ LVF+FM D L + A + +GLEYLH
Sbjct: 64 GLLDAFGH----KSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH 117
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ ILHRD+K +N+LLDEN K+ D G+AK + + + T Y AP
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVVTRWYRAP 169
Query: 406 EYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
E R + D+++ G +L EL+
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-38
Identities = 56/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDML 276
D+ +G+G V + VAVK K+ S ++E++M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 277 SRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVL 321
+ H +++ L+G C++ ++ E+ GNLR+ L
Sbjct: 73 KMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 322 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
E ++ V+ A ARG+EYL + +HRD+ + N+L+ E+ KI D G+A+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
+++ + + APE + SDV+SFGV+L E+ T + +
Sbjct: 186 HHIDYYKKTTN---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 442 KGE 444
E
Sbjct: 243 VEE 245
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-38
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 223 ATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL 279
A ++ +G+G V++ + GR VA+KR + Q G + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 280 ---HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
H +VV L C+ R R +L + + +L LD V G+ +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
RGL++LH R++HRD+K NIL+ + K+ D G+A+ + S + +
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSV 175
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y APE + + D++S G + E+ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-37
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 18/215 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR-LH 280
+ F ++G+G V+ + + A+K K D V + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H + + + V E++ G+L + + A G
Sbjct: 62 HPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILG 115
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L++LH I++RD+K NILLD++ + KI D GM K + GT
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-----AKTNTFCGTP 167
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE + + + D +SFGV+L E++ G+ P
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 44/214 (20%), Positives = 89/214 (41%), Gaps = 19/214 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+K+ + +G+G V+R + + K K +G + E+ +L+ H +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRN 62
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
++ L +++FEF+ ++ + ++ E +N V+ L++
Sbjct: 63 ILHLHESFES----MEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQF 117
Query: 344 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
LH I H DI+ NI+ + KI + G A++LK + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------PGDNFRLLFTAPE 168
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y+APE S +D++S G ++ L++G P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-37
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 20/215 (9%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++ + ++G G VY+ +L D G +VA+K+ E+ ++ +L HC++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIV 76
Query: 286 PLVGYCSEF--RGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLE 342
L + + LV +++P R + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 343 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y+H I HRDIK N+LLD + K+ D G AK+L +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRY 187
Query: 402 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
Y APE + DV+S G VL EL+ G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-36
Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 16/214 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
+ F +G+G VY+ + G +VA+K+ + S + E+ +L L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V L+ +L + + +L+ +D + G+ + +GL
Sbjct: 62 NIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+ H R+LHRD+K N+L++ K+ D G+A+ T Y
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWY 168
Query: 403 FAPE-YAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE S D++S G + E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 6e-36
Identities = 39/215 (18%), Positives = 71/215 (33%), Gaps = 17/215 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+++ +G G +Y G + G VA+K + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGV 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+P + +C ++V E + + T + +A +EY
Sbjct: 64 GIPTIRWCGAEGD---YNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEY 118
Query: 344 LHEAAAPRILHRDIKSSNIL---LDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQG 398
+H +HRD+K N L + I D G+AK+ + + G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
T Y + + S D+ S G VL+ G
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 54/214 (25%), Positives = 81/214 (37%), Gaps = 17/214 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F ++G+G V + GR A+K + + D V +TE +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+ L V E+ G L L + L
Sbjct: 65 PFLTALKYAFQT----HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH +++RDIK N++LD++ + KITD G+ K +DG GT
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-----TFCGTPE 170
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D + GVV+ E++ GR P
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-35
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 25/225 (11%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVD 274
E+ D + +G G + V + + + G A K K + ++ EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
+L + H +V+ L + +L+ E + G L D L E + +
Sbjct: 66 ILKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFL 119
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRLKADGLPSCS 390
G+ YLH +I H D+K NI+L + KI D G+A ++
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 175
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ GT + APE L +D++S GV+ L++G P
Sbjct: 176 -----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-35
Identities = 49/220 (22%), Positives = 92/220 (41%), Gaps = 13/220 (5%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHC 282
K+ +GQG V++ + G+ VA+K+ + + L E+ +L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 283 HVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+VV L+ C S + + LVF+F + + ++ ++ RV +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
L L+ +ILHRD+K++N+L+ + K+ D G+A+ S +
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK-NSQPNRYTNRVV 183
Query: 399 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 437
T Y PE + R D++ G ++ E+ T +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 7e-35
Identities = 40/211 (18%), Positives = 74/211 (35%), Gaps = 19/211 (9%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ +LV + + G + L + + T A ++ +HE
Sbjct: 70 GQEGL---HNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 352 ILHRDIKSSNILLDENLN-----AKITDLGMAKRLKAD--GLPSCSSSPARMQGTFGYFA 404
+++RDIK N L+ + + D GM K + + GT Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ S D+ + G V + + G P
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLP 212
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (320), Expect = 3e-34
Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 14/212 (6%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCH 283
+K+ G +G+G VY+ Q G A+K+ + + S + E+ +L L H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+V L RL++ + +L+ LD V G+ T + + G+ Y
Sbjct: 62 IVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAY 115
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
H+ R+LHRD+K N+L++ KI D G+A+ + +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRA 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ S D++S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (313), Expect = 1e-32
Identities = 46/214 (21%), Positives = 79/214 (36%), Gaps = 20/214 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
D+F +G G V + G A+K Q + L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+V L + +V E++ G + L + + A
Sbjct: 101 PFLVKLEFSFKDNS----NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH +++RD+K N+L+D+ ++TD G AKR + GT
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR--------VKGRTWTLCGTPE 203
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE + + D ++ GV++ E+ G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 9e-32
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 25/214 (11%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLSRLHHCH-- 283
++G GG VY G ++D VA+K + + + EV +L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
V+ L+ + +L+ E + + + + +
Sbjct: 71 VIRLLDWFER----PDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 344 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
H +LHRDIK NIL+D N K+ D G LK GT Y
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 403 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP 435
PE+ R + V+S G++L +++ G P
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 44/214 (20%), Positives = 79/214 (36%), Gaps = 15/214 (7%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
K+ +G+G V++ + IVA+KR + S L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V L LVFEF + ++ + + +GL
Sbjct: 62 NIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLG 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+ H +LHRD+K N+L++ N K+ + G+A+ A + +
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYR 168
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
S D++S G + EL +P+
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 49/216 (22%), Positives = 80/216 (37%), Gaps = 20/216 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
+ VG G V G VA+K+ E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 283 HVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
+V+ L+ E LV FM + + D + +G
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLGEDRIQFLVYQMLKG 133
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L Y+H I+HRD+K N+ ++E+ KI D G+A++ S T
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--------DSEMTGYVVTR 182
Query: 401 GYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP 435
Y APE + R + D++S G ++ E+ITG+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 115 bits (288), Expect = 2e-29
Identities = 43/219 (19%), Positives = 83/219 (37%), Gaps = 24/219 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 282
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 90
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+++ L + + LVFE + N + + L + + + L+
Sbjct: 91 NIITLADIVKDPVSRTPA--LVFEHVNNTDFKQ-----LYQTLTDYDIRFYMYEILKALD 143
Query: 343 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H I+HRD+K N+++D E+ ++ D G+A+ + +
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV------RVASRY 194
Query: 402 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS 439
+ PE + D++S G +L +I ++P
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 2e-27
Identities = 40/215 (18%), Positives = 84/215 (39%), Gaps = 18/215 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
++ +G G V R VA+K+ + E+ ++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 283 HVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
+++ L+ + + + LV E M + V+ ++ + + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCG 131
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
+++LH I+HRD+K SNI++ + KI D G+A+ + + T
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP------YVVTR 182
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE + D++S G ++ E++ +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 50/215 (23%), Positives = 85/215 (39%), Gaps = 16/215 (7%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHH 281
+++ + VG G V G VAVK+ + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+V+ L+ + R + G D + V + + D + RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG--ADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
+Y+H I+HRD+K SN+ ++E+ KI D G+A+ T
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH--------TDDEMTGYVATRW 183
Query: 402 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP 435
Y APE + + D++S G ++ EL+TGR
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 9e-27
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 21/220 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQ---GGPNADSVFLTEVDMLS 277
+ F ++G G V+ + G++ A+K K TE +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 337
+ + + Y + K + L +++ G L L T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLIL---DYINGGELFTHL-----SQRERFTEHEVQIYV 135
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ L I++RDIK NILLD N + +TD G++K AD +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD----ETERAYDFC 191
Query: 398 GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
GT Y AP+ G + D +S GV++ EL+TG P
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (256), Expect = 8e-25
Identities = 42/215 (19%), Positives = 79/215 (36%), Gaps = 19/215 (8%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--------- 282
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 283 --HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H++ L+ + + ++VFE + L G+ I+ G
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLG 137
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L+Y+H I+H DIK N+L++ + + +L K T
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPE--NLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y +PE + +D++S ++ ELITG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.8 bits (183), Expect = 2e-16
Identities = 22/168 (13%), Positives = 43/168 (25%), Gaps = 38/168 (22%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT---------QGGPNADSVFLTE--------V 273
++G+G S V+ VK K + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
L +L V + + ++ E + L + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNA--------VLMELIDAKELYRV---------RVENPDEV 108
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
+ + I+H D+ N+L+ E I D + +
Sbjct: 109 LDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 460 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.69 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 92.49 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 82.08 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.37 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=361.80 Aligned_cols=206 Identities=28% Similarity=0.368 Sum_probs=175.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||+||+|++. +|+.||||++.........+.+.+|+++|++++||||+++++++.+ +...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~----~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc----CceeE
Confidence 357888999999999999999985 5899999999766544445568999999999999999999999887 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999999753 46999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.... ........||+.|+|||++.+..+ +.++|||||||+||||+||+.||.....
T Consensus 155 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 155 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp ETTE---ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred cCCc---cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 4321 122344679999999999988776 6789999999999999999999976544
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=362.82 Aligned_cols=206 Identities=26% Similarity=0.417 Sum_probs=177.8
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
+|+...++|++.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+++|++++|||||+++|++.+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----- 79 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----- 79 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----
Confidence 3444567788899999999999999999888999999997543 344569999999999999999999998754
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.+++.......+++..++.++.|||+||.|||+.+ |+||||||+||||++++.+||+|||++
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccce
Confidence 24589999999999999987665566999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
+....... .......||+.|+|||++....++.++|||||||+||||+||..|+..
T Consensus 157 ~~~~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 157 RLIEDNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp EECSSSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EEccCCcc----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 87754331 122345688999999999989999999999999999999996666544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-47 Score=367.32 Aligned_cols=208 Identities=27% Similarity=0.425 Sum_probs=164.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-C---cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||+||+|.+.. + ..||||.+.........+.|.+|+++|++++|||||+++|++.+ ...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~ 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STP 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee----CCE
Confidence 345567899999999999998753 2 35899998766555556679999999999999999999999876 446
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++.... ..+++.+++.++.|||+||+|||+++ |+||||||+||||+.++++||+|||+++.
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence 799999999999999987543 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
.................||+.|+|||.+....++.++|||||||+||||+| |+.||....
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 765432222222333457899999999999999999999999999999998 899997654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-47 Score=361.85 Aligned_cols=208 Identities=30% Similarity=0.470 Sum_probs=172.1
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
|+...++|++.+.||+|+||+||+|++. ..||||+++... .....+.|.+|+++|++++|||||+++|++.+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----- 75 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----- 75 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----
Confidence 3445678999999999999999999864 359999997543 34556679999999999999999999998754
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.+++.... ..+++..++.++.|||+||+|||+++ |+||||||+||||++++.+||+|||++
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla 151 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLA 151 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCS
T ss_pred cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccce
Confidence 34689999999999999997543 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
+....... ........||+.|+|||++.. ..++.++|||||||+||||+||+.||.....
T Consensus 152 ~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 152 TVKSRWSG---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp CC---------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred eeccccCC---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 87644321 122344678999999999863 4589999999999999999999999986543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-46 Score=357.26 Aligned_cols=201 Identities=26% Similarity=0.435 Sum_probs=177.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|+++|++++||||+++++++.+ ....+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----CCEEE
Confidence 357999999999999999999874 5899999999765433 34568999999999999999999999887 45789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~ 167 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (293)
T ss_dssp EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence 99999999999998865 45999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 168 ~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 168 PEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp STT-----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccc-----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 432 12334579999999999999999999999999999999999999997643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=353.80 Aligned_cols=200 Identities=30% Similarity=0.466 Sum_probs=164.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|+|.+ ....++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceecc----CCceEEE
Confidence 5677889999999999999999888999999997543 345669999999999999999999999976 3467999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++|+|.+++... ...+++..++.++.|+|.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999999998754 355899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhC-CCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHR 438 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG-~~Pf~~ 438 (460)
.. .......||+.|+|||++....++.++|||||||+||||+|+ ++||..
T Consensus 155 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 155 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred Cc----eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 32 122335688999999999999999999999999999999995 555543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-47 Score=363.67 Aligned_cols=208 Identities=27% Similarity=0.389 Sum_probs=179.7
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
+|+...++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.|.+|+++|++++|||||+++|++.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEee----
Confidence 34455677888899999999999999986 48899999987543 345569999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
....++||||+++|+|.+++.......+++..++.++.|||.||+|||+++ |+||||||+||||++++.+||+|||+
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccc
Confidence 446799999999999999997766677999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
++....+... ......|++.|+|||++....++.++||||||+++|||++|..||...
T Consensus 162 a~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 162 SRLMTGDTYT----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp TTTCCSSSSE----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eeecCCCCce----eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 9876543221 122345788999999999999999999999999999999987777543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=358.61 Aligned_cols=209 Identities=22% Similarity=0.326 Sum_probs=166.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||+||+|+.. +|+.||||.+..... ....+.+.+|+++|++++||||+++++++.+.. +...+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--CCEEE
Confidence 56889999999999999999875 589999999976543 223455889999999999999999999886522 34679
Q ss_pred EEEeecCCCCHHHHhccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 303 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qia~~l~yLH~~~--~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
+||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+||||++++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999999643 2356999999999999999999999864 235999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
+....+. .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 162 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~ 218 (269)
T d2java1 162 RILNHDT-----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218 (269)
T ss_dssp HHC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eecccCC-----CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC
Confidence 8765432 12334678999999999999999999999999999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=353.90 Aligned_cols=200 Identities=25% Similarity=0.408 Sum_probs=176.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC--CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||+||+|++. +++.||+|++... ........+.+|++++++++||||+++++++.+ ....
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE----CCEE
Confidence 46888899999999999999985 5889999998643 123345568999999999999999999999886 5578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 82 ~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 157 ~~~-------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 157 PSS-------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CCC-------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCC-------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 432 2234579999999999999999999999999999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=368.53 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=179.5
Q ss_pred HhcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 223 ~~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
..++|++.+.||+|+||+||+|.+. +|+.||+|+++....+.....+.+|+.+|++++|||||++++++.+ ....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC----SSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 3578999999999999999999975 5899999999876666666779999999999999999999999986 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+ ++ |+||||||+||||++++++||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999999754 459999999999999999999997 47 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~-------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 155 LIDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHHHT-------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cCCCc-------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 65432 234679999999999999999999999999999999999999997644
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=356.20 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=175.0
Q ss_pred cCCcccce-eeeeCcEEEEEEEEc---CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNI-VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~-LG~G~fG~Vy~~~~~---~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|.+.+. ||+|+||+||+|.+. ++..||||+++........+.|.+|+++|++++|||||+++|++.+ ..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ce
Confidence 44555664 999999999999764 3557999999876655556779999999999999999999999864 24
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++.... ..+++.+++.++.|+|.||+|||+++ |+||||||+||||++++.+||+|||+++.
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 689999999999999986533 56999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
....... ........||+.|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 159 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 159 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccc--cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence 7554321 122334568899999999999999999999999999999998 999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=346.59 Aligned_cols=203 Identities=24% Similarity=0.416 Sum_probs=179.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|++|++++++++||||++++|++.+ +...++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECC----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEE
Confidence 6788999999999999999999888899999998643 345579999999999999999999999976 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||+++|+|.+++.... ..+++..+..++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999999986543 45899999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
.. .......+|+.|+|||.+....++.++||||||+++|||+| |+.||.....
T Consensus 154 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~ 207 (258)
T d1k2pa_ 154 EY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 207 (258)
T ss_dssp SC----CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred Cc----eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH
Confidence 32 12334568899999999999999999999999999999998 8999987653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=349.39 Aligned_cols=201 Identities=27% Similarity=0.383 Sum_probs=171.4
Q ss_pred ccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 229 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
..+.||+|+||+||+|.+. +++.||+|.+.... .....+.|.+|+++|++++||||+++++++.+........++|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 3467999999999999986 48899999987543 233445689999999999999999999998776555667899999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc-CCCcEEEEecCCccccccCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 385 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~-~~~~vkl~DFGla~~~~~~~ 385 (460)
|+++|+|.+++... ..+++.++..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+++.....
T Consensus 93 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp CCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred CCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 99999999999764 46999999999999999999999875 4599999999999996 5789999999999754322
Q ss_pred CCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 386 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
......||+.|+|||++.+ .++.++|||||||+||||++|+.||....
T Consensus 169 ------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 169 ------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp ------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 2234579999999998865 69999999999999999999999997543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=355.49 Aligned_cols=202 Identities=23% Similarity=0.347 Sum_probs=174.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
+.|++.+.||+|+||+||+|.+. +++.||||+++... ....+.|.+|+++|++++|||||++++++.+ +...++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCeEEE
Confidence 46888899999999999999975 58999999997643 3444568999999999999999999999886 557899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||++.....
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999998653 256999999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCCcccCccccc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.. .......||+.|+|||++. ...++.++|||||||+||||+||+.||....
T Consensus 163 ~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~ 219 (288)
T d2jfla1 163 TI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN 219 (288)
T ss_dssp HH-----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred Cc-----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence 21 1122356899999999883 4568999999999999999999999997654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=353.55 Aligned_cols=203 Identities=27% Similarity=0.408 Sum_probs=174.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||+||+|... +++.||||++.... .....+.+.+|+++|++++||||+++++++.+ ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC----SSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE----CCEE
Confidence 56888999999999999999985 58999999986431 23344568999999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999998754 56999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
...... .......||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 159 ~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 159 SPESKQ---ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp C-------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCcc---cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 543211 1233457999999999999999999999999999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=358.51 Aligned_cols=212 Identities=25% Similarity=0.427 Sum_probs=175.4
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEcC------CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
|+...++|++.+.||+|+||+||+|++.. ...||||.+...........|.+|+.+|+++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 33445788899999999999999998753 2369999997766666666799999999998 8999999999998
Q ss_pred eccCccceEEEEEeecCCCCHHHHhccccC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qia~~l~yLH~~~~~~ 351 (460)
+ ....++||||+++|+|.++|+.... ..+++..++.++.||+.||+|||+++
T Consensus 112 ~----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--- 184 (325)
T d1rjba_ 112 L----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--- 184 (325)
T ss_dssp S----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred e----CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6 4467999999999999999965421 24899999999999999999999998
Q ss_pred eEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh
Q 012599 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (460)
Q Consensus 352 ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt 431 (460)
|+||||||+|||++.++.+||+|||+|+........ .......||+.|+|||.+....++.++|||||||+||||+|
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt 261 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh
Confidence 999999999999999999999999999876544321 11223567999999999999999999999999999999998
Q ss_pred -CCCCCCCCCC
Q 012599 432 -GRQPIHRSIT 441 (460)
Q Consensus 432 -G~~Pf~~~~~ 441 (460)
|+.||.....
T Consensus 262 ~g~~Pf~~~~~ 272 (325)
T d1rjba_ 262 LGVNPYPGIPV 272 (325)
T ss_dssp TSCCSSTTCCC
T ss_pred CCCCCCCCCCH
Confidence 8999976543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=347.72 Aligned_cols=217 Identities=25% Similarity=0.383 Sum_probs=171.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCC-----cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
+.|+..++||+|+||.||+|.+... ..||||+++..........|++|++++++++|||||+++|++.+ ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~----~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----YK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec----CC
Confidence 5677789999999999999987642 46999999766555555679999999999999999999999976 45
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+.+++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 679999999999999988653 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHHHhhc
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWTAT 453 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~~~~~ 453 (460)
........ ........||+.|+|||++....++.++||||||++||||++|..||..... ...+...+..
T Consensus 159 ~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~ 228 (283)
T d1mqba_ 159 VLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAIND 228 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHT
T ss_pred cccCCCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHHhc
Confidence 76543211 1122334688999999999999999999999999999999997666654322 2344444443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=350.96 Aligned_cols=202 Identities=30% Similarity=0.447 Sum_probs=170.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|++.+.||+|+||+||+|.+.+++.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ ...++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CCeEE
Confidence 46788999999999999999999888899999997543 344569999999999999999999999854 24589
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.+++.......++|.+++.++.|||.||+|||+.+ |+||||||+||||++++++||+|||+++....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999999998765567999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......||+.|+|||++..+.++.++||||||++||||+||..||...
T Consensus 166 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 166 NEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCc----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 332 2233356899999999999999999999999999999999976666543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=348.67 Aligned_cols=198 Identities=28% Similarity=0.440 Sum_probs=166.1
Q ss_pred ceeeeeCcEEEEEEEEcC---CcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
+.||+|+||+||+|.+.+ ++.||||+++... .+...+.|.+|+++|++++|||||+++|+|.. ...++|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CCEEEEEE
Confidence 479999999999998753 4689999997543 33344569999999999999999999999853 24689999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.++++.. ..+++.+++.++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999999754 55999999999999999999999998 99999999999999999999999999987654322
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
. ........||+.|+|||.+....++.++|||||||++|||+| |+.||....
T Consensus 163 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~ 215 (277)
T d1xbba_ 163 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215 (277)
T ss_dssp E--EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred c--cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence 1 112233568899999999999999999999999999999998 899998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-45 Score=352.85 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=160.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+.|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+|++++||||+++++++.+ +...+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES----GGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 467899999999999999999986 5899999999866544444568899999999999999999999876 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc---CCCcEEEEecCCcc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK 379 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~---~~~~vkl~DFGla~ 379 (460)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++
T Consensus 84 lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999999753 56999999999999999999999998 99999999999994 57899999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 159 ~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 159 MEDPGS------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EccCCC------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence 664432 2234579999999999999999999999999999999999999997543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=351.59 Aligned_cols=202 Identities=26% Similarity=0.330 Sum_probs=178.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||.||+|+.. +|+.||||+++... .....+.+.+|+.+|++++||||+++++++.+ ....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc----cccc
Confidence 56889999999999999999974 68999999997431 23345568899999999999999999999886 5678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 156 ~~~~-----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCC-----cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 4432 22344689999999999999999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-44 Score=348.95 Aligned_cols=198 Identities=27% Similarity=0.382 Sum_probs=171.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
+.|+.++.||+|+||+||+|... +++.||||++....... ..+.+.+|+++|++++|||||++++++.+ ....
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 90 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTA 90 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE----CCEE
Confidence 45888999999999999999875 58899999997654322 23458899999999999999999999876 4578
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|..++... ..+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||++...
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999999998776543 56999999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCCcccCcccccc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ....||+.|+|||++.+ +.++.++|||||||++|||++|+.||....
T Consensus 166 ~~~---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 166 APA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp SSB---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCC---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 432 23569999999999853 568999999999999999999999997643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=341.75 Aligned_cols=202 Identities=25% Similarity=0.361 Sum_probs=176.5
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-----ChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
.++|++.+.||+|+||+||+|... +|+.||||+++..... ...+.|.+|+.+|++++|||||++++++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence 467899999999999999999985 5899999999754221 234568999999999999999999999876
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC----cEEEE
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~----~vkl~ 373 (460)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 56789999999999999999764 46999999999999999999999998 99999999999998776 49999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||++....... ......||+.|+|||++....++.++|||||||+||||++|+.||....
T Consensus 160 DfG~a~~~~~~~------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 160 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp CCTTCEECTTSC------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred chhhhhhcCCCc------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 999998765432 2234568999999999999999999999999999999999999997643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-44 Score=348.67 Aligned_cols=199 Identities=28% Similarity=0.354 Sum_probs=175.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC--CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ......+.+.+|+.+|++++||||+++++++.+ ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee----CCee
Confidence 46888999999999999999985 5899999998643 123345568999999999999999999999876 5678
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999998754 45889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... .....||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 155 ~~~--------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 155 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccc--------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 432 234579999999999999999999999999999999999999997643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-44 Score=348.68 Aligned_cols=213 Identities=25% Similarity=0.430 Sum_probs=179.8
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeee
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~ 290 (460)
+.+|+.++++|++.+.||+|+||+||+|+.. +++.||||+++........+.|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667889999999999999999999864 3578999999866555556679999999999999999999999
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhcccc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAA 348 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qia~~l~yLH~~~ 348 (460)
+.+ ....++||||+++|+|.+++.... ...+++.+++.++.|+|.||+|||+.+
T Consensus 85 ~~~----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 85 CAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp ECS----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecc----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 876 446699999999999999996421 124889999999999999999999998
Q ss_pred CCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHH
Q 012599 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428 (460)
Q Consensus 349 ~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~e 428 (460)
|+||||||+|||||.++.+||+|||+++........ .......+++.|+|||.+....++.++|||||||+|||
T Consensus 161 ---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 161 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---eEeeEEcccceEECCCCcEEEccchhheeccCCccc---cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 999999999999999999999999999876543321 22334568899999999999999999999999999999
Q ss_pred HHhCC-CCCCCC
Q 012599 429 LITGR-QPIHRS 439 (460)
Q Consensus 429 lltG~-~Pf~~~ 439 (460)
|++|. .||...
T Consensus 235 ll~~~~~p~~~~ 246 (301)
T d1lufa_ 235 IFSYGLQPYYGM 246 (301)
T ss_dssp HHTTTCCTTTTS
T ss_pred HHccCCCCCCCC
Confidence 99986 566654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=345.79 Aligned_cols=205 Identities=27% Similarity=0.455 Sum_probs=170.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-Cc----EEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~ 299 (460)
++|++.+.||+|+||+||+|.+.. |+ +||+|+++........+.|.+|++++++++|||||+++|+|.+ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 458889999999999999998753 43 6999999876666677789999999999999999999999975 2
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++++||+.+|+|.+++... ...+++..++.++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 457889999999999998764 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
........ .......||+.|+|||.+..+.++.++||||||++||||+| |+.||.....
T Consensus 160 ~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~ 219 (317)
T d1xkka_ 160 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219 (317)
T ss_dssp HTTTTCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG
T ss_pred eccccccc---ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH
Confidence 76543321 12233468999999999999999999999999999999999 8889876544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-43 Score=349.85 Aligned_cols=201 Identities=25% Similarity=0.341 Sum_probs=175.6
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
-++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+ ....+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE----TTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 357899999999999999999875 58999999997543 2334568899999999999999999999886 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc--CCCcEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~--~~~~vkl~DFGla~~ 380 (460)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 9999999999999996532 45999999999999999999999998 99999999999996 467899999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~~~------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 176 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp CCTTS------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 65432 223467899999999999999999999999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=343.25 Aligned_cols=207 Identities=24% Similarity=0.377 Sum_probs=166.6
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcC----CcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCc
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 297 (460)
...++|++.+.||+|+||.||+|.+.. +..||||.++........+.|.+|+++|++++||||++++|++.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---- 79 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 79 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 345778899999999999999998753 356899998765555555679999999999999999999999853
Q ss_pred cceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 298 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
...++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred -CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence 3569999999999999988653 356899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~ 441 (460)
++....... .......||+.|+|||.+....++.++|||||||++|||+| |+.||.....
T Consensus 155 a~~~~~~~~----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 155 SRYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred heeccCCcc----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence 987654321 12334568899999999999999999999999999999998 8999976544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-43 Score=348.28 Aligned_cols=201 Identities=25% Similarity=0.369 Sum_probs=175.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|+++|++++||||+++++++.+ +...++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 56889999999999999999975 59999999987543 2234568899999999999999999999876 557899
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc--CCCcEEEEecCCcccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRL 381 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~--~~~~vkl~DFGla~~~ 381 (460)
||||+++|+|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||++...
T Consensus 104 vmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceec
Confidence 99999999999988653 245999999999999999999999998 99999999999998 6789999999999887
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 180 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 180 NPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp CTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred CCCC------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5432 2234568999999999999999999999999999999999999997543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-43 Score=335.54 Aligned_cols=210 Identities=27% Similarity=0.389 Sum_probs=173.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|++.+.||+|+||+||+|.+. +|+.||||+++...... ....|.+|+++++.++||||+++++++.........
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467889999999999999999874 68999999997654332 344689999999999999999999998875555556
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++++|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999998754 46999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
....... ........||+.|+|||++.+..+++++|||||||+||||+||+.||....
T Consensus 161 ~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 161 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp CC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hcccccc--ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 5433211 123344679999999999999999999999999999999999999997543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-43 Score=348.31 Aligned_cols=198 Identities=24% Similarity=0.323 Sum_probs=175.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccC--CCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~ 301 (460)
++|++++.||+|+||.||+|.+. +|+.||||++... ......+.+++|+.+|+.++||||+++++++.+ ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc----cccc
Confidence 57889999999999999999985 5999999998643 123344568999999999999999999999876 4567
Q ss_pred EEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccc
Q 012599 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (460)
Q Consensus 302 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~ 381 (460)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999999754 46999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .....||+.|+|||++.+..++.++|||||||+||||+||+.||...
T Consensus 192 ~~~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc--------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 432 23457999999999999999999999999999999999999999754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=337.03 Aligned_cols=209 Identities=28% Similarity=0.422 Sum_probs=169.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
.++|+..+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++||||++++|+|.+. ....++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec---CCcEEE
Confidence 35677789999999999999998 57889999997532 345699999999999999999999998652 234699
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
||||+++|+|.++|.......++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999997654455899999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcCchhHHHHhhc
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWTAT 453 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~~~~~~~l~~~~~~ 453 (460)
. .....++..|+|||++.+..+++++||||||+++|||+| |+.||..... ..+..++..
T Consensus 156 ~--------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~ 215 (262)
T d1byga_ 156 T--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK 215 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT
T ss_pred C--------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHc
Confidence 2 223357889999999999999999999999999999998 7888876533 344555443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-43 Score=347.16 Aligned_cols=209 Identities=27% Similarity=0.388 Sum_probs=173.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHH---HHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~E---i~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+| +.+++.++||||+++++++.+ .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----C
Confidence 57889999999999999999986 58999999986321 11222334444 566667789999999999876 4
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.++|... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 5789999999999999999764 45899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcCchhHHH
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~~~~~l~~ 449 (460)
+...... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......+...+..
T Consensus 155 ~~~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~ 219 (364)
T d1omwa3 155 CDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219 (364)
T ss_dssp EECSSSC-------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH
T ss_pred eecCCCc-------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 8765432 234579999999999875 568999999999999999999999998765544434433
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=341.79 Aligned_cols=202 Identities=25% Similarity=0.403 Sum_probs=173.7
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC--CCChhHHHHHHHHHHH-hcCCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLS-RLHHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~--~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+..|..++. .++||||+++++++.+ +..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----KEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----SSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----CCc
Confidence 57888999999999999999886 58999999996431 2233344667777665 6899999999999887 557
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 78 ~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 153 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 153 NMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc-----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 54432 22334579999999999999999999999999999999999999997654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=344.01 Aligned_cols=202 Identities=24% Similarity=0.304 Sum_probs=173.6
Q ss_pred hcCCcccc-eeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 224 TDKFSGSN-IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 224 ~~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
.++|.+.+ .||+|+||+||+|.+. +++.||||+++.. ..+.+|++++.++ +||||+++++++.+....+..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35777764 6999999999999874 5899999998632 3478899987655 899999999998765555667
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC---CCcEEEEecCC
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~---~~~vkl~DFGl 377 (460)
.++||||+++|+|.++|.......+++.++..++.|++.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999998655567999999999999999999999998 999999999999985 55799999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 161 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 161 AKETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CEECCCCC------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred eeeccCCC------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 98765432 2234579999999999999999999999999999999999999997543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=340.13 Aligned_cols=215 Identities=27% Similarity=0.404 Sum_probs=170.0
Q ss_pred hHHHHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceee
Q 012599 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 289 (460)
Q Consensus 217 ~~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g 289 (460)
...|+...++|++.+.||+|+||.||+|.+. +++.||||+++........+.+.+|...+.++ +|+||+++++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3456666788999999999999999999864 24689999998665555566688888888887 7899999999
Q ss_pred eeeeccCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 012599 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (460)
Q Consensus 290 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~ 355 (460)
++.+. +...++||||+++|+|.++++... ...+++.+++.++.||++||+|||+++ |+||
T Consensus 85 ~~~~~---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 85 ACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EECST---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeccC---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 87652 335699999999999999996532 234889999999999999999999998 9999
Q ss_pred CcCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC-C
Q 012599 356 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-Q 434 (460)
Q Consensus 356 DLk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~-~ 434 (460)
||||+||||++++++||+|||+++....... ........||+.|+|||.+....++.++|||||||++|||+||. .
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTT---SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCccceeECCCCcEEEccCcchhhcccccc---ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 9999999999999999999999987654322 12233457999999999999999999999999999999999965 5
Q ss_pred CCCCCC
Q 012599 435 PIHRSI 440 (460)
Q Consensus 435 Pf~~~~ 440 (460)
||....
T Consensus 236 p~~~~~ 241 (299)
T d1ywna1 236 PYPGVK 241 (299)
T ss_dssp SSTTCC
T ss_pred CCCCCC
Confidence 676543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-42 Score=330.66 Aligned_cols=202 Identities=29% Similarity=0.429 Sum_probs=174.7
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC--------hhHHHHHHHHHHHhcC-CCCccceeeeeee
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLH-HCHVVPLVGYCSE 293 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~--------~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~ 293 (460)
.++|++.+.||+|+||+||+|+.. +++.||||+++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999874 68999999997653222 1234889999999996 9999999999876
Q ss_pred ccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEE
Q 012599 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (460)
Q Consensus 294 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~ 373 (460)
+...++||||+++|+|.++|+.. ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEc
Confidence 56789999999999999999754 46999999999999999999999998 9999999999999999999999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCcccccc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
|||+++...... ......||+.|+|||.+.. ..++.++||||+||+||||++|+.||....
T Consensus 153 DFG~a~~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 153 DFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp CCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cchheeEccCCC------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999998765432 2234578999999998853 446889999999999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=333.57 Aligned_cols=201 Identities=27% Similarity=0.458 Sum_probs=171.4
Q ss_pred ceeeeeCcEEEEEEEEcCC----cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEEEe
Q 012599 231 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g----~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV~e 306 (460)
++||+|+||+||+|.+.++ ..||||+++........+.|.+|+++|++++||||++++|++.+. +...++|||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~lv~E 109 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLP 109 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---TTEEEEEEE
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---CCceEEEEE
Confidence 6899999999999987542 358999997655555567799999999999999999999998753 246799999
Q ss_pred ecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccCCC
Q 012599 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (460)
Q Consensus 307 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~~~ 386 (460)
|+++|+|.+++... ...+++..++.++.|+|.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp CCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999998764 345889999999999999999999998 99999999999999999999999999987765443
Q ss_pred CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 387 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
.. ........||+.|+|||.+....++.++||||||++||||+||+.||...
T Consensus 186 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 186 DS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CC-TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred cc-ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 22 12233456899999999999999999999999999999999988888654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-42 Score=334.14 Aligned_cols=213 Identities=27% Similarity=0.428 Sum_probs=172.6
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC-Cc--EEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeeeeccCccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~~~ 300 (460)
++|++.+.||+|+||.||+|.+.+ +. .||||+++........+.|.+|+++|+++ +||||++++|++.+ ...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----CCe
Confidence 678888999999999999998754 33 57888887655555566799999999999 79999999999987 557
Q ss_pred EEEEEeecCCCCHHHHhccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC
Q 012599 301 RLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~ 366 (460)
.++||||+++|+|.++|+.. ....+++..++.++.|||.||.|||+.+ |+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence 89999999999999999643 2356999999999999999999999998 999999999999999
Q ss_pred CCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCCcCch
Q 012599 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ-PIHRSITKGEE 445 (460)
Q Consensus 367 ~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~-Pf~~~~~~~~~ 445 (460)
++.+||+|||+++...... ......||..|+|||.+....++.++||||||+++|||++|.. ||.... ..
T Consensus 163 ~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~ 233 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CA 233 (309)
T ss_dssp GGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH
T ss_pred CCceEEccccccccccccc------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HH
Confidence 9999999999997654332 2233468899999999999999999999999999999999765 565432 33
Q ss_pred hHHHHhhc
Q 012599 446 SLVLWTAT 453 (460)
Q Consensus 446 ~l~~~~~~ 453 (460)
.+...+..
T Consensus 234 ~~~~~i~~ 241 (309)
T d1fvra_ 234 ELYEKLPQ 241 (309)
T ss_dssp HHHHHGGG
T ss_pred HHHHHHHh
Confidence 45454443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=333.77 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=174.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.++|++.+.||+|+||+||+|.+. +++.||||.++... .....+.+|+++|+.++||||+++++++.+ ....+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 578999999999999999999886 58899999997542 234458899999999999999999999876 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC--CCcEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~--~~~vkl~DFGla~~ 380 (460)
+||||+++|+|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 78 lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999999999999753 245899999999999999999999998 999999999999985 45899999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......+|+.|+|||.+....++.++|||||||++|||++|+.||....
T Consensus 154 ~~~~~------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~ 207 (321)
T d1tkia_ 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET 207 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccCC------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence 64432 1233568899999999999999999999999999999999999997654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=335.17 Aligned_cols=205 Identities=27% Similarity=0.375 Sum_probs=165.8
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHH--HHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD--MLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~--~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
.+|...+.||+|+||.||+|++ +|+.||||+++.. ....+..|.+ .+.+++||||++++|++.+.......++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3456678999999999999997 6889999998643 2233444544 4457899999999999987665556789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCcCCCCEEEcCCCcEEEEecCC
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-----APRILHRDIKSSNILLDENLNAKITDLGM 377 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~-----~~~ivH~DLk~~NIll~~~~~vkl~DFGl 377 (460)
+||||+++|+|.++|+. ..++|..++.++.|+|.||+|||+.. .++|+||||||+||||++++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999975 45899999999999999999999741 24599999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCccccCCcccCccccccCC------CCchhHHHHHHHHHHHHHhCCCCCCC
Q 012599 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITGRQPIHR 438 (460)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwSlGvll~elltG~~Pf~~ 438 (460)
++......... ........||+.|+|||++.... ++.++||||||++||||+||..||..
T Consensus 155 ~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEE-CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcce-eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 98775543211 12334467999999999886542 57799999999999999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=331.87 Aligned_cols=205 Identities=29% Similarity=0.372 Sum_probs=163.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEcC--C--cEEEEEEeccCCC--CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCcc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~vaVK~l~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 298 (460)
++|++.+.||+|+||.||+|++.. + ..||||+++.... ....+.|.+|+++|++++||||++++|++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 568888999999999999998642 2 3689999875532 3334579999999999999999999999964
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||+++|+|.+++.... ..+++..++.++.|+|.||.|||+++ |+||||||+||||+.++++||+|||++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 24589999999999999887543 45999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~~~~ 440 (460)
+......... .......|+..|+|||.+....++.++||||||+++|||+| |+.||....
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 159 RALPQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp EECCC-CCEE--EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred hhcccCCCcc--eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC
Confidence 9775443221 12233457889999999999999999999999999999998 899997543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=330.98 Aligned_cols=197 Identities=28% Similarity=0.365 Sum_probs=163.5
Q ss_pred cceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC----hhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEEE
Q 012599 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~lV 304 (460)
+++||+|+||+||+|.+. +|+.||||+++...... ....+.+|+++|++++||||+++++++.+ +...++|
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----~~~~~iv 78 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----KSNISLV 78 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----TTCCEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----CCceeeh
Confidence 578999999999999975 58999999987543221 23458899999999999999999999876 4567999
Q ss_pred EeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccccC
Q 012599 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (460)
Q Consensus 305 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~~ 384 (460)
|||++++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 79 mE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence 999988777766543 255899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 385 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 154 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 154 N-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp C-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c-----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence 2 12334578999999998864 567999999999999999999999997543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=333.66 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=173.2
Q ss_pred HHhcCCcccceeeeeCcEEEEEEEEcC--------CcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 222 HATDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 222 ~~~~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
...++|.+.+.||+|+||.||+|+... +..||||+++..........+.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345678888999999999999998632 3479999998766555556788999999888 8999999999998
Q ss_pred eccCccceEEEEEeecCCCCHHHHhcccc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk 358 (460)
+ +...++||||+++|+|.++|.... ...+++.+++.++.|++.||+|||+.+ |+|||||
T Consensus 90 ~----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiK 162 (299)
T d1fgka_ 90 Q----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 162 (299)
T ss_dssp S----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred c----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeec
Confidence 6 456799999999999999996543 234899999999999999999999998 9999999
Q ss_pred CCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 012599 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (460)
Q Consensus 359 ~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~ellt-G~~Pf~ 437 (460)
|+|||++.++.+||+|||+++........ .......+++.|+|||.+..+.++.++||||||+++|||++ |+.||.
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 99999999999999999999877654322 22344568899999999999999999999999999999998 788886
Q ss_pred CCC
Q 012599 438 RSI 440 (460)
Q Consensus 438 ~~~ 440 (460)
...
T Consensus 240 ~~~ 242 (299)
T d1fgka_ 240 GVP 242 (299)
T ss_dssp TCC
T ss_pred CCC
Confidence 543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=328.81 Aligned_cols=202 Identities=25% Similarity=0.432 Sum_probs=170.4
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ....+.+.+|+++|++++||||+++++++.+ ....+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~----~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc----cccee
Confidence 57899999999999999999974 589999999975432 2234568999999999999999999999987 55789
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+||||+. +++.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 9999995 56666665555567999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...
T Consensus 154 ~~~-----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 154 VPV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp CCS-----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCc-----ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 432 2233457899999999877655 588999999999999999999999754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=332.84 Aligned_cols=211 Identities=25% Similarity=0.368 Sum_probs=177.2
Q ss_pred HHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhc-CCCCccceeeeee
Q 012599 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (460)
Q Consensus 220 l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~ 292 (460)
|+...++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|+.+++++ +|||||+++|++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3444577888899999999999999862 46789999998766555566799999999999 7999999999997
Q ss_pred eccCccceEEEEEeecCCCCHHHHhcccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~D 356 (460)
+ ....++||||+++|+|.++++... ...+++..++.++.||++||+|||+++ ++|||
T Consensus 98 ~----~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrD 170 (311)
T d1t46a_ 98 I----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRD 170 (311)
T ss_dssp S----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred e----CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 6 345799999999999999996532 124899999999999999999999998 99999
Q ss_pred cCCCCEEEcCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCC-
Q 012599 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP- 435 (460)
Q Consensus 357 Lk~~NIll~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~P- 435 (460)
|||+|||++.++.+|++|||+++........ .......||+.|+|||.+....++.++||||||+++|||+|+..|
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence 9999999999999999999999876543321 122345789999999999999999999999999999999995444
Q ss_pred CCCCC
Q 012599 436 IHRSI 440 (460)
Q Consensus 436 f~~~~ 440 (460)
|....
T Consensus 248 ~~~~~ 252 (311)
T d1t46a_ 248 YPGMP 252 (311)
T ss_dssp STTCC
T ss_pred CCCCC
Confidence 54433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=334.82 Aligned_cols=211 Identities=28% Similarity=0.420 Sum_probs=177.5
Q ss_pred HHHHHhcCCcccceeeeeCcEEEEEEEEc------CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeee
Q 012599 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (460)
Q Consensus 219 ~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~ 292 (460)
+|+...++|++.+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||++++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34445578888899999999999999863 257899999986555555566999999999999999999999987
Q ss_pred eccCccceEEEEEeecCCCCHHHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEE
Q 012599 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll 364 (460)
. ....++||||+++|+|.+++.... ...+++..+..++.|+|+||.|||+.+ |+||||||+|||+
T Consensus 94 ~----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 94 Q----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp S----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred c----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 6 446699999999999999985421 134789999999999999999999998 9999999999999
Q ss_pred cCCCcEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCC-CCCCCC
Q 012599 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QPIHRS 439 (460)
Q Consensus 365 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~-~Pf~~~ 439 (460)
++++++||+|||+++........ .......+|+.|+|||.+....++.++||||||++||||+||. .||...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred cCCceEEEeecccceeccCCcce---eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999876554321 1223346889999999999999999999999999999999985 666544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=324.36 Aligned_cols=207 Identities=26% Similarity=0.390 Sum_probs=170.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-C-CcEEEEEEeccCCC-CChhHHHHHHHHHHHhc---CCCCccceeeeeeecc-C
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-G 296 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~-~ 296 (460)
.++|++++.||+|+||+||+|.+. + ++.||||+++.... ......+.+|+++|+.+ +||||+++++++.... .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 3 67799999865422 22233467888887766 7999999999986532 2
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
.....+++|||++++++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3457899999998776654443 34466999999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 162 LARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp SCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hhhhhcccc------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence 987654332 2334579999999999999999999999999999999999999997654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-41 Score=323.04 Aligned_cols=202 Identities=24% Similarity=0.375 Sum_probs=169.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||+||+|++.+|+.||||+++... .....+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc----CCceeE
Confidence 5788999999999999999999999999999997543 23334568999999999999999999999876 456799
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcccccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~~ 383 (460)
+|||+.++.+..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+.....
T Consensus 78 ~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99999777666665533 56999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 384 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
... ......+++.|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~ 205 (286)
T d1ob3a_ 153 PVR-----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS 205 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Ccc-----ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence 321 2233457899999999875 456999999999999999999999997643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=328.68 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=171.4
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
+++|++++.||+|+||+||+|.+. +|+.||||++.........+.+++|+++|++++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457889999999999999999874 6999999999765544445568999999999999999999999876433223334
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55566779999999964 45999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
...... .......||+.|+|||++. ...++.++||||+|+++|||++|+.||....
T Consensus 161 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 161 PDHDHT--GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp GGGCBC--CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCccc--eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 433211 1234456899999999985 4567999999999999999999999997654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=321.38 Aligned_cols=200 Identities=24% Similarity=0.359 Sum_probs=167.9
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCC-----hhHHHHHHHHHHHhcC--CCCccceeeeeeecc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFR 295 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~ 295 (460)
.++|++.+.||+|+||+||+|... +|+.||||+++...... ....+.+|+.+|++++ ||||+++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 367889999999999999999975 58999999987532111 1123678999999996 8999999999876
Q ss_pred CccceEEEEEeecCC-CCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-CCcEEEE
Q 012599 296 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKIT 373 (460)
Q Consensus 296 ~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-~~~vkl~ 373 (460)
....++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred --CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEEC
Confidence 4577999999975 6888888653 56999999999999999999999998 999999999999985 4799999
Q ss_pred ecCCccccccCCCCCCCCCCCccccCCcccCccccccCCC-CchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
|||+++..... ......||+.|+|||++....+ +.++|||||||+||||+||+.||...
T Consensus 154 DFG~a~~~~~~-------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 154 DFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CCTTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccceecccc-------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 99999865432 2234579999999999987665 67799999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-40 Score=320.24 Aligned_cols=211 Identities=22% Similarity=0.301 Sum_probs=169.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCC-CCChhHHHHHHHHHHHhcCCCCccceeeeeeecc----Ccc
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKR 298 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 298 (460)
++|++.+.||+|+||+||+|.+. +|+.||||++.... .......+.+|+++|++++|+|++++++++.... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999999999999975 69999999986543 2334456899999999999999999999986532 123
Q ss_pred ceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCc
Q 012599 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (460)
Q Consensus 299 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla 378 (460)
...++||||++++.+..+... ...++...+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 457999999987766655443 356899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
+......... ........||+.|+|||.+... .++.++|||||||++|||++|+.||....+
T Consensus 165 ~~~~~~~~~~-~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 165 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecccccccc-cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 8765433221 1223345799999999998754 689999999999999999999999976543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-39 Score=311.72 Aligned_cols=206 Identities=18% Similarity=0.225 Sum_probs=173.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCC-CCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||+||+|++. +|+.||||++....... .+.+|++.++.++| +|++.+++++.+ ....+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeec----CCccE
Confidence 57889999999999999999975 58899999986543322 37889999999964 899999988776 55779
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcC-----CCcEEEEecCC
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGM 377 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~-----~~~vkl~DFGl 377 (460)
+||||+ +++|.++++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccce
Confidence 999999 78999998653 356999999999999999999999998 999999999999974 56799999999
Q ss_pred ccccccCCC--CCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 378 AKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 378 a~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
++....... ...........||+.|+|||.+.+..++.++||||||+++|||+||+.||......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 987754322 11223344568999999999999999999999999999999999999999865544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-39 Score=309.54 Aligned_cols=206 Identities=20% Similarity=0.293 Sum_probs=168.9
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~l 303 (460)
++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+..|+++++.++|+|++..++.+... ....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~---~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEE---TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEec---CCEEEE
Confidence 46889999999999999999874 5899999998765332 2378999999999888777666555442 446789
Q ss_pred EEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEc---CCCcEEEEecCCccc
Q 012599 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKR 380 (460)
Q Consensus 304 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~---~~~~vkl~DFGla~~ 380 (460)
||||+ +++|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.
T Consensus 81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999 66777776543 356999999999999999999999998 99999999999986 456799999999998
Q ss_pred cccCCCCC--CCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 381 LKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 381 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
........ .........||+.|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 76543221 12234456799999999999999999999999999999999999999976544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-39 Score=318.53 Aligned_cols=201 Identities=26% Similarity=0.357 Sum_probs=163.7
Q ss_pred CCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCccceeeeeeecc--CccceEE
Q 012599 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMRL 302 (460)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~~~~~ 302 (460)
+|+..++||+|+||+||+|++. +|+.||||+++..... +.+|+++|++++|+||+++++++.... ......+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 3666789999999999999986 5899999999754321 347999999999999999999986543 2334678
Q ss_pred EEEeecCCCCHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCccc
Q 012599 303 LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKR 380 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~ 380 (460)
+||||++++.+...... .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999976543333221 22356999999999999999999999998 99999999999999765 899999999987
Q ss_pred cccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... ......||..|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 173 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 173 LVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CCTTS------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ccCCc------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence 65432 2233568999999998765 578999999999999999999999997654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-39 Score=317.65 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=166.1
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccc
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~ 299 (460)
.++|++.+.||+|+||+||+|.+. +|+.||||+++..... ...+.+.+|+++|+.++|||||++++++..... ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999975 5999999999754322 234458899999999999999999999876432 233
Q ss_pred eEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCcc
Q 012599 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (460)
Q Consensus 300 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~ 379 (460)
..++||||+ +.+|..+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 569999999 6788887754 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCccccCCcccCcccccc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 170 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCc--------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 76432 234568999999998876 456999999999999999999999997653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=316.25 Aligned_cols=205 Identities=27% Similarity=0.359 Sum_probs=171.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc----CCcEEEEEEeccCC---CCChhHHHHHHHHHHHhcCC-CCccceeeeeeeccC
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRG 296 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vaVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~ 296 (460)
++|++.+.||+|+||+||+|... +|+.||||.++... .....+.+.+|++++++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 56889999999999999999862 47899999986432 12233457899999999966 899999999877
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecC
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFG 376 (460)
....+++|||+.+|+|.+++... ..+.......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 45789999999999999999764 45788999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCCCCCCCccccCCcccCccccccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 012599 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (460)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwSlGvll~elltG~~Pf~~~~~~ 442 (460)
+++....... .......|++.|+|||.+... .++.++|||||||+||||++|+.||......
T Consensus 175 ~a~~~~~~~~----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 175 LSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp EEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred chhhhccccc----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9987644321 122345689999999988654 4688999999999999999999999876543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=305.45 Aligned_cols=202 Identities=23% Similarity=0.329 Sum_probs=173.3
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCC-CChhHHHHHHHHHHHhcCCCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++++.||+|+||+||+|++. +++.||||+++.... ......+.+|+.+|+.++||||+++++++.+ ....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc----cccee
Confidence 57889999999999999999975 688999999975543 3445678999999999999999999999877 45679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~~~ 382 (460)
+|+|++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...
T Consensus 78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999988887643 56899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCcccCccccccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 383 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... ......++..|+|||.+.... ++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 206 (292)
T d1unla_ 153 IPVR-----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_dssp SCCS-----CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred CCCc-----cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC
Confidence 4432 223345678899999887654 6999999999999999999999986543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.8e-38 Score=309.14 Aligned_cols=197 Identities=20% Similarity=0.295 Sum_probs=168.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccCccceEE
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 302 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~~~~~ 302 (460)
++|++.+.||+|+||+||+|++. +|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++.... ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~--~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC--CCcee
Confidence 57999999999999999999984 5899999998743 3456889999999995 999999999887532 34679
Q ss_pred EEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCC-cEEEEecCCcccc
Q 012599 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 381 (460)
Q Consensus 303 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~-~vkl~DFGla~~~ 381 (460)
+||||+++++|.++. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999999998764 45899999999999999999999999 99999999999998654 6999999999876
Q ss_pred ccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 012599 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (460)
Q Consensus 382 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~~ 441 (460)
.... ......+|+.|+|||.+... .++.++||||+|+++|||++|+.||.....
T Consensus 181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 181 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred cCCC------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 5432 23345688999999998764 479999999999999999999999976543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=306.61 Aligned_cols=201 Identities=21% Similarity=0.272 Sum_probs=161.2
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC--ccce
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAM 300 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~--~~~~ 300 (460)
++|++++.||+|+||+||+|.+. +|+.||||+++..... .....+.+|+.++++++||||+++++++..... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67899999999999999999986 5999999999765332 233458899999999999999999999865322 3467
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.++||||+.+ ++.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 8999999965 5555553 34899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~ 439 (460)
..... ......+|+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus 169 ~~~~~------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 169 AGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccc------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 54432 233456899999999999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-38 Score=310.31 Aligned_cols=203 Identities=25% Similarity=0.356 Sum_probs=166.8
Q ss_pred hcCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCC-ChhHHHHHHHHHHHhcCCCCccceeeeeeeccC-ccce
Q 012599 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 300 (460)
Q Consensus 224 ~~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~~~ 300 (460)
.++|++.+.||+|+||+||+|.+. +|+.||||+++..... ...+.+.+|+++|++++|||++++++++..... ....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999875 6999999999754322 233458899999999999999999998865322 1233
Q ss_pred EEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 301 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+++++|+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 4666778889999999964 45999999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCcccCccccccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 381 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.... .....|++.|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~--------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 171 TDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp CTGG--------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCcc--------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 5432 2234688999999987664 56899999999999999999999997543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-33 Score=277.23 Aligned_cols=201 Identities=23% Similarity=0.255 Sum_probs=158.1
Q ss_pred cCCcccceeeeeCcEEEEEEEEc-CCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-----------CCCccceeeeee
Q 012599 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYCS 292 (460)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~ 292 (460)
++|++.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35888999999999999999985 68999999997532 23345788999888875 578999998876
Q ss_pred eccCccceEEEEEeecCCC-CHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCcCCCCEEEcCCC--
Q 012599 293 EFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENL-- 368 (460)
Q Consensus 293 ~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~-~~~~~ivH~DLk~~NIll~~~~-- 368 (460)
.... ...+++|++...+ +............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 91 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 91 HKGP--NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEET--TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred eccc--cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence 5332 2445566555444 34444444445668999999999999999999998 76 99999999999998654
Q ss_pred ----cEEEEecCCccccccCCCCCCCCCCCccccCCcccCccccccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 012599 369 ----NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (460)
Q Consensus 369 ----~vkl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwSlGvll~elltG~~Pf~~~~ 440 (460)
.++++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||....
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cccceeeEeecccccccccc--------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 3999999999765432 233568999999999999999999999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.2e-24 Score=193.92 Aligned_cols=165 Identities=15% Similarity=0.111 Sum_probs=118.9
Q ss_pred cccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCC-------------Ch----hHHHHHHHHHHHhcCCCCccceeee
Q 012599 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------NA----DSVFLTEVDMLSRLHHCHVVPLVGY 290 (460)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~-------------~~----~~~f~~Ei~~l~~l~H~nIv~l~g~ 290 (460)
.+.+.||+|+||+||+|.+.+|+.||||+++..... .. ...+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 346889999999999999989999999987632110 00 1124567888999999999988765
Q ss_pred eeeccCccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCcCCCCEEEcCCCcE
Q 012599 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (460)
Q Consensus 291 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~~~~ivH~DLk~~NIll~~~~~v 370 (460)
.. .+++|||+++..+.+ ++......++.|++.+|.|||+.+ |+||||||+|||++++ .+
T Consensus 83 ~~--------~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 EG--------NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp ET--------TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred cC--------CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 22 279999998765433 334445678999999999999998 9999999999999975 58
Q ss_pred EEEecCCccccccCCCCCCCCCCCccccCCcccCcc-----ccccCCCCchhHHHHHHHHH
Q 012599 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-----YAMVGRASLMSDVFSFGVVL 426 (460)
Q Consensus 371 kl~DFGla~~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~sDVwSlGvll 426 (460)
+|+|||+|....... ...|+... .+..+.|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~-------------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEG-------------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTT-------------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCC-------------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999997653221 01122110 01236678889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=1.3e-07 Score=86.79 Aligned_cols=150 Identities=15% Similarity=0.110 Sum_probs=99.7
Q ss_pred HHHHHHhcCCcccceeeeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcC-CCCccceeeeeeeccC
Q 012599 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 296 (460)
Q Consensus 218 ~~l~~~~~~f~~~~~LG~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 296 (460)
.++....++|...+..+.++.+.||+... +++.+++|+........ ...+.+|...+..+. +--+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--- 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERH--- 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEE---
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEec---
Confidence 35666667777665544455578999875 55667888876443222 123678888888774 4345677766554
Q ss_pred ccceEEEEEeecCCCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 012599 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------- 348 (460)
Q Consensus 297 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH~~~---------------------------- 348 (460)
+...++||+++++.++.+.... ... ...++.++++.+..||+..
T Consensus 82 -~~~~~lv~~~l~G~~~~~~~~~----~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 82 -DGWSNLLMSEADGVLCSEEYED----EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp -TTEEEEEEECCSSEEHHHHTTT----CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred -CCceEEEEEecccccccccccc----ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 3466999999999888665421 111 2334556666666676432
Q ss_pred ----------------------------CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 ----------------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 ----------------------------~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=6.9e-07 Score=81.23 Aligned_cols=130 Identities=18% Similarity=0.129 Sum_probs=82.8
Q ss_pred eeeeCc-EEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCC--CccceeeeeeeccCccceEEEEEeecC
Q 012599 233 VGQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (460)
Q Consensus 233 LG~G~f-G~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~~~~~~~~~~lV~e~~~ 309 (460)
+..|.. +.||+....++..+++|........ .+..|...++.+... .+.+++++..+ +...++||+|++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~----~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeeccc----ccceEEEEEeee
Confidence 444443 6899999888888999987654322 367888888877433 34566766554 345689999998
Q ss_pred CCCHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 012599 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-------------------------------------------- 345 (460)
Q Consensus 310 ~gsL~~~l~~~~~~~l~~~~~~~i~~qia~~l~yLH-------------------------------------------- 345 (460)
+.++.+.. ... ..++.++++.|.-||
T Consensus 90 G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 86653310 111 111222333333333
Q ss_pred -------hCC----CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 346 -------EAA----APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 346 -------~~~----~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
... .+.++|+|+.+.|||++++..+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 23489999999999999876678999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.78 E-value=3.1e-05 Score=75.12 Aligned_cols=76 Identities=20% Similarity=0.172 Sum_probs=47.8
Q ss_pred ceeeeeCcEEEEEEEEcC-CcEEEEEEecc------CCCCChhHHHHHHHHHHHhcC-C--CCccceeeeeeeccCccce
Q 012599 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKT------QGGPNADSVFLTEVDMLSRLH-H--CHVVPLVGYCSEFRGKRAM 300 (460)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vaVK~l~~------~~~~~~~~~f~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~~~ 300 (460)
+.||.|....||+....+ ++.++||.-.. ...+....+...|.+.|+.+. + ..+.+++.+.. ..
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~------~~ 105 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------EM 105 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET------TT
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC------CC
Confidence 468989999999998765 67899997532 112222333566888887763 2 34556665432 23
Q ss_pred EEEEEeecCCCC
Q 012599 301 RLLVFEFMPNGN 312 (460)
Q Consensus 301 ~~lV~e~~~~gs 312 (460)
.++|||++++..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEeccCCcc
Confidence 489999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00054 Score=64.12 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=78.3
Q ss_pred eCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc--cceeeee-eeccCccceEEEEEeecCCCC
Q 012599 236 GGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPLVGYC-SEFRGKRAMRLLVFEFMPNGN 312 (460)
Q Consensus 236 G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~-~~~~~~~~~~~lV~e~~~~gs 312 (460)
+..-.||++...+|+.+++|..+.... ..+.+..|...+..|....+ +..+..- ..........+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 334789999999999999999875432 33457889998888753322 1111110 000012345688999997643
Q ss_pred H-----HHH------h-------cccc---CCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CC
Q 012599 313 L-----RDC------L-------DGVL---VEGMNWDT-------------------RVAIAIGAARGLEYLHE----AA 348 (460)
Q Consensus 313 L-----~~~------l-------~~~~---~~~l~~~~-------------------~~~i~~qia~~l~yLH~----~~ 348 (460)
+ ..+ + .... ....++.. ...+...+.+.++.+.. ..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 2 111 1 1000 01122111 11122222333333332 22
Q ss_pred CCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 349 APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 349 ~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
...++|+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3458999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.17 E-value=0.001 Score=64.00 Aligned_cols=73 Identities=19% Similarity=0.264 Sum_probs=49.1
Q ss_pred cceeeeeCcEEEEEEEEcCC--------cEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc-cceeeeeeeccCccce
Q 012599 230 SNIVGQGGSSYVYRGQLTDG--------RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAM 300 (460)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g--------~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~~~ 300 (460)
.+.|+.|-.-.+|+....++ +.|++++.- .. . ......+|..+++.+.-.++ .++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-------
Confidence 35677799999999987643 456666654 22 2 23345689999988853344 477777643
Q ss_pred EEEEEeecCCCCH
Q 012599 301 RLLVFEFMPNGNL 313 (460)
Q Consensus 301 ~~lV~e~~~~gsL 313 (460)
.+|+||+++..|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999986543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.69 E-value=0.022 Score=52.06 Aligned_cols=160 Identities=11% Similarity=0.086 Sum_probs=82.3
Q ss_pred echHHHHHHhcCCccccee-----eeeCcEEEEEEEEcCCcEEEEEEeccCCCCChhHHHHHHHHHHHhcCCCCc--cce
Q 012599 215 FSYSALEHATDKFSGSNIV-----GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPL 287 (460)
Q Consensus 215 ~~~~~l~~~~~~f~~~~~L-----G~G~fG~Vy~~~~~~g~~vaVK~l~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l 287 (460)
.+.++++....+|.+.++. ..|---+.|+.+..+|+ +++|+........ +...|++++..|...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 4557888888888775444 35666889999887765 8899886543332 24456667776642222 111
Q ss_pred e----eeeeeccCccceEEEEEeecCCCCHHH-----------Hh---c----ccc---CCCCCHH--------------
Q 012599 288 V----GYCSEFRGKRAMRLLVFEFMPNGNLRD-----------CL---D----GVL---VEGMNWD-------------- 328 (460)
Q Consensus 288 ~----g~~~~~~~~~~~~~lV~e~~~~gsL~~-----------~l---~----~~~---~~~l~~~-------------- 328 (460)
+ |.... ........++.+..+..... .+ + ... .......
T Consensus 79 i~~~~g~~~~--~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 79 LPRKDGELLG--ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CCBTTCCSCE--EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ceecCCCcce--eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 1 11000 01223456677776543210 00 0 000 0000000
Q ss_pred ----HHHHHHHHHHHHHHHHHhC-CCCCeEecCcCCCCEEEcCCCcEEEEecCCccc
Q 012599 329 ----TRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (460)
Q Consensus 329 ----~~~~i~~qia~~l~yLH~~-~~~~ivH~DLk~~NIll~~~~~vkl~DFGla~~ 380 (460)
.....+..+...+.-.+.. -..++||+|+.++||+++.+...-|+||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111222222222222211 123599999999999999887778999998763
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.49 E-value=0.012 Score=36.29 Aligned_cols=26 Identities=15% Similarity=0.451 Sum_probs=19.8
Q ss_pred HhhhhhccccccccCcccceEEeccCCCCCc
Q 012599 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (460)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (460)
+..++.|.+ ...+|+|+|..||.||-
T Consensus 9 C~~~A~C~N-----t~Gsy~C~C~~Gy~GdG 34 (40)
T d1gl4a2 9 CSVHAECRD-----YATGFCCRCVANYTGNG 34 (40)
T ss_dssp SCTTEEEEE-----CSSCEEEEECTTEEECS
T ss_pred CCCCCEeec-----CCCCeEeECCCCCcCCC
Confidence 345666765 34689999999999986
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.08 E-value=0.2 Score=31.84 Aligned_cols=16 Identities=31% Similarity=0.852 Sum_probs=12.9
Q ss_pred CcccceEEeccCCCCC
Q 012599 31 GQKNWKCTCSSSLQGD 46 (460)
Q Consensus 31 ~~~~~~~~~~~~~~~~ 46 (460)
..++|+|.|..||.|.
T Consensus 24 ~~~~y~C~C~~G~~G~ 39 (48)
T d1autl1 24 GIGSFSCDCRSGWEGR 39 (48)
T ss_dssp CSSCCCEEECTTEEST
T ss_pred CCCCCeEeCCCCCcCC
Confidence 4578999999998873
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.37 E-value=0.11 Score=32.41 Aligned_cols=23 Identities=17% Similarity=0.595 Sum_probs=17.8
Q ss_pred hhhccccccccCcccceEEeccCCCCCc
Q 012599 20 RSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (460)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (460)
++.|.+ -..+|+|.|..||+++.
T Consensus 15 ~~~C~N-----t~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 15 RGQCVN-----TPGDFECKCDEGYESGF 37 (44)
T ss_dssp TSCEEE-----ETTEEEECCCSSEEECT
T ss_pred CCEeEc-----CCCCeEEeCCCCCccCC
Confidence 456765 45699999999998874
|